Document:

EX-4.6

 Exhibit 4.6 
 SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”) dated as of June 13, 2014 among DaVita HealthCare Partners Inc., a Delaware corporation (the
“Company”), each of the entities listed on the signature pages hereto under the caption “Current Subsidiary Guarantors” (each, a “Current Guarantor” and, collectively, the “Current
Guarantors”), each of the entities listed on the signature pages hereof under the caption “Additional Guarantors” (each, an “Additional Guarantor” and, collectively, the “Additional Guarantors”),
and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). 
 RECITALS 

WHEREAS, the Company, the Guarantors (as defined in the Indenture referred to below) party thereto and the Trustee have entered into an
Indenture dated as of August 28, 2012 (the “Indenture”) relating to the Company’s 5.750% Senior Notes due 2022, as amended by the First Supplemental Indenture thereto, dated as of November 1, 2012 (the “First
Supplemental Indenture”); 
 WHEREAS, on the date hereof, the Company, the Current Guarantors, the Additional
Guarantors and the Trustee are entering into an Indenture (the “2024 Indenture”) relating to the Company’s 5.125% Senior Notes due 2024; 
 WHEREAS, in accordance with Section 4.19 of the Indenture and the other terms thereof, each of the Additional Guarantors is to become a Subsidiary Guarantor (as defined in the Indenture) under the
Indenture; 
 WHEREAS, all acts and requirements necessary to make this Second Supplemental Indenture the legal, valid and
binding obligation of the Company, the Current Guarantors and the Additional Guarantors have been done. 
 NOW, THEREFORE, in
consideration of the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Second Supplemental Indenture hereby agree as follows: 

Section 1. The terms “Second Supplemental Indenture,” “Current Guarantors,” “Additional Guarantors,”
“Additional Guarantor” and “Indenture” have the respective meanings set forth in the first paragraph and recitals above. Other capitalized terms used herein have the respective meanings ascribed thereto in the Indenture.

 Section 2. Each Additional Guarantor hereby agrees, jointly and severally with all other Guarantors, and fully and
unconditionally, to be a Subsidiary Guarantor under the Indenture and to Guarantee, on a joint and several basis with the other Guarantors, the full and prompt payment of the principal of, premium, if any, and interest on the Notes and all other
obligations of the Company under the Indenture on a senior basis, in each case on the terms and subject to the conditions set forth in Article Eleven of the Indenture, and to be bound by (and shall be entitled to the benefits of) all other
applicable provisions of the Indenture as a Subsidiary Guarantor. 
 Section 3. This Second Supplemental Indenture is an
amendment supplemental to the Indenture, and the First Supplemental Indenture, and the Indenture, the First Supplemental Indenture and this Second Supplemental Indenture will henceforth be read together. 

Section 4. This Second Supplemental Indenture shall become effective concurrently with the effectiveness of the 2024 Indenture.

 Section 5. This Second Supplemental Indenture will be governed by and construed in accordance with the laws of the
State of New York, as applied to contracts made and performed within the State of New York, without regard to principles of conflicts of law. 

 Section 6. This Second Supplemental Indenture may be signed in various counterparts
which together will constitute one and the same instrument. 
 Section 7. The recitals and statements herein are deemed to
be those of the Company, the Current Guarantors and the Additional Guarantors and not of the Trustee. The Trustee makes no representations as to the validity or sufficiency of this Second Supplemental Indenture. 

[Signature pages follow] 

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly executed as of the date first written above. 
  

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	Chetan P. Mehta
	Title:	 	Group Vice President, Finance

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly exe- cuted as of the date first written above. 
  

	
	 CURRENT GUARANTORS:

	
	 ALAMOSA DIALYSIS, LLC

	 CARROLL COUNTY DIALYSIS FACILITY, INC.

	 CONTINENTAL DIALYSIS CENTER OF SPRINGFIELD-FAIRFAX, INC.

	 CONTINENTAL DIALYSIS CENTER, INC.

	 DAVITA – WEST, LLC

	 DAVITA OF NEW YORK, INC.

	 DAVITA RX, LLC

	 DIALYSIS HOLDINGS, INC.

	 DIALYSIS SPECIALISTS OF DALLAS, INC.

	 DNH MEDICAL MANAGEMENT, INC. (DBA THE CAMDEN GROUP)

	 DNP MANAGEMENT COMPANY, LLC

	 DOWNRIVER CENTERS, INC.

	 DVA HEALTHCARE OF MARYLAND, INC.

	 DVA HEALTHCARE OF MASSACHUSETTS, INC.

	 DVA HEALTHCARE OF PENNSYLVANIA, INC.

	 DVA HEALTHCARE PROCUREMENT SERVICES, INC.

	 DVA HEALTHCARE RENAL CARE, INC.

	 DVA LABORATORY SERVICES, INC.

	 DVA OF NEW YORK, INC.

	 DVA RENAL HEALTHCARE, INC.

	 EAST END DIALYSIS CENTER, INC.

	 ELBERTON DIALYSIS FACILITY, INC.

	 FLAMINGO PARK KIDNEY CENTER, INC.

	 FORT DIALYSIS, LLC

	 FREEHOLD ARTIFICIAL KIDNEY CENTER, L.L.C.

	 GREENSPOINT DIALYSIS, LLC

	 HEALTHCARE PARTNERS ASC-LB, LLC

	 HEALTHCARE PARTNERS HOLDINGS, LLC

	 HEALTHCARE PARTNERS NEVADA, LLC

	 HEALTHCARE PARTNERS SOUTH FLORIDA, LLC

	 HEALTHCARE PARTNERS, LLC

	 HILLS DIALYSIS, LLC

	 HOUSTON KIDNEY CENTER/TOTAL RENAL CARE INTEGRATED SERVICE NETWORK LIMITED PARTNERSHIP

	 JSA CARE PARTNERS, LLC

	 JSA HEALTHCARE CORPORATION

	 JSA HEALTHCARE NEVADA, L.L.C.

	 JSA HOLDINGS, INC.

	 JSA P5 NEVADA, L.L.C.

	 KIDNEY CARE SERVICES, LLC

	 KNICKERBOCKER DIALYSIS, INC.

	 LIBERTY RC, INC.

	 LINCOLN PARK DIALYSIS SERVICES, INC.

	 MAPLE GROVE DIALYSIS, LLC

	 MASON-DIXON DIALYSIS FACILITIES, INC.

	 NEPHROLOGY MEDICAL ASSOCIATES OF GEORGIA, LLC

	 NEPTUNE ARTIFICIAL KIDNEY CENTER, L.L.C.

	 NORTH ATLANTA DIALYSIS CENTER, LLC

 
	
	 NORTH COLORADO SPRINGS DIALYSIS, LLC

	 NORTHRIDGE MEDICAL SERVICES GROUP, INC.

	 PALO DIALYSIS, LLC

	 PATIENT PATHWAYS, LLC

	 PHYSICIANS CHOICE DIALYSIS OF ALABAMA, LLC

	 PHYSICIANS CHOICE DIALYSIS, LLC

	 PHYSICIANS DIALYSIS ACQUISITIONS, INC.

	 PHYSICIANS DIALYSIS VENTURES, INC.

	 PHYSICIANS DIALYSIS, INC.

	 PHYSICIANS MANAGEMENT, LLC

	 RENAL LIFE LINK, INC.

	 RENAL TREATMENT CENTERS—CALIFORNIA, INC.

	 RENAL TREATMENT CENTERS—HAWAII, INC.

	 RENAL TREATMENT CENTERS—ILLINOIS, INC.

	 RENAL TREATMENT CENTERS—MID-ATLANTIC, INC.

	 RENAL TREATMENT CENTERS—NORTHEAST, INC.

	 RENAL TREATMENT CENTERS—SOUTHEAST, LP

	 RENAL TREATMENT CENTERS—WEST, INC.

	 RENAL TREATMENT CENTERS, INC

	 RMS LIFELINE, INC.

	 ROCKY MOUNTAIN DIALYSIS SERVICES, LLC

	 SHINING STAR DIALYSIS, INC.

	 SIERRA ROSE DIALYSIS CENTER, LLC

	 SOUTHWEST ATLANTA DIALYSIS CENTERS, LLC

	 THE DAVITA COLLECTION, INC.

	 THP SERVICES, INC.

	 TOTAL ACUTE KIDNEY CARE, INC.

	 TOTAL RENAL CARE TEXAS LIMITED PARTNERSHIP

	 TOTAL RENAL CARE, INC.

	 TOTAL RENAL LABORATORIES, INC.

	 TOTAL RENAL RESEARCH, INC.

	 TRC—INDIANA, LLC

	 TRC OF NEW YORK, INC.

	 TRC WEST, INC.

	 TREE CITY DIALYSIS, LLC

	 VILLAGEHEALTH DM, LLC

  

			
	By:	 	  

	Name:	 	Chetan P. Mehta
	Title:	 	Group Vice President

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly executed as of the date first written above. 
  

			
	ADDITIONAL GUARANTORS:
	
	ABQ HEALTH PARTNERS, LLC
	ARIZONA INTEGRATED PHYSICIANS, INC.
	HEALTHCARE PARTNERS ARIZONA, LLC
	MEDICAL GROUP HOLDING COMPANY, LLC
	LAS VEGAS SOLARI HOSPICE CARE, LLC
		
	By:	 	  

	Name:	 	Chetan P. Mehta
	Title:	 	Group Vice President

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly executed as of the date first written above. 
  

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	  

	Name:	 	
	Title:	 	

 Signature Page to Second Supplemental IndentureEX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
  

 
  

CREDIT AGREEMENT 
 Dated as of
June 24, 2014 
 among 

DaVita HealthCare Partners Inc., 

as Borrower, 
 The Guarantors Party
Hereto, 
 The Lenders Party Hereto, 

and 
 JPMorgan Chase Bank, N.A.,

 as Administrative Agent and Collateral Agent 

Barclays Bank PLC, and 
 Wells
Fargo Bank, National Association 
 as 

Co-Syndication Agents 
 Bank of
America, N.A., 
 Credit Suisse AG, 

Goldman Sachs Bank USA 
 JPMorgan
Chase Bank, N.A., 
 Morgan Stanley Senior Funding, Inc., and 

SunTrust Bank, 
 as 

Co-Documentation Agents 
  

 
 Barclays Bank
PLC, 
 Wells Fargo Securities, LLC, 

Credit Suisse Securities (USA) LLC, 

Goldman Sachs Bank USA, 
 J.P.
Morgan Securities, LLC 
 Bank of America, N.A., 

Morgan Stanley Senior Funding, Inc., and 

SunTrust Robinson Humphrey, Inc. 

as 
 Joint Lead Arrangers and Joint
Bookrunners 
 The Bank of Nova Scotia, 

Credit Agricole Securities (USA) Inc. 

The Bank of Tokyo-Mitsubishi UFJ, Ltd., and 

Sumitomo Mitsui Banking Corporation, 

as 
 Senior Managing Agents 

HSBC Securities (USA) Inc., 
 Fifth
Third Bank, and 
 Compass Bank 

as 
 Managing Agents 

 
  

 

 TABLE OF CONTENTS 

 

									
	 	 	 	  	 	  	Page	 
		
	 SECTION 1 DEFINITIONS
	  	 	1	  
				
		 	 1.1
	  	Defined Terms	  	 	1	  
		 	 1.2
	  	Classification of Loans	  	 	47	  
		 	 1.3
	  	Terms Generally	  	 	47	  
		 	 1.4
	  	Accounting Terms; GAAP	  	 	48	  
		 	 1.5
	  	Resolution of Drafting Ambiguities	  	 	48	  
		 	 1.6
	  	Exchange Rates; Currency Equivalents	  	 	48	  
		 	 1.7
	  	Additional Alternative Currencies	  	 	49	  
		 	 1.8
	  	Change of Currency	  	 	50	  
		
	 SECTION 2 AMOUNT AND TERMS OF COMMITMENTS
	  	 	50	  
				
		 	 2.1
	  	Term Commitments	  	 	50	  
		 	 2.2
	  	Procedure for Term Loan Borrowing	  	 	51	  
		 	 2.3
	  	Repayment of Term Loans	  	 	51	  
		 	 2.4
	  	Revolving Commitments	  	 	52	  
		 	 2.5
	  	Procedure for Revolving Loan Borrowing	  	 	52	  
		 	 2.6
	  	Swingline Commitment	  	 	53	  
		 	 2.7
	  	Procedure for Swingline Borrowing; Refunding of Swingline Loans	  	 	53	  
		 	 2.8
	  	Commitment Fees, etc	  	 	55	  
		 	 2.9
	  	Termination or Reduction of Revolving Commitments	  	 	56	  
		 	 2.10
	  	Optional Prepayments	  	 	56	  
		 	 2.11
	  	Mandatory Prepayments and Commitment Reductions	  	 	56	  
		 	 2.12
	  	Conversion and Continuation Options	  	 	59	  
		 	 2.13
	  	Limitations on Eurodollar Tranches	  	 	59	  
		 	 2.14
	  	Interest Rates and Payment Dates	  	 	60	  
		 	 2.15
	  	Computation of Interest and Fees	  	 	60	  
		 	 2.16
	  	Inability to Determine Interest Rate	  	 	61	  
		 	 2.17
	  	Pro Rata Treatment and Payments	  	 	61	  
		 	 2.18
	  	Requirements of Law	  	 	63	  
		 	 2.19
	  	Taxes	  	 	65	  
		 	 2.20
	  	Indemnity	  	 	67	  
		 	 2.21
	  	Change of Lending Office	  	 	67	  
		 	 2.22
	  	Replacement of Lenders	  	 	67	  
		 	 2.23
	  	Repayment of Loans; Evidence of Debt	  	 	68	  
		 	 2.24
	  	Increase in Commitments	  	 	68	  
		 	 2.25
	  	Extensions of Term Loans and Revolving Commitments	  	 	71	  
		 	 2.26
	  	Defaulting Lenders	  	 	73	  
		 	 2.27
	  	Refinancing Amendments	  	 	75	  
		
	 SECTION 3 LETTERS OF CREDIT
	  	 	76	  
				
		 	 3.1
	  	LC Commitment	  	 	76	  
		 	 3.2
	  	Notice of Issuance, Amendment, Renewal, Extension; Certain Conditions	  	 	77	  
		 	 3.3
	  	Fees and Other Charges	  	 	77	  

  
 -i- 

									
	 	 	 	  	 	  	Page	 
				
		 	 3.4
	  	Participations	  	 	77	  
		 	 3.5
	  	Reimbursement	  	 	78	  
		 	 3.6
	  	Obligations Absolute	  	 	79	  
		 	 3.7
	  	Disbursement Procedures	  	 	79	  
		 	 3.8
	  	Interim Interest	  	 	79	  
		 	 3.9
	  	Replacement of the Issuing Lender	  	 	80	  
		 	 3.10
	  	Cash Collateralization	  	 	80	  
		 	 3.11
	  	Provisions Related to Extended Revolving Commitments	  	 	81	  
		
	 SECTION 4 REPRESENTATIONS AND WARRANTIES
	  	 	81	  
				
		 	 4.1
	  	Organization; Power	  	 	81	  
		 	 4.2
	  	Capital Stock; Subsidiaries	  	 	81	  
		 	 4.3
	  	Authorization; No Conflicts	  	 	81	  
		 	 4.4
	  	No Approvals	  	 	82	  
		 	 4.5
	  	Enforceability	  	 	82	  
		 	 4.6
	  	Litigation	  	 	82	  
		 	 4.7
	  	Financial Statements; Projections	  	 	82	  
		 	 4.8
	  	Properties	  	 	83	  
		 	 4.9
	  	Intellectual Property	  	 	84	  
		 	 4.10
	  	No Material Misstatements	  	 	84	  
		 	 4.11
	  	Margin Stock	  	 	84	  
		 	 4.12
	  	Investment Company Act	  	 	84	  
		 	 4.13
	  	Solvency	  	 	84	  
		 	 4.14
	  	Employee Benefit Plans	  	 	84	  
		 	 4.15
	  	Environmental Laws	  	 	85	  
		 	 4.16
	  	Taxes	  	 	86	  
		 	 4.17
	  	 Government Reimbursement Programs; Medicare/Medicaid/Tricare; Commercial Reimbursement Programs; Corporate Practice of
Medicine
	  	 	86	  
		 	 4.18
	  	Agreements	  	 	89	  
		 	 4.19
	  	Use of Proceeds	  	 	89	  
		 	 4.20
	  	Labor Matters	  	 	89	  
		 	 4.21
	  	Insurance	  	 	89	  
		 	 4.22
	  	Security Documents	  	 	89	  
		 	 4.23
	  	Anti-Terrorism Law	  	 	90	  
		
	 SECTION 5 CONDITIONS PRECEDENT
	  	 	91	  
				
		 	 5.1
	  	Conditions to Initial Credit Extension	  	 	91	  
		 	 5.2
	  	Conditions to All Credit Extensions	  	 	93	  
		
	 SECTION 6 AFFIRMATIVE COVENANTS
	  	 	94	  
				
		 	 6.1
	  	Reporting Requirements	  	 	94	  
		 	 6.2
	  	Compliance with Laws, Etc.	  	 	97	  
		 	 6.3
	  	Payment of Taxes, Etc.	  	 	97	  
		 	 6.4
	  	Compliance with Environmental Laws	  	 	97	  
		 	 6.5
	  	Insurance	  	 	97	  
		 	 6.6
	  	Preservation of Corporate Existence, Etc.	  	 	98	  
		 	 6.7
	  	Visitation Rights	  	 	98	  
		 	 6.8
	  	Keeping of Books	  	 	99	  

  
 -ii- 

									
	 	 	 	  	 	  	Page	 
				
		 	 6.9
	  	Maintenance of Properties, Etc	  	 	99	  
		 	 6.10
	  	Transactions with Affiliates	  	 	99	  
		 	 6.11
	  	Use of Proceeds	  	 	99	  
		 	 6.12
	  	Additional Collateral; Additional Guarantors	  	 	99	  
		 	 6.13
	  	Security Interests; Further Assurances	  	 	100	  
		 	 6.14
	  	Information Regarding Collateral	  	 	101	  
		 	 6.15
	  	Ratings	  	 	101	  
		 	 6.16
	  	Management Services Agreements	  	 	101	  
		 	 6.17
	  	Post-Closing Actions	  	 	102	  
		
	 SECTION 7 NEGATIVE COVENANTS
	  	 	102	  
				
		 	 7.1
	  	Liens, Etc.	  	 	102	  
		 	 7.2
	  	Debt	  	 	104	  
		 	 7.3
	  	Change in Nature of Business	  	 	106	  
		 	 7.4
	  	Mergers, Etc.	  	 	107	  
		 	 7.5
	  	Sales, Etc., of Assets	  	 	107	  
		 	 7.6
	  	Investments in Other Persons	  	 	110	  
		 	 7.7
	  	Restricted Payments	  	 	113	  
		 	 7.8
	  	Accounting Changes	  	 	114	  
		 	 7.9
	  	 Prepayments of Other Debt; Modifications of Constitutive Documents and Other Documents, etc
	  	 	114	  
		 	 7.10
	  	Negative Pledge	  	 	115	  
		 	 7.11
	  	Payment Restrictions Affecting Subsidiaries	  	 	115	  
		 	 7.12
	  	Non-Guarantor Domestic Subsidiaries	  	 	116	  
		 	 7.13
	  	Issuance of Additional Stock	  	 	116	  
		 	 7.14
	  	Anti-Terrorism Law; Anti-Money Laundering	  	 	117	  
		 	 7.15
	  	Embargoed Person	  	 	117	  
		 	 7.16
	  	Financial Covenant	  	 	117	  
		
	 SECTION 8 EVENTS OF DEFAULT
	  	 	118	  
				
		 	 8.1
	  	Events of Default	  	 	118	  
		 	 8.2
	  	Application of Proceeds	  	 	120	  
		
	 SECTION 9 THE AGENTS
	  	 	121	  
				
		 	 9.1
	  	Appointment and Authority	  	 	121	  
		 	 9.2
	  	Rights as a Lender	  	 	122	  
		 	 9.3
	  	Exculpatory Provisions	  	 	122	  
		 	 9.4
	  	Reliance by Agent	  	 	123	  
		 	 9.5
	  	Delegation of Duties	  	 	123	  
		 	 9.6
	  	Resignation of Agent	  	 	123	  
		 	 9.7
	  	Non-Reliance on Agent and Other Lenders	  	 	124	  
		 	 9.8
	  	No Other Duties, etc	  	 	124	  
		
	 SECTION 10 GUARANTEE
	  	 	124	  
				
		 	 10.1
	  	The Guarantee	  	 	124	  
		 	 10.2
	  	Obligations Unconditional	  	 	125	  
		 	 10.3
	  	Reinstatement	  	 	126	  

  
 -iii- 

									
	 	 	 	  	 	  	Page	 
				
		 	 10.4
	  	Subrogation; Subordination	  	 	126	  
		 	 10.5
	  	Remedies	  	 	126	  
		 	 10.6
	  	Instrument for the Payment of Money	  	 	126	  
		 	 10.7
	  	Continuing Guarantee	  	 	126	  
		 	 10.8
	  	General Limitation on Guaranteed Obligations	  	 	126	  
		 	 10.9
	  	Release of Guarantors	  	 	127	  
		 	 10.10
	  	Keepwell	  	 	127	  
		
	 SECTION 11 MISCELLANEOUS
	  	 	127	  
				
		 	 11.1
	  	Amendments and Waivers	  	 	127	  
		 	 11.2
	  	Notices	  	 	130	  
		 	 11.3
	  	No Waiver; Cumulative Remedies	  	 	132	  
		 	 11.4
	  	Survival	  	 	132	  
		 	 11.5
	  	Expenses; Indemnity; Damage Waiver	  	 	132	  
		 	 11.6
	  	Successors and Assigns; Participations and Assignments	  	 	134	  
		 	 11.7
	  	Adjustments; Set-off	  	 	137	  
		 	 11.8
	  	Counterparts; Integration; Effectiveness	  	 	137	  
		 	 11.9
	  	Severability	  	 	138	  
		 	 11.10
	  	WAIVER OF JURY TRIAL	  	 	138	  
		 	 11.11
	  	GOVERNING LAW	  	 	138	  
		 	 11.12
	  	Submission to Jurisdiction; Waivers	  	 	138	  
		 	 11.13
	  	Acknowledgments	  	 	139	  
		 	 11.14
	  	Releases of Guarantees and Liens	  	 	139	  
		 	 11.15
	  	Confidentiality	  	 	140	  
		 	 11.16
	  	Headings	  	 	140	  
		 	 11.17
	  	USA PATRIOT Act	  	 	140	  
		 	 11.18
	  	Interest Rate Limitation	  	 	140	  
		 	 11.19
	  	Third Party Beneficiary	  	 	141	  

  
 -iv- 

			
	SCHEDULES:
		
	I	    	Commitments
	II	    	Specified LC Sublimits
	1.1	    	Existing Letters of Credit
	4.2	    	Subsidiaries
	4.4	    	Consents, Authorizations, Filings and Notices
	4.8	    	Real Property
	7.1(c)	    	Existing Liens
	7.2(b)	    	Existing Debt
	7.6	    	Investments
	
	EXHIBITS:
		
	A	    	[Reserved]
	B	    	Form of Compliance Certificate
	C	    	Form of Solvency Certificate
	D	    	[Reserved]
	E	    	Form of Assignment and Assumption
	F	    	[Reserved]
	G	    	Form of Prepayment Option Notice
	H	    	Form of Borrowing Request
	I	    	[Reserved]
	J	    	Form of Exemption Certificate
	K	    	[Reserved]
	L	    	Form of Joinder Agreement
	M	    	Form of Intercompany Note
	N-1	    	Form of Revolving Loan Note
	N-2	    	Form of Tranche A Term Loan Note
	N-3	    	Form of Tranche B Term Loan Note
	N-4	    	Form of Swingline Note
	O	    	Form of LC Request
	P	    	Form of Interest Election Request
	Q	    	Form of First Lien Intercreditor Agreement

  
 -v- 

 This CREDIT AGREEMENT, dated as of June 24, 2014 (as may be amended, restated, supplemented
or otherwise modified from time to time, this “Agreement”), among DaVita HealthCare Partners Inc., a Delaware corporation (the “Borrower”), the Guarantors (as defined in Section 1.1) party hereto, the
several banks and other financial institutions or entities from time to time lenders under this Agreement (the “Lenders”), Bank of America, N.A., Credit Suisse AG, Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., Morgan Stanley
Senior Funding, Inc. and SunTrust Bank, as co-documentation agents (in such capacity, the “Documentation Agents”), Barclays Bank PLC and Wells Fargo Bank, National Association, as co-syndication agents (in such capacity, the
“Syndication Agents”), and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent. 
 WITNESSETH:

 WHEREAS, the Borrower, the guarantors party thereto, the lenders party thereto from time to time and JPMorgan Chase Bank, N.A., as
administrative agent and collateral agent, are party to that certain credit agreement, dated as of October 10, 2010, (as amended, the “Existing Credit Agreement”); 

WHEREAS, the Borrower has made a tender offer (the “Tender Offer”) for any and all of its outstanding 6.375% senior notes due
2018 (the “Existing Notes”); 
 WHEREAS, in connection with the Transactions, the Borrower has issued $1,750,000,000
aggregate principal amount of 5.125% Senior Notes due 2024 (the “New Senior Notes”) pursuant to the New Senior Notes Indenture; 

WHEREAS, in connection with the consummation of the Transactions, the Borrower has requested the Lenders to extend credit in the form of
(a) Tranche A Term Loans on the Closing Date, in an aggregate principal amount of $1,000,000,000, (b) Tranche B Term Loans on the Closing Date in an aggregate principal amount of $3,500,000,000, (c) Dollar Revolving Commitments in an
aggregate principal amount of $700,000,000 and (d) Alternative Currency Revolving Commitments in an aggregate principal amount of $300,000,000; and 

WHEREAS, the proceeds of the Loans are to be used in accordance with Section 4.19; 

NOW, THEREFORE, the Lenders are willing to extend such credit to Borrower and the Issuing Lender is willing to issue letters of credit for the
account of Borrower on the terms and subject to the conditions set forth herein. Accordingly, the parties hereto agree as follows: 
 SECTION
1 
 DEFINITIONS 
 1.1
Defined Terms. As used in this Agreement, the terms listed in this Section 1.1 shall have the respective meanings set forth in this Section 1.1. 

“2020 Notes” shall mean the 6.625% Senior Notes due 2020 in an aggregate principal amount of $775,000,000 outstanding as of
the Closing Date issued pursuant to the 2020 Senior Notes Indenture. 
 “2020 Senior Notes Documents” shall mean the 2020
Notes, the 2020 Senior Notes Indenture and the 2020 Senior Notes Guarantees. 

 “2020 Senior Notes Guarantees” shall mean the guarantees by the Guarantors of
the 2020 Notes pursuant to the 2020 Senior Notes Indenture. 
 “2020 Senior Notes Indenture” shall mean the indenture dated
as of October 20, 2010, as amended by the First Supplemental Indenture dated as of November 1, 2012, each by and among the Borrower, the Guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as trustee, pursuant to
which the 2020 Notes were issued, as the same may be further amended or supplemented from time to time. 
 “2022 Notes”
shall mean the 5.750% Senior Notes due 2022 in an aggregate principal amount of $1,250,000,000 outstanding as of the Closing Date issued pursuant to the 2022 Senior Notes Indenture. 

“2022 Senior Notes Documents” shall mean the 2022 Notes, the 2022 Senior Notes Indenture and the 2022 Senior Notes
Guarantees. 
 “2022 Senior Notes Guarantees” shall mean the guarantees by the Guarantors of the 2022 Notes pursuant to the
2022 Senior Notes Indenture. 
 “2022 Senior Notes Indenture” shall mean the indenture dated as of August 28, 2012, as
amended by the First Supplemental Indenture dated as of November 1, 2012, each by and among the Borrower, the Guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as trustee, pursuant to which the 2022 Notes were
issued, as the same may be further amended or supplemented from time to time. 
 “ABR” shall mean, for any day, a rate per
annum (rounded upwards, if necessary, to the next 1/100 of 1%) equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus
 1⁄2 of 1% and (c) the Eurodollar Base Rate applicable on such day (or, if such date is not a Business Day, the immediately preceding Business Day) if a
Eurodollar Loan with an Interest Period of one month were being made on such day plus 1%. For purposes hereof: “Prime Rate” shall mean the rate of interest per annum publicly announced from time to time by the Person serving
as Administrative Agent as its prime rate in effect at its principal office in New York City (the Prime Rate not being intended to be the lowest rate of interest charged by the Person serving as Administrative Agent in connection with extensions of
credit to debtors). Any change in the ABR due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective as of the opening of business on the effective day of such change in the Prime Rate or the Federal Funds Effective
Rate, respectively. Notwithstanding the foregoing, the ABR with respect to any Tranche B Term Loan will be deemed to be 1.75% per annum if the ABR calculated pursuant to this definition would otherwise be less than 1.75% per annum.

 “ABR Loans” shall mean Loans the rate of interest applicable to which is based upon the ABR. ABR Loans shall be
denominated in Dollars. 
 “Additional Excluded Taxes” shall have the meaning given to such term in
Section 2.19(a). 
 “Additional Refinancing Lender” shall mean, at any time, any bank, financial institution or
other institutional lender or investor (other than any such bank, financial institution or other institutional lender or investor that is a Lender at such time) that agrees to provide any portion of Credit Agreement Refinancing Debt pursuant to a
Refinancing Amendment in accordance with Section 2.27; provided that 

  
 -2- 

 
each Additional Refinancing Lender shall be subject to the approval of (i) the Administrative Agent, such approval not to be unreasonably withheld or delayed, to the extent that each such
Additional Refinancing Lender is not then an existing Lender, an Affiliate of a then existing Lender or an Approved Fund, (ii) in the case of any Other Revolving Commitments, the Issuing Lender and the Swingline Lender and (iii) the
Borrower. 
 “Adjustment Date” shall have the meaning given to such term in the definition of “Pricing Grid.”

 “Administrative Agent” shall mean JPMorgan Chase Bank, N.A., together with its affiliates, as the arranger of the
Commitments and as the administrative agent for the Lenders under this Agreement and the other Loan Documents, together with any of its successors. 

“Administrative Questionnaire” shall mean an Administrative Questionnaire in a form supplied by the Administrative Agent.

 “Affiliate” shall mean, as to any Person, any other Person that, directly or indirectly, is in control of, is controlled
by, or is under common control with, such Person. For purposes of this definition, “control” of a Person shall mean the power, directly or indirectly, to direct or cause the direction of the management and policies of such Person, whether
by contract or otherwise. 
 “Agents” shall mean, collectively, the Syndication Agents, the Documentation Agents, the
Collateral Agent and the Administrative Agent. 
 “Aggregate Exposure” shall mean, with respect to any Lender at any time,
an amount equal to the sum of (i) the aggregate then unpaid principal amount of such Lender’s Term Loans and (ii) the amount of such Lender’s Revolving Commitment then in effect or, if the Revolving Commitments have been
terminated, the amount of such Lender’s Revolving Extensions of Credit then outstanding. 
 “Aggregate Exposure
Percentage” shall mean, with respect to any Lender at any time, the ratio (expressed as a percentage) of such Lender’s Aggregate Exposure at such time to the Aggregate Exposure of all Lenders at such time. 

“Agreement” shall have the meaning given to such term in the preamble hereto. 

“Alternative Currency” shall mean each of Dollars, Euro and Sterling and each other currency that is approved in accordance
with Section 1.7. 
 “Alternative Currency Equivalent” shall mean, at any time, with respect to any amount
denominated in Dollars, (i) if the applicable Alternative Currency is other than Dollars, the equivalent amount thereof in such Alternative Currency as determined by the Administrative Agent at such time on the basis of the Spot Rate
(determined in respect of the most recent Revaluation Date) for the purchase of such Alternative Currency with Dollars or (ii) if the applicable Alternative Currency is Dollars, such amount. 

“Alternative Currency LC Obligations” shall mean, at any time, an amount equal to the sum of (a) the aggregate then
undrawn and unexpired amount of the then outstanding Alternative Currency Letters of Credit and (b) the aggregate amount of all LC Disbursements in respect of Alternative Currency Letters of Credit that have not then been reimbursed pursuant to
Section 3.5. The Alternative Currency LC Obligations of any Lender at any time shall be its Alternative Currency Revolving Percentage of the total Alternative Currency LC Obligations at such time. 

 

  
 -3- 

 “Alternative Currency Letter of Credit” shall mean each Letter of Credit issued
under the Alternative Currency Revolving Facility. 
 “Alternative Currency Revolving Commitment” shall mean, as to any
Lender, the obligation of such Lender, if any, to make Alternative Currency Revolving Loans and participate in Swingline Loans and Alternative Currency Letters of Credit in an aggregate principal and/or face amount not to exceed the amount set forth
opposite such Lender’s name on Schedule II, in an Increase Joinder or in the Assignment and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof. 

“Alternative Currency Revolving Extensions of Credit” shall mean, as to any Alternative Currency Revolving Lender at any
time, an amount equal to the sum of (a) the aggregate principal amount of all Alternative Currency Revolving Loans held by such Lender then outstanding, (b) such Lender’s Alternative Currency Revolving Percentage of the LC Obligations
then outstanding and (c) such Lender’s Alternative Currency Revolving Percentage of the aggregate principal amount of Swingline Loans then outstanding. 

“Alternative Currency Revolving Facility” shall mean the Alternative Currency Revolving Commitments and the Alternative
Currency Revolving Loans made thereunder. 
 “Alternative Currency Revolving Lender” shall mean each Lender that has an
Alternative Currency Revolving Commitment or holds Alternative Currency Revolving Loans. 
 “Alternative Currency Revolving
Loans” shall have the meaning given to such term in Section 2.4(a). 
 “Alternative Currency Revolving
Percentage” shall mean, as to any Alternative Currency Revolving Lender at any time, the percentage which such Lender’s Alternative Currency Revolving Commitment then constitutes of the Total Alternative Currency Revolving Commitments
or, at any time after the Alternative Currency Revolving Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such Lender’s Alternative Currency Revolving Loans then outstanding constitutes of the
aggregate principal amount of the Alternative Currency Revolving Loans then outstanding; provided that, in the event that the Alternative Currency Revolving Loans are paid in full prior to the reduction to zero of the Total Alternative
Currency Revolving Extensions of Credit, the Alternative Currency Revolving Percentages shall be the Alternative Currency Revolving Percentages in effect immediately prior to such payment in full. 

“Anti-Terrorism Laws” shall have the meaning given to such term in Section 4.23. 

“Applicable Margin” shall mean, for each Type of Loan, the rate per annum set forth under the relevant column heading below:

  

									
	 	  	ABR Loans	 	 	Eurodollar Loans	 
	 Revolving Loans and Swingline Loans
	  	 	0.75	% 	 	 	1.75	% 
	 Tranche A Term Loans
	  	 	0.75	% 	 	 	1.75	% 
	 Tranche B Term Loans
	  	 	1.75	% 	 	 	2.75	% 

  
 -4- 

 ; provided that on and after the first Adjustment Date occurring after the completion of the Fiscal
Quarter of the Borrower ending September 30, 2014, the Applicable Margin in respect of all Loans (other than the Tranche B Term Loans) will be determined pursuant to the Pricing Grid. 

“Applicable Participants” shall mean (i) with respect to any Alternative Currency Letter of Credit, the Alternative
Currency Revolving Lenders and (ii) with respect to any Dollar Letters of Credit, the Dollar Revolving Lenders. 

“Application” shall mean an application, in such form as the Issuing Lender may specify from time to time, requesting the
Issuing Lender to open a Letter of Credit. 
 “Approved Fund” shall have the meaning given to such term in
Section 11.6(b). 
 “Asset Sale” shall mean any Disposition of property (including sales and issuances of
Capital Stock of any Subsidiary (other than sales and issuances that do not decrease the percentage ownership of the Borrower and its Subsidiaries in each class of Capital Stock of such Subsidiary)) or series of related Dispositions of property
(excluding any such Disposition permitted by clause (a), (b), (c), (d), (e), (i), (j)(ii) or (m) (solely with respect to an Investment pursuant to Section 7.6(e) or Section 7.6(f)) of Section 7.5) that yields
Net Cash Proceeds to any Group Member (valued at the initial principal amount thereof in the case of non-cash proceeds consisting of notes or other debt securities and valued at fair market value in the case of other non-cash proceeds) in excess of
$50,000,000 (provided that the issuance and sale of the Borrower’s stock by the Borrower shall not be deemed an “Asset Sale”). 

“Assignee” shall have the meaning given to such term in Section 11.6(b). 

“Assignment and Assumption” shall mean an Assignment and Assumption, substantially in the form of Exhibit E. 

“Available Amount” shall mean, at any date of determination (the “Available Amount Reference Date”), an
amount equal to (a) Cumulative Consolidated Net Income minus (b) the aggregate sum of (i) Investments made pursuant to Section 7.6(k)(ii), (ii) the amount of purchases, redemptions, acquisitions, dividends and
distributions made pursuant to Section 7.7(d)(ii) and (iii) the amount of payments, prepayments, redemptions or acquisitions of Debt pursuant to Section 7.9(a)(ii)(y), in each case during the period from and including
the Business Day immediately following the Closing Date through and including the Available Amount Reference Date (without taking into account the intended usage of the Available Amount on such Available Amount Reference Date). For the avoidance of
doubt, if the Available Amount is a negative amount, it shall not reduce availability hereunder under any other exception or provision not based on the Available Amount. 

“Available Alternative Currency Revolving Commitment” shall mean, as to any Alternative Currency Revolving Lender at any
time, an amount equal to (a) such Lender’s Alternative Currency Revolving Commitment then in effect minus (b) such Lender’s Alternative Currency Revolving Extensions of Credit then outstanding; provided that in calculating
any Lender’s Alternative Currency Revolving Extensions of Credit for the purpose of determining such Lender’s Available Alternative Currency Revolving Commitment pursuant to Section 2.8(a), the aggregate principal amount of
Swingline Loans then outstanding shall be deemed to be zero. 
 “Available Dollar Revolving Commitment” shall mean, as to
any Dollar Revolving Lender at any time, an amount equal to (a) such Lender’s Dollar Revolving Commitment then in effect minus (b) such Lender’s Dollar Revolving Extensions of Credit then outstanding. 

  
 -5- 

 “Available Revolving Commitment” shall mean, collectively, the Available Dollar
Revolving Commitment and the Available Alternative Currency Revolving Commitment. 
 “Bankruptcy Event” shall mean, with
respect to any Person, such Person has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, administrator, custodian, assignee for the benefit of creditors or similar Person charged with the
reorganization or liquidation of its business appointed for it, or, in the good faith determination of the Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any such
proceeding or appointment; provided that a Bankruptcy Event shall not result solely by virtue of any ownership interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority or instrumentality thereof if
such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such
Governmental Authority or instrumentality) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person. 

“Benefitted Lender” shall have the meaning given to such term in Section 11.7(a). 

“Board” shall mean the Board of Governors of the Federal Reserve System of the United States (or any successor). 

“Board of Directors” shall mean, with respect to any Person, (i) in the case of any corporation, the board of directors
of such Person, (ii) in the case of any limited liability company, the board of managers of such Person, (iii) in the case of any partnership, the Board of Directors of the general partner of such Person and (iv) in any other case,
the functional equivalent of the foregoing. 
 “Borrower” shall have the meaning given to such term in the preamble hereto.

 “Borrowing Date” shall mean any Business Day specified by the Borrower as a date on which the Borrower requests the
relevant Lenders to make Loans hereunder. 
 “Borrowing Request” shall mean a Borrowing Request substantially in the form
of Exhibit H. 
 “Business Associate Agreement” shall have the meaning given to such term in
Section 6.17(b). 
 “Business Day” shall mean (i) with respect to Obligations denominated in Dollars, a
day other than a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by law to close and (ii) with respect to Obligations denominated in an Alternative Currency (other than Dollars), a day on
which banks are open for general business in London and, in each case, 
 (a) if such day relates to any interest rate
settings as to a Eurodollar Loan denominated in Dollars, any fundings, disbursements, settlements and payments in Dollars in respect of any such Eurodollar Loan, or any other dealings in Dollars to be carried out pursuant to this Agreement in
respect of any such Eurodollar Loan, means any such day on which dealings in deposits in Dollars are conducted by and between banks in the London interbank eurodollar market; 

  
 -6- 

 (b) if such day relates to any interest rate settings as to a Eurodollar Loan
denominated in Euro, any fundings, disbursements, settlements and payments in Euro in respect of any such Eurodollar Loan, or any other dealings in Euro to be carried out pursuant to this Agreement in respect of any such Eurodollar Loan, means
(i) a TARGET Day and (ii) a day on which banks are open for general business in London; 
 (c) if such day relates
to any interest rate settings as to a Eurodollar Loan denominated in Sterling, means any such day on which dealings in deposits in Sterling are conducted by and between banks in the London or other applicable offshore interbank market for Sterling;
and 
 (d) if such day relates to any fundings, disbursements, settlements and payments in Sterling in respect of a
Eurodollar Loan denominated in Sterling, or any other dealings in Sterling to be carried out pursuant to this Agreement in respect of any such Eurodollar Loan (other than any interest rate settings), means any such day on which banks are open for
foreign exchange business in London. 
 “Capital Assets” shall mean, with respect to any Person, all equipment, fixed
assets and Real Property or improvements of such Person, or replacements or substitutions therefor or additions thereto, that, in accordance with GAAP, have been or should be reflected as additions to property, plant or equipment on the balance
sheet of such Person. 
 “Capital Expenditures” shall mean, with respect to any Person for any period, all expenditures
made directly or indirectly by such Person during such period for Capital Assets related to maintaining, replacing or repairing existing property or assets (including any Dialysis Facility) of such Person (whether paid in cash or other consideration
or accrued as a liability), but, for the avoidance of doubt, excluding any Investments permitted by Section 7.6(e), (f), (k) and (m) and development of the Denver Headquarters. For purposes of this
definition, the purchase price of equipment or other fixed assets that are purchased simultaneously with the trade-in of existing assets or with insurance proceeds shall be included in Capital Expenditures only to the extent of the amount by which
such purchase price exceeds the credit granted by the seller of such assets for the assets being traded in at such time or the amount of such insurance proceeds, as the case may be. 

“Capital Stock” shall mean any and all shares, interests, participations or other equivalents (however designated) of capital
stock of a corporation, any and all equivalent ownership interests in a Person (other than a corporation) and any and all warrants, rights or options to purchase any of the foregoing. 

“Capitalized Lease” shall mean any lease with respect to which the lessee is required to recognize concurrently the
acquisition of property or an asset and the incurrence of a liability in accordance with GAAP (provided that, if there is a change in GAAP with respect to “Capitalized Leases” after the Closing Date and the Borrower shall deliver an
irrevocable written notice electing to disregard such change, each reference in this Agreement to a “Capitalized Lease” shall be determined based on GAAP as in effect on the Closing Date; provided, further, that the Borrower
shall provide to the Administrative Agent and the Lenders a written reconciliation between the calculation of any affected item in amounts required to be reported under Sections 6.1(b) and (c) (including any Compliance
Certificate) before and after giving effect to such change in GAAP). 
 “Capitalized Lease Obligations” shall mean, with
respect to any Capitalized Lease, the amount required to be capitalized in the financial statements of the lessee in accordance with GAAP (provided that, each reference in this Agreement to “Capitalized Lease Obligations” shall be
determined based on GAAP as in effect on the Closing Date; provided that if there is a change in GAAP with respect to “Capitalized Lease Obligations” after the Closing Date, the Borrower shall provide to the Administrative

  
 -7- 

 
Agent and the Lenders a written reconciliation between the calculation of any affected item in amounts required to be reported under Sections 6.1(b) and (c) (including any
Compliance Certificate) before and after giving effect to such change in GAAP). 
 “Cash Equivalents” shall mean
(a) securities with maturities of one year or less from the date of acquisition, issued, fully guaranteed or insured by the United States of America (or any agency or instrumentality thereof), or any foreign government or supranational
organization, in each case, rated AAA by S&P and Aaa by Moody’s, (b) securities with maturities of one year or less from the date of acquisition issued, fully guaranteed by any State of the United States of America or any political
subdivision thereof either (i) rated at least AA- or SP1 by S&P or Aa3 or MIG1 by Moody’s, or carrying an equivalent rating by a nationally recognized rating agency if both of the two named rating agencies cease publishing ratings of
investments or (ii) fully collateralized by securities described in clause (a) and/or cash, (c) certificates of deposit, time deposits, overnight bank deposits, bankers’ acceptances and repurchase agreements issued by a Qualified
Issuer or fully insured or guaranteed by the United States of America (or any agency or instrumentality thereof) to the extent the same are backed by the full faith and credit of the United States of America having maturities of one year or less
from the date of acquisition, (d) commercial paper of an issuer rated at least A-2 by S&P or P-2 by Moody’s, or carrying an equivalent rating by a nationally recognized rating agency if both of the two named rating agencies cease
publishing ratings of investments, and having maturities of 270 days or less from the date of acquisition, (e) money market accounts or funds, a substantial portion of the assets of which constitute Cash Equivalents described in clauses
(a) through (d) above, with, issued by or managed by Qualified Issuers, (f) money market accounts or funds, a substantial portion of the assets of which constitute Cash Equivalents described in clauses (a) through (d) above,
which money market accounts or funds have net assets of not less than $500,000,000 and have the highest rating available of either S&P or Moody’s, or carrying an equivalent rating by a nationally recognized rating agency if both of the two
named rating agencies cease publishing ratings of investments and (g) money market accounts or funds rated at least AA by S&P and at least Aa by Moody’s. 

“Cash Flow from Operating Activities” shall mean the net cash provided by operating activities of the Borrower and its
Subsidiaries, determined on a Consolidated basis in accordance with GAAP, as set forth on the financial statements delivered by the Borrower pursuant to Section 6.1(b). 

“Cash Management Agreement” shall mean any agreement to provide cash management services, including treasury, depository,
overdraft, purchasing card, travel and entertainment card, credit or debit card, electronic funds transfer and other cash management arrangements. 

“Cash Management Bank” shall mean any Person that, at the time it enters into a Cash Management Agreement, is a Lender or an
Affiliate of a Lender, in its capacity as a party to such Cash Management Agreement. 
 “CERCLA” shall mean the
Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended, 42 U.S.C. § 9601 et seq., and all implementing regulations. 

“CERCLIS” shall mean the Comprehensive Environmental Response, Compensation and Liability Information System maintained by
the U.S. Environmental Protection Agency. 
 “Change in Law” shall have the meaning given to such term in
Section 2.18(b). 

  
 -8- 

 “Change of Control” shall mean at any time: 

(a) any “person” or “group” (each as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act)
(i) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of Voting Interests in the Borrower (including through securities convertible into or exchangeable for such Voting Interests)
representing 35% or more of the combined voting power of all of the Voting Interests in the Borrower (on a fully diluted basis) or (ii) otherwise has the ability, directly or indirectly, to elect a majority of the Board of Directors of the
Borrower; 
 (b) during any period of two consecutive years, individuals who at the beginning of such period constituted the
Board of Directors of the Borrower (together with any new directors whose election to such Board of Directors or whose nomination for election was approved by a vote of a majority of the members of the Board of Directors of the Borrower, which
members comprising such majority were either directors at the beginning of such period or were elected or nominated by such directors) have ceased for any reason to constitute a majority of the Board of Directors of the Borrower; or 

(c) the occurrence of a Specified Change of Control; 

provided that notwithstanding the foregoing the occurrence of a reorganization that results in all the Capital Stock of the Borrower being held by a
Parent Entity shall not result in a Change of Control; provided, further, that the shareholders of the Parent Entity immediately after such reorganization are substantially the same as the shareholders of the Borrower (with
substantially equivalent ownership percentages) immediately preceding such reorganization. 
 “Charges” shall have the
meaning given to such term in Section 11.18. 
 “Class,” when used in reference to any Loan or borrowing,
refers to whether such Loan, or the Loans comprising such borrowing, are Dollar Revolving Loans, Alternative Currency Revolving Loans, Tranche A Term Loans, Tranche B Term Loans, Incremental Term Loans, Extended Term Loans, Other Revolving Loans or
Other Term Loans; when used in reference to any Commitment, refers to whether such Commitment is a Tranche A Term Commitment, Tranche B Term Commitment, Dollar Revolving Commitment, Alternative Currency Revolving Commitment, Incremental Term Loan
Commitment, Incremental Revolving Commitment, Extended Revolving Commitment, Other Term Loan Commitment or Other Revolving Commitment; and, when used in reference to any Lender, refers to whether such Lender has a Loan or Commitment with respect to
a particular Class. 
 “Closing Date” shall mean the date on which the conditions precedent set forth in Sections
5.1 and 5.2 shall have been satisfied. 
 “Code” shall mean the Internal Revenue Code of 1986, as amended from
time to time. 
 “Collateral” shall mean all property of the Loan Parties, now owned or hereafter acquired, upon which a
Lien is purported to be created by any Security Document. 
 “Collateral Agent” shall mean JPMorgan Chase Bank, N.A., in
its capacity as collateral agent for the Secured Parties and the Issuing Lender, and its successors. 

  
 -9- 

 “Commitment” shall mean, as to any Lender, the sum of the Tranche A Term
Commitment, the Tranche B Term Commitment and the Revolving Commitment of such Lender and any Commitment extended by such Lender as provided in Section 2.24. 

“Commitment Fee Rate” shall mean
 1⁄2 of 1% per annum; provided that on and after the first Adjustment Date occurring after the completion of the first Fiscal Quarter of the
Borrower ending at least three months after the Closing Date, the Commitment Fee Rate will be determined pursuant to the Pricing Grid. 

“Commodity Exchange Act” shall mean the Commodity Exchange Act (7 U.S.C. § 1 et seq.), as amended from time to
time, and any successor statute. 
 “Communications” shall have the meaning given to such term in
Section 11.2(d). 
 “Compliance Certificate” shall mean a certificate duly executed by a Responsible Officer
substantially in the form of Exhibit B. 
 “Conduit Lender” shall mean any special purpose corporation
organized and administered by any Lender for the purpose of making Loans otherwise required to be made by such Lender and designated by such Lender in a written instrument; provided that the designation by any Lender of a Conduit Lender shall
not relieve the designating Lender of any of its obligations to fund a Loan under this Agreement if, for any reason, its Conduit Lender fails to fund any such Loan, and the designating Lender (and not the Conduit Lender) shall have the sole right
and responsibility to deliver all consents and waivers required or requested under this Agreement with respect to its Conduit Lender, and provided, further, that no Conduit Lender shall (a) be entitled to receive any greater
amount pursuant to Section 2.18, 2.19, 2.20 or 11.5 than the designating Lender would have been entitled to receive in respect of the extensions of credit made by such Conduit Lender or (b) be deemed to have any
Commitment. 
 “Confidential Information Memorandum” shall mean the Confidential Information Memorandum dated June 2014,
and furnished to certain Lenders. 
 “Consolidated” or “consolidated” shall mean the consolidation of
accounts in accordance with GAAP; provided that, except for purposes of Consolidated financial statements delivered pursuant to Section 6.1, the Physician Groups (and their respective Subsidiaries) will not be Consolidated for any
purpose under the Loan Documents. 
 “Consolidated Current Assets” shall mean at any date, all amounts (other than cash and
Cash Equivalents) that would, in conformity with GAAP, be set forth opposite the caption “total current assets” (or any like caption) on a consolidated balance sheet of the Borrower and its Subsidiaries at such date. 

“Consolidated Current Liabilities” shall mean at any date, all amounts that would, in conformity with GAAP, be set forth
opposite the caption “total current liabilities” (or any like caption) on a consolidated balance sheet of the Borrower and its Subsidiaries at such date, but excluding (a) the current portion of any Funded Debt of the Borrower and its
Subsidiaries and (b) without duplication of clause (a) above, all Debt consisting of Revolving Loans or Swingline Loans to the extent otherwise included therein. 

  
 -10- 

 “Consolidated EBITDA” shall mean with respect to any Person for any period, the
amount equal to the sum of (a) the Consolidated Net Income of such Person and its Subsidiaries for such period plus (b) the sum of each of the following expenses that have been deducted in the determination of the Consolidated Net
Income of such Person and its Subsidiaries for such period: (i) the Consolidated Interest Expense of such Person and its Subsidiaries for such period and any cash charges for refinancing any of the Obligations, (ii) all income tax expense
(whether federal, state, local, foreign or otherwise) of such Person and its Subsidiaries for such period, (iii) all depreciation expense of such Person and its Subsidiaries for such period, (iv) all amortization expense of such Person and
its Subsidiaries for such period, (v) cash fees, expenses, charges, debt extinguishment costs and other costs incurred in connection with the Transactions, (vi) all non-cash charges otherwise deducted in determining the Consolidated Net
Income of such Person and its Subsidiaries for such period (excluding any non-cash charge that results in an accrual of a reserve for cash charges in any future period or amortization of a prepaid cash expense that was paid in a prior period not
included in the calculation); provided that for any period, the amount of non-cash charges arising from the write-off of current assets shall not be included in this subclause (vi), (vii) consolidated expenses for valuation adjustments
or impairment charges, (viii) all expenses and charges relating to non-controlling interests and equity income in Subsidiaries, (ix) all extraordinary losses subtracted in determining the Consolidated Net Income of such Person and its
Subsidiaries for such period, (x) any losses of a Person (other than a Subsidiary) in which the Borrower or any of its Subsidiaries has an ownership interest that is accounted for using the equity method, (xi) cash fees, expenses, charges,
debt extinguishment costs and other costs incurred in connection with any Investments permitted by Section 7.6(e), (f), (j), (k) or (m) and (xii) unusual or nonrecurring losses or charges for
such period minus (c) all extraordinary gains added in determining the Consolidated Net Income of such Person and its Subsidiaries for such period, minus (d) the aggregate amount of all non-cash items increasing Consolidated
Net Income (other than the accrual of revenue or recording of receivables in the ordinary course of business)for such period, minus (e) unusual or nonrecurring gains for such period. 

Consolidated EBITDA shall be calculated on a Pro Forma Basis to give effect to Specified Transactions that have been made at any time on or
after the first day of the Measurement Period thereof but prior to or contemporaneously with the event for which the calculation is made (such date, the “Reference Date”) as if each such Specified Transaction had been consummated on
the day prior to the first day of such period. For purposes of Investments made pursuant to Section 7.6(m), Consolidated EBITDA shall be calculated to give effect to any Pro Forma Physician Group Adjustments. Notwithstanding anything to
the contrary contained in this paragraph, when calculating the Leverage Ratio for purposes of (i) the Pricing Grid, (ii) the ECF Percentage and (iii) determining actual compliance (and not compliance on a Pro Forma Basis) with any
covenant pursuant to Section 7.16, (A) any Specified Transactions that occurred subsequent to the end of the applicable Measurement Period shall not be given pro forma effect and (B) such calculations shall be based on the
financial statements delivered pursuant to Section 6.1(b) or (c), as applicable, for the relevant Measurement Period. 

“Consolidated Interest Expense” shall mean, with respect to any Person for any period, the gross interest expense accrued on
all Debt of such Person and its Subsidiaries during such period, determined on a Consolidated basis and in accordance with GAAP for such period, including, without limitation, (a) in the case of the Borrower, all fees paid or payable pursuant
to Section 2.8, (b) commissions, discounts and other fees and charges paid or payable in connection with letters of credit (including, without limitation, the Letters of Credit), (c) all amortization of original issue discount
in respect of all Debt of such Person and its Subsidiaries, (d) all dividends on Redeemable Preferred Interests, to the extent paid or payable in cash, (e) commissions, discounts, yield and other fees and charges incurred in connection
with any Permitted Receivables Financing which are payable to any Person other than the Borrower or a Guarantor, (f) imputed interest on Capitalized Lease Obligations of the Borrower and its Subsidiaries for such period and (g) cash
contributions to any employee stock ownership plan or similar trust to the extent such contributions are used by such plan or trust to pay interest or fees to any Person (other than such Person and its Subsidiaries) in connection with Debt incurred
by such plan or trust, minus interest income of the Borrower and its Subsidiaries received upon cash and Cash Equivalents during such period. 

  
 -11- 

 Consolidated Interest Expense shall be calculated on a Pro Forma Basis to give effect to
Specified Transactions that have been made during or after the relevant Measurement Period but prior to or contemporaneously with the Reference Date as if each such Specified Transaction had been effected on the first day of such period; it being
understood that for purposes of such calculations (i) any Debt newly incurred during such Measurement Period that bears interest at a floating rate will be assumed to bear interest for the entire Measurement Period at the rate borne by such
Debt on the date of incurrence and (ii) the amount of Debt under any revolving credit facility drawn for working capital purposes in the ordinary course of business outstanding on the Reference Date will be deemed to be (x) the average
daily balance of such Debt during such Measurement Period or such shorter period for which such facility was outstanding or (y) if such facility was created after the end of such Measurement Period, the average daily balance of such Debt during
the period from the date of creation of such facility to the Reference Date. 
 “Consolidated Net Income” shall mean, for
any period, the consolidated net income (or net loss) of the Borrower and its Subsidiaries, determined on a Consolidated basis in accordance with GAAP; provided that there shall be excluded (a) the income (or deficit) of any Person
accrued prior to the date it becomes a Subsidiary of the Borrower or is merged into or consolidated with the Borrower or any of its Subsidiaries (provided that such income (or deficit) may be included in pro forma calculations as otherwise
provided in this Agreement), (b) the income (or deficit) of any Person (other than a Subsidiary of the Borrower) in which the Borrower or any of its Subsidiaries has an ownership interest, except to the extent that any such income is actually
received by the Borrower or such Subsidiary in the form of dividends or similar distributions and (c) the undistributed earnings of any Subsidiary of the Borrower to the extent that the declaration or payment of dividends or similar
distributions by such Subsidiary is not at the time permitted by the terms of any Contractual Obligation (other than under any Loan Document) or Requirement of Law applicable to such Subsidiary. 

“Consolidated Tangible Assets” shall mean, with respect to any Person, the consolidated assets of such Person and its
Subsidiaries as determined in accordance with GAAP (and if applicable as appearing within the Required Financial Information) minus goodwill and other amortizable intangible assets. 

“Constitutive Documents” shall mean, with respect to any Person, the certificate of incorporation or registration (including,
if applicable, certificate of change of name), articles of incorporation or association, memorandum of association, charter, bylaws, certificate of limited partnership, partnership agreement, trust agreement, joint venture agreement, certificate of
formation, articles of organization, limited liability company operating or members agreement, joint venture agreement or one or more similar agreements, instruments or documents constituting the organizational or governing documents of such Person.

 “Contingent Obligation” shall mean, with respect to any Person, any obligation or arrangement of such Person to
guarantee or intended to guarantee any Debt, (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, without limitation, (a) the direct or
indirect guarantee, endorsement (other than for collection or deposit in the ordinary course of business), co-making, discounting with recourse or sale with recourse by such Person of the primary obligations of a primary obligor, (b) the
obligation to make take-or-pay or similar payments, if required, regardless of non-performance by any other party or parties to an agreement or (c) any obligation of such Person, whether or not contingent, (i) to purchase any such primary
obligation or any property constituting direct or indirect security therefor, (ii) to advance or supply funds (A) for the purchase or 

  
 -12- 

 
payment of any such primary obligation or (B) to maintain working capital, equity capital, net worth or other balance sheet condition or any income statement condition of the primary obligor
or otherwise to maintain the solvency of the primary obligor, (iii) to purchase, lease or otherwise acquire property, assets, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability
of the primary obligor to make payment of such primary obligation or (iv) otherwise to assure or hold harmless the holder of such primary obligation against loss in respect thereof. The amount of any Contingent Obligation shall be deemed to be
an amount equal to the stated or determinable amount of the primary obligation in respect of which such Contingent Obligation is made (or, if less, the maximum amount of such primary obligation for which such Person may be liable pursuant to the
terms of the agreement, instrument or other document evidencing such Contingent Obligation) or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder),
as determined by such Person in good faith. 
 “Contractual Obligation” shall mean, as to any Person, any provision of any
security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound. 

“Control” shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management
or policies of a Person, whether through the ownership of voting securities, by contract or otherwise, and the terms “Controlling” and “Controlled” shall have meanings correlative thereto. 

“Credit Agreement Refinancing Debt” shall mean (a) Permitted First Priority Refinancing Debt, (b) Permitted Second
Priority Refinancing Debt, (c) Permitted Unsecured Refinancing Debt or (d) other Debt incurred pursuant to a Refinancing Amendment, in each case, issued, incurred or otherwise obtained (including by means of the extension or renewal of
existing Debt) in exchange for, or to extend, renew, replace, repurchase, retire or refinance, in whole or part, existing Term Loans or existing Revolving Loans (or unused Revolving Commitments), or any then-existing Credit Agreement Refinancing
Debt (“Refinanced Debt”); provided that (i) such Debt has a maturity no earlier than, and a Weighted Average Life to Maturity equal to or greater than, the Refinanced Debt, (ii) such Debt shall not have a greater
principal amount than the principal amount of the Refinanced Debt plus accrued interest, fees, premiums (if any) and penalties thereon and reasonable fees and expenses associated with the refinancing, (iii) the terms and conditions of such Debt
(except as otherwise provided in clause (ii) above and with respect to pricing, premiums and optional prepayment or redemption terms) are substantially identical to, or (taken as a whole) are no more materially favorable, taken as a whole, to
the lenders or holders providing such Debt in the good faith determination of the Borrower than, those applicable to the Refinanced Debt being refinanced (except for covenants or other provisions applicable only to periods after the Latest Maturity
Date at the time of incurrence of such Debt), (iv) such Debt is not at any time guaranteed by any Subsidiaries other than Subsidiaries that are Guarantors, (v) such Debt does not have scheduled amortization payments of principal or
payments of principal and is not subject to mandatory redemption, repurchase, prepayment, sinking fund obligations or prepayments at the option of the holders thereof (except customary asset sale or change of control provisions that provide for the
prior repayment in full of the Loans and all other Obligations), in each case prior to the Latest Maturity Date at the time such Debt is incurred, (vi) to the extent secured, the security agreements relating to such Debt are substantially the
same as or more favorable to the Loan Parties than the Security Documents (with such differences as are reasonably satisfactory to the Administrative Agent) and (vii) such Refinanced Debt shall be repaid, repurchased, retired, defeased or
satisfied and discharged, and all accrued interest, fees, premiums (if any) and penalties in connection therewith shall be paid, on the date such Credit Agreement Refinancing Debt is issued, incurred or obtained. 

  
 -13- 

 “Credit Extension” shall mean, as the context may require, (i) the making
of a Loan by a Lender or (ii) the issuance of any Letter of Credit, or the amendment, extension or renewal of any existing Letter of Credit, by the Issuing Lender. 

“Credit Party” shall mean the Administrative Agent, the Issuing Lender, the Swingline Lender or any other Lender. 

“Cumulative Consolidated Net Income” shall mean, as of any date, 50% of the cumulative Consolidated Net Income (or, if such
Cumulative Consolidated Net Income shall be a loss, 100% of such loss) of the Borrower and its Subsidiaries since the fiscal quarter beginning January 1, 2012 to the end of the last fiscal period (taken as one accounting period) for which
financial statements have been provided to the Lenders pursuant to Section 6.1(b) or (c) prior to such date. 

“Debt” shall mean, with respect to any Person (without duplication), (a) all indebtedness of such Person for borrowed
money, (b) all Obligations of such Person for the deferred purchase price of property or services (other than current trade payables or other accrued liabilities incurred in the ordinary course of such Person’s business, (c) all
obligations of such Person evidenced by notes, bonds, debentures or other similar instruments, or upon which interest payments are customarily made, (d) all obligations of such Person created or arising under any conditional sale or other title
retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all
Capitalized Lease Obligations of such Person, (f) all obligations, contingent or otherwise, of such Person under acceptance, letter of credit or similar facilities (excluding reimbursement obligations thereunder to the extent issued in relation
to trade payables and that are discharged within 30 days after they become due), (g) the amount of all obligations of such Person with respect to the redemption, repayment or other repurchase of any Redeemable Preferred Interest, valued at the
greater of its voluntary or involuntary liquidation preference plus accrued and unpaid dividends, (h) for purposes of Section 7.2 and 8.1(f) only, all net obligations of such Person in respect of Swap Agreements,
take-or-pay agreements or other similar arrangements, (i) all obligations of such Person under any synthetic lease, tax retention operating lease, off-balance sheet loan or similar off-balance sheet financing if the transaction giving rise to
such obligation is considered indebtedness for borrowed money for tax purposes but is classified as an operating lease in accordance with GAAP, (j) all Contingent Obligations of such Person, and (k) all indebtedness and other payment
obligations referred to in clauses (a) through (j) above of another Person secured by (or for which the holder of such indebtedness or other payment obligations has an existing right, contingent or otherwise, to be secured by) any Lien on
property (including, without limitation, accounts and contract rights) owned by such Person, even though such Person has not assumed or become liable for the payment of such indebtedness or other payment obligations; provided that for the
purposes of this subclause (k) the amount thereof shall be equal to the lesser of (i) the amount of such indebtedness or other payment obligations and (ii) the fair market value of the property subject to such Lien. The Debt of any
Person shall include the Debt of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person’s ownership interest in or other relationship with
such entity, except to the extent the terms of such Debt expressly provide that such Person is not liable therefor. To the extent not otherwise included, Debt shall include the amount of any Permitted Receivables Financing. For the avoidance of
doubt, and without any implication to the contrary, no Intercompany Receivables or any transactions giving rise thereto shall constitute Debt. 

“Default” shall mean any Event of Default, whether or not any requirement for the giving of notice, the lapse of time, or
both, has been satisfied. 

  
 -14- 

 “Defaulting Lender” shall mean any Lender that (a) has failed, within two
Business Days of the date required to be funded or paid, to (i) fund any portion of its Loans, (ii) fund any portion of its participations in Letters of Credit or Swingline Loans or (iii) pay over to any Credit Party any other amount
required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender’s good faith determination that a condition precedent to
funding (specifically identified and including the particular default, if any) has not been satisfied, or, in the case of clause (iii) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such
Lender’s good faith dispute concerning the amount of costs and expenses claimed by the Administrative Agent to be reimbursed pursuant to Section 11.5(c), (b) has notified the Borrower or any Credit Party in writing, or has made
a public statement to the effect, that it does not intend or expect to comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender’s good faith
determination that a condition precedent (specifically identified and including the particular default, if any) to funding a loan under this Agreement cannot be satisfied) or generally under other agreements in which it commits to extend credit,
(c) has failed, within three Business Days after request by a Credit Party, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations (and is financially able
to meet such obligations) to fund prospective Loans and participations in then outstanding Letters of Credit and Swingline Loans under this Agreement; provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause
(c) upon such Credit Party’s receipt of such certification in form and substance satisfactory to it and the Administrative Agent; or (d) has become the subject of a Bankruptcy Event. 

“Denver Headquarters” shall mean that certain real property owned by the Borrower and located at 2000 16th Street, Denver, Colorado. 
 “Designated Non-Cash Consideration” shall
mean the fair market value of non-cash consideration as determined by the Borrower in good faith received by the Borrower or any of its Subsidiaries in connection with a lease, sale, transfer or other disposition of any assets pursuant to
Section 7.5(f) that is designated as Designated Non-Cash Consideration pursuant to a certificate of a Responsible Officer of the Borrower, setting forth the basis of such valuation. 

“Designated Prepayment Amount” shall have the meaning given to such term in Section 2.11(e). 

“Dialysis Facilities” shall have the meaning given to such term in Section 4.17(a). 

“Disposition” shall mean, with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer
or other disposition thereof. The terms “Dispose” and “Disposed of” shall have correlative meanings. 

“Disqualified Lenders” shall mean those Persons who are competitors of the Borrower and who are identified in writing to the
Administrative Agent for further distribution to the Lenders; provided that, with respect to any competitor identified in writing to the Administrative Agent after the Closing Date, if the Required Lenders instruct the Administrative Agent to
object to such competitor within 60 days after receipt of such identification by the Borrower, such competitor shall not be a “Disqualified Lender” hereunder. 

“Documentation Agents” shall have the meaning given to such term in the preamble hereto. 

  
 -15- 

 “Dollars” and “$” shall mean lawful currency of the United
States. 
 “Dollar Equivalent” shall mean, at any time, (a) with respect to any amount denominated in Dollars, such
amount, and (b) with respect to any amount denominated in any Alternative Currency (other than Dollars), the equivalent amount thereof in Dollars as determined by the Administrative Agent at such time on the basis of the Spot Rate (determined
in respect of the most recent Revaluation Date) for the purchase of Dollars with such Alternative Currency. 
 “Dollar LC
Obligations” shall mean, at any time, an amount equal to the sum of (a) the aggregate then undrawn and unexpired amount of the then outstanding Dollar Letters of Credit and (b) the aggregate amount of all LC Disbursements in
respect of Dollar Letters of Credit that have not then been reimbursed pursuant to Section 3.5. The Dollar LC Obligations of any Dollar Revolving Lender at any time shall be its Dollar Revolving Percentage of the total Dollar LC
Obligations at such time. 
 “Dollar Letter of Credit” shall mean each Letter of Credit issued under the Dollar Revolving
Facility. 
 “Dollar Revolving Commitment” shall mean, as to any Lender, the obligation of such Lender, if any, to make
Dollar Revolving Loans and to participate in Dollar Letters of Credit hereunder in an aggregate principal and/or face amount not to exceed the amount set forth opposite such Lender’s name on Schedule II, in an Increase Joinder or in the
Assignment and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof. 

“Dollar Revolving Extensions of Credit” shall mean, as to any Dollar Revolving Lender at any time, an amount equal to the sum
of (a) aggregate principal amount of all Dollar Revolving Loans held by such Lender then outstanding and (b) such Lender’s Dollar Revolving Percentage of the LC Obligations then outstanding. 

“Dollar Revolving Facility” shall mean the Dollar Revolving Commitments and the Dollar Revolving Loans made thereunder. 

“Dollar Revolving Lender” shall mean each Lender that has a Dollar Revolving Commitment or holds Dollar Revolving Loans. 

“Dollar Revolving Loans” shall have the meaning given to such term in Section 2.4(a). 

“Dollar Revolving Percentage” shall mean, as to any Dollar Revolving Lender at any time, the percentage which such
Lender’s Dollar Revolving Commitment then constitutes of the Total Dollar Revolving Commitments or, at any time after the Dollar Revolving Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such
Lender’s Dollar Revolving Loans then outstanding constitutes of the aggregate principal amount of the Dollar Revolving Loans then outstanding; provided that, in the event that the Dollar Revolving Loans are paid in full prior to the
reduction to zero of the Total Dollar Revolving Extensions of Credit, the Dollar Revolving Percentages shall be the Dollar Revolving Percentages in effect immediately prior to such payment in full. 

“Domestic Person” shall mean a Person that is organized under the laws of, or whose property is located in, a jurisdiction
within the United States. 

  
 -16- 

 “Domestic Subsidiary” shall mean any Subsidiary of the Borrower organized under
the laws of any jurisdiction within the United States. 
 “ECF Percentage” shall mean (i) with respect to any Fiscal
Year at the end of which the Leverage Ratio is greater than 4.0 to 1.00, 25%; and (ii) with respect to any Fiscal Year at the end of which the Leverage Ratio is less than or equal to 4.0 to 1.00, 0%. 

“Embargoed Person” shall have the meaning assigned to such term in Section 7.15. 

“EMU” shall mean the economic and monetary union in accordance with the Treaty of Rome 1957, as amended by the Single
European Act 1986, the Maastricht Treaty of 1992 and the Amsterdam Treaty of 1998. 
 “EMU Legislation” shall mean the
legislative measures of the European Council for the introduction of, changeover to or operation of a single or unified European currency. 

“Environmental Action” shall mean any outstanding action, suit, demand, demand letter, claim, notice of noncompliance or
violation, notice of liability or potential liability, investigation, proceeding, consent order or consent agreement, abatement order or other order or directive (conditional or otherwise) relating in any way to any Environmental Law, any
Environmental Permit or any Hazardous Materials or arising from alleged injury or threat to health, safety, natural resources or the environment, including, (a) by any Governmental Authority for enforcement, cleanup, removal, response, remedial
or other actions or damages and (b) by any applicable Governmental Authority or any other third party for damages, contribution, indemnification, cost recovery, compensation or injunctive relief. 

“Environmental Law” shall mean any Requirement of Law relating to (a) the generation, use, handling, transportation,
treatment, storage, disposal or Release of Hazardous Materials, (b) pollution or the protection of the Environment or health or safety or (c) occupational safety and health, industrial hygiene, land use or the protection of human, plant or
animal health or welfare, including, without limitation, CERCLA, in each case as amended from time to time, and including the regulations promulgated and the rulings issued from time to time thereunder. 

“Environment” shall mean ambient air, indoor air, surface water, groundwater, drinking water, soil, land surface and
subsurface strata, and natural resources such as wetlands, flora and fauna. 
 “Environmental Liability” shall mean any
liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), of any Group Member directly or indirectly resulting from or based upon (a) violation of any
Environmental Law, (b) the generation, use, handling, transportation, storage or treatment of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the Release or threatened Release of any Hazardous Materials or
(e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing. 

“Environmental Permit” shall mean any permit, approval, identification number, license or other authorization required under
any Environmental Law. 
 “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended from time to
time. 

  
 -17- 

 “ERISA Affiliate” shall mean any Person that for purposes of Title IV of ERISA
is a member of the controlled group of any Loan Party, or under common control with any Loan Party, within the meaning of Section 414 of the Code. 

“ERISA Event” shall mean (a) (i) the occurrence of a reportable event, within the meaning of Section 4043 of
ERISA, with respect to any Plan unless the 30-day notice requirement with respect to such event has been waived by the PBGC under the regulations in effect on the Closing Date or (ii) the requirements of Section 4043(b) of ERISA are met
with respect to a contributing sponsor, as defined in Section 4001(a)(13) of ERISA, of a Plan, and an event described in paragraph (9), (10), (11), (12) or (13) of Section 4043(c) of ERISA could reasonably be expected to occur
with respect to such Plan within the following 30 days; (b) with respect to any Plan, the failure to satisfy the minimum funding standard under Section 412 of the Code and Section 302 of ERISA, whether or not waived, or the failure to
make any required contribution to a Multiemployer Plan; (c) the application for a minimum funding waiver with respect to a Plan; (d) the provision by the administrator of any Plan of a notice of intent to terminate such Plan pursuant to
Section 4041(a)(2) of ERISA (including any such notice with respect to a plan amendment referred to in Section 4041(e) of ERISA); (e) the cessation of operations at a facility of any Loan Party or any ERISA Affiliate in the
circumstances described in Section 4062(e) of ERISA; (f) the partial or complete withdrawal by any Loan Party or any ERISA Affiliate from a Multiemployer Plan; (g) the conditions for imposition of a lien under Section 303(k) of
ERISA shall have been met with respect to any Plan; (h) the institution by the PBGC of proceedings to terminate a Plan pursuant to Section 4042 of ERISA, or the occurrence of any event or condition described in Section 4042 of ERISA,
that constitutes grounds for the termination of, or the appointment of a trustee to administer, a Plan; or (i) the occurrence of a nonexempt prohibited transaction with respect to an employee benefit plan maintained or contributed to by a Group
Member (within the meaning of Section 4975 of the Code or Section 406 of ERISA) which could result in material liability to any Loan Party. 

“Euro” and “€” shall mean the lawful currency of the Participating Member States introduced in
accordance with the EMU Legislation. 
 “Eurodollar Loans” shall mean Loans the rate of interest applicable to which is
based upon the Eurodollar Rate. Eurodollar Loans may be denominated in Dollars or an Alternative Currency (other than Dollars). 

“Eurodollar Rate” shall mean, for any Interest Period with respect to a LIBOR Loan of any currency, the LIBOR Screen Rate as
of approximately 11:00 a.m., London time, two Business Days prior to the commencement of such Interest Period, for deposits in such currency for such Interest Period; provided that if a LIBOR Screen Rate shall not be available at the
applicable time for the applicable Interest Period, then the Eurodollar Rate for such currency and Interest Period shall be the Interpolated Rate; provided, further, that in no event shall the Eurodollar Rate for any Interest Period
for any Tranche B Term Loan at any time be less than 0.75% per annum. 
 “Eurodollar Tranche” shall mean,
collectively, Eurodollar Loans under a particular Facility the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same
day). 
 “Events of Default” shall have the meaning given to such term in Section 8.1. 

“Excess Cash Flow” shall mean, for any Fiscal Year of the Borrower, the excess, if any, of (a) Cash Flow from Operating
Activities over (b) the sum, without duplication, of (i) the aggregate amount (A) actually paid by the Borrower and its Subsidiaries during such Fiscal Year and (B) expected

  
 -18- 

 
as of the last day of such Fiscal Year to be paid in the first Fiscal Quarter following such Fiscal Year, on account of Capital Expenditures or any other expenditures for Capital Assets
(excluding the principal amount of Debt incurred in connection with such expenditures and any such expenditures financed with the proceeds of any Reinvestment Deferred Amount); provided that (I) any amount deducted on account of such
committed expenditure pursuant to clause (B) shall not be deducted in the calculation of Excess Cash Flow for the following Fiscal Year to the extent such amount is actually paid in the first Fiscal Quarter of the following Fiscal Year, and
(II) to the extent any such committed amount is not actually paid in the first Fiscal Quarter of the following Fiscal Year, such unspent amount shall not be deducted in the calculation of Excess Cash Flow for the preceding Fiscal Year, (ii) the
aggregate amount of all prepayments of Revolving Loans and Swingline Loans during such Fiscal Year to the extent of accompanying permanent optional reductions of the Revolving Commitments and all optional prepayments of the Term Loans during such
Fiscal Year, (iii) the aggregate amount of all regularly scheduled principal payments of Funded Debt (including the Term Loans) of the Borrower and its Subsidiaries made during such Fiscal Year (other than in respect of any revolving credit
facility to the extent there is not an equivalent permanent reduction in commitments thereunder), (iv) the aggregate amount actually paid during such Fiscal Year, or expected to be paid in the first Fiscal Quarter of the following Fiscal Year
pursuant to letters of intent or acquisition agreements, on Investments pursuant to Section 7.6(e), (f), (j), (k) or (m) pursuant to this clause (iv) without giving effect to any part of an
Investment that was permitted by utilizing the Available Amount; provided that (I) any amount deducted on account of such letter of intent or acquisition agreement shall not be deducted in the calculation of Excess Cash Flow for the
following Fiscal Year to the extent such amount is actually paid in the first Fiscal Quarter of the following Fiscal Year and (II) to the extent any such committed amount is not actually paid in the first Fiscal Quarter of the following Fiscal Year,
such unspent amount shall not be deducted in the calculation of Excess Cash Flow for the preceding Fiscal Year and (v) the aggregate amount of distributions on account of non-controlling interests in Subsidiaries. 

“Excess Cash Flow Application Date” shall have the meaning given to such term in Section 2.11(c). 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time, and the regulations promulgated
and the rulings issued thereunder. 
 “Executive Order” shall have the meaning given to such term in
Section 4.23(a). 
 “Excluded Swap Obligation” shall mean, with respect to any Guarantor, any Swap Obligation
if, and to the extent that, all or a portion of the guaranty of such Guarantor of, or the grant by such Guarantor of a security interest to secure, such Swap Obligation (or any Guaranty thereof) is or becomes illegal under the Commodity Exchange Act
or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor’s failure for any reason to constitute an “eligible contract
participant” as defined in the Commodity Exchange Act (determined after giving effect to Section 10.10 and any other “keepwell, support or other agreement” for the benefit of such Guarantor and any and all guarantees of such
Guarantor’s Swap Obligations by other Loan Parties) at the time the guaranty of such Guarantor, or a grant by such Guarantor of a security interest, becomes effective with respect to such Swap Obligation. If a Swap Obligation arises under a
master agreement governing more than one swap, such exclusion shall apply only to the portion of such Swap Obligation that is attributable to swaps for which such Guaranty or security interest is or becomes excluded in accordance with the first
sentence of this definition. 
 “Existing Credit Agreement” shall have the meaning given to such term in the recitals
hereto. 

  
 -19- 

 “Existing Issuing Bank” shall mean each bank which issued Existing Letters of
Credit. 
 “Existing Letters of Credit” shall mean all letters of credit outstanding on the Closing Date, as more fully
described on Schedule 1.1 hereto. 
 “Existing Notes” shall have the meaning given to such term in the recitals
hereto. 
 “Extended Revolving Commitment” shall have the meaning given to such term in Section 2.25(a). 

“Extended Term Loans” shall have the meaning given to such term in Section 2.25(a). 

“Extending Revolving Lender” shall have the meaning given to such term in Section 2.25(a). 

“Extending Term Lender” shall have the meaning given to such term in Section 2.25(a). 

“Extension” shall have the meaning given to such term in Section 2.25(a). 

“Extension Offer” shall have the meaning given to such term in Section 2.25(a). 

“Facility” shall mean each of (a) the Tranche A Term Commitments and the Tranche A Term Loans made thereunder (the
“Tranche A Term Facility”), (b) the Tranche B Term Commitments and the Tranche B Term Loans made thereunder (the “Tranche B Term Facility”), (c) the Revolving Facility, (d) the Extended Term Loans, if
any, and (e) the Extended Revolving Commitments, if any, as the case may be. 
 “Federal Funds Effective Rate” shall
mean, for any day, the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank
of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day of such transactions received by the Administrative Agent from three federal funds brokers of recognized standing
selected by it. 
 “Fee Payment Date” shall mean (a) the third Business Day following the last day of each March,
June, September and December and (b) the last day of the Revolving Commitment Period. 
 “FIRREA” shall mean the
Financial Institutions Reform, Recovery and Enforcement Act of 1989, as amended. 
 “First Lien Intercreditor Agreement”
shall mean an intercreditor agreement substantially in the form of Exhibit Q hereto (in such form or with immaterial changes thereto which the Administrative Agent is hereby authorized to enter into) together with any material changes
thereto requested by Borrower in light of prevailing market conditions, which material changes shall be posted to the Lenders not less than five (5) Business Days before execution thereof and, if the Required Lenders shall not have objected to
such changes within five (5) Business Days after posting, then the Required Lenders shall be deemed to have agreed that the Administrative Agent’s entry into such intercreditor agreement (with such changes) is reasonable and to have
consented to such intercreditor agreement (with such changes) and to the Administrative Agent’s execution thereof. 

  
 -20- 

 “Fiscal Quarter” shall mean, with respect to the Borrower or any of its
Subsidiaries, the period commencing January 1 in any Fiscal Year and ending on the next succeeding March 31, the period commencing April 1 in any Fiscal Year and ending on the next succeeding June 30, the period commencing
July 1 in any Fiscal Year and ending on the next succeeding September 30 or the period commencing October 1 in any Fiscal Year and ending on the next succeeding December 31, as the context may require, or, if any such Subsidiary
was not in existence on the first day of any such period, the period commencing on the date on which such Subsidiary is incorporated, organized, formed or otherwise created and ending on the last day of such period. 

“Fiscal Year” shall mean, with respect to the Borrower or any of its Subsidiaries, the period commencing on January 1 in
any calendar year and ending on the next succeeding December 31 or, if any such Subsidiary was not in existence on January 1 in any calendar year, the period commencing on the date on which such Subsidiary is incorporated, organized,
formed or otherwise created and ending on the next succeeding December 31. 
 “Foreign Subsidiary” shall mean any
Subsidiary of the Borrower that is not a Domestic Subsidiary. 
 “Funded Debt” of any Person shall mean all Debt as set
forth on the balance sheet of such Person determined on a Consolidated basis in accordance with GAAP, including, without limitation, (i) the aggregate amount of Government Reimbursement Program Costs (exclusive of, with respect to the
determination of Funded Debt in any period, the portion of Government Reimbursement Program Costs paid in such period), (ii) in the case of the Borrower, the Loans, (iii) any Receivables Transaction Amount and (iv) all obligations of
such Person to purchase, redeem, retire, defease or otherwise make any payment in respect of any preferred Capital Stock in such Person or any other Person; provided, however, that the term “Funded Debt” shall not include any
Contingent Obligations of such Person (if and to the extent such Contingent Obligations would otherwise be included in such term on any date of determination) that are incurred solely to support any obligations, Debt or Government Reimbursement
Program Costs of the Borrower or one or more Subsidiaries of the Borrower to the extent such Contingent Obligations are otherwise expressly permitted to be incurred under Section 7.2. 

“Funding Office” shall mean, with respect to any currency, the office of the Administrative Agent specified in
Section 11.2 or such other office as may be specified from time to time by the Administrative Agent as its funding office by written notice to the Borrower and the Lenders. 

“GAAP” shall mean generally accepted accounting principles in the United States as in effect from time to time applied on a
consistent basis, subject to Section 1.4. 
 “Government Reimbursement Program Costs” shall mean, with respect
to any payable of the Borrower and its Subsidiaries, the sum of: 
 (i) all amounts (including punitive and other similar
amounts) agreed to be paid in settlement or payable as a result of a final, non-appealable judgment, award or similar order relating to participation in Medical Reimbursement Programs; 

(ii) all final, non-appealable fines, penalties, forfeitures or other amounts rendered pursuant to criminal indictments or
other criminal proceedings relating to participation in Medical Reimbursement Programs; and 

  
 -21- 

 (iii) the amount of final, non-appealable recovery, damages, awards, penalties,
forfeitures or similar amounts rendered in any litigation, suit, arbitration, investigation or other legal or administrative proceeding of any kind relating to participation in Medical Reimbursement Programs. 

“Government Reimbursement Programs” shall have the meaning given to such term in Section 4.17(a). 

“Governmental Authority” shall mean any nation or government, any state or other political subdivision thereof, any agency,
authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government (including any supranational authority such
as the European Union or the European Central Bank), any securities exchange and any self-regulatory organization (including the National Association of Insurance Commissioners). 

“Governmental Authorization” shall mean any authorization, approval, consent, franchise, license, covenant, order, ruling,
permit, certification, exemption, notice, declaration or similar right, undertaking or other action of, to or by, or any filing, qualification or registration with, any Governmental Authority. 

“Group Members” shall mean the Borrower and its Subsidiaries. 

“Guaranteed Obligations” shall have the meaning given to such term in Section 10.1. 

“Guarantor” shall mean, except as permitted by Section 6.12 or Section 7.12, each Subsidiary of the
Borrower (other than any Special Purpose Receivables Subsidiary and any Regulated Subsidiary, including, without limitation, and for so long as such Subsidiary remains a Regulated Subsidiary, DaVita HealthCare Partners Plan, Inc.). 

“Hazardous Materials” shall mean (a) petroleum or petroleum products, by-products or breakdown products, radioactive
materials, asbestos, asbestos-containing materials, polychlorinated biphenyls and radon gas and (b) any other chemicals, materials, substances, wastes (including medical and human waste), constituents, pollutants or contaminants subject to
regulation or which can give rise to liability under any Environmental Law. 
 “HCP LLC” shall mean HealthCare Partners,
LLC. 
 “HCPAMG” shall mean HealthCare Partners Affiliates Medical Group, a California general partnership. 

“HPMGI” shall mean HealthCare Partners Medical Group, Inc. 

“HIPAA” shall have the meaning given to such term in Section 4.17(b). 

“Impacted Interest Period” shall mean, with respect to a LIBOR Screen Rate, an Interest Period which shall not be available
at the applicable time. 
 “Increase Effective Date” shall have the meaning given to such term in
Section 2.24(a). 
 “Increase Joinder” shall have the meaning given to such term in
Section 2.24(c). 

  
 -22- 

 “Incremental Term Loan Commitment” shall have the meaning given to such term in
Section 2.24(a). 
 “Incremental Term A Loans” shall have the meaning given to such term in
Section 2.24(c). 
 “Incremental Term B Loans” shall have the meaning given to such term in
Section 2.24(c). 
 “Incremental Term Loans” shall have the meaning given to such term in
Section 2.24(c). 
 “Indemnitee” shall have the meaning given to such term in Section 11.5(b). 

“Information” shall have the meaning given to such term in Section 11.15. 

“Insurance Policies” shall mean the insurance policies and coverages required to be maintained by each Loan Party which is an
owner of Mortgaged Property with respect to the applicable Mortgaged Property pursuant to Section 6.5 and all renewals and extensions thereof. 

“Insurance Requirements” shall mean, collectively, all provisions of the Insurance Policies, all requirements of the issuer
of any of the Insurance Policies and all orders, rules, regulations and any other requirements of the National Board of Fire Underwriters (or any other body exercising similar functions) binding upon each Loan Party which is an owner of Mortgaged
Property and applicable to the Mortgaged Property or any use or condition thereof. 
 “Intellectual Property” shall mean,
collectively, all rights, priorities and privileges relating to intellectual property, whether arising under United States, multinational or foreign laws or otherwise, including copyrights, copyright licenses, patents, patent licenses, trademarks,
trademark licenses, trade names, service marks, domain names, trade secrets, proprietary information, technology, know-how and processes, and all rights to sue at law or in equity for any infringement or other impairment thereof, including the right
to receive all proceeds and damages therefrom. 
 “Intercompany Note” shall mean a promissory note substantially in the
form of Exhibit M. 
 “Intercompany Receivables” shall mean any debits or credits by and among the Borrower and
its Subsidiaries arising in connection with any centralized purchasing, payment or other cash management or treasury services, in each case, in the ordinary course of business. 

“Intercreditor Agreements” shall mean the First Lien Intercreditor Agreement and the Junior Lien Intercreditor Agreement,
collectively, in each case to the extent in effect. 
 “Interest Election Request” shall mean an Interest Election Request,
substantially in the form of Exhibit P. 
 “Interest Payment Date” shall mean (a) as to any ABR Loan
(other than any Swingline Loan), the last day of each March, June, September and December to occur while such Loan is outstanding and the final Maturity Date of the Facility under which such Loan was made, (b) as to any Eurodollar Loan having
an Interest Period of three months or less, the last day of such Interest Period and the Maturity Date of the Facility under which such Loan was made, (c) as to any Eurodollar Loan having an Interest Period longer than three months, each day
that is three months, or a whole multiple thereof, after the first 

  
 -23- 

 
day of such Interest Period, the last day of such Interest Period and the Maturity Date of the Facility under which such Loan was made, (d) as to any Loan (other than any Revolving Loan that
is an ABR Loan and any Swingline Loan), the date of any repayment or prepayment made in respect thereof and (e) as to any Swingline Loan, the day that such Loan is required to be repaid. 

“Interest Period” shall mean, as to any Eurodollar Loan, (a) initially, the period commencing on the borrowing or
conversion date, as the case may be, with respect to such Eurodollar Loan and ending (x) one week thereafter or (y) one, two, three or six or (if available to all Lenders under the relevant Facility) twelve months thereafter, as selected
by the Borrower in its notice of borrowing or notice of conversion, as the case may be, given with respect thereto; and (b) thereafter, each period commencing on the last day of the next preceding Interest Period applicable to such Eurodollar
Loan and ending one, two, three or six or (if available to all Lenders under the relevant Facility) or twelve months thereafter, as selected by the Borrower by irrevocable notice to the Administrative Agent not later than 11:00 A.M., Local Time, on
the date that is three Business Days prior to the last day of the then current Interest Period with respect thereto; provided that all of the foregoing provisions relating to Interest Periods are subject to the following: 

(a) if any Interest Period would otherwise end on a day that is not a Business Day, such Interest Period shall be extended to
the next succeeding Business Day unless the result of such extension would be to carry such Interest Period into another calendar month in which event such Interest Period shall end on the immediately preceding Business Day; 

(b) the Borrower may not select an Interest Period under a particular Facility that would extend beyond the Maturity Date of
such Facility; and 
 (c) any Interest Period that begins on the last Business Day of a calendar month (or on a day for which
there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of a calendar month. 

“Interpolated Rate” shall mean, at any time, for any Interest Period, the rate per annum (rounded to the same number of
decimal places as the LIBOR Screen Rates) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between:
(a) the LIBOR Screen Rate for the longest period (for which the LIBOR Screen Rate is available) that is shorter than the Impacted Interest Period and (b) the LIBOR Screen Rate for the shortest period (for which the LIBOR Screen Rate is
available) that exceeds the Impacted Interest Period, in each case, as of 11:00 a.m., London Time, two Business Days prior to the commencement of such Interest Period. When determining the rate for a period which is less than the shortest period for
which the LIBOR Screen Rate is available, the LIBOR Screen Rate for purposes of paragraph (a) above shall be deemed to be the overnight screen rate where “overnight screen rate” means the overnight rate determined by the
Administrative Agent from such service as the Administrative Agent may select. 
 “Investment” shall mean, with respect to
any Person, any loan or advance to such Person, any purchase or other acquisition of Capital Stock or Debt of, or the property and assets comprising a division or business unit or all or a substantial part of the business of, such Person, any
capital contribution to such Person or any other investment in such Person, including, without limitation, any acquisition by way of a merger or consolidation (or similar transaction) and any arrangement pursuant to which the investor incurs Debt of
the types referred to in clause (j) or (k) of the definition of “Debt” set forth in this Section 1.1 in respect of such Person, but excluding advances or extensions of credit to customers and receivables arising in
the ordinary course of business and in connection with any Physician Group. For the avoidance of doubt, without any implication to the contrary, no Intercompany Receivables or any transactions giving rise thereto shall constitute Investments. 

  
 -24- 

 “Issuing Lender” shall mean any of (i) JPMorgan Chase Bank, N.A.,
(ii) Wells Fargo Bank, National Association, (iii) Barclays Bank PLC, or in each case, any affiliate thereof, in its capacity as issuer of any Letter of Credit, (iv) any other Lender reasonably satisfactory to the Administrative Agent
that from time to time agrees in writing to issue Letters of Credit hereunder; provided that, if any Extension or Extensions of Revolving Commitments is or are effected in accordance with Section 2.25, then on the occurrence of
the Revolving Termination Date and on each later date which is or was at any time a Maturity Date with respect to Revolving Commitments (each, an “Issuing Lender/Swingline Termination Date”), each Issuing Lender at such time shall
have the right to resign as an Issuing Lender on, or on any date within twenty (20) Business Days after, the respective Issuing Lender/Swingline Termination Date, in each case upon not less than ten (10) days’ prior written notice
thereof to the Borrower and the Administrative Agent and, in the event of any such resignation and upon the effectiveness thereof, the respective entity so resigning shall retain all of its rights hereunder and under the other Loan Documents as an
Issuing Lender with respect to all Letters of Credit theretofore issued by it (which Letters of Credit shall remain outstanding in accordance with the terms hereof until their respective expirations) but shall not be required to issue any further
Letters of Credit hereunder, and (v) solely with respect to the Existing Letters of Credit, each Existing Issuing Bank. If at any time and for any reason (including as a result of resignations as contemplated by the proviso to the preceding
sentence), each Issuing Lender has resigned in such capacity in accordance with the preceding sentence, then no Person shall be an Issuing Lender hereunder obligated to issue Letters of Credit unless and until (and only for so long as) a Lender (or
affiliate of a Lender) reasonably satisfactory to the Administrative Agent and the Borrower agrees to act as Issuing Lender hereunder. 

“Issuing Lender/Swingline Termination Date” shall have the meaning given to such term in the definition of “Issuing
Lender.” 
 “Joinder Agreement” shall mean a joinder agreement substantially in the form of Exhibit L.

 “Junior Lien Intercreditor Agreement” shall mean an intercreditor agreement by and among the Collateral Agent and the
collateral agents or other representatives for the holders of Indebtedness secured by Liens on the Collateral that are intended to rank junior to the Liens securing the Obligations and that are otherwise Liens permitted pursuant to
Section 7.1, providing that all proceeds of Collateral shall first be applied to repay the Obligations in full prior to being applied to any obligations under the Indebtedness secured by such junior Liens and that until the termination
of the Commitments and the repayment in full (or cash collateralization of outstanding Letters of Credit) of all Obligations (other than contingent obligations not then due and payable), the Collateral Agent shall have the sole right to exercise
remedies against the Collateral (subject to customary exceptions and the expiration of any standstill periods) and otherwise in form and substance reasonably satisfactory to the Collateral Agent. 

“Latest Maturity Date” shall mean, at any date of determination, the latest Maturity Date applicable to any Loan or
Commitment hereunder at such time, including the latest maturity date of any Refinancing Term Loan, any Refinancing Term Commitment, any Extended Term Loan, any Extended Revolving Commitment, any Incremental Term Loans, any Increased Revolving
Commitments or any Other Revolving Commitments, in each case as extended in accordance with this Agreement from time to time. 

  
 -25- 

 “LC Commitment” shall mean $325,000,000, which amount shall be allocated among
the Issuing Lenders in the respective amounts set forth beside each Issuing Lender in Schedule II hereto. 
 “LC
Disbursement” shall mean a payment by the Issuing Lender pursuant to a Letter of Credit. 
 “LC Obligations” shall
mean, at any time, the aggregate Alternative Currency LC Obligations and Dollar LC Obligations. 
 “LC Request” shall mean
an LC Request, substantially in the form of Exhibit O. 
 “Lenders” shall have the meaning given to such term
in the preamble hereto; provided that unless the context otherwise requires, each reference herein to the Lenders shall be deemed to include any Conduit Lender. 

“Lending Office” shall mean, as to any Lender, the office or offices of such Lender described as such in such Lender’s
Administrative Questionnaire, or such other office or offices as a Lender may from time to time notify the Borrower and the Administrative Agent. 

“Letters of Credit” shall have the meaning given to such term in Section 3.1(a). 

“Leverage Ratio” shall mean, at any date of determination, the ratio of (a) (i) all Funded Debt of the Borrower and
its Subsidiaries, including Debt in respect of Specified Letters of Credit outstanding as of such date (assuming that the maximum amount of each such Specified Letter of Credit is fully drawn) plus (ii) to the extent not otherwise
included in subclause (a)(i) of this definition, the face amount of all Letters of Credit issued for the account of the Borrower or any of its Subsidiaries minus (iii) unrestricted cash and Cash Equivalents of the Borrower and its
Subsidiaries on a Consolidated basis to (b) Consolidated EBITDA of the Borrower and its Subsidiaries for the most recently completed Measurement Period prior to such date. 

The Leverage Ratio shall be calculated on a Pro Forma Basis to give effect to any Debt incurred, assumed or permanently repaid or extinguished
after the relevant Measurement Period but prior to or contemporaneously with the Reference Date as if such incurrence, assumption, repayment or extinguishment had been effected on the last day of such period. Notwithstanding anything to the contrary
contained in this paragraph, when calculating the Leverage Ratio for purposes of (i) the Pricing Grid (ii) the ECF Percentage and (iii) determining actual compliance (and not compliance on a Pro Forma Basis) with
Section 7.16(a), (A) any Debt incurred, assumed or permanently repaid or extinguished subsequent to the end of the applicable Measurement Period shall not be given pro forma effect and (B) such calculations shall
be based on the financial statements delivered pursuant to Section 6.1(b) or (c), as applicable, for the relevant Measurement Period. 

“LIBOR Screen Rate” shall mean the London interbank offered rate administered by the ICE Benchmark Administration Limited (or
any other Person that takes over the administration of such rate) for the applicable currency for a period equal in length to such Interest Period as displayed on pages LIBOR01 or LIBOR02 of the Reuters screen or, in the event such rate does not
appear on either of such Reuters pages, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative
Agent from time to time in its reasonable discretion; provided, that, if any LIBOR Screen Rate shall be less than zero, such rate shall be deemed to be zero for purposes of this Agreement. 

  
 -26- 

 “Lien” shall mean any mortgage, deed of trust, pledge, hypothecation,
assignment, deposit arrangement, encumbrance, lien (statutory or other), charge or other security interest or any preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including any
conditional sale or other title retention agreement and any capital lease having substantially the same economic effect as any of the foregoing). 

“Loan” shall mean any loan made by any Lender pursuant to this Agreement (including pursuant to Section 2.24).

 “Loan Documents” shall mean this Agreement, the Security Documents and the Notes. 

“Loan Parties” shall mean each Group Member that is a party to a Loan Document. 

“Local Time” shall mean the local time in (i) London with respect to Obligations denominated in an Alternative Currency
and (ii) New York City, otherwise. 
 “Majority Facility Lenders” shall mean, with respect to any Facility, the
holders of more than 50% of the aggregate unpaid principal amount of the Term Loans, Extended Term Loans or the Total Revolving Extensions of Credit, as the case may be, outstanding under such Facility (or, in the case of the Dollar Revolving
Facility or the Alternative Currency Revolving Facility, prior to any termination, respectively, of the Dollar Revolving Commitments or the Alternative Currency Revolving Commitments, the holders of more than 50% of the Total Dollar Revolving
Commitments or Total Alternative Currency Revolving Commitments, respectively). 
 “Management Services Agreement” shall
mean each of those certain agreements by and between a Group Member (or any Physician Group with an existing agreement with a Group Member for the provision of management services) and any Physician Group pursuant to which such Group Member (or
Physician Group) provides management services to such Physician Group; provided that each Management Services Agreement (i) existing on the Closing Date and (ii) entered into in connection with an acquisition of a Physician Group
pursuant to Section 7.2(m) shall, in each case, provide that a substantial portion of the management fees (which, for the avoidance of doubt and without any implication to the contrary, shall not include any fees for reimbursement of
expenses and other cost sharing arrangements) payable thereunder shall be paid to a Loan Party (or any Physician Group with an existing agreement to pay fees to a Loan Party for the provision of management services). 

“Mandatory Prepayment Date” shall have the meaning given to such term in Section 2.11(e). 

“Margin Stock” shall mean “margin stock” as defined in Regulation U of the Board, as the same may be amended
or supplemented from time to time. 
 “Material Adverse Effect” shall mean a material adverse effect on (a) the
business, property, operations, or financial condition of the Borrower and its Subsidiaries taken as a whole, (b) the validity or enforceability of this Agreement or any of the other Loan Documents or the rights or remedies of the
Administrative Agent, the Collateral Agent or the Lenders hereunder or thereunder or (c) the Collateral or the Liens in favor of the Collateral Agent (for its benefit and for the benefit of the other Secured Parties) on the Collateral or on the
priority of such Liens. 

  
 -27- 

 “Material Subsidiary” shall mean, as of any date, (a) any Subsidiary of the
Borrower that accounted for more than 5% of Consolidated Net Income of the Borrower and its Subsidiaries for the most recently completed Fiscal Quarter on or prior to such date as reflected in the Required Financial Information most recently
delivered to the Administrative Agent and the Lenders on or prior to such date and determined in accordance with GAAP for such period and (b) each other Subsidiary of the Borrower that, when combined with any other Subsidiary, each of which at
the time of determination is the subject of an Event of Default under Section 8.1(g), would constitute a Material Subsidiary under clause (a) above. 

“Maturity Date” shall mean (i) with respect to the Tranche A Term Loans that have not been extended pursuant to
Section 2.25, the Tranche A Term Loan Maturity Date, (ii) with respect to the Tranche B Term Loans that have not been extended pursuant to Section 2.25, the Tranche B Term Loan Maturity Date, (iii) with respect to
the Revolving Commitments that have not been extended pursuant to Section 2.25, the Revolving Termination Date and (iv) with respect to any Class of Extended Term Loans or Extended Revolving Commitments, the final maturity date as
specified in the applicable Extension Offer accepted by the respective Lender or Lenders; provided that if any such day is not a Business Day, the applicable Maturity Date shall be the Business Day immediately succeeding such day. 

“Maximum Rate” shall have the meaning given to such term in Section 11.18. 

“Measurement Period” shall mean, at any date of determination, the most recently completed four consecutive Fiscal Quarters
ended prior to such date for which financial information is (or is required to be) available. 
 “Medicaid” shall mean that
means-tested entitlement program under Title XIX of the Social Security Act that provides federal grants to states for medical assistance based on specific eligibility criteria (Social Security Act of 1965, Title XIX, P.L. 89-87, as amended; 42
U.S.C. § 1396 et seq.). 
 “Medical Reimbursement Programs” shall mean the Medicare, Medicaid and
Tricare programs and any other health care program operated by or financed in whole or in part by any federal, state or local government. 

“Medicare” shall mean that government-sponsored entitlement program under Title XVIII of the Social Security Act that
provides for a health insurance system for eligible elderly and disabled individuals (Social Security Act of 1965, Title XVIII, P.L. 89-87, as amended; 42 U.S.C. § 1395 et seq.). 

“Minimum Extension Condition” shall have the meaning given to such term in Section 2.25(b). 

“Minority Investment” shall have the meaning given to such term in Section 7.6(f). 

“Moody’s” shall mean Moody’s Investors Service, Inc. 

“Mortgaged Properties” shall mean each Real Property, if any, which shall be subject to a Mortgage delivered after the
Closing Date pursuant to Section 6.12(c). 
 “Mortgages” shall mean each of the mortgages and deeds of trust
made by any Loan Party in favor of, or for the benefit of, the Collateral Agent for the benefit of the Secured Parties, in a form reasonably satisfactory to the Collateral Agent. 

  
 -28- 

 “Multiemployer Plan” shall mean a multiemployer plan as defined in
Section 4001(a)(3) of ERISA to which any Group Member or ERISA Affiliate is required to contribute or could otherwise have liability. 

“Net Cash Proceeds” shall mean (a) in connection with any Asset Sale or any Recovery Event, the proceeds thereof in the
form of cash and Cash Equivalents (including any such proceeds received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise, but only as and when received) of such
Asset Sale or Recovery Event, net of attorneys’ fees, accountants’ fees, investment banking fees, amounts required to be applied to the repayment of Debt secured by a Lien expressly permitted hereunder on any asset that is the subject of
such Asset Sale or Recovery Event (other than any Lien pursuant to a Security Document) and other customary fees and expenses actually incurred (or estimated by the Borrower in good faith) in connection therewith, and net of (i) taxes paid or
reasonably estimated to be payable as a result thereof (after taking into account any available tax credits or deductions and any tax sharing arrangements), (ii) amounts reserved in accordance with GAAP against liabilities relating to breaches
of representations and warranties and indemnification obligations, liabilities related to environmental matters or other liabilities associated with the property and liabilities relating to assets subject to such sale, lease, transfer or other
disposition that are not assumed by the purchaser in such Asset Sale and (iii) in the case of any Asset Sale by a Subsidiary, the amount of any payments or distributions required to be made in respect of such transaction to owners of Capital
Stock in such Subsidiary other than the Borrower or any other Subsidiary and (b) in connection with any issuance or sale of Capital Stock or any incurrence of Debt, the cash proceeds received from such issuance or incurrence, net of
attorneys’ fees, investment banking fees, accountants’ fees, underwriting discounts and commissions and other customary fees and expenses actually incurred in connection therewith. 

“New Senior Notes” shall mean the 5.125% Senior Notes due 2024 in an aggregate principal amount of $1,750,000,000 outstanding
as of the Closing Date issued pursuant to the New Senior Notes Indenture. 
 “New Senior Notes Documents” shall mean the
New Senior Notes, the New Senior Notes Indenture and the New Senior Notes Guarantees. 
 “New Senior Notes Guarantees”
shall mean the guarantees by the Guarantors of the New Senior Notes pursuant to the New Senior Notes Indenture. 
 “New Senior Notes
Indenture” shall mean the indenture dated as of June 13, 2014 by and among the Borrower, the Guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as trustee, pursuant to which the New Senior Notes were issued,
as the same may be amended or supplemented from time to time. 
 “NMTC” shall mean a new market tax credit as defined in
Section 45D of the Code. 
 “NMTC Documents” shall mean any credit, loan or finance agreement and any other document,
agreement or instrument governing or otherwise relating to any NMTC Indebtedness. 
 “NMTC Indebtedness” shall mean any
Debt incurred by a NMTC Subsidiary, including in the form of an intercompany loan from the Borrower or another Subsidiary in connection with an NMTC financing, the proceeds of which such NMTC Subsidiary will substantially concurrently use to acquire
real property, renovate real property or construct improvements on real property, in each case after the Closing Date (any such acquisition, renovation or construction, an “NMTC Investment”). 

  
 -29- 

 “NMTC Property” shall mean any fixed assets which are acquired, renovated or
improved with the proceeds of NMTC Indebtedness and any related capital contributions. 
 “NMTC Subsidiary” shall mean a
Domestic Subsidiary that receives an intercompany loan in the form of NMTC Indebtedness or any related capital contributions. 

“Nominee Agreement” shall mean, with respect to any Physician Group, any agreement pursuant to which the Borrower or one of
its Subsidiaries has the right, or has the right to appoint another party (a “designated physician”) with the right, to require the owners of a Physician Group to transfer all of their interests in the Physician Group to a Person, who may
be required to have certain qualifications, designated by the Borrower or one of its Subsidiaries or a designating physician, as the case may be. 

“Non-Excluded Taxes” shall have the meaning given to such term in Section 2.19(a). 

“Non-Guarantor Domestic Subsidiary” shall mean a Domestic Subsidiary of the Borrower that is not a Guarantor. 

“Non-Guarantor Subsidiary” shall mean a Subsidiary of the Borrower that is not a Guarantor. 

“Non-U.S. Lender” shall have the meaning given to such term in Section 2.19(e). 

“Notes” shall mean, collectively, each promissory note in the form of
Exhibit N-1, N-2, N-3 or N-4, as applicable, evidencing
Loans. 
 “NPL” shall mean the National Priorities List under CERCLA. 

“Obligations” shall mean (a) obligations of the Borrower and the other Loan Parties from time to time arising under or
in respect of the due and punctual payment of (i) the principal of and premium, if any, and interest (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether
allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or otherwise, (ii) each payment required to be made by the Borrower and the other Loan
Parties under this Agreement in respect of any Letter of Credit, when and as due, including payments in respect of Reimbursement Obligations, interest thereon and obligations to provide cash collateral and (iii) all other monetary obligations,
including fees, costs, expenses and indemnities, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding,
regardless of whether allowed or allowable in such proceeding), of the Borrower and the other Loan Parties under this Agreement and the other Loan Documents, and (b) the due and punctual performance of all covenants, agreements, obligations and
liabilities of the Borrower and the other Loan Parties under or pursuant to this Agreement and the other Loan Documents; provided that Obligations shall exclude any Excluded Swap Obligations. 

“OFAC” shall have the meaning given to such term in Section 4.23(b)(v). 

“OID” shall have the meaning given to such term in Section 2.24(c)(vi). 

“Other Revolving Commitments” shall mean one or more Classes of revolving credit commitments hereunder that result from a
Refinancing Amendment. 

  
 -30- 

 “Other Revolving Loans” shall mean one or more Classes of Revolving Loans that
result from a Refinancing Amendment. 
 “Other Taxes” shall mean any and all present or future stamp or documentary taxes
or any other excise or property taxes, charges or similar levies arising from any payment made hereunder or under any other Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other
Loan Document. 
 “Other Term Loan Commitments” shall mean one or more Classes of term loan commitments hereunder that
result from a Refinancing Amendment. 
 “Other Term Loans” shall mean one or more Classes of Term Loans that result from a
Refinancing Amendment. 
 “Parent” shall mean, with respect to any Lender, any Person as to which such Lender is, directly
or indirectly, a Subsidiary. 
 “Parent Entity” shall mean, for purposes of the provisos to the definition of “Change
of Control,” a newly created entity having, at the time of consummation of a reorganization transaction permitted by such provisos, no assets with a fair market value in excess of $1.0 million (other than Capital Stock of the Borrower and its
Subsidiaries) and no liabilities with a fair market value in excess of $1.0 million, in each case that would be reflected on an unconsolidated balance sheet of such entity at such time. 

“Participant” shall have the meaning given to such term in Section 11.6(c)(i). 

“Participant Register” shall have the meaning given to such term in Section 11.6(c)(iii). 

“Participating Member State” shall mean each state so described in any EMU Legislation. 

“Patriot Act” shall have the meaning given to such term in Section 4.23(a). 

“PBGC” shall mean the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA (or any
successor). 
 “Permitted First Priority Refinancing Debt” shall mean any secured Debt (including any Registered Equivalent
Notes) incurred by the Borrower in the form of one or more series of senior secured notes; provided that (i) such Debt otherwise constitutes Credit Agreement Refinancing Debt, (ii) such Debt is secured by the Collateral on a
pari passu basis (but without regard to the control of remedies) with the Obligations and is not secured by any property or assets of the Borrower or any Subsidiary other than the Collateral, and (iii) a Senior Representative
acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement; provided that if such Debt is the initial Permitted First Priority Refinancing Debt
incurred by the Borrower, then the Borrower, the Subsidiary Guarantors, the Administrative Agent and the Senior Representative for such Debt shall have executed and delivered a First Lien Intercreditor Agreement. Permitted First Priority Refinancing
Debt will include any Registered Equivalent Notes issued in exchange therefor. 
 “Permitted Liens” shall mean the
following types of Liens (excluding any such Lien imposed pursuant to Section 430(k) of the Code or by ERISA or any such Lien relating to or imposed in connection with any Environmental Action): (a) Liens for taxes, assessments and governmental
charges 

  
 -31- 

 
or levies to the extent not otherwise required to be paid under Section 6.3; (b) Liens imposed by law, such as materialmen’s, mechanics’, carriers’,
landlords’, workmen’s and repairmen’s Liens and other similar Liens arising in the ordinary course of business securing obligations (other than Debt for borrowed money) (i) that are not overdue for a period of more than 60 days
or (ii) the amount, applicability or validity of which are being contested in good faith and with respect to which the Borrower or any of its Subsidiaries, as the case may be, has established reserves in accordance with GAAP; (c) pledges
or deposits to secure obligations incurred in the ordinary course of business under workers’ compensation laws, unemployment insurance or similar social security legislation (other than in respect of employee benefit plans subject to ERISA) or
to secure public, regulatory or statutory obligations; (d) Liens, pledges and deposits securing the performance of, or payment in respect of, bids, tenders, leases, contracts (other than for the repayment of borrowed money), surety and appeal
bonds, letters of credit, and other obligations of a similar nature incurred in the ordinary course of business; (e) any interest or title of a lessor or sublessor and any restriction or encumbrance to which the interest or title of such lessor
or sublessor may be subject that is incurred in the ordinary course of business and, either individually or when aggregated with all other Permitted Liens in effect on any date of determination, could not be reasonably expected to have a Material
Adverse Effect; (f) Liens in favor of customs and revenue authorities arising as a matter of law or pursuant to a bond to secure payment of customs duties in connection with the importation of goods; (g) Liens arising out of judgments or
awards that do not constitute an Event of Default under Section 8.1(i) and in respect of which the Borrower or any of its Subsidiaries subject thereto shall be prosecuting an appeal or proceedings for review in good faith and, pending
such appeal or proceedings, shall have secured within 30 days after the entry thereof a subsisting stay of execution and shall be maintaining reserves, in accordance with GAAP, with respect to any such judgment or award; (h) unperfected Liens
of suppliers and vendors to secure the purchase price of the property or assets sold; (i) protective UCC filings by lessors under operating leases; (j) any easements, rights of way, restrictions, defects, encroachments and other
encumbrances on title to Real Property which either individually or when aggregated with all other Permitted Liens, would not be reasonably expected to have a Material Adverse Effect; and (k) bankers’ Liens, rights of setoff and other
similar Liens with respect to cash and Cash Equivalents. 
 “Permitted Other Debt” shall mean Debt of the Borrower or any
other Loan Party; provided that immediately after giving pro forma effect thereto and to the use of the proceeds thereof, (i) no Event of Default shall be continuing or result therefrom, (ii) if such Debt is unsecured, the Borrower
and the Subsidiaries will be in compliance on a Pro Forma Basis (as of the date of such incurrence), after giving effect to any such incurrence, with the covenant set forth in Section 7.16, (iii) if such Debt is secured by a Lien on
the Collateral that is junior to the Lien on the Collateral securing the Obligations, the Borrower and the Subsidiaries will be in compliance on a Pro Forma Basis (as of the date of such incurrence), after giving effect to any such incurrence, with
a Leverage Ratio that is no greater than 0.25x less than the then applicable Leverage Ratio pursuant to the covenant set forth in Section 7.16 (e.g., if the applicable Leverage Ratio under Section 7.16 is 5.00:1.00, then
compliance with this provision would require a Leverage Ratio of no greater than 4.75:1.00), (iv) if such Debt is secured by a Lien on the Collateral that is pari passu with the Lien securing the Obligations, such Debt shall not exceed
the sum of (x) the Shared Incremental Amount and (y) an additional amount such that the Senior Secured Leverage Ratio, on a Pro Forma Basis (as of the date of such incurrence), after giving effect to such incurrence, is no greater than
3.50:1.00, (v) such Debt does not mature prior to the date that is ninety-one (91) days after the Latest Maturity Date at the time such Debt is incurred or the maturity date of such Debt can be extended subject to any customary conditions
to a date that is ninety-one (91) days after the Latest Maturity Date at the time such Debt is incurred, (vi) such Debt shall be in the form of debt securities or junior lien or unsecured credit facility, (vii) if such Debt is
secured, (x) such Debt is secured by the Collateral on a pari passu or junior basis (but without regard to the control of remedies) with the Obligations and is not secured by any property or assets of the Borrower or any Subsidiary other
than the Collateral and (y) such Debt is subject to an Intercreditor Agreement, (viii) such Debt shall not be guaranteed by any Subsidiaries that are not 

  
 -32- 

 
Guarantors hereunder and (ix) such Debt shall have terms and conditions (other than pricing, rate floors, discounts, fees, premiums and optional prepayment or redemption provisions) that in
the good faith determination of the Borrower are not materially less favorable (when taken as a whole) to the Borrower than the terms and conditions of the Loan Documents (when taken as a whole). 

“Permitted Physician Group Loans” shall mean loans or advances to any Physician Group which funds may be used
contemporaneously to finance the acquisition of the equity interests or assets of one or more additional Physician Groups and any Subsidiaries thereof (excluding Subsidiaries organized or acquired in contemplation of such transaction);
provided that (1) immediately before and immediately after giving pro forma effect to any such loan or advance, no Default shall have occurred and be continuing, (2) immediately after giving effect to such loan or advance and any
incurrence of Debt by the Borrower or any Subsidiary made to fund such loan or advance, the Borrower and its Subsidiaries shall be in compliance on a Pro Forma Basis with Section 7.12 and Section 7.16, (3) any such loan
or advance shall be evidenced by a Physician Group Note that, if such loan or advance is greater than $5,000,000, will be delivered to the Collateral Agent for the benefit of the Secured Parties, (4) any additional Physician Group acquired as
an entity pursuant to the foregoing shall enter into a Management Services Agreement with a Group Member (or a Physician Group with a Management Services Agreement with a Group Member) and Nominee Agreements, (5) any acquisition of an
additional Physician Group shall be consummated in compliance with all applicable laws in all material respects and (6) the Borrower shall deliver a certificate of a Responsible Officer, in form and substance reasonably satisfactory to the
Administrative Agent, certifying in the corporate capacity of such Responsible Officer that all of the requirements set forth in clauses (1) through (4) and, to its knowledge based on advice of counsel, (5) have been satisfied or will
be satisfied on or prior to the consummation of such purchase or other acquisition. 
 “Permitted Receivables Documents”
shall mean all documents and agreements evidencing, relating to or otherwise governing a Permitted Receivables Financing. 

“Permitted Receivables Financing” shall mean one or more transactions pursuant to which (i) Receivables Assets or
interests therein are sold to or financed by one or more Special Purpose Receivables Subsidiaries, and (ii) such Special Purpose Receivables Subsidiaries finance their acquisition of such Receivables Assets or interests therein, or the
financing thereof, by selling or borrowing against such Receivables Assets; provided that (A) recourse to Borrower or any Subsidiary (other than the Special Purpose Receivables Subsidiaries) and any obligations or agreements of Borrower
or any Subsidiary (other than the Special Purpose Receivables Subsidiaries) in connection with such transactions shall be limited to the extent customary for similar transactions in the applicable jurisdictions (including, to the extent applicable,
in a manner consistent with the delivery of a “true sale”/“absolute transfer” opinion with respect to any transfer by Borrower or any Subsidiary (other than a Special Purpose Receivables Subsidiary), and (B) the sum of
(x) the aggregate Receivables Transaction Amount outstanding at any time pursuant to clause (a) of the definition of Receivables Transaction Amount and (y) the aggregate Receivables Transaction Amount since the Closing Date pursuant
to clause (b) of the definition of “Receivables Transaction Amount” shall not exceed $500,000,000. 
 “Permitted
Refinancing” shall mean, with respect to any Debt, any modification, refinancing, refunding, renewal or extension of such Debt; provided that (a) the principal amount (or accreted value, if applicable) thereof does not exceed
the principal amount (or accreted value, if applicable) of the Debt so modified, refinanced, refunded, renewed or extended except by an amount equal to unpaid accrued interest and premium thereon plus other amounts paid, and fees and expenses
incurred, in connection with such modification, refinancing, refunding, renewal or extension and by an amount equal to any existing commitments unutilized thereunder; (b) the Debt resulting from such modification, refinancing, refunding,
renewal or extension has a final maturity date equal to or later than the final maturity date of 

  
 -33- 

 
the Indebtedness being modified, refinanced, refunded, renewed or extended; (c) immediately after giving effect thereto, no Default shall have occurred and be continuing; (d) if the
Debt being modified, refinanced, refunded, renewed or extended is subordinated in right of payment to the Obligations, the Debt resulting from such modification, refinancing, refunding, renewal or extension is subordinated in right of payment to the
Obligations on terms at least as favorable to the Lenders as those contained in the documentation governing the Debt being modified, refinanced, refunded, renewed or extended; and (e) no Person that is not an obligor under the Debt being
modified, refinanced, refunded, renewed or extended shall be an obligor under such modification, refinancing, refunding, renewal or extension. 

“Permitted Second Priority Refinancing Debt” shall mean secured Debt (including any Registered Equivalent Notes) incurred by
the Borrower in the form of one or more series of second lien (or other junior lien) secured notes or second lien (or other junior lien) secured loans; provided that (i) such Debt otherwise constitutes Credit Agreement Refinancing Debt,
(ii) such Debt is secured by the Collateral on a second priority (or other junior priority) basis to the liens securing the Obligations and the obligations in respect of any Permitted First Priority Refinancing Debt and is not secured by any
property or assets of the Borrower or any Subsidiary other than the Collateral and (iii) a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a Junior Lien
Intercreditor Agreement; provided that if such Debt is the initial Permitted Second Priority Refinancing Debt incurred by the Borrower, then the Borrower, the Subsidiary Guarantors, the Administrative Agent and the Senior Representative for
such Debt shall have executed and delivered a Junior Lien Intercreditor Agreement. Permitted Second Priority Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor. 

“Permitted Unsecured Refinancing Debt” shall mean unsecured Debt (including any Registered Equivalent Notes) which
constitutes Credit Agreement Refinancing Debt, incurred by the Borrower in the form of one or more series of senior unsecured notes or loans. 

“Person” shall mean an individual, partnership, corporation, limited liability company, business trust, joint stock company,
trust, unincorporated association, joint venture, Governmental Authority or other entity of whatever nature. 
 “Physician
Groups” shall mean HealthCare Partners Affiliates Medical Group, Seismic Medical Group, PC, HealthCare Partners Medical Group (Bacchus), Ltd., JSA Professional Association, Healthcare Partners Medical Group, Inc., Physician Associates of
the Greater San Gabriel Valley, a Medical Group Inc., Northridge Medical Group, Inc., Talbert Medical Group, Inc. and any other professional corporation, limited liability company, partnership or other entity that, directly or indirectly, provides
or arranges medical services and (i) provides or arranges such services in a state that only permits the equity interests of such entity to be held by one or more licensed physicians or licensed professionals or professional entities and
(ii) has entered into and remains party to a Management Services Agreement and a Nominee Agreement. 
 “Physician Group
Note” shall mean a note issued by a Physician Group to the Borrower or a Guarantor that (i) is issued in connection with a Permitted Physician Group Loan, (ii) contains covenants restricting the Physician Group from incurring
financial indebtedness (other than financial indebtedness existing upon acquisition of such Physician Group and not incurred in contemplation of such acquisition(s) and other customary exceptions) and paying dividends or distributions, and
(iii) to the extent (x) not prohibited by a Requirement of Law and (y) that such capital stock or membership interest is actually owned by the Physician Group issuing the note, is secured by a pledge of the capital stock or membership
interests of each Physician Group acquired by the Physician Group issuing the note. 

  
 -34- 

 “Plan” shall mean at a particular time, any employee benefit plan that is
covered by Title IV of ERISA or Section 412 of the Code and in respect of which the Borrower or ERISA Affiliate is (or, if such plan were terminated at such time, would under Section 4069 of ERISA be deemed to be) an “employer”
as defined in Section 3(5) of ERISA, other than any Multiemployer Plan. 
 “Platform” shall have the meaning given to
such term in Section 11.2(d). 
 “Post-Increase Revolving Lenders” shall have the meaning given to such term in
Section 2.24(d). 
 “Pre-Increase Revolving Lenders” shall have the meaning given to such term in
Section 2.24(d). 
 “Premises” shall have the meaning given to such term in the applicable Mortgage. 

“Prepayment Option Notice” shall have the meaning given to such term in Section 2.11(e). 

“Pricing Grid” shall mean the table set forth below. 

For all Loans (other than Tranche B Term Loans) and the Commitment Fee Rate: 

 

							
	 Leverage Ratio
	  	Applicable Margin for
Eurodollar Loans	  	Applicable Margin
for ABR Loans	  	Commitment
Fee Rate
	>3.0 to 1.0	  	2.00%	  	1.00%	  	0.500%
	<3.0 to 1.0 but >2.25 to 1.0	  	1.75%	  	0.75%	  	0.500%
	<2.25 to 1.0	  	1.50%	  	0.50%	  	0.375%

 For the purposes of the Pricing Grid, changes in the Applicable Margin resulting from changes in the Leverage
Ratio shall become effective on the date (the “Adjustment Date”) that is (x) in the case of calculation of the Leverage Ratio as of the last day of the first three Fiscal Quarters of any Fiscal Year, one Business Day after the
date on which financial statements are delivered to the Lenders pursuant to Section 6.1(c) and (y) in the case of calculation of the Leverage Ratio as of the last day of any Fiscal Year, one Business Day after the date on which the
annual financial statements are delivered to Lenders setting forth such financial information and accompanied by such certifications as are required with respect to annual financial information pursuant to Section 6.1(b). Such Applicable
Margin shall remain in effect until the next change to be effected pursuant to this paragraph. If any financial statements referred to above are not delivered within the time periods specified in Section 6.1, then, until the date that is
one Business Day after the date on which such financial statements are delivered, the highest rate set forth in each column of the Pricing Grid shall apply. In addition, at all times while an Event of Default shall have occurred and be continuing,
the highest rate set forth in each column of the Pricing Grid shall apply. Each determination of the Leverage Ratio pursuant to the Pricing Grid shall be made in a manner consistent with the determination thereof pursuant to
Section 7.16(a). 
 “primary obligations” shall have the meaning given to such term in the definition of
“Contingent Obligation” set forth in this Section 1.1. 
 “primary obligor” shall have the meaning
given to such term in the definition of “Contingent Obligation” set forth in this Section 1.1. 

  
 -35- 

 “Prime Rate” shall have the meaning given to such term in the definition of
“ABR.” 
 “Pro Forma Basis” shall mean on a pro forma basis in accordance with GAAP and Regulation S-X;
provided that notwithstanding the provisions of Regulation S-X, (i) pro forma adjustments may include operating expense reductions for such period resulting from the transaction which is being given pro forma effect which are identified
and factually supported in a certificate in which a Responsible Officer of the Borrower certifies that such reductions are reasonably expected to be sustainable and have been realized or the steps necessary for such realization have been taken or
are reasonably expected to be taken within twelve months following any such transaction and (ii) pro forma adjustments may include Pro Forma Physician Group Adjustments. 

“Pro Forma Physician Group Adjustments” shall mean pro forma adjustments arising out of (i) the entering into of
Management Services Agreements in connection with Investments made pursuant to Section 7.6(m) and (ii) the termination of Management Services Agreements in connection with the sale of a Physician Group. In the case of clauses
(i) and (ii) of the preceding sentence, pro forma effect shall be given to the revenue that would have been expected to be received or that will no longer be received, as the case may be, and the expenses that would have been expected to
be incurred or that will no longer be incurred, as the case may be, by the Borrower or a Subsidiary in connection with such Management Services Agreement. Pro Forma Physician Group Adjustments shall be identified and factually supported in a
certificate in which a Responsible Officer of the Borrower certifies that such adjustments are made in good faith and based on assumptions believed to be reasonable. 

“Qualified ECP Guarantor” shall mean, at any time, each Loan Party with total assets exceeding $10,000,000 or that qualifies
at such time as an “eligible contract participant” under the Commodity Exchange Act and can cause another person to qualify as an “eligible contract participant” at such time under Section 1a(18)(A)(v)(II) of the Commodity
Exchange Act. 
 “Qualified Issuer” shall mean any commercial bank that has a combined capital and surplus in excess of
$500,000,000. 
 “Real Property” shall mean, collectively, all right, title and interest (including any leasehold, mineral
or other estate) in and to any and all parcels of or interests in real property owned, leased or operated by any Person, whether by lease, license or other means, together with, in each case, all easements, hereditaments and appurtenances relating
thereto, all improvements and appurtenant fixtures and equipment, all general intangibles and contract rights and other property and rights incidental to the ownership, lease or operation thereof. 

“Receivables Assets” shall mean a right to receive payment arising from a sale or lease of goods or the performance of
services by the Borrower or any of its Subsidiaries pursuant to an arrangement with another Person pursuant to which such other Person is obligated to pay for goods or services under terms that permit the purchase of such goods and services on
credit and all proceeds thereof and rights (contractual or otherwise) and collateral related thereto and shall include, in any event, any items of property that would be classified as an account receivable of the Borrower or any of its Subsidiaries
or an “account,” “chattel paper,” “payment intangible” or “instrument” under the Uniform Commercial Code as in effect in the State of New York and any “supporting obligations” or “proceeds”
as so defined of any such items. 
 “Receivables Transaction Amount” shall mean (a) in the case of any Receivables
Assets securitization, the amount of obligations outstanding under the legal documents entered into as part of such Receivables Assets securitization on any date of determination that would be characterized as principal

  
 -36- 

 
if such Receivables Assets securitization were structured as a secured lending transaction rather than as a purchase and (b) in the case of any sale or factoring of Receivables Assets (but
excluding any transaction included under clause (a) hereof), the cash purchase price paid by the buyer in connection with its purchase of Receivables Assets (including any bills of exchange) less the amount of collections received in respect of
such Receivables Assets and paid to such buyer, excluding any amounts applied to purchase fees or discount or in the nature of interest, in each case as determined in good faith and in a consistent and commercially reasonable manner by the Borrower.

 “Recovery Event” shall mean any settlement of or payment in respect of any property or casualty insurance claim or any
condemnation proceeding relating to any asset of any Group Member. 
 “Redeemable Preferred Interest” shall mean, with
respect to any Person, (a) any Capital Stock of such Person that, by its terms or by the terms of any security into which it is convertible, exercisable or exchangeable, is, or upon the happening of an event or the passage of time or both would
be, required to be redeemed or repurchased (including at the option of the holder thereof) by such Person or any of its Subsidiaries, in whole or in part, earlier than six months after the Latest Maturity Date; provided, however, that
(i) any Capital Stock that would constitute a Redeemable Preferred Interest solely because the holders thereof have the right to require the issuer to repurchase such a Redeemable Preferred Interest upon the occurrence of a change of control
shall not be so treated if the terms thereof (a) do not trigger any rights upon any circumstance constituting a change of control under such Redeemable Preferred Interest that would not constitute a Change of Control under this Agreement and
(b) do not permit either any repurchase by such Person or any rights of the holder of such Capital Stock to assert any claim in respect of such failure to purchase as long as any Event of Default exists hereunder and (ii) any Capital Stock
in any Subsidiary or Minority Investment that the Borrower or any Subsidiary may be required to repurchase from any joint venture partner or other investor in such Subsidiary or Minority Investment shall not constitute Redeemable Preferred Interest.

 “Refinanced Debt” shall have the meaning given to such term in the definition of Credit Agreement Refinancing Debt. 

“Refinanced Term Loans” shall have the meaning given to such term in Section 11.1. 

“Refinancing” shall mean (i) the repayment in full and the termination of any commitment to make extensions of credit
under the Existing Credit Agreement and (ii)(A)(x) the consummation of the Tender Offer and (y) with respect to any Existing Notes not purchased by the Company pursuant to the Tender Offer, the Borrower having irrevocably called such Existing
Notes for redemption and having deposited the full payment price therefor pursuant to the terms of the indenture governing the Existing Notes and (B) in the absence of the consummation of the Tender Offer, the Borrower having irrevocably called
all Existing Notes for redemption and having deposited the full payment price therefor pursuant to the terms of the indenture governing the Existing Notes. 

“Refinancing Amendment” shall mean an amendment to this Agreement executed by each of (a) the Borrower, (b) the
Administrative Agent, (c) each Additional Refinancing Lender and (d) each Lender that agrees to provide any portion of Refinancing Term Loans, Other Revolving Commitments or Other Revolving Loans incurred pursuant thereto, in accordance
with Section 2.27. 
 “Refinancing Series” shall mean all Refinancing Term Loans or Refinancing Term
Commitments that are established pursuant to the same Refinancing Amendment (or any subsequent Refinancing Amendment to the extent such Refinancing Amendment expressly provides that the Refinancing Term Loans or Refinancing Term Commitments provided
for therein are intended to be a part of any previously established Refinancing Series) and that provide for the same effective yield and amortization schedule. 

  
 -37- 

 “Refinancing Term Commitments” shall mean one or more term loan commitments
hereunder that fund Refinancing Term Loans of the applicable Refinancing Series hereunder pursuant to a Refinancing Amendment. 

“Refinancing Term Loans” shall mean one or more term loans hereunder that result from a Refinancing Amendment. 

“Refunded Swingline Loans” shall have the meaning given to such term in Section 2.7(b). 

“Register” shall have the meaning given to such term in Section 11.6(b)(iv). 

“Registered Equivalent Notes” shall mean, with respect to any notes originally issued in an offering pursuant to Rule 144A
under the Securities Act or other private placement transaction under the Securities Act of 1933, substantially identical notes (having the same guarantees) issued in a dollar-for-dollar exchange therefor pursuant to an exchange offer registered
with the SEC. 
 “Regulated Subsidiary” shall mean each future direct and indirect Subsidiary of the Borrower regulated by
a state health, insurance or human services agency in the United States. 
 “Reimbursement Obligation” shall mean the
obligation of the Borrower to reimburse the Issuing Lender pursuant to Section 3.5 for amounts drawn under Letters of Credit. 

“Reinvestment Deferred Amount” shall mean, with respect to any Reinvestment Event, the aggregate Net Cash Proceeds received
by any Group Member in connection therewith that are not applied to prepay the Term Loans the Revolving Loans pursuant to Section 2.11(b) as a result of the delivery of a Reinvestment Notice. 

“Reinvestment Event” shall mean any Asset Sale or Recovery Event in respect of which the Borrower has delivered a
Reinvestment Notice. 
 “Reinvestment Notice” shall mean a written notice executed by a Responsible Officer stating that no
Event of Default has occurred and is continuing and that the Borrower (directly or indirectly through a Subsidiary) intends and expects to use all or a specified portion of the Net Cash Proceeds of an Asset Sale or Recovery Event to acquire or
repair assets useful in its business. 
 “Reinvestment Prepayment Amount” shall mean, with respect to any Reinvestment
Event, the Reinvestment Deferred Amount relating thereto less any amount expended prior to the relevant Reinvestment Prepayment Date to acquire or repair assets useful in the Borrower’s business. 

“Reinvestment Prepayment Date” shall mean, with respect to any Reinvestment Event, the earliest of (a) the date
occurring on the second anniversary of such Reinvestment Event, (b) if the Borrower shall not have entered into a binding commitment to reinvest the Net Cash Proceeds received in connection with such Reinvestment Event, the date occurring 540
days after such Reinvestment Event and (c) the date on which the Borrower shall have determined not to acquire or repair assets useful in the Borrower’s business with all or any portion of the relevant Reinvestment Deferred Amount. 

  
 -38- 

 “Related Parties” shall mean, with respect to any specified Person, such
Person’s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person’s Affiliates. 

“Release” shall mean any release, spill, emission, discharge, deposit, disposal, leaking, pumping, pouring, dumping,
emptying, injecting or leaching into the Environment, or into, from or through any structure or facility. 
 “Replacement Term
Loans” shall have the meaning given to such term in Section 11.1. 
 “Repricing Transaction” shall
mean the prepayment, refinancing, substitution or replacement of all or a portion of the Tranche B Term Loans with the incurrence by any Group Member of any debt financing having an effective interest cost or weighted average yield (with the
comparative determinations to be made by the Administrative Agent consistent with generally accepted financial practices, after giving effect to, among other factors, margin, interest rate floors, upfront or similar fees or original issue discount
shared with all providers of such financing, but excluding the effect of any arrangement, structuring, syndication or other fees payable in connection therewith that are not shared with all providers of such financing, and without taking into
account any fluctuations in the Eurodollar Rate (other than due to the last sentence of the definition thereof)) that is less than the effective interest cost or weighted average yield (as determined by the Administrative Agent on the same basis) of
such Tranche B Term Loans so repaid, refinanced, substituted or replaced, including without limitation, as may be effected through any amendment to this Agreement relating to the interest rate for, or weighted average yield of, such Tranche B Term
Loans. 
 “Required Financial Information” shall mean, at any date of determination, the Consolidated financial statements
of the Borrower and its Subsidiaries most recently delivered to the Administrative Agent and the Lenders on or prior to such date pursuant to, and satisfying all of the requirements of, Section 6.1(b) or 6.1(c) and accompanied by
the certificates and other information required to be delivered therewith. 
 “Required Lenders” shall mean, at any time,
the holders of more than 50% of the sum of (i) the aggregate unpaid principal amount of the Term Loans then outstanding and (ii) the Total Revolving Commitments then in effect or, if the Revolving Commitments have been terminated, the
Total Revolving Extensions of Credit then outstanding. 
 “Requirement of Law” shall mean, as to any Person, any law,
treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject. 

“Responsible Officer” shall mean, with respect to the Borrower or any of its Subsidiaries, the chief executive officer, the
president, the chief financial officer, the principal accounting officer or the treasurer (or the equivalent of any of the foregoing) or any other officer, partner or member (or Person performing similar functions) of the Borrower or any such
Subsidiary responsible for overseeing the administration of, or reviewing compliance with, all or any portion of this Agreement or any of the other Loan Documents. 

“Revaluation Date” shall mean (a) with respect to Alternative Currency Revolving Loans, each of the following:
(i) each Borrowing Date of a Eurodollar Loan denominated in an Alternative Currency, (ii) each date of a continuation of a Eurodollar Loan denominated in an Alternative Currency pursuant to Section 2.12(b), (iii) the date
of any partial reduction of the Alternative Currency Revolving 

  
 -39- 

 
Commitments pursuant to Section 2.11(f)(ii) and (iv) after a Default has occurred and is continuing, such additional dates as the Administrative Agent shall determine or the
Required Lenders shall require; and (b) with respect to an Alternative Currency Letter of Credit, each of the following: (i) each date of issuance of an Alternative Currency Letter of Credit, (ii) each date of an amendment of any
Alternative Currency Letter of Credit having the effect of increasing the amount thereof, (iii) each date of any payment by an Issuing Lender under any Alternative Currency Letter of Credit and (iv) such additional dates as the
Administrative Agent or an Issuing Lender shall reasonably determine or the Required Lenders shall require. 
 “Revolving
Commitment” shall mean, as to any Revolving Lender, collectively, the Dollar Revolving Commitment and the Alternative Currency Revolving Commitment of such Revolving Lender. 

“Revolving Commitment Period” shall mean the period from and including the Closing Date to but excluding the Business Day
preceding the latest Maturity Date applicable to the Revolving Facility. 
 “Revolving Extensions of Credit” shall mean,
collectively, the Dollar Revolving Extensions of Credit and the Alternative Currency Revolving Extensions of Credit. 
 “Revolving
Facility” shall mean, collectively, the Dollar Revolving Facility and the Alternative Currency Revolving Facility. 

“Revolving Lenders” shall mean, collectively, the Dollar Revolving Lenders and Alternative Currency Revolving Lenders. 

“Revolving Loans” shall mean, collectively, the Dollar Revolving Loans and Alternative Currency Revolving Loans. 

“Revolving Percentage” shall mean, as to any Revolving Lender, collectively, the Dollar Revolving Percentage and the
Alternative Currency Revolving Percentage of such Revolving Lender. 
 “Revolving Termination Date” shall mean
June 24, 2019. 
 “S&P” shall mean Standard & Poor’s Financial Services, LLC. 

“Sale and Leaseback Transaction” with respect to any Person shall mean an arrangement to sell or transfer any property, real
or personal, used or useful in such Person’s business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property which it intends to use for substantially the same purpose or purposes as the property
being sold or transferred. 
 “Sanctions Authorities” shall have the meaning given to such term in
Section 4.23(b)(v). 
 “SEC” shall mean the Securities and Exchange Commission, any successor thereto and any
analogous Governmental Authority. 
 “Secured Cash Management Agreement” shall mean any Cash Management Agreement that is
entered into by and between the Borrower or any Subsidiary and any Cash Management Bank; provided that the aggregate amount of Debt under all Secured Cash Management Agreements shall not exceed $25,000,000 at any time outstanding. 

  
 -40- 

 “Secured Obligations” shall mean (a) the Obligations and (b) the due
and punctual payment and performance of all obligations of the Borrower and the other Loan Parties under or in respect of each Specified Swap Agreement and each Secured Cash Management Agreement and each Specified Letter of Credit, in each case,
whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party or
any Affiliate thereof of any proceeding under any bankruptcy, insolvency, receivership or other similar proceeding naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such
proceeding. 
 “Secured Parties” shall mean, collectively, the Administrative Agent, the Collateral Agent, each other
Agent, the Lenders, each Cash Management Bank, each party to a Specified Swap Agreement (other than any Group Member) and each issuing lender of a Specified Letter of Credit, if, in the case of any Person not already a party to this Agreement, such
Person executes and delivers to the Administrative Agent a letter agreement in form and substance acceptable to the Administrative Agent pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan
Documents and (ii) agrees to be bound by the provisions of Sections 11.5, 11.11 and 11.12 as if it were a Lender and as if the fair market value of its Secured Obligations constituted Loans hereunder. 

“Security Agreement” shall mean that certain Security Agreement, dated as of the Closing Date, by and among the Loan Parties
and the Administrative Agent. 
 “Security Agreement Collateral” shall mean all property pledged or granted as collateral
pursuant to the Security Agreement (a) on the Closing Date or (b) thereafter pursuant to Section 6.12. 

“Security Documents” shall mean, collectively, the Security Agreement, the Mortgages (if any) and all other security
documents hereafter delivered to the Collateral Agent granting a Lien on any property of any Person to secure the obligations and liabilities of any Loan Party under any Loan Document. 

“Senior Secured Leverage Ratio” shall mean, at any date of determination, the ratio of (a) (i) all Funded Debt of the
Borrower and its Subsidiaries that is secured by a Lien on any asset or property of the Borrower or any Subsidiary (other than any Lien that is junior to the Lien securing the Obligations pursuant to the Junior Lien Intercreditor Agreement),
including Debt in respect of Specified Letters of Credit outstanding as of such date (assuming that the maximum amount of each such Specified Letter of Credit is fully drawn) plus (ii) to the extent not otherwise included in subclause
(a)(i) of this definition, the face amount of all Letters of Credit issued for the account of the Borrower or any of its Subsidiaries minus (iii) unrestricted cash and Cash Equivalents of the Borrower and its Subsidiaries on a
Consolidated basis to (b) Consolidated EBITDA of the Borrower and its Subsidiaries for the most recently completed Measurement Period prior to such date. 

The Senior Secured Leverage Ratio shall be calculated on a Pro Forma Basis to give effect to any Debt incurred, assumed or permanently repaid
or extinguished after the relevant Measurement Period but prior to or contemporaneously with the Reference Date as if such incurrence, assumption, repayment or extinguishment had been effected on the last day of such period. 

“Senior Representative” shall mean, with respect to any series of Permitted First Priority Refinancing Debt, Permitted Second
Priority Refinancing Debt, Permitted Other Debt or any Indebtedness incurred pursuant to Section 7.2(v), the trustee, administrative agent, collateral agent, security agent or similar agent under the indenture or agreement pursuant to
which such Debt is issued, incurred or otherwise obtained, as the case may be, and each of their successors in such capacities. 

  
 -41- 

 “Shared Incremental Amount” shall mean (x) $1,500,000,000 minus
(y) the aggregate outstanding principal amount of all Incremental Term Loans and/or Permitted Other Debt incurred or issued in reliance on the Shared Incremental Amount. 

“Solvent” shall mean, when used with respect to any Person, that, as of any date of determination, (a) the amount of the
“present fair saleable value” of the assets of such Person will, as of such date, exceed the amount of all “liabilities of such Person, contingent or otherwise,” as of such date, as such quoted terms are determined in accordance
with applicable federal and state laws governing determinations of the insolvency of debtors, (b) the present fair saleable value of the assets of such Person will, as of such date, be greater than the amount that will be required to pay the
liability of such Person on its debts as such debts become absolute and matured, (c) such Person will not have, as of such date, an unreasonably small amount of capital with which to conduct its business, and (d) such Person will be able
to pay its debts as they mature. For purposes of this definition, (i) “debt” shall mean liability on a “claim,” and (ii) “claim” shall mean any (x) right to payment, whether or not such a right is reduced
to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured or (y) right to an equitable remedy for breach of performance if such breach gives rise to a right to
payment, whether or not such right to an equitable remedy is reduced to judgment, fixed, contingent, matured or unmatured, disputed, undisputed, secured or unsecured. 

“Special Purpose Licensed Entity” shall mean any Person in a related business of the Borrower and its Subsidiaries that
(i) the Borrower and its Subsidiaries are prohibited from engaging in directly under applicable law, including provisions of state law (a) prohibiting the ownership of healthcare facilities by public companies, (b) prohibiting the
corporate practice of medicine or (c) otherwise restricting the ability of the Borrower or one of its Subsidiaries to acquire directly a required license to operate a healthcare facility, and (ii) has entered into a transaction or series
of transactions with the Borrower or any of its Subsidiaries under which: 
 (x) the Borrower or any of its Subsidiaries
provides management, administrative or consulting services to the Special Purpose Licensed Entity, 
 (y) the owners of the
Special Purpose Licensed Entity are prohibited from transferring any of their interests in the Special Purpose Licensed Entity without the consent of the Borrower or one of its Subsidiaries, and 

(z) the Borrower or one of its Subsidiaries has the right to require the owners of the Special Purpose Licensed Entity to
transfer all of their interests in the Special Purpose Licensed Entity to a Person designated by the Borrower or one of its Subsidiaries. 

“Special Purpose Receivables Subsidiary” shall mean a direct or indirect Subsidiary of the Borrower established in connection
with a Permitted Receivables Financing for the acquisition of Receivables Assets or interests therein, and which is organized in a manner intended to reduce the likelihood that it would be substantively consolidated with the Borrower or any of the
Subsidiaries (other than Special Purpose Receivables Subsidiaries) in the event the Borrower or any such Subsidiary becomes subject to a proceeding under the U.S. Bankruptcy Code (or other insolvency law). 

“Specified Alternative Currency LC Sublimit” shall mean, with respect to any Issuing Lender, the amount set forth beside each
Issuing Lender on Schedule II hereto with respect to Alternative Currency Letters of Credit or in each case such other amount as is specified in the agreement pursuant to which such Person becomes an Issuing Lender hereunder. 

  
 -42- 

 “Specified Change of Control” shall mean a “Change of Control” (or any
other defined term having a similar purpose) as defined in the 2020 Senior Notes Indenture, in the 2022 Senior Notes Indenture or the New Senior Notes Indenture. 

“Specified Dollar LC Sublimit” shall mean, with respect to any Issuing Lender, the amount set forth beside such Issuing
Lender on Schedule II hereto with respect to Dollar Letters of Credit or in each case such other amount as is specified in the agreement pursuant to which such Person becomes an Issuing Lender hereunder. 

“Specified Letter of Credit” shall mean any letter of credit issued by any Lender (at the time of the issuance of such letter
of credit) or affiliate thereof for the account of the Borrower or any Subsidiary, which the Borrower designates as a “Specified Letter of Credit” by notice in writing to the Administrative Agent. 

“Specified Loan Party” shall mean any Loan Party that is not an “eligible contract participant” under the Commodity
Exchange Act (determined prior to giving effect to Section 10.10. 
 “Specified Swap Agreement” shall mean any
Swap Agreement entered into by the Borrower or any Subsidiary and any Lender (at the time of the execution of such Swap Agreement) or affiliate thereof in respect of interest rates or currency exchange rates. 

“Specified Transaction” shall mean (a) the acquisition of any Subsidiary permitted under Section 7.6(e) or
(k) , (b) the consummation of any Asset Sale and (c) the incurrence, assumption, permanent repayment or extinguishment of any Debt. 

“Spot Rate” for a currency shall mean the rate determined by the Administrative Agent to be the rate quoted by the Person
acting in such capacity as the spot rate for the purchase by such Person of such currency with another currency through its principal foreign exchange trading office at approximately 11:00 a.m. on the date two Business Days prior to the date as of
which the foreign exchange computation is made; provided that the Administrative Agent may obtain such spot rate from another financial institution designated by the Administrative Agent if the Person acting in such capacity does not have as
of the date of determination a spot buying rate for any such currency. 
 “Sterling” and “£” shall
mean the lawful currency of the United Kingdom. 
 “Subsidiary” shall mean, with respect to any Person (the
“parent”) at any date, any corporation, limited liability company, partnership, association or other business entity (a) (i) of which securities or other ownership interests representing more than 50% of the voting power
of all Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of the Board of Directors thereof are, as of such date, owned, Controlled or held by the parent and/or one or more subsidiaries of the parent
and (ii) that is, as of such date, otherwise Controlled by the parent and/or one or more subsidiaries of the parent; or (b) designated as a “Subsidiary” by the Borrower by written notice to the Administrative Agent and
(i) of which securities or other ownership interests representing more than 50% of the voting power of all Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of the Board of Directors thereof
are, as of such date, owned, Controlled or held by the parent and/or one or more subsidiaries of the parent, (ii) that is, as of such date, otherwise Controlled by the parent and/or one or more subsidiaries of the parent or (iii) the
accounts of which would be consolidated with 

  
 -43- 

 
those of the parent in the parent’s Consolidated financial statements; provided, however, that (i) entities shall not be deemed Subsidiaries so long as the assets of each
such entity do not exceed $25,000 (unless the Borrower shall elect to include such entity as a Guarantor) and (ii) California Medical Group Insurance Company, Risk Retention Group, HealthCare Partners Institute for Applied Research and
Education, the Physician Groups and their respective subsidiaries shall not be deemed Subsidiaries of the Borrower for any purpose under the Loan Documents, except that such entities may be included in the Borrower’s Consolidated financial
statements. Unless the context requires otherwise, “Subsidiary” refers to a Subsidiary of the Borrower. 

“Survey” shall mean a survey of any Mortgaged Property (and all improvements thereon) which is (a) (i) prepared by
a surveyor or engineer licensed to perform surveys in the jurisdiction where such Mortgaged Property is located, (ii) dated (or redated) not earlier than six months prior to the date of delivery thereof unless there shall have occurred within
six months prior to such date of delivery any exterior construction on the site of such Mortgaged Property or any easement, right of way or other interest in the Mortgaged Property has been granted or become effective through operation of law or
otherwise with respect to such Mortgaged Property which, in either case, can be depicted on a survey, in which events, as applicable, such survey shall be dated (or redated) after the completion of such construction or if such construction shall not
have been completed as of such date of delivery, not earlier than 20 days prior to such date of delivery, or after the grant or effectiveness of any such easement, right of way or other interest in the Mortgaged Property, (iii) certified
by the surveyor (in a manner reasonably acceptable to the Administrative Agent) to the Administrative Agent, the Collateral Agent and the Title Company, (iv) complying in all respects with the minimum detail requirements of the American Land
Title Association as such requirements are in effect on the date of preparation of such survey and (v) sufficient for the Title Company to remove all standard survey exceptions from the title insurance policy (or commitment) relating to such
Mortgaged Property and issue the endorsements of a type reasonably requested by the Collateral Agent or (b) otherwise acceptable to the Collateral Agent. 

“Swap Agreement” shall mean any agreement with respect to any swap, forward, future or derivative transaction or option or
similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or
any similar transaction or any combination of these transactions; provided that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of
the Borrower or any of its Subsidiaries shall be a “Swap Agreement.” 
 “Swap Obligations” shall mean with
respect to any Guarantor any obligation to pay or perform under any agreement, contract or transaction that constitutes a “swap” within the meaning of Section 1a(47) of the Commodity Exchange Act. 

“Swingline Commitment” shall mean the obligation of the Swingline Lender to make Swingline Loans pursuant to
Section 2.6 in an aggregate principal amount at any one time outstanding not to exceed $100,000,000. 
 “Swingline
Lender” shall mean JPMorgan Chase Bank, N.A., in its capacity as the lender of Swingline Loans; provided that, if any Extension or Extensions of Alternative Currency Revolving Commitments is or are effected in accordance with
Section 2.25, then on the occurrence of each Issuing Lender/Swingline Termination Date, the Swingline Lender at such time shall have the right to resign as Swingline Lender on, or on any date within twenty (20) Business Days after,
the respective Issuing Lender/Swingline Termination Date, in each case upon not less than ten (10) days’ prior written notice thereof to the Borrower and the Administrative Agent and, in the event of any such resignation and upon the 

  
 -44- 

 
effectiveness thereof, the Borrower shall repay any outstanding Swingline Loans made by the respective entity so resigning and such entity shall not be required to make any further Swingline
Loans hereunder. If at any time and for any reason (including as a result of resignations as contemplated by the proviso to the preceding sentence), the Swingline Lender has resigned in such capacity in accordance with the preceding sentence, then
no Person shall be the Swingline Lender hereunder or obligated to make Swingline Loans unless and until (and only for so long as) a Lender (or affiliate of a Lender) reasonably satisfactory to the Administrative Agent and the Borrower agrees to act
as the Swingline Lender hereunder. 
 “Swingline Loans” shall have the meaning given to such term in
Section 2.6(a). 
 “Swingline Participation Amount” shall have the meaning given to such term in
Section 2.7(c). 
 “Syndication Agents” shall have the meaning given to such term in the preamble hereto. 

“TARGET Day” shall mean any day on which the Trans-European Automated Real-time Gross Settlement Express Transfer (TARGET)
payment system (or, if such payment system ceases to be operative, such other payment system (if any) determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euro. 

“Taxes” shall mean (i) all present or future income, stamp or other taxes, levies, imposts, duties, deductions,
withholdings, assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto, and (ii) all transferee, successor, joint and several, contractual or other
liability (including, without limitation, liability pursuant to Treas. Reg. §1.1502-6 (or any similar state, local or foreign provision)) in respect of any items described in clause (i). 

“Tender Offer” shall have the meaning given to such term in the recitals hereto. 

“Term Lenders” shall mean, collectively, the Tranche A Term Lenders and the Tranche B Term Lenders. 

“Term Loans” shall mean, collectively, the Tranche A Term Loans and the Tranche B Term Loans. 

“Title Company” shall mean any title insurance company as shall be retained by the Borrower and reasonably acceptable to the
Administrative Agent. 
 “Total Alternative Currency Revolving Commitments” shall mean, at any time, the aggregate amount
of the Alternative Currency Revolving Commitments then in effect. The original amount of the Total Alternative Currency Revolving Commitments is the Alternative Currency Equivalent of $300,000,000. 

“Total Alternative Currency Revolving Extensions of Credit” shall mean, at any time, the aggregate amount of the Alternative
Currency Revolving Extensions of Credit of the Alternative Currency Revolving Lenders outstanding at such time. 
 “Total Dollar
Revolving Commitments” shall mean, at any time, the aggregate amount of the Dollar Revolving Commitments then in effect. The original amount of the Total Dollar Revolving Commitments is $700,000,000. 

  
 -45- 

 “Total Dollar Revolving Extensions of Credit” shall mean, at any time, the
aggregate amount of the Dollar Revolving Extensions of Credit of the Dollar Revolving Lenders outstanding at such time. 
 “Total
Revolving Commitments” shall mean, at any time, the aggregate amount of the Revolving Commitments then in effect. 
 “Total
Revolving Extensions of Credit” shall mean, at any time, the aggregate amount of the Revolving Extensions of Credit of the Revolving Lenders outstanding at such time. 

“Tranche A Term Commitment” shall mean, as to any Lender, the obligation of such Lender, if any, to make a Tranche A Term
Loan to the Borrower in a principal amount not to exceed the amount set forth opposite such Lender’s name on Schedule I. The original aggregate amount of the Tranche A Term Commitments is $1,000,000,000. 

“Tranche A Term Facility” shall have the meaning given to such term in the definition of “Facility.” 

“Tranche A Term Lender” shall mean each Lender that has a Tranche A Term Commitment or that holds a Tranche A Term Loan. 

“Tranche A Term Loan” shall have the meaning given to such term in Section 2.1. 

“Tranche A Term Loan Maturity Date” shall mean June 24, 2019. 

“Tranche A Term Percentage” shall mean, as to any Tranche A Term Lender at any time, the percentage which such Lender’s
Tranche A Term Commitment then constitutes of the aggregate Tranche A Term Commitments (or, at any time after the Closing Date, the percentage which the aggregate principal amount of such Lender’s Tranche A Term Loans then outstanding
constitutes of the aggregate principal amount of the Tranche A Term Loans then outstanding). 
 “Tranche B Term Commitment”
shall mean, as to any Lender, the obligation of such Lender, if any, to make a Tranche B Term Loan to the Borrower in a principal amount not to exceed the amount set forth opposite such Lender’s name on Schedule I or in an Increase
Joinder. The original aggregate amount of the Tranche B Term Commitments is $3,500,000,000. 
 “Tranche B Term Facility”
shall have the meaning given to such term in the definition of “Facility.” 
 “Tranche B Term Lender” shall mean
each Lender that has a Tranche B Term Commitment or that holds a Tranche B Term Loan. 
 “Tranche B Term Loan” shall have
the meaning given to such term in Section 2.1. 
 “Tranche B Term Loan Maturity Date” shall mean June 24,
2021. 
 “Tranche B Term Percentage” shall mean, as to any Tranche B Term Lender at any time, the percentage which such
Lender’s Tranche B Term Commitment then constitutes of the aggregate Tranche B Term Commitments (or, at any time after the Closing Date, the percentage which the aggregate principal amount of such Lender’s Tranche B Term Loans then
outstanding constitutes of the aggregate principal amount of the Tranche B Term Loans then outstanding). 

  
 -46- 

 “Transaction Documents” shall mean the New Senior Notes Documents and the Loan
Documents. 
 “Transactions” shall mean, collectively, (a) the execution, delivery and performance of the Loan
Documents and the initial borrowings hereunder; (b) the Refinancing; (c) the issuance of the New Senior Notes and (d) the payment of all fees and expenses owing in connection with the foregoing. 

“Transferred Guarantor” shall have the meaning given to such term in Section 10.9. 

“Tricare” shall mean the managed health care program that is established by the Department of Defense under Title 10,
Subtitle A, Part II, Chapter 55 (10 U.S.C. §1071 et seq.) for members of the military, military retirees, and their dependents, and includes the competitive selection of contractors to financially underwrite the
delivery of health care services under the Civilian Health and Medical Program of the Uniformed Services. 
 “Type” shall
mean, as to any Loan, its nature as an ABR Loan or a Eurodollar Loan. 
 “UCC” shall mean the Uniform Commercial Code as in
effect from time to time (except as otherwise specified) in any applicable state or jurisdiction. 
 “United States” shall
mean the United States of America. 
 “Voting Interests” shall mean shares of Capital Stock issued by a corporation, or
equivalent Capital Stock of any other Person, the holders of which are ordinarily, in the absence of contingencies, entitled to vote for the election of directors (or persons performing similar functions) of such Person, even if the right so to vote
has been suspended by the happening of such a contingency. 
 “Weighted Average Life to Maturity” shall mean, when applied
to any Debt at any date, the number of years obtained by dividing: (a) the sum of the products obtained by multiplying (i) the amount of each then remaining installment, sinking fund, serial maturity or other required payments of
principal, including payment at final maturity, in respect thereof, by (ii) the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such payment; by (b) the then outstanding
principal amount of such Debt. 
 “Wholly Owned Subsidiary” shall mean, as to any Person, any other Person all of the
Capital Stock of which (other than directors’ qualifying shares required by law) is owned by such Person directly and/or through other Wholly Owned Subsidiaries. 

“Withdrawal Liability” shall have the meaning specified in Part I of Subtitle E of Title IV of ERISA. 

1.2 Classification of Loans. For purposes of this Agreement, Loans may be classified and referred to by Class (e.g., a
“Revolving Loan”) or by Type (e.g., a “Eurodollar Loan”) or by Class and Type (e.g., a “Eurodollar Revolving Loan”). 

1.3 Terms Generally. The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined.
Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include,” “includes” and “including” shall be deemed to be followed by the phrase
“without limitation.” The word “will” shall be construed to have the same meaning and effect as the word “shall.” Unless the context requires otherwise (a) any definition of or reference to any Loan Document,
agreement, instrument or other document herein 

  
 -47- 

 
shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments,
supplements or modifications set forth herein), (b) any reference herein to any Person shall be construed to include such Person’s successors and assigns, (c) the words “herein,” “hereof” and “hereunder,”
and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d) all references herein to Sections, Exhibits and Schedules shall be construed to refer to Sections of, and
Exhibits and Schedules to, this Agreement, unless otherwise indicated, (e) any reference to any law or regulation herein shall refer to such law or regulation as amended, modified or supplemented from time to time, (f) the words
“asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights and
(g) “on,” when used with respect to the Mortgaged Property or any property adjacent to the Mortgaged Property, shall mean “on, in, under, above or about.” 

1.4 Accounting Terms; GAAP. Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be
construed in accordance with GAAP, as in effect from time to time; provided that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change in GAAP
occurring after the Closing Date or in the application thereof on such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether
any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such
notice shall have been withdrawn or such provision amended in accordance herewith; provided that the Borrower shall provide to the Administrative Agent and the Lenders a written reconciliation, between calculations of the affected item in
amounts required to be reported under Sections 6.1(b) and (c) (including in any Compliance Certificate) before and after giving effect to such change in GAAP. 

For the avoidance of doubt, Persons that are not Subsidiaries shall not be included in any calculation relevant to Section 7.16.

 1.5 Resolution of Drafting Ambiguities. Each Loan Party acknowledges and agrees that it was represented by counsel in connection
with the execution and delivery of the Loan Documents to which it is a party, that it and its counsel reviewed and participated in the preparation and negotiation hereof and thereof and that any rule of construction to the effect that ambiguities
are to be resolved against the drafting party shall not be employed in the interpretation hereof or thereof. 
 1.6 Exchange Rates;
Currency Equivalents.  
 (a) The Administrative Agent shall determine the Spot Rates as of each Revaluation Date to be
used for calculating Dollar Equivalent amounts of Alternative Currency Revolving Loans or Alternative Currency Letters of Credit, as applicable, outstanding. Such Spot Rates shall become effective as of such Revaluation Date and shall be the Spot
Rates employed in converting any amounts between the applicable currencies until the next Revaluation Date to occur. Except for purposes of financial statements delivered by Loan Parties hereunder or calculating financial covenants hereunder or
except as otherwise provided herein, the applicable amount of any currency (other than Dollars) for purposes of the Loan Documents shall be such Dollar Equivalent amount as so determined by the Administrative Agent. 

(b) Wherever in this Agreement in connection with an Alternative Currency Revolving Loan, an Alternative Currency Letter of Credit, or a
conversion, continuation or prepayment of an Alternative Currency Revolving Loan, an amount, such as a required minimum or multiple amount, is 

  
 -48- 

 
expressed in Dollars, but such Alternative Currency Revolving Loan or Alternative Currency Letter of Credit, as applicable, is denominated in an Alternative Currency, such amount shall be the
relevant Alternative Currency Equivalent of such Dollar amount (rounded to the nearest unit of such Alternative Currency, with 0.5 of a unit being rounded upward), as determined by the Administrative Agent. 

1.7 Additional Alternative Currencies. 

(a) The Borrower may from time to time request that Alternative Currency Revolving Loans be made and/or Alternative Currency Letters of Credit
be issued in a currency other than those specifically listed in the definition of “Alternative Currency”; provided that such requested currency is a lawful currency (other than Dollars) that is readily available and freely
transferable and convertible into Dollars. In the case of any such request with respect to the making of Alternative Currency Revolving Loans, such request shall be subject to the approval of the Administrative Agent and the Alternative Currency
Revolving Lenders; and in the case of any such request with respect to the issuance of Alternative Currency Letters of Credit, such request shall be subject to the approval of the Administrative Agent and an Issuing Lender. 

(b) Any such request shall be made to the Administrative Agent not later than 11:00 a.m., Local Time, 20 Business Days prior to the date of
the desired extension of credit (or, in the case of any such request pertaining to Alternative Currency Letters of Credit, the Issuing Lender, in its or their sole discretion). In the case of any such request pertaining to Alternative Currency
Revolving Loans, the Administrative Agent shall promptly notify each Alternative Currency Revolving Lender of any request pursuant to this Section 1.7 and in the case of any such request pertaining to Alternative Currency Letters of
Credit, the Administrative Agent shall promptly notify the Issuing Lender thereof. Each Alternative Currency Revolving Lender (in the case of any such request pertaining to Alternative Currency Revolving Loans) or Issuing Lender (in the case of a
request pertaining to Alternative Currency Letters of Credit) shall notify the Administrative Agent, not later than 11:00 a.m., Local Time, ten Business Days after receipt of such request whether it consents, in its sole discretion, to the making of
Alternative Currency Revolving Loans or the issuance of Alternative Currency Letters of Credit , as the case may be, denominated in such currency. 

(c) Any failure by an Alternative Currency Revolving Lender or Issuing Lender, as the case may be, to respond to such request within the time
period specified in the preceding sentence shall be deemed to be a refusal by such Alternative Currency Revolving Lender or Issuing Lender, as the case may be, to permit Alternative Currency Revolving Loans to be made or Alterative Currency Letters
of Credit to be issued in such requested currency. If the Administrative Agent and all the Alternative Currency Revolving Lenders consent to making Alternative Currency Revolving Loans in such requested currency, the Administrative Agent shall so
notify the Borrower and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Alternative Currency Revolving Loans; and if the Administrative Agent and an Issuing Lender consent to the
issuance of Alternative Currency Letters of Credit in such requested currency, the Administrative Agent shall so notify the Company and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of
any Letter of Credit issuances by such consenting Issuing Lender. If the Administrative Agent shall fail to obtain consent to any request for an additional currency under this Section 1.7, the Administrative Agent shall promptly so
notify the Borrower. 

  
 -49- 

 1.8 Change of Currency. 

(a) Each obligation of the Borrower to make a payment denominated in the national currency unit of any member state of the European Union that
adopts the Euro as its lawful currency after the Closing Date shall be redenominated into Euro at the time of such adoption (in accordance with the EMU Legislation). If, in relation to the currency of any such member state, the basis of accrual of
interest expressed in this Agreement in respect of that currency shall be inconsistent with any convention or practice in the London interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced
by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency; provided that if any Alternative Currency Revolving Loans in the currency of such member state is outstanding
immediately prior to such date, such replacement shall take effect, with respect to such Alternative Currency Revolving Loans, at the end of the then current Interest Period. 

(b) Each provision of this Agreement shall be subject to such reasonable changes of construction as the Administrative Agent may from time to
time specify to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro. 

(c) Each provision of this Agreement also shall be subject to such reasonable changes of construction as the Administrative Agent may from
time to time specify to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency. 

SECTION 2 
 AMOUNT AND TERMS OF
COMMITMENTS 
 2.1 Term Commitments. Subject to the terms and conditions hereof, (a) each Tranche A Term Lender severally
agrees to make a term loan denominated in Dollars (a “Tranche A Term Loan”) to the Borrower on the Closing Date in an amount not to exceed the amount of the Tranche A Term Commitment of such Lender, (b) each Tranche B Term
Lender severally agrees to make a term loan denominated in Dollars (a “Tranche B Term Loan”) to the Borrower on the Closing Date in an amount not to exceed the amount of the Tranche B Term Commitment of such Lender. The Term Loans
may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrower and notified to the Administrative Agent in accordance with Sections 2.2 and 2.12. Amounts borrowed under this Section 2.1 and repaid may
not be reborrowed. 
 2.2 Procedure for Term Loan Borrowing. The Borrower shall give the Administrative Agent irrevocable notice in
the form of a Borrowing Request (which notice must be received by the Administrative Agent prior to 1:00 P.M., New York City time, (a) in the case of any Tranche A Term Loans and Tranche B Term Loans, three Business Days prior to the
anticipated Closing Date, in the case of Eurodollar Loans, or (b) in the case of any Tranche A Term Loans and Tranche B Term Loans, one Business Day prior to the anticipated Closing Date, in the case of ABR Loans) requesting that the Term
Lenders make the Term Loans on the Closing Date and specifying the amount to be borrowed under each Class. Upon receipt of such notice the Administrative Agent shall promptly notify each Term Lender thereof. Not later than 12:00 Noon, New York City
time, on the Closing Date, each Term Lender shall make available to the Administrative Agent at the Funding Office an amount in immediately available funds equal to the Term Loan to be made by such Term Lender. The Administrative Agent shall credit
the account of the Borrower on the books of such office of the Administrative Agent with the aggregate of the amounts made available to the Administrative Agent by the Term Lenders in immediately available funds. 

  
 -50- 

 2.3 Repayment of Term Loans. 

(a) The Tranche A Term Loan of each Tranche A Term Lender shall mature in 20 consecutive quarterly installments and on the Tranche A Term
Loan Maturity Date, in an amount equal to such Lender’s Tranche A Term Percentage multiplied by the amount set forth below opposite such installment: 
  

					
	 Installment Due Date
	  	Principal Amount	 
	 September 30, 2014
	  	$	12,500,000	  
	 December 31, 2014
	  	$	12,500,000	  
	 March 31, 2015
	  	$	12,500,000	  
	 June 30, 2015
	  	$	12,500,000	  
	 September 30, 2015
	  	$	12,500,000	  
	 December 31, 2015
	  	$	12,500,000	  
	 March 31, 2016
	  	$	12,500,000	  
	 June 30, 2016
	  	$	12,500,000	  
	 September 30, 2016
	  	$	18,750,000	  
	 December 31, 2016
	  	$	18,750,000	  
	 March 31, 2017
	  	$	18,750,000	  
	 June 30, 2017
	  	$	18,750,000	  
	 September 30, 2017
	  	$	25,000,000	  
	 December 31, 2017
	  	$	25,000,000	  
	 March 31, 2018
	  	$	25,000,000	  
	 June 30, 2018
	  	$	25,000,000	  
	 September 30, 2018
	  	$	25,000,000	  
	 December 31, 2018
	  	$	25,000,000	  
	 March 31, 2019
	  	$	25,000,000	  
	 Tranche A Term Loan Maturity Date
	  	$	650,000,000	  

 (b) The Tranche B Term Loan of each Tranche B Term Lender shall mature (i) in 27 consecutive quarterly
installments on the last day of each September, December, March and June (commencing on September 30, 2014), each in an amount equal to such Lender’s Tranche B Term Percentage multiplied by 0.25% of the aggregate principal amount of the
Tranche B Term Loans outstanding on the Closing Date immediately after funding the Tranche B Term Facility and (ii) on the Tranche B Term Loan Maturity Date in an amount equal to all remaining outstanding Tranche B Term Loans of such Tranche B
Term Lender. 
 2.4 Revolving Commitments. 

(a) Subject to the terms and conditions hereof, (1) each Dollar Revolving Lender severally agrees to make revolving credit loans in
Dollars (“Dollar Revolving Loans”) to the Borrower from time to time during the Revolving Commitment Period in an aggregate principal amount at any one time outstanding which, when added to such Lender’s Dollar Revolving
Percentage of the LC Obligations then outstanding, does not exceed the amount of such Lender’s Dollar Revolving Commitment and (2) each Alternative Currency Revolving Lender severally agrees to make revolving credit loans in one or more
Alternative Currencies (“Alternative Currency Revolving Loans”) to the Borrower from time to time during the Revolving Commitment Period in an aggregate principal amount at any one time outstanding which, when added to such
Lender’s Alternative Currency Revolving Percentage of the sum of (i) the LC Obligations then outstanding and (ii) the aggregate principal amount of the Swingline Loans then outstanding, does not exceed the amount of such Lender’s
Alternative Currency Revolving Commitment. 

  
 -51- 

 
During the Revolving Commitment Period the Borrower may use the Revolving Commitments by borrowing, prepaying the Revolving Loans in whole or in part, and reborrowing, all in accordance with the
terms and conditions hereof. The Dollar Revolving Loans and Alternative Currency Revolving Loans denominated in Dollars may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrower and notified to the Administrative Agent in
accordance with Sections 2.5 and 2.12. The Alternative Currency Revolving Loans denominated in an Alternative Currency other than Dollars shall be Eurodollar Loans. 

(b) The Borrower shall repay all outstanding Revolving Loans on the applicable Maturity Date. 

2.5 Procedure for Revolving Loan Borrowing. The Borrower may borrow under the Revolving Commitments during the Revolving Commitment
Period on any Business Day; provided that the Borrower shall give the Administrative Agent irrevocable notice in the form of a Borrowing Request (which notice must be received by the Administrative Agent prior to 2:00 P.M., New York City
time, (a)(i) three Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans denominated in Dollars or (ii) four Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans denominated in
Alternative Currencies (other than Dollars), or (b) one Business Day prior to the requested Borrowing Date, in the case of ABR Loans) (provided that any such notice of a borrowing of ABR Loans under the Alternative Currency Revolving
Facility to finance payments required by Section 3.5 may be given not later than 1:00 P.M., New York City time, on the date of the proposed borrowing), specifying (i) the amount of Revolving Loans to be borrowed, (ii) the
requested Borrowing Date, (iii) the Revolving Facility pursuant to which such Loan is to be made, (iv) the currency of the Revolving Loans to be borrowed, (v) if the Revolving Loans to be borrowed are denominated in Dollars, the Type
of Revolving Loans to be borrowed and (vi) in the case of Eurodollar Loans, the respective amounts of each such Type of Loan and the respective lengths of the initial Interest Period therefor. Each borrowing under the Dollar Revolving
Commitments and each borrowing under the Alternative Currency Revolving Commitments denominated in Dollars shall be in an amount equal to (x) in the case of ABR Loans, $1,000,000 or a whole multiple thereof (or, if the then aggregate Available
Revolving Commitments are less than $1,000,000, such lesser amount) and (y) in the case of Eurodollar Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof; provided that the Swingline Lender may request, on behalf of the
Borrower, borrowings denominated in Dollars under the Alternative Currency Revolving Commitments that are ABR Loans in other amounts pursuant to Section 2.7. Each borrowing under the Alternative Currency Revolving Commitments (other than
a borrowing denominated in Dollars) shall be in an amount equal to the Alternative Currency Equivalent of $5,000,000 or a whole multiple of $1,000,000 in excess thereof. Upon receipt of any such notice from the Borrower, the Administrative Agent
shall promptly notify each Revolving Lender thereof. Each Revolving Lender will make the amount of its pro rata share of each borrowing available to the Administrative Agent for the account of the Borrower at the Funding Office for the
applicable currency prior to 12:00 Noon, New York City time, on the Borrowing Date requested by the Borrower in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the Borrower by the Administrative
Agent crediting the account of the Borrower on the books of such office with the aggregate of the amounts made available to the Administrative Agent by the Revolving Lenders and in like funds as received by the Administrative Agent. 

2.6 Swingline Commitment. 

(a) Subject to the terms and conditions hereof, the Swingline Lender agrees to make a portion of the credit otherwise available to the Borrower
under the Alternative Currency Revolving Commitments from time to time after the Closing Date and during the Revolving Commitment Period by making swing line loans denominated in Dollars (“Swingline Loans”) to the Borrower;
provided that (i)

  
 -52- 

 
the aggregate principal amount of Swingline Loans outstanding at any time shall not exceed the Swingline Commitment then in effect and (ii) the Borrower shall not request, and the Swingline
Lender shall not make, any Swingline Loan if, after giving effect to the making of such Swingline Loan, the aggregate amount of the Available Alternative Currency Revolving Commitments would be less than zero. During the Revolving Commitment Period,
the Borrower may use the Swingline Commitment by borrowing, repaying and reborrowing, all in accordance with the terms and conditions hereof. Swingline Loans shall be ABR Loans only. 

(b) The Borrower shall repay to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the applicable
Maturity Date in accordance with Section 2.7(f) and the first date after such Swingline Loan is made that is the 15th or last day of a calendar month and is at least two Business Days after such Swingline Loan is made; provided that on
each date that an Alternative Currency Revolving Loan denominated in Dollars is borrowed, the Borrower shall repay all Swingline Loans then outstanding. 

2.7 Procedure for Swingline Borrowing; Refunding of Swingline Loans. 

(a) To request a Swingline Loan, the Borrower shall notify the Administrative Agent of such request by telephone (confirmed by telecopy of a
Borrowing Request), not later than 2:00 P.M., New York City time, on the day (which shall be a Business Day during the Revolving Commitment Period) of a proposed Swingline Loan. Each such notice shall be irrevocable and shall specify the requested
date (which shall be a Business Day) and amount of the requested Swingline Loan. The Administrative Agent will promptly advise the Swingline Lender of any such notice received from the Borrower. The Swingline Lender shall make each Swingline Loan
available to the Borrower by means of a credit to the general deposit account of the Borrower with the Swingline Lender (or, in the case of a Swingline Loan made to finance the reimbursement of an LC Disbursement as provided in
Section 3.5, by remittance to the Issuing Lender) by 4:00 P.M., New York City time, on the requested date of such Swingline Loan. Each borrowing under the Swingline Commitment shall be in an amount equal to $500,000 or a whole
multiple of $100,000 in excess thereof. 
 (b) The Swingline Lender, at any time and from time to time in its sole and absolute discretion
may, on behalf of the Borrower (which hereby irrevocably directs the Swingline Lender to act on its behalf), on one Business Day’s notice given by the Swingline Lender no later than 2:00 P.M., New York City time, request each Alternative
Currency Revolving Lender to make, and each Alternative Currency Revolving Lender hereby agrees to make, an Alternative Currency Revolving Loan denominated in Dollars, in an amount equal to such Alternative Currency Revolving Lender’s
Alternative Currency Revolving Percentage of the aggregate amount of the Swingline Loans; provided that, notwithstanding the foregoing, no Alternative Currency Revolving Lender shall be obligated to make any Alternative Currency Revolving
Loan if after giving effect to the making of such Alternative Currency Revolving Loan the outstanding amount of Alternative Currency Revolving Extensions of Credit of such Lender exceed such Lender’s Alternative Currency Revolving Commitment
(the “Refunded Swingline Loans”) outstanding on the date of such notice, to repay the Swingline Lender. Each Alternative Currency Revolving Lender shall make the amount of such Alternative Currency Revolving Loan available to the
Administrative Agent at the Funding Office for Dollar-denominated payments in immediately available funds, not later than 10:00 A.M., New York City time, one Business Day after the date of such notice. The proceeds of such Alternative Currency
Revolving Loans shall be immediately made available by the Administrative Agent to the Swingline Lender for application by the Swingline Lender to the repayment of the Refunded Swingline Loans. The Borrower irrevocably authorizes the Swingline
Lender to charge the Borrower’s accounts with the Administrative Agent (up to the amount available in each such account) in order to immediately pay the amount of such Refunded Swingline Loans to the extent amounts received from the Alternative
Currency Revolving Lenders are not sufficient to repay in full such Refunded Swingline Loans. 

  
 -53- 

 (c) If prior to the time an Alternative Currency Revolving Loan denominated in Dollars would have
otherwise been made pursuant to Section 2.7(b), one of the events described in Section 8.1(g) shall have occurred and be continuing with respect to the Borrower or if for any other reason, as determined by the Swingline
Lender in its sole discretion, Alternative Currency Revolving Loans may not be made as contemplated by Section 2.7(b), each Alternative Currency Revolving Lender shall, on the date such Alternative Currency Revolving Loan was to have
been made pursuant to the notice referred to in Section 2.7(b), purchase for cash an undivided participating interest in the then outstanding Swingline Loans by paying to the Swingline Lender an amount (the “Swingline
Participation Amount”) equal to (i) such Alternative Currency Revolving Lender’s Alternative Currency Revolving Percentage times (ii) the sum of the aggregate principal amount of Swingline Loans then outstanding that
were to have been repaid with such Alternative Currency Revolving Loans. 
 (d) Whenever, at any time after the Swingline Lender has
received from any Alternative Currency Revolving Lender such Lender’s Swingline Participation Amount, the Swingline Lender receives any payment on account of the Swingline Loans, the Swingline Lender will distribute to such Lender its Swingline
Participation Amount (appropriately adjusted, in the case of interest payments, to reflect the period of time during which such Lender’s participating interest was outstanding and funded and, in the case of principal and interest payments, to
reflect such Lender’s pro rata portion of such payment if such payment is not sufficient to pay the principal of and interest on all Swingline Loans then due); provided, however, that in the event that such payment
received by the Swingline Lender is required to be returned, such Alternative Currency Revolving Lender will return to the Swingline Lender any portion thereof previously distributed to it by the Swingline Lender. 

(e) Each Alternative Currency Revolving Lender’s obligation to make the Loans referred to in Section 2.7(b) and to purchase
participating interests pursuant to Section 2.7(c) shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such Alternative
Currency Revolving Lender or the Borrower may have against the Swingline Lender, the Borrower or any other Person for any reason whatsoever; (ii) the occurrence or continuance of a Default or the failure to satisfy any of the other conditions
specified in Section 5; (iii) any adverse change in the financial condition of the Borrower; (iv) any breach of this Agreement or any other Loan Document by the Borrower, any other Loan Party or any other Alternative Currency
Revolving Lender; or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing. 
 (f)
If the Maturity Date shall have occurred in respect of any tranche of Alternative Currency Revolving Commitments at a time when another tranche or tranches of Alternative Currency Revolving Commitments is or are in effect with a longer Maturity
Date, then on the earliest occurring Maturity Date all then outstanding Swingline Loans shall be repaid in full (and there shall be no adjustment to the participations in such Swingline Loans as a result of the occurrence of such Maturity Date);
provided, however, that if on the occurrence of such earliest Maturity Date (after giving effect to any repayments of Alternative Currency Revolving Loans and any reallocation of Letter of Credit participations as contemplated in
Section 3.10), there shall exist sufficient unutilized Extended Revolving Commitments that are the Alternative Currency Revolving Commitments so that the respective outstanding Swingline Loans could be incurred pursuant to such Extended
Revolving Commitments which will remain in effect after the occurrence of such Maturity Date, then there shall be an automatic adjustment on such date of the Swingline Participation Amounts of each Alternative Currency Revolving Lender that is an
Extending Revolving Lender and such outstanding Swingline Loans shall be deemed to have been incurred solely pursuant to the relevant Extended Revolving Commitments, and such Swingline Loans shall not be so required to be repaid in full on such
earliest Maturity Date. 

  
 -54- 

 2.8 Commitment Fees, etc. 

(a) The Borrower agrees to pay to the Administrative Agent for the account of each Revolving Lender a commitment fee for the period from and
including the Closing Date to the last day of the Revolving Commitment Period, computed at the Commitment Fee Rate on the average daily amount of the Available Dollar Revolving Commitment and/or Available Alternative Currency Revolving Commitment,
as applicable, of such Lender during the period for which payment is made, payable quarterly in arrears on each Fee Payment Date, commencing on the first such date to occur after the Closing Date and on the Maturity Date for the Revolving Facility.

 (b) The Borrower agrees to pay to the Administrative Agent the fees in the amounts and on the dates previously agreed to in writing by
the Borrower and the Administrative Agent. 
 (c) The Borrower will pay to the Administrative Agent for the account of each Applicable
Participant in accordance with its Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, a fee for each Letter of Credit with respect to which it is an Applicable Participant equal to the product of (i) the
Dollar Equivalent of the daily maximum amount then available to be drawn on such Letters of Credit and (ii) a per annum rate equal to the Applicable Margin then in effect with respect to Eurodollar Loans under the Revolving Facility, payable
quarterly in arrears on each Fee Payment Date after the issuance date. In addition, the Borrower shall pay to the Issuing Lender for its own account a fronting fee of 0.125% per annum on the undrawn and unexpired amount of each Letter of
Credit, payable quarterly in arrears on each Fee Payment Date after the issuance date. 
 (d) In addition to the foregoing fees, the
Borrower shall pay or reimburse the Issuing Lender for such normal and customary costs and expenses (including issuance fees) as are incurred or charged by the Issuing Lender in issuing, negotiating, effecting payment under, amending or otherwise
administering any Letter of Credit. 
 (e) The Borrower agrees to pay on the Closing Date (w) to each Tranche A Term Lender party to
this Agreement on the Closing Date, as fee compensation for the funding of such Tranche A Term Lender’s Tranche A Term Loan, a funding fee in an amount agreed between such Tranche A Term Lender and the Borrower, (x) to each Tranche B Term
Lender party to this Agreement on the Closing Date, as fee compensation for the funding of such Tranche B Term Lender’s Tranche B Term Loan, a funding fee in an amount equal to 0.50% of the stated principal amount of such Tranche B Term
Lender’s Tranche B Term Loan funded on the Closing Date, (y) to each Dollar Revolving Lender party to this Agreement on the Closing Date, as compensation for the Dollar Revolving Commitment of such Dollar Revolving Lender, a commitment fee
in the amount agreed between such Dollar Revolving Lender and the Borrower and (z) to each Alternative Currency Revolving Lender party to this Agreement on the Closing Date, as compensation for the Alternative Currency Revolving Commitment of
such Alternative Currency Revolving Lender, a commitment fee in the amount agreed between such Alternative Currency Revolving Lender and the Borrower. 

(f) All fees payable hereunder (subject to Section 2.26) shall be paid on the dates due, in immediately available funds, to the
Administrative Agent (or to the Issuing Lender, in the case of fees payable to it) for distribution, in the case of facility fees and participation fees, to the Lenders. Fees paid shall not be refundable under any circumstances. 

  
 -55- 

 2.9 Termination or Reduction of Revolving Commitments. The Borrower shall have the right,
upon not less than three Business Days’ notice to the Administrative Agent, to terminate, or from time to time to reduce the amount of, the Revolving Commitments under one or more Revolving Facilities; provided that no such termination
or reduction of Revolving Commitments shall be permitted if, after giving effect thereto and to any prepayments of the Revolving Loans and Swingline Loans made on the effective date thereof, (i) the Total Alternative Currency Revolving
Extensions of Credit would exceed the Total Alternative Currency Revolving Commitments, (ii) the Total Dollar Revolving Extensions of Credit would exceed the Total Dollar Revolving Commitments or (iii) the Total Revolving Extensions of
Credit would exceed the Total Revolving Commitments. Any such reduction shall be in an amount equal to (i) with respect to the Alternative Currency Revolving Commitments, $1,000,000, a whole multiple thereof, or the remaining aggregate amount
of the Alternative Currency Revolving Commitments, and shall reduce permanently the Alternative Currency Revolving Commitments then in effect and (ii) with respect to the Dollar Revolving Commitments, $1,000,000, a whole multiple thereof, or
the remaining aggregate amount of the Dollar Revolving Commitments, and shall reduce permanently the Dollar Revolving Commitments then in effect. The Revolving Commitment (other than any Extended Revolving Commitment) of each Revolving Lender shall
automatically and permanently terminate on the Revolving Termination Date. On the respective Maturity Date applicable thereto, the Extended Revolving Commitment of each Extending Revolving Commitment shall automatically and permanently terminate.

 2.10 Optional Prepayments. The Borrower may at any time and from time to time prepay the Loans, in whole or in part, without
premium (except as set forth in Section 2.11(h)) or penalty, upon irrevocable notice delivered to the Administrative Agent no later than 2:00 P.M., New York City time, (i) three Business Days prior thereto, in the case of Eurodollar
Loans denominated in Dollars and (ii) four Business Days prior thereto in the case of Eurodollar Loans denominated in Alternative Currencies (other than Dollars), and no later than 2:00 P.M., New York City time, one Business Day prior thereto,
in the case of ABR Loans, which notice shall specify the date and amount of prepayment, the installment or installments of the respective Classes of the Loans to be repaid and whether the prepayment is of Eurodollar Loans or ABR Loans (it being
understood that the Borrower may elect to prepay one Class of Term Loans without prepaying another); provided that in the case of Swingline Loans notice may be given no later than 2:00 P.M. New York City time on the date of prepayment;
and provided, further, that if a Eurodollar Loan is prepaid on any day other than the last day of the Interest Period applicable thereto, the Borrower shall also pay any amounts owing pursuant to Section 2.20. Upon receipt
of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. If any such notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with (except in the
case of Revolving Loans that are ABR Loans and Swingline Loans) accrued interest to such date on the amount prepaid. Partial prepayments of a Class of Term Loans shall be in an aggregate principal amount of $1,000,000 or a whole multiple thereof.
Partial prepayments of Revolving Loans denominated in an Alternative Currency (other than Dollars) shall be in an aggregate principal amount of the Alternative Currency Equivalent of $1,000,000 or a whole multiple thereof. Partial prepayments of
Revolving Loans denominated in Dollars shall be in an aggregate principal amount of $1,000,000 or a whole multiple thereof. Partial prepayments of Swingline Loans shall be in an aggregate principal amount of $100,000 or a whole multiple thereof.

 2.11 Mandatory Prepayments and Commitment Reductions. 

(a) If any Redeemable Preferred Interests or Debt shall be issued or incurred by any Group Member (excluding any Debt incurred in accordance
with Section 7.2 (other than Credit Agreement Refinancing Debt) or Capital Stock issued in compliance with Section 7) an amount equal to 100% of the Net Cash Proceeds thereof shall be applied on the date of such issuance or
incurrence toward the prepayment of the Term Loans and the Revolving Loans as set forth in Section 2.11(d). 

  
 -56- 

 (b) If on any date any Group Member shall receive Net Cash Proceeds from any Asset Sale or
Recovery Event and such Net Cash Proceeds are not prohibited under any Requirements of Law to be distributed or otherwise transferred without the consent or approval of a Governmental Authority then, to the extent a Reinvestment Notice shall not
have been delivered in respect thereof, such Net Cash Proceeds shall be applied within ten days after the date that all post-closing adjustments associated therewith have been completed toward the prepayment of the Term Loans and the Revolving Loans
as set forth in Section 2.11(d) ; provided that, notwithstanding the foregoing, on each Reinvestment Prepayment Date, an amount equal to the Reinvestment Prepayment Amount with respect to the relevant Reinvestment Event shall be
applied toward the prepayment of the Term Loans and the Revolving Loans as set forth in Section 2.11(d). 
 (c) If, for any
Fiscal Year of the Borrower commencing with the Fiscal Year ending December 31, 2015, there shall be Excess Cash Flow, the Borrower shall, on the relevant Excess Cash Flow Application Date, apply the ECF Percentage of such Excess Cash Flow
toward the prepayment of the Term Loans and the reduction of the Revolving Commitments as set forth in Section 2.11(d). Each such prepayment and commitment reduction shall be made on a date (an “Excess Cash Flow Application
Date”) no later than five days after the earlier of (i) the date on which the financial statements of the Borrower referred to in Section 6.1(b), for the Fiscal Year with respect to which such prepayment is made, are
required to be delivered to the Administrative Agent (for distribution to the Agents and the Lenders) and (ii) the date such financial statements are actually delivered. 

(d) Amounts to be applied in connection with prepayments made pursuant to this Section 2.11 shall be applied, first, to the
prepayment of the Term Loans in accordance with Section 2.17(b) and, second, to reduce the Swingline Loans and then Revolving Loans without a permanent reduction of the Revolving Commitments. The application of any prepayment
pursuant to this Section 2.11 shall be made, first, to ABR Loans and, second, to Eurodollar Loans. Each prepayment of the Loans under this Section 2.11 (except in the case of Revolving Loans that are ABR Loans
and Swingline Loans) shall be accompanied by accrued interest to the date of such prepayment on the amount prepaid. 
 (e) Notwithstanding
anything to the contrary in Section 2.11(d) or 2.17, with respect to the amount of any mandatory prepayment described in Section 2.11 that is allocated to Tranche B Term Loans (such amount, the “Designated
Prepayment Amount”), at any time when Tranche A Term Loans remain outstanding, the Borrower will, in lieu of applying such amount to the prepayment of Tranche B Term Loans, as provided in Section 2.11(d) above, on the date
specified in Section 2.11 for such prepayment, give the Administrative Agent telephonic notice (promptly confirmed in writing) requesting that the Administrative Agent prepare and provide to each Tranche B Term Lender a notice (each, a
“Prepayment Option Notice”) as described below. As promptly as practicable after receiving such notice from the Borrower, the Administrative Agent will send to each Tranche B Term Lender a Prepayment Option Notice, which shall be in
the form of Exhibit G, and shall include an offer by the Borrower to prepay on the date (each a “Mandatory Prepayment Date”) that is 10 Business Days after the date of the Prepayment Option Notice, the relevant Term
Loans of such Lender by an amount equal to the portion of the Designated Prepayment Amount indicated in such Lender’s Prepayment Option Notice as being applicable to such Lender’s Tranche B Term Loans. On the Mandatory Prepayment Date,
(i) the Borrower shall pay to the relevant Tranche B Term Lenders the aggregate amount necessary to prepay that portion of the outstanding relevant Term Loans as described above in respect of which such Lenders have accepted prepayment (it
being understood that a failure to respond to a Prepayment Option Notice shall be deemed an acceptance of the prepayment referenced therein) and (ii) the Borrower shall pay to the Tranche A Term Lenders an amount equal to the portion of the
Designated Prepayment Amount not accepted by the relevant Lenders, and such amount shall be applied to the prepayment of the Tranche A Term Loans; provided that if after the application of amounts pursuant to clause (ii), any portion of the
Designated Prepayment Amount not accepted by the Tranche B Term Lenders shall remain, such amount shall be used to prepay the Tranche B Term Loans on a pro rata basis. 

  
 -57- 

 (f) Revolving Loan Prepayments. 

(i) In the event of the termination of all the Alternative Currency Revolving Commitments, the Borrower shall, on the date of such termination,
repay or prepay all its outstanding Alternative Currency Revolving Loans and all outstanding Swingline Loans and replace all outstanding Alternative Currency Letters of Credit or cash collateralize all outstanding Alternative Currency Letters of
Credit in accordance with the procedures set forth in Section 3.10. In the event of the termination of all the Dollar Revolving Commitments, the Borrower shall, on the date of such termination, repay or prepay all its outstanding Dollar
Revolving Loans and replace all outstanding Dollar Letters of Credit or cash collateralize all outstanding Dollar Letters of Credit in accordance with the procedures set forth in Section 3.10. 

(ii) In the event of any partial reduction of the Alternative Currency Revolving Commitments, then (x) at or prior to the effective date
of such reduction, the Administrative Agent shall notify the Borrower and the Alternative Currency Revolving Lenders of the sum of the Alternative Currency Revolving Extensions of Credit after giving effect thereto and (y) if the sum of the
Alternative Currency Revolving Extensions of Credit would exceed the aggregate amount of Alternative Currency Revolving Commitments after giving effect to such reduction, then the Borrower shall, on the date of such reduction, first, repay or
prepay Swingline Loans, second, repay or prepay Alternative Currency Revolving Loans and third, replace outstanding Alternative Currency Letters of Credit or cash collateralize outstanding Alternative Currency Letters of Credit in
accordance with the procedures set forth in Section 3.10, in an aggregate amount sufficient to eliminate such excess. In the event of any partial reduction of the Dollar Revolving Commitments, then (x) at or prior to the effective
date of such reduction, the Administrative Agent shall notify the Borrower and the Dollar Revolving Lenders of the sum of the Dollar Revolving Extensions of Credit after giving effect thereto and (y) if the sum of the Dollar Revolving
Extensions of Credit would exceed the aggregate amount of Dollar Revolving Commitments after giving effect to such reduction, then the Borrower shall, on the date of such reduction, first, repay or prepay Dollar Revolving Loans and
second, replace outstanding Dollar Letters of Credit or cash collateralize outstanding Dollar Letters of Credit in accordance with the procedures set forth in Section 3.10, in an aggregate amount sufficient to eliminate such
excess. 
 (iii) In the event that the sum of all Alternative Currency Revolving Lenders’ Alternative Currency Revolving Extensions of
Credit exceeds the Alternative Currency Revolving Commitments then in effect (including, without limitation, as a result of any Revaluation Date or as a result of currency fluctuations), the Borrower shall, without notice or demand, immediately
first, repay or prepay Swingline Loans, second, repay or prepay Alternative Currency Revolving Loans, and third, replace outstanding Alternative Currency Letters of Credit or cash collateralize outstanding Alternative Currency
Letters of Credit in accordance with the procedures set forth in Section 3.10, in an aggregate amount sufficient to eliminate such excess. In the event that the sum of all Dollar Revolving Lenders’ Dollar Revolving Extensions of
Credit exceeds the Dollar Revolving Commitments then in effect, the Borrower shall, without notice or demand, immediately first, repay or prepay Dollar Revolving Loans, and second, replace outstanding Dollar Letters of Credit or cash
collateralize outstanding Dollar Letters of Credit in accordance with the procedures set forth in Section 3.10, in an aggregate amount sufficient to eliminate such excess. 

(iv) In the event that the aggregate LC Obligations exceed the LC Commitment then in effect, the Borrower shall, without notice or demand,
immediately replace outstanding Letters of Credit or cash collateralize outstanding Letters of Credit in accordance with the procedures set forth in Section 3.10, in an aggregate amount sufficient to eliminate such excess. 

  
 -58- 

 (g) [Reserved]. 

(h) In the event that, on or prior to the date that is six months after the Closing Date, the Borrower (x) prepays, refinances,
substitutes or replaces any Tranche B Term Loan pursuant to a Repricing Transaction (including, for avoidance of doubt, any prepayment made pursuant to Section 2.11(a) that constitutes a Repricing Transaction), or (y) effects any
amendment of this Agreement resulting in a Repricing Transaction, the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable Tranche B Term Lenders, (I) in the case of clause (x), a prepayment premium
of 1.00% of the aggregate principal amount of the Tranche B Term Loan so prepaid, refinanced, substituted or replaced and (II) in the case of clause (y), a fee equal to 1.00% of the aggregate principal amount of the applicable Tranche B Term Loan
outstanding immediately prior to such amendment. Such amounts shall be due and payable on the date of effectiveness of such Repricing Transaction. 

2.12 Conversion and Continuation Options. 

(a) The Borrower may elect from time to time to convert Eurodollar Loans denominated in Dollars to ABR Loans by giving the Administrative Agent
prior irrevocable notice of such election pursuant to an Interest Election Request no later than 2:00 P.M., Local Time, on the Business Day preceding the proposed conversion date; provided that any such conversion of Eurodollar Loans may only
be made on the last day of an Interest Period with respect thereto. The Borrower may elect from time to time to convert ABR Loans denominated in Dollars to Eurodollar Loans by giving the Administrative Agent prior irrevocable notice of such election
no later than 2:00 P.M., Local Time, on the third Business Day preceding the proposed conversion date (which notice shall specify the length of the initial Interest Period therefor); provided that no ABR Loan under a particular Facility may
be converted into a Eurodollar Loan when any Event of Default has occurred and is continuing and the Administrative Agent or the Majority Facility Lenders in respect of such Facility have determined by written notice in its or their sole discretion
not to permit such conversions. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. No Revolving Loan may be converted into or continued as a Revolving Loan denominated in a different
currency, but instead must be prepaid in the original currency of such Revolving Loan and reborrowed in the other currency. 
 (b) Any
Eurodollar Loan may be continued as such upon the expiration of the then current Interest Period with respect thereto by the Borrower giving irrevocable notice to the Administrative Agent pursuant to an Interest Election Request, in accordance with
the applicable provisions of the term “Interest Period” set forth in Section 1.1, of the length of the next Interest Period to be applicable to such Loans; provided that the Borrower may not elect to continue a
Eurodollar Loan under a particular Facility as such when any Event of Default has occurred and is continuing and the Administrative Agent has or the Majority Facility Lenders in respect of such Facility have determined by written notice in its or
their sole discretion not to permit such continuations, and provided, further, that if the Borrower shall fail to give any required notice as described above in this paragraph or if such continuation is not permitted pursuant to the
preceding proviso (i) if such Loans are denominated in Dollars, such shall be automatically converted to ABR Loans on the last day of such then expiring Interest Period and (ii) if such Loans are denominated in an Alternative Currency
(other than Dollars), such Loans shall be automatically continued as Eurodollar Loans with an Interest Period of one month. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. 

2.13 Limitations on Eurodollar Tranches. Notwithstanding anything to the contrary in this Agreement, all borrowings, conversions and
continuations of Eurodollar Loans and all selections of Interest Periods shall be in such amounts and be made pursuant to such elections so that (a) after giving effect thereto, the aggregate principal amount of the Eurodollar Loans comprising
each Eurodollar 

  
 -59- 

 
Tranche shall be equal to (i) with respect to Eurodollar Loans denominated in Dollars, $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (ii) with respect to Eurodollar
Loans denominated in an Alternative Currency (other than Dollars), the Alternative Currency Equivalent of $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (b) no more than fifteen Eurodollar Tranches shall be outstanding at
any one time. 
 2.14 Interest Rates and Payment Dates. 

(a) Each Eurodollar Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to the
Eurodollar Rate determined for such day plus the Applicable Margin. 
 (b) Each ABR Loan shall bear interest at a rate per annum equal to
the ABR plus the Applicable Margin. 
 (c) Upon the occurrence and during the continuance of an Event of Default under
Section 8.1(a), (b) or (g), if all or a portion of the principal amount of any Loan or Reimbursement Obligation or any interest payable on any Loan or Reimbursement Obligation or any commitment fee or other amount
payable hereunder shall not be paid when due (whether at the stated maturity, by acceleration or otherwise), such overdue amount shall bear interest at a rate per annum equal to the greater of (i) the rate then applicable to ABR Loans under the
relevant Facility plus 2% (or, in the case of any such other amounts that do not relate to a particular Facility, the rate then applicable to ABR Loans under the Revolving Facility plus 2%) and (ii) the actual rate applicable to
such amount plus 2%, from the date of such non-payment until such amount is paid in full (after as well as before judgment). 

(d) Interest shall be payable in arrears on each Interest Payment Date; provided that interest accruing pursuant to paragraph
(c) of this Section shall be payable from time to time on demand. 
 2.15 Computation of Interest and Fees. 

(a) Interest and fees payable pursuant hereto shall be calculated on the basis of a 360-day year for the actual days elapsed, except that, with
respect to ABR Loans the rate of interest on which is calculated on the basis of the Prime Rate, the interest thereon shall be calculated on the basis of a 365- (or 366-, as the case may be) day year for the actual days elapsed or, in the case of
interest in respect of Loans denominated in Alternative Currencies as to which market practice differs from the foregoing, in accordance with such market practice. The Administrative Agent shall as soon as practicable notify the Borrower and the
relevant Lenders of each determination of a Eurodollar Rate. Any change in the interest rate on a Loan resulting from a change in the ABR or the Eurodollar Rate shall become effective as of the opening of business on the day on which such change
becomes effective. The Administrative Agent shall as soon as practicable notify the Borrower and the relevant Lenders of the effective date and the amount of each such change in interest rate. 

(b) Each determination of an interest rate by the Administrative Agent pursuant to any provision of this Agreement shall be conclusive and
binding on the Borrower and the Lenders in the absence of manifest error. The Administrative Agent shall, at the request of the Borrower, deliver to the Borrower a statement showing the quotations used by the Administrative Agent in determining any
interest rate pursuant to Section 2.14(a). 

  
 -60- 

 2.16 Inability to Determine Interest Rate. If prior to the first day of any Interest
Period: 
 (a) the Administrative Agent shall have determined (which determination shall be conclusive and binding upon the
Borrower) that, by reason of circumstances affecting the relevant market, adequate and reasonable means do not exist for ascertaining the Eurodollar Rate for such Interest Period, or 

(b) the Administrative Agent shall have received notice from the Majority Facility Lenders in respect of the relevant Facility
that the Eurodollar Rate determined or to be determined for such Interest Period will not adequately and fairly reflect the cost to such Lenders (as conclusively certified by such Lenders) of making or maintaining their affected Loans during such
Interest Period, 
 the Administrative Agent shall give telecopy or telephonic notice thereof to the Borrower and the relevant Lenders as soon as
practicable thereafter. If such notice is given (and until such notice is withdrawn), (w) any Eurodollar Loans denominated in Dollars under the relevant Facility requested to be made on the first day of such Interest Period shall be made as ABR
Loans, (x) any Loans denominated in Dollars under the relevant Facility that were to have been converted on the first day of such Interest Period to Eurodollar Loans shall be continued as ABR Loans, (y) any outstanding Eurodollar Loans
denominated in Dollars under the relevant Facility shall be converted, on the last day of the then-current Interest Period, to ABR Loans and (z) any outstanding Eurodollar Loans denominated in an Alternative Currency (other than Dollars) shall
be continued with an interest applicable thereto equal to the sum of (I) the Applicable Margin for such Eurodollar Loans and (II) the rate for each day during such Interest Period reasonably determined by the Administrative Agent to be the cost
of funds of representative participating members in the interbank eurodollar market selected by the Administrative Agent (which may include Lenders) for maintaining loans similar to the relevant Loans (provided that any change in the rate
determined pursuant to this clause (II) shall be effective as of the opening of business on the effective day of any change in the relevant component of such rate). Until such notice has been withdrawn by the Administrative Agent, no further
Eurodollar Loans denominated in Dollars under the relevant Facility shall be made or continued as such, nor shall the Borrower have the right to convert Loans denominated in Dollars under the relevant Facility to Eurodollar Loans. 

2.17 Pro Rata Treatment and Payments. 

(a) Each borrowing by the Borrower from the Lenders hereunder, each payment by the Borrower on account of any commitment fee and any reduction
of the Commitments of the Lenders shall be made pro rata according to the respective Tranche A Term Percentages, Tranche B Term Percentages, Dollar Revolving Percentages or Alternative Currency Revolving Percentages, as the case may
be, of the relevant Lenders in the Class subject to reduction. 
 (b) Each payment (including each prepayment) by the Borrower on account of
principal of and interest on the Term Loans shall be made pro rata according to the respective outstanding principal amounts of the Term Loans then held by the Term Lenders (except (i) as otherwise provided in
Section 2.11(e), (ii) that an optional prepayment pursuant to Section 2.10 need only be made pro rata according to the respective outstanding principal amounts of the Term Loans of the applicable Class
being prepaid then held by the Term Lenders, (iii) any prepayment of Term Loans with the Net Cash Proceeds of Credit Agreement Refinancing Debt shall be applied solely to each applicable Class of Refinanced Debt and (iv) any prepayment of
Term Loans with the Net Cash Proceeds of Debt pursuant to Section 2.11(a) may be applied to a Class or Classes of Term Loans as directed by the Borrower). The amount of 

  
 -61- 

 
each principal prepayment of the Term Loans shall be applied to reduce the then remaining installments of the Tranche A Term Loans and Tranche B Term Loans, as the case may be, pro
rata based upon the respective then remaining principal amounts thereof. Amounts prepaid on account of the Term Loans may not be reborrowed. Notwithstanding any other provision of this Section 2.17(b), a Lender may, at its option,
and if agreed by the Borrower, in connection with any prepayment of Term Loans pursuant to Section 2.10 or Section 2.11, exchange such Lender’s portion of the Term Loan to be repaid for Debt of the Borrower, in lieu of
such Lender’s pro ratio portion of such prepayment (and any such Term Loans so exchanged shall be deemed repaid for all purposes under the Loan Documents). 

(c) Each payment (including each prepayment) by the Borrower on account of principal of and interest on the Revolving Loans shall be made
pro rata according to the respective outstanding principal amounts of the Revolving Loans then held by the relevant Revolving Lenders. 

(d) All payments (including prepayments) to be made by the Borrower hereunder, whether on account of principal, interest, fees or otherwise,
shall be made without setoff or counterclaim and shall be made prior to 1:00 P.M., New York City time, on the due date thereof to the Administrative Agent, for the account of the Lenders, at the Funding Office for the applicable currency, in
the currency in which the applicable Loan was made and in immediately available funds. The Administrative Agent shall distribute such payments to the Lenders promptly upon receipt in like funds as received. If any payment hereunder (other than
payments on the Eurodollar Loans) becomes due and payable on a day other than a Business Day, such payment shall be extended to the next succeeding Business Day. If any payment on a Eurodollar Loan becomes due and payable on a day other than a
Business Day, the maturity thereof shall be extended to the next succeeding Business Day unless the result of such extension would be to extend such payment into another calendar month, in which event such payment shall be made on the immediately
preceding Business Day. In the case of any extension of any payment of principal pursuant to the preceding two sentences, interest thereon shall be payable at the then applicable rate during such extension. 

(e) Unless the Administrative Agent shall have been notified in writing by any Lender prior to a borrowing that such Lender will not make the
amount that would constitute its share of such borrowing available to the Administrative Agent, the Administrative Agent may assume that such Lender is making such amount available to the Administrative Agent, and the Administrative Agent may, in
reliance upon such assumption, make available to the Borrower a corresponding amount. If such amount is not made available to the Administrative Agent by the required time on the Borrowing Date therefor, such Lender shall pay to the Administrative
Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the Federal Funds Effective Rate and (ii) a rate determined by the Administrative Agent in accordance with banking industry rules on interbank
compensation, for the period until such Lender makes such amount immediately available to the Administrative Agent. A certificate of the Administrative Agent submitted to any Lender with respect to any amounts owing under this paragraph shall be
conclusive in the absence of manifest error. If such Lender’s share of such borrowing is not made available to the Administrative Agent by such Lender within three Business Days after such Borrowing Date, the Administrative Agent shall also be
entitled to recover such amount with interest thereon at the rate per annum applicable to (i) with respect to borrowings under the Dollar Revolving Facility, ABR Loans under the Dollar Revolving Facility or (ii) with respect to borrowings
under the Alternative Currency Revolving Facility, Eurodollar Loans under the Alternative Currency Revolving Facility, in each case, on demand, from the Borrower. 

(f) Unless the Administrative Agent shall have been notified in writing by the Borrower prior to the date of any payment due to be made by the
Borrower hereunder that the Borrower will not make such payment to the Administrative Agent, the Administrative Agent may assume that the Borrower is 

  
 -62- 

 
making such payment, and the Administrative Agent may, but shall not be required to, in reliance upon such assumption, make available to the Lenders their respective pro rata shares
of a corresponding amount. If such payment is not made to the Administrative Agent by the Borrower within three Business Days after such due date, the Administrative Agent shall be entitled to recover, on demand, from each Lender to which any amount
which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily average Federal Funds Effective Rate. Nothing herein shall be deemed to limit the rights of the Administrative
Agent or any Lender against the Borrower. 
 (g) If any Lender shall fail to make any payment required to be made by it pursuant to
Section 2.5, Section 2.7(c), Section 3.4, Section 3.5 or Section 11.5(c), then the Administrative Agent may, in its discretion and notwithstanding any contrary provision hereof,
(i) apply any amounts thereafter received by the Administrative Agent for the account of such Lender for the benefit of the Administrative Agent, the Swingline Lender or the Issuing Lender to satisfy such Lender’s obligations to it under
such Section until all such unsatisfied obligations are fully paid, and/or (ii) until such failure to make payment has been cured, hold any such amounts in a segregated account as cash collateral for, and application to, any future funding
obligations of such Lender under any such Section, in the case of each of clauses (i) and (ii) above, in any order as determined by the Administrative Agent in its discretion. 

2.18 Requirements of Law. If the adoption of or any change in any Requirement of Law or in the interpretation or application thereof or
compliance by any Lender or Issuing Lender with any request or directive (whether or not having the force of law) from any central bank or other Governmental Authority made subsequent to the Closing Date: 

(i) shall subject any Lender or Issuing Lender to any tax of any kind whatsoever with respect to this Agreement, any Letter of
Credit, any Application or any Eurodollar Loan made by it, or change the basis of taxation of payments to such Lender or Issuing Lender in respect thereof (except for Non-Excluded Taxes covered by Section 2.19 and Taxes imposed on the
overall net income of such Lender or Issuing Lender); 
 (ii) shall impose, modify or hold applicable any reserve, special
deposit, compulsory loan or similar requirement against assets held by, deposits or other liabilities in or for the account of, advances, loans or other extensions of credit by, or any other acquisition of funds by, any office of such Lender or
Issuing Lender that is not otherwise included in the determination of the Eurodollar Rate; or 
 (iii) shall impose on such
Lender or Issuing Lender any other condition; 
 and the result of any of the foregoing is to increase the cost to such Lender or Issuing Lender, by an
amount that such Lender or Issuing Lender deems to be material, of making, converting into, continuing or maintaining Eurodollar Loans or issuing or participating in Letters of Credit, or to reduce any amount receivable hereunder in respect thereof,
then, in any such case, the Borrower shall promptly pay such Lender or Issuing Lender, upon its demand, any additional amounts necessary to compensate such Lender or Issuing Lender for such increased cost or reduced amount receivable. If any Lender
or Issuing Lender becomes entitled to claim any additional amounts pursuant to this paragraph, it shall promptly notify the Borrower (with a copy to the Administrative Agent) of the event by reason of which it has become so entitled. 

  
 -63- 

 (b) If any Lender or Issuing Lender shall have determined that the adoption of or any change in
any Requirement of Law regarding capital adequacy or liquidity or in the interpretation or application thereof or compliance by such Lender or Issuing Lender or any corporation Controlling such Lender or Issuing Lender with any request or directive
regarding capital adequacy (whether or not having the force of law) from any Governmental Authority made subsequent to the Closing Date (each, a “Change in Law”); provided, however, that notwithstanding anything herein
to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives
promulgated by the Bank for International settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed
to be a “Change in Law,” regardless of the date enacted, adopted or issued) shall have the effect of reducing the rate of return on such Lender’s or Issuing Lender’s or such corporation’s capital as a consequence of its
obligations hereunder or under or in respect of any Letter of Credit to a level below that which such Lender or Issuing Lender or such corporation could have achieved but for such Change in Law (taking into consideration such Lender’s or
Issuing Lender’s or such corporation’s policies with respect to capital adequacy and liquidity) by an amount deemed by such Lender or Issuing Lender to be material, then from time to time, after submission by such Lender or Issuing Lender
to the Borrower (with a copy to the Administrative Agent) of a written request therefor, the Borrower shall pay to such Lender or Issuing Lender such additional amount or amounts as will compensate such Lender or such corporation for such reduction.

 (c) Each request by a Lender or Issuing Lender for the payment of an additional amount under this Section 2.18 shall be
accompanied by a certificate showing in reasonable detail the method of calculation and the allocation (which shall be reasonable) thereof. Such certificate as to any additional amounts payable pursuant to this Section submitted by any Lender or
Issuing Lender to the Borrower (with a copy to the Administrative Agent) shall be conclusive in the absence of manifest error. Notwithstanding anything to the contrary in this Section, the Borrower shall not be required to compensate a Lender or
Issuing Lender pursuant to this Section for any amounts incurred more than six months prior to the date that such Lender or Issuing Lender notifies the Borrower of such Lender’s or Issuing Lender’s intention to claim compensation therefor;
provided that, if the change in law giving rise to such claim have a retroactive effect, then such six-month period shall be extended to include the period of such retroactive effect. The obligations of the Borrower pursuant to this Section
shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder. 
 (d) If at any time
any Lender shall have determined that the making or continuance of any Eurodollar Loan has been made unlawful by any law or governmental rule, regulation or order, or any Governmental Authority has imposed material restrictions on the authority of a
Lender to purchase or sell, or to take deposits of, Dollars in the London interbank market, then such Lender shall promptly give notice (by telephone promptly confirmed in writing) to the Borrower and to the Administrative Agent of such
determination (which notice the Administrative Agent shall promptly transmit to each of the other Lenders). Thereafter the Borrower shall either (x) if the affected Eurodollar Loan is then being made initially or pursuant to a conversion,
cancel such borrowing by giving the Administrative Agent telephonic notice (confirmed in writing) on the same date that the Borrower was notified by the affected Lender or the Administrative Agent pursuant to this Section 2.18(d) or
(y) if the affected Eurodollar Loan is then outstanding, upon at least three Business Days’ written notice to the Administrative Agent, require the affected Lender to convert such Eurodollar Loan into a ABR Loan, provided that, if
more than one Lender is affected at any time, then all affected Lenders must be treated the same pursuant to this Section 2.18(d). 

  
 -64- 

 2.19 Taxes. 

(a) All payments made by any Loan Party under this Agreement or any other Loan Document shall be made free and clear of, and without deduction
or withholding for or on account of, any Taxes, excluding overall net income taxes and franchise taxes (imposed in lieu of net income taxes) imposed on the Administrative Agent or any Lender by a jurisdiction as a result of the recipient being
organized or having its principal office or, in the case of any Lender, having its applicable lending office in such jurisdiction or as a result of any present or former connection between the Administrative Agent or any Lender and the jurisdiction
imposing such Taxes (other than a connection arising solely from the Administrative Agent or such Lender having executed, delivered, enforced, become a party to, performed its obligations under, received payments under, received or perfected a
security interest under, or engaged in any other transaction pursuant to, any Loan Document), including branch profits taxes imposed by the United States or any similar tax imposed by any other jurisdiction in which the Borrower is located. If any
such non-excluded Taxes (“Non-Excluded Taxes”) or Other Taxes are required to be withheld or deducted from any amounts payable (which shall include deductions applicable to additional sums payable under this Section) to the
Administrative Agent or any Lender hereunder, the amounts so payable to the Administrative Agent or such Lender shall be increased to the extent necessary to yield to the Administrative Agent or such Lender (after payment of all Non-Excluded Taxes
and Other Taxes) interest or any such other amounts payable hereunder at the rates or in the amounts specified in this Agreement; provided, however, that the Borrower shall not be required to increase any such amounts payable to any
Lender with respect to any Non-Excluded Taxes (i) that are attributable to such Lender’s failure to comply with the requirements of paragraph (e) or (f) of this Section, (ii) that are United States federal withholding taxes
imposed on amounts payable to such Lender at the time such Lender becomes a party to this Agreement, except to the extent that such Lender’s assignor (if any) was entitled, at the time of assignment, to receive additional amounts from the
Borrower with respect to such Non-Excluded Taxes pursuant to this paragraph; provided that this subclause (ii) shall not apply to any Tax imposed on a Lender in connection with an interest or participation in any Loan or other obligation
that such Lender was required to acquire pursuant to Section 11.7 or (iii) that are imposed pursuant to Sections 1471 through 1474 of the Code other than by reason of a change in law after the Closing Date (such Non-Excluded Taxes
referred to in clauses (i) through (iii), “Additional Excluded Taxes”). 
 (b) In addition, the Borrower shall timely
pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law. 
 (c) The Borrower and the Guarantors shall
indemnify the Administrative Agent, or the affected Lender, as applicable, within 10 days after demand therefor, for the full amount of any Non-Excluded Taxes or Other Taxes, but excluding Additional Excluded Taxes (including Non-Excluded Taxes or
Other Taxes imposed or asserted on or attributable to amounts payable under this Section, but excluding Additional Excluded Taxes) paid by the Administrative Agent or such Lender, as the case may be, and any penalties, interest and reasonable
expenses arising therefrom or with respect thereto, whether or not such Non-Excluded Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or
liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error. 

(d) As soon as practicable after any payment of Non-Excluded Taxes or Other Taxes by the Borrower to a Governmental Authority, the Borrower
shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably
satisfactory to the Administrative Agent. 

  
 -65- 

 (e) Each Lender that is not a “U.S. Person” as defined in Section 7701(a)(30) of
the Code (a “Non-U.S. Lender”) shall deliver to the Borrower and the Administrative Agent (or, in the case of a Participant, to the Lender from which the related participation shall have been
purchased) two copies of either U.S. Internal Revenue Service Form W-8BEN or Form W-8ECI, or, in the case of a Non-U.S. Lender claiming exemption from U.S. federal withholding tax under Section 871(h) or
881(c) of the Code with respect to payments of “portfolio interest,” a statement substantially in the form of Exhibit J and a Form W-8BEN, or any subsequent versions thereof or successors thereto, properly completed and duly
executed by such Non-U.S. Lender claiming complete exemption from, or a reduced rate of, U.S. federal withholding tax on all payments by the Borrower under this Agreement and the other Loan Documents. Such
forms shall be delivered by each Non-U.S. Lender on or before the date it becomes a party to this Agreement (or, in the case of any Participant, on or before the date such Participant purchases the related
participation). In addition, each Non-U.S. Lender shall deliver such forms promptly upon the obsolescence or invalidity of any form previously delivered by such Non-U.S.
Lender. Each Non-U.S. Lender shall promptly notify the Borrower at any time it determines that it is no longer in a position to provide any previously delivered certificate to the Borrower (or any other form of certification adopted by the U.S.
taxing authorities for such purpose). Notwithstanding any other provision of this paragraph, a Non-U.S. Lender shall not be required to deliver any form pursuant to this paragraph that such Non-U.S. Lender is not legally able to deliver. 
 (f) A Lender that is entitled to an exemption from or
reduction of non-U.S. withholding tax under the law of the jurisdiction in which the Borrower is located, or any treaty to which such jurisdiction is a party, with respect to payments under this Agreement shall deliver to the Borrower (with a copy
to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by the Borrower, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without
withholding or at a reduced rate; provided that such Lender is legally entitled to complete, execute and deliver such documentation and in such Lender’s sole judgment such completion, execution or submission would not be materially
disadvantageous to such Lender and would not materially prejudice the legal position of such Lender. 
 (g) If the Administrative Agent or
any Lender determines, in its sole discretion, that it has received a refund of any Non-Excluded Taxes or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to
this Section 2.19, it shall pay over such refund to the Borrower (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section 2.19 with respect to the Non-Excluded Taxes
or Other Taxes giving rise to such refund), net of all reasonable out-of-pocket expenses of the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such
refund); provided that the Borrower, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental
Authority) to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary, in no event will any Lender be
required to pay any amount to the Borrower the payment of which would place such Lender in a less favorable net after-tax position than such Lender would have been in if the additional amounts giving rise to such refund of any Non-Excluded Taxes or
Other Taxes had never been paid. This paragraph shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes which it deems confidential) to the Borrower
or any other Person. 
 (h) The agreements in this Section shall survive the termination of this Agreement and the payment of the Loans and
all other amounts payable hereunder. 

  
 -66- 

 2.20 Indemnity. The Borrower agrees to indemnify each Lender for, and to hold each Lender
harmless from, any loss or expense that such Lender may sustain or incur as a consequence of (a) default by the Borrower in making a borrowing of, conversion into or continuation of Eurodollar Loans after the Borrower has given a notice
requesting the same in accordance with the provisions of this Agreement, (b) default by the Borrower in making any prepayment of or conversion from Eurodollar Loans after the Borrower has given a notice thereof in accordance with the provisions
of this Agreement or (c) the making of a prepayment of Eurodollar Loans on a day that is not the last day of an Interest Period with respect thereto. Such indemnification may include an amount equal to the excess, if any, of (i) the amount
of interest that would have accrued on the amount so prepaid, or not so borrowed, converted or continued, for the period from the date of such prepayment or of such failure to borrow, convert or continue to the last day of such Interest Period (or,
in the case of a failure to borrow, convert or continue, the Interest Period that would have commenced on the date of such failure) in each case at the applicable rate of interest for such Loans provided for herein (excluding, however, the
Applicable Margin included therein, if any) minus (ii) the amount of interest (as reasonably determined by such Lender) that would have accrued to such Lender on such amount by placing such amount on deposit for a comparable period with leading
banks in the interbank eurodollar market. A certificate as to any amounts payable pursuant to this Section submitted to the Borrower by any Lender shall be conclusive in the absence of manifest error. This covenant shall survive the termination of
this Agreement and the payment of the Loans and all other amounts payable hereunder. 
 2.21 Change of Lending Office. Each Lender
agrees that, upon the occurrence of any event giving rise to the operation of Section 2.18 or 2.19(a) with respect to such Lender, it will, if requested by the Borrower, use reasonable efforts (subject to overall policy
considerations of such Lender) to designate another lending office for any Loans affected by such event with the object of avoiding the consequences of such event; provided that such designation is made on terms that, in the sole judgment of
such Lender, cause such Lender and its lending office(s) to suffer no economic, legal or regulatory disadvantage, and provided, further, that nothing in this Section shall affect or postpone any of the obligations of the Borrower or
the rights of any Lender pursuant to Section 2.18 or 2.19(a). 
 2.22 Replacement of Lenders. The Borrower shall
be permitted to replace any Lender that (a) requests reimbursement for amounts owing pursuant to Section 2.18 or 2.19(a), (b) is a Defaulting Lender or (c) is replaced pursuant to the third paragraph of
Section 11.1 with a replacement financial institution; provided that (i) such replacement does not conflict with any Requirement of Law, (ii) no Event of Default shall have occurred and be continuing at the time of such
replacement, (iii) if applicable, prior to any such replacement, such Lender shall not have taken appropriate action under Section 2.21 so as to eliminate the continued need for payment of amounts owing pursuant to
Section 2.18 or 2.19(a), (iv) the replacement financial institution shall purchase, at par, all Loans and other amounts owing to such replaced Lender on or prior to the date of replacement, (v) the Borrower shall be
liable to such replaced Lender under Section 2.20 if any Eurodollar Loan owing to such replaced Lender shall be purchased other than on the last day of the Interest Period relating thereto, (vi) the replacement financial
institution, if not already a Lender, shall be reasonably satisfactory to the Administrative Agent, (vii) the replaced Lender shall be obligated to make such replacement in accordance with the provisions of Section 11.6
(provided that the Borrower shall be obligated to pay the registration and processing fee referred to therein) and by its execution of this Agreement each Lender hereby authorizes the Administrative Agent to act as its agent in executing any
documents to replace such Lender in accordance with this Section 2.22, (viii) until such time as such replacement shall be consummated, the Borrower shall pay all additional amounts (if any) required pursuant to
Section 2.18 or 2.19(a), as the case may be, and (ix) any such replacement shall not be deemed to be a waiver of any rights that the Borrower, the Administrative Agent or any other Lender shall have against the replaced
Lender. Notwithstanding the foregoing, this Section 2.22 may only be utilized with respect to a replaced Lender in respect of any amendment to this Agreement after the 

  
 -67- 

 
Closing Date and prior to the date that is six months after the Closing Date that constitutes a Repricing Transaction pursuant to Section 2.11(h) if such replaced Tranche B Term
Lender is paid a fee equal to 1.0% of the principal amount of such Tranche B Term Lender’s Tranche B Term Loans being replaced and repaid. 

2.23 Repayment of Loans; Evidence of Debt. 

(a) The Borrower hereby unconditionally promises to pay (i) to the Administrative Agent for the account of each Lender the then unpaid
principal amount of each Revolving Loan on the Revolving Termination Date (or with respect to any Revolving Loans outstanding with respect to an Extended Revolving Commitment, the Maturity Date applicable thereto), (ii) to the Administrative
Agent for the account of each Lender the Term Loans in accordance with Section 2.3; provided that, to the extent specified in the respective Extension Offer, amortization payments with respect to Extended Term Loans for periods
prior to the Tranche A Term Loan Maturity Date and the Tranche B Term Loan Maturity Date, as applicable, may be reduced (but not increased) and amortization payments required with respect to Extended Term Loans for periods after the Tranche A Term
Loan Maturity Date and the Tranche B Term Loan Maturity Date, as applicable, shall be as specified in the respective Extension Offer and (iii) to the Swingline Lender the then unpaid principal amount of each Swingline Loan in accordance with
Section 2.6(b). 
 (b) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the
indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder. 

(c) The Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made hereunder, the Facility,
Type and currency thereof and the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii) the amount of any sum
received by the Administrative Agent hereunder for the account of the Lenders and each Lender’s share thereof. 
 (d) The entries made
in the accounts maintained pursuant to paragraph (b) or (c) of this Section shall be prima facie evidence of the existence and amounts of the obligations recorded therein; provided that the failure of any Lender or the
Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the Borrower to repay the Loans in accordance with the terms of this Agreement. 

(e) Any Lender may request that Loans made by it be evidenced by a promissory note. In such event, the Borrower shall prepare, execute and
deliver to such Lender a promissory note payable to the order of such Lender (or, if requested by such Lender, to such Lender and its registered assigns) and in a form approved by the Administrative Agent. Thereafter, the Loans evidenced by such
promissory note and interest thereon shall at all times (including after assignment pursuant to Section 11.6) be represented by one or more promissory notes in such form payable to the order of the payee named therein (or, if such
promissory note is a registered note, to such payee and its registered assigns). 
 2.24 Increase in Commitments. 

(a) The Borrower may by written notice to the Administrative Agent elect to request (x) prior to the Revolving Termination Date, an
increase to the existing Revolving Commitments under one or more of the Revolving Facilities (“Increased Revolving Commitment”) and/or (y) the establishment 

  
 -68- 

 
of one or more new term loan Commitments (each, an “Incremental Term Loan Commitment”) in an amount not less than $100,000,000 individually and in an amount not to exceed the sum
of (A) the Shared Incremental Amount and (B) an amount of Incremental Term Loans or Increased Revolving Commitments such that the Senior Secured Leverage Ratio is no more than 3.50 to 1.00 as of the last day of the most recently ended
period of four fiscal quarters of the Borrower for which financial statements are internally available, determined on the applicable Increase Effective Date, after giving effect to any such incurrence on a Pro Forma Basis, and, in each case, with
respect to any Increased Revolving Commitments, assuming a borrowing of the maximum amount of Loans available thereunder, and excluding the cash proceeds of any such Incremental Term Loans or Increased Revolving Commitments (provided that,
for the avoidance of doubt, any Incremental Term Loans or Increased Revolving Commitments incurred or issued pursuant to clause (B) on any Increase Effective Date on which the Senior Secured Leverage Ratio test in this clause (B) is met
shall remain authorized pursuant to clause (B) if such Senior Secured Leverage Ratio test is not met as of any subsequent date). Each such notice shall specify (i) the date (each, an “Increase Effective Date”) on which
Borrower proposes that the increased or new Commitments shall be effective, which shall be a date not fewer than 10 Business Days after the date on which such notice is delivered to the Administrative Agent and (ii) the identity of each
Assignee to whom Borrower proposes any portion of such increased or new Commitments be allocated and the amounts of such allocations; provided that any existing Lender approached to provide all or a portion of the increased or new Commitments
may elect or decline, in its sole discretion, to provide such increased or new Commitment; provided, further, that any existing Lender that does not respond shall be deemed to have declined to provide such increased or new Commitment.

 (b) The increased or new Commitments shall become effective, as of such Increase Effective Date; provided that: 

(i) each of the conditions set forth in Section 5.2 shall be satisfied; 

(ii) no Default shall have occurred and be continuing or would result from the borrowings to be made on the Increase Effective
Date; 
 (iii) after giving pro forma effect to the borrowings to be made on the Increase Effective Date and to any change in
Consolidated EBITDA and any increase in Debt resulting from the consummation of any acquisition permitted by this Agreement concurrently with such borrowings as of the date of the most recent financial statements delivered pursuant to
Section 6.1(b) or (c), the Borrower shall be in compliance with each of the covenants set forth in Section 7.16; 

(iv) the Borrower shall make any payments required pursuant to Section 2.20 in connection with any adjustment of
Revolving Loans pursuant to Section 2.24(d); and 
 (v) the Borrower shall deliver or cause to be delivered any
legal opinions or other documents reasonably requested by the Administrative Agent in connection with any such transaction. 

(c) The terms and provisions of Loans made pursuant to the new Commitments shall be as follows: 

(i) terms and provisions of Loans made pursuant to Incremental Term Loan Commitments shall be, except as otherwise set forth
herein or in the Increase Joinder, identical to (i) the Tranche B Term Loans (“Incremental Term B Loans”) or (ii) the Tranche A Term Loans (“Incremental Term A Loans”, and together with any Incremental
Term B Loans, the “Incremental Term Loans”) 

  
 -69- 

 
(it being understood that Incremental Term Loans may be part of an existing Class of Term Loans); provided that the aggregate principal amount of all Incremental Term A Loans shall not
exceed (A) $1,000,000,000 plus (B) an amount equal to the excess, if any, of (x) the amount of Tranche A Term Loans outstanding on the Closing Date less (y) the amount of Tranche A Term Loans outstanding on the applicable
Increase Effective Date; 
 (ii) any Loans made pursuant to Incremental Term Loan Commitments shall rank pari passu in
right of payment and of security with the Term Loans; 
 (iii) all terms and provisions (including Maturity Date) of
Revolving Loans made pursuant to new Commitments shall be identical to the existing Revolving Loans; provided that in connection with any such new Commitments for additional Revolving Loans, the Borrower may pay to the Lenders providing such
Commitments a fee in an amount not to exceed the highest upfront fee paid to Revolving Lenders of the applicable Revolving Facility on the Closing Date; 

(iv) the weighted average life to maturity of all (x) Incremental Term B Loans shall be no shorter than the weighted
average life to maturity of the existing Tranche B Term Loans and (y) Incremental Term A Loans shall be no shorter than the weighted average life to maturity of the existing Tranche A Term Loans; 

(v) the maturity date of (x) all Incremental Term B Loans shall not be earlier than the latest Maturity Date with respect
to the Tranche B Term Loans as then in effect and (y) all Incremental Term A Loans shall not be earlier than the latest Maturity Date with respect to the Tranche A Term Loans as then in effect; and 

(vi) the interest rate margins for (x) the new Incremental Term A Loans shall be determined by Borrower and the applicable
new Lenders and (y) the new Incremental Term B Loans shall be determined by Borrower and the applicable new Lenders; provided, however, that the interest rate margins for the new Incremental Term B Loans, shall not be greater than
the highest interest rate margins that may, under any circumstances, be payable with respect to any Tranche B Term Loans plus 50 basis points (and the interest rate margins applicable to the Tranche B Term Loans shall be increased to the
extent necessary to achieve the foregoing); provided, further, that in determining the interest rate margins applicable to the existing Tranche B Term Loans, and the Incremental Term B Loans, as applicable, (x) original issue
discount or upfront or similar fees (collectively, “OID”) payable by the Borrower to the Lenders of the existing Tranche B Term Loans or the Incremental Term B Loans in the primary syndication thereof shall be included (with OID
being equated to interest based on an assumed four-year life to maturity), (y) customary arrangement or commitment fees payable to arrangers (or their respective affiliates) shall be excluded and (z) if the Incremental Term B Loans include
an interest rate floor greater than the interest rate floor applicable to the Tranche B Term Loans, such increased amount shall be equated to interest rate margins for purposes of determining whether an increase in the interest rate margins for the
Tranche B Term Loans shall be required, to the extent an increase in the interest rate floor in the Tranche B Term Loans would cause an increase in the interest rate margins, and in such case the interest rate floor (but not the Applicable Margin)
applicable to the Tranche B Term Loans shall be increased by such increased amount. 
 The increased or new Commitments shall be effected by a joinder
agreement (the “Increase Joinder”) executed by Borrower, the Administrative Agent and each Lender making such increased or new Commitment, in form and substance satisfactory to each of them. The Increase Joinder may, without the
consent of any other Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the opinion of the Administrative Agent, to effect the provisions of this Section 2.24. 

  
 -70- 

 (d) To the extent the Commitments being increased on the relevant Increase Effective Date are
Revolving Commitments, then each of the Revolving Lenders having a Revolving Commitment under the applicable Revolving Facility prior to such Increase Effective Date (the “Pre-Increase Revolving Lenders”) shall assign to any
Revolving Lender which is acquiring a new or additional Revolving Commitment under the applicable Revolving Facility on the Increase Effective Date (the “Post-Increase Revolving Lenders”), and such Post-Increase Revolving Lenders
shall purchase from each Pre-Increase Revolving Lender, at the principal amount thereof, such interests in the Revolving Loans under the applicable Revolving Facility (which purchases shall be deemed prepayments of such Revolving Loans for purposes
of Section 2.20) and, in the case of Alternative Currency Revolving Commitments, participation interests in LC Obligations and Swingline Loans outstanding on such Increase Effective Date as shall be necessary in order that, after giving
effect to all such assignments and purchases, such Revolving Loans under the applicable Revolving Facility and, in the case of Alternative Currency Revolving Commitments, participation interests in LC Obligations and Swingline Loans will be held by
Pre-Increase Revolving Lenders and Post-Increase Revolving Lenders ratably in accordance with their Revolving Commitments under the applicable Revolving Facility after giving effect to such Increased Revolving Commitments under the applicable
Revolving Facility. 
 (e) On any Increase Effective Date on which new Commitments for term loans under Incremental Term Loan Commitments
are effective, subject to the satisfaction of the foregoing terms and conditions, each Lender of such new Commitment shall make a new Term Loan to the Borrower in an amount equal to its new Commitment. 

(f) The Loans and Commitments established pursuant to this paragraph shall constitute Loans and Commitments under, and shall be entitled to
all the benefits afforded by, this Agreement and the other Loan Documents, and shall, without limiting the foregoing, benefit equally and ratably from Section 10 hereof and security interests created by the Security Documents. The Loan
Parties shall take any actions reasonably required by the Administrative Agent to ensure and/or demonstrate that the Lien and security interests granted by the Security Documents continue to be perfected under the UCC or otherwise after giving
effect to the establishment of any such Class of Term Loans or any such new Commitments. 
 2.25 Extensions of Term Loans and Revolving
Commitments. 
 (a) Notwithstanding anything to the contrary in this Agreement, pursuant to one or more offers (each, an
“Extension Offer”) made from time to time by the Borrower to all Lenders of Term Loans with a like Maturity Date or Revolving Commitments with a like Maturity Date, in each case on a pro rata basis (based on the
aggregate outstanding principal amount of the respective Term Loans or Revolving Commitments with the same Maturity Date, as the case may be) and on the same terms to each such Lender, the Borrower may from time to time offer to extend the maturity
date of any Term Loans and/or Revolving Commitments under any Revolving Facility and otherwise modify the terms of such Term Loans and/or such Revolving Commitments pursuant to the terms of the relevant Extension Offer (including, without
limitation, by increasing the interest rate or fees payable in respect of such Term Loans and/or such Revolving Commitments (and related outstandings) and/or modifying the amortization schedule in respect of such Lender’s Term Loans) (each, an
“Extension,” and each group of Term Loans or Revolving Commitments, as applicable, in each case as so extended, as well as the original Term Loans and the original Revolving Commitments (in each case not so extended), being a
separate Class; any Extended Term Loans shall constitute a separate Class of Term Loans from the Class of Term Loans 

  
 -71- 

 
from which they were converted, and any Extended Revolving Commitments shall constitute a separate Class of Revolving Commitments from the Class of Revolving Commitments from which they were
converted), so long as the following terms are satisfied: (i) no Default shall have occurred and be continuing at the time an Extension Offer is delivered to the Lenders, (ii) except as to interest rates, fees and final maturity, the
Revolving Commitment under any Revolving Facility of any Revolving Lender (an “Extending Revolving Lender”) extended pursuant to an Extension (an “Extended Revolving Commitment”), and the related outstandings, shall
be a Revolving Commitment under such Revolving Facility (or related outstandings, as the case may be) with the same terms as the applicable original Revolving Commitments (and related outstandings); provided that (x) subject to the
provisions of Section 2.7(f) and Section 3.10 to the extent dealing with Swingline Loans and Letters of Credit which mature or expire after a Maturity Date when there exist Extended Revolving Commitments with a longer
Maturity Date, all Swingline Loans and Letters of Credit shall be participated in on a pro rata basis by all Alternative Currency Revolving Lenders in accordance with their pro rata share of the Alternative Currency
Revolving Facility (and except as provided in Section 2.7(f) or Section 3.10, without giving effect to changes thereto on an earlier Maturity Date with respect to Swingline Loans and Letters of Credit theretofore incurred or
issued) and all borrowings under the Alternative Currency Revolving Commitments and repayments thereunder shall be made on a pro rata basis (except for (A) payments of interest and fees at different rates on Extended Revolving Commitments (and
related outstandings) and (B) repayments required upon the Maturity Date of the non-extending Alternative Currency Revolving Commitments) and (y) at no time shall there be Revolving Commitments hereunder (including Extended Revolving
Commitments and any original Revolving Commitments) which have more than three different Maturity Dates, (iii) except as to interest rates, fees, amortization, final maturity date, premium, required prepayment dates and participation in
prepayments (which shall, subject to immediately succeeding clauses (iv), (v) and (vi), be determined by the Borrower and set forth in the relevant Extension Offer), the Term Loans of any Term Lender (an “Extending Term
Lender”) extended pursuant to any Extension (“Extended Term Loans”) shall have the same terms as the Class of Term Loans subject to such Extension Offer, (iv) the final maturity date of any Extended Term Loans shall be
no earlier than the then Latest Maturity Date hereunder and the amortization schedule applicable to Term Loans pursuant to Section 2.3 for periods prior to the Tranche A Term Loan Maturity Date or the Tranche B Term Loan Maturity Date,
as applicable, may not be increased, (v) the Weighted Average Life to Maturity of any Extended Term Loans shall be no shorter than the remaining Weighted Average Life to Maturity of the Term Loans extended thereby, (vi) any Extended Term
Loans may participate on a pro rata basis or a less than pro rata basis (but not greater than a pro rata basis) in any voluntary or mandatory repayments or prepayments hereunder, in each case as specified in the respective Extension Offer,
(vii) if the aggregate principal amount of applicable Term Loans (calculated on the face amount thereof) or applicable Revolving Commitments, as the case may be, in respect of which applicable Term Lenders or applicable Revolving Lenders, as
the case may be, shall have accepted the relevant Extension Offer (as hereinafter provided) shall exceed the maximum aggregate principal amount of applicable Term Loans or applicable Revolving Commitments, as the case may be, offered to be extended
by the Borrower pursuant to such Extension Offer, then the applicable Term Loans or applicable Revolving Loans, as the case may be, of the applicable Term Lenders or applicable Revolving Lenders, as the case may be, shall be extended ratably up to
such maximum amount based on the respective principal amounts (but not to exceed actual holdings of record) with respect to which such Term Lenders or such Revolving Lenders, as the case may be, have accepted such Extension Offer (as hereinafter
provided), (viii) all documentation in respect of such Extension shall be consistent with the foregoing, and (ix) any applicable Minimum Extension Condition shall be satisfied unless waived by the Borrower. Following any such Extension
Offer, the Administrative Agent shall notify the applicable Lenders thereof, each of whom shall, in its sole discretion, determine whether or not to accept such Extension Offer. 

  
 -72- 

 (b) With respect to all Extensions accepted by the relevant Lenders and consummated by the
Borrower pursuant to this Section 2.25, (i) such Extensions shall not constitute voluntary or mandatory payments or prepayments for purposes of Sections 2.10 and 2.11 and (ii) no Extension Offer is required to be
in any minimum amount or any minimum increment; provided that the Borrower may at its election specify as a condition (a “Minimum Extension Condition”) to consummating any such Extension that a minimum amount (to be
determined and specified in the relevant Extension Offer in the Borrower’s sole discretion and which may be waived by the Borrower) of Term Loans or Revolving Commitments (as applicable) of any or all applicable Classes be tendered. The
Administrative Agent and the Lenders hereby consent to the Extensions and the other transactions contemplated by this Section 2.25 (including, for the avoidance of doubt, payment of any interest, fees or premium in respect of any
Extended Term Loans and/or Extended Revolving Commitments on such terms as may be set forth in the relevant Extension Offer) and hereby waive the requirements of any provision of this Agreement (including, without limitation, Sections 2.10,
2.11 and 2.17) or any other Loan Document that may otherwise prohibit any such Extension or any other transaction contemplated by this Section 2.25. 

(c) The Lenders hereby irrevocably authorize the Administrative Agent and Collateral Agent to enter into amendments to this Agreement and the
other Loan Documents with the Borrower as may be necessary in order to establish new Classes or sub-Classes in respect of Revolving Commitments or Term Loans so extended and such technical amendments as may be necessary or appropriate in the
reasonable opinion of the Administrative Agent and the Borrower in connection with the establishment of such new Classes or sub-Classes, in each case on terms consistent with this Section 2.25. Notwithstanding the foregoing, each of the
Administrative Agent and the Collateral Agent shall have the right (but not the obligation) to seek the advice or concurrence of the Required Lenders with respect to any matter contemplated by this Section 2.25(c) and, if either the
Administrative Agent or the Collateral Agent seeks such advice or concurrence, it shall be permitted to enter into such amendments with the Borrower in accordance with any instructions actually received by such Required Lenders and shall also be
entitled to refrain from entering into such amendments with the Borrower unless and until it shall have received such advice or concurrence; provided, however, that whether or not there has been a request by the Administrative Agent or
the Collateral Agent for any such advice or concurrence, all such amendments entered into with the Borrower by the Administrative Agent or the Collateral Agent hereunder shall be binding and conclusive on the Lenders. Without limiting the foregoing,
in connection with any Extensions the respective Loan Parties shall (at their expense) amend (and the Collateral Agent is hereby directed to amend) any Mortgage that has a maturity date prior to the then latest Maturity Date so that such maturity
date is extended to the then latest Maturity Date (or such later date as may be advised by local counsel to the Collateral Agent). 
 (d) In
connection with any Extension, the Borrower shall provide the Administrative Agent at least ten (10) Business Days’ (or such shorter period as may be agreed by the Administrative Agent) prior written notice thereof, and shall agree to such
procedures, if any, as may be established by, or acceptable to, the Administrative Agent, in each case acting reasonably to accomplish the purposes of this Section 2.25. 

(e) Notwithstanding the foregoing provisions of this Section 2.25 and, for the avoidance of doubt, no Lender shall have such
Lender’s Commitment or Loans extended without the written consent of such Lender. 
 2.26 Defaulting Lenders. Notwithstanding
any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender hereunder, then the following provisions shall apply for so long as such Lender is a Defaulting Lender: 

(a) fees shall cease to accrue on the Commitment of such Defaulting Lender pursuant to Section 2.8(a); 

  
 -73- 

 (b) the Commitments and the Total Revolving Extensions of Credit of such
Defaulting Lender shall not be included in determining whether the Required Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to Section 11.1);
provided that this clause (b) shall not apply to the vote of a Defaulting Lender in the case of an amendment, waiver or other modification requiring the consent of each Lender or each Lender affected thereby; 

(c) if any Swingline Loan or Letter of Credit is outstanding at the time such Lender becomes a Defaulting Lender then: 

(i) unless a Default shall have occurred and be continuing, all or any part of the Swingline Participation Amount and LC
Obligations of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Alternative Currency Revolving Percentages but only to the extent the sum of all non-Defaulting Lenders’ Alternative
Currency Revolving Extensions of Credit plus such Defaulting Lender’s Swingline Participation Amount and LC Obligations do not exceed the total of all non-Defaulting Lenders’ Alternative Currency Revolving Commitments; 

(ii) if the reallocation described in clause (i) above cannot, or can only partially, be effected, the Borrower shall
within one Business Day following notice by the Administrative Agent (x) first, prepay such Swingline Participation Amount and (y) second, cash collateralize for the benefit of the Issuing Lender only the Borrower’s obligations
corresponding to such Defaulting Lender’s LC Obligations (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in Section 3.10 for so long as such LC
Obligations are outstanding; 
 (iii) if the Borrower cash collateralizes any portion of such Defaulting Lender’s
Alternative Currency Revolving Percentage of the LC Obligations pursuant to clause (ii) above, the Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to Section 2.8(c) with respect to such Defaulting
Lender’s Alternative Currency Revolving Percentage of the LC Obligations during the period such Defaulting Lender’s LC Obligations are cash collateralized; 

(iv) if the LC Obligations of the non-Defaulting Lenders are reallocated pursuant to clause (i) above, then the fees
payable to the Lenders pursuant to Section 2.8(a) and Section 2.8(c) shall be adjusted in accordance with such non-Defaulting Lenders’ Alternative Currency Revolving Percentages; and 

(v) if all or any portion of such Defaulting Lender’s LC Obligations is neither reallocated nor cash collateralized
pursuant to clause (i) or (ii) above, then, without prejudice to any rights or remedies of the Issuing Lender or any other Lender hereunder, all letter of credit fees payable under Section 2.8(c) with respect to such Defaulting
Lender’s LC Obligations shall be payable to the Issuing Lender until and to the extent that such LC Obligations are reallocated and/or cash collateralized; and 

(d) so long as such Lender is a Defaulting Lender, the Swingline Lender shall not be required to fund any Swingline Loan and
the Issuing Lender shall not be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure and the Defaulting Lender’s then outstanding LC Obligations will be 100% covered by the Alternative
Currency Revolving Commitments of the non-Defaulting Lenders and/or cash collateral will be provided by 

  
 -74- 

 
the Borrower in accordance with Section 2.26(c), and participating interests in any newly made Swingline Loan or any newly issued or increased Letter of Credit shall be allocated
among non-Defaulting Alternative Currency Revolving Lenders in a manner consistent with Section 2.26(c)(i) (and such Defaulting Lender shall not participate therein). 

If (i) a Bankruptcy Event with respect to a Parent of any Lender shall occur following the Closing Date and for so long as such event
shall continue or (ii) the Swingline Lender or the Issuing Lender has a good faith belief that any Lender has defaulted in fulfilling its obligations under one or more other agreements in which such Lender commits to extend credit, the
Swingline Lender shall not be required to fund any Swingline Loan and the Issuing Lender shall not be required to issue, amend or increase any Letter of Credit, unless the Swingline Lender or the Issuing Lender, as the case may be, shall have
entered into arrangements with the Borrower or such Lender, satisfactory to the Swingline Lender or the Issuing Lender, as the case may be, to defease any risk to it in respect of such Lender hereunder. 

In the event that the Administrative Agent, the Borrower, the Swingline Lender and the Issuing Lender each agrees that a Defaulting Lender has
adequately remedied all matters that caused such Lender to be a Defaulting Lender, then the Swingline Participation Amount and LC Obligations of the Lenders shall be readjusted to reflect the inclusion of such Lender’s Alternative Currency
Revolving Commitment and on such date such Lender shall purchase at par such of the Revolving Loans of the other Lenders (other than Swingline Loans) as the Administrative Agent shall determine may be necessary in order for such Lender to hold such
Loans in accordance with its Revolving Percentage. 
 2.27 Refinancing Amendments. 

(a) At any time after the Closing Date, the Borrower may obtain from any existing Lender or any other Person reasonably satisfactory to the
Borrower and, in the case of any Other Revolving Commitments, the Administrative Agent, the Swingline Lender and the Issuing Bank (any such existing Lender or other Person being called an “Additional Refinancing Lender”) Credit
Agreement Refinancing Debt in respect of (a) all or any portion of the Term Loans then outstanding under this Agreement (which for purposes of this clause (a) will be deemed to include any then outstanding Other Term Loans) or
(b) all or any portion of the Revolving Commitments (including the corresponding portion of the Revolving Loans) under this Agreement (which for purposes of this clause (b) will be deemed to include any then outstanding Other
Revolving Commitments (including the corresponding portion of the Other Revolving Loans)), in the form of (x) Other Term Loans or Other Term Loan Commitments in the case of clause (a) or (y) Other Revolving Loans or Other
Revolving Commitments in the case of clauses (a) and (b), in each case pursuant to a Refinancing Amendment; provided that such Credit Agreement Refinancing Debt (i) will rank pari passu or junior in right
of payment and of security with the other Loans and Commitments hereunder, (ii) have such pricing, interest, fees, premiums and optional prepayment terms as may be agreed by the Borrower and the Additional Refinancing Lenders thereof,
(iii) not be secured by any assets that do not constitute Collateral and (iv) except as permitted in clause (ii), will otherwise be treated hereunder no more materially favorably taken as a whole, including with respect to covenants
and events of default, in the good faith determination of the Borrower than the Refinanced Debt; provided, further, that the terms and conditions applicable to such Credit Agreement Refinancing Debt may provide for additional or
different financial or other covenants or other provisions that are agreed by the Borrower and the applicable Additional Refinancing Lenders to the extent applicable only after the Latest Maturity Date as determined on the date such Credit Agreement
Refinancing Debt is incurred or obtained. 
 (b) The effectiveness of any Refinancing Amendment shall be subject to the satisfaction on the
date thereof of each of the conditions set forth in Section 5.2 and, to the extent reasonably requested by the Administrative Agent, to receipt by the Administrative Agent of (i) customary legal opinions,

  
 -75- 

 
board resolutions and officers’ certificates consistent with those delivered on the Closing Date other than changes to such legal opinion resulting from a change in law, change in fact or
change to counsel’s form of opinion reasonably satisfactory to the Administrative Agent and (ii) reaffirmation agreements and/or such amendments to the Collateral Documents as may be reasonably requested by the Administrative Agent in
order to ensure that such Credit Agreement Refinancing Debt is provided with the benefit of the applicable Loan Documents. 
 (c) Each
issuance of Credit Agreement Refinancing Debt under Section 2.27(a) shall be in an aggregate principal amount that is (x) not less than $25,000,000 and (y) an integral multiple of $1,000,000 in excess thereof. 

(d) Each of the parties hereto hereby agrees that this Agreement and the other Loan Documents may be amended pursuant to a Refinancing
Amendment, without the consent of any other Lenders, to the extent (but only to the extent) necessary to (i) reflect the existence and terms of the Credit Agreement Refinancing Debt incurred pursuant thereto and (ii) effect such other
amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the provisions of this Section 2.27, and the Required Lenders
hereby expressly authorize the Administrative Agent to enter into any such Refinancing Amendment. 
 SECTION 3 

LETTERS OF CREDIT 
 3.1
LC Commitment. 
 (a) Subject to the terms and conditions hereof, the Issuing Lender, in reliance on the agreements of the other
Applicable Participants set forth in Section 3.4, agrees to issue letters of credit (x) denominated in Dollars, in the case of Dollar Letters of Credit or (y) denominated in Dollars or in any other Alternative Currency, in the
case of Alternative Currency Letters of Credit (collectively, “Letters of Credit”), in each case for the account of the Borrower or a Subsidiary on any Business Day during the Revolving Commitment Period in such form as may be
approved from time to time by the Issuing Lender; provided that the Issuing Lender shall have no obligation to issue any Letter of Credit if, after giving effect to such issuance, (i) the LC Obligations would exceed the LC Commitment or
(ii) the aggregate amount of the Available Revolving Commitments would be less than zero. Each Letter of Credit shall expire no later than the earlier of (x) the first anniversary of its date of issuance and (y) the date that is
fifteen Business Days prior to the Revolving Termination Date (or with respect to any Letters of Credit outstanding with respect to an Extended Revolving Commitment, the Maturity Date applicable thereto); provided that any Letter of Credit
with a one-year term may provide for the renewal thereof for additional one-year periods (which shall in no event extend beyond the date referred to in clause (y) above). 

(b) The Issuing Lender shall not at any time be obligated to issue any Letter of Credit if such issuance would conflict with, or cause the
Issuing Lender or any Applicable Participant to exceed any limits imposed by, any applicable Requirement of Law. In the event of any inconsistency between the terms and conditions of this Agreement and the terms and conditions of any Application or
other agreement submitted by the Borrower to, or entered into by the Borrower with, the Issuing Lender relating to any Letter of Credit, the terms and conditions of this Agreement shall control. 

(c) All Existing Letters of Credit shall be deemed to be issued hereunder and shall constitute Letters of Credit subject to the terms hereof.

  
 -76- 

 (d) Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any
obligations of, or is for the account of, a Subsidiary, the Borrower shall be obligated to reimburse the Issuing Lender hereunder for any and all drawings under such Letter of Credit. 

3.2 Notice of Issuance, Amendment, Renewal, Extension; Certain Conditions. To request the issuance of a Letter of Credit (or the
amendment, renewal or extension of an outstanding Letter of Credit), the Borrower shall hand deliver or telecopy (or transmit by electronic communication, if arrangements for doing so have been approved by the Issuing Lender) to the Issuing Lender
and the Administrative Agent (reasonably in advance of the requested date of issuance, amendment, renewal or extension) a notice pursuant to an LC Request requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be
amended, renewed or extended, and specifying the date of issuance, amendment, renewal or extension (which shall be a Business Day), the date on which such Letter of Credit is to expire (which shall comply with Section 3.1(a)), the amount
of such Letter of Credit, whether such Letter of Credit is to be a Dollar Letter of Credit or an Alternative Currency Letter of Credit, the currency in which such Letter of Credit is to be denominated (which, in the case of a Dollar Letter of
Credit, shall be in Dollars, and, in the case of an Alternative Currency Letter of Credit, shall be in Dollars or any other Alternative Currency), the name and address of the beneficiary thereof and such other information as shall be necessary to
prepare, amend, renew or extend such Letter of Credit. If requested by the Issuing Lender, the Borrower also shall submit an Application on the Issuing Lender’s standard form in connection with any request for a Letter of Credit. A Dollar
Letter of Credit shall be issued, amended, renewed or extended only if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that), after giving effect to such issuance,
amendment, renewal or extension, (i) the LC Obligations shall not exceed the LC Commitment, (ii) the Available Dollar Revolving Commitments would not be less than zero and (iii) the Dollar LC Obligations with respect to any Issuing
Lender would not exceed the applicable Specified Dollar LC Sublimit of such Issuing Lender then in effect. An Alternative Currency Letter of Credit shall be issued, amended, renewed or extended only if (and upon issuance, amendment, renewal or
extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that), after giving effect to such issuance, amendment, renewal or extension, (i) the LC Obligations shall not exceed the LC Commitment, (ii) the
Available Alternative Currency Revolving Commitments would not be less than zero and (iii) the Alternative Currency LC Obligations with respect to any Issuing Lender would not exceed the applicable Specified Alternative Currency LC Sublimit of
such Issuing Lender then in effect Upon request of an Issuing Lender, the Administrative Agent will provide written confirmation to such Issuing Lender of (i) the amount available under the Alternative Currency LC Commitment or Dollar LC
Commitment, as applicable, as of such date and (ii) the aggregate Total Alternative Currency Revolving Extensions of Credit or Total Dollar Revolving Extensions of Credit, as applicable, then outstanding. 

3.3 Fees and Other Charges. The Borrower shall pay the fees specified in Section 2.8. 

3.4 Participations. By the issuance of a Letter of Credit (or an amendment to a Letter of Credit increasing the amount thereof) and
without any further action on the part of the Issuing Lender or the Lenders, the Issuing Lender hereby grants to each Applicable Participant, and each Applicable Participant hereby acquires from the Issuing Lender, a participation in such Letter of
Credit equal to such Lender’s Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, of the aggregate amount available to be drawn under such Letter of Credit. In consideration and in furtherance of the
foregoing, (x) each Alternative Currency Revolving Lender hereby absolutely and unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Lender, such Lender’s Alternative Currency Revolving Percentage of
(i) each LC Disbursement in respect of any Alternative Currency Letter of Credit made by the Issuing Lender in Dollars and (ii) the Dollar Equivalent, using the 

  
 -77- 

 
Spot Rate on the date such payment is required, of each LC Disbursement in respect of any Alternative Currency Letter of Credit made by the Issuing Lender in an Alternative Currency other than
Dollars and, in each case, not reimbursed by the Borrower on the date due as provided in Section 3.5, or of any reimbursement payment required to be refunded to the Borrower for any reason and (y) each Dollar Revolving Lender hereby
absolutely and unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Lender, such Lender’s Dollar Revolving Percentage of each LC Disbursement in respect of any Dollar Letter of Credit made by the Issuing
Lender in Dollars and not reimbursed by the Borrower on the date due as provided in Section 3.5, or of any reimbursement payment required to be refunded to the Borrower for any reason. Each Applicable Participant acknowledges and agrees
that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any
Letter of Credit or the occurrence and continuance of a Default or reduction or termination of the Revolving Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever. 

3.5 Reimbursement. If the Issuing Lender shall make any LC Disbursement in respect of a Letter of Credit, the Borrower shall reimburse
such LC Disbursement by paying to the Administrative Agent an amount equal to the Dollar Equivalent (for Letters of Credit denominated in Alternative Currencies, calculated using the Spot Rate when such payment is due), of such LC Disbursement, in
Dollars, or at the option of the Borrower with respect to any Alternative Currency Letter of Credit, in the applicable Alternative Currency other than Dollars to the extent such LC Disbursement is made in such Alternative Currency, in each case, not
later than 1:00 P.M., New York City time, on the date that such LC Disbursement is made, if the Borrower shall have received notice of such LC Disbursement prior to 12:00 noon, New York City time, on such date, or, if such notice has not been
received by the Borrower prior to such time on such date, then not later than 1:00 P.M., New York City time, on (i) the Business Day that the Borrower receives such notice, if such notice is received prior to 12:00 noon, New York City time, on
the day of receipt, or (ii) the Business Day immediately following the day that the Borrower receives such notice, if such notice is not received prior to such time on the day of receipt; provided that, if such LC Disbursement is not
less than $1,000,000, the Borrower may, subject to the conditions to borrowing set forth herein, request in accordance with Section 2.5 or 2.6 that such payment be financed with a Revolving Loan of the same Class denominated in
Dollars that is an ABR Loan or Swingline Loan in an amount equal to the Dollar Equivalent of such LC Disbursement and, to the extent so financed, the Borrower’s obligation to make such payment shall be discharged and replaced by the resulting
Revolving Loan denominated in Dollars that is an ABR Loan or Swingline Loan. If the Borrower fails to make such payment when due, the Administrative Agent shall notify each Applicable Participant of the applicable LC Disbursement, the payment then
due from the Borrower in respect thereof and such Lender’s Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, thereof. Promptly following receipt of such notice, each Applicable Participant shall pay to the
Administrative Agent its Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, of the Dollar Equivalent of the payment then due from the Borrower, in the same manner as provided in Section 2.5 (without
regard to minimum amounts) and Section 2.17(e) with respect to Loans made by such Applicable Participant (and such Sections shall apply, mutatis mutandis, to the payment obligations of the Applicable Participants), and the
Administrative Agent shall promptly pay to the Issuing Lender the amounts so received by it from the Applicable Participants. Promptly following receipt by the Administrative Agent of any payment from the Borrower pursuant to this paragraph, the
Administrative Agent shall distribute such payment to the Issuing Lender or, to the extent that Applicable Participants have made payments pursuant to this paragraph to reimburse the Issuing Lender, then to such Applicable Participants and the
Issuing Lender as their interests may appear. Any payment made by an Applicable Participant pursuant to this paragraph to reimburse the Issuing Lender for any LC Disbursement (other than the funding of ABR Revolving Loans or a Swingline Loan as
contemplated above) shall not constitute a Loan and shall not relieve the Borrower of its obligation to reimburse such LC Disbursement. 

  
 -78- 

 3.6 Obligations Absolute. The Borrower’s obligation to reimburse LC Disbursements as
provided in Section 3.5 shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement under any and all circumstances whatsoever and irrespective of (i) any lack of
validity or enforceability of any Letter of Credit or this Agreement, or any term or provision therein, (ii) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any
statement therein being untrue or inaccurate in any respect, (iii) payment by the Issuing Lender under a Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit, or
(iv) any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this Section, constitute a legal or equitable discharge of, or provide a right of setoff against, the
Borrower’s obligations hereunder. Neither the Administrative Agent, the Lenders nor the Issuing Lender, nor any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of
any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any
draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control
of the Issuing Lender; provided that the foregoing shall not be construed to excuse the Issuing Lender from liability to the Borrower to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are
hereby waived by the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by the Issuing Lender’s failure to exercise care when determining whether drafts and other documents presented under a Letter of
Credit comply with the terms thereof. The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of the Issuing Lender (as finally determined by a court of competent jurisdiction), the Issuing
Lender shall be deemed to have exercised care in each such determination. In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in
substantial compliance with the terms of a Letter of Credit, the Issuing Lender may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information
to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit. 

3.7 Disbursement Procedures. The Issuing Lender shall, promptly following its receipt thereof, examine all documents purporting to
represent a demand for payment under a Letter of Credit. The Issuing Lender shall promptly notify the Administrative Agent and the Borrower by telephone (confirmed by telecopy) of such demand for payment and whether the Issuing Lender has made or
will make an LC Disbursement thereunder; provided that any failure to give or delay in giving such notice shall not relieve the Borrower of its obligation to reimburse the Issuing Lender and the Applicable Participants with respect to any
such LC Disbursement. 
 3.8 Interim Interest. If the Issuing Lender shall make any LC Disbursement, then, unless the Borrower shall
reimburse such LC Disbursement in full on the date such LC Disbursement is made, the unpaid amount thereof shall bear interest, for each day from and including the date such LC Disbursement is made to but excluding the date that the Borrower
reimburses such LC Disbursement, at the rate per annum then applicable to Alternative Currency Revolving Loans denominated in the applicable Alternative Currency which are ABR Loans or Dollar Revolving Loans which are ABR Loans, as applicable;
provided that, if the Borrower fails to reimburse such LC Disbursement when due pursuant to 

  
 -79- 

 
Section 3.5, then Section 2.14(c) shall apply. Interest accrued pursuant to this Section shall be for the account of the Issuing Lender, except that interest accrued on
and after the date of payment by any Applicable Participant pursuant to Section 3.5 to reimburse the Issuing Lender shall be for the account of such Applicable Participant to the extent of such payment. 

3.9 Replacement of the Issuing Lender. The Issuing Lender may be replaced at any time with another party eligible to become the Issuing
Lender as provided herein, by written notice given by the Borrower (with the approval of the successor Issuing Lender and the Administrative Agent) to the replaced Issuing Lender; provided that prior to such replacement all Letters of Credit
issued by the replaced Issuing Lender are terminated or cash collateralized on terms satisfactory to the replaced Issuing Lender. The Administrative Agent shall notify the Lenders of any such replacement of the Issuing Lender. At the time any such
replacement shall become effective, the Borrower shall pay all unpaid fees accrued for the account of the replaced Issuing Lender pursuant to Section 3.3). From and after the effective date of any such replacement, (i) the successor
Issuing Lender shall have all the rights and obligations of the Issuing Lender under this Agreement with respect to Letters of Credit to be issued thereafter and (ii) references herein to the term “Issuing Lender” shall be deemed to
refer to such successor or to any previous Issuing Lender, or to such successor and all previous Issuing Lenders, as the context shall require. After the replacement of an Issuing Lender hereunder, the replaced Issuing Lender shall remain a party
hereto and shall continue to have all the rights and obligations of an Issuing Lender under this Agreement with respect to Letters of Credit issued by it prior to such replacement, but shall not be required to issue additional Letters of Credit.

 3.10 Cash Collateralization. (i) If any Event of Default shall occur and be continuing, on the Business Day that the Borrower
receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans has been accelerated, Lenders with LC Obligations representing greater than 50% of the total LC Obligations) demanding the deposit of cash
collateral pursuant to this Section, or (ii) if required by Section 2.26(d), on the Business Day the Borrower receives the notice contemplated by Section 2.26(c)(ii), the Borrower shall deposit in an account with the
Collateral Agent, in the name of the Collateral Agent and for the benefit of the Secured Parties, an amount in cash equal to 105% of the Dollar Equivalent of the LC Obligations as of such date plus any accrued and unpaid interest thereon;
provided that the obligation to deposit such cash collateral shall become effective immediately, and such deposit shall become immediately due and payable, without demand or other notice of any kind, upon the occurrence of any Event of
Default with respect to the Borrower described in Section 8.1(g). Such deposit shall be held by the Collateral Agent as collateral for the payment and performance of the obligations of the Borrower under this Agreement. The Collateral
Agent shall have exclusive dominion and control, including the exclusive right of withdrawal, over such account. Other than any interest earned on the investment of such deposits, which investments shall be made at the option and sole discretion of
the Collateral Agent and at the Borrower’s risk and expense, such deposits shall not bear interest. Interest or profits, if any, on such investments shall accumulate in such account. Moneys in such account shall be applied by the Collateral
Agent to reimburse the Issuing Lender for LC Disbursements for which it has not been reimbursed and, to the extent not so applied, shall be held for the satisfaction of the reimbursement obligations of the Borrower for the LC Obligations at such
time or, if the maturity of the Loans has been accelerated (but subject to the consent of Lenders with LC Obligations representing greater than 50% of the total LC Obligations), be applied to satisfy other obligations of the Borrower under this
Agreement, and any surplus remaining shall be returned to the Borrower after all Events of Default triggering such deposit cease to exist. If the Borrower is required to provide an amount of cash collateral hereunder as a result of the occurrence of
an Event of Default, such amount (to the extent not applied as aforesaid) shall be returned to the Borrower within three Business Days after all Events of Default have been cured or waived. 

  
 -80- 

 3.11 Provisions Related to Extended Revolving Commitments. If the Maturity Date in respect
of any Class of Alternative Currency Revolving Commitments occurs prior to the expiration of any Alternative Currency Letter of Credit or any Class of Dollar Revolving Commitments occurs prior to the expiration of any Dollar Letter of Credit, then
(i) if one or more other Classes of Revolving Commitments in respect of which the Maturity Date shall not have occurred are then in effect, such Letter of Credit shall automatically be deemed to have been issued (including for purposes of the
obligations of the Revolving Lenders to purchase participations therein and to make Revolving Loans and payments in respect thereof pursuant to Section 3.5) under (and ratably participated in by Lenders pursuant to) the Revolving
Commitments in respect of such non-terminating Classes up to an aggregate amount not to exceed the aggregate principal amount of the unutilized Revolving Commitments thereunder at such time (it being understood that no partial face amount of any
Letter of Credit may be so reallocated and no Letter of Credit denominated in an Alternative Currency may be reallocated to Revolving Commitments that do not permit Borrowings in such currency) and (ii) to the extent not reallocated pursuant to
immediately preceding clause (i), the Borrower shall cash collateralize any such Letter of Credit in accordance with Section 3.10. Except to the extent of reallocations of participations pursuant to clause (i) of the immediately
preceding sentence, the occurrence of a Maturity Date with respect to a given Class of Revolving Commitments shall have no effect upon (and shall not diminish) the percentage participations of the Applicable Participants in any Letter of Credit
issued before such Maturity Date. 
 SECTION 4 

REPRESENTATIONS AND WARRANTIES 

Each Loan Party represents and warrants to the Administrative Agent, the Collateral Agent, the Issuing Lender and each of the Lenders that:

 4.1 Organization; Power. Each Loan Party and each of its Subsidiaries (i)(x) is duly organized and validly existing and
(y) in good standing (if such concept is applicable) under the laws of the jurisdiction of its organization, (ii) is duly qualified and in good standing as a foreign business enterprise (if such concept is applicable) in each other
jurisdiction in which it owns or leases property or in which the conduct of its business requires it to so qualify or be licensed and (iii) has all requisite power and authority (including, without limitation, all material Governmental
Authorizations) to own or lease and operate its properties and to carry on its business as now conducted and as proposed to be conducted, except in the case of the foregoing clauses (i)(y), (ii) and (iii), where the failure to be so qualified
or licensed would not, individually or in the aggregate, result in a Material Adverse Effect. 
 4.2 Capital Stock; Subsidiaries. As
of the Closing Date, the Borrower and its Subsidiaries do not have any Subsidiaries other than those specifically disclosed on Schedule 4.2. All of the outstanding Capital Stock of each such Subsidiary (A) (in the case of
Subsidiaries that are corporations) has been validly issued, is fully paid and non-assessable and (B) to the extent owned by the Borrower or one or more of its Subsidiaries, is free and clear of all Liens, except those created under the
Security Documents or Liens permitted pursuant to Section 7.1. 
 4.3 Authorization; No Conflicts. The execution,
delivery and performance by each Loan Party of each Loan Document to which it is or is to be a party, and the consummation of the Transactions, are within such Loan Party’s corporate, partnership or limited liability company powers, as
applicable, have been duly authorized by all necessary corporate, partnership or limited liability company action, as applicable, do not (i) contravene such Loan Party’s Constitutive Documents, (ii) violate any Requirements of Law,
(iii) conflict with or result in the breach of, or constitute a default or require any payment to be made under, any material contract, loan agreement, indenture, mortgage, deed of trust, lease or

  
 -81- 

 
other instrument binding on or affecting any Loan Party or any of its properties that would reasonably be likely to have a Material Adverse Effect or (iv) except for the Liens created under
the Loan Documents, result in or require the creation or imposition of any Lien upon or with respect to any of the properties of any Loan Party. No Loan Party is in violation of any such Requirements of Law, the violation of which would be
reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. 
 4.4 No Approvals. No Governmental
Authorization, and no other authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required for (i) the due execution, delivery, recordation, filing or performance by any Loan Party of any
Loan Document to which it is or is to be a party, or for the consummation of the Transactions, (ii) the grant by any Loan Party of the Liens granted by it pursuant to the Security Documents, (iii) the perfection or maintenance of the Liens
created under the Security Documents on such of the Collateral located in the United States in which a Lien may be perfected by the filing of financing statements, the recordation of security agreements with the U.S. Patent and Trademark Office or
the U.S. Copyright Office or the delivery of Collateral (including the first priority nature thereof) or (iv) the exercise by any Agent or any Lender of its rights under the Loan Documents or the remedies in respect of the Collateral pursuant
to the Security Documents, except for (A) the authorizations, approvals, filings and actions described on Schedule 4.4 hereto, all of which either (i) have been duly obtained and are in full force and effect or will be obtained and
in full force and effect prior to the Closing Date or (ii) the failure to obtain could not reasonably be expected to result in a Material Adverse Effect, (B) filings, notices, recordings and other similar actions necessary for the creation
or perfection of the Liens and security interests contemplated by the Loan Documents and (C) the actions required by laws generally with respect to the exercise by secured creditors of their rights and remedies. 

4.5 Enforceability. This Agreement has been, and each other Loan Document when delivered hereunder will have been, duly executed and
delivered by each Loan Party thereto. This Agreement is, and each other Loan Document when delivered hereunder will be, the legal, valid and binding obligation of each Loan Party thereto, enforceable against such Loan Party in accordance with its
terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at
law. 
 4.6 Litigation. There is no action, suit, investigation, litigation or proceeding affecting any Loan Party or any of its
Subsidiaries, including any Environmental Action, pending or, to the knowledge of the Loan Parties, threatened before any Governmental Authority or arbitrator (i) that, if adversely determined, would be reasonably likely, individually or in the
aggregate, to have a Material Adverse Effect or (ii) that purports to affect the legality, validity or enforceability of any Loan Document or the consummation of the Transactions, except as disclosed prior to the Closing Date in the
Borrower’s filings made with the SEC. 
 4.7 Financial Statements; Projections. 

(a) Historical Financial Statements. Borrower has heretofore delivered to the Lenders the Consolidated balance sheets and related
statements of income, stockholders’ equity and cash flows of Borrower (i) as of and for the Fiscal Years ended December 31, 2011, December 31, 2012 and December 31, 2013, audited by and accompanied by the unqualified
opinion of KPMG LLP, independent public accountants, and (ii) as of and for the three-month period ended March 31, 2014 and for the comparable period of the preceding Fiscal Year, in each case, certified by the chief financial officer of
Borrower. Such financial statements and all financial statements delivered pursuant to Sections 6.1(b) and (c) have been prepared in accordance with GAAP and present fairly in all material respects the financial condition

  
 -82- 

 
and results of operations and cash flows of Borrower as of the dates and for the periods to which they relate except, in the case of interim financial statements, for the absence of footnotes and
the same being subject to year-end audit adjustments. 
 (b) No Liabilities. Except as set forth in the financial statements referred
to in Section 4.7(a), there are no liabilities of any Group Member of any kind, whether accrued, contingent, absolute, determined, determinable or otherwise, which could reasonably be expected to result in a Material Adverse Effect, and
there is no existing condition, situation or set of circumstances which could reasonably be expected to result in such a liability, other than liabilities under the Loan Documents, the 2020 Senior Notes Documents and the 2022 Senior Notes Documents.
Since December 31, 2013, there has been no event, change, circumstance or occurrence that, individually or in the aggregate, has had or could reasonably be expected to have a Material Adverse Effect (excluding the Borrower’s entering into
the Loan Documents, the 2020 Senior Notes Documents, the 2022 Senior Notes Documents, the New Senior Notes Documents and the Acquisition). 

(c) Forecasts. The forecasts of financial performance of Borrower and its subsidiaries furnished to the Lenders have been prepared in
good faith by Borrower and based on assumptions believed by Borrower to reasonable. 
 4.8 Properties. 

(a) Generally. Each Group Member has good title to, or valid leasehold interests in, all its property material to its business, free and
clear of all Liens except for Liens permitted pursuant to Section 7.1 and minor irregularities or deficiencies in title that, individually and in the aggregate, do not interfere with its ability to conduct its business as currently
conducted or to utilize such property for its intended purpose. 
 (b) Real Property. Schedule 4.8 contains a true and
complete list of each interest in Real Property (i) owned by a Loan Party as of the Closing Date and describes the type of interest therein held by such Loan Party and whether such owned Real Property is leased and (ii) leased, subleased
or otherwise occupied or utilized by any Loan Party, as lessee, sublessee, franchisee or licensee, as of the Closing Date and describes the type of interest therein held by such Loan Party. 

(c) Collateral. Each Group Member owns or has rights to use all of the Collateral and all rights with respect to any of the foregoing
used in, necessary for or material to each Group Member’s business as currently conducted. (i) To the knowledge of the Loan Parties, the use by each Group Member of such Collateral and all such rights with respect to the foregoing do not
infringe on the rights of any Person other than such infringement which could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect and (ii) no claim has been made and remains outstanding that any
Group Member’s use of any Collateral does or may violate the rights of any third party that could, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. 

  
 -83- 

 4.9 Intellectual Property. Except to the extent the same would not be expected,
individually or in the aggregate, to have a Material Adverse Effect, (i) each Loan Party owns, or is licensed to use, all Intellectual Property necessary for the conduct of its business as currently conducted, (ii) to the knowledge of such
Loan Party, no claim has been asserted and is pending by any Person challenging or questioning the use of any such Intellectual Property or the validity or effectiveness of any such Intellectual Property, nor does any Loan Party know of any valid
basis for any such claim and (iii) to the knowledge of such Loan Party, the use of such Intellectual Property by each Loan Party does not infringe the rights of any Person. 

4.10 No Material Misstatements. Neither the Confidential Information Memorandum nor any other information, exhibit or report furnished
by any Loan Party to any Agent or any Lender in connection with the negotiation and syndication of the Loan Documents or pursuant to the terms of the Loan Documents taken as a whole in combination with the Borrower’s most recent Form 10-K, and
each Form 10-Q and Form 8-K subsequent to such Form 10-K, in each case, filed or furnished with the SEC, contained, as of the date such information exhibit or report was so furnished, any untrue statement of a material fact or omitted to state a
material fact necessary to make the statements made therein not misleading, except with respect to any projections or forecasts contained in such materials, the Group Members represent only that the same were prepared in good faith on the basis of
assumptions believed to be reasonable, at the time made and at the time furnished, it being recognized by the Lenders that such projections and forecasts as they relate to future events are not to be viewed as fact and that actual results during the
period or periods covered by such projections and forecasts may differ from such projections and forecasts. 
 4.11 Margin Stock. No
Group Member is engaged in the business of extending credit for the purpose of purchasing or carrying Margin Stock, and no proceeds of any Loan or drawings under any Letter of Credit will be used to purchase or carry any Margin Stock or to extend
credit to others for the purpose of purchasing or carrying any Margin Stock, except for purchases of the Borrower’s Capital Stock permitted by Section 7.7. 

4.12 Investment Company Act. Neither any Loan Party nor any of its Subsidiaries is an “investment company,” or an
“affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company,” as such terms are defined in the Investment Company Act of 1940, as amended. Neither the making of any Loans, nor
the issuance of any Letters of Credit, nor the application of the proceeds or repayment thereof by the Borrower, nor the consummation of the other transactions contemplated by the Loan Documents and Transaction Documents, will violate any provision
of any such Act or any rule, regulation or order of the SEC thereunder. 
 4.13 Solvency. As of the Closing Date, and after giving
effect to the incurrence of all indebtedness and obligations being incurred on the Closing Date in connection herewith, each Loan Party is, individually and together with its Subsidiaries, Solvent. 

4.14 Employee Benefit Plans. 

(i) No ERISA Event has occurred or is reasonably expected to occur that has resulted in or is reasonably expected to result in a material
liability of any Loan Party. 
 (ii) Schedule B (Actuarial Information) to the most recent annual report (Form 5500 Series) for each Plan,
copies of which have been filed with the Internal Revenue Service and furnished to the Lenders, is complete and accurate and fairly presents the funding status of such Plan, and since the date of such Schedule B there has been no material adverse
change in such funding status. 

  
 -84- 

 (iii) Neither any Loan Party nor any ERISA Affiliate has incurred or is reasonably expected to
incur any Withdrawal Liability exceeding $10,000,000 to any Multiemployer Plan. 
 (iv) Neither any Loan Party nor any ERISA Affiliate has
been notified by the sponsor of a Multiemployer Plan that such Multiemployer Plan is in reorganization or has been terminated, within the meaning of Title IV of ERISA, and no such Multiemployer Plan is reasonably expected to be in reorganization or
to be terminated, within the meaning of Title IV of ERISA. 
 (v) Each Loan Party is in compliance in all material respects with the
presently applicable provisions of ERISA and the Code with respect to each Plan. 
 (vi) The present value of all accumulated benefit
obligations of all underfunded Plans (based on the assumptions used for purposes of Statement of Financial Accounting Standards No. 87) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair
market value of the assets of all such underfunded Plans by an amount that could reasonably be expected to have a Material Adverse Effect. 

(vii) The Loan Parties do not maintain or contribute to any plan, program, policy, arrangement or agreement with respect to employees (or
former employees) employed outside the United States or Puerto Rico. 
 (viii) Each Loan Party is in compliance in all material respects
with the provisions of applicable law with respect to each employee benefit plan maintained or contributed to with respect to employees (or former employees) employed in Puerto Rico. No Loan Party has incurred, or reasonably expects to incur, any
material obligation in connection with the termination of, or withdrawal from, any employee benefit plan maintained or contributed to with respect to employees (or former employees) employed in Puerto Rico. 

4.15 Environmental Laws. 

(i) The operations and properties of each Loan Party comply with all applicable Environmental Laws and Environmental Permits, except where any
such failure to comply would not be reasonably expected to have a Material Adverse Effect; any past non-compliance with such Environmental Laws and Environmental Permits has been resolved without ongoing obligations or costs, except where any such
failure to comply would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect; no Environmental Action is pending or, to the Loan Parties’ knowledge threatened, against any Loan Party; and no
circumstances exist that, in each case, could be reasonably likely to (A) form the basis of an Environmental Action against any Loan Party or any of properties currently owned or operated by any of them that could, individually or in the
aggregate, have a Material Adverse Effect or (B) cause any such property owned by any Loan Party to be subject to any restrictions on ownership, occupancy, use or transferability under any Environmental Law that could, individually or in the
aggregate, have a Material Adverse Effect. 
 (ii) To Borrower’s knowledge, none of the properties currently or formerly owned or
operated by any Loan Party is listed or formally proposed for listing on the NPL or on the CERCLIS or any analogous foreign, state or local list; and except to the extent that any of the following would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, (A) there are no and, to the Loan Parties’ knowledge, never have been any underground or aboveground storage tanks or related piping or any surface impoundments, land disposal
areas, septic tanks, pits, sumps or lagoons in which Hazardous Materials are being or have been treated, stored or disposed on any property currently 

  
 -85- 

 
owned or operated by any Loan Party or, to their knowledge, on any property formerly owned or operated by any Loan Party, (B) there is no asbestos or asbestos-containing material on or at
any facility or property currently owned or operated by any Loan Party, and (C) there has been no Release of Hazardous Materials on, at, under or from any property currently or, to Borrower’s knowledge formerly owned or operated by any
Loan Party. 
 (iii) (A) No Loan Party is undertaking, and has not completed, either individually or together with other potentially
responsible parties, any investigation or remedial or response action relating to any actual or threatened Release of Hazardous Materials at any location; and (B) all Hazardous Materials generated, used, treated, handled or stored at, or
transported to or from, any property currently or formerly owned or operated by any Loan Party have been disposed of in a manner that could not reasonably be expected to result in liability to any Loan Party that, in the case of (A) and (B),
either individually or in the aggregate, would have a Material Adverse Effect. 
 4.16 Taxes. Each Loan Party has duly filed, has
caused to be duly filed or has been included in all material tax returns (Federal, state, local and foreign) required to be filed and has paid all material Taxes whether or not shown to be due on a tax return, together with applicable interest and
penalties. Each Loan Party has made adequate provision in accordance with GAAP for all Taxes not yet due and payable. Each Loan Party is unaware of any proposed or pending tax assessments, deficiencies or audits that could be reasonably expected to,
individually or in the aggregate, result in a Material Adverse Effect. No Loan Party has ever been a party to any understanding or arrangement constituting a “tax shelter” within the meaning of Section 6662(d)(2)(C)(iii) of the Code
or within the meaning of Section 6111(c) or Section 6111(d) of the Code as in effect immediately prior to the enactment of the American Jobs Creation Act of 2004, or has ever “participated” in a “reportable transaction”
within the meaning of Treasury Regulation Section 1.6011-4, except as could not be reasonably expected to, individually or in the aggregate, result in a Material Adverse Effect. 

4.17 Government Reimbursement Programs; Medicare/Medicaid/Tricare; Commercial Reimbursement Programs; Corporate Practice of Medicine.

 (a) The dialysis facilities operated by each Group Member (the “Dialysis Facilities”), the Physician Groups and the
Regulated Subsidiaries (i) are qualified for participation in the Medicare programs and the Medicaid programs and Tricare programs in which they participate (together with their respective intermediaries or carriers, the “Government
Reimbursement Programs”), (ii) are entitled to reimbursement under Government Reimbursement Programs for services rendered to qualified beneficiaries of Government Reimbursement Programs in which the Borrower and its Subsidiaries
participate, and with respect to the Physician Groups and Regulated Subsidiaries those Government Reimbursement Programs in which they participate, and (iii) comply in all respects with the conditions of participation in all Government
Reimbursement Programs in which they participate, except, in each case of clauses (i), (ii) and (iii), to the extent any such failure would not reasonably be expected to (x) have a Material Adverse Effect or (y) result in Consolidated
net operating revenues for any (including any future) four Fiscal Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower, and except
for the fact that Dialysis Facilities (i) newly developed by Group Members may from time to time be awaiting an initial Medicare certification and/or initial Medicare or Medicaid provider number in accordance with normal business practice
because of standard waiting times between the proper timely filing of the relevant documents therefor and the receipt of such certification and/or provider number and (ii) acquired by Group Members may from time to time be awaiting a Medicare
certification and/or Medicare or Medicaid provider number issued in the name of such Group Member in accordance with normal business practice because of standard waiting times between the proper timely filing of the relevant documents therefor and
the receipt 

  
 -86- 

 
of such provider number. There is no pending or, to the Loan Parties’ knowledge, threatened proceeding or investigation by any of the Government Reimbursement Programs with respect to
(i) any Group Member’s, Physician Group’s or Regulated Subsidiary’s qualification or right to participate in any Government Reimbursement Program in which it participates or has participated, (ii) the compliance or
non-compliance by any Group Member, Physician Group or Regulated Subsidiary with the terms or provisions of any Government Reimbursement Program in which it participates or has participated, or (iii) the right of any Group Member, Physician
Group or Regulated Subsidiary to receive or retain amounts received or due or to become due from any Government Reimbursement Program in which it participates or has participated, in each case of clauses (i), (ii) and (iii), which proceeding or
investigation, together with all other such proceedings and investigations, would reasonably be expected to (x) have a Material Adverse Effect or (y) result in Consolidated net operating revenues for any (including any future) four Fiscal
Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower. 

(b) No Group Member nor any of their respective officers, directors, managers or partners on behalf of any Group Member, and no Physician
Group or Regulated Subsidiary nor any of their respective officers, directors, managers or partners on behalf of any Physician Group or Regulated Subsidiary has (A) committed any act that would cause any of them to incur a civil monetary
penalty under or violated 42 U.S.C. § 1320a-7a or § 1320a-7b or knowingly or willfully violated any of the other federal statutes applicable to Government Reimbursement Programs or the regulations promulgated pursuant to such
statutes or related state or local statutes or regulations, including but not limited to the following: (i) knowingly and willfully making or causing to be made a false statement or representation of a material fact in any applications for any
benefit or payment; (ii) knowingly and willfully making or causing to be made any false statement or representation of a material fact for use in determining rights to any benefit or payment; (iii) failing to disclose knowledge by a
claimant of the occurrence of any event affecting the initial or continued right to any benefit or payment on its own behalf or on behalf of another, with intent to secure such benefit or payment fraudulently; (iv) knowingly and willfully
soliciting, receiving, offering or paying any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind or offering to pay such remuneration (a) in return for referring an individual
to a Person for the furnishing or arranging for the furnishing of any item or service for which payment may be made in whole or in part by Medicare, Medicaid or other applicable government payers, or (b) in return for purchasing, leasing or
ordering or arranging for or recommending the purchasing, leasing or ordering of any good, facility, service or item for which payment may be made in whole or in part by Medicare, Medicaid or other applicable government payers, (B) knowingly
and willfully presented or caused to be presented a claim for a medical or other item or service that was not provided as claimed, or was for a medical or other item or service and the Person knew or should have known the claim was false or
fraudulent or (C) in violation of 42 U.S.C. § 1395nn, presented or caused to be presented a claim to any individual, third party payor or other entity for a designated health service furnished pursuant to a referral by a physician if
the physician (or an immediate family member) had a financial relationship with the Borrower or any of its Subsidiaries or any Physician Group or Regulated Subsidiary for which there was no permissible exception, except in the case of each of (A),
(B) and (C) as would not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. Neither the Borrower nor any of its Subsidiaries, nor any of their respective officers, directors, managers or partners, on
behalf of the Borrower or any of its Subsidiaries, and no Physician Group or Regulated Subsidiary nor any of their respective officers, directors, managers or partners on behalf of any Physician Group or Regulated Subsidiary, has violated the
federal false claims act, 31 U.S.C. §3729, including, but not limited to, by (i) knowingly and willfully presenting or causing to be presented to a government official a false claim for payment or approval, (ii) knowingly and
willfully making, using or causing to be made or used, a false record or statement to get a false or fraudulent claim paid or approved by the government or (iii) conspiring to defraud the government by knowingly and willfully getting a false or
fraudulent claim paid, except as would 

  
 -87- 

 
not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. With respect to this Section, knowledge of an individual director, officer, manager or partner of a
Group Member, Physician Group or Regulated Subsidiary or any of any of the events described in this Section shall not be imputed to a Group Member, Physician Group or Regulated Subsidiary unless such knowledge was obtained or learned by the
director, officer, manager or partner in his or her official capacity as a director , officer, manager or partner of a Group Member, Physician Group or Regulated Subsidiary. Except as individually or in the aggregate could not reasonably be expected
to have a Material Adverse Effect, the Borrower and each of its Subsidiaries and each Physician Group and Regulated Subsidiary is in compliance with the privacy and security rules promulgated under the Health Insurance Portability and Accountability
Act of 1996 found at 45 C.F.R. parts 160-164 (collectively, “HIPAA”) and the amendments to HIPAA made under the Health Information Technology for Economic and Clinical Health Act amendments to the American Recovery and Reinvestment
Act of 2009. To the knowledge of the Borrower, neither the Borrower nor any of its Subsidiaries nor any Physician Group or Regulated Subsidiary has violated 18 U.S.C. § 1347 including, but not limited to, knowingly and willfully executing or
attempting to execute a scheme or artifice by means of false or fraudulent pretenses (i) to defraud any health care benefit program, or (ii) to obtain any money or property owned by, or under the custody or control of, any health benefit
program, except as would not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. 
 (c) The Physician
Groups and the Regulated Subsidiaries (i) are qualified for participation in the Medicare managed care programs (including, without limitation, the Medicare Advantage program) and Medicaid managed care programs and all other non-Governmental
Reimbursement Programs in which they participate (together with their respective intermediaries, carriers, and third party administrators, the “Commercial Plans”) and (ii) are entitled to reimbursement under Commercial Plans
for services rendered to qualified beneficiaries of Commercial Plans in which the Physician Groups and Regulated Subsidiaries participate, and (iii) comply in all material respects with the requirements of all Commercial Plans in which they
participate except, in each case of clauses (i), (ii) and (iii), to the extent any such failure would not reasonably be expected to (x) have a Material Adverse Effect or (y) result in Consolidated net operating revenues for any
(including any future) four Fiscal Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower. There is no pending or, to the Loan
Parties’ knowledge, threatened proceeding, audit or investigation by any of the Commercial Plans with respect to (i) any Physician Group’s or Regulated Subsidiary’s qualification or right to participate in any Commercial Plan in
which it participates or has participated, (ii) the compliance or non-compliance by any Physician Group or Regulated Subsidiary with the terms or provisions of any Commercial Plan in which it participates or has participated, or (iii) the
right of any Physician Group or Regulated Subsidiary to receive or retain amounts received or due or to become due from any Commercial Plan in which it participates or has participated, which proceeding or investigation, together with all other such
proceedings, audits and investigations, would reasonably be expected to (x) have a Material Adverse Effect or (y) result in Consolidated net operating revenues for any (including any future) four Fiscal Quarter period of the Borrower
constituting less than 95% of Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower. 

(d) HCP LLC, HPMGI, HCPAMG and each other Physician Group and Regulated Subsidiary is operated in compliance with the corporate practice of
medicine laws (whether statutory or common law) of each state in which it does business, except as would not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. There is no pending or, to the Loan Parties’
knowledge, threatened proceeding or investigation by any Governmental Authority with regard to the compliance of HCP LLC, HPMGI, HCPAMG or any other Physician Group or Regulated Subsidiary with corporate practice of medicine laws, except as would
not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. 

  
 -88- 

 4.18 Agreements. No Group Member is a party to any agreement or instrument or subject to
any corporate or other constitutional restriction that has resulted or could reasonably be expected to result in a Material Adverse Effect. No Loan Party is in default in any manner under any provision of any agreement or instrument to which it is a
party or by which it or any of its property is or may be bound, and no condition exists which, with the giving of notice or the lapse of time or both, would constitute such a default, in each case where such default could reasonably be expected to
result in a Material Adverse Effect. 
 4.19 Use of Proceeds. Borrower will use the proceeds of (a) the Tranche A Term Loans and
Tranche B Term Loans (i) to finance the Refinancing, (ii) for general corporate purposes, including, without limitation, stock repurchases, acquisitions and investments, and (iii) to pay related fees, commissions and expenses and
(b) the Revolving Loans and Swingline Loans on and after the Closing Date for working capital and general corporate purposes (including, without limitation, stock repurchases, acquisitions and investments). 

4.20 Labor Matters. Except as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect, as
of the Closing Date, (i) there are no strikes, lockouts or slowdowns against any Group Member pending or, to the knowledge of any Group Member, threatened, (ii) the hours worked by and payments made to employees of any Group Member have
not been in violation of the Fair Labor Standards Act of 1938, as amended, or any other applicable Requirement of Law dealing with such matters and (iii) all payments due from any Group Member on account of wages and employee health and welfare
insurance and other benefits, have been paid or accrued as a liability on the books of such Group Member. The consummation of the Transactions will not give rise to any right of termination or right of renegotiation on the part of any union under
any collective bargaining agreement to which any Group Member is bound. 
 4.21 Insurance. All insurance maintained by the Group
Members is in full force and effect, all premiums have been duly paid, no Group Member has received notice of violation or cancellation thereof, the Premises, and the use, occupancy and operation thereof, comply in all material respects with all
Insurance Requirements, and there exists no default under any Insurance Requirement. Each Group Member has insurance in such amounts and covering such risks and liabilities as are customary for companies of a similar size engaged in similar
businesses in similar locations. 
 4.22 Security Documents. 

(a) Security Agreement. The Security Agreement is effective to create in favor of the Collateral Agent for the benefit of the Secured
Parties, legal, valid and enforceable Liens on, and security interests in, the Security Agreement Collateral and, when (i) the financing statements and other filings in appropriate form are filed in the jurisdictions of organization or
formation of the Loan Parties and (ii) upon the taking of possession or control by the Collateral Agent of the Security Agreement Collateral with respect to which a security interest may be perfected only by possession or control (which
possession or control shall be given to the Collateral Agent to the extent possession or control by the Collateral Agent is required by each Security Agreement), the Liens created by the Security Agreement shall constitute fully perfected Liens on,
and security interests in, all right, title and interest of the grantors in the Security Agreement Collateral (other than such Security Agreement Collateral in which a security interest cannot be perfected under the UCC as in effect at the relevant
time in the relevant jurisdiction) in each case subject to no Liens other than Liens permitted pursuant to Section 7.1. 

  
 -89- 

 (b) Copyright Office Filing. When the Security Agreement or a short form thereof is filed
in the United States Copyright Office, the Liens created by the Security Agreement shall constitute fully perfected Liens on, and security interests in, all right, title and interest of the grantors thereunder in the Registered Copyrights and
Registered Copyright Licenses (each as defined in the Security Agreement), in each case subject to no Liens other than Liens permitted pursuant to Section 7.1. 

(c) Mortgages. Each Mortgage is effective to create, in favor of the Collateral Agent, for its benefit and the benefit of the Secured
Parties, legal, valid and enforceable first priority Liens on, and security interests in, all of the Loan Parties’ right, title and interest in and to the Mortgaged Properties thereunder and the proceeds thereof, subject only to Liens permitted
pursuant to Section 7.1 or other Liens acceptable to the Collateral Agent, and when any Mortgage executed and delivered after the Closing Date in accordance with the provisions of Sections 6.12 and 6.13 is filed in the
offices specified in the local counsel opinion delivered with respect thereto in accordance with the provisions of Sections 6.12 and 6.13, the Mortgages shall constitute fully perfected Liens on, and security interests in, all
right, title and interest of the Loan Parties in the Mortgaged Properties and the proceeds thereof, in each case prior and superior in right to any other Person, other than Liens permitted by such Mortgage. 

(d) Valid Liens. Each Security Document delivered after the Closing Date pursuant to Sections 6.12 and 6.13 will,
upon execution and delivery thereof, be effective to create in favor of the Collateral Agent, for the benefit of the Secured Parties, legal, valid and enforceable Liens on, and security interests in, all of the Loan Parties’ right, title and
interest in and to the Collateral thereunder, and when all appropriate filings or recordings are made in the appropriate offices as may be required under applicable law, such Security Document will constitute fully perfected Liens on, and security
interests in, all right, title and interest of the Loan Parties in such Collateral, in each case subject to no Liens other than Liens permitted pursuant to Section 7.1. 

4.23 Anti-Terrorism Law. 

(a) No Loan Party and, to the knowledge of the Loan Parties, none of its Affiliates is in violation of any Requirement of Law relating to
terrorism, corruption, bribery or money laundering (“Anti-Terrorism Laws”), including Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (the “Executive Order”), and the Uniting and
Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56 (the “Patriot Act”). 

(b) No Loan Party and to the knowledge of the Loan Parties, no Affiliate of any Loan Party acting or benefiting in any capacity in connection
with the Loans is any of the following: 
 (i) a Person that is listed in the annex to, or is otherwise subject to the
provisions of, the Executive Order; 
 (ii) a Person owned or Controlled by, or acting for or on behalf of, any Person that
is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order; 
 (iii) a Person with which
any Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law; 
 (iv) a Person
that commits, threatens or conspires to commit or supports “terrorism” as defined in the Executive Order; or 

  
 -90- 

 (v) a Person that is named as a “specially designated national and blocked
person” on the most current list published by the U.S. Treasury Department Office of Foreign Assets Control (“OFAC”) at its official website or any replacement website or other replacement official publication of such list.

 (c) No Loan Party knowingly (i) conducts any business or engages in making or receiving any contribution of funds, goods or services
to or for the benefit of any Person described in paragraph (b) above, (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order, or (iii) engages
in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law. 

(d) No part of the proceeds of the Loans will be used, directly or indirectly, by any Loan Party or any of its subsidiaries (i) for any
payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper
advantage, in violation of the United States Foreign Corrupt Practices Act of 1977, as amended or (ii) for the purpose of financing the activities of any Person subject to U.S. sanctions administered by OFAC in violation of OFAC. 

SECTION 5 
 CONDITIONS
PRECEDENT 
 5.1 Conditions to Initial Credit Extension. The obligation of each Lender and, if applicable, the Issuing Lender to
fund the initial Credit Extension requested to be made by it shall be subject to the prior or concurrent satisfaction of each of the conditions precedent set forth in this Section 5.1. 

(a) Loan Documents. There shall have been delivered to the Administrative Agent an executed counterpart of each of the Loan Documents.

 (b) Corporate Documents. The Administrative Agent shall have received: 

(i) a certificate of the secretary or assistant secretary of each Loan Party dated the Closing Date, certifying (A) that
attached thereto is a true and complete copy of each Constitutive Document of such Loan Party certified (to the extent applicable) as of a recent date by the Secretary of State of the state of its organization, (B) that attached thereto is a
true and complete copy of resolutions duly adopted by the Board of Directors of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such Loan Party is a party and, in the case of the Borrower, the
borrowings hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect and (C) as to the incumbency and specimen signature of each officer executing any Loan Document or any other document
delivered in connection herewith on behalf of such Loan Party (together with a certificate of another officer as to the incumbency and specimen signature of the secretary or assistant secretary executing the certificate in this clause (i));

 (ii) a certificate as to the good standing of each Loan Party (in so-called “long-form” if available) as of a
recent date, from such Secretary of State (or other applicable Governmental Authority); and 

  
 -91- 

 (iii) such other documents as the Lenders, the Issuing Lender or the
Administrative Agent may reasonably request (including bring-down good standing certificates). 
 (c) Officers’ Certificate. The
Administrative Agent shall have received a certificate, dated the Closing Date and signed by two Responsible Officers of the Borrower, confirming compliance with the conditions precedent set forth in Sections 5.2(b) and (c). 

(d) Financings and Other Transactions, Etc. 

(i) The Refinancing shall have been consummated or shall be consummated on the Closing Date, in each case in accordance with
the terms hereof and the terms of the Transaction Documents, without the waiver or amendment of any such terms not approved by the Administrative Agent. 

(ii) All Liens in favor of the existing lenders under the Existing Credit Agreement shall simultaneously with the consummation
of the Refinancing be unconditionally released; and the Administrative Agent shall have received from any Person holding any Lien securing any such debt, such UCC termination statements, mortgage releases, releases of assignments of leases and
rents, releases of security interests in Intellectual Property and other instruments, in each case in proper form for recording, as the Administrative Agent shall have reasonably requested to release and terminate of record the Liens securing such
debt. 
 (e) Opinions of Counsel. The Administrative Agent shall have received, on behalf of itself, the other Agents, the Lenders
and the Issuing Lender, a favorable written opinion of (i) Sidley Austin, LLP, special counsel for the Loan Parties, (ii) Kim Rivera, Chief Legal Officer of the Borrower and (iii) Cole, Scott & Kissane, P.A, special Florida
counsel for the Loan Parties, and (iv) Lionel Sawyer & Collins, special Nevada counsel for the Loan Parties, in each case (A) dated the Closing Date, (B) addressed to the Agents, the Issuing Lender and the Lenders and
(C) in form and substance reasonably satisfactory to the Administrative Agent. 
 (f) Solvency Certificate. The Administrative
Agent shall have received a solvency certificate in the form of Exhibit C, dated the Closing Date and signed by the chief financial officer of the Borrower. 

(g) Fees. The arrangers, Administrative Agent and the Lenders shall have received all fees and other amounts due and payable on or
prior to the Closing Date, including, to the extent invoiced, reimbursement or payment of all out-of-pocket expenses (including the invoiced legal fees and expenses of Cahill Gordon & Reindel LLP, special counsel to the
Agents) required to be reimbursed or paid by the Borrower on or prior to the Closing Date hereunder or under any other Loan Document. 

(h) Personal Property Requirements. The Collateral Agent shall have received: 

(i) all certificates, agreements or instruments necessary to perfect the Collateral Agent’s security interest, for the
benefit of the Secured Parties, in all Pledged Collateral (as defined in the Security Agreement), in each case, with the exception of those items permitted to be delivered after the Closing Date pursuant to the terms of the Security Agreement; 

(ii) UCC financing statements in appropriate form for filing under the UCC, filings with the United States Patent and Trademark
Office and United States Copyright Office and such other documents under applicable Requirements of Law in each jurisdiction as may be necessary 

  
 -92- 

 
or appropriate or, in the opinion of the Collateral Agent, desirable to perfect the Liens created, or purported to be created, by the Security Documents and with respect to all UCC financing
statements required to be filed pursuant to the Loan Documents; 
 (iii) copies of UCC, United States Patent and Trademark
Office and United States Copyright Office, tax and judgment lien searches, bankruptcy and pending lawsuit searches or equivalent reports or searches, each of a recent date listing all effective financing statements, lien notices or comparable
documents that name any Loan Party as debtor and that are filed in those state and county jurisdictions in which any property of any Loan Party is located and the state and county jurisdictions in which any Loan Party is organized or maintains its
principal place of business and such other searches that the Collateral Agent deems necessary or appropriate, none of which encumber the Collateral covered or intended to be covered by the Security Documents (other than Liens permitted pursuant to
Section 7.1 or any other Liens acceptable to the Collateral Agent); and 
 (iv) evidence acceptable to the
Collateral Agent of payment or arrangements for payment by the Loan Parties of all applicable recording taxes, fees, charges, costs and expenses required for the recording of the Security Documents. 

(i) USA Patriot Act. The Lenders shall have received, sufficiently in advance of the Closing Date, all documentation and other
information required by bank regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation, the Patriot Act, including, without limitation, the information
described in Section 11.17. 
 5.2 Conditions to All Credit Extensions. The obligation of each Lender and
each Issuing Lender to make any Credit Extension (including the initial Credit Extension) shall be subject to, and to the satisfaction of, each of the conditions precedent set forth below. 

(a) Notice. The Administrative Agent shall have received a notice as required by Section 2.2 or 2.5 if Loans are
being requested or, in the case of the issuance, amendment, extension or renewal of a Letter of Credit, the Issuing Lender and the Administrative Agent shall have received an Application or notice as required by Section 3.2 or, in the
case of a Swingline Loan, the Swingline Lender and the Administrative Agent shall have received a notice as required by Section 2.7. 

(b) No Default. At the time of and immediately after giving effect to such Credit Extension and the application of the proceeds
thereof, no Default shall have occurred and be continuing on such date. 
 (c) Representations and Warranties. Each of the
representations and warranties made by any Loan Party set forth in Section 4 or in any other Loan Document shall be true and correct in all material respects (except that any representation and warranty that is qualified as to
“materiality” or “Material Adverse Effect” shall be true and correct in all respects) on and as of the date of such Credit Extension with the same effect as though made on and as of such date, except to the extent such
representations and warranties expressly relate to an earlier date. 
 (d) In the case of an Alternative Currency Revolving Loan, there
shall not have occurred any change in national or international financial, political or economic conditions or currency exchange rates or exchange controls which in the reasonable opinion of the Administrative Agent or the Required Lenders (in the
case of any Loans to be denominated in an Alternative Currency) would make it impracticable for such extension of credit to be denominated in the relevant Alternative Currency. 

  
 -93- 

 Each notice of borrowing or an Application and the acceptance by the Borrower of the proceeds of
such Credit Extension shall constitute a representation and warranty by the Borrower and each other Loan Party that on the date of such Credit Extension (both immediately before and after giving effect to such Credit Extension and the application of
the proceeds thereof) the conditions contained in Sections 5.2(b) and (c) have been satisfied. The Borrower shall provide such information including calculations in reasonable detail of the covenants in
Section 7.16 as the Administrative Agent may reasonably request to confirm that the conditions in Sections 5.2(b) and (c) have been satisfied. 

SECTION 6 
 AFFIRMATIVE
COVENANTS 
 Each Loan Party warrants, covenants and agrees with each Lender that, so long as this Agreement shall remain in effect and
until the Commitments have been terminated and the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document shall have been paid in full and all Letters of Credit have been canceled or have
expired and all amounts drawn thereunder have been reimbursed in full or have been cash collateralized at 105% of the face amount thereof, unless the Required Lenders shall otherwise consent in writing, each Loan Party will, and will cause each of
its Subsidiaries to: 
 6.1 Reporting Requirements. The Borrower will furnish to the Administrative Agent (for distribution to the
Agents and Lenders): 
 (a) Default Notice. As soon as possible and in any event within five days after the Borrower
knows of the occurrence of a Default or any event, development or occurrence reasonably likely to have a Material Adverse Effect continuing on the date of such statement, a statement of the chief financial officer of the Borrower setting forth
details of such Default or other event, development or occurrence and the action that the Borrower has taken and proposes to take with respect thereto. 

(b) Annual Financials. As soon as available and in any event within 90 days after the end of each Fiscal Year (or such
earlier date on which Borrower is required to file Form 10-K under the Exchange Act), a copy of the annual audit report for such year for the Borrower and its Subsidiaries, including therein Consolidated and consolidating balance sheets of the
Borrower and its Subsidiaries as of the end of such Fiscal Year and a Consolidated and consolidating statements of income and a Consolidated statement of cash flows of the Borrower and its Subsidiaries for such Fiscal Year, in each case accompanied
by an unqualified opinion of KPMG LLP or other independent public accountants of recognized national standing, together with (i) a certificate of such accounting firm to the Lenders stating that in the course of the regular audit of the
business of the Borrower and its Subsidiaries, which audit was conducted by such accounting firm in accordance with generally accepted auditing standards, such accounting firm has obtained no knowledge that a Default has occurred and is continuing,
or if, in the opinion of such accounting firm, a Default has occurred and is continuing, a statement as to the nature thereof, (ii) a Compliance Certificate and (iii) a certificate of the Chief Financial Officer of the Borrower stating
that to the best of such officer’s knowledge, no Default has occurred and is continuing or, if a Default has occurred and is continuing, a statement as to the nature thereof and the action that the Borrower has taken and proposes to take with
respect thereto. 

  
 -94- 

 (c) Quarterly Financials. As soon as available and in any event within 45
days (or such earlier date on which the Borrower is required to file form 10-Q under the Exchange Act) after the end of each of the first three Fiscal Quarters of each Fiscal Year, Consolidated and consolidating balance sheets of the Borrower and
its Subsidiaries as of the end of such quarter and Consolidated and consolidating statements of income for the period commencing at the end of the previous Fiscal Quarter and ending with the end of such Fiscal Quarter and Consolidated and
consolidating statements of income and a Consolidated statement of cash flows of the Borrower and its Subsidiaries for the period commencing at the end of the previous Fiscal Year and ending with the end of such Fiscal Quarter, setting forth in each
case in comparative form the corresponding figures for the corresponding date or period of the preceding Fiscal Year, all in reasonable detail and duly certified (subject to normal year-end audit adjustments) by the chief financial officer of the
Borrower as having been prepared in accordance with generally accepted accounting principles (except that such financial statements may not contain all required notes and may be subject to year-end audit adjustments) and having been subject to a SAS
100 or equivalent review by KPMG LLP or other independent public accountants of recognized national standing, together with (i) a certificate of said officer stating that to the best of such officer’s knowledge, no Default has occurred and
is continuing or, if a Default has occurred and is continuing, a statement as to the nature thereof and the action that the Borrower has taken and proposes to take with respect thereto and (ii) a Compliance Certificate. 

(d) Annual Forecasts. As soon as available and in any event no later than 90 days after the end of each Fiscal Year, a
reasonably detailed forecast for such Fiscal Year, in form and substance reasonably satisfactory to the Administrative Agent. 

(e) Litigation. Promptly after the commencement thereof, notice of all actions, suits, investigations, litigation and
proceedings by on behalf of or before any Governmental Authority or arbitrator affecting any Loan Party or any of its Subsidiaries of the type described in Section 4.6, and include with such notice a copy of any relevant citation,
summons, subpoena, order to show cause or other document. 
 (f) Securities Reports. Promptly after the sending or
filing thereof, copies of all proxy statements, financial statements and reports that any Loan Party or any of its Subsidiaries sends to its stockholders, and copies of all regular, periodic and special reports, and all registration statements, that
any Loan Party or any of its Subsidiaries files with the SEC or any governmental authority that may be substituted therefor, or with any national securities exchange. 

(g) ERISA. 

(i) ERISA Events and ERISA Reports. (A) Promptly and in any event within 10 days after any Loan Party or any ERISA
Affiliate knows or has reason to know that any ERISA Event has occurred, a statement of the chief financial officer of the Borrower describing such ERISA Event and the action, if any, that such Loan Party or such ERISA Affiliate has taken and
proposes to take with respect thereto and (B) on the date any records, documents or other information must be furnished to the PBGC with respect to any Plan pursuant to Section 4010 of ERISA, a copy of such records, documents and
information. 
 (ii) Plan Terminations. Promptly and in any event within two Business Days after receipt thereof by
any Loan Party or any ERISA Affiliate, copies of each notice from the PBGC stating its intention to terminate any Plan or to have a trustee appointed to administer any Plan. 

  
 -95- 

 (iii) Plan Annual Reports. Promptly and in any event within 30 days after
the filing thereof with the Internal Revenue Service, copies of each Schedule B (Actuarial Information) to the annual report (Form 5500 Series) with respect to each Plan. 

(iv) Multiemployer Plan Notices. Promptly and in any event within five Business Days after receipt thereof by any Loan
Party or any ERISA Affiliate from the sponsor of a Multiemployer Plan, copies of each notice concerning (A) the imposition of Withdrawal Liability by any such Multiemployer Plan, (B) the reorganization or termination, within the meaning of
Title IV of ERISA, of any such Multiemployer Plan or (C) the amount of liability incurred, or that may be incurred, by such Loan Party or any ERISA Affiliate in connection with any event described in clause (A) or (B). 

(h) Environmental Conditions. Promptly after the assertion or occurrence thereof, notice of any Environmental Action
against or of any noncompliance by any Loan Party or any of its Subsidiaries with any Environmental Law or Environmental Permit that could reasonably be expected to have a Material Adverse Effect. 

(i) Financial Officer’s Certificate Regarding Collateral. Concurrently with any delivery of financial statements
under Section 6.1(b), a certificate of the chief financial officer setting forth any updates or supplements to certified disclosure required pursuant to the Security Agreement or confirming that there has been no change in such
information since the date of the certified disclosure or most recent certification. 
 (j) Regulatory Notice.
Promptly provide notice that any Loan Party knows or has reason to know (A) that Dialysis Facilities have lost their qualification to participate in Government Reimbursement Programs as would have a Material Adverse Effect, (B) of an
investigation described in Section 4.17(a) or (C) of any violation described in Section 4.17(b) that would have a Material Adverse Effect. 

(k) Other Information. Such other information respecting the business, financial condition, operations or properties of
any Loan Party or any of its Subsidiaries as any Agent or any Lender, through the Administrative Agent, may from time to time reasonably request. 

(l) Physician Group. With each set of Consolidated financial statements referred to in Sections 6.1(b) and 6.1(c) above,
a reconciliation reflecting the adjustments necessary to eliminate the accounts of the Physician Groups and their respective Subsidiaries (which may be in footnote form only) from such Consolidated financial statements. 

Documents required to be delivered pursuant to Section 6.1(b) or (c) (to the extent any such documents are included in materials
otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i) on which the Borrower posts such documents, or provides a link thereto on the Borrower’s website; or
(ii) on which such documents are posted on the Borrower’s behalf on an Internet or intranet website or www.sec.gov, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether
sponsored by the Administrative Agent); provided that: (A) the Borrower shall deliver paper copies of such documents to the Administrative Agent upon its reasonable request until a written notice to cease delivering paper copies is given
by the Administrative Agent, (B) the Borrower shall notify the Administrative Agent (by telecopier or electronic mail) of the posting of any such documents and upon its reasonable request, provide to the Administrative Agent by electronic mail
electronic versions (i.e., soft copies) of such documents and (iii) the Lenders shall be deemed to have received such information on the date such 

  
 -96- 

 
information is posted on the applicable website pursuant to clause (i) or (ii) above. The Administrative Agent shall have no obligation to request the delivery of or maintain paper
copies of the documents referred to above, and each Lender shall be solely responsible for timely accessing posted documents and maintaining its copies of such documents. 

6.2 Compliance with Laws, Etc. Comply, and cause each of its Subsidiaries to comply, in all material respects, with all applicable
Requirements of Law, such compliance to include, without limitation, compliance with (x) ERISA, the Racketeer Influenced and Corrupt Organizations Chapter of the Organized Crime Control Act of 1970 and all applicable laws and regulations under
the federal Social Security Act and all other applicable federal and state healthcare laws, except to the extent that non-compliance could not be reasonably expected, individually or in the aggregate, to result in a Material Adverse Effect and
(y) the Patriot Act and all other laws and regulations relating to money-laundering and terrorist activities. 
 6.3 Payment of
Taxes, Etc. 
 (a) Pay and discharge, and cause each of its Subsidiaries to pay and discharge, before the same shall become delinquent,
(i) all Taxes imposed upon it or upon its property and (ii) all lawful claims that, if unpaid, might by law become a Lien upon its property; provided, however, that neither the Borrower nor any of its Subsidiaries shall be
required to pay or discharge any such Tax, assessment, charge or claim (A) the non-payment or non-discharge of which could not be reasonably expected, individually or in the aggregate, to result in a Material Adverse Effect or (B) that is
being contested in good faith and (in the case of clause (a)(i)) by proper proceedings and as to which appropriate reserves are being maintained in accordance with GAAP, unless and until any Lien resulting therefrom attaches to its property and
becomes enforceable against its other creditors and subjects the property to a substantial risk of forfeiture. 
 (b) File or cause to be
filed all material tax returns required to be filed by it by the due dates (including any proper extensions) therefor. 
 6.4 Compliance
with Environmental Laws. Except as could not reasonably be expected to result in a Material Adverse Effect, comply, and cause each of its Subsidiaries and all lessees and other Persons operating or occupying its properties to comply, with all
applicable Environmental Laws and Environmental Permits; obtain and renew and cause each of its Subsidiaries to obtain and renew all Environmental Permits necessary for its operations and properties that are the legal responsibility of the Borrower
or such Subsidiary; and conduct, and cause each of its Subsidiaries to conduct, any investigation, study, sampling and testing, and undertake any cleanup, removal, remedial or other action required under Environmental Laws to address the presence,
or Release or threatened Release of Hazardous Materials at, on, under or from any of its properties, in accordance with the requirements of all applicable Environmental Laws; provided, however, that neither the Borrower nor any of its
Subsidiaries shall be required to undertake any such cleanup, removal, remedial or other action to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves are being maintained in
accordance with GAAP requirements with respect to such circumstances. 
 6.5 Insurance. 

(a) Generally. Keep its insurable property adequately insured at all times by financially sound and reputable insurers; maintain such
other insurance, to such extent and against such risks as is customary with companies in the same or similar businesses operating in the same or similar locations, including insurance with respect to Mortgaged Properties and other properties
material to the business 

  
 -97- 

 
of the Group Members against such casualties and contingencies and of such types and in such amounts with such deductibles as is customary in the case of similar businesses operating in the same
or similar locations; provided that with respect to physical hazard insurance, neither the Collateral Agent nor the applicable Group Member shall agree to the adjustment of any claim thereunder in excess of $250,000 without the consent of the
other (such consent not to be unreasonably withheld or delayed); provided, further, that no consent of any Group Member shall be required during an Event of Default. 

(b) Requirements of Insurance. All such insurance shall (i) provide that no cancellation, material reduction in amount or material
change in coverage thereof shall be effective until at least 30 days after receipt by the Collateral Agent of written notice thereof, (ii) name the Collateral Agent as mortgagee (in the case of property insurance) or additional insured on
behalf of the Secured Parties (in the case of liability insurance) or additional loss payee (in the case of property insurance), as applicable and (iii) if reasonably requested by the Collateral Agent, include a breach of warranty clause. 

(c) Flood Insurance. With respect to each Mortgaged Property, obtain flood insurance in such total amount as the Administrative Agent
or the Required Lenders may from time to time require, if at any time the area in which any improvements are located on any Mortgaged Property is designated a “flood hazard area” in any Flood Insurance Rate Map published by the Federal
Emergency Management Agency (or any successor agency), and otherwise comply with the National Flood Insurance Program as set forth in the Flood Disaster Protection Act of 1973, as amended from time to time. 

(d) Broker’s Report. Deliver to the Administrative Agent and the Collateral Agent and the Lenders a report of a reputable
insurance broker with respect to such insurance and such supplemental reports with respect thereto as the Administrative Agent or the Collateral Agent may from time to time reasonably request. 

(e) Mortgaged Properties. No Loan Party that is an owner of Mortgaged Property shall take any action that is reasonably likely to be
the basis for termination, revocation or denial of any insurance coverage required to be maintained under such Loan Party’s respective Mortgage or that could be the basis for a defense to any claim under any Insurance Policy maintained in
respect of the Premises, and each Loan Party shall otherwise comply in all material respects with all Insurance Requirements in respect of the Premises; provided, however, that each Loan Party may, at its own expense and after written
notice to the Administrative Agent, (i) contest the applicability or enforceability of any such Insurance Requirements by appropriate legal proceedings, the prosecution of which does not constitute a basis for cancellation or revocation of any
insurance coverage required under this Section 6.5 or (ii) cause the Insurance Policy containing any such Insurance Requirement to be replaced by a new policy complying with the provisions of this Section 6.5. 

6.6 Preservation of Corporate Existence, Etc. Preserve and maintain, and cause each of its Material Subsidiaries to preserve and
maintain, its existence, legal structure, legal name, rights (charter and statutory) and material franchises except, in each case, as otherwise permitted by Section 7.4. 

6.7 Visitation Rights. At any reasonable time and from time to time, and, unless a Default shall have occurred and be continuing, not
more than two times during any calendar year and upon reasonable notice, permit any of the Agents or any of the Lenders, or any agents or representatives thereof, to examine and make copies of and abstracts from the records and books of account of,
and visit the properties of, the Borrower and any of its Subsidiaries, and to discuss the affairs, finances and accounts of the Borrower and any of its Subsidiaries with any of their officers or directors and with their independent certified public
accountants (provided that representatives of the Borrower shall be entitled to notice of and to participate in any such discussion). 

  
 -98- 

 6.8 Keeping of Books. Keep, and cause each of its Subsidiaries to keep, proper books of
record and account, in which full and correct entries shall be made of all financial transactions sufficient to permit the preparation of financial statements based thereon in accordance with GAAP. 

6.9 Maintenance of Properties, Etc. Maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, absent events
or circumstances leading to a Recovery Event, all of its properties that are material in the conduct of its business in good working order and condition, ordinary wear and tear excepted. 

6.10 Transactions with Affiliates. Conduct, and cause each of its Subsidiaries to conduct, all transactions otherwise permitted under
the Loan Documents with any of their Affiliates on terms that are fair and reasonable and no less favorable to the Borrower or such Subsidiary (with respect to any Physician Group and its Subsidiaries, taking into account all transactions with such
Physician Group and its Subsidiaries as a whole) than it would obtain in a comparable arm’s-length transaction with a Person not an Affiliate (it being understood that the Transactions are deemed to be on such terms) except
(a) transactions between or among the Borrower and its Subsidiaries, (b) any transaction permitted by Section 7.6(f) or (m) or Section 7.7 and (c) notional pooling cash management arrangements in
the ordinary course of business. 
 6.11 Use of Proceeds. Use the proceeds of the Loans only for the purposes set forth in
Section 4.19. 
 6.12 Additional Collateral; Additional Guarantors. 

(a) Subject to this Section 6.12, with respect to any property acquired after the Closing Date by any Loan Party that is intended
to be subject to the Lien created by any of the Security Documents but is not so subject, within 15 Business Days following the end of the Fiscal Quarter in which such acquisition occurs (i) execute and deliver to the Administrative Agent and
the Collateral Agent such amendments or supplements to the relevant Security Documents or such other documents as the Administrative Agent or the Collateral Agent shall deem necessary or advisable to grant to the Collateral Agent, for its benefit
and for the benefit of the other Secured Parties, a Lien on such property subject to no Liens other than Liens permitted pursuant to Section 7.1, and (ii) take all actions necessary to cause such Lien to be duly perfected to the
extent required by such Security Document in accordance with all applicable Requirements of Law, including the filing of financing statements in such jurisdictions as may be reasonably requested by the Administrative Agent. The Borrower shall
otherwise take such actions and execute and/or deliver to the Collateral Agent such documents as the Administrative Agent or the Collateral Agent shall require to confirm the validity, perfection and priority of the Lien of the Security Documents on
such after-acquired properties. 
 (b) With respect to any Person that is or becomes a Subsidiary after the Closing Date required to become
a Guarantor in order for the Loan Parties to remain in compliance with Section 7.12 as of the end of the Fiscal Quarter in which such Person becomes a Subsidiary, within 15 Business Days following the end of such Fiscal Quarter
(i) deliver to the Collateral Agent the certificates, if any, representing all of the Capital Stock of such Subsidiary to the extent held by a Loan Party, together with undated stock powers or other appropriate instruments of transfer executed
and delivered in blank by a duly authorized officer of the holder(s) of such Capital Stock, and all intercompany notes owing from such Subsidiary to any Loan Party that together with undated instruments of transfer executed and delivered in blank by
a duly authorized officer of such Loan Party; provided that Capital Stock of Foreign Subsidiaries required to be delivered shall be limited to (A) Voting Interests of any Subsidiary which is a first-tier controlled foreign corporation
(as defined in Section 957(a) of the Code) representing 65% of the total voting 

  
 -99- 

 
power of all outstanding Voting Interests of such Subsidiary and (B) 100% of the Capital Stock not constituting Voting Interests of any such Subsidiary, except that any such Capital Stock
constituting “stock entitled to vote” within the meaning of Treasury Regulation Section 1.956-2(c)(2) shall be treated as Voting Interests for purposes of this Section 6.12(b) and (ii) cause such new Subsidiary
(A) to execute a Joinder Agreement or such comparable documentation to become a Guarantor and a joinder agreement to the applicable Security Agreement, substantially in the form annexed thereto, (B) to execute a Business Associate
Agreement and (C) to take all actions necessary or advisable in the opinion of the Administrative Agent or the Collateral Agent to cause the Lien created by the applicable Security Agreement to be duly perfected to the extent required by such
agreement in accordance with all applicable Requirements of Law, including the filing of financing statements in such jurisdictions as may be reasonably requested by the Administrative Agent or the Collateral Agent; provided that, if any
Subsidiary that is not a Guarantor is a guarantor of or shall guarantee Debt of a Loan Party or Debt of a Loan Party is or shall otherwise become a Contingent Obligation of any Subsidiary that is not a Guarantor, such Subsidiary shall become a
Guarantor hereunder and comply with Section 6.12 and Section 6.13 and all other applicable provisions hereof. 
 (c)
Other than with respect to the Denver Headquarters, promptly grant to the Collateral Agent, within 15 Business Days of the end of the Fiscal Quarter in which the acquisition thereof occurred, a security interest in and Mortgage on each Real Property
owned in fee by such Loan Party as is acquired by such Loan Party after the Closing Date and that, together with any improvements thereon, individually has a fair market value of at least $20.0 million as additional security for the Secured
Obligations (unless the subject property is already mortgaged to a third party to the extent permitted by Section 7.1). Such Mortgages shall be granted pursuant to documentation reasonably satisfactory in form and substance to the
Administrative Agent and the Collateral Agent and shall constitute valid and enforceable perfected Liens subject only to Liens permitted by Section 7.1, or other Liens acceptable to the Collateral Agent. The Mortgages or instruments
related thereto shall be duly recorded or filed in such manner and in such places as are required by law to establish, perfect, preserve and protect the Liens in favor of the Collateral Agent required to be granted pursuant to the Mortgages and all
taxes, fees and other charges payable in connection therewith shall be paid in full. Such Loan Party shall otherwise take such actions and execute and/or deliver to the Collateral Agent such documents as the Administrative Agent or the Collateral
Agent shall require to confirm the validity, perfection and priority of the Lien of any existing Mortgage or new Mortgage against such after-acquired Real Property (including a title insurance policy, a Survey, a life of loan flood hazard
determination (together with a notice regarding the special flood hazard area status and flood disaster assistance with respect to such after-acquired Real Property executed by the Borrower) and a local counsel opinion (each in form and substance
reasonably satisfactory to the Administrative Agent and the Collateral Agent) in respect of such Mortgage). 
 6.13 Security Interests;
Further Assurances. Promptly, upon the reasonable request of the Administrative Agent, the Collateral Agent or any Lender, at the Borrower’s expense, execute, acknowledge and deliver, or cause the execution, acknowledgment and delivery of,
and thereafter register, file or record, or cause to be registered, filed or recorded, in an appropriate governmental office, any document or instrument supplemental to or confirmatory of the Security Documents or otherwise deemed by the
Administrative Agent or the Collateral Agent reasonably necessary or desirable for the continued validity, perfection and priority of the Liens on the Collateral covered thereby subject to no other Liens except as permitted by the applicable
Security Document, or obtain any consents or waivers as may be necessary or appropriate in connection therewith. Deliver or cause to be delivered to the Administrative Agent and the Collateral Agent from time to time such other documentation,
consents, authorizations, approvals and orders in form and substance reasonably satisfactory to the Administrative Agent and the Collateral Agent as the Administrative Agent and the Collateral Agent shall reasonably deem necessary to perfect or
maintain the Liens on the Collateral pursuant to the Security Documents. Upon the exercise by 

  
 -100- 

 
the Administrative Agent, the Collateral Agent or any Lender of any power, right, privilege or remedy pursuant to any Loan Document which requires any consent, approval, registration,
qualification or authorization of any Governmental Authority execute and deliver all applications, certifications, instruments and other documents and papers that the Administrative Agent, the Collateral Agent or such Lender may reasonably require.
If the Administrative Agent, the Collateral Agent or the Required Lenders determine that they are required by a Requirement of Law to have appraisals prepared in respect of the Real Property of any Loan Party constituting Collateral, Borrower shall
provide to the Administrative Agent appraisals that satisfy the applicable requirements of the Real Estate Appraisal Reform Amendments of FIRREA and are otherwise in form and substance satisfactory to the Administrative Agent and the Collateral
Agent. 
 6.14 Information Regarding Collateral. Not effect any change (i) in any Loan Party’s legal name, (ii) in the
location of any Loan Party’s chief executive office, (iii) in any Loan Party’s identity or organizational structure, (iv) in any Loan Party’s Federal Taxpayer Identification Number or organizational identification number, if
any, or (v) in any Loan Party’s jurisdiction of organization (in each case, including by merging with or into any other entity, reorganizing, dissolving, liquidating, reorganizing or organizing in any other jurisdiction), until (A) it
shall have given the Collateral Agent and the Administrative Agent not less than 30 days’ prior written notice, or such lesser notice period agreed to by the Collateral Agent (it being understood that with respect to changes solely due to
transactions permitted by Section 7.4(a) or (b) notice may be delivered promptly after such change), of its intention so to do, clearly describing such change and providing such other information in connection therewith as
the Collateral Agent or the Administrative Agent may reasonably request and (B) (other than with respect to changes solely due to transactions permitted by Section 7.4(a) or (b)) it shall have taken all action reasonably
satisfactory to the Collateral Agent to maintain the perfection and priority of the security interest of the Collateral Agent for the benefit of the Secured Parties in the Collateral, if applicable. Each Loan Party agrees to promptly provide the
Collateral Agent with certified Constitutive Documents reflecting any of the changes described in the preceding sentence. Each Loan Party also agrees to promptly notify the Collateral Agent of any change in the location of any office in which it
maintains books or records relating to Collateral owned by it or any office or facility at which Collateral is located (including the establishment of any such new office or facility), other than changes in location of Mortgaged Property. 

6.15 Ratings. Use commercially reasonable efforts to cause (x) S&P and Moody’s to continue to issue ratings for the
Facilities, (y) Moody’s to continue to issue a corporate family rating (or the equivalent thereof) and (z) S&P to continue to issue a corporate credit rating (or the equivalent thereof) (it being understood, in each case, that
such obligation shall not require the Borrower to maintain a specific rating). 
 6.16 Management Services Agreements. The Borrower
shall, and shall cause each of its Subsidiaries to cause, (i) with respect to each Management Services Agreement with a Loan Party to which it is party as of the Closing Date, within thirty (30) days after the Closing Date, and
(ii) with respect to each Management Services Agreement with a Loan Party that it enters into after the Closing Date, to contain provisions providing for the assignability of such agreement to the Collateral Agent or any Person designated by
the Collateral Agent in connection with its enforcement of its rights and exercise of its remedies, for the benefit of the Secured Parties, upon the enforcement of its rights and exercise of its remedies under the Loan Documents. 

  
 -101- 

 6.17 Post-Closing Actions. To the extent not satisfied on the Closing Date and unless such
requirement is waived or extended, in the reasonable discretion of the Administrative Agent, the Borrower shall, and shall cause each of its Subsidiaries to: 

(a) Master Intercompany Note. The Borrower shall deliver to the Collateral Agent, within 10 days after the Closing Date, the
Intercompany Note executed by and among the Borrower and each of its Subsidiaries, accompanied by instruments of transfer undated and endorsed in blank. 

(b) HIPAA. Within 5 days after the Closing Date, each Group Member shall enter into a Business Associate Agreement (a “Business
Associate Agreement”) defined under the privacy regulations promulgated pursuant to HIPAA reasonably acceptable to the Administrative Agent and the Collateral Agent that permits disclosure to the Administrative Agent and the Collateral
Agent of any protected health information (as defined in HIPAA) that may be associated with the Collateral. 
 (c) Insurance. Within
10 days after the Closing Date, the Administrative Agent shall receive a copy of, or a certificate as to coverage under (including endorsements thereto), the insurance policies required by Section 6.5 and the applicable provisions of the
Security Documents, each of which shall name the Collateral Agent, on behalf of the Secured Parties, as additional insured, in form and substance satisfactory to the Administrative Agent. 

SECTION 7 
 NEGATIVE COVENANTS

 Each Loan Party covenants and agrees with each Lender that, so long as this Agreement shall remain in effect and until the Commitments
have been terminated and the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document have been paid in full and all Letters of Credit have been canceled or have expired and all amounts drawn
thereunder have been reimbursed in full or have been cash collateralized at 105% of the face amount thereof, unless the Required Lenders shall otherwise consent in writing, no Loan Party will, nor will they cause or permit any Subsidiaries to: 

7.1 Liens, Etc. Create, incur, assume or suffer to exist, or permit any of its Subsidiaries to create, incur, assume or suffer to
exist, any Lien on or with respect to any of its properties of any character whether now owned or hereafter acquired or assign, or permit any of its Subsidiaries to assign, any accounts or other right to receive income, except: 

(a) Liens created under the Loan Documents; 

(b) Permitted Liens; 

(c) Liens existing on the Closing Date and described on Schedule 7.1(c) hereto; 

(d) Liens upon or in an asset acquired or held by the Borrower or any of its Subsidiaries to secure the purchase price of such
property or equipment or to secure Debt incurred solely for the purpose of financing the acquisition, construction or improvement of any such asset to be subject to such Liens, or Liens existing on any such property or equipment at the time of
acquisition (other than any such Liens created in contemplation of such acquisition that do not secure the purchase price), or extensions, renewals or replacements of any of the foregoing; provided, however, that (i) such Liens
shall be created not more than 180 days after the date of acquisition or completion of construction or improvement and (ii) no such Lien shall extend to or cover any asset other than the asset being acquired, constructed or improved and any
attachments thereto and proceeds thereof, and no such extension, renewal or replacement shall extend to or cover any asset not theretofore subject to the Lien being extended, renewed or replaced; provided further that the aggregate
principal amount of the Debt secured by Liens permitted by this clause (d) shall not exceed the amount permitted under Section 7.2(e) at any time outstanding; 

  
 -102- 

 (e) Liens arising in connection with Capitalized Leases permitted under
Section 7.2(f); provided that no such Lien shall extend to or cover any assets other than the assets subject to such Capitalized Leases; 

(f) Liens arising in connection with Debt permitted under Section 7.2(l); provided that no such Lien shall
extend to or cover any assets other than the assets of the relevant borrowing entity; 
 (g) the replacement, extension or
renewal of any Lien permitted by clause (c) above upon or in the same property theretofore subject thereto or the replacement, extension or renewal (without increase in the amount (except by an amount equal to accrued and unpaid interest and
premium thereon plus fees, original issue discount and expenses incurred in connection with such replacement, extension or renewal) or change in any direct or contingent obligor) of the Debt secured thereby; 

(h) Liens on assets of the Borrower or any of its Subsidiaries arising in connection with Sale and Leaseback Transactions
permitted under Section 7.5(h); 
 (i) Liens on assets that are the subject of, or are customarily subject to
Liens relating to, Permitted Receivables Financings; 
 (j) Liens existing on property at the time of its acquisition or
existing on the property of any Person at the time such Person becomes a Subsidiary of the Borrower, in each case after the Closing Date; provided that (A) such Lien was not created in contemplation of such acquisition or such Person
becoming a Subsidiary of the Borrower, (B) such Lien does not extend to or cover any other assets or property (other than the proceeds or products thereof and other than after-acquired property to the extent included in the grant of such Lien),
and (C) the Debt secured thereby is permitted under Section 7.2(p); 
 (k) customary Liens and setoff rights
securing obligations in respect of notional pooling cash management arrangements in the ordinary course of business; 
 (l)
other Liens not otherwise permitted by the foregoing clauses of this Section 7.1 securing an aggregate principal amount at any time outstanding not to exceed $100,000,000; 

(m) Liens on the Collateral to secure Debt permitted under Section 7.2(r); provided that a Senior
Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a (i) a First Lien Intercreditor Agreement if such Debt is secured by the Collateral on a pari passu
basis (but without regard to the control of remedies) with the Obligations, or (ii) a Junior Lien Intercreditor Agreement if such Debt is secured by the Collateral on a second priority (or other junior priority) basis to the liens securing the
Obligations; 
 (n) Liens on the Collateral securing obligations in respect of Permitted First Priority Refinancing Debt or
Permitted Second Priority Refinancing Debt and any Permitted Refinancing of any of the foregoing; provided that a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the
provisions of a (i) a First Lien 

  
 -103- 

 
Intercreditor Agreement if such Debt is secured by the Collateral on a pari passu basis (but without regard to the control of remedies) with the Obligations, or (ii) a Junior
Lien Intercreditor Agreement if such Debt is secured by the Collateral on a second priority (or other junior priority) basis to the liens securing the Obligations; 

(o) Liens on the Collateral to secure Debt permitted under Section 7.2(v) on a pari passu basis (but without
regard to the control of remedies) with the Obligations; provided that a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor
Agreement; 
 (p) Liens on Collateral to secure Debt permitted under Section 7.2(s); provided that such
Debt constitutes a Secured Obligation; and 
 (q) Liens on NMTC Property securing the NMTC Indebtedness the proceeds of which
are (or will be) used to acquire, renovate or improve such NMTC Property; provided that if such Liens are on property that is (or is required to be) Collateral then such Liens are subordinated to the Liens securing the Obligations pursuant to
an intercreditor agreement in form and substance reasonably satisfactory to the Administrative Agent. 
 7.2 Debt. Create, incur,
assume or suffer to exist, or permit any of its Subsidiaries to create, incur, assume or suffer to exist, any Debt, except: 

(a) Debt under the Loan Documents; 

(b) (i) the 2020 Senior Notes and the 2020 Senior Notes Guarantees and, in each case, any Permitted Refinancing thereof;
provided that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this Section 7.2(b)(i) shall not exceed $775,000,000, (ii) the 2022 Senior Notes and the 2022 Senior Notes Guarantees and,
in each case, any Permitted Refinancing thereof; provided that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this Section 7.2(b)(ii) shall not exceed $1,250,000,000, (iii) the New
Senior Notes and the New Senior Notes Guarantees, and, in each case, any Permitted Refinancing thereof; provided that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this Section 7.2(b)(iii)
shall not exceed $1,750,000,000, and (iv) Debt existing on the Closing Date and described on Schedule 7.2(b) hereto and any Permitted Refinancing thereof; 

(c) Debt of the Borrower in respect of Swap Agreements (A) existing on the Closing Date and described in Schedule
7.2(b) hereto or (B) entered into from time to time after the Closing Date with counterparties that are Lenders at the time such Swap Agreement is entered into (or Affiliates of such Lender at such time); provided that, in all cases
under this clause (c), all such Swap Agreements shall not be speculative in nature (including, without limitation, with respect to the term and purpose thereof); 

(d) Debt of (A) the Borrower owing to any Subsidiary, and (B) any of the Subsidiaries owing to the Borrower or any
other Subsidiary; provided that with respect to any loan or advance by a Loan Party, (i) any such Debt shall be evidenced by an Intercompany Note and pledged by such Loan Party as Collateral pursuant to the Security Documents and
(ii) if such loan or advance is to a Non-Guarantor Subsidiary, such loan or advance is permitted by Section 7.6; 

  
 -104- 

 (e) Debt incurred and secured by Liens expressly permitted under
Section 7.1(d) (or with respect to NMTC Indebtedness) and any Permitted Refinancing thereof; provided that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this Section 7.2(e),
when aggregated with the principal amount of all Debt outstanding at such time under Section 7.2(f), shall not exceed the greater of $325,000,000 or 7.5% of the Consolidated Tangible Assets of the Borrower and its Subsidiaries; 

(f) Capitalized Leases incurred and any Permitted Refinancing thereof; provided that the aggregate principal amount of
all such Debt at any one time outstanding pursuant to this Section 7.2(f), when aggregated with the principal amount of all Debt outstanding at such time under Section 7.2(e), shall not exceed the greater of $325,000,000 or
7.5% of the Consolidated Tangible Assets of the Borrower and its Subsidiaries; 
 (g) Contingent Obligations of (A) the
Borrower guaranteeing any obligations of any Subsidiary and (B) any Subsidiary of the Borrower guaranteeing any obligations of the Borrower or any other Subsidiary; provided that each such primary obligation is not otherwise prohibited
under the terms of the Loan Documents; and provided, further, that any guaranty of obligations of any Non-Guarantor Subsidiary by a Loan Party is permitted by Section 7.6; 

(h) (i) Debt in an aggregate amount not to exceed $150,000,000 at any time outstanding and (ii) any Permitted Refinancing
thereof; 
 (i) endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; 
 (j) Debt comprised of indemnities given by the Borrower or any of its Subsidiaries, or guarantees or
other similar undertakings by the Borrower or any of its Subsidiaries entered into in lieu thereof, in favor of the purchaser of property and assets of the Borrower and its Subsidiaries being sold, leased, transferred or otherwise disposed of in
accordance with this Agreement and covering liabilities incurred by the Borrower or its applicable Subsidiary in respect of such property and assets prior to the date of consummation of the sale, lease, transfer or other disposition thereof, which
indemnities, guarantees or undertakings are required under the terms of the documentation for such sale, lease, transfer or other disposition; 

(k) Debt comprised of liabilities or other obligations assumed or retained by the Borrower or any of its Subsidiaries from
Subsidiaries of the Borrower that are, or all or substantially all of the property and assets of which are, sold, leased, transferred or otherwise disposed of pursuant to Section 7.5(c) or (f); provided that such
liabilities or other obligations were not created or incurred in contemplation of the related sale, lease, transfer or other disposition; 

(l) secured and unsecured Debt of Non-Guarantor Subsidiaries and Foreign Subsidiaries in an aggregate amount not to exceed
$1,000,000,000 at any time outstanding; 
 (m) Debt comprised of guarantees given by the Borrower or any of its Subsidiaries
in respect of any Special Purpose Licensed Entity which obligations, when aggregated with the aggregate amount of all Investments made under Section 7.6(i) hereof, shall not exceed $150,000,000 at any time outstanding; 

(n) Debt under Cash Management Agreements and similar arrangements in each case in connection with cash management and deposit
accounts in the ordinary course of business or Debt under notional pooling cash management arrangements in the ordinary course of business; 

  
 -105- 

 (o) Debt in connection with Permitted Receivables Financings; 

(p) Debt of any Person that becomes a Subsidiary of the Borrower (or of any Person not previously a Subsidiary of the Borrower
that is merged or consolidated with or into the Borrower or one of its Subsidiaries) after the Closing Date as a result of an Investment pursuant to Section 7.6(e) or (j) or Debt of any Person that is assumed by the Borrower
or any of its Subsidiaries in connection with an acquisition of assets by the Borrower or such Subsidiary in an Investment pursuant to Section 7.6(j), and any Permitted Refinancing thereof; provided that (A) such Debt is not
incurred in contemplation of such Investment and (B) the Borrower and the Subsidiaries will be in compliance on a Pro Forma Basis with the covenant set forth in Section 7.16; and 

(q) Debt incurred in the ordinary course of business with respect to performance bonds, surety bonds, completion bonds,
guaranty bonds, appeal bonds or customs bonds, letters of credit, and other obligations of a similar nature required in the ordinary course of business or in connection with the enforcement of rights or claims of the Borrower or any of its
Subsidiaries or in connection with judgments that do not result in a Default or to secure obligations under workers’ compensation laws, unemployment insurance or similar social security legislation (other than in respect of employee benefit
plans subject to ERISA), public or statutory obligations or payment of customs duties in connection with the importation of goods. 

(r) Permitted Other Debt and any Permitted Refinancing thereof; 

(s) Debt (other than Debt for borrowed money) incurred by the Borrower or any of its Subsidiaries supported by any Specified
Letter of Credit and any Permitted Refinancing thereof; provided that on a Pro Forma Basis, on the date such Specified Letter of Credit is issued, after giving effect to any such incurrence (and assuming that the maximum amount of any such
Specified Letters of Credit are fully drawn), the Senior Secured Leverage Ratio is no more than 3.50:1.00; 
 (t) Credit
Agreement Refinancing Debt; 
 (u) Debt incurred by the Borrower or any of its Subsidiaries in connection with the
Acquisition, or any other Investment permitted by Section 7.6, constituting indemnification obligations or obligations in respect of purchase price (including earnouts) or other similar adjustments; 

(v) Debt incurred by a Group Member under a letter of credit facility in an aggregate amount not to exceed $100,000,000 at any
time outstanding; and 
 (w) NMTC Indebtedness, so long as the Borrower and the Subsidiaries will be in compliance on a Pro
Forma Basis with the covenant set forth in Section 7.16. 
 7.3 Change in Nature of Business. Engage or permit any of its
Subsidiaries to engage in any business other than healthcare services and any businesses incidental, complementary, ancillary or related thereto; provided that a Special Purpose Receivables Subsidiary may engage in any Permitted Receivables
Financing. 

  
 -106- 

 7.4 Mergers, Etc. Merge into or consolidate with any Person or permit any Person to merge
into it, or permit any of its Subsidiaries to do so, except that: 
 (a) any of the Subsidiaries may merge into or
consolidate with the Borrower; provided that the Borrower is the surviving corporation; 
 (b) any Subsidiary of the
Borrower may merge into or consolidate with any other Subsidiary of the Borrower; provided that, in the case of any such merger or consolidation involving a Wholly Owned Subsidiary, the Person formed by or surviving such merger or
consolidation shall be a Wholly Owned Subsidiary of the Borrower; provided, further, that, in the case of any such merger or consolidation to which a Guarantor is a party, the Person formed by such merger or consolidation shall be a
Guarantor; 
 (c) in connection with any purchase or other acquisition of Capital Stock of, or property and assets of, any
Person permitted under Section 7.6(e), the Borrower may permit any other Person to merge into or consolidate with it (provided that (i) the Borrower is the surviving entity or (ii) the surviving entity (x) is a
Domestic Person and (y) simultaneously with such merger or consolidation agrees to be bound by the terms hereof and of the Loan Documents and assume the Borrower’s obligations hereunder and thereunder pursuant to an agreement or instrument
satisfactory in form and substance to the Administrative Agent (and shall thereafter be the Borrower hereunder), and any of the Subsidiaries of the Borrower may merge into or consolidate with any other Person or permit any other Person to merge into
or consolidate with it; provided that the Person with which such Subsidiary is merging or consolidating (i) shall be engaged in a business permitted by Section 7.3, (ii) shall take all actions required under
Section 6.12 and (iii) shall be a Guarantor if the merging Subsidiary was a Guarantor prior to such transaction; and 

(d) in connection with any sale, transfer or other disposition of all or substantially all of the Capital Stock of, or the
property and assets of, any Person permitted under Sections 7.5(c) or (f), any of the Subsidiaries of the Borrower may merge into or consolidate with any other Person or permit any other Person to merge into or consolidate with it;

 provided, however, that in each case, immediately after giving effect thereto, no event shall occur and be continuing that constitutes a
Default. 
 7.5 Sales, Etc., of Assets. Sell, lease, transfer or otherwise dispose of, or permit any of its Subsidiaries to sell
(including sales and issuances of Capital Stock of any Subsidiary (other than sales and issuances that do not decrease the percentage ownership of the Borrower and its Subsidiaries in each class of Capital Stock of such Subsidiary)), lease, transfer
or otherwise dispose of, any assets, or grant any option or other right to purchase, lease or otherwise acquire any assets, except (provided that the issuance and sale of stock by the Borrower shall not be subject to this
Section 7.5): 
 (a) the Borrower and its Subsidiaries may sell inventory in the ordinary course of business;

 (b) (A) the Borrower may sell, lease, transfer or otherwise dispose of any of its property or assets to any of the
Subsidiaries, and (B) any of the Subsidiaries may sell, lease, transfer or otherwise dispose of any of its property or assets to the Borrower or any of the other Subsidiaries; provided that, in each case (other than in connection with
Intercompany Receivables), (x) if the transferor in such transaction is a Domestic Subsidiary and the transferee in such transaction is a Domestic Subsidiary, on a pro forma basis, the Borrower and its Subsidiaries would be in compliance with
Section 7.12 and Section 7.16 and (y) if the transferee in such transaction is a Foreign Subsidiary, such transaction is permitted by Section 7.6; 

  
 -107- 

 (c) any Subsidiary of the Borrower that is no longer actively engaged in any
business or activities and does not have property and assets with an aggregate book value in excess of $1,000,000 may be wound up, liquidated or dissolved so long as such winding up, liquidation or dissolution is determined in good faith by
management of the Borrower to be in the best interests of the Borrower and its Subsidiaries; 
 (d) the Borrower and its
Subsidiaries may sell, lease, transfer or otherwise dispose of any obsolete, damaged or worn out equipment thereof or any other equipment that is otherwise no longer useful in the conduct of their businesses; 

(e) the Borrower and its Subsidiaries may lease or sublease Real Property to the extent required for their respective
businesses and operations in the ordinary course so long as such lease or sublease is not otherwise prohibited under the terms of the Loan Documents; 

(f) the Borrower and its Subsidiaries may sell, lease, transfer or otherwise dispose of property and assets not otherwise
permitted to be sold, leased, transferred or disposed of pursuant to this Section 7.5 so long as the aggregate book value of all of the property and assets of the Borrower and its Subsidiaries sold, leased, transferred or otherwise
disposed of pursuant to this clause (f) does not exceed $625,000,000 in the aggregate since the Closing Date; provided that: 

(A) the gross proceeds received from any such sale, lease, transfer or other disposition shall be at least equal to the fair
market value of the property and assets so sold, leased, transferred or otherwise disposed of, determined at the time of such sale, lease, transfer or other disposition; 

(B) at least 75% of the value of the aggregate consideration received from any such sale, lease, transfer or other disposition
shall be in cash; provided that (i) up to one-third of such 75% may consist of notes or other obligations received by the Borrower or such Subsidiary that are due and payable or otherwise converted by the Borrower or such Subsidiary into
cash within 365 days of receipt, which cash (to the extent received) shall constitute Net Cash Proceeds attributable to the original transaction; (ii) any unsubordinated Debt of the Borrower or any of its Subsidiaries (as shown on the
Borrower’s or such Subsidiary’s most recent balance sheet) that is assumed by the transferee of any such assets shall constitute cash for purposes of this Section 7.5(f), so long as the Borrower and all of its Subsidiaries are
fully and unconditionally released therefrom; and (iii) any Designated Non-Cash Consideration received by the Borrower or any of its Subsidiaries, having an aggregate fair market value, taken together with all other Designated Non-Cash
Consideration received pursuant to this clause (B) after the Closing Date not to exceed $100,000,000 at the time of receipt of such Designated Non-Cash Consideration shall be deemed to be cash for purposes of this Section 7.5(f) (it
being understood that the fair market value of each item of Designated Non-Cash Consideration is measured at the time of receipt without giving effect to subsequent changes in value); provided that if such Designated Non-Cash Consideration is
sold for, or otherwise converted into, cash, such cash shall constitute Net Cash Proceeds attributable to the original transaction; 

(C) immediately before and immediately after giving pro forma effect to any such sale, lease, transfer or other disposition, no
Default shall have occurred and be continuing; 

  
 -108- 

 (D) with respect to any disposition under this subsection that exceeds
$50,000,000, within five Business Days prior to such disposition, and with respect to any other disposition under this subsection, within 15 Business Days after such disposition, the Borrower shall deliver to the Administrative Agent, on behalf of
the Lenders, a certificate identifying the property disposed of and stating (a) that immediately before and after giving effect thereto, no Default existed or will exist, (b) that the consideration received or to be received by the
Borrower or such Subsidiary for such property has been determined by the Borrower or the applicable Subsidiary to be not less than the fair market value of such property, (c) the total expected consideration to be paid in respect of such
disposition and (d) the expected Net Cash Proceeds resulting from such disposition; and 
 (E) if and to the extent that
the Net Cash Proceeds of any transaction effected pursuant to this Section 7.5(f) shall not have been reinvested (pursuant to a Reinvestment Notice), such Net Cash Proceeds shall be applied to prepay Loans to the extent, and in
accordance with, Section 2.11; 
 (g) the Borrower and its Subsidiaries may exchange assets and properties with
another Person; provided that: 
 (A) the assets or properties received by the Borrower or its Subsidiaries shall be
used in a business permitted by Section 7.3 as conducted immediately prior to such transaction, or in an incidental or related business; 

(B) the total consideration received by the Borrower or such Subsidiary for such assets or property shall have been determined
by the Borrower or such Subsidiary to be not less than the fair market value of the assets or property exchanged; 
 (C)
immediately before and immediately after giving pro forma effect to any such exchange, no Default shall have occurred and be continuing; 

(D) any cash received by the Borrower or any such Subsidiary in connection with such exchange shall be treated as Net Cash
Proceeds subject to Section 2.11 and any cash paid by the Borrower or any Subsidiary in connection with such exchange shall be treated as an acquisition expenditure under Section 7.6(e); 

(E) with respect to any exchange under this subsection that involves assets and/or property with a value in excess of
$50,000,000, within five Business Days prior to such exchange, and with respect to any other exchange under this Section 7.5(g), within fifteen Business Days after such exchange, the Borrower shall deliver to the Administrative Agent, on
behalf of the Lenders, a certificate identifying the assets or property disposed of and acquired in such exchange, and stating (a) that immediately before and after giving effect thereto, no Default existed or will exist, (b) that the
total consideration received by or expected to be received by the Borrower or such Subsidiary for such assets or property has been determined by the Borrower or such Subsidiary to be not less than the fair market value of the assets or property
exchanged, and (c) the amount, if any, of the expected cash to be paid or Net Cash Proceeds to be received in connection with such exchange; 

  
 -109- 

 (F) if Collateral is exchanged the assets and properties received in exchange
shall constitute Collateral and Sections 6.12 and 6.13 shall be complied with; 
 (h) the Borrower and its
Subsidiaries may enter into Sale and Leaseback Transactions (i) with respect to the Denver Headquarters and (ii) with respect to any other property; provided that the aggregate value of property sold or transferred under this
subclause (ii) shall not exceed $225,000,000 since the Closing Date; provided that the Net Cash Proceeds from such transaction are applied in accordance with Section 2.11(b); 

(i) the Borrower and its Subsidiaries may purchase, sell or otherwise transfer (including by capital contribution) Receivables
Assets pursuant to Permitted Receivables Financings; 
 (j) the Borrower and its Subsidiaries may sell, lease, transfer or
otherwise dispose of assets or property (i) in anticipation of any Investment pursuant to Section 7.6(e), (f), (h), (i), (k), (l) and (m) (including as a result of discussion with
antitrust regulators in connection with such Investment) or (ii) as required pursuant to any consent decree or similar order or agreement, which decree, order or agreement is issued or entered into prior to the consummation of such Investment
and in connection therewith by the Antitrust Division of the U.S. Department of Justice, the Bureau of Competition of the U.S. Federal Trade Commission and/or any similar state or foreign regulatory agency or body; 

(k) within 180 days of the acquisition by the Borrower or any Subsidiary of any Real Property after the Closing Date the
Borrower or such Subsidiary may sell or otherwise transfer such Real Property in connection with a Sale and Leaseback Transaction so long as the Borrower shall be in compliance with Section 7.2 after giving effect to such Sale and
Leaseback Transaction; provided that the Net Cash Proceeds from such transaction are applied in accordance with Section 2.11(b); 

(l) any Subsidiary of the Borrower may issue additional Capital Stock to management or employees and physicians under contract
with the Borrower or any of its Subsidiaries in an amount not in excess of $15,000,000 in the aggregate in any twelve month period; and 

(m) The Borrower and its Subsidiaries may enter into any transfer or disposition of property or assets constituting an
Investment pursuant to Section 7.6(e), (f), (h), (i), (k), (l) , (m) or (n). 

7.6 Investments in Other Persons. Make or hold, or permit any of its Subsidiaries to make or hold, any Investment in any Person,
except: 
 (a) Investments by the Borrower and its Subsidiaries in Cash Equivalents; 

(b) Investments existing on the Closing Date and described on Schedule 7.6 hereto; 

(c) Investments by the Borrower in Swap Agreements permitted under Section 7.2(c); 

(d) Investments in accounts receivable in the ordinary course of business or notes received in transactions permitted by
Sections 7.5(f) and (j); 

  
 -110- 

 (e) the purchase or other acquisition of (1) Capital Stock of any Person
that, upon the consummation thereof, will be more than 50% owned by the Borrower or one or more of its Wholly Owned Subsidiaries (including, without limitation, as a result of a merger or consolidation) or (2) all or substantially all the
property and assets of a Person or consisting of a line of business or business unit of a Person; provided that, with respect to each purchase or other acquisition made pursuant to this clause (e): 

(A) the lines of business of the Person to be (or the property and assets of which are to be) so purchased or otherwise
acquired shall be permitted by Section 7.3; 
 (B)(1) immediately before and immediately after giving pro
forma effect to any such purchase or other acquisition, no Default shall have occurred and be continuing and (2) immediately after giving effect to such purchase or other acquisition, the Borrower and its Subsidiaries shall be in
compliance on a Pro Forma Basis with Section 7.12 and Section 7.16; 
 (C) the aggregate amount of
consideration paid or provided by the Borrower and its Subsidiaries after the Closing Date pursuant to this Section 7.6(e)(C) (under clause (i) below) for the purchase or acquisition for Persons that will be Foreign Subsidiaries,
when taken together with any Investments made in Foreign Subsidiaries pursuant to Section 7.6(h)(ii)(y)(A), shall not exceed (i) $2,000,000,000 or (ii) if the Leverage Ratio for the most recent Measurement Period is less than
3.50:1.00 (both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), consideration in an unlimited amount; provided that if the amount of all such cash payments exceeds the
limitation set forth in clause (i) of this clause (C) during any period during which the Leverage Ratio test in clause (ii) of this clause (C) is met, such excess cash payments shall not constitute an Event of Default if such
Leverage Ratio test is not met in any subsequent Measurement Period; 
 (D) the Borrower shall have delivered to the
Administrative Agent, on behalf of the Lenders, at least three Business Days prior to the date on which any such purchase or other acquisition in which the total cash consideration is more than $50,000,000 is to be consummated, a certificate of a
Responsible Officer, in form and substance reasonably satisfactory to the Administrative Agent, certifying that all of the requirements set forth in this clause (e) have been satisfied or will be satisfied on or prior to the consummation of
such purchase or other acquisition and containing a copy of any existing financial statements of the business to be acquired in the Borrower’s possession; and 

(E) Sections 6.12 and 6.13 are complied with; 

(f) Investments by the Borrower or any Subsidiary in 50% or less of the Capital Stock of another Person (the “Minority
Investment”); provided that (i) the Borrower or any Subsidiary owns at least 20% (on a fully diluted basis) of the issued and outstanding Capital Stock of such Person, (ii) the aggregate outstanding amount of Minority
Investments made by the Borrower and any Subsidiary shall not exceed $350,000,000 at any one time outstanding, (iii) the Borrower or any Subsidiary shall have full control over all bank accounts of such Person if the Borrower or any Subsidiary
is the largest holder of Capital Stock of such Person, (iv) the Borrower or any Subsidiary shall control or act as the managing general partner of such Person if such Person is a partnership and if the Borrower or any Subsidiary is the largest
holder of Capital Stock of such Person, and (v) immediately before and after giving effect thereto, no Default shall exist; 

  
 -111- 

 (g) notes from employees issued to the Borrower representing payment for Capital
Stock of the Borrower or representing payment of the exercise price of options to purchase Capital Stock of the Borrower, and employee relocation expenses incurred in the ordinary course of business, in an aggregate amount at any time outstanding
not to exceed $30,000,000; 
 (h) Investments by (i) any Subsidiary of the Borrower in the Borrower and (ii) the
Borrower or any of its Subsidiaries in any Subsidiary of the Borrower; provided that (x) no Investment in any Non-Guarantor Domestic Subsidiary shall be made unless, after giving pro forma effect thereto, the Borrower and its
Subsidiaries shall be in compliance with Section 7.12 and Section 7.16 and (y) no Investment in any Foreign Subsidiary shall be made unless the aggregate amount of Investments by the Borrower and its Subsidiaries in
Foreign Subsidiaries after the Closing Date pursuant to this Section 7.6(h)(ii)(y) (under clause (A) below), when taken together with any Investments made in Foreign Subsidiaries pursuant to Section 7.6(e)(C)(i) shall
not exceed (A) $2,000,000,000 or (B) if the Leverage Ratio for the most recent Measurement Period is less than 3.50:1.00 (as of the date of such Investment (or, with respect to Investments in existence on the Closing Date, as of the
Closing Date)), both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), an unlimited amount; provided that if the amount of all such cash payments exceeds the limitation
set forth in clause (x) of this clause (ii) during any period during which the Leverage Ratio test in clause (y)(B) of this clause (ii) is met, such excess cash payments shall not constitute an Event of Default if such Leverage Ratio
test is not met in any subsequent Measurement Period; 
 (i) Investments of the Borrower or any of its Subsidiaries in any
Special Purpose Licensed Entity which, when aggregated with the aggregate amount of all obligations guaranteed under Section 7.2(m), shall not exceed $150,000,000 at any time; 

(j) Investments arising as a result of Permitted Receivables Financings; 

(k) Investments by the Borrower or any of its Subsidiaries (i) in an aggregate amount outstanding not to exceed the sum of
(x) $250,000,000 plus (y) $750,000,000 minus the aggregate amount of purchases, redemptions, acquisitions, dividends and distributions pursuant to Section 7.7(d)(i) and payments, prepayments, redemptions or acquisitions of Debt
pursuant to Section 7.9(a)(ii)(x) since the Closing Date, (ii) in an aggregate amount not to exceed the Available Amount on the date of such Investment or (iii) if the Leverage Ratio for the most recent Measurement Period is
less than 3.50:1.00 (as of the date of such Investment (or, with respect to Investments in existence on the Closing Date, as of the Closing Date)), both before and after giving effect to such transaction (including any use of cash with respect
thereto) on a Pro Forma Basis), in an unlimited amount; provided that if the amount of all such Investments exceeds the limitation set forth in clauses (i) and (ii) of this Section during any period during which the Leverage Ratio test in
clause (iii) of this Section is met, such excess Investments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period; provided, further, in the case of each transaction under this
Section 7.6(k)(iii), that immediately prior to each such transaction and after giving effect thereto the aggregate amount of the Available Revolving Commitment is not less than $75,000,000; 

(l) [Reserved]; 

(m) Investments pursuant to any Permitted Physician Group Loan; and 

  
 -112- 

 (n) (i) Investments by the Borrower or any Domestic Subsidiary in an NMTC
Subsidiary in the form of NMTC Indebtedness and any related capital contribution and (ii) NMTC Investments by an NMTC Subsidiary in an aggregate amount not to exceed the portion of the related NMTC Indebtedness and any related capital
contribution received by such NMTC Subsidiary. 
 7.7 Restricted Payments. Declare or pay any dividends, purchase, redeem, retire,
defease or otherwise acquire for value any of its Capital Stock now or hereafter outstanding, return any capital to its stockholders, partners or members (or the equivalent Persons thereof) as such, make any distribution of assets, Capital Stock,
obligations or securities to its stockholders, partners or members (or the equivalent Persons thereof) as such, or permit any of its Subsidiaries to do any of the foregoing, or permit any of its Subsidiaries to purchase, redeem, retire, defease or
otherwise acquire for value any Capital Stock of the Borrower, except that, so long as no Default shall have occurred and be continuing at the time of any action described below or would result therefrom: 

(a) the Borrower may (A) declare and pay dividends and distributions payable in its common Capital Stock, (B) except
to the extent the Net Cash Proceeds thereof are required to be applied to the prepayment of the Loans pursuant to Section 2.11, purchase, redeem, retire, defease or otherwise acquire Capital Stock with the proceeds received
contemporaneously from the issue of new Capital Stock with equal or inferior voting powers, designations, preferences and rights, and (C) repurchase its Capital Stock owned by management or employees and physicians under contract with the
Borrower or any of its Subsidiaries in an amount not in excess of $25,000,000 in the aggregate in any twelve month period; 

(b) any Subsidiary of the Borrower may (A) declare and pay cash dividends to the Borrower, and (B) declare and pay
cash dividends to any other Loan Party of which it is a Subsidiary; 
 (c) any of the non-Wholly Owned Subsidiaries of the
Borrower may declare and pay or make dividends and other distributions to its shareholders, partners or members (or the equivalent Persons thereof) generally so long as the Borrower and each of the Subsidiaries that own any of the Capital Stock
thereof receive at least their respective proportionate shares of any such dividend or distribution (based upon their relative holdings of the Capital Stock thereof and taking into account the relative preferences, if any, of the various classes of
the Capital Stock thereof); 
 (d) so long as no Default is continuing or will be continuing after such transaction, the
Borrower may (A) purchase, redeem or otherwise acquire for value any of its Capital Stock or (B) declare and pay dividends and distributions payable in either (i) cash (in the aggregate for both clauses (A) and (B)), when taken
together with the aggregate amount of payments, prepayments, redemptions or acquisitions of Debt pursuant to Section 7.9(a)(ii)(x) and Investments pursuant to Section 7.6(k)(i)(y) not to exceed $750,000,000, (ii) cash
(in the aggregate for both clauses (A) and (B)), in an amount not to exceed the Available Amount on the date of each such purchase, redemption, acquisition, dividend and distribution or (iii) if the Leverage Ratio for the most recent
Measurement Period is less than 3.50:1.00 (as of the date of such transaction, both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), cash in any amount; provided that
if the amount of all such cash payments exceeds the limitation set forth in clauses (i) and (ii) of this Section during any period during which the Leverage Ratio test in clause (iii) of this Section is met, such excess cash payments
shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period; provided further, in the case of each transaction under this Section 7.7(d)(iii), that immediately prior
to each such transaction and after giving effect thereto the aggregate amount of the Available Revolving Commitment is not less than $75,000,000; 

  
 -113- 

 (e) the Borrower may consummate the Refinancing on the Closing Date; and 

(f) so long as no Default is continuing or will be continuing after such transaction, the Borrower may repurchase its common
stock from its then existing shareholders in one or more transactions for an aggregate purchase price not to exceed $1,200,000,000. 
 7.8
Accounting Changes. Make or permit any change in (i) accounting policies or reporting practices, except as allowed by GAAP (or as otherwise provided pursuant to Section 1.4), or (ii) Fiscal Year. 

7.9 Prepayments of Other Debt; Modifications of Constitutive Documents and Other Documents, etc. Directly or indirectly: 

(a) make (or give any notice in respect thereof) any voluntary or optional payment or prepayment on or redemption or
acquisition for value of, or any prepayment or redemption as a result of any asset sale, change of control or similar event of, any Debt outstanding under the 2020 Senior Notes, the 2022 Senior Notes, the New Senior Notes, any Debt that is secured
on second priority (or other junior priority) basis (including any Permitted Second Priority Refinancing Debt or any Permitted Other Debt that is secured on second priority (or other junior priority) basis), any unsecured Permitted Other Debt or any
subordinated Debt (collectively, “Junior Financing”); except for (i) any Permitted Refinancing of any Junior Financing and (ii) so long as no Default is continuing or will be continuing after such transaction, the
voluntary or optional payment or prepayment or redemption or acquisition for value of Junior Financing (x) in an aggregate amount for this clause (ii), when taken together with the aggregate amount of purchases, redemptions, acquisitions,
dividends and distributions pursuant to Section 7.7(d)(i) and Investments pursuant to Section 7.6(k)(i)(y), not to exceed $750,000,000, (y) in an aggregate amount not to exceed the Available Amount, on the date of each
such payment, prepayment, redemption or acquisition of Debt or (z) if the Leverage Ratio for the most recent Measurement Period is less than 3.50:1.00 (as of the date of such transaction, both before and after giving effect to such transaction
(including any use of cash with respect thereto) on a Pro Forma Basis), cash in any amount; provided that if the amount of all such cash payments exceeds the limitation set forth in clause (ii)(x) and (y) of this Section during any
period during which the Leverage Ratio test in clause (ii)(z) of this Section is met, such excess cash payments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period; provided,
further, in the case of each transaction under this Section 7.9(a)(ii)(z), that immediately prior to each such transaction and after giving effect thereto the aggregate amount of the Available Revolving Commitment is not less than
$75,000,000; 
 (b) amend or modify, or permit the amendment or modification of, any provision of any Junior Financing, any
NMTC Indebtedness or any Permitted Receivables Documents in any manner that is adverse in any material respect to the interests of the Lenders; 

(c) terminate, amend, modify or change any of its Constitutive Documents (including by the filing or modification of any
certificate of designation) or any agreement to which it is a party with respect to its Capital Stock (including any stockholders’ agreement), or enter into any new agreement with respect to its Capital Stock, other than any such amendments,
modifications or changes or such new agreements which are not adverse in any material respect to the interests 

  
 -114- 

 
of the Lenders or are pursuant to Requirements of Law; provided that the Loan Parties may issue such Capital Stock, so long as such issuance is not prohibited by Section 7.13
or any other provision of this Agreement, and may amend their Constitutive Documents to authorize any such Capital Stock; 

(d) except as may be required to comply with any law, regulation or court or administrative decision, terminate, amend or
modify a Business Associate Agreement without the consent of the parties thereto; or 
 (e) amend or modify, or permit the
amendment or modification of, any provision of any Management Services Agreement entered into with a Loan Party in any manner that would require a substantial portion of the management fees (which, for the avoidance of doubt and without any
implication to the contrary, shall not include any fees for reimbursement of expenses and other cost sharing arrangements) payable thereunder to be paid to any entity other than a Loan Party. 

7.10 Negative Pledge. Enter into or suffer to exist, or permit any Loan Party to enter into or suffer to exist, any agreement
prohibiting or conditioning the creation or assumption of any Lien upon any of its property or assets except (i) in favor of the Secured Parties, (ii) in connection with (A) any Debt permitted by Section 7.2(e) solely to
the extent that the agreement or instrument governing such Debt prohibits a Lien on the property acquired with the proceeds of such Debt, or (B) any Capitalized Lease permitted by Section 7.2(f) solely to the extent that such
Capitalized Lease prohibits a Lien on the property subject thereto, or (C) any Debt outstanding on the date any Subsidiary of the Borrower becomes such a Subsidiary (so long as such agreement was not entered into solely in contemplation of such
Subsidiary becoming a Subsidiary of the Borrower), or (D) any Debt permitted by Section 7.2(l) solely to the extent that the agreement or instrument governing such Debt prohibits a Lien on the property of the relevant borrowing
entity or (E) the 2020 Senior Notes, (F) the 2022 Senior Notes, (G) the New Senior Notes, (H) Permitted Other Debt , (I) any Debt permitted by Section 7.2(o) or (J) any NMTC Documents; provided that
any such restriction relates only to related NMTC Property or (iii) pursuant to any Requirements of Law. 
 7.11 Payment
Restrictions Affecting Subsidiaries. Directly or indirectly, enter into or suffer to exist, or permit any of its Subsidiaries to enter into or suffer to exist, any agreement or arrangement limiting the ability of any of its Subsidiaries to
declare or pay dividends or other distributions in respect of its Capital Stock or repay or prepay any Debt owed to, make loans or advances to, or otherwise transfer assets to or invest in, the Borrower or any Subsidiary of the Borrower (whether
through a covenant restricting dividends, loans, asset transfers or investments, a financial covenant or otherwise), except (i) the Loan Documents; (ii) any agreement in effect at the time such Subsidiary becomes a Subsidiary of the
Borrower, so long as such agreement was not entered into solely in contemplation of such Person becoming a Subsidiary of the Borrower; (iii) restrictions on transfer contained in Debt incurred pursuant to Sections 7.2(e) and (f);
provided that such restrictions relate only to the transfer of the property financed with such Debt; (iv) in connection with and pursuant to any Permitted Refinancing, replacements of restrictions that are not more restrictive than those
being replaced and do not apply to any other Person or assets than those that would have been covered by the restrictions in the Debt so refinanced; (v) restrictions contained in any Permitted Receivables Document with respect to any Special
Purpose Receivables Subsidiary; (vi) solely with respect to Subsidiaries that are not Guarantors, restrictions under the Constitutive Documents governing such Subsidiary: (A) with respect to existing Subsidiaries, existing on the Closing
Date; and (B) with respect to Subsidiaries created or acquired after the Closing Date: (1) prohibiting such Subsidiary from guaranteeing Debt of the Borrower or another Subsidiary; (2) restricting dividend payments and other
distributions solely to permit pro rata dividends and other 

  
 -115- 

 
distributions in respect of any Capital Stock of such Subsidiary; (3) limiting transactions with the Borrower or another Subsidiary to those with terms that are fair and reasonable to such
Subsidiary and no less favorable to such Subsidiary than could have been obtained in an arm’s length transaction with an unrelated third party; and (4) limiting such Subsidiary’s ability to transfer assets or incur Debt without the
consent of the holders of the Capital Stock of such Subsidiary; provided that all restrictions permitted by this clause (vi) shall no longer be permitted in the event any such Subsidiary becomes a Guarantor; (vii) restrictions
contained in Debt incurred pursuant to Section 7.2(l) with respect to the borrowers thereunder; (viii) encumbrances or restrictions (A) that restrict in a customary manner the subletting, assignment or transfer of any property
or asset that is subject to a lease, license or similar contract entered into in the ordinary course of business, or the assignment or transfer of any lease, license or contract entered into in the ordinary course of business, (B) arising by
virtue of any transfer of, agreement to transfer, option or right with respect to, or Lien on, any property or assets of the Borrower or any Subsidiary and (ix) restrictions imposed by any agreement governing Debt entered into on or after the
Closing Date and permitted under Section 7.2 (including, without limitation, the New Senior Notes and any Permitted Refinancing in respect thereof) that are, taken as a whole, in the good faith judgment of the Borrower, no more restrictive with
respect to the Borrower or any Subsidiary than customary market terms for Debt of such type (and, in any event, are no more restrictive than the restrictions contained in this Agreement), so long as the Borrower shall have determined in good faith
that such restrictions will not affect its obligation or ability to make any payments required hereunder and (C) pursuant to any Requirement of Law. 

7.12 Non-Guarantor Domestic Subsidiaries. Permit at any time the aggregate Consolidated Tangible Assets (calculated without
duplication) at such time of all Non-Guarantor Domestic Subsidiaries (whether or not any such Subsidiary is existing on the Closing Date but not including any Special Purpose Receivables Subsidiary nor any Regulated Subsidiary (nor the value of any
Investment therein)) to exceed 29% of the Consolidated Tangible Assets of the Borrower and its Domestic Subsidiaries (excluding any Special Purpose Receivables Subsidiary and any Regulated Subsidiary but including the value of any Investment therein
held by the Borrower or any other Domestic Subsidiary). 
 7.13 Issuance of Additional Stock. Permit any of its Subsidiaries to issue
any additional Capital Stock, except, subject to Section 6.12, as follows: 
 (i) in connection with a permitted
Investment or to employees or consultants in the ordinary course of business; 
 (ii) the Borrower and any Subsidiary thereof
may organize new Subsidiaries and any Subsidiary may issue additional Capital Stock to (x) any Loan Party, (y) any Non-Guarantor Domestic Subsidiary, if on a pro forma basis, the Borrower and its Subsidiaries would be in compliance with
Section 7.12 and Section 7.16 and (z) any Foreign Subsidiary in a transaction permitted by Sections 7.6(e), (f), (h) or (k); or 

(iii) subject to compliance with the provisions this Agreement, including Section 7.6, Section 7.12 and
Section 7.16, any Subsidiary of the Borrower may (i) issue additional Capital Stock or (ii) sell outstanding Capital Stock thereof, in each case to any Subsidiary of the Borrower or any Persons other than Affiliates of the
Borrower or its Subsidiaries (it being understood that any such sales and issuances that decrease the percentage ownership of the Borrower or any of its Subsidiaries in any class of Capital Stock of such Subsidiary shall be subject to
Section 7.5). 

  
 -116- 

 7.14 Anti-Terrorism Law; Anti-Money Laundering. 

(a) Directly or indirectly, (i) knowingly conduct any business or engage in making or receiving any contribution of funds, goods or
services to or for the benefit of any Person described in Section 4.23, (ii) knowingly deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order or any other
Anti-Terrorism Law, or (iii) knowingly engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law (and
the Loan Parties shall deliver to the Lenders any certification or other evidence requested from time to time by any Lender in its reasonable discretion, confirming the Loan Parties’ compliance with this Section 7.14). 

(b) Cause or permit any of the funds of such Loan Party that are used to repay the Loans to be derived from any unlawful activity with the
result that the making of the Loans would be in violation of any Requirement of Law. 
 7.15 Embargoed Person. Knowingly cause or
permit (a) any of the funds or properties of the Loan Parties that are used to repay the Loans to constitute property of, or be beneficially owned directly or indirectly by, any Person subject to sanctions or trade restrictions under United
States law (“Embargoed Person” or “Embargoed Persons”) that is identified on (1) the “List of Specially Designated Nationals and Blocked Persons” maintained by OFAC and/or on any other similar list
maintained by OFAC pursuant to any authorizing statute including, but not limited to, the International Emergency Economic Powers Act, 50 U.S.C. §§ 1701 et seq., The Trading with the Enemy Act, 50 U.S.C. App. 1 et
seq., and any Executive Order or Requirement of Law promulgated thereunder, with the result that the investment in the Loan Parties (whether directly or indirectly) is prohibited by a Requirement of Law, or the Loans made by the Lenders would
be in violation of a Requirement of Law, or (2) the Executive Order, any related enabling legislation or any other similar Executive Orders, (b) any Embargoed Person to have any direct or indirect interest, of any nature whatsoever in the
Loan Parties, with the result that the investment in the Loan Parties (whether directly or indirectly) is prohibited by a Requirement of Law or the Loans are in violation of a Requirement of Law or (c) all or any part of the proceeds of the
Loans to fund or finance any business activities or transactions of any Embargoed Person. 
 7.16 Financial Covenant. 

(a) Maximum Leverage Ratio. Permit the Leverage Ratio, measured as of the end of any Measurement Period ending during any period set
forth in the set forth in the table below, to exceed the ratio set forth opposite such period in the table below: 
  

			
	 Test Period
	  	Leverage Ratio
	 September 30, 2014 - June 30, 2016
	  	5.00 to 1.00
	 September 30, 2016 and thereafter
	  	4.50 to 1.00

  
 -117- 

 SECTION 8 

EVENTS OF DEFAULT 
 8.1
Events of Default. If any of the following events (“Events of Default”) shall occur on or after the Closing Date: 

(a) the Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of any LC Disbursement
when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise; 

(b) the Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in
paragraph (a) of this Section) payable under this Agreement when and as the same shall become due and payable, and such failure shall continue unremedied for a period of three Business Days; 

(c) any representation or warranty made or deemed made by or on behalf of any Group Member in or in connection with this
Agreement or any amendment or modification hereof or waiver hereunder, or in any report, certificate, financial statement or other document furnished pursuant to or in connection with this Agreement or any amendment or modification hereof or waiver
hereunder, shall prove to have been incorrect in any material respect when made or deemed made; 
 (d) any Loan Party shall
fail to observe or perform any covenant, condition or agreement contained in Sections 6.1, 6.6 (with respect to the Borrower’s existence), 6.10 or 6.11 or in Section 7; 

(e) any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in any Loan Document (other
than those specified in paragraph (a), (b) or (d) of this Section), and such failure shall continue unremedied for a period of 30 days after notice thereof from the Administrative Agent to the Borrower (which notice will be given at the
request of any Lender); 
 (f) any Group Member shall (i) default in making any payment of any principal of any Debt
(including any Contingent Obligation, but excluding the Loans) on the scheduled or original due date with respect thereto; or (ii) default in making any payment of any interest on any such Debt beyond the period of grace, if any, provided in
the instrument or agreement under which such Debt was created; or (iii) default in the observance or performance of any other agreement or condition relating to any such Debt or contained in any instrument or agreement evidencing, securing or
relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or beneficiary of such Debt (or a trustee or agent on behalf of such holder or
beneficiary) to cause, with the giving of notice if required, such Debt to become due prior to its stated maturity or (in the case of any such Debt constituting a Contingent Obligation) to become payable; provided that a default, event or
condition described in clause (i), (ii) or (iii) of this paragraph (f) shall not at any time constitute an Event of Default unless, at such time, one or more defaults, events or conditions of the type described in clauses (i),
(ii) and (iii) of this paragraph (f) shall have occurred and be continuing with respect to Debt the outstanding principal amount of which exceeds in the aggregate $75,000,000; 

  
 -118- 

 (g) (i) the Borrower or any Material Subsidiary shall commence any case,
proceeding or other action (A) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it,
or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or
(B) seeking appointment of a receiver, trustee, custodian, conservator or other similar official for it or for all or any substantial part of its assets, or the Borrower or any Material Subsidiary shall make a general assignment for the benefit
of its creditors; or (ii) there shall be commenced against the Borrower or any Material Subsidiary any case, proceeding or other action of a nature referred to in clause (i) above that (A) results in the entry of an order for relief
or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of 60 days; or (iii) there shall be commenced against the Borrower or any Material Subsidiary any case, proceeding or other action
seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets that results in the entry of an order for any such relief that shall not have been vacated, discharged, or stayed
or bonded pending appeal within 60 days from the entry thereof; or (iv) the Borrower or any Material Subsidiary shall take any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in
clause (i), (ii), or (iii) above; or (v) the Borrower or any Material Subsidiary shall generally not, or shall be unable to, or shall admit in writing its inability to, pay its debts as they become due; 

(h) an ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, has resulted
or could reasonably be expected to result in liabilities of the Loan Parties in an aggregate amount exceeding $75,000,000 or in the imposition of a Lien or security interest on any assets of a Loan Party; 

(i) (A) one or more judgments or decrees shall be entered against any Group Member involving in the aggregate a liability (not
paid or fully covered by insurance as to which the relevant insurance company has acknowledged coverage) of $75,000,000 or more, and such judgments or decrees are not paid, discharged or stayed for a period of 60 consecutive days, or any action
shall be legally taken by a judgment creditor to attach or levy upon any assets of any Group Member to enforce any such judgment or (B) any Group Member shall enter into any settlement of a claim (including claims by Governmental Authorities
for violations or alleged violations of Requirements of Law) which settlements, individually or in the aggregate, amount to $75,000,000 or more and any Group Member fails to make any payment required to be made thereunder or any action shall be
legally taken by a creditor to attach or levy upon any assets of any Group Member to enforce any such settlement; 
 (j) any
of the Security Documents shall cease, for any reason, to be in full force and effect, or any Loan Party or any Affiliate of any Loan Party shall so assert, or any Lien created by any of the Security Documents shall cease to be enforceable and of
the same effect and priority purported to be created thereby, except, in the case of any such cessation that is attributable to an event of a type contemplated by Section 8.1(g), this provision shall apply only to the Borrower or a
Material Subsidiary; 
 (k) the guarantee pursuant to Section 10 of any Guarantor shall cease, for any reason, to
be in full force and effect or any Loan Party or any Affiliate of any Loan Party shall so assert, except, in the case of any such cessation that is attributable to an event of a type contemplated by Section 8.1(g), this provision shall
apply only to the Borrower or a Material Subsidiary; 

  
 -119- 

 (l) a Change of Control shall occur; 

(m) the Borrower or any Subsidiary, in each case to the extent it is engaged in the business of providing services for which
Medicare or Medicaid reimbursement is sought, shall for any reason, including, without limitation, as the result of any finding, designation or decertification, lose its right or authorization, or otherwise fail to be eligible, to participate in
Medicaid or Medicare programs or to accept assignments or rights to reimbursements under Medicaid regulations or Medicare regulations, or the Borrower or any Subsidiary has, for any reason, had its right to receive reimbursements under Medicaid or
Medicare regulations suspended, and such loss, failure or suspension (together with all such other losses, failures and suspensions continuing at such time) shall have resulted in (x) a Material Adverse Effect or (y) Consolidated net
operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for any preceding four Fiscal Quarter period of the Borrower; or 

(n) the Borrower or any Subsidiary of the Borrower shall for any reason terminate a Business Associate Agreement between such
entity and the Collateral Agent; 
 then, and in every such event (other than an event with respect to the Borrower described in paragraph (g) of this
Section), and at any time thereafter during the continuance of such event, the Administrative Agent may with the consent of the Required Lenders, and at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the
following actions, at the same or different times: (i) terminate the Commitments, and thereupon the Commitments shall terminate immediately, and (ii) declare the Loans then outstanding to be due and payable in whole (or in part, in which
case any principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other
obligations of the Borrower accrued hereunder, shall become due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower; and in case of any event with respect to the
Borrower described in paragraph (g) of this Section, the Commitments shall automatically terminate and the principal of the Loans then outstanding, together with accrued interest thereon and all fees and other obligations of the Borrower
accrued hereunder, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower. 

8.2 Application of Proceeds. The proceeds received by the Collateral Agent in respect of any sale of, collection from or other
realization upon all or any part of the Collateral pursuant to the exercise by the Collateral Agent of its remedies shall be applied, in full or in part, together with any other sums then held by the Collateral Agent pursuant to this Agreement,
promptly by the Collateral Agent as follows: 
 (a) First, to the payment of all reasonable costs and expenses, fees,
commissions and taxes of such sale, collection or other realization including compensation to the Collateral Agent and its agents and counsel, and all expenses, liabilities and advances made or incurred by the Collateral Agent in connection
therewith and all amounts for which the Collateral Agent is entitled to indemnification pursuant to the provisions of any Loan Document, together with interest on each such amount at the highest rate then in effect under this Agreement from and
after the date such amount is due, owing or unpaid until paid in full; 

  
 -120- 

 (b) Second, to the payment of all other reasonable costs and expenses of
such sale, collection or other realization including compensation to the other Secured Parties and their agents and counsel and all costs, liabilities and advances made or incurred by the other Secured Parties in connection therewith, together with
interest on each such amount at the highest rate then in effect under this Agreement from and after the date such amount is due, owing or unpaid until paid in full; 

(c) Third, without duplication of amounts applied pursuant to clauses (a) and (b) above, to the indefeasible
payment in full in cash, pro rata, of interest, premium and other amounts constituting Obligations (other than principal and Reimbursement Obligations), any fees, premiums and scheduled periodic payments due under Specified Swap
Agreements constituting Secured Obligations and any interest accrued thereon and any fees and interest due under any Secured Cash Management Agreements constituting Secured Obligations and any reimbursement or other payment obligations, interest and
obligations to provide cash collateral in respect of any Specified Letter of Credit constituting Secured Obligations (provided if more than $25,000,000 of Debt is outstanding under Cash Management Agreements that would be Secured Cash
Management Agreements but for the dollar limitation contained in the definition of “Secured Cash Management Agreement,” each Cash Management Bank shall be deemed to be holding Secured Obligations on a pro rata basis when taken together
with the amount of Debt under all Cash Management Agreements held by Cash Management Banks) , in each case equally and ratably in accordance with the respective amounts thereof then due and owing; 

(d) Fourth, to the indefeasible payment in full in cash, pro rata, of the principal amount of the
Obligations (including Reimbursement Obligations) and any breakage, termination or other payments under Specified Swap Agreements constituting Secured Obligations and any interest accrued thereon and the principal amount owing under Secured Cash
Management Agreements constituting Secured Obligations (provided if more than $25,000,000 of Debt is outstanding under Cash Management Agreements that would be Secured Cash Management Agreements but for the dollar limitation contained in the
definition of “Secured Cash Management Agreement,” each Cash Management Bank shall be deemed to be holding Secured Obligations on a pro rata basis when taken together with the amount of Debt under all Cash Management Agreements held by
Cash Management Banks); and 
 (e) Fifth, the balance, if any, to the Person lawfully entitled thereto (including the
applicable Loan Party or its successors or assigns) or as a court of competent jurisdiction may direct. 
 In the event that any such
proceeds are insufficient to pay in full the items described in clauses (a) through (e) of this Section 8.2, the Loan Parties shall remain liable, jointly and severally, for any deficiency. 

SECTION 9 
 THE AGENTS 

9.1 Appointment and Authority. Each of the Lenders and the Issuing Lender hereby irrevocably appoints JPMorgan Chase Bank, N.A. to act
on its behalf as the Administrative Agent and the Collateral Agent hereunder and under the other Loan Documents and authorizes such Agents to take such actions on its behalf and to exercise such powers as are delegated to such Agents by the terms
hereof and thereof, together with such actions and powers as are reasonably incidental thereto. With the exception of the second and fifth sentences of Section 9.6, the provisions of this Section are solely for the benefit of the
Administrative Agent, the Collateral Agent, the Lenders and the Issuing Lender, and neither the Borrower 

  
 -121- 

 
nor any other Loan Party shall have rights as a third party beneficiary of any of such provisions. The Lenders hereby authorize the Administrative Agent to enter into any First Lien Intercreditor
Agreement, any Junior Lien Intercreditor Agreement or other intercreditor agreement or arrangement permitted under this Agreement and any such intercreditor agreement is binding upon the Lenders. The Administrative Agent may effect any amendment or
supplement to any First Lien Intercreditor Agreement, any Junior Lien Intercreditor Agreement or other intercreditor agreement or arrangement permitted under this Agreement that is for the purpose of adding the holders of Permitted First Priority
Refinancing Debt, or Permitted Second Priority Refinancing Debt or Permitted Other Debt permitted to be incurred under this Agreement, as expressly contemplated by the terms of such First Lien Intercreditor Agreement, such Junior Lien Intercreditor
Agreement or such other intercreditor agreement or arrangement permitted under this Agreement, as applicable. 
 9.2 Rights as a
Lender. Each Person serving as an Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not an Agent and the term “Lender” or
“Lenders” shall, unless otherwise expressly indicated or unless the context otherwise requires, include each Person serving as an Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend
money to, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if such Person were not an Agent hereunder and without any
duty to account therefor to the Lenders. 
 9.3 Exculpatory Provisions. No Agent shall have any duties or obligations except those
expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, no Agent: 

(i) shall be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing;

 (ii) shall have any duty to take any discretionary action or exercise any discretionary powers, except discretionary
rights and powers expressly contemplated hereby or by the other Loan Documents that such Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided
for herein or in the other Loan Documents); provided that such Agent shall not be required to take any action that, in its judgment or the judgment of its counsel, may expose such Agent to liability or that is contrary to any Loan Document or
applicable Requirements of Law; and 
 (iii) shall, except as expressly set forth herein and in the other Loan Documents,
have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to Borrower or any of its Affiliates that is communicated to or obtained by the Person serving as such Agent or any of its Affiliates in any
capacity. 
 No Agent shall be liable for any action taken or not taken by it (x) with the consent or at the request of the Required Lenders (or such
other number or percentage of the Lenders as shall be necessary, or as such Agent shall believe in good faith shall be necessary, under the circumstances as provided in Section 11.1) or (y) in the absence of its own gross negligence
or willful misconduct. No Agent shall be deemed to have knowledge of any Default unless and until notice describing such Default is given to such Agent by the Borrower, a Lender or the Issuing Lender. 

  
 -122- 

 No Agent shall be responsible for or have any duty to ascertain or inquire into (i) any
statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or
therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness
of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in Section 5 or elsewhere herein, other than to confirm receipt of items expressly required
to be delivered to such Agent. Without limiting the generality of the foregoing, the use of the term “agent” in this Agreement with reference to the Administrative Agent or the Collateral Agent is not intended to connote any fiduciary or
other implied (or express) obligations arising under agency doctrine of any applicable law. Instead, such term is used merely as a matter of market custom and is intended to create or reflect only an administrative relationship between independent
contracting parties. 
 9.4 Reliance by Agent. Each Agent shall be entitled to rely upon, and shall not incur any liability for
relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been
signed, sent or otherwise authenticated by the proper Person. Each Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying
thereon. In determining compliance with any condition hereunder to the making of a Loan, or the issuance of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or the Issuing Lender, the Administrative Agent may
presume that such condition is satisfactory to such Lender or the Issuing Lender unless the Administrative Agent shall have received notice to the contrary from such Lender or the Issuing Lender prior to the making of such Loan or the issuance of
such Letter of Credit. Each Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the
advice of any such counsel, accountants or experts. 
 9.5 Delegation of Duties. Each Agent may perform any and all of its duties and
exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by such Agent. Each Agent and any such
sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Section shall apply to any such sub-agent and to the Related Parties of each Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit
facilities provided for herein as well as activities as Agent. 
 9.6 Resignation of Agent. Each Agent may at any time give notice of
its resignation to the Lenders, the Issuing Lender and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, in consultation with the Borrower, to appoint a successor, which shall be a bank with an
office in the United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the
retiring Agent gives notice of its resignation, then the retiring Agent may on behalf of the Lenders and the Issuing Lender, appoint a successor Agent meeting the qualifications set forth above; provided that if the Agent shall notify the
Borrower and the Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and (1) the retiring Agent shall be discharged from its duties and
obligations hereunder and under the other Loan Documents (except that in the case of any collateral security held by the Collateral Agent on behalf of the Lenders or the Issuing Lender under any of the Loan Documents, the retiring Collateral Agent
shall continue to hold such collateral security as nominee until such time as a successor Collateral Agent is appointed) and (2) all payments, communications and determinations provided to be made by, to or through an Agent shall instead be
made by or to each Lender and 

  
 -123- 

 
the Issuing Lender directly, until such time as the Required Lenders appoint a successor Agent as provided for above in this paragraph. Upon the acceptance of a successor’s appointment as
Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and obligations hereunder
or under the other Loan Documents (if not already discharged therefrom as provided above in this paragraph). The fees payable by the Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between
the Borrower and such successor. After the retiring Agent’s resignation hereunder and under the other Loan Documents, the provisions of this Section 9 and Section 11.5 shall continue in effect for the benefit of such
retiring Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting as Agent. 

9.7 Non-Reliance on Agent and Other Lenders. Each Lender and the Issuing Lender acknowledges that it has, independently and without
reliance upon any Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender and the Issuing Lender also acknowledges that
it will, independently and without reliance upon any Agent or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or
based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder. 
 9.8 No
Other Duties, etc. Anything herein to the contrary notwithstanding, none of the bookmanagers, arrangers, Syndication Agents or Documentation Agents listed on the cover page hereof shall have any powers, duties or responsibilities under this
Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, the Collateral Agent, a Lender or the Issuing Lender hereunder. 

SECTION 10 
 GUARANTEE 

10.1 The Guarantee. The Guarantors hereby jointly and severally guarantee, as a primary obligor and not as a surety to each Secured
Party and their respective successors and assigns, the prompt payment in full when due (whether at stated maturity, by required prepayment, declaration, demand, by acceleration or otherwise) of the principal of and interest (including any interest,
fees, costs or charges that would accrue but for the provisions of the Title 11 of the United States Code after any bankruptcy or insolvency petition under Title 11 of the United States Code) on the Loans made by the Lenders to, and the Notes held
by each Lender of, Borrower, and all other Secured Obligations from time to time owing to the Secured Parties by any Loan Party under or in respect of any Loan Document, Specified Swap Agreement, Specified Letter of Credit or Secured Cash Management
Agreement, in each case strictly in accordance with the terms thereof (such obligations being herein collectively called the “Guaranteed Obligations”; provided that Guaranteed Obligations shall exclude any Excluded Swap
Obligations). The Guarantors hereby jointly and severally agree that if Borrower or other Guarantor(s) shall fail to pay in full when due (whether at stated maturity, by acceleration or otherwise) any of the Guaranteed Obligations, the Guarantors
will promptly pay the same in cash, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Guaranteed Obligations, the same will be promptly paid in full when due (whether at
extended maturity, by acceleration or otherwise) in accordance with the terms of such extension or renewal. 

  
 -124- 

 10.2 Obligations Unconditional. The obligations of the Guarantors under
Section 10.1 shall constitute a guaranty of payment and to the fullest extent permitted by applicable Requirements of Law, are absolute, irrevocable and unconditional, joint and several, irrespective of the value, genuineness, validity,
regularity or enforceability of the Guaranteed Obligations of Borrower under this Agreement, the Notes, if any, or any other agreement or instrument referred to herein or therein, or any substitution, release or exchange of any other guarantee of or
security for any of the Guaranteed Obligations, and irrespective of any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a surety or guarantor (except for payment in full). Without limiting
the generality of the foregoing, it is agreed that the occurrence of any one or more of the following shall not alter or impair the liability of the Guarantors hereunder, which shall remain absolute, irrevocable and unconditional under any and all
circumstances as described above: 
 (i) at any time or from time to time, without notice to the Guarantors, the time for any
performance of or compliance with any of the Guaranteed Obligations shall be extended, or such performance or compliance shall be waived; 

(ii) any of the acts mentioned in any of the provisions of this Agreement or the Notes, if any, or any other agreement or
instrument referred to herein or therein shall be done or omitted; 
 (iii) the maturity of any of the Guaranteed Obligations
shall be accelerated, or any of the Guaranteed Obligations shall be amended in any respect, or any right under the Loan Documents or any other agreement or instrument referred to herein or therein shall be amended or waived in any respect or any
other guarantee of any of the Guaranteed Obligations or any security therefor shall be released or exchanged in whole or in part or otherwise dealt with; 

(iv) any Lien or security interest granted to, or in favor of, the Issuing Lender or any Lender or Agent as security for any of
the Guaranteed Obligations shall fail to be perfected; 
 (v) the release of any other Guarantor pursuant to
Section 10.9; 
 (vi) any bankruptcy, insolvency, reorganization, arrangement, readjustment, composition,
liquidation or the like of any Loan Party; or 
 (vii) any lack of validity or enforceability of any Loan Document or any
other agreement or instrument relating thereto against any Loan Party. 
 The Guarantors hereby expressly waive diligence, presentment,
demand of payment, protest and all notices whatsoever, and any requirement that any Secured Party exhaust any right, power or remedy or proceed against Borrower under this Agreement or the Notes, if any, or any other agreement or instrument referred
to herein or therein, or against any other Person under any other guarantee of, or security for, any of the Guaranteed Obligations. The Guarantors waive any and all notice of the creation, renewal, extension, waiver, termination or accrual of any of
the Guaranteed Obligations and notice of or proof of reliance by any Secured Party upon this Guarantee or acceptance of this Guarantee, and the Guaranteed Obligations, and any of them, shall conclusively be deemed to have been created, contracted or
incurred in reliance upon this Guarantee, and all dealings between Borrower and the Secured Parties shall likewise be conclusively presumed to have been had or consummated in reliance upon this Guarantee. This Guarantee shall be construed as a
continuing, absolute, irrevocable and unconditional guarantee of payment without regard to any right of offset with respect to the Guaranteed Obligations at any time or from time to time held by Secured Parties, and the obligations and liabilities
of the Guarantors hereunder 

  
 -125- 

 
shall not be conditioned or contingent upon the pursuit by the Secured Parties or any other Person at any time of any right or remedy against Borrower or against any other Person which may be or
become liable in respect of all or any part of the Guaranteed Obligations or against any collateral security or guarantee therefor or right of offset with respect thereto. This Guarantee shall remain in full force and effect and be binding in
accordance with and to the extent of its terms upon the Guarantors and the successors and assigns thereof, and shall inure to the benefit of the Lenders, and their respective successors and assigns, notwithstanding that from time to time since the
Closing Date there may be no Guaranteed Obligations outstanding. 
 10.3 Reinstatement. The obligations of the Guarantors under this
Section 10 shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of Borrower or other Loan Party in respect of the Guaranteed Obligations is rescinded or must be otherwise restored by any
holder of any of the Guaranteed Obligations, whether as a result of any proceedings in bankruptcy or reorganization or otherwise. 
 10.4
Subrogation; Subordination. Each Guarantor hereby agrees that until the indefeasible payment and satisfaction in full in cash of all Guaranteed Obligations and the expiration and termination of the Commitments of the Lenders under this
Agreement it shall not assert or exercise any right or remedy, direct or indirect, arising by reason of any performance by it of its guarantee in Section 10.1, whether by subrogation or otherwise, against Borrower or any other Guarantor
of any of the Guaranteed Obligations or any security for any of the Guaranteed Obligations. Any Debt of any Loan Party permitted pursuant to Section 7.2(d) shall be subordinated to such Loan Party’s Secured Obligations in the manner
set forth in the Intercompany Note evidencing such Debt. 
 10.5 Remedies. The Guarantors jointly and severally agree that, as
between the Guarantors and the Lenders, the obligations of Borrower under this Agreement and the Notes, if any, may be declared to be forthwith due and payable as provided in Section 8.1 (and shall be deemed to have become automatically
due and payable in the circumstances provided in Section 8.1) for purposes of Section 10.1, notwithstanding any stay, injunction or other prohibition preventing such declaration (or such obligations from becoming
automatically due and payable) as against Borrower and that, in the event of such declaration (or such obligations being deemed to have become automatically due and payable), such obligations (whether or not due and payable by Borrower) shall
forthwith become due and payable by the Guarantors for purposes of Section 10.1. 
 10.6 Instrument for the Payment of
Money. Each Guarantor hereby acknowledges that the guarantee in this Section 10 constitutes an instrument for the payment of money, and consents and agrees that any Lender or Agent, at its sole option, in the event of a dispute by
such Guarantor in the payment of any moneys due hereunder, shall have the right to bring a motion-action under New York CPLR Section 3213. 

10.7 Continuing Guarantee. Subject to Section 11.14, the guarantee in this Section 10 is a continuing guarantee
of payment, and shall apply to all Guaranteed Obligations whenever arising. 
 10.8 General Limitation on Guaranteed Obligations. If
in any action or proceeding involving any state corporate limited partnership or limited liability company law, or any applicable state, federal or foreign bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer law or regulation,
or other law affecting the rights of creditors generally, the obligations of any Guarantor under Section 10.1 would otherwise be held or determined to be void, voidable, invalid or unenforceable, or subordinated to the claims of any
other creditors, on account of the amount of its liability under Section 10.1, then, notwithstanding any other provision to the contrary, the amount of such liability shall, without any further action by such Guarantor, any Loan Party or
any other Person, be automatically limited and reduced to the highest amount that is valid and enforceable and not subordinated to the claims of other creditors. 

  
 -126- 

 10.9 Release of Guarantors. If, in compliance with the terms and provisions of the Loan
Documents, all or substantially all of the Capital Stock or property of any Guarantor is sold or otherwise transferred from such Guarantor (a “Transferred Guarantor”) to a Person or Persons, none of which is Borrower or a
Subsidiary, such Transferred Guarantor shall, upon the consummation of such sale or transfer, be released from its obligations under this Agreement (including under Section 11.5 hereof) and its obligations to pledge and grant any
Collateral owned by it pursuant to any Security Document and, in the case of a sale of all or substantially all of the Capital Stock of the Transferred Guarantor, the pledge of such Capital Stock to the Collateral Agent pursuant to the Security
Agreement shall be released, and the Collateral Agent shall take such actions as are necessary to effect each such release in accordance with the relevant provisions of the Security Documents within no more than 30 days from notice to the Collateral
Agent of such transfer. If, in compliance with the terms and provisions of the Loan Documents (including, without limitation, Sections 7.5 and 7.13), Capital Stock of a Guarantor is sold or otherwise transferred so that such Guarantor
is no longer a Wholly Owned Subsidiary of the Borrower, upon the consummation of such sale or transfer, such Guarantor shall be released, subject to pro forma compliance with Section 7.12, from its obligations under this Agreement
(including under this Section 10 and Section 11.5 hereof) and its obligations to pledge and grant any Collateral owned by it pursuant to any Security Document, and the Collateral Agent shall take such actions as are necessary
to effect each such release in accordance with the relevant provisions of the Security Documents and to acknowledge in writing such release and the termination of the guarantee of such Guarantor if requested. 

10.10 Keepwell. Each Loan Party that is a Qualified ECP Guarantor at the time the guaranty or the grant of the security interest
hereunder and under the other Loan Documents, in each case, by any Specified Loan Party, becomes effective with respect to any Swap Obligation, hereby jointly and severally, absolutely, unconditionally and irrevocably undertakes to provide such
funds or other support to each Specified Loan Party with respect to such Swap Obligation as may be needed by such Specified Loan Party from time to time to honor all of its obligations under its guarantee and the other Loan Documents in respect of
such Swap Obligation (but, in each case, only up to the maximum amount of such liability that can be hereby incurred without rendering such Qualified ECP Guarantor’s obligations and undertakings under this Section 10 voidable under
applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations and undertakings of each Qualified ECP Guarantor under this Section 10.10 shall remain in full force and effect
until the Guaranteed Obligations have been indefeasibly paid and performed in full. Each Qualified ECP Guarantor intends this Section 10.10 to constitute, and this Section 10.10 shall be deemed to constitute, a guarantee of
the obligations of, and a “keepwell, support, or other agreement” for the benefit of, each Specified Loan Party for all purposes of the Commodity Exchange Act. 

SECTION 11 
 MISCELLANEOUS

 11.1 Amendments and Waivers. Neither this Agreement, any other Loan Document, nor any terms hereof or thereof may be amended,
supplemented or modified except in accordance with the provisions of this Section 11.1. Amendments prior to the completion of the syndication of the Commitments (as determined by the Administrative Agent) shall, in addition to the other
consents required by this Section 11.1, require the consent of the Administrative Agent. Subject to the preceding sentence, the Required Lenders and each Loan Party to the relevant Loan Document may, or, with the written consent

  
 -127- 

 
of the Required Lenders, the Administrative Agent or the Collateral Agent, as applicable, and each Loan Party to the relevant Loan Document may, from time to time, (a) enter into written
amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this Agreement or the other Loan Documents or changing in any manner the rights of the Lenders or of the Loan Parties
hereunder or thereunder or (b) waive, on such terms and conditions as the Required Lenders or the Administrative Agent or Collateral Agent, as the case may be, may specify in such instrument, any of the requirements of this Agreement or the
other Loan Documents or any Default and its consequences; provided, however, pursuant to Section 2.25, the Commitments and the Total Revolving Extensions of Credit of a Defaulting Lender shall not be included in determining
whether the Required Lenders have taken or may take any action hereunder; provided, further, that no such waiver and no such amendment, supplement or modification shall (i) reduce or forgive the principal amount or extend the
final scheduled date of maturity of any Loan, extend the scheduled date of any amortization payment in respect of any Term Loan, reduce the stated rate of any interest, premium or fee payable hereunder (except (x) in connection with the waiver
of applicability of any post-default increase in interest rates and (y) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not constitute a reduction in the rate of interest or fees for
purposes of this clause (i)) or extend the scheduled date of any payment thereof, or increase the amount or extend the expiration date of any Lender’s Revolving Commitment under the applicable Revolving Facility or increase the maximum duration
of Interest Periods hereunder or alter the provisions of Section 8.2 (it being understood that if additional Classes of Term Loans or additional Loans under this Agreement consented to by the Required Lenders or additional Loans pursuant
to Section 2.24 are made, such new Loans being included on a pro rata basis within Section 8.2 shall not be considered an alteration thereof), in each case without the written consent of each Lender directly
affected thereby; (ii) eliminate or reduce the voting rights of any Lender under this Section 11.1 without the written consent of such Lender; (iii) reduce any percentage specified in the definition of “Required
Lenders,” consent to the assignment or transfer by the Borrower of any of its rights and obligations under this Agreement and the other Loan Documents, release all or substantially all of the Collateral or release all or substantially all of
the Guarantors from their guarantee under Section 10, in each case without the written consent of all Lenders (it being understood that lenders added pursuant to Section 2.24 or lenders under additional Classes of Term Loans
or additional Loans under this Agreement consented to by the Required Lenders being included in such definition shall not be deemed to require the written consent of all Lenders); (iv) amend, modify or waive any provision of
Section 2.17 without the written consent of the Majority Facility Lenders in respect of each Facility adversely affected thereby; (v) reduce the percentage specified in the definition of Majority Facility Lenders with respect to any
Facility without the written consent of all Lenders under such Facility; (vi) change the application of prepayments as among or between Facilities under Section 2.11(d), without the written consent of the Majority Facility Lenders
of each Facility that is being allocated a lesser prepayment as a result thereof (it being understood that if additional Classes of Term Loans or additional Loans under this Agreement consented to by the Required Lenders or additional Loans pursuant
to Section 2.24 are made, such new Loans may be included on a pro rata basis in the various prepayments required pursuant to Section 2.11(d)); (vii) expressly change or waive any condition precedent in
Section 5.2 to any borrowing under the Revolving Facility without the written consent of the Majority Facility Lenders with respect to the applicable Revolving Facility; (viii) amend, modify or waive any provision of
Section 9 without the written consent of the Administrative Agent; (ix) amend, modify or waive any provision of Section 2.6 or 2.7 without the written consent of the Swingline Lender; (x) amend, modify or
waive any provision of Section 3 without the written consent of the Issuing Lender; (xi) amend Section 1.7 or the definition of “Alternative Currency” without the written consent of each Alternative Currency
Revolving Lender, or (xii) amend, modify or waive any provision of this Section 11.1 without the written consent of each Lender. Any such waiver and any such amendment, supplement or modification shall apply equally to each of the
Lenders and shall be binding upon the Loan Parties, the Lenders, the Administrative Agent and all future holders of the Loans. In the case of any waiver, the Loan Parties, the Lenders and the Administrative

  
 -128- 

 
Agent shall be restored to their former position and rights hereunder and under the other Loan Documents, and any Default or waived shall be deemed to be cured and not continuing; but no such
waiver shall extend to any subsequent or other Default, or impair any right consequent thereon. Notwithstanding the foregoing, amendments to or waivers of any other terms or provisions relating solely to the Revolving Facility (including, without
limitation, the waiver of conditions to borrowings, amendments and waivers related to pricing and other modifications affecting only the Revolving Facility, but not increases in the amount of Revolving Commitments) will require only the written
approval of the Majority Facility Lenders with respect to the Revolving Facility (or each Revolving Lender to the extent the applicable amendment, waiver or modification would otherwise require more than the consent of the Required Lenders), the
Administrative Agent, the Swingline Lender (if applicable pursuant to clause (x) of this paragraph), the Issuing Lender (if applicable pursuant to clause (xi) of this paragraph) and the Borrower. 

Without the consent of any other Person, the applicable Loan Party or Parties and the Administrative Agent and/or Collateral Agent may (in its
or their respective sole discretion, or shall, to the extent required by any Loan Document) enter into any amendment or waiver of any Loan Document, or enter into any new agreement or instrument, to effect the granting, perfection, protection,
expansion or enhancement of any security interest in any Collateral or additional property to become Collateral for the benefit of the Secured Parties, or as required by local law to give effect to, or protect, any security interest for the benefit
of the Secured Parties, in any property or so that the security interests therein comply with applicable Requirements of Law. 
 If, in
connection with any proposed change, waiver, discharge or termination of the provisions of this Agreement as contemplated by this Section that requires the consent of all of the Lenders affected, the consent of more than 50% of the Lenders whose
consent is required is obtained but the consent of one or more of such other Lenders whose consent is required is not obtained, then the Borrower shall have the right to replace all, but not less than all, of such non-consenting Lender or Lenders
(so long as all non-consenting Lenders are so replaced) with one or more Persons pursuant to Section 2.22 so long as at the time of such replacement each such new Lender consents to the proposed change, waiver, discharge or termination.

 Notwithstanding the foregoing, this Agreement may be amended (or amended and restated) solely with the written consent of the
Administrative Agent, the Borrower and the Lenders providing the relevant Replacement Term Loans (as such term is defined below) to permit the refinancing of all or any portion of any Class of Term Loans outstanding as of the applicable date of
determination (the “Refinanced Term Loans”) with a replacement term loan tranche hereunder (the “Replacement Term Loans”); provided that (i) the aggregate principal amount of such Replacement Term Loans
shall not exceed the aggregate principal amount of such Refinanced Term Loans plus premiums, accrued interest, fees and expenses in connection therewith, (ii) the Applicable Margin for such Replacement Term Loans shall not be higher than the
Applicable Margin for such Refinanced Term Loans, unless any such higher Applicable Margin applies after the Maturity Date for the Refinanced Term Loans, (iii) the Weighted Average Life to Maturity and final maturity of such Replacement Term
Loans shall not be shorter than the Weighted Average Life to Maturity and final maturity of such Refinanced Term Loans at the time of such refinancing (without giving effect to nominal amortization for periods where amortization has been eliminated
as a result of a prepayment of the applicable Refinanced Term Loans), (iv) the mandatory prepayment and optional prepayment provisions of the Replacement Term Loans shall not require more than pro rata payments and may permit optional
prepayments and mandatory prepayments to be paid in respect of the Term Loans not constituting Refinanced Term Loans and (v) the covenants, events of default and guarantees shall be not materially more restrictive (taken as a whole) (as
determined in good faith by the Borrower) to the Lenders providing such Replacement Term Loans than the covenants, events of default and guarantees applicable to such Refinanced Term Loans, except to the extent necessary to provide for covenants,
events of default and guarantees applicable to any period after the maturity date in respect of the Refinanced Term Loans in effect immediately prior to such refinancing. 

  
 -129- 

 11.2 Notices. 

(a) Except in the case of notices and other communications expressly permitted to be given by telephone (and subject to paragraph
(b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopy, as follows: 

(i) if to a Loan Party, to the Borrower at DaVita Inc., 1551 Wewatta Street, Denver, Colorado 80202, Attention of Vice
President - Finance (Telecopy No. 866-845-2762), with a copy to DaVita Inc., 1551 Wewatta Street, Denver, Colorado 80202, Attention of Chief Legal Officer (Telecopy No. 310-536-2701); 

(ii) if to the Administrative Agent or the Collateral Agent, to JPMorgan Chase Bank, Loan and Agency Services Group, 1111
Fannin, 10th Floor, Houston, Texas 77002, Attention of Agency Services (Telecopy No. (713) 750-2782), with a copy to (a) JPMorgan Chase Bank, 383 Madison Avenue, New York 10179, Attention of Dawn Lee Lum (Telecopy No. 212-270-3279)
and (b) J.P. Morgan Europe Ltd., Loan and Agency Department, 125 London Wall, London EC2Y 5 AJ, Attention: Sue Dalton (Telecopy No. 44 207 7777 2360), with respect to Alternative Currency Revolving Facility; 

(iii) if to the Issuing Lender, to it at Letter of Credit Department, 10420 Highland Manor Drive, Floor 4, Tampa, FL 33610-9128, Attention of James Alonzo (Telecopy No. (813) 432-5162), with a copy to JPMorgan Chase Bank, 383 Madison Avenue, New York, NY 10179, Attention of Dawn Lee Lum (Telecopy No. 212-270-3279); 

(iv) if to the Swingline Lender, to it at Loan and Agency Services Group, 11111 Fannin, 10th Floor, Houston, Texas 77002,
Attention of Agency Services (Telecopy No. (713) 750-2782), with a copy to JPMorgan Chase Bank, 383 Madison Avenue, New York, NY 10179, Attention of Dawn Lee Lum (Telecopy No. 212-270-3279); and 

(v) if to any other Lender, to it at its address (or telecopy number) set forth in its Administrative Questionnaire. 

(b) Any party hereto may change its address or telecopy number for notices and other communications hereunder by notice to the other parties
hereto. All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt. 

(c) Electronic Communications. Notices and other communications to the Lenders and the Issuing Lender hereunder may (subject to
Section 11.2(d)) be delivered or furnished by electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent;
provided that the foregoing shall not apply to notices to any Lender or the Issuing Lender pursuant to Section 2 if such Lender or the Issuing Lender, as applicable, has notified the Administrative Agent that it is incapable of
receiving notices under such Section by electronic communication. The Administrative Agent, the Collateral Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications
pursuant to procedures approved by it (including as set forth in Section 11.2(d)); provided that approval of such procedures may be limited to particular notices or communications. 

  
 -130- 

 Unless the Administrative Agent otherwise prescribes, (i) notices and other communications
sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgement from the intended recipient (such as by the “return receipt requested” function, as available, return e-mail or other written
acknowledgement); provided that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next
business day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing
clause (i) of notification that such notice or communication is available and identifying the website address therefor. 
 (d)
Posting. Each Loan Party hereby agrees that it will provide to the Administrative Agent all information, documents and other materials that it is obligated to furnish to the Administrative Agent pursuant to this Agreement and any other Loan
Document, including all notices, requests, financial statements, financial and other reports, certificates and other information materials, but excluding any such communication that (i) relates to a request for a new, or a conversion of an
existing, Loan or other extension of credit (including any election of an interest rate or interest period relating thereto), (ii) relates to the payment of any principal or other amount due under this Agreement prior to the scheduled date
therefor, (iii) provides notice of any Default under this Agreement or (iv) is required to be delivered to satisfy any condition precedent to the effectiveness of this Agreement and/or any borrowing or other extension of credit hereunder
(all such non-excluded communications, collectively, the “Communications”), by transmitting the Communications in an electronic/soft medium in a format reasonably acceptable to the Administrative Agent at
dawn.leelum@jpmorgan.com or at such other e-mail address(es) provided to the Borrower from time to time or in such other form, including hard copy delivery thereof, as the Administrative Agent shall require. In addition, each Loan Party
agrees to continue to provide the Communications to the Administrative Agent in the manner specified in this Agreement or any other Loan Document or in such other form, including hard copy delivery thereof, as the Administrative Agent shall require.
Nothing in this Section 11.2 shall prejudice the right of the Agents, any Lender or any Loan Party to give any notice or other communication pursuant to this Agreement or any other Loan Document in any other manner specified in this
Agreement or any other Loan Document or as any such Agent shall require. 
 To the extent consented to by the Administrative Agent in
writing from time to time, Administrative Agent agrees that receipt of the Communications by the Administrative Agent at its e-mail address(es) set forth above shall constitute effective delivery of the Communications to the Administrative Agent for
purposes of the Loan Documents; provided that the Borrower shall also deliver to the Administrative Agent an executed original of each Compliance Certificate required to be delivered hereunder. 

Each Loan Party further agrees that Administrative Agent may make the Communications available to the Lenders by posting the Communications on
Intralinks or a substantially similar electronic transmission system (the “Platform”). The Platform is provided “as is” and “as available.” The Agents do not warrant the accuracy or completeness of the
Communications, or the adequacy of the Platform and expressly disclaim liability for errors or omissions in the communications. No warranty of any kind, express, implied or statutory, including, without limitation, any warranty of merchantability,
fitness for a particular purpose, non-infringement of third party rights or freedom from viruses or other code defects, is made by any Agent in connection with the Communications or the Platform. In no event shall the Administrative Agent or any of
its Related Parties have any liability to the Loan Parties, any Lender or any other Person for damages of any kind, including direct or indirect, special, incidental or consequential 

  
 -131- 

 
damages, losses or expenses (whether in tort, contract or otherwise) arising out of any Loan Party’s or the Administrative Agent’s transmission of communications through the Internet,
except to the extent the liability of such Person is found in a final non-appealable judgment by a court of competent jurisdiction to have resulted from such Person’s gross negligence or willful misconduct. 

11.3 No Waiver; Cumulative Remedies. No failure to exercise and no delay in exercising, on the part of the Administrative Agent or any
Lender, any right, remedy, power or privilege hereunder or under the other Loan Documents shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further
exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law. 

11.4 Survival. All covenants, agreements, representations and warranties made by the Loan Parties herein and in the certificates or
other instruments delivered in connection with or pursuant to this Agreement shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of this Agreement and the making of any Loans and
issuance of any Letters of Credit, regardless of any investigation made by any such other party or on its behalf and notwithstanding that the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender may have had notice or
knowledge of any Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount
payable under this Agreement is outstanding and unpaid or any Letter of Credit is outstanding and so long as the Commitments have not expired or terminated. The provisions of Sections 2.18, 2.19, 2.20 and 11.5 and
Section 9 shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or
the termination of this Agreement or any provision hereof. 
 11.5 Expenses; Indemnity; Damage Waiver. 

(a) The Borrower shall pay (i) all reasonable out-of-pocket expenses incurred by the Administrative Agent, the Collateral Agent and their
respective Affiliates, including the reasonable fees, charges and disbursements of counsel for the Administrative Agent and the Collateral Agent, in connection with the syndication of the credit facilities provided for herein, the preparation and
administration of this Agreement, the Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii) all reasonable
out-of-pocket expenses incurred by the Issuing Lender in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all reasonable out-of-pocket expenses incurred by the
Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender, including the fees, charges and disbursements of any counsel for the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender, in connection with the
enforcement or protection of its rights in connection with this Agreement, including its rights under this Section, or in connection with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during
any workout, restructuring or negotiations in respect of such Loans or Letters of Credit; provided that the Borrower shall not be obligated to pay legal fees and expenses incurred pursuant to clauses (i) and (ii) above in connection
with the syndication of the credit facilities or the preparation of the Loan Documents prior to the initial Credit Extension. 

  
 -132- 

 (b) The Borrower shall indemnify the Administrative Agent (or any sub-agent thereof), the
Collateral Agent (or any sub-agent thereof), the Issuing Lender and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an “Indemnitee”), against, and hold each Indemnitee harmless
from, any and all losses, claims, damages, liabilities and related expenses, including the fees, charges and disbursements of any counsel for any Indemnitee, incurred by or asserted against any Indemnitee arising out of, in connection with or as a
result of (i) the execution or delivery of this Agreement, any Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the
consummation of the Transactions or any other transactions contemplated hereby or thereby, (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by the Issuing Lender to honor a demand for payment under a
Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) any actual or alleged presence or Release or threatened Release of Hazardous Materials at, on,
under or from any property owned or operated by any Group Member, any Environmental Liability related in any way to any Group Member or any violation of healthcare laws related in any way to any Group Member, or (iv) any actual or prospective
claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, regardless of whether brought by a third party or by a Loan Party and regardless of whether any Indemnitee is a
party thereto; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and
nonappealable judgment to have arisen from the material breach by such Indemnitee of this Agreement or to have been incurred primarily by reason of the gross negligence or willful misconduct of such Indemnitee and that if any Indemnitee shall
receive indemnification that is later disallowed by this proviso, it shall promptly repay to the Borrower any such funds. 
 (c) To the
extent that the Borrower fails to pay any amount required to be paid by it to the Administrative Agent (or any sub-agent thereof), the Collateral Agent (or any sub-agent thereof), the Issuing Lender or the Swingline Lender under paragraph
(a) or (b) of this Section, each Lender severally agrees to pay to the Administrative Agent, the Collateral Agent, the Issuing Lender or the Swingline Lender, as the case may be, such Lender’s Aggregate Exposure Percentage (determined
as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was
incurred by or asserted against the Administrative Agent, the Collateral Agent, the Issuing Lender or the Swingline Lender in its capacity as such. 

(d) To the extent permitted by applicable law, the Borrower shall not assert, and hereby waives, any claim against any Indemnitee, on any
theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any Loan Document or any agreement or instrument
contemplated hereby or thereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof. No Indemnitee referred to in paragraph (b) above shall be liable for any damages arising from the use by unintended recipients of
any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby.

 (e) All amounts due under this Section shall be payable promptly after written demand therefor. 

  
 -133- 

 11.6 Successors and Assigns; Participations and Assignments. 

(a) The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and
assigns permitted hereby (including any affiliate of the Issuing Lender that issues any Letter of Credit), except that (i) the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written
consent of each Lender (and any attempted assignment or transfer by the Borrower without such consent shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this
Section. Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby (including any Affiliate of the Issuing Lender that
issues any Letter of Credit), Participants (to the extent provided in paragraph (c) of this Section) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Lender and the Lenders)
any legal or equitable right, remedy or claim under or by reason of this Agreement. 
 (b) (i) Subject to the conditions set forth in
paragraph (b)(ii) below, any Lender may assign to one or more assignees (other than the Borrower or a natural person) (each, an “Assignee”) all or a portion of its rights and obligations under this Agreement (including all or a
portion of Commitments and the Loans at the time owing to it) with the prior written consent (such consent not to be unreasonably withheld or delayed) of: 

(A) the Borrower; provided that no consent of the Borrower shall be required for an assignment to a Lender, an affiliate
of a Lender, an Approved Fund or, if an Event of Default under Section 8.1(a), 8.1(b) or 8.1(g) has occurred and is continuing, any other Person (other than a Disqualified Lender); provided, further, that the
Borrower shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within five (5) Business Days after having received notice thereof; 

(B) the Administrative Agent; provided that no consent of the Administrative Agent shall be required for an assignment
to a Lender, an affiliate of a Lender or an Approved Fund; and 
 (C) the Issuing Lender and the Swingline Lender;
provided that no consent of the Issuing Lender or the Swingline Lender shall be required for an assignment of all or any portion of a Term Loan. 

(ii) Assignments shall be subject to the following additional conditions: 

(A) except in the case of an assignment to a Lender, an affiliate of a Lender or an Approved Fund or an assignment of the
entire remaining amount of the assigning Lender’s Commitments or Loans under any Facility, the amount of the Commitments or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption
with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 (or, in the case of the Tranche B Term Facility, $1,000,000) unless each of the Borrower and the Administrative Agent otherwise consents;
provided that (1) no such consent of the Borrower shall be required if an Event of Default under Sections 8.1(a), (b) or (g) has occurred and is continuing and (2) such amounts shall be aggregated in
respect of each Lender and its affiliates or Approved Funds, if any; 
 (B) each partial assignment shall be made as an
assignment of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement; provided that this clause shall not be construed to prohibit the assignment of a proportionate part of all the assigning
Lender’s rights and obligations in respect of one Facility; 

  
 -134- 

 (C) the parties to each assignment shall execute and deliver to the
Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500 (provided that the Administrative Agent may waive such fee in its sole discretion); and 

(D) the Assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire. 

For the purposes of this Section 11.6, the term “Approved Fund” has the following meaning: 

“Approved Fund” means any Person (other than a natural person) that is engaged in making, purchasing, holding
or investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that
administers or manages a Lender. 
 (iii) Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) below, from and
after the effective date specified in each Assignment and Assumption the Assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under
this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all
of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.18, 2.19, 2.20 and 11.5). Any
assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 11.6 shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and
obligations in accordance with paragraph (c) of this Section. 
 (iv) The Administrative Agent, acting for this purpose as an agent of
the Borrower, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amount of the Loans and
LC Disbursements owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive, and the Borrower, the Administrative Agent, the Issuing Lender and the Lenders
shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the
Agents, the Borrower, the Issuing Lender and any Lender, at any reasonable time and from time to time upon reasonable prior notice. 
 (v)
Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an Assignee, the Assignee’s completed Administrative Questionnaire (unless the Assignee shall already be a Lender hereunder), the processing and
recordation fee referred to in paragraph (b) of this Section and any written consent to such assignment required by paragraph (b) of this Section, the Administrative Agent shall accept such Assignment and Assumption and record the
information contained therein in the Register; provided that if either the assigning Lender or the assignee shall have failed to make any payment required to be made by it pursuant to Section 2.7(b) or (c), 3.4,
3.5, 2.17(e) or 11.5, the Administrative Agent shall have no obligation to accept such Assignment and Assumption and record the information therein in the Register unless and until such payment shall have been made in full,
together with all accrued interest thereon. No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph. 

  
 -135- 

 (c) (i) Any Lender may, without the consent of the Borrower, the Administrative Agent, the
Issuing Lender or the Swingline Lender, sell participations to one or more banks or other entities (other than a Disqualified Lender) (a “Participant”) in all or a portion of such Lender’s rights and obligations under this
Agreement (including all or a portion of its Commitments and the Loans owing to it); provided that (A) such Lender’s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to
the other parties hereto for the performance of such obligations and (C) the Borrower, the Administrative Agent, the Issuing Lender and the other Lenders shall continue to deal solely and directly with such Lender in connection with such
Lender’s rights and obligations under this Agreement. Any agreement pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment,
modification or waiver of any provision of this Agreement; provided that such agreement may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that (1) requires the
consent of each Lender directly affected thereby pursuant to the second proviso to the third sentence of Section 11.1 and (2) directly affects such Participant. Subject to paragraph (c)(ii) of this Section, the Borrower agrees that
each Participant shall be entitled to the benefits of Sections 2.18, 2.19 and 2.20, and shall be subject to Section 2.21, to the same extent as if it were a Lender and had acquired its interest by assignment pursuant
to paragraph (b) of this Section. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 11.7(b) as though it were a Lender; provided such Participant shall be subject to
Section 11.7(a) as though it were a Lender. Notwithstanding the foregoing, each Loan Party and the Lenders acknowledge and agree that the Administrative Agent shall not have any responsibility to determine the compliance of any Lender
with the requirements of this Section 11.6(c) (it being understood that each Lender shall be responsible for ensuring its own compliance with the requirements of this Section). 

(ii) A Participant shall not be entitled to receive any greater payment under Section 2.18 or 2.19 than the applicable
Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower’s prior written consent, which shall not be unreasonably
withheld or delayed. Any Participant that is a Non-U.S. Lender shall not be entitled to the benefits of Section 2.19 unless such Participant agrees to comply with Section 2.19(e). 

(iii) Each Lender that sells a participation, acting solely for this purpose as a non-fiduciary agent of the Borrower, shall maintain at one
of its offices a register on which it enters the names and addresses of each Participant and the principal amounts (and related interest amounts) of each Participant’s interest in the Loans or other obligations under this Agreement (the
“Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a
Participant’s interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit
or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive, and such Lender shall treat each Person whose name is recorded in the
Participant Register pursuant to the terms hereof as the owner of such participation for all purposes of this Agreement, notwithstanding notice to the contrary. 

(d) Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure
obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank, and this Section shall not apply to any such pledge or assignment of a security interest; provided that no such pledge or
assignment of a security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or Assignee for such Lender as a party hereto. 

  
 -136- 

 (e) Notwithstanding the foregoing, any Conduit Lender may assign any or all of the Loans it may
have funded hereunder to its designating Lender without the consent of the Borrower or the Administrative Agent and without regard to the limitations set forth in Section 11.6(b). Each of the Borrower, each Lender and the Administrative
Agent hereby confirms that it will not institute against a Conduit Lender or join any other Person in instituting against a Conduit Lender any bankruptcy, reorganization, arrangement, insolvency or liquidation proceeding under any state bankruptcy
or similar law, for one year and one day after the payment in full of the latest maturing commercial paper note issued by such Conduit Lender; provided, however, that each Lender designating any Conduit Lender hereby agrees to
indemnify, save and hold harmless each other party hereto for any loss, cost, damage or expense arising out of its inability to institute such a proceeding against such Conduit Lender during such period of forbearance. 

(f) The Borrower, at its sole expense and upon receipt of written notice from the relevant Lender, agrees to issue Note(s) to any Lender
requiring Note(s) to facilitate transactions of the type described in this Section 11.6. 
 11.7 Adjustments; Set-off.

 (a) Except to the extent that this Agreement expressly provides for payments to be allocated to a particular Lender or to the Lenders
under a particular Facility, if any Lender (a “Benefitted Lender”) shall receive any payment of all or part of the Obligations owing to it, or receive any collateral in respect thereof (whether voluntarily or involuntarily, by
set-off, pursuant to events or proceedings of the nature referred to in Section 8.1(g), or otherwise), in a greater proportion than any such payment to or collateral received by any other Lender, if any, in respect of the Obligations
owing to such other Lender, such Benefitted Lender shall purchase for cash from the other Lenders a participating interest in such portion of the Obligations owing to each such other Lender, or shall provide such other Lenders with the benefits of
any such collateral, as shall be necessary to cause such Benefitted Lender to share the excess payment or benefits of such collateral ratably with each of the Lenders; provided, however, that if all or any portion of such excess
payment or benefits is thereafter recovered from such Benefitted Lender, such purchase shall be rescinded, and the purchase price and benefits returned, to the extent of such recovery, but without interest. 

(b) If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and
from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other obligations at any time owing by such Lender or Affiliate to
or for the credit or the account of the Borrower against any of and all the obligations of the Borrower now or hereafter existing under this Agreement held by such Lender, irrespective of whether or not such Lender shall have made any demand under
this Agreement and although such obligations may be unmatured. The rights of each Lender under this Section are in addition to other rights and remedies (including other rights of setoff) which such Lender may have. 

(c) Notwithstanding the provisions of this Agreement, if at any time any Lender, any Issuing Lender or any of their respective Affiliates
maintains one or more deposit accounts for the Borrower or any Guarantor into which Medicare and/or Medicaid receivables are deposited, such Lender or Issuing Lender or their applicable Affiliate hereby waives the right of setoff set forth herein.

 11.8 Counterparts; Integration; Effectiveness. This Agreement may be executed in counterparts (and by different parties hereto on
different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement and any 

  
 -137- 

 
separate letter agreements with respect to fees payable to the Administrative Agent constitute the entire contract among the parties relating to the subject matter hereof and supersede any and
all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 5.1, this Agreement shall become effective when it shall have been executed by the Administrative Agent and
when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their
respective successors and assigns. Delivery of an executed counterpart of a signature page of this Agreement by telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 

11.9 Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable
such provision in any other jurisdiction. 
 11.10 WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY
OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

11.11 GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY,
AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES
THEREOF). 
 11.12 Submission to Jurisdiction; Waivers. Each party hereby irrevocably and unconditionally: 

(a) submits for itself and its property in any legal action or proceeding relating to this Agreement and the other Loan
Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction of the courts of the State of New York, New York County, the courts of the United States for the Southern
District of New York, and appellate courts from any thereof; 
 (b) consents that any such action or proceeding may be
brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim
the same and agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law; 

  
 -138- 

 (c) agrees that service of process in any such action or proceeding may be
effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to it at its address set forth in Section 11.2 or at such other address of which the Administrative Agent
shall have been notified pursuant thereto; 
 (d) agrees that nothing herein shall affect the right to effect service of
process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction; and 
 (e) waives, to
the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding referred to in this Section any special, exemplary, punitive or consequential damages. 

11.13 Acknowledgments. Each of the Loan Parties hereby acknowledges that: 

(a) it has been advised by counsel in the negotiation, execution and delivery of this Agreement and the other Loan Documents;

 (b) neither the Administrative Agent or the Collateral Agent nor any Lender has any fiduciary relationship with or duty to
any Loan Party arising out of or in connection with this Agreement or any of the other Loan Documents, and the relationship between the Administrative Agent, the Collateral Agent and Lenders, on one hand, and the Loan Parties, on the other hand, in
connection herewith or therewith is solely that of debtor and creditor; and 
 (c) no joint venture is created hereby or by
the other Loan Documents or otherwise exists by virtue of the transactions contemplated hereby among the Lenders or among the Loan Parties and the Lenders. 

11.14 Releases of Guarantees and Liens. 

(a) Notwithstanding anything to the contrary contained herein or in any other Loan Document, the Collateral Agent is hereby irrevocably
authorized by each Lender (without requirement of notice to or consent of any Lender except as expressly required by Section 11.1) to take any action requested by the Borrower having the effect of releasing any Collateral or any
Guarantor (i) (A) subject to compliance with Section 7.12 and Section 10.9, if such Person ceases to be a Subsidiary as a result of a transaction or designation permitted hereunder or (B) at any time that such
release would not cause a breach of Section 7.12; provided that, in the case of clauses (A) and (B) no such release shall occur if such Guarantor continues to be a guarantor in respect of the 2020 Senior Notes, the 2022 Senior
Notes, the New Senior Notes, any Permitted Other Debt or any Credit Agreement Refinancing Debt, (ii) with (A) the sale of such Collateral or the sale of all or substantially all of Capital Stock of such Guarantor, in each case, to a Person
or Persons, none of which is the Borrower or a Subsidiary in compliance with the terms and provisions of the Loan Documents or (B) a transaction that has been consented to in accordance with Section 11.1 or (iii) under the
circumstances described in paragraph (b) below. 
 (b) At such time as the Loans, the LC Disbursements and the other accrued
obligations (including accrued indemnity obligations) under the Loan Documents (other than obligations under or in respect of Swap Agreements) shall have been paid in full, the Commitments have been terminated and no Letters of Credit shall be
outstanding, the Collateral shall be released from the Liens created by 

  
 -139- 

 
the Security Documents, and the Security Documents and all obligations (other than those expressly stated to survive such termination) of the Collateral Agent and each Loan Party under the
Security Documents shall terminate, all without delivery of any instrument or performance of any act by any Person. 
 11.15
Confidentiality. Each of the Administrative Agent, the Collateral Agent, the Issuing Lender and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its
and its Affiliates’ directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such
Information and instructed to keep such Information confidential), (b) to the extent requested by any regulatory authority, including by any self-regulatory body having jurisdiction over such Lender, (c) to the extent required by
applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party to this Agreement, (e) in connection with the exercise of any remedies hereunder or any suit, action or proceeding relating to this
Agreement or the enforcement of rights hereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section, to (i) any assignee of or Participant in, or any prospective assignee of or Participant
in, any of its rights or obligations under this Agreement, (ii) any pledgee or prospective pledgee referred to in Section 11.6(d) or (iii) any actual or prospective counterparty (or its advisors) to any swap or derivative
transaction relating to the Borrower and its obligations, (g) with the consent of the Borrower or (h) to the extent such Information (i) becomes publicly available other than as a result of a breach of this Section or
(ii) becomes available to the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender on a nonconfidential basis from a source other than the Borrower. For the purposes of this Section, “Information” means
all information received from the Borrower relating to the Borrower or its business, other than any such information that is available to the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender on a nonconfidential basis
prior to disclosure by the Borrower; provided that, in the case of information received from the Borrower after the Closing Date, such information is clearly identified at the time of delivery as confidential. Any Person required to maintain
the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person
would accord to its own confidential information. 
 11.16 Headings. Section headings and the Table of Contents used herein are for
convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement. 

11.17 USA PATRIOT Act. Each Lender that is subject to the requirements of the Patriot Act hereby notifies the Borrower that pursuant to
the requirements of the Patriot Act, it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender to identify
the Borrower in accordance with the Patriot Act. 
 11.18 Interest Rate Limitation. Notwithstanding anything herein to the contrary,
if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts which are treated as interest on such Loan under applicable law (collectively, the “Charges”), shall exceed the maximum
lawful rate (the “Maximum Rate”) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan hereunder,
together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the operation of
this Section shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be 

  
 -140- 

 
increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been
received by such Lender. 
 11.19 Third Party Beneficiary. None of the provisions contained in this Agreement are intended by the
parties hereto, nor shall they be deemed, to confer any benefit on any Person not a party to this Agreement other than, to the extent provided herein, any Indemnitee or Secured Party. The representations and warranties of the Loan Parties contained
herein are provided for the benefit of the Administrative Agent, the Collateral Agent, the Issuing Lender and each of the Lenders and their respective successors and permitted assigns in accordance herewith, and are not being provided for the
benefit of any other Person (which other Person shall include, for this purpose, without limitation, any shareholder of any Loan Party). 

[SIGNATURE PAGES FOLLOW] 

  
 -141- 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered by their proper and duly authorized officers as of the day and year first above written. 
  

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	GUARANTORS LISTED ON APPENDIX A
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 S-1 

			
	 JPMORGAN CHASE BANK, N.A., as Administrative Agent and Collateral Agent

		
	By:	 	  

	Name:	 	
	Title:	 	

  
 S-2 

 APPENDIX A 

Guarantors 
 ABQ Health Partners, LLC 

Alamosa Dialysis, LLC 
 ARIZONA INTEGRATED PHYSICIANS, INC. 

CARROLL COUNTY DIALYSIS FACILITY, INC. 
 CONTINENTAL DIALYSIS
CENTER OF SPRINGFIELD-FAIRFAX, INC. 
 CONTINENTAL DIALYSIS CENTERS, INC. 

DaVita - West, LLC 
 DaVita of New York, Inc. 

DaVita Rx, LLC 
 Dialysis Holdings, Inc. 

Dialysis Specialists of Dallas, Inc. 
 DNH MEDICAL MANAGEMENT,
INC. (dba the Camden Group) 
 DNP Management Company, LLC 

Downriver Centers, Inc. 
 DVA Healthcare of Maryland, Inc. 

DVA HEALTHCARE OF MASSACHUSETTS, INC. 
 DVA Healthcare of
Pennsylvania, Inc. 
 DVA Healthcare Procurement Services, Inc. 

DVA HEALTHCARE RENAL CARE, INC. 
 DVA Laboratory Services, Inc.

 DVA of New York, Inc. 
 DVA Renal Healthcare, Inc. 

EAST END DIALYSIS CENTER, INC. 
 ELBERTON DIALYSIS FACILITY, INC.

 Flamingo Park Kidney Center, Inc. 
 Fort Dialysis, LLC 

FREEHOLD ARTIFICIAL KIDNEY CENTER, L.L.C. 
 Greenspoint Dialysis,
LLC 
 HealthCare Partners Arizona, LLC 
 HealthCare Partners
ASC - LB, LLC 
 HealthCare Partners Holdings, LLC 
 HealthCare
Partners Nevada, LLC 
 HEALTHCARE PARTNERS SOUTH FLORIDA, LLC 

HealthCare Partners, LLC 
 Hills Dialysis, LLC 

HOUSTON KIDNEY CENTER/TOTAL RENAL CARE INTEGRATED SERVICE NETWORK LIMITED PARTNERSHIP 

JSA Care Partners, LLC 
 JSA HEALTHCARE CORPORATION 

JSA HealthCare Nevada, L.L.C. 
 JSA Holdings, Inc. 

JSA P5 Nevada, L.L.C. 
 Kidney Care Services, LLC 

Knickerbocker Dialysis, Inc. 

  
 Appendix A-1 

	
	 Las Vegas Solari Hospice Care LLC

	 Liberty RC, Inc.

	 Lincoln Park Dialysis Services, Inc.

	 Maple Grove Dialysis, LLC

	 MASON-DIXON DIALYSIS FACILITIES, INC.

	 Medical Group Holding Company, LLC

	 Nephrology Medical Associates of Georgia, LLC

	 NEPTUNE ARTIFICIAL KIDNEY CENTER, L.L.C.

	 North Atlanta Dialysis Center, LLC

	 North Colorado Springs Dialysis, LLC

	 Northridge Medical Services Group, Incorporated

	 Palo Dialysis, LLC

	 Patient Pathways, LLC

	 Physicians Choice Dialysis Of Alabama, LLC

	 Physicians Choice Dialysis, LLC

	 Physicians Dialysis Acquisitions, Inc.

	 Physicians Dialysis Ventures, Inc.

	 Physicians Dialysis, Inc.

	 Physicians Management, LLC

	 Renal Life Link, Inc.

	 Renal Treatment Centers - California, Inc.

	 Renal Treatment Centers - Hawaii, Inc.

	 Renal Treatment Centers - Illinois, Inc.

	 Renal Treatment Centers - Mid-Atlantic, Inc.

	 Renal Treatment Centers - Northeast, Inc.

	 RENAL TREATMENT CENTERS – SOUTHEAST, LP

	 Renal Treatment Centers - West, Inc.

	 Renal Treatment Centers, Inc.

	 RMS Lifeline Inc.

	 Rocky Mountain Dialysis Services, LLC

	 SHINING STAR DIALYSIS, INC.

	 Sierra Rose Dialysis Center, LLC

	 Southwest Atlanta Dialysis Centers, LLC

	 The DaVita Collection, Inc.

	 THP Services, Inc.

	 TOTAL ACUTE KIDNEY CARE, INC.

	 Total Renal Care, Inc.

	 Total Renal Care Texas Limited Partnership

	 Total Renal Laboratories, Inc.

	 TOTAL RENAL RESEARCH, INC.

	 TRC - Indiana, LLC

	 TRC OF NEW YORK, INC.

	 TRC WEST, INC.

	 Tree City Dialysis, LLC

	 VillageHealth DM, LLC

  
 Appendix A-2 

 Schedule 1.1 

Existing Letters of Credit 
  

											
	 Loan Party
	  	 Issuing Bank
	  	Amount	 	  	 Beneficiary
	  	 L/C No.

	 DaVita HealthCare Partners Inc.
	  	CSFB	  	 	8,920,000	  	  	National Union Fire Insurance Co. of Pittsburgh PA	  	TS-07002067
	 DaVita HealthCare Partners Inc.
	  	CSFB	  	 	14,100,000	  	  	National Union Fire Insurance Co. of Pittsburgh PA	  	TS-07002188
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	28,000	  	  	American Casualty Company of Reading Pennsylvania	  	TPTS-206601
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	1,000,000	  	  	SCAN Health Plan	  	TPTS-207249
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	10,000,000	  	  	National Union Fire Insurance Co. of Pittsburgh PA	  	S-771647
	 DaVita HealthCare Partners Inc.
	  	Nordea Bank, New York	  	 	4,085,777	  	  	Pacific Employers Insurance Company	  	TPTS-205344
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	1,500,000	  	  	National Union Fire Insurance Co. of Pittsburgh PA	  	TS-07004309
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	500,000	  	  	OMNINET MOUNTAIN, LP	  	S-645489
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	3,900,000	  	  	National Union Fire Insurance Co. of Pittsburgh & others	  	JPM TPTS-683015
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	5,000,000	  	  	National Union Fire Insurance Co. of Pittsburgh & others	  	JPM TPTS-759411
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	5,000,000	  	  	National Union Fire Insurance Co. of Pittsburgh & others	  	S-312398
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	11,900,000	  	  	National Union Fire Insurance Co. of Pittsburgh PA	  	S-283094
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	1,000,000	  	  	State of Nevada - Dept of Business & Industry - Div of Insurance	  	JPM TFTS-392238
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	318,767	  	  	Columbia Casualty Co.	  	TFTS-254085
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	300,000	  	  	Travelers Indemnity Co.	  	TFTS-254082
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	883,000	  	  	Liberty Mutual Insurance Co.	  	TFTS-254083
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	831,233	  	  	Columbia Casualty Co.	  	TFTS-254071
	 DaVita HealthCare Partners Inc.
	  	JPMorgan	  	 	13,054,560	  	  	JPMorgan Chase Bank, Riyad	  	S-833022

 Schedule 4.2 

Subsidiaries 
  

															
	 	  	 Current Legal Entities Owned
	  	 Record Owner/Percentage Owned/Owner Type
	  	 Certificate No.
	  	 Number of
Shares/Interest
	 	 	 Pledged
Percent
	 
	1	  	Aberdeen Dialysis, LLC	  	 Renal Treatment Centers - Mid-Atlantic, Inc.- 60% - Managing Member

Nephrology Investments of Aberdeen, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	2	  	Able Dialysis, LLC	  	 Total Renal Care, Inc.- 70.5% - Managing Member

NMCR Health Dialysis, LLC- 29.5% - Member
	  	N/A	  	 	70.5	% 	 	 	70.5	% 
						
	3	  	ABQ Health Partners Endoscopy Center, LLC	  	ABQ Health Partners, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	4	  	ABQ Health Partners, LLC	  	Medical Group Holding Company- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	5	  	Accountable Kidney Care, LLC	  	Total Renal Care, Inc. - 100% -Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	6	  	Acton Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	7	  	Alamosa Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

															
						
	8	  	Alexandria Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	9	  	Alomie Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	10	  	American Fork Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

AFDI, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	11	  	Amery Dialysis, LLC	  	 Total Renal Care, Inc.- 75% - Managing Member

Amery Regional Medical Center, Inc.- 25% - Member
	  	N/A	  	 	75	% 	 	 	75	% 
						
	12	  	Anderson Kidney Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	13	  	Animas Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

LACNA Dialysis Services, P.C.- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	14	  	Arcadia Gardens Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

Arcadia Nephrology Group, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	15	  	Argyle Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	16	  	Arizona Integrated Physicians, Inc.	  	HealthCare Partners Arizona, LLC - 100% - Shareholder	  	1	  	 	1,000	  	 	 	100	% 

  
 Sch 4.2-2 

															
						
	17	  	Astro, Hobby, West Mt. Renal Care Limited Partnership	  	Total Renal Care, Inc.- 1% - General Partner TRC West, Inc.- 99% - Limited Partner	  	N/A	  	 	100	% 	 	 	100	% 
						
	18	  	Atlantic Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Mayo Clinic- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	19	  	Austin Dialysis Centers, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

HMB Holdings, LLC- 13% - Limited Partner
 Renal Treatment Centers
- Southeast, LP- 86% - Limited Partner
	  	N/A	  	 	87	% 	 	 	87	% 
						
	20	  	Bagby Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	21	  	Bainbridge Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

BJAMN-FW, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	22	  	Barnell Dialysis, LLC	  	Renal Treament Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	23	  	Barrington Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	24	  	Barton Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Kidney Care Tucson, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	25	  	Basin Dialysis, LLC	  	Total Renal Care, Inc.- 55% - Managing Member Renal Partners IV, LLc- 45% - Member	  	N/A	  	 	55	% 	 	 	55	% 

  
 Sch 4.2-3 

															
						
	26	  	Bastrop Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	27	  	Bayshore Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	28	  	Beachside Dialysis, LLC	  	 Affiliated Health Services, Inc. - 10% - Member

Harper Woods JV, LLC - 39% - Member
 Renal Treatment Centers -
Illinois, Inc. - Managing Member - 51%
	  	N/A	  	 	51	% 	 	 	51	% 
						
	29	  	Beacon Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

Kidney Associates Holding Company, L.C.- 24% - Member
 Ruth I
Wintz MD- 8% - Member
 Dolon Das MD- 8% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	30	  	Beals Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	31	  	Bear Creek Dialysis Center, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Bear Creek Nephrology Group- 30% - Limited Partner
 TRC West,
Inc.- 69% - Limited Partner
	  	N/A	  	 	70	% 	 	 	70	% 
						
	32	  	Beck Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	33	  	Belfair Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-4 

															
						
	34	  	Bellevue Dialysis, LLC	  	 Katy West Dialysis Partners- 24% - Manager

Waseem Peracha, M.D.- 5% - Manager
 Renal Treatment Centers -
Southeast, LP- 51% - Managing Member
 HNG Horizon Dialysis Partners, LLC- 20% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	35	  	Beverly Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Mountaineer Medical Associate, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	36	  	Beverly Hills Dialysis Partnership	  	 Total Renal Care, Inc.- 99.955% - General Partner

DaVita HealthCare Partners Inc.- 0.045% - Partner
	  	N/A	  	 	99.955	% 	 	 	99.955	% 
						
	37	  	Bidwell Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	38	  	Birch Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Advanced Peritoneal Dialysis, LLC- 9.7% - Member
 Advanced
Dialysis, LLC- 10.3% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	39	  	Bladon Dialysis, LLC	  	 Total Renal Care, Inc.- 60.1% - Managing Member

Hutchinson Clinic, P.A.- 13.3% - Member
 Prairie Dunes Dialysis
LLC- 13.3% - Member
 Promise Regional Medical Center - Hutchinson, Inc.- 13.3% - Member
	  	N/A	  	 	60.1	% 	 	 	60.1	% 
						
	40	  	Blake Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	41	  	Blanco Dialysis, LLC	  	 Total Renal Care, Inc.- 87.5% - Managing Member

Apple Avenue Renal Partners, LLC- 12.5% - Member
	  	N/A	  	 	87.50	% 	 	 	87.50	% 

  
 Sch 4.2-5 

															
						
	42	  	Bliss Dialysis, LLC	  	 Berkshire Investment Venture, LLC- 40% - Member

Total Renal Care, Inc.- 60% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	43	  	Bluegrass Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Nephrology Investments of Florence, LLC- 17% - Member
 Saint
Elizabeth Medical Center, Inc.- 32% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	44	  	Bohama Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

Racho Kidney Center LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	45	  	Borrego Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Heartland Dialysis Partners, LLC- 29.5% - Member
 Community
Limited Care Dialysis Center- 19.5% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	46	  	Bottle Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Shawnee Kidney Care, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	47	  	Bowan Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Beltline Home Dialysis Operation, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	48	  	Braidwood Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	49	  	Brantley Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	50	  	Bridges Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Torch Group, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-6 

															
						
	51	  	Bright Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 51% - Managing Member

Ft. Pierce Kidney Care, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	52	  	Brighton Dialysis Center, LLC	  	 Renal Treatment Centers - West, Inc.- 60% - Managing Member

Western Nephrology & Metabolic Bone Disease, P.C.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	53	  	Brook Dialysis LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Acei, LLC- 20% - Member
 Mataji, LLC- 20% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	54	  	Brownsville Kidney Center, Ltd	  	 ISD Renal, Inc.- 90% - Managing Member

Preston Ukoli MD- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	55	  	Brownwood Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Promod Duggal MD- 5% - Member
 Barry Hecht MD- 5% -
Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	56	  	Bruno Dialysis, LLC	  	Renal Treatment Centers - California, Inc.- 64% - Managing Member Renal Investments Partnership II- 20% - Member NSMG Partners MainPlace, LLC- 16% - Member	  	N/A	  	 	64	% 	 	 	64	% 
						
	57	  	Buford Dialysis, LLC	  	 Renal Treatment Centers - Mid-Atlantic, Inc.- 90% - Managing Member

Quality Kidney Care, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	58	  	Bulfinch Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-7 

															
						
	59	  	Bullards Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	60	  	Burney Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Dwight McLeish MD- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	61	  	Butano Dialysis, LLC	  	 Total Renal Care, Inc.- 75% - Managing Member

Hanford Community Hospital, d/b/a Adventist Medical Center - Hanford- 25% - Member
	  	N/A	  	 	75	% 	 	 	75	% 
						
	62	  	Caballo Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	63	  	Caddo Dialysis, LLC	  	 Total Renal Care, Inc.- 85% - Managing Member

Mast Enterprise LLC- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 
						
	64	  	Calaveras Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	65	  	Camino Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Eureka Partners, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	66	  	Campton Dialysis, LLC	  	 Total Renal Care, Inc.- 90.6504 - Managing Member

Zenith Swarthmore, LLC - 9.3496% - Member
	  	N/A	  	 	90.6504	% 	 	 	90.6504	% 
						
	67	  	Cannon Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-8 

															
						
	68	  	Canyon Springs Dialysis, LLC	  	 Renal Treatment Centers - California, Inc.- 70% - Managing Member

NAMG Dialysis Ventures IV, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	69	  	Capelville Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	70	  	Capes Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 85% - Managing Member

Arkansas Renal Systems, Inc.- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 
						
	71	  	Capital Dialysis Partnership	  	 Total Renal Care, Inc.- 52.595% - General Partner

Capital Dialysis, LLC- 47.405% - Partner
	  	N/A	  	 	52.60	% 	 	 	52.60	% 
						
	72	  	Cardinal Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	73	  	Carlsbad Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

TRIASN, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	74	  	Carroll County Dialysis Facility Limited Partnership	  	 Carroll County Dialysis Facility, Inc.- 66.67% - General Partner

Carroll County Medical Services- 33.33% - Limited Partner
	  	N/A	  	 	66.67	% 	 	 	66.67	% 
						
	75	  	Carroll County Dialysis Facility, Inc.	  	Total Renal Care, Inc. - 100% - Shareholder	  	3	  	 	100	  	 	 	100	% 

  
 Sch 4.2-9 

															
						
	76	  	Cascades Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 55% - Managing Member

Helen H. Lee, M.D.- 1% - Member
 Anil Sheth, M.D.- 3.75% -
Member
 Rupinder Chatha, M.D.- 3.75% - Member
 Richard Foley,
M.D.- 11.25% - Member
 Rendentor Roy, M.D.- 3.75% - Member

Vijayaprakash Sreenarasimhaiah, M.D.- 3.75% - Member
 Washington
Sereatan, M.D.- 3.75% - Member
 Gene Forrester, M.D.- 10.25% - Member

Ariel Velasco, M.D.- 3.75% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	77	  	Catello Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	78	  	Caverns Dialysis, LLC	  	 Total Renal Care, Inc.- 84.6% - Managing Member

Radburn Dialysis Center Physicians, LLC- 15.4% - Member
	  	N/A	  	 	84.6	% 	 	 	84.6	% 
						
	79	  	Cedar Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Medical Sciences Consultants, LLC- 20% - Member
 Rabia Al-Sbaiti
MD- 10% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	80	  	Centennial LV, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Centennial HD LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	81	  	Central Carolina Dialysis Centers, LLC	  	Total Renal Care of North Carolina, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	82	  	Central Georgia Dialysis, LLC	  	 Renal Treatment Centers - Mid-Atlantic, Inc.- 70% - Managing Member

Martinez Business Holdings, LLLP- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 

  
 Sch 4.2-10 

															
						
	83	  	Central Iowa Dialysis Partners, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 70% - Managing Member

Central Iowa Dialysis Investors, LLC- 30%
	  	N/A	  	 	70	% 	 	 	70	% 
						
	84	  	Central Kentucky Dialysis Centers, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 80% - Managing Member

Patel Family Dialysis, LLC- 10% - Member
 Bhatti Investments, LLC-
10% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	85	  	Cerito Dialysis Partners, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Mittal Dialysis Enterprises, PLLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	86	  	Chadron Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	87	  	Channel Dialysis, LLC	  	 NAMG DIALYSIS VENTURES VII, LLC- 30% - Managing Member

Total Renal Care, Inc.- 60% - Member
 Bryan L. Stone, M.D.- 10% -
Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	88	  	Cheraw Dialaysis, LLC	  	Total Renal Care, Inc. - 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	89	  	Chicago Heights Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 77.93% - Managing Member

William B Evans MD- 22.07% - Member
	  	N/A	  	 	77.93	% 	 	 	77.93	% 
						
	90	  	Chipeta Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-11 

															
						
	91	  	Churchill Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 70% - Managing Member

Valley Baptist Medical Center- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	92	  	Cimarron Dialysis, LLC	  	 DVA Renal Healthcare, Inc.- 55% - Managing Member

Heartland Dialysis Partners, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	93	  	Cinco Rios Dialysis, LLC	  	Total Renal Care, Inc.- 60% - Managing Member NAMG Dialysis Ventures VIII, LLC- 40% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	94	  	Clark Dialysis, LLC	  	 Total Renal Care, Inc.- 79% - Managing Member

Annapolis Nephrology, LLC- 21% - Member
	  	N/A	  	 	79	% 	 	 	79	% 
						
	95	  	Clayton Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 80% - Managing Member

JAMN Partners, LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	96	  	Clearee Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	97	  	Cleburne Dialysis, LLC	  	 Total Renal Care, Inc.- 50.1% - Managing Member

Coral Hills Nephrology, LLC- 49.9% - Member
	  	N/A	  	 	50.1	% 	 	 	50.1	% 
						
	98	  	Clifton Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	99	  	Clinton Township Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member

Midwest Clinton Township JV, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-12 

															
						
	100	  	Clover Dialysis, LLC	  	 Total Renal Care, Inc.- 92.1894% - Managing Member

Premier Dialysis LLC- 7.8106% - Member
	  	N/A	  	 	92.1894	% 	 	 	92.1894	% 
						
	101	  	Coast Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Coast Dialysis Partners, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	102	  	Cobbles Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	103	  	Colleton Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Clinton Dialysis JV LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	104	  	Columbus-RNA-DaVita, LLC	  	 DVA Renal Healthcare, Inc.- 60% - Managing Member

RNA Dialysis Ventures, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	105	  	Commerce Township Dialysis Center, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 55% - Managing Member

Commerce Dialysis, LLC- 10% - Member
 Huron Valley Dialysis, LLC-
35% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	106	  	Conconully Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Laurel Meadows Partners, Inc.- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	107	  	Continental Dialysis Center of Springfield-Fairfax, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	22	  	 	95	  	 	 	100	% 
						
	108	  	Continental Dialysis Centers, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	9	  	 	100	  	 	 	100	% 

  
 Sch 4.2-13 

															
						
	109	  	Coral Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	110	  	Cottonwood Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	None	  
						
	111	  	Court Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Adena Health System- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	112	  	Cowell Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Mount Sinai Hospital Medical Center of Chicago- 22% - Member
 Zoa
Associates, Inc.- 27% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	113	  	Creek Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	114	  	Crystals Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

NAMG Dialysis Ventures V, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	115	  	Curecanti Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 61% - Managing Member

Osunsanya Dialysis, LLC- 13% - Member
 Gregory Wells MD- 13% -
Member
 Sriram, LLC- 13% - Member
	  	N/A	  	 	61	% 	 	 	61	% 
						
	116	  	Curlew Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Jonathan Nester MD- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 

  
 Sch 4.2-14 

															
						
	117	  	Dallas-Fort Worth Nephrology II, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	118	  	Dallas-Fort Worth Nephrology, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

HEAL Partners, LLC- 7.65% - Limited Partner
 TRC West, Inc.-
91.35% - Limited Partner
	  	N/A	  	 	92.35	% 	 	 	92.35	% 
						
	119	  	Damon Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

American Health Network of Indiana, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	120	  	Davis Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 95% - Managing Member

Northwest Iowa Hospital Corporation- 5% - Member
	  	N/A	  	 	95	% 	 	 	95	% 
						
	121	  	DaVita - Riverside II, LLC	  	 Renal Treatment Centers - California, Inc.- 60% - Managing Member

NAMG Dialysis Ventures II, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	122	  	DaVita - West, LLC	  	Renal Treatment Centers, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	123	  	DaVita Dakota Dialysis Center, LLC	  	 Renal Treatment Centers - West, Inc.- 55% - Managing Member

Red River Valley Dialysis, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	124	  	DaVita El Paso East, L.P.	  	Total Renal Care, Inc.- 1% - General Partner Eastside Dialysis Consultants, LLC- 40% - Limited Partner TRC West, Inc.- 59% - Limited Partner	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-15 

															
						
	125	  	DaVita HealthCare Partners Inc.	  	N/A	  	N/A	  	 	N/A	  	 	 	NA	  
						
	126	  	DaVita of New York, Inc.	  	DaVita HealthCare Partners Inc.- 100%- Common Voting- Shareholder	  	2	  	 	100	  	 	 	100	% 
						
	127	  	DaVita Rx, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	128	  	DaVita Tidewater - Virginia Beach, LLC	  	Renal Treatment Centers - Mid-Atlantic, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	129	  	DaVita Tidewater, LLC	  	Renal Treatment Centers - Mid-Atlantic, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	130	  	DaVita-Riverside, LLC	  	 Renal Treatment Centers - California, Inc.- 60% - Managing Member

NAMG Dialysis Ventures, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	131	  	Desoto Dialysis, LLC	  	 Akinfemi Afolabi, M.D., LLC- 40% - Member

Total Renal Care, Inc.- 60% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	132	  	Diablo Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	133	  	Dialysis Holdings, Inc.	  	DVA Renal Healthcare, Inc.- 100% - Shareholder	  	1	  	 	40,000,000	  	 	 	100	% 

  
 Sch 4.2-16 

															
						
	134	  	Dialysis of Des Moines, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 51% - Managing Member

Quality Renal Services, L.L.C.- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	135	  	Dialysis of North Atlanta, LLC	  	Renal Treatment Centers - Mid-Atlantic, Inc.- 100% - Manager	  	N/A	  	 	100	% 	 	 	100	% 
						
	136	  	Dialysis of Northern Illinois, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member

Rockford Nephrology Partners, Ltd.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	137	  	Dialysis Specialists of Dallas, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	5	  	 	10,000	  	 	 	100	% 
						
	138	  	DNH Medical Management, Inc. (dba the Camden Group)	  	HealthCare Partners, LLC- 100% - Shareholder	  	43	  	 	4,175	  	 	 	100	% 
						
	139	  	DNP Management Company, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	140	  	Dolores Dialysis, LLC	  	Total Renal Care, Inc.- 51% - Managing Member David M. Alderman- 19.5% - Member Bryan L. Stone- 19.5% - Member NAMG Dialysis Ventures VI, LLC- 10% - Member	  	N/A	  	 	51	% 	 	 	51	% 
						
	141	  	Dome Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Westerville Renal Care, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-17 

															
						
	142	  	Doves Dialysis, LLC	  	 DVA Renal Healthcare, Inc.- 70% - Managing Member

Inland South Dialysis, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	143	  	Downriver Centers, Inc.	  	Renal Treatment Centers - Illinois, Inc.- 100%- Common - Shareholder	  	14	  	 	125	  	 	 	100	% 
						
	144	  	Downtown Houston Dialysis Center, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Stephen Fadem, M.D.- 5% - Limited Partner
 Wasae Tabibi, M.D.- 5%
- Limited Partner
 URR, LLC- 25% - Limited Partner
 TRC West,
Inc.- 59% - Limited Partner
 Joey Buquing, M.D.- 5% - Limited Partner
	  	N/A	  	 	0.6	  	 	 	60	% 
						
	145	  	Durango Dialysis Center, LLC	  	 Renal Treatment Centers - West, Inc.- 51% - Managing Member

Mark F. Bevan, M.D.- 44% - Member
 Mark Saddler, M.D.- 5% -
Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	146	  	DVA Healthcare - Southwest Ohio, LLC	  	 Community Limited Care Dialysis Center- 19.5% - Member

DVA Renal Healthcare, Inc.- 80.5% - Member
	  	N/A	  	 	80.5	% 	 	 	80.5	% 
						
	147	  	DVA Healthcare of Maryland, Inc.	  	DVA Renal Healthcare, Inc.- 100% - Shareholder	  	2	  	 	2,000	  	 	 	100	% 
						
	148	  	DVA Healthcare of Massachusetts, Inc.	  	DVA Renal Healthcare, Inc.- 100%- Common - Shareholder	  	1	  	 	1,000	  	 	 	100	% 
						
	149	  	DVA Healthcare of New London, LLC	  	 DVA Renal Healthcare, Inc.- 51% - Managing Member

L & M Home Care Services, Inc.- 24.5% - Member
 CONNcare,
Inc.- 24.5% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-18 

															
						
	150	  	DVA Healthcare of Norwich, LLC	  	 DVA Renal Healthcare, Inc.- 51% - Managing Member

CONNcare, Inc.- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	151	  	DVA Healthcare of Pennsylvania, Inc.	  	DVA Renal Healthcare, Inc.- 100%- Common - 1,000	  	2	  	 	1,000	  	 	 	100	% 
						
	152	  	DVA Healthcare of Tuscaloosa, LLC	  	 DVA Renal Healthcare, Inc.- 51% - Managing Member

DCH Holdings, Inc.- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	153	  	DVA Healthcare Procurement Services, Inc.	  	DVA Renal Healthcare, Inc.- 100%- Common - Shareholder	  	2	  	 	100	  	 	 	100	% 
						
	154	  	DVA Healthcare Renal Care, Inc.	  	Dialysis Holdings, Inc.- 100%- Common - Shareholder	  	1	  	 	250	  	 	 	100	% 
						
	155	  	DVA Laboratory Services, Inc.	  	DVA Renal Healthcare, Inc.- 100%- Common - Shareholder	  	4	  	 	100	  	 	 	100	% 
						
	156	  	DVA of New York, Inc.	  	DVA Renal Healthcare, Inc.- 100% - Shareholder	  	2	  	 	100	  	 	 	100	% 
						
	157	  	DVA Renal Healthcare, Inc.	  	DaVita HealthCare Partners Inc.- 100%- Common - Shareholder	  	4	  	 	10,000	  	 	 	100	% 
						
	158	  	DVA/Washington University Healthcare of Greater St. Louis, LLC	  	 DVA Renal Healthcare, Inc.- 51% - Managing Member

Washington University- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-19 

															
						
	159	  	East End Dialysis Center, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	2	  	 	1,000	  	 	 	100	% 
						
	160	  	East Ft. Lauderdale, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

Albert Casaretto, M.D.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	161	  	East Houston Kidney Center, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Julie Robeson, M.D.- 8%
 Stephen Fadem, M.D.- 8%

Wasae Tabibi, M.D.- 8%
 URR, LLC- 8%

TRC West, Inc.- 59%
 Joey Buquing, M.D.- 8%
	  	N/A	  	 	60	% 	 	 	60	% 
						
	162	  	Ebrea Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Kidney Doctors Home Therapies, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	163	  	Edisto Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	164	  	Elberton Dialysis Facility, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	6	  	 	750	  	 	 	100	% 
						
	165	  	Eldrist Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	166	  	Elgin Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 90% - Managing Member

AccessCare Dialysis, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 

  
 Sch 4.2-20 

															
						
	167	  	Elk Grove Dialysis Center, LLC	  	 Renal Treatment Centers - California, Inc.- 51% - Managing Member

Jane O’Green Koening, M.D., Inc.- 33% - Member
 Ratnaji
Nallamothu, M.D.- 16% - Member
	  	N/A	 	 	51	% 	 	 	51	% 
						
	168	  	Empire State DC, Inc.	  	DaVita of New York, Inc.- 100%- Common Shareholder	  	N/R1	 	 	100	  	 	 	100	% 
						
	169	  	Enchanted Dialysis, LLC	  	 Knickerbocker Dialysis, Inc.- 60% - Managing Member

Rochester General Hospital- 40% - Member
	  	N/A	 	 	60	% 	 	 	60	% 
						
	170	  	Etowah Dialysis, LLC	  	Total Renal Care, Inc.- 60% - Managing Member St. Luke’s Health Network, Inc.- 40% - Member	  	N/A	 	 	60	% 	 	 	60	% 
						
	171	  	Eufaula Dialysis, LLC	  	 Total Renal Care, Inc.- 63.676781% - Managing Member

M&S Dialysis, LLC- 16.323219% - Member
 St. Joseph’s
Hospital and Medical Center- 20% - Member
	  	N/A	 	 	63.676781	% 	 	 	63.676781	% 
						
	172	  	Everglades Dialysis, LLC	  	 Munson Dialysis Center- 10% - Member
 Total
Renal Care, Inc.- 90% - Member
	  	N/A	 	 	90	% 	 	 	90	% 
						
	173	  	Fairfield Dialysis, LLC	  	 Total Renal Care, Inc.- 84% - Managing Member

Dialysis Asset Management, LLC- 16% - Member
	  	N/A	 	 	84	% 	 	 	84/	% 
						
	174	  	Falcon, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	 	 	100	% 	 	 	100	% 

  
 Sch 4.2-21 

															
						
	175	  	Fanthorp Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Mankato Clinic, Ltd.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	176	  	Farragut Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	177	  	Fenton Dialysis, LLC	  	 Total Renal Care, Inc.-60% - Managing Member

AXOLOTL, LLC - 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	178	  	Fields Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Nephrology Investments of Florence, LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	179	  	Five Star Dialysis, LLC	  	 Total Renal Care, Inc. - 51% - Managing Member

FSD, LLC - 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	180	  	Flagler Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	181	  	Flamingo Park Kidney Center, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	6	  	 	85	  	 	 	100	% 
						
	182	  	Flor Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	183	  	Forester Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Renal Investors, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 

  
 Sch 4.2-22 

															
						
	184	  	Fort Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	185	  	Foss Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	186	  	Freehold Artificial Kidney Center, L.L.C.	  	DVA Renal Healthcare, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	187	  	Freeportbay Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Rockford Nephrology Associates, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	188	  	Fremont Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

MKC Bloomfield Hills Dialysis Center, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	189	  	Fullerton Dialysis Center, LLC	  	 Renal Treatment Centers - California, Inc.- 60% - Managing Member

Renal Investment Partnership II- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	190	  	Ganois Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	191	  	Gardenside Dialysis, LLC	  	 Total Renal Care, Inc.- 82.5% - Managing Member

Mast Enterprise LLC- 17.5% - Member
	  	N/A	  	 	82.5	% 	 	 	82.5	% 
						
	192	  	Garner Dialysis, LLC	  	 Mary Greeley Medical Center 1111- 40% - Member

Renal Treatment Centers - Illinois, Inc.- 60% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-23 

															
						
	193	  	Garrett Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

JVBURNS, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	194	  	GDC Resources, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	195	  	Gertrude Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	196	  	Geyser Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 51% - Managing Member

Northern Iowa Dialysis Investors, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	197	  	GiveLife Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member

Midwest Grosse Pointe JV LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	198	  	Givhan Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	199	  	Glacier Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 69% - Managing Member

1960 Medical Directorship, LLC- 31% - Member
	  	N/A	  	 	69	% 	 	 	69	% 
						
	200	  	Glassland Dialysis, LLC	  	 Total Renal Care, Inc.- 96% - Managing Member

Jack E. Rubin MD- 4% - Member
	  	N/A	  	 	96	% 	 	 	96	% 
						
	201	  	Golden Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 90% - Managing Member

KAHD Capital, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 

  
 Sch 4.2-24 

															
						
	202	  	Golden Sun Bear, LLC	  	RMS Lifeline Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	203	  	Goldendale Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Brookstone Renal HHD, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	204	  	Goliad Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	205	  	Gordina Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	206	  	Goza Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	207	  	Grand Home Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

The Ishanashi Family Limited Liability Partnership- 16.33% - Member

Tara’s Holdings LLC- 17.33% - Member
 Sandip G Patel MD- 2% -
Member
 The Azanaf Family Limited Liability Partnership- 13.33% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	208	  	Great Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

McKinney Dialysis Investors, Inc.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	209	  	Greater Las Vegas Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

RRT, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-25 

															
						
	210	  	Greater Los Angeles Dialysis Centers, LLC	  	 Total Renal Care, Inc.- 52.59% - Managing Member

Mendez Transplant Associates- 25.56% - Member
 Rafael G. Mendez,
M.D.- 7.9% - Member
 Robert Mendez, M.D.- 7.9% - Member

National Renal Transplant Services, Inc.- 6.05% - Member
	  	N/A	  	 	52.59	% 	 	 	52.59	% 
						
	211	  	Green Country Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member

Renal Dialysis Associates of Davenport, P.C.- 26.67% - Member

Rajendra Dahal MD- 13.33% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	212	  	Green Desert Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

Barney, Makhija & Qazi LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	213	  	Greenleaf Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Member
 Central
Florida Purchasing Cooperative, LLC- 40%
	  	N/A	  	 	60	% 	 	 	60	% 
						
	214	  	Greenspoint Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	215	  	Greenwood Dialysis, LLC	  	 Renal Treatment Centers - West, Inc.- 85% - Managing Member

Greenwood Investment Group, LLC- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 
						
	216	  	Griffin Dialysis, LLC	  	 Total Renal Care, Inc.- 54% - Managing Member

Capital Dialysis, LLC- 46% - Member
	  	N/A	  	 	54	% 	 	 	54	% 
						
	217	  	Griffs Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-26 

															
						
	218	  	Grove Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	219	  	Gulch Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	220	  	Hagerstown Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Antietam Dialysis, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	221	  	Hanford Dialysis, LLC	  	DVA Healthcare Renal Care, Inc.- 100% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	222	  	Hardy Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	60	% 
						
	223	  	Harmony Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Steven Ong MD- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	224	  	Harris Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

Athens Dialysis Holdings, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	225	  	Hart Dialysis, LLC	  	Total Renal Care, Inc.- 51% - Managing Member Nirav Gandhi MD- 5% - Member Nausheen Ali MD- 19% - Member Exceptional Renal Care, LLC- 25% - Member	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-27 

															
						
	226	  	Hawaiian Gardens Dialysis Center, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	227	  	Hazelton Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	228	  	Headlands Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	229	  	HealthCare Partners Arizona, LLC	  	HealthCare Partners, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	230	  	HealthCare Partners ASC-LB, LLC	  	 HealthCare Partners Associates Medical Group, Inc.- 1% - Member

HealthCare Partners, LLC- 99% - Member
	  	N/A	  	 	100	% 	 	 	100	% 
						
	231	  	HealthCare Partners Holdings, LLC	  	DaVita HealthCare Partners Inc.- 100%- Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	232	  	HealthCare Partners Nevada, LLC	  	HealthCare Partners, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	233	  	HealthCare Partners South Florida, LLC	  	HealthCare Partners, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	234	  	HealthCare Partners, LLC	  	HealthCare Partners Holdings, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-28 

															
						
	235	  	Heavener Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	236	  	Heideck Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	237	  	Heyburn Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Hilliard Partners, LLC- 24.5% - Member
 RNA Dialysis Ventures,
LLC- 24.5% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	238	  	Hialeah Kidney Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	239	  	Higbee Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 90% - Managing Member

The Dialysis Cottage, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	240	  	Hills Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	241	  	Hochatown Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 75% - Managing Member Renal Reddy, LLC- 5% - Member Douglas Park I, Ltd.- 20% - Member	  	N/A	  	 	75	% 	 	 	75	% 
						
	242	  	Holiday Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-29 

															
						
	243	  	Honey Dialysis, LLC	  	Renal Treatment Centers - Mid-Atlantic, Inc.- 100% - Member	  	N/A	 	 	100	% 	 	 	100	% 
						
	244	  	Honeyman Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 51% - Managing Member

IPC Nephrology, PLLC- 44% - Member
 St. Luke’s Methodist- 5%
- Member
	  	N/A	 	 	51	% 	 	 	51	% 
						
	245	  	Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership	  	 Total Renal Care, Inc.- 1% - General Partner

TRC West, Inc.- 99% - Limited Partner
	  	N/A	 	 	100	% 	 	 	100	% 
						
	246	  	Hugo Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP - 100% - Member	  	N/A	 	 	100	% 	 	 	100	% 
						
	247	  	Humboldt Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Southcoast Medical Group, LLC- 40% - Member
	  	N/A	 	 	60	% 	 	 	60	% 
						
	248	  	Hunter Dialysis, LLC	  	Total Renal Care, Inc.-95% - Managing Member SYS Consultants, Inc. - 5% - Member	  	N/A	 	 	95	% 	 	 	95	% 
						
	249	  	Huntington Artificial Kidney Center, Ltd.	  	DaVita of New York, Inc.- 100%- Common - Shareholder	  	N/R1	 	 	200	  	 	 	100	% 
						
	250	  	Huntington Park Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	 	 	100	% 	 	 	100	% 

  
 Sch 4.2-30 

															
						
	251	  	 Hunts Dialysis, LLC
	  	 Renal Treatment Centers - Southeast, LP - 60% - Managing Member

Round Rock Dialysis LLC - 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	252	  	 Hyde Dialysis, LLC
	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	253	  	 Indian River Dialysis Center, LLC
	  	 Renal Treatment Centers - Southeast, LP- 83.32% - Managing Member

PRI Dialysis, LLC- 16.68% - Member
	  	N/A	  	 	83.32	% 	 	 	83.32	% 
						
	254	  	 Ionia Dialysis, LLC
	  	 Renal Life Link, Inc.- 55% - Managing Member

Ionia Dialysis Operations, LLC- 32% - Member
 Royal Spartan
Holdings, LLC- 13% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	255	  	 ISD Bartlett, LLC
	  	 ISD Renal, Inc.- 93% - Managing Member
 Omar
Hamze MD- 7% - Member
	  	N/A	  	 	93	% 	 	 	0	% 
						
	256	  	 ISD Brandon, LLC
	  	ISD Renal, Inc.- 56.6% - Managing Member Gary Davis MD- 13.3% - Member James Bill Moore MD- 30.1% - Member	  	N/A	  	 	56.60	% 	 	 	0	% 
						
	257	  	 ISD Buffalo Grove, LLC
	  	ISD Renal, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	0	% 
						
	258	  	 ISD Canton, LLC
	  	 ISD Renal, Inc.- 90% - Managing Member
 S.B.
Holdings, LLC- 10% - Member
	  	N/A	  	 	100	% 	 	 	0	% 
						
	259	  	 ISD Corpus Christi, LLC
	  	ISD Renal, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	0	% 

  
 Sch 4.2-31 

															
						
	260	  	ISD I Holding Company, Inc.	  	DVA Healthcare Renal Care, Inc.- 100%- Common - Shareholder	  	3	  	 	1,000	  	 	 	100	% 
						
	261	  	ISD Kansas City, LLC	  	ISD Renal, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	0	% 
						
	262	  	ISD Kendallville, LLC	  	ISD Renal, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	0	% 
						
	263	  	ISD Las Vegas, LLC	  	 ISD Renal, Inc.- 90% - Managing Member

Dialysis Associates of Nevada, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	0	% 
						
	264	  	ISD Lees Summit, LLC	  	ISD Renal, Inc.- 80% - Managing Member Barry C Wood MD- 10% - Member Jim I Mertz MD- 10% - Member	  	N/A	  	 	80	% 	 	 	0	% 
						
	265	  	ISD Plainfield, LLC	  	 ISD Renal, Inc.- 74% - Managing Member
 NIM
Investment Holdings, LLC- 26% - Member
	  	N/A	  	 	74	% 	 	 	0	% 
						
	266	  	ISD Renal, Inc.	  	ISD II Holding Company, Inc.- 100%- Common -Shareholder	  	C-4	  	 	100	  	 	 	0	  
						
	267	  	ISD Schaumburg, LLC	  	ISD Renal, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	0	% 
						
	268	  	ISD Spring Valley, LLC	  	 ISD Renal, Inc.- 51% - Managing Member
 Sun
Valley Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	0	% 

  
 Sch 4.2-32 

															
						
	269	  	ISD Summit Renal Care, LLC	  	 ISD Renal, Inc.- 95% - Managing Member

NEONA, LLC- 5% - Member
	  	N/A	  	 	95	% 	 	 	0	% 
						
	270	  	ISD Trenton, LLC	  	 ISD Renal, Inc.- 92.5% - Managing Member

Mercer Renal Associates- 7.5% - Member
	  	N/A	  	 	92.5	% 	 	 	0.0	% 
						
	271	  	Jacinto Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Ardmore Center Ranch, Inc.- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	272	  	Jedburg Dialysis, LLC	  	Total Renal Care, Inc.- 60% - Managing Member Jedburg Dialysis Partners, LLC- 40% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	273	  	Joshua Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Andover Dialysis Center, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	274	  	JSA Care Partners, LLC	  	HealthCare Partners Accountable Care Organization, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	275	  	JSA Healthcare Corporation	  	JSA Holdings, Inc.- 100% - Shareholder	  	102	  	 	1130.906	  	 	 	100	% 
						
	276	  	JSA Healthcare Nevada, L.L.C.	  	JSA Holdings, Inc.- 100% - Member	  	N/A	  	 	1	  	 	 	100	% 
						
	277	  	JSA Holdings, Inc.	  	HealthCare Partners, LLC- 100% - Member	  	24	  	 	1000	  	 	 	100	% 

  
 Sch 4.2-33 

															
						
	278	  	JSA P5 Nevada, L.L.C.	  	JSA Holdings, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	279	  	Kamiah Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	280	  	Kavett Dialysis, LLC	  	Total Renal Care, Inc.- 70% - Managing Member Advanced Dialysis Institute, Inc.- 30% - Member	  	N/A	  	 	70	% 	 	 	70	% 
						
	281	  	Kearn Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

Georgetown Dialysis, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	282	  	Kenai Dialysis, LLC	  	 Total Renal Care, Inc.- 94.76% - Managing Member

ARIA Investors, LLC- 5.24% - Member
	  	N/A	  	 	94.76	% 	 	 	94.76	% 
						
	283	  	Kerricher Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	284	  	Kidney Care Services, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	285	  	Kidney Centers of Michigan, L.L.C.	  	Renal Treatment Centers - Illinois, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	286	  	Kidney Home Center, LLC	  	 Total Renal Care, Inc.- 51% -Managing Member

Home Dialysis Specialists, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-34 

															
						
	287	  	Kimball Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Member
 NEPA
Nephrology Commonwealth, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	288	  	Kinswa Dialysis, LLC	  	Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member Indus Investments of Fremont, LLC- 40% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	289	  	Knickerbocker Dialysis, Inc.	  	DaVita of New York, Inc.- 100%- Common - Shareholder	  	3	  	 	100	  	 	 	100	% 
						
	290	  	Kobuk Dialysis, LLC	  	Renal Treatment Centers - Illlinois, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	291	  	Lakeshore Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

Renal Partners V, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	292	  	Landing Dialysis, LLC	  	 Total Renal Care, Inc.- 83.1% - Managing Member

Muhammad Ahsan Baig MD- 1.9% - Member
 Alexander Kosenko MD- 5% -
Member
 Peter Barzyk MD- 5% - Member
 Asim Singh MD- 5% -
Member
	  	N/A	  	 	83.10	% 	 	 	83.10	% 
						
	293	  	Landsford Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	294	  	Lapham Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

North Atlanta Nephrology, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 

  
 Sch 4.2-35 

															
						
	295	  	Las Olas De Sequoia, LLC	  	RMS Lifeline Inc.- 51% - Managing Member South Florida Vascular Solutions, LLC- 49% - Member	  	N/A	  	 	51	% 	 	 	51	% 
						
	296	  	Las Vegas Pediatric Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

PEDS HD, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	297	  	Las Vegas Solari Hospice Care LLC	  	HealthCare Partners Nevada, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	298	  	Lassen Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	299	  	Lathrop Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 80% - Managing Member

Thomas Rajan MD- 10% - Member
 Carlos Bahrami MD- 10% -
Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	300	  	Latrobe Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Stanley Vermillion MD- 20% - Member
 Martin Tran, D.O.- 20% -
Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	301	  	Lawrenceburg Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member

Pupizion, Inc.- 20% - Member
 Bepo, Inc.- 20% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	302	  	Leasburg Dialysis, LLC	  	Total Renal Care, Inc.- 55% - Managing Member NASTL Dialysis, LLC- 45% - Member	  	N/A	  	 	55	% 	 	 	55	% 

  
 Sch 4.2-36 

															
						
	303	  	Liberty RC, Inc.	  	DaVita of New York, Inc.- 100%- Common - 100- Shareholder	  	5	  	 	100	% 	 	 	100	% 
						
	304	  	Lifeline Pensacola, LLC	  	RMS Lifeline Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	305	  	Lifeline Vascular Center- Niceville, LLC	  	 RMS Lifeline Inc. - 51% - Managing Member

CVI Management, L.L.C. - 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	306	  	Lifeline Vascular Center Of South Orlando, LLC	  	 RMS Lifeline Inc.- 80% - Managing Member
 IMS
Vascular Partners of Orlando, Inc.- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	307	  	Lifeline Vascular Center- Orlando, LLC	  	 RMS Lifeline Inc.- 80% - Managing Member

Renal Access of Central Florida, LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	308	  	Lighthouse Dialysis, LLC	  	 Total Renal Care, Inc.- 65% - Managing Member

Hanford Community Hospital, dba Adventist Medical Center - CA- 25% - Member

Thong Do, MD, Inc.- 5% - Member
 Tom Yang, MD, Inc.- 5% -
Member
	  	N/A	  	 	65	% 	 	 	65	% 
						
	309	  	Limon Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

District Heights Nephrology, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	310	  	Lincoln Park Dialysis Services, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	3	  	 	1,000	  	 	 	100	% 

  
 Sch 4.2-37 

															
						
	311	  	Lincolnton Dialysis, LLC	  	 Total Renal Care, Inc.- 77% - Managing Member

Renal Partners LLC- 12.5% - Member
 Intermed Consultants Holdings,
LLC- 10.5% - Member
	  	N/A	  	 	89.50	% 	 	 	89.50	% 
						
	312	  	Little Rock Dialysis Centers, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	313	  	Livingston Dialysis, LLC	  	 Total Renal Care, Inc.- 90.453% - Managing Member

Forest Hill Nephrology Group, LLC- 9.547% - Member
	  	N/A	  	 	89.50	% 	 	 	89.50	% 
						
	314	  	Llano Dialysis, LLC	  	 DVA Healthcare Renal Care, Inc.- 60% - Managing Member

East Bay Nephrology Dialysis Holdings II, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	315	  	Lockhart Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

Pahrump HD, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	316	  	Lockport Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	317	  	Lone Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	318	  	Long Beach Dialysis Center, LLC	  	Renal Treatment Centers - California, Inc.- 93.3111% - Managing Member JAYRAJ Enterprises, LLC- 6.6889% - Member	  	N/A	  	 	93.3111	% 	 	 	93.3111	% 
						
	319	  	Longworth Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

CN Ventures, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-38 

															
						
	320	  	Lord Baltimore Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Rolling Run Investors, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	321	  	Lory Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Nephrology Investments of Central Ohio, LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	322	  	Los Arcos Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	323	  	Loup Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

NHS Fenton, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	324	  	Lourdes Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Renal Ventures of Central Florida, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	325	  	Lurleen Dialysis, LLC	  	 Total Renal Care, Inc.- 83% - Managing Member

Mast Enterprise LLC- 17% - Member
	  	N/A	  	 	83	% 	 	 	83	% 
						
	326	  	Mackinaw Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	327	  	Madison Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	328	  	Magnolia Dialysis, LLC	  	 Total Renal Care, Inc. - 60% - Managing Member

Ibis East, LLC - 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-39 

															
						
	329	  	Magoffin Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Deborah Medical Investment, LLC- 10% - Member
 Kidney Care
Ventures - Browns Mills, LLC- 20% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	330	  	Mahoney Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Union County Hospital Association- 6% - Member
 Dennison Renal
Meadowhawk Dialysis, LLC- 21.5% - Member
 RNA Dialysis Ventures, LLC- 21.5% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	331	  	Mammoth Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Orlando Castillo MD- 10% - Member
 Jayesh Shah MD- 8% - Member

Jason Rothschild MD- 10% - Member
 Pablo Ruiz-Ramon MD- 7% -
Member
 Lawrence Wong MD- 5% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	332	  	Manchester Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	333	  	Manito Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	334	  	Manzano Dialysis, LLC	  	 Total Renal Care, Inc.- 95% - Managing Member

Pius Kurian, M.D., LLC- 2.5% - Member
 GVAV, LLC- 2.5% -
Member
	  	N/A	  	 	95	% 	 	 	95	% 
						
	335	  	Maple Grove Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	336	  	Marlton Dialysis Center, LLC	  	ISD Renal, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-40 

															
						
	337	  	Martin Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Hamam, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	338	  	Marysville Dialysis Center, LLC	  	 Renal Treatment Centers - California, Inc.- 80% - Managing Member

Robert Polhemus, M.D.- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	339	  	Mason-Dixon Dialysis Facilities, Inc.	  	 Total Renal Care, Inc.- 100% Preferred (authorized but not issued) - 1,000

Total Renal Care, Inc.- 100%- Common - 2,000
	  	3	  	 	2,000	  	 	 	100	% 
						
	340	  	Mazonia Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	341	  	Medical Group Holding Company, LLC	  	HealthCare Partners, LLC - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	342	  	Memorial Dialysis Center, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Memorial Dialysis Partners, L.P.- 20% - Limited Partner
 Total
Renal Care Texas Limited Partnership- 79% - Limited Partner
	  	N/A	  	 	80	% 	 	 	80	% 
						
	343	  	Mena Dialysis Center, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	344	  	Mendocino Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 58.75% - Managing Member

Dr. Buhriwahla- 2.25% - Member
 Amir A. Memon MD- 10% - Member

Naqi Idris MD- 10% - Member
 Michael J. Wallis MD- 10% -
Member
 Shahzeb R. Naqvi MD- 9% - Member
	  	N/A	  	 	58.75	% 	 	 	58.75	% 

  
 Sch 4.2-41 

															
						
	345	  	Meridian Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	346	  	Mermet Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	347	  	Mesilla Dialysis, LLC	  	 Total Renal Care, Inc.- 95% - Managing Member

Sanju Varghese, M.D.- 1% - Member
 Pius Kurian, M.D., LLC- 2% -
Member
 GVAV, LLC- 2% - Member
	  	N/A	  	 	95	% 	 	 	95	% 
						
	348	  	Mid-City New Orleans Dialysis Center, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	349	  	Middlesex Dialysis Center, LLC	  	Physicians Dialysis Ventures, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	350	  	Milo Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 75% - Managing Member

Cedar-Brainard Surgery Center, Inc.- 25% - Member
	  	N/A	  	 	75	% 	 	 	75	% 
						
	351	  	Minam Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 80% - Managing Member

Amarillo Kidney Specialists LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	352	  	Mission Dialysis Services, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-42 

															
						
	353	  	Mocca Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	354	  	Moncrief Dialysis Center/Total Renal Care Limited Partnership	  	 Total Renal Care, Inc.- 1% - General Partner

TRC West, Inc.- 99% - Limited Partner
	  	N/A	  	 	100	% 	 	 	100	% 
						
	355	  	Morro Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Miami Health, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	356	  	Mountain West Dialysis Services, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

DNPC LLLP- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	357	  	Mulgee Dialysis, LLC	  	Total Renal Care, Inc.- 60% - Managing Member Malay Das MD- 5% - Member Hawthorne Dialysis Holdings, LLC- 35% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	358	  	Muskogee Dialysis, LLC	  	Renal Treatment Centers - West, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	359	  	Nadell Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Kidney Care Quad Cities, LLC- 16.33% - Member
 Renal Dialysis
Associates of Davenport, P.C.- 32.67% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	360	  	National Trail Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Ahsan Ullah MD- 10% - Member
 Sanju Varghese, M.D., LLC- 10% -
Member
 Pius Kurian MD- 10% - Member
 GVAV, LLC- 10% -
Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-43 

															
						
	361	  	 Natomas Dialysis, LLC
	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	362	  	 Navarro Dialysis, LLC
	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	363	  	 Neff Dialysis, LLC
	  	 Total Renal Care, Inc.- 51% - Managing Member

Moorhead Medical Services, LLP- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	364	  	 Nephrology Medical Associates of Georgia, LLC
	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	365	  	 Neptune Artificial Kidney Center, L.L.C.
	  	DVA Renal Healthcare, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	366	  	 New Bay Dialysis, LLC
	  	 Renal Life Link, Inc.- 80% - Managing Member

Mast Enterprise LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	367	  	 New Springs Dialysis, LLC
	  	 Renal Treatment Centers - Illinois, Inc.- 85% - Managing Member

Mast Enterprise LLC- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 
						
	368	  	 Nisene Dialysis, LLC
	  	 Total Renal Care, Inc.- 51% - Managing Member

Lake Region Medical Services, LLP- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	369	  	 Nolia Dialysis, LLC
	  	Renal Treatment Centers - Southeast, LP - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-44 

															
						
	370	  	North Atlanta Dialysis Center, LLC	  	Renal Treatment Centers - Mid-Atlantic, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	371	  	North Austin Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 87% - Managing Member

Cedar Park Dialysis, LLC- 13% - Member
	  	N/A	  	 	87	% 	 	 	87	% 
						
	372	  	North Colorado Springs Dialysis, LLC	  	Renal Treatment Centers - West, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	373	  	Northridge Medical Services Group, Incorporated	  	HealthCare Partners, LLC- 100% - Shareholder	  	8	  	 	1,000	  	 	 	100	% 
						
	374	  	Nuevo Dialysis, LLC	  	Renal Treatment Centers - California, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	375	  	Oasis Dialysis, LLC	  	 Tam V. Ho MD- 5% - Member
 Kidney Associates
Holding Company, L.C.- 15% - Member
 Juan Jorge Olivero MD- 2.5% - Member

Peter Tuan Nguyen MD- 2.5% - Member
 Juan Jose Olivero MD- 5% -
Member
 Renal Treament Centers - Southeast, LP- 70% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	376	  	Ohio River Dialysis, LLC	  	 DVA Renal Healthcare, Inc.- 55% - Managing Member

Nephrology Investments of Florence, LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	377	  	Okanogan Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Lauderhill Dialysis Ventures, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-45 

															
						
	378	  	Olive Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	379	  	Open Access Lifeline, LLC	  	RMS Lifeline Inc.- 80% - Managing Member Open Access Vascular Access Center, Inc.- 20% - Member	  	N/A	  	 	80	% 	 	 	80	% 
						
	380	  	Orange Dialysis, LLC	  	Renal Treatment Centers - California, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	381	  	Ordust Dialysis, LLC	  	 Total Renal Care, Inc. - 51% - Member
 West
Herndon Home Dialysis Investment Group, LLC - 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	382	  	Osage Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Kidney Healthcare, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	383	  	Owasso Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Owasso Investment Venture, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	384	  	Pacheco Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	385	  	Paladina Health, LLC	  	DaVita DPC Holding Co., LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	386	  	Palmetto Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

NHS Arnold, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-46 

															
						
	387	  	Palo Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	388	  	Palomar Dialysis, LLC	  	 Total Renal Care, Inc.- 75.8323% - Managing Member

Livermore Dialysis, LLC- 24.1677% - Member
	  	N/A	  	 	75.83	% 	 	 	75.83	% 
						
	389	  	Parker Dialysis, LLC	  	 MacBen Enterprises, LLC- 10%- Units - Member

Total Renal Care, Inc.- 90%- Units - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	390	  	Parkside Dialysis, LLC	  	 Renal Treatment Centers - Mid-Atlantic, Inc. - 51% - Managing Member

Pikesville Dialysis Investors, LLC - 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	391	  	Patient Pathways, LLC	  	VillageHealth DM, LLC- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	392	  	Patoka Dialysis, LLC	  	 Total Renal Care, Inc.- 65% - Managing Member

Deerfield Dialysis Ventures, LLC- 35% - Member
	  	N/A	  	 	65	% 	 	 	65	% 
						
	393	  	Peaks Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 56% - Managing Member anil sheth- 9% - Member Devaraj Munikrishynappa, M.D.- 1% - Member West Oaks Dialysis- 14% - Member Redentor Roy- 6% - Member Rupinder K. Chatha, M.D.- 6% - Member
Vijayaprakash Sreenarasimhaiah, M.D.- 5% - Member Washington Sereatan, M.D.- 2% - Member Ariel Velasco, M.D.- 1% - Member	  	N/A	  	 	56	% 	 	 	56	% 

  
 Sch 4.2-47 

															
						
	394	  	Pearl Dialysis, LLC	  	 Rajeev Kaul MD- 5% - Member
 Total Renal
Care, Inc.- 55% - Member
 Intermed Consultants Holdings, LLC- 20% - Member

William Scott Stuart, Jr. MD- 20% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	395	  	Pekin Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	396	  	Pendster Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	397	  	Percha Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	398	  	Pfeiffer Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 55% - Managing Member

Westpoint Dialysis Partners- 10% - Member
 Wassem Peracha MD- 35%
- Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	399	  	Physicians Choice Dialysis Of Alabama, LLC	  	Physicians Choice Dialysis, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	400	  	Physicians Choice Dialysis, LLC	  	Physicians Management, LLC- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	401	  	Physicians Dialysis Acquisitions, Inc.	  	Physicians Dialysis, Inc.- 100%- Common - 1,000	  	3	  	 	1,000	  	 	 	100	% 

  
 Sch 4.2-48 

															
						
	402	  	Physicians Dialysis of Houston, LLP	  	 Physicians Dialysis Ventures, Inc.- 64.38% - General Partner

U.T. Physicians- 35.62% - Partner
	  	N/A	  	 	64.38	% 	 	 	64.38	% 
						
	403	  	Physicians Dialysis of Lancaster, LLC	  	 Physicians Dialysis Ventures, Inc.- 85% - Managing Member

Lancaster Dialysis Ventures, LLC- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 
						
	404	  	Physicians Dialysis Ventures, Inc.	  	Physicians Dialysis, Inc.- 100%- Common - Shareholder	  	3	  	 	1,000	  	 	 	100	% 
						
	405	  	Physicians Dialysis, Inc.	  	DaVita HealthCare Partners Inc.- 100%	  	1	  	 	100	  	 	 	100	% 
						
	406	  	Physicians Management, LLC	  	Physicians Dialysis Ventures, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	407	  	Pible Dialysis, LLC	  	Total Renal Care, Inc.- 51% - Managing Member DNPC LLLP- 49% - Member	  	N/A	  	 	51	% 	 	 	51	% 
						
	408	  	Pike Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	409	  	Pine Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

TRUCDAO, L.L.C.- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	410	  	Pittsburgh Dialysis Partners, LLC	  	 Total Renal Care, Inc.- 50% - Managing Member

REA Enterprise In Dialysis, LLC- 50% - Member
	  	N/A	  	 	50	% 	 	 	50	% 

  
 Sch 4.2-49 

															
						
	411	  	Plaine Dialysis, LLC	  	 Total Renal Care, Inc.- 75% - Managing Member

Venu M. Kondle, M.D.- 15% - Member
 Subil Go, M.D.- 5% -
Member
 Robert Polhemus, M.D.- 5% - Member
	  	N/A	  	 	75	% 	 	 	75	% 
						
	412	  	Platte Dialysis, LLC	  	 Renal Treatment Centers - West, Inc.- 51% - Managing Member

Tahlequah City Hospital- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	413	  	Pobello Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 79% - Managing Member

Lone Star Dialysis, LLC- 5% - Member
 Northwest Memorial
Nephrology Associates, PLLC- 5% - Member
 Bellfort Dialysis Partners, LLC- 11% - Member
	  	N/A	  	 	79	% 	 	 	79	% 
						
	414	  	Pointe Dialysis, LLC	  	Total Renal Care, Inc.- 85% - Managing Member Pointe Dialysis Partners, LLC- 15% - Member	  	N/A	  	 	85	% 	 	 	85	% 
						
	415	  	Pokagon Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	416	  	Ponca Dialysis, LLC	  	 Total Renal Care, Inc.- 86% - Managing Member

Healthy Renal, LLC- 14% - Member
	  	N/A	  	 	86	% 	 	 	86	% 
						
	417	  	Ponderosa Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-50 

															
						
	418	  	Portola Dialysis, LLC	  	 Total Renal Care, Inc.- 87.5% - Managing Member

Renal Investors, LLC- 12.5% - Member
	  	N/A	  	 	87.5	% 	 	 	87.5	% 
						
	419	  	Powerton Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	420	  	Priday Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Archana N. Dhawan MD- 10% - Member
 De Paul Ventures - San Jose
Dialysis, LLC- 10% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	421	  	Prineville Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Monroe Nephrology, LLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	422	  	Prings Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	423	  	Rainer Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	424	  	Rancho Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Dover Dialysis Investors, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	425	  	Rayburn Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 80% - Managing Member

Douglas S Park- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	426	  	Red Willow Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-51 

															
						
	427	  	Redcliff Dialysis, LLC	  	 Total Renal Care, Inc.- 72% - Managing Member

Millburn Dialysis, LLC- 28% - Member
	  	N/A	  	 	72	% 	 	 	72	% 
						
	428	  	Reef Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	429	  	Refuge Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

The Everett Clinic, P.S.- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	430	  	Renal Clinic Of Houston, LLC	  	Renal Treatment Centers - Southeast, LP- 75% - Managing Member RPLP Partners- 15% - Member Sealy Nephrology Group- 10% - Member	  	N/A	  	 	75	% 	 	 	75	% 
						
	431	  	Renal Life Link, Inc.	  	DaVita HealthCare Partners Inc.- 100%	  	1	  	 	100	  	 	 	100	% 
						
	432	  	Renal Treatment Centers - California, Inc.	  	Renal Treatment Centers, Inc.- 100%- Common - Shareholder	  	1	  	 	100	  	 	 	100	% 
						
	433	  	Renal Treatment Centers - Hawaii, Inc.	  	Renal Treatment Centers, Inc.- 100%- Common - Shareholder	  	1	  	 	100	  	 	 	100	% 
						
	434	  	Renal Treatment Centers - Illinois, Inc.	  	Renal Treatment Centers, Inc.- 100%- Common - Shareholder	  	1	  	 	100	  	 	 	100	% 

  
 Sch 4.2-52 

															
						
	435	  	Renal Treatment Centers - Mid-Atlantic, Inc.	  	Renal Treatment Centers, Inc.- 100%- Common - Shareholder	  	1	  	 	100	  	 	 	100	% 
						
	436	  	Renal Treatment Centers - Northeast, Inc.	  	Renal Treatment Centers, Inc.- 100%- Common - Shareholder	  	1	  	 	100	  	 	 	100	% 
						
	437	  	Renal Treatment Centers - Southeast, LP	  	 Renal Treatment Centers, Inc.- 1% - General Partner

DaVita - West, LLC- 99% - Limited Partner
	  	N/A	  	 	100	% 	 	 	100	% 
						
	438	  	Renal Treatment Centers - West, Inc.	  	Renal Treatment Centers, Inc.- 100%- Common - Shareholder	  	1	  	 	100	  	 	 	100	% 
						
	439	  	Renal Treatment Centers, Inc.	  	DaVita HealthCare Partners Inc.- 100%	  	1864	  	 	100	  	 	 	100	% 
						
	440	  	Rickwood Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	441	  	Riddle Dialysis, LLC	  	 Renal Treatment Centers - Northeast, Inc.- 70% - Managing Member

Riddle Memorial Hospital- 10% - Member
 Zenith Renal Group, LLC-
20% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	442	  	Rio Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Intermed Consultants Holdings, LLC- 10% - Member
 William Scott
Stuart, Jr. MD- 30% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-53 

															
						
	443	  	Ripley Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	444	  	Rita Ranch Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	445	  	River Valley Dialysis, LLC	  	 DVA Healthcare - Southwest Ohio, LLC- 70.5% - Managing Member

Nephrology Investments of Florence, LLC- 29.5% - Member
	  	N/A	  	 	70.5	% 	 	 	70.5	% 
						
	446	  	RMS Lifeline Inc.	  	Total Renal Care, Inc.- Common - 100%- Shareholder	  	 4 - 9,260,732/shrs,

8-3,346,085/shrs,
 10-

26,094,831/shrs11-

211,640/shrs13-
 243,902/shrs15-

1,406,735/shrs16-

136,996/shrs
	  	 	40,700,921	  	 	 	100	% 
						
	447	  	RNA - DaVita Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

RNA Dialysis Ventures, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	448	  	Roaring Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	449	  	Robinson Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-54 

															
						
	450	  	Rochester Dialysis Center, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 60% - Managing Member

Michigan Dialysis Partners, LLC- 10% - Member
 Rochester Dialysis
Partners, LLC- 30% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	451	  	Rocky Mountain Dialysis Services, LLC	  	Renal Treatment Centers - West, Inc.- 100% - Manager	  	N/A	  	 	100	% 	 	 	100	% 
						
	452	  	Roose Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Stockton Kidney Clinic, LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	453	  	Ross Clark Circle Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	454	  	Roushe Dialysis, LLC	  	Total Renal Care, Inc.- 90% - Managing Member KCM II, LLC- 10% - Member	  	N/A	  	 	90	% 	 	 	90	% 
						
	455	  	Royale Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Cobb Nephrology/Hypertension Associates, P.C.- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	456	  	Rusk Dialysis, LLC	  	 Total Renal Care, Inc.- 90% - Managing Member

Cleveland Nephrology, PLLC- 10% - Member
	  	N/A	  	 	90	% 	 	 	90	% 
						
	457	  	Russell Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

CYEAD Investing, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-55 

															
						
	458	  	Rye Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	459	  	Saddleback Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Lowcountry Medical Clinic, LLC- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	460	  	SafeHarbor Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Tampa Nephrology Holdings, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	461	  	Sahara Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Cheltenham Dialysis Partners, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	462	  	SAKDC-DaVita Dialysis Partners, L.P.	  	Total Renal Care, Inc.- 1% - General Partner SAKDC JV I, LLC- 49% - Limited Partner TRC West, Inc.- 50% - Limited Partner	  	N/A	  	 	51	% 	 	 	51	% 
						
	463	  	San Marcos Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Inland North Dialysis LLC- 35% - Member
 Reiss Investments LLC- 5%
- Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	464	  	Sandlin Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Tango Kilo, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	465	  	Sands Dialysis, LLC	  	 Total Renal Care, Inc.- 85% - Managing Member

Del Boca Dialysis Ventures, LLC- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 

  
 Sch 4.2-56 

															
						
	466	  	Sandusky Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 51% - Managing Member

Firelands Dialysis Services, LLC- 17% - Member
 Gwang O. Kim,
M.D.- 16% - Member
 Essam B. Elashi, M.D.- 16% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	467	  	Santa Fe Springs Dialysis, LLC	  	Renal Treatment Centers - California, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	468	  	Santee Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	469	  	Santiam Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 51% - Managing Member Renal, LLC- 49% - Member	  	N/A	  	 	51	% 	 	 	51	% 
						
	470	  	Sapelo Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Marina Dialysis, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	471	  	Seabay Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	472	  	Seasons Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	473	  	Seminole Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-57 

															
						
	474	  	Seneca Dialysis, LLC	  	 Renal Life Link, Inc.- 65% - Managing Member

Mercy Hospital of Tiffin, Ohio- 35% - Member
	  	N/A	  	 	65	% 	 	 	65	% 
						
	475	  	Shadow Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	476	  	Shayano Dialysis, LLC	  	 Total Renal Care, Inc.- 76.4465% - Managing Member

San Leandro Dialysis, LLC- 23.5535% - Member
	  	N/A	  	 	76.4465	% 	 	 	76.4465	% 
						
	477	  	Shelby Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	478	  	Sherman Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

International Dialysis Group, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	479	  	Shining Star Dialysis, Inc.	  	Total Renal Care, Inc.- 100%- Common - Managing Member	  	3	  	 	100	  	 	 	100	% 
						
	480	  	Shoals Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Hy Sussman MD- 5% - Member
 Southcoast Medical Group, LLC- 35% -
Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	481	  	Shone Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Mazen Abdalla MD- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	482	  	Siena Dialysis Center, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Henderson Dialysis LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-58 

															
						
	483	  	Sierra Rose Dialysis Center, LLC	  	Renal Treatment Centers - West, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	484	  	Silverwood Dialysis, LLC	  	 Total Renal Care, Inc.- 100% - Managing Member

Renal Ventures, LLC- 33.37% - Member
	  	N/A	  	 	100	% 	 	 	100	% 
						
	485	  	Simcoe Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	486	  	Simeon Dialysis, LLC	  	 Total Renal Care, Inc.- 65% - Managing Member

St. Joseph’s Hospital and Medical Center- 35% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	487	  	Skagit Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	488	  	Snowdale Dialysis, LLC	  	Renal Treatment Centers - Mid-Atlantic, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	489	  	Soledad Dialysis Center, LLC	  	Renal Treatment Centers - California, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	490	  	Somerville Dialysis Center, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Mittal Dialysis Enterprises, PLLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	491	  	South Central Florida Dialysis Partners, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Dialysis Partners I, Inc.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-59 

															
						
	492	  	South Fork Dialysis, LLC	  	 Total Renal Care, Inc.- 76% - Managing Member

Central Valley Dialysis Investment Group, LLC- 24% - Member
	  	N/A	  	 	76	% 	 	 	76	% 
						
	493	  	South Shore Dialysis Center, L.P.	  	Total Renal Care, Inc.- 1% - General Partner Mahendra Agraharkar MD- 40% - Limited Partner TRC West, Inc.- 59% - Limited Partner	  	N/A	  	 	60	% 	 	 	60	% 
						
	494	  	Southcrest Dialysis, LLC	  	 Renal Treatment Centers - West, Inc.- 60% - Managing Member

SC Venture, LLC- 25% - Member
 Southcrest Investment Group, LLC-
15% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	495	  	Southern Colorado Joint Ventures, LLC	  	 Renal Treatment Centers - West, Inc.- 60% - Managing Member

Physicians Investment Group I, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	496	  	Southern Hills Dialysis Center, LLC	  	 Renal Treatment Centers - West, Inc.- 60% - Managing Member

SHDC, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	497	  	Southlake Dialysis, LLC	  	 Renal Treatment Centers - West, Inc.- 60% - Managing Member

Broken Arrow Investment Venture, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	498	  	Southwest Atlanta Dialysis Centers, LLC	  	 Renal Treatment Centers - Mid-Atlantic, Inc.- 79% - Managing Member

Total Renal Care, Inc.- 21% - Member
	  	N/A	  	 	100	% 	 	 	100	% 
						
	499	  	Southwest Indiana Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	500	  	Sprewell Dialysis, LLC	  	Renal Treatment Centers, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-60 

															
						
	501	  	Springs Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 90% - Managing Member Flower Mound Dialysis Investors, LLC- 10% - Member	  	N/A	  	 	90	% 	 	 	90	% 
						
	502	  	St. Luke’s Dialysis, LLC	  	Renal Treatment Centers - Illinois, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	503	  	Star Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Renal Care Consultants, PC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	504	  	Steam Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	505	  	Steele Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	506	  	Stewart Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	507	  	Stines Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

TKS Center of Excellence, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	508	  	Storrie Dialysis, LLC	  	 Total Renal Care, Inc.- 95% - Managing Member

Pius Kurian, M.D., LLC- 2.5% - Member
 GVAV, LLC- 2.5% -
Member
	  	N/A	  	 	95	% 	 	 	95	% 
						
	509	  	Strongsville Dialysis, LLC	  	Renal Life Link, Inc.- 90% - Managing Member Rafiq Hussain, M.D.- 5% - Member Insuck Chang- 5% - Member	  	N/A	  	 	90	% 	 	 	90	% 

  
 Sch 4.2-61 

															
						
	510	  	Sugarite Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Mast Enterprise LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	511	  	Sugarloaf Dialysis, LLC	  	 Renal Treatment Centers - Mid-Atlantic, Inc.- 70% - Managing Member

Quality Kidney Care, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	512	  	Summit Dialysis Center, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Hagstrom 1997 Limited Partnership- 10.5% - Limited Partner
 Tam
Viet Ho, M.D.- 4% - Limited Partner
 TRC West, Inc.- 74% - Limited Partner

Juan J. Olivero, M.D.- 10.5% - Limited Partner
	  	N/A	  	 	75	% 	 	 	75	% 
						
	513	  	Sun City Dialysis Center, L.L.C.	  	 Renal Treatment Centers - West, Inc.- 51% - Managing Member

Tara’s Holdings LLC- 29% - Member
 Sandip G Patel MD- 2% -
Member
 The Ishanashni Family Limited Liability Partnership- 10.5% - Member

The Azanaf Family Limited Partnership, Number One- 7.5% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	514	  	Sun City West Dialysis Center, LLC	  	Total Renal Care, Inc.- 51% - Managing Member The Azanaf Family Limited Partnership, Number One- 10.3333% - Member The Ishanashi Family Limited Liability Partnership- 10.83333% - Member William L. Weiss, MD- 6% - Member
Tara’s Holdings LLC- 10.8333% - Member Sandip G Patel MD- 2% - Member Southwest Kidney Dialysis, LLC- 9% - Member	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-62 

															
						
	515	  	Sunset Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	516	  	Swanson Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	517	  	Talbert Health Plan	  	THP Services, Inc. - 100% - Shareholder	  	1	  	 	1000	  	 	 	100	% 
						
	518	  	Talimena Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Nephrology Associates of Miami LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	519	  	Tannor Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	520	  	Taylor Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 60% - Managing Member Taylor Kidney Associates, LLC- 40% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	521	  	Tel-Huron Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	522	  	Tennessee Valley Dialysis Center, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Stan Vermillion, M.D.- 20% - Member
 Martin Tran, D.O.- 20% -
Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	523	  	Teton Dialysis, LLC	  	Renal Treatment Centers - Southeast, LP- 100% - Entity	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-63 

															
						
	524	  	The DaVita Collection, Inc.	  	DaVita HealthCare Partners Inc.- 100%	  	1	  	 	100	% 	 	 	100	% 
						
	525	  	The Woodlands Dialysis Center, LP	  	 Total Renal Care, Inc.- 1% - General Partner

Barry Neeland- 2% - Limited Partner
 Richard Foley- 11.25% -
Limited Partner
 Darshan Tolat, M.D.- 10% - Limited Partner

Gene Forrester, M.D.- 11.25% - Limited Partner
 TRC West, Inc.-
64.5% - Limited Partner
	  	N/A	  	 	65.5	% 	 	 	65.5	% 
						
	526	  	THP Services, Inc.	  	HealthCare Partners, LLC- 100% - Shareholder	  	2	  	 	1,000,000	  	 	 	100	% 
						
	527	  	Tortugas Dialysis, LLC	  	Total Renal Care, Inc.- 60% - Managing Member Mittal Dialysis Enterprises, PLLC- 15% - Member Olufemi Adeleye, M.D.- 25% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	528	  	Total Acute Kidney Care, Inc.	  	Total Renal Care, Inc.- 100%- Common - 100	  	3	  	 	100	  	 	 	100	% 
						
	529	  	Total Renal Care of North Carolina, LLC	  	 Total Renal Care, Inc.- 85% - Managing Member

Neil Realty Co.- 15% - Member
	  	N/A	  	 	85	% 	 	 	85	% 
						
	530	  	Total Renal Care Texas Limited Partnership	  	 Total Renal Care, Inc.- 1% - General Partner

TRC West, Inc.- 99% - Limited Partner
	  	N/A	  	 	100	% 	 	 	100	% 
						
	531	  	Total Renal Care, Inc.	  	DaVita HealthCare Partners Inc.- 100%- Common - 100- Holding Company	  	7	  	 	100	  	 	 	100	% 

  
 Sch 4.2-64 

															
						
	532	  	Total Renal Care/Eaton Canyon Dialysis Center Partnership	  	 Total Renal Care, Inc.- 87.5% - General Partner

Renal Treatment Centers - California, Inc.- 12.5% - Partner
	  	N/A	  	 	100	% 	 	 	100	% 
						
	533	  	Total Renal Laboratories, Inc.	  	Total Renal Care, Inc.- 100%- Common - 100	  	7	  	 	100	  	 	 	100	% 
						
	534	  	Total Renal Research, Inc.	  	Total Renal Care, Inc.- 100%- Common - 500	  	2	  	 	500	  	 	 	100	% 
						
	535	  	Townsend Dialysis, LLC	  	Total Renal Care, Inc.- 51% - Managing Member Broward Home Dialysis Ventures, LLC- 49% - Member	  	N/A	  	 	51	% 	 	 	51	% 
						
	536	  	Transmountain Dialysis, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Southwest Dialysis Consultants, LLC- 40% - Limited Partner
 TRC
West, Inc.- 59% - Limited Partner
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-65 

															
						
	537	  	TRC - Four Corners Dialysis Clinics, L.L.C.	  	 Class A - Chinle - Total Renal Care, Inc. - 51% - Managing Member

Class D - Shiprock - Total Renal Care, Inc. - 51% - Member
 Class
G - Hopi Dialysis Center - Mark F. Bevan, M.D. - 50% - Member
 Class E - Tuba City - Mark F. Bevan, M.D. - 49% - Member

Class G - Hopi Dialysis Center - Total Renal Care, Inc. - 50% - Member

Class C - Kayenta - Total Renal Care, Inc. - 51% - Member
 Class B
- Farmington - Mark F. Bevan, M.D. - 49% - Member
 Class F - Cortez - Total Renal Care, Inc. - 50% - Member

Class E - Tuba City - Total Renal Care, Inc. - 51% - Member
 Class
C - Kayenta - Mark F. Bevan, M.D. - 49% - Member
 Class F - Cortez - Mark F. Bevan, M.D. - 50% - Member

Class A - Chinle - Mark F. Bevan, M.D. - 49% - Member
 Class D -
Shiprock - Mark F. Bevan, M.D. - 49% - Member
 Class B - Farmington - Total Renal Care, Inc. - 51% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	538	  	TRC - Indiana, LLC	  	 Total Renal Care, Inc.- 10% - Managing Member

Renal Treatment Centers - Illinois, Inc.- 90% - Member
	  	N/A	  	 	100	% 	 	 	100	% 
						
	539	  	TRC - Petersburg, LLC	  	East End Dialysis Center, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-66 

															
						
	540	  	TRC El Paso Limited Partnership	  	 Total Renal Care, Inc.- 1% - General Partner

Dionicio Alvarez, M.D.- 49.9% - Limited Partner
 TRC West, Inc.-
49.1% - Limited Partner
	  	N/A	  	 	50.10	% 	 	 	50.10	% 
						
	541	  	TRC of New York, Inc.	  	Total Renal Care, Inc.- 100%- Common - Shareholder	  	C0001	  	 	100	  	 	 	100	% 
						
	542	  	TRC West, Inc.	  	Total Renal Care, Inc.- 100%- Common - 100	  	C0001	  	 	100	  	 	 	100	% 
						
	543	  	TRC-Dyker Heights, L.P.	  	 TRC of New York, Inc.- 70% - General Partner

Sonia Borra, M.D.- 10% - Limited Partner
 New York Methodist
Hospital- 10% - Limited Partner
 Henry Lipner, M.D.- 10% - Limited Partner
	  	N/A	  	 	70	% 	 	 	70	% 
						
	544	  	TRC-Georgetown Regional Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Georgetown University- 20% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	545	  	Tree City Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	546	  	Tugman Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

NHS Chambers, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	547	  	Tulsa Dialysis, LLC	  	Renal Treatment Centers - West, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-67 

															
						
	548	  	Tumalo Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 70% - Managing Member

John A. Stevenson Investments, LLC- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	549	  	Turlock Dialysis Center, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	550	  	Tustin Dialysis Center, LLC	  	 Renal Treatment Centers - California, Inc.- 60% - Managing Member

Renal Investment Partnership- 20% - Member
 NSMG Partners- 20% -
Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	551	  	Tyler Dialysis, LLC	  	 Total Renal Care, Inc.- 81% - Managing Member

Health Management Services Organization, Inc.- 19% - Member
	  	N/A	  	 	81	% 	 	 	81	% 
						
	552	  	Ukiah Dialysis, LLC	  	 ZFSS Enterprises, LLC- 5% - Member
 NHN
Investors - Woodlands II, L.L.C.- 22% - Member
 RPMC Dialysis Enterprises, L.L.C.- 22% - Member

Renal Treatment Centers - Southeast, LP- 51% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	553	  	Unicoi Dialysis, LLC	  	 Total Renal Care, Inc.- 80% - Managing Member

Central New Jersey Dialysis Ventures, LLC- 5% - Member
 Renal
Prospective, LLC- 5% - Member
 EBJV Associates LLC- 10% - Member
	  	N/A	  	 	80	% 	 	 	80	% 
						
	554	  	University Dialysis Center, LLC	  	Total Renal Care, Inc.- 51% - Managing Member Capital Dialysis, LLC- 49% - Member	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-68 

															
						
	555	  	Upper Valley Dialysis, L.P.	  	 Total Renal Care, Inc.- 1% - General Partner

Alfredo Gonzalez, M.D.- 20% - Limited Partner
 Diane Demick, M.D.-
20% - Limited Partner
 TRC West, Inc.- 59% - Limited Partner
	  	N/A	  	 	60	% 	 	 	60	% 
						
	556	  	USC-DaVita Dialysis Center, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

USC Internal Medicine, Inc.- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	557	  	UT Southwestern DVA Healthcare, L.L.P.	  	 UT Southwestern Health Systems- 49% - Partner

DVA Renal Healthcare, Inc.- 51% - Partner
	  	N/A	  	 	51	% 	 	 	51	% 
						
	558	  	Valley Springs Dialysis, LLC	  	 Total Renal Care, Inc.- 55% - Managing Member

Barney, Makhija & Qazi LLC- 45% - Member
	  	N/A	  	 	55	% 	 	 	55	% 
						
	559	  	Verde Dialysis, LLC	  	 Total Renal Care, Inc.- 83% - Managing Member

Mast Enterprise LLC- 17% - Member
	  	N/A	  	 	83	% 	 	 	83	% 
						
	560	  	Versailles Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	561	  	Victory Dialysis, LLC	  	 DVA Healthcare Renal Care, Inc.- 51% - Managing Member

Glen Burnie Investors, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	562	  	VillageHealth DM, LLC	  	Total Renal Care, Inc.- 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 

  
 Sch 4.2-69 

															
						
	563	  	Villanueva Dialysis, LLC	  	 Total Renal Care, Inc.- 65% - Managing Member

Nephro Group, LLC- 35% - Member
	  	N/A	  	 	65	% 	 	 	65	% 
						
	564	  	Volo Dialysis, LLC	  	Total Renal Care, Inc. - 100% - Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	565	  	Walcott Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	566	  	Wallowa Dialysis, LLC	  	 Avita Health System- 6% - Member
 Total Renal
Care, Inc.- 94% - Member
	  	N/A	  	 	94	% 	 	 	94	% 
						
	567	  	Walton Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	568	  	Wauseon Dialysis, LLC	  	 Renal Treatment Centers - Illinois, Inc.- 74% - Managing Member

Indus Investments of Wauseon, LLC- 26% - Member
	  	N/A	  	 	74	% 	 	 	74	% 
						
	569	  	Weldon Dialysis, LLC	  	Total Renal Care, Inc.- 100% - Managing Member	  	N/A	  	 	100	% 	 	 	100	% 
						
	570	  	Wesley Chapel Dialysis, LLC	  	Total Renal Care, Inc.- 54% - Managing Member Florida Medical Clinic, P.A.- 40% - Member FMC Nephrology, LLC- 6% - Member	  	N/A	  	 	54	% 	 	 	54	% 
						
	571	  	West Elk Grove Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-70 

															
						
	572	  	West Sacramento Dialysis, LLC	  	 Total Renal Care, Inc.- 51% - Managing Member

Capital Dialysis, LLC- 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 
						
	573	  	Weston Dialysis Center, LLC	  	 Renal Treatment Centers - Southeast, LP- 86.47% - Managing Member

Cleveland Clinic Florida- 13.53% - Member
	  	N/A	  	 	86.47	% 	 	 	86.47	% 
						
	574	  	Whitney Dialysis, LLC	  	 Total Renal Care, Inc.- 50.1% - Managing Member

PG South LLC- 49.9% - Member
	  	N/A	  	 	50.1	% 	 	 	50.1	% 
						
	575	  	Wilder Dialysis, LLC	  	 Total Renal Care, Inc.- 70% - Managing Member

Mazen Abdalla MD- 30% - Member
	  	N/A	  	 	70	% 	 	 	70	% 
						
	576	  	Willowbrook Dialysis Center, L.P.	  	Total Renal Care, Inc.- 1% - General Partner Rupinder K. Chatha, M.D.- 5% - Limited Partner Krishna Raman, M.D.- 4% - Limited Partner Vijayaprakash Sreenarasimhaiah, M.D.- 0.88% - Limited Partner Washington Sereatan, M.D.- 3% -
Limited Partner Redentor R. Roy, M.D.- 1% - Limited Partner Anil U. Sheth, M.D.- 6% - Limited Partner Rahul Prakash, M.D.- 10% - Limited Partner Umesh Jain- 5% - Limited Partner TRC West, Inc.- 59.12% - Limited Partner Ariel Velasco, M.D.- 5% -
Limited Partner	  	N/A	  	 	60.12	% 	 	 	60.12	% 
						
	577	  	Windcreek Dialysis, LLC	  	 Total Renal Care, Inc.- 73.9038% - Managing Member

Leawood Medical Services LLC- 14.7599% - Member
 DADAC Partners,
LLC- 11.3363% - Member
	  	N/A	  	 	73.9038	% 	 	 	73.9038	% 
						
	578	  	Winds Dialysis, LLC	  	 Renal Treatment Centers - Southeast, LP- 60% - Managing Member

CYEAD Investing, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 

  
 Sch 4.2-71 

															
						
	579	  	Wood Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Cypresswood Renal Associates- 20% - Member
 Cypresswood North
Nephrology- 20% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	580	  	Wooten Dialysis, LLC	  	 Total Renal Care, Inc.- 94% - Managing Member

Viswanathan Iyer MD- 6% - Member
	  	N/A	  	 	94	% 	 	 	94	% 
						
	581	  	Wyandotte Central Dialysis, LLC	  	 Renal Treatment Centers - West, Inc.- 61.6519% - Managing Member

Richard A. Schumacher, M.D.- 5.2894% - Member
 Venu Nair, M.D.-
7.9341% - Member
 Sunganthi Beeki, M.D.- 6.6117% - Member

Andrew J. Stingo MD- 5.2894% - Member
 Kristine Gish Herron, M.D.-
5.2894% - Member
 Kirk A Duncan, M.D.- 7.9341% - Member
	  	N/A	  	 	61.6519	% 	 	 	61.6519	% 
						
	582	  	Wyler Dialysis, LLC	  	DVA Healthcare Renal Care, Inc.- 60% - Managing Member Pryor/Mayes Dialysis, LLC- 40% - Member	  	N/A	  	 	60	% 	 	 	60	% 
						
	583	  	Yargol Dialysis, LLC	  	 Total Renal Care, Inc.- 60% - Managing Member

Chirag Patel MD- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	584	  	Ybor City Dialysis, LLC	  	 Total Renal Care, Inc.- 95% - Managing Member

Jayesh Shah MD- 5% - Member
	  	N/A	  	 	95	% 	 	 	95	% 
						
	586	  	Yucaipa Dialysis, LLC	  	 Renal Treatment Centers - California, Inc.- 60% - Managing Member

NAMG Dialysis Ventures III, LLC- 40% - Member
	  	N/A	  	 	60	% 	 	 	60	% 
						
	587	  	Zara Dialysis, LLC	  	 Total Renal Care, Inc. - 51% - Managing Member

PKA Investment Company, LLC - 49% - Member
	  	N/A	  	 	51	% 	 	 	51	% 

  
 Sch 4.2-72 

															
						
	588	  	Zephyrhills Dialysis Center, LLC	  	 DVA Healthcare Renal Care, Inc.- 54% - Managing Member

Florida Medical Clinic, P.A.- 40% - Member
 FMC Nephrology, LLC-
6% - Member
	  	N/A	  	 	54	% 	 	 	54	% 

  

	1	No record of share certificate. 

	2	No record of share certificate; Assignment Separate From Certificate to current shareholder in file. 

  
 Sch 4.2-73 

 Schedule 4.4 

Consents, Authorizations, Filings and Notices 

None. 

 Schedule 4.8 

Real Property 
 List each
interest in Real Property owned by DaVita and its Subsidiaries and describe the interest therein held by DaVita or its Subsidiaries and whether such owned Real Property is leased to a third party and all leased, sub-leased or otherwise occupied or
utilized by DaVita or its Subsidiaries, as lessee, sublessee, franchisee or licensee and describe the type of interest herein held by DaVita or its Subsidiaries 
  

															
	 Kidney Care

	 Entity
	 	 Center Name
	 	 Address
	 	 City
	 	 St
	 	 Zip
	 	 Owned/Leased
	 	 Subleased

	 Bagby Dialysis, LLC
	 	Henry County	 	671 Ozark Road	 	Abbeville	 	AL	 	36310-2629	 	Leased	 	No
	 Curecanti Dialysis, LLC
	 	Dothan Home Training	 	1763 E. Main Street	 	Dothan	 	AL	 	36301-3045	 	Leased	 	No
	 DVA Healthcare of Tuscaloosa, LLC
	 	Tuscaloosa University	 	220 15th St.	 	Tuscaloosa	 	AL	 	35401	 	Leased	 	No
	 DVA Healthcare of Tuscaloosa, LLC
	 	Fayette	 	2450 Temple Ave North	 	Fayette	 	AL	 	35555-1160	 	Leased	 	No
	 DVA Healthcare of Tuscaloosa, LLC
	 	Pickens County	 	289 William E. Hill Dr.	 	Carollton	 	AL	 	35447-3247	 	Leased	 	No
	 DVA Healthcare of Tuscaloosa, LLC
	 	Greene County	 	544 Us Hwy 43	 	Eutaw	 	AL	 	35462-4017	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Birmingham East	 	1005 East Park Drive	 	Birmingham	 	AL	 	35235-2560	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Athens	 	15953 Athens Limestone Lane	 	Athens	 	AL	 	35613-2214	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Boaz	 	16 Central Henderson Road	 	Boaz	 	AL	 	35957-5922	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Dothan	 	1757 East Main Street	 	Dothan	 	AL	 	36301-3045	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Ozark	 	214 E Hospital Avenue	 	Ozark	 	AL	 	36360	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Dothan	 	216 Graceland	 	Dothan	 	AL	 	36305-7346	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Eufaula	 	220 South Orange Street	 	Eufaula	 	AL	 	36027-1612	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Northport	 	2401 Hospital Drive	 	Northport	 	AL	 	35476-3392	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Rainbow City	 	2800 Rainbow Drive	 	Rainbow City	 	AL	 	35906-5811	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Gadsden	 	409 South 1st Street	 	Gadsden	 	AL	 	35901-5358	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Demopolis	 	511 South Cedar Street	 	Demopolis	 	AL	 	36732-2235	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Tuscaloosa	 	805 Old Mill St	 	Tuscaloosa	 	AL	 	35401-7132	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Ozark	 	TBD/Roy Parker and Highway 231	 	Ozark	 	AL	 	36360-2038	 	Leased	 	Yes

															
	 DVA Renal Healthcare, Inc.
	 	Bessemer	 	100 Westlake Mall	 	Bessemer	 	AL	 	35020	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Sheffield	 	1120 South Jackson Highway	 	Sheffield	 	AL	 	35660-5777	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Russellville	 	14897 Highway 43	 	Russellville	 	AL	 	35653-1954	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Birmingham North	 	1917 32nd Avenue North	 	Birmingham	 	AL	 	35207-3333	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Ensley	 	2630 Avenue East Ensley	 	Birmingham	 	AL	 	35218-2163	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Sylacauga	 	289 James Payton Bolevard	 	Sylacauga	 	AL	 	35150-8064	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Florence	 	422 East Doctor Hicks Blvd.	 	Florence	 	AL	 	35630-5763	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Birmingham Central	 	728 Richard Arrington Blvd South	 	Birmingham	 	AL	 	35233-2106	 	Leased	 	Yes
	 Farragut Dialysis, LLC
	 	Monarch	 	2958 Dorchester Dr.	 	Montgomery	 	AL	 	36116	 	Leased	 	No
	 Flor Dialysis, LLC
	 	Steel City	 	1809 Avenue H	 	Ensley	 	AL	 	35218	 	Leased	 	No
	 Flor Dialysis, LLC
	 	Magic City	 	300 22nd Street South	 	Birmingham	 	AL	 	35233-2209	 	Leased	 	Yes
	 Harris Dialysis, LLC
	 	Limestone County	 	16236 Lucas Ferry Road	 	Athens	 	AL	 	35611	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Walker County	 	260 6th Avenue North	 	Jasper	 	AL	 	35504-7419	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Walker County	 	589 Highway 78 West	 	Jasper	 	AL	 	35504-7419	 	Leased	 	Yes
	 MGD-Medical Practice (Lifeline)
	 	Lf-Huntsville	 	1311 N. Memorial Parkway	 	Huntsville	 	AL	 	35801	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Gadsden	 	300 Medical Center Drive	 	Gadsden	 	AL	 	35903-1139	 	Leased	 	No
	 Physicians Choice Dialysis of Alabama, LLC
	 	Pdi Montgomery	 	1001 Forest Avenue	 	Montgomery	 	AL	 	36106-1181	 	Leased	 	No
	 Physicians Choice Dialysis of Alabama, LLC
	 	Pdi Elmore	 	125 Hospital Drive	 	Wetumpka	 	AL	 	36092-1626	 	Leased	 	No
	 Physicians Choice Dialysis of Alabama, LLC
	 	Pdi Prattville	 	1815 Glynwood Drive	 	Prattville	 	AL	 	36066	 	Leased	 	No
	 Physicians Choice Dialysis of Alabama, LLC
	 	Pdi East Montgomery	 	6890 Winston Blount Blvd	 	Montgomery	 	AL	 	36117-3516	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Brewton	 	1023 Douglas Ave	 	Brewton	 	AL	 	36426-1586	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	South Baldwin	 	150 W Peachtree Avenue	 	Foley	 	AL	 	36535-2244	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Anniston	 	1600 Noble Street	 	Anniston	 	AL	 	36201-3839	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Leeds	 	1650 Maxey Dr.	 	Leeds	 	AL	 	35094-7512	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Renaissance	 	1840 Darby Drive	 	Florence	 	AL	 	35630-2623	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Phenix	 	1900 Opelika Rd	 	Phenix	 	AL	 	36867-3640	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Center Point	 	2337 1st St Ne	 	Center Point	 	AL	 	35215-3619	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Opelika	 	2340 Pepperell Pkwy	 	Opelika	 	AL	 	36801-6240	 	Leased	 	Yes

  
 Sch 4.8-2 

															
	 Renal Treatment Centers-Southeast, LP
	 	Baldwin County Hhd/Pd	 	27880 N Main St	 	Daphne	 	AL	 	36526-7080	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	East Gadsden	 	300 Medical Center Drive	 	Gadsden	 	AL	 	35903-1139	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Crown	 	3007 27th St N	 	Birmingham	 	AL	 	35207-4549	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Hayneville	 	327 Hayneville Plaza	 	Hayneville	 	AL	 	36040	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Gulf Shores	 	3947 Gulf Shores Pkwy	 	Gulf Shores	 	AL	 	36542-2859	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Springville	 	40 Purple Heart Blvd	 	Springville	 	AL	 	35146-4008	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	White Bluff	 	505-F Highway 80 West	 	Demopolis	 	AL	 	36732-4147	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Greystone	 	5406 Highway 280	 	Birmingham	 	AL	 	35242-6592	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Enterprise	 	6002 Boll Weevil Circle	 	Enterprise	 	AL	 	36330-9420	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Perry County	 	611 East Lafayette St.	 	Marion	 	AL	 	36756-2325	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Muscle Shoals	 	716 State St	 	Muscle Shoals	 	AL	 	35661-2940	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Talladega	 	724 East Battle Street	 	Talladega	 	AL	 	35160-2583	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Andalusia	 	757 South Three Notch Street	 	Andalusia	 	AL	 	36420-4403	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Atmore	 	807 East Craig Street	 	Atmore	 	AL	 	36502-3017	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Phenix City	 	TBD	 	Phenix City	 	AL	 	36867-3640	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Jewel	 	West Town Plaza	 	Bessemer	 	AL	 	35020	 	Leased	 	No
	 Ross Clark Circle Dialysis, LLC
	 	Wiregrass	 	1450 Ross Clark Circle	 	Dothan	 	AL	 	36301-4770	 	Leased	 	No
	 Sprewell Dialysis, LLC
	 	Model City	 	1724 Leighton Avenue	 	Anniston	 	AL	 	36207-3833	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Birmingham (Southland Division Office)	 	3500 Blue Lake Drive	 	Birmingham	 	AL	 	30328	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Saline County	 	1200 North Main Street	 	Benton	 	AR	 	72015-3341	 	Leased	 	Yes
	 Capes Dialysis, LLC
	 	Independence County	 	1710 Harrison St	 	Batesville	 	AR	 	72501-7315	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Newport	 	1914 & 1912 Mclain	 	Newport	 	AR	 	72112-3659	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Little Rock Midtown	 	2 Lile Court	 	Little Rock	 	AR	 	72205-6241	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Pulaski County	 	202 John Harden Drive	 	Jacksonville	 	AR	 	72076-3775	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Conway	 	2445 Christina Lane	 	Conway	 	AR	 	72034-6798	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Searcy	 	3210 Langley Drive	 	Searcy	 	AR	 	72143-6020	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Springhill	 	3401 Springhill Drive	 	North Little Rock	 	AR	 	72117-2925	 	Leased	 	No
	 Capes Dialysis, LLC
	 	Springhill Home Training	 	3401 Springhill Drive	 	North Little Rock	 	AR	 	72117-2945	 	Leased	 	No

  
 Sch 4.8-3 

															
	 DVA Healthcare Renal Care, Inc.
	 	CLSD-El Dorado	 	308 1/2 Cordell	 	El Dorado	 	AR	 	71730	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	Central Little Rock	 	6 Freeway Drive	 	Little Rock	 	AR	 	72204-2486	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Marion	 	1120 State Highway 77	 	Marion	 	AR	 	72364-9046	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Osceola	 	1332 W Keiser Ave	 	Osceola	 	AR	 	72370-2919	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Osceola	 	1420 W Keiser Avenue	 	Osceola	 	AR	 	72370-2919	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Marion	 	2921 Highway 77 S	 	Marion	 	AR	 	72364-9046	 	Leased	 	No
	 Little Rock Dialysis Centers, LLC
	 	Jacksonville	 	400 Tp White Drive	 	Jacksonville	 	AR	 	72076-3287	 	Leased	 	No
	 Little Rock Dialysis Centers, LLC
	 	North Little Rock	 	4505 East Mccain Boulevard	 	North Little Rock	 	AR	 	72117-2902	 	Leased	 	No
	 Mena Dialysis Center, LLC
	 	Mena	 	1106 Crestwood Circle	 	Mena	 	AR	 	71953-5516	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Ashley	 	1019 Fred Lagrone Dr	 	Crossett	 	AR	 	71635-4546	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Ouachita Valley	 	1114 Washington St Nw	 	Camden	 	AR	 	71701-3827	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Hot Springs	 	115 Wrights St	 	Hot Springs	 	AR	 	71913-6240	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Forrest City	 	1501 N Washington St	 	Forrest City	 	AR	 	72335-2152	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Malvern	 	1590 Tanner St	 	Rockport	 	AR	 	72104-2023	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Ouachita	 	1900 Malvern Ave	 	Hot Springs	 	AR	 	71901-7776	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Bradley County	 	204 North Bragg Street	 	Warren	 	AR	 	71671-2500	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Marked Tree	 	216 Hester Parker Drive	 	Marked Tree	 	AR	 	72365-2023	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Degray	 	312 Professional Park Dr	 	Arkadelphia	 	AR	 	71923-5355	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	River Valley	 	3121 W 2nd Ct	 	Russellville	 	AR	 	72801-4504	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	South Little Rock	 	6115 Baseline Road	 	Little Rock	 	AR	 	72209-4725	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	South Arkansas	 	620 W Grove St	 	El Dorado	 	AR	 	71730-4462	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bentonville	 	1104 Se 30th Street	 	Bentonville	 	AR	 	72712-4290	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hempstead	 	1803 South Laurel	 	Hope	 	AR	 	71801-8219	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Southwest Arkansas	 	219 North Dudney	 	Magnolia	 	AR	 	71753-3110	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Southwest Arkansas	 	225 North Dudney	 	Magnolia	 	AR	 	71753-3110	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Siloam Springs	 	500 S. Mount Olive St.	 	Siloam Springs	 	AR	 	72761-3602	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fayetteville	 	509 E Millsap Rd	 	Fayetteville	 	AR	 	72703-4862	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Springdale	 	708 Quandt Ave	 	Springdale	 	AR	 	72764-5309	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Miller County	 	816 East Street	 	Texarkana	 	AR	 	71854-6808	 	Leased	 	No

  
 Sch 4.8-4 

															
	 Barton Dialysis, LLC
	 	Tucson Central	 	2901, 2903, 2905 E. Grant Road	 	Tucson	 	AZ	 	85716-2717	 	Leased	 	No
	 Calaveras Dialysis, LLC
	 	Papago	 	5115 East Thomas Road, Suite 115	 	Phoenix	 	AZ	 	85018-7914	 	Leased	 	No
	 Desert Rocks Dialysis, LLC
	 	Sweetwater Ridge	 	7362 W Thunderbird Rd	 	Peoria	 	AZ	 	85381-5028	 	Leased	 	No
	 DNP Management Company, LLC
	 	Dnp Phoenix Management Service	 	2149 Warner Road	 	Tempe	 	AZ	 	85284-3495	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Yuma	 	2130 W 24th Street	 	Yuma	 	AZ	 	85364-6122	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Yuma South	 	7179 East 31st Place	 	Yuma	 	AZ	 	85365-8392	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Division	 	121 W. Ajo Way	 	Tucson	 	AZ	 	94010-1816	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Nogales	 	1605 N Industrial Park Drive	 	Nogales	 	AZ	 	85621-4577	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tucson West	 	1780 West Anklam Road	 	Tuscon	 	AZ	 	85745-2632	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tucson West Land	 	1780 West Anklan Road	 	Tucson	 	AZ	 	85745-2632	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tucson South Central	 	2024 East Irvington	 	Tucson	 	AZ	 	85714-1825	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tucson South	 	3662 South 16th Avenue	 	Tucson	 	AZ	 	85713-6001	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Sierra Vista	 	629 North Hwy 90	 	Sierra Vista	 	AZ	 	85635-2257	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tucson East	 	6420 E. Broadway, Suite C300	 	Tucson	 	AZ	 	85710-3534	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Pascua Yaqui Tribe	 	7490 S. Camino De Oeste	 	Tucson	 	AZ	 	85746-9308	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Sells	 	Health And Humans Services Complex, Highway 86 Milepost 113	 	Sells	 	AZ	 	85634-3030	 	Leased	 	No
	 Grand Home Dialysis, LLC
	 	Grand Home	 	14674 W Mountain View Blvd	 	Surprise	 	AZ	 	85374-2708	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Cottonwood	 	1697-1699 East Cottonwood Street	 	Cottonwood	 	AZ	 	86326-4120	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Cottonwood	 	203 S Candy Lane	 	Cottonwood	 	AZ	 	86326-4120	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Prescott	 	980 Willow Creek Road	 	Prescott	 	AZ	 	86301-1619	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Phoenix 1b	 	1100 E University Drive	 	Tempe	 	AZ	 	85281	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Phoenix	 	2620 North 3rd St	 	Phoenix	 	AZ	 	85008	 	Leased	 	No
	 Northwest Tucson Dialysis, LLC
	 	Northwest Tucson	 	2945 West Ina Road	 	Tucson	 	AZ	 	85741-2366	 	Leased	 	No
	 Rita Ranch Dialysis, LLC
	 	Rita Ranch	 	7355 South Houghton Road	 	Tucson	 	AZ	 	85747-9379	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Mountain Vista	 	10238 East Hampton Avenue	 	Mesa	 	AZ	 	85209-3317	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Mesa	 	1134 East University Drive	 	Mesa	 	AZ	 	85203-8048	 	Leased	 	No

  
 Sch 4.8-5 

															
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Arrowhead	 	20325 North 51st Avenue	 	Glendale	 	AZ	 	85308-4625	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Tempe	 	2149 Warner Road	 	Tempe	 	AZ	 	85284-3496	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Power Road	 	301 S Power Road	 	Mesa	 	AZ	 	85206-5243	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Phoenix	 	337 East Coronado Rd	 	Phoenix	 	AZ	 	85004-1582	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Raven	 	3540 E. Baseline Road	 	Phoenix	 	AZ	 	85042-9628	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Maryvale	 	4845 West Mcdowell Road	 	Phoenix	 	AZ	 	85035-4076	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Gilbert	 	5222 East Baseline Road	 	Gilbert	 	AZ	 	85234-2963	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Wickenburg	 	811 N Tegner	 	Wickenburg	 	AZ	 	85390-5409	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Estrella	 	8410 West Thomas Road	 	Phoenix	 	AZ	 	85037-3356	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Brookwood	 	8910 N. 43rd Avenue, Suite 107	 	Glendale	 	AZ	 	85302-5340	 	Leased	 	No
	 Southwest Kidney-DaVita Dialysis Partners, LLC
	 	Ocotillo	 	975 W Chandler Heights Rd	 	Chandler	 	AZ	 	85248-5724	 	Leased	 	No
	 Sun City Dialysis Center, L.L.C.
	 	Palm Brook	 	14664 North Del Webb Boulevard	 	Sun City	 	AZ	 	85351-2137	 	Leased	 	No
	 Sun City West Dialysis Center, LLC
	 	Westbrook	 	13907 W. Camino Del Sol	 	Sun City West	 	AZ	 	85375-4405	 	Leased	 	No
	 Sun Desert Dialysis, LLC
	 	Desert Dialysis	 	13000 N 103rd Ave	 	Sun City	 	AZ	 	85351	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Yuma III	 	1185 South Redondo Way	 	Yuma	 	AZ	 	85365-5305	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Westside Divisional Office	 	225 E German Rd	 	Gilbert	 	AZ	 	85297-2909	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Camelback	 	7321 East Osborn Road	 	Scottsdale	 	AZ	 	85251-6418	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Rim Country	 	809 W. Longhorn Road	 	Payson	 	AZ	 	85541-4280	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Desert Mountain	 	9220 East Mountain View Road	 	Scottsdale	 	AZ	 	85258-5134	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Kayenta VI Estates 132	 	#30 Owl Rock Drive	 	Kayenta	 	AZ	 	86033	 	Leased	 	No

  
 Sch 4.8-6 

															
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City 136-B	 	136B S Oak	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np18	 	500 Edgewater Dr	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Center	 	500 Edgewater Drive	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Chinle	 	District 10	 	Chinle	 	AZ	 	86503-0879	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Kayenta	 	Highway 163, PO Box 217	 	Kayenta	 	AZ	 	86033	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Hopi	 	Highway 264, PO Box 964	 	Polacca	 	AZ	 	86042	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Kayenta Mobile Home 236	 	Kayenta Mobile Home Park, Space #236	 	Kayenta	 	AZ	 	86033	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Kayenta Mobile Home 297	 	Kayenta Mobile Home Park, Space #297	 	Kayenta	 	AZ	 	86033	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Kayenta Mobile Home 302	 	Kayenta Mobile Home Park, Space #302	 	Kayenta	 	AZ	 	86033	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Chinle	 	PO Box 879	 	Chinle	 	AZ	 	86503-0879	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Hopi #2028	 	PO Box 923	 	Polacca	 	AZ	 	86042	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Hopi-#2033	 	PO Box 923	 	Polacca	 	AZ	 	86042	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np09	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np20	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np50	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No

  
 Sch 4.8-7 

															
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np72	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np80	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Np89	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Tuba City Sp71	 	Tuba City Mobile Home Park	 	Tuba City	 	AZ	 	86045-2905	 	Leased	 	No
	 Animas Dialysis, LLC
	 	Montebello	 	1721 W. Whittier Blvd	 	Montebello	 	CA	 	90640-4004	 	Leased	 	No
	 Animas Dialysis, LLC
	 	East Los Angeles	 	950 Eastern Avenue	 	Los Angeles	 	CA	 	90022-4801	 	Leased	 	No
	 Arcadia Gardens Dialysis, LLC
	 	Arcadia	 	3722 E. Colorado Boulevard	 	Pasadena	 	CA	 	91107-3872	 	Leased	 	No
	 Beverly Hills Dialysis Partnership
	 	Beverly Hills	 	50 North La Cienega Blvd	 	Beverly Hills	 	CA	 	90211-2284	 	Leased	 	No
	 Bohama Dialysis, LLC
	 	Rancho Cucamonga Home	 	8219 Rochester Ave	 	Rancho Cucamonga	 	CA	 	91730-0722	 	Leased	 	No
	 Bruno Dialysis, LLC
	 	Mainplace	 	972 Town And County Road	 	Orange	 	CA	 	92868-4714	 	Leased	 	No
	 Bullards Dialysis, LLC
	 	Placerville	 	3311 Coach Lane	 	Cameron Park	 	CA	 	95682-1446	 	Leased	 	No
	 Butano Dialysis, LLC
	 	Sequoia	 	440 N. 11th Avenue	 	Hanford	 	CA	 	93230	 	Leased	 	No
	 Canyon Springs Dialysis, LLC
	 	Moreno Valley	 	22555 Alessandro Blvd, Bldg 5	 	Moreno Valley	 	CA	 	92553-8533	 	Leased	 	Yes
	 Capital Dialysis Partnership
	 	North Highlands	 	4612 Roseville Road	 	North Highlands	 	CA	 	95660-5175	 	Leased	 	No
	 Capital Dialysis Partnership
	 	Orangevale	 	9267 Greenback Lane	 	Orangevale	 	CA	 	95662-4863	 	Leased	 	No
	 Channel Dialysis, LLC
	 	Bermuda Dunes	 	78-010 Wildcat Dr.	 	Palm Desert	 	CA	 	92211-1116	 	Leased	 	No
	 Cheraw Dialysis, LLC
	 	El Sobrante	 	3380 San Pablo Dam Road	 	San Pablo	 	CA	 	94803-7218	 	Leased	 	No
	 Chipeta Dialysis, LLC
	 	Los Alamitos	 	4141 Katella Avenue	 	Los Alamitos	 	CA	 	90720-3406	 	Leased	 	No
	 Cinco Rios Dialysis, LLC
	 	Sun City	 	1702 Illinois Ave	 	Perris	 	CA	 	92571-9371	 	Leased	 	No
	 Clearee Dialysis, LLC
	 	North Madera	 	720 North I Street	 	Madera	 	CA	 	93637-3079	 	Leased	 	No
	 Clover Dialysis, LLC
	 	Stevens Creek	 	100 O’Conner Drive	 	San Jose	 	CA	 	95128-1628	 	Leased	 	No
	 Cobbles Dialysis, LLC
	 	Channel Island	 	3541 West Fifth Street	 	Oxnard	 	CA	 	93030	 	Leased	 	Yes
	 Conconully Dialysis, LLC
	 	Laurel Meadows	 	3 Rossi Circle	 	Salias	 	CA	 	93907-2356	 	Leased	 	Yes
	 Coral Dialysis, LLC
	 	Stockton	 	1810 S. Fresno Avenue	 	Stockton	 	CA	 	95202	 	Leased	 	No
	 Crystals Dialysis, LLC
	 	Highland Ranch	 	7223 Church Street, Suite A-14	 	Highland	 	CA	 	92346-6837	 	Leased	 	No

  
 Sch 4.8-8 

															
	 Davita - Riverside II, LLC
	 	Magnolia West	 	11161 Magnolia Avenue	 	Riverside	 	CA	 	92505-3605	 	Leased	 	No
	 Davita - Riverside II, LLC
	 	Norco	 	1901 Town & Country Drive	 	Norco	 	CA	 	92860-3611	 	Leased	 	No
	 Davita - Riverside, LLC
	 	Diamond Valley	 	1030 E. Florida Avenue	 	Hemet	 	CA	 	92543-4511	 	Leased	 	No
	 Davita - Riverside, LLC
	 	Murrieta	 	27602 Clinton Keith Rd	 	Murrieta	 	CA	 	92562-8513	 	Leased	 	No
	 Davita - Riverside, LLC
	 	Hemet	 	3050 W Florida Avenue	 	Hemet	 	CA	 	92545-3619	 	Leased	 	No
	 Davita - Riverside, LLC
	 	Lake Elsinore	 	32291 Mission Trail Road, Bldg S	 	Lake Elsinore	 	CA	 	92530	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Park Place-Casita	 	2201 Park Place, Unit 102	 	El Segundo	 	CA	 	90245-4814	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	San Jose	 	3162 S White Road, Suite 250	 	San Jose	 	CA	 	90245-4814	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Playa Davita	 	601 Hawaii Street	 	El Segundo	 	CA	 	90245-4814	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Cabana- IT	 	841 Apollo Street	 	El Segundo	 	CA	 	90245-4814	 	Leased	 	No
	 DaVita Rx, LLC
	 	Davita Rx Divisonal Office	 	1111 Bayhill Drive	 	San Bruno	 	CA	 	94066-2302	 	Leased	 	No
	 DaVita Rx, LLC
	 	Davita Rx	 	Airport Trade Center	 	San Bruno	 	CA	 	94066-2302	 	Leased	 	No
	 Dolores Dialysis, LLC
	 	Cathedral City	 	30885 Date Palm Drive	 	Cathedral City	 	CA	 	92234-2958	 	Leased	 	No
	 Doves Dialysis, LLC
	 	Carmel Mountain	 	9850 A-D Carmel Mountain Road	 	San Diego	 	CA	 	92129-2892	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Glendale	 	1000 E Palmer Avenue	 	Glendale	 	CA	 	91205	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Manteca	 	1156 South Main Street	 	Manteca	 	CA	 	95337-9505	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Burbank	 	1211 San Fernando Blvd	 	Burbank	 	CA	 	91504-4234	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	North Hollywood	 	12126 Victory Blvd	 	Los Angeles	 	CA	 	91606-3205	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Inglewood	 	125 E Arbor Vitae	 	Inglewood	 	CA	 	90301	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Westminster South	 	14014 Magnolia Street	 	Westminster	 	CA	 	92683-4736	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Daly City	 	1498 Southgate Avenue	 	Daly City	 	CA	 	94015-4015	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	San Francisco	 	1499 Webster St.	 	San Francisco	 	CA	 	94115-3705	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	The Grove-Irvine-Admin	 	15253 Bake Parkway	 	Irvine	 	CA	 	92618	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	The Grove-Irvine Corporate West-Admin	 	15261 & 15271 Laguna Canyon Road	 	Irvine	 	CA	 	92618	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Costa Mesa	 	1590 Scenic	 	Costa Mesa	 	CA	 	92626-1400	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Victor Valley	 	16041 & 16049 Kamana Road	 	Apple Valley	 	CA	 	92307-1331	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	White Memorial	 	1700 Cesar E Chavez Ave	 	Los Angeles	 	CA	 	90033-2472	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Fontana	 	17590 Foothill Boulevard	 	Fontana	 	CA	 	92335-8416	 	Leased	 	No

  
 Sch 4.8-9 

															
	 DVA Healthcare Renal Care, Inc.
	 	Pomona	 	2111 N. Garey Ave	 	Pomona	 	CA	 	91767-2328	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Berkeley	 	2655 Shattuck Ave	 	Berkeley	 	CA	 	94704-3237	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Selma	 	2711 Cinema Way	 	Selma	 	CA	 	93662-2662	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Imperial	 	2738 W Imperial Highway	 	Inglewood	 	CA	 	90303-3111	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Berkeley	 	2920 Telegraph Avenue	 	Berkeley	 	CA	 	94705-2031	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Northeast Bakersfield	 	3761 Mall View Rd	 	Bakersfield	 	CA	 	93306-3048	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hanford	 	402 West Eighth Street	 	Hanford	 	CA	 	93230-4536	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Tracy	 	425 West Beverly Place, Suite A & B	 	Tracy	 	CA	 	95376-3086	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Chino	 	4445 Riverside Ave	 	Chino	 	CA	 	91710-3961	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Fresno	 	4753 W. Shaw Avenue	 	Fresno	 	CA	 	93722-6209	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Oakland	 	5354 Claremont Ave	 	Oakland	 	CA	 	94618-1035	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Stockton Home Training	 	545 East Cleveland, Suite C	 	Stockton	 	CA	 	95204-5535	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Los Banos	 	60 G Street Building 5	 	Los Banos	 	CA	 	93635-3658	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Upland	 	600 North 13th Ave	 	Upland	 	CA	 	91786-4957	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Chinatown	 	636 Clay Street	 	San Francisco	 	CA	 	94111-2502	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Bakersfield South	 	7701 White Lane	 	Bakersfield	 	CA	 	93309-0201	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Bakersfield	 	8501 Brimhall, Building 500	 	Bakersfield	 	CA	 	93312-2258	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Delano	 	905 Main Street	 	Delano	 	CA	 	93215-3714	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Alameda County	 	10700 Macarthur Blvd	 	Oakland	 	CA	 	94605-5260	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Palm Springs	 	1074-8 N. Palm Canyon Drive	 	Palm Springs	 	CA	 	92262-4854	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Division	 	1100 Grove Avenue	 	Ontario	 	CA	 	91761-4572	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Anaheim	 	1107 West La Palma Ave	 	Anaheim	 	CA	 	92801-2804	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Atwater	 	1201 Commerce Avenue	 	Atwater	 	CA	 	95301-5224	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Santa Monica	 	1260 15th Street	 	Santa Monica	 	CA	 	90404-1136	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	San Ysidro	 	1445 30th St	 	San Diego	 	CA	 	92154-3496	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Huntington Beach	 	16892 Bolsa Chica	 	Huntington Beach	 	CA	 	92649-3571	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Los Angeles Downtown	 	2001-2021 South Flower Street	 	Los Angeles	 	CA	 	90007-1342	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Escondido	 	203 East Second Avenue	 	Escondido	 	CA	 	92025-4212	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	San Diego Acute	 	2232 Verus Street #D	 	San Diego	 	CA	 	92154-4706	 	Leased	 	No

  
 Sch 4.8-10 

															
	 DVA Renal Healthcare, Inc.
	 	Fullerton	 	230 Orangefair Mall	 	Fullerton	 	CA	 	92832-3037	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Saddleback	 	23141 Plaza Pointe Drive	 	Laguna Hills	 	CA	 	92653-1425	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Central Valley Acutes	 	2370 North Walnut Avenue	 	Turlock	 	CA	 	95340-0964	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Mission Viejo	 	27640 Marguerite Parkway	 	Mission Viejo	 	CA	 	92692-3604	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	San Diego East	 	292 Euclid Ave	 	San Diego	 	CA	 	92114-3629	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Auburn	 	3126 Professional Drive	 	Auburn	 	CA	 	95603-2411	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	San Juan Capistrano South	 	31736 Rancho Viejo Road	 	San Juan Capistrano	 	CA	 	92675-2783	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Encinitas	 	332 Santa Fe Drive	 	Encinitas	 	CA	 	92024-5143	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Merced	 	3393 G Street	 	Merced	 	CA	 	95340-1308	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Grass Valley	 	360 Crown Point Circle	 	Grass Valley	 	CA	 	95945-2543	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Visalia	 	5429 West Cypress	 	Visalia	 	CA	 	93277-8341	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tulare	 	545 East Tulare Avenue	 	Tulare	 	CA	 	93274-4220	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Benicia	 	560 First Street	 	Benicia	 	CA	 	94510-3293	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Pacific Gold Reg 2	 	568 E Herndon Ave	 	Fresno	 	CA	 	93720-2989	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Hi-Desert	 	58457 - 29 Palms Highway	 	Yucca Valley	 	CA	 	92284-5879	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Banning	 	6090 West Ramsey St	 	Banning	 	CA	 	92220-3052	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	College	 	6535 University Ave	 	San Diego	 	CA	 	92115-5810	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Fresno North	 	770 West Pinedale Avenue	 	Fresno	 	CA	 	93711-5744	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tower	 	8635 West Third Street, Suite 560w	 	Los Angeles	 	CA	 	90048-6110	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	San Diego South	 	995 Gateway Center Way	 	San Diego	 	CA	 	92102-4550	 	Leased	 	No
	 Edisto Dialysis, LLC
	 	Garden Grove	 	13052 and 13054 N. Harbor Blvd.	 	Garden Grove	 	CA	 	92843-1744	 	Leased	 	No
	 Eldrist Dialysis, LLC
	 	Arcadia Oaks	 	721 West Huntington Drive	 	Arcadia	 	CA	 	91007	 	Leased	 	No
	 Elk Grove Dialysis Center, LLC
	 	Elk Grove	 	9281 Office Park Circle	 	Elk Grove	 	CA	 	95758-8069	 	Leased	 	No
	 Flagler Dialysis, LLC
	 	Moreno Valley	 	22620 Goldencrest Drive	 	Moreno Valley	 	CA	 	92553-9032	 	Leased	 	No
	 Fullerton Dialysis Center, LLC
	 	Crossroads	 	Crossroads Center	 	Fullerton	 	CA	 	92831-1707	 	Leased	 	No
	 Glassland Dialysis, LLC
	 	Los Angeles	 	3901 S. Western Avenue	 	Los Angeles	 	CA	 	90062-1112	 	Leased	 	No
	 Goliad Dialysis, LLC
	 	North Sacramento	 	251 Lathrop Way, Suite A	 	Sacramento	 	CA	 	95815-4223	 	Leased	 	No
	 Greater Los Angeles Dialysis Centers, LLC
	 	Wilshire	 	1212 Wilshire Blvd	 	Los Angeles	 	CA	 	90017-1902	 	Leased	 	No
	 Greater Los Angeles Dialysis Centers, LLC
	 	University Park	 	3986 S Figueroa Street	 	Los Angeles	 	CA	 	90037-1222	 	Leased	 	No

  
 Sch 4.8-11 

															
	 Greater Los Angeles Dialysis Centers, LLC
	 	Hollywood	 	5108 Sunset Blvd.	 	Los Angeles	 	CA	 	90027-5708	 	Leased	 	No
	 Griffin Dialysis, LLC
	 	Calvine	 	8243 E. Stockton Blvd.	 	Sacramento	 	CA	 	95828-8200	 	Leased	 	No
	 Hanford Dialysis, LLC
	 	Hanford	 	900 North Douty Street	 	Hanford	 	CA	 	93230-3918	 	Leased	 	No
	 Harmony Dialysis, LLC
	 	Fairfield Downtown	 	1800 North Texas Street	 	Fairfield	 	CA	 	94533-4441	 	Leased	 	No
	 Hart Dialysis, LLC
	 	Anaheim West	 	1821 - 1823 West Lincoln Avenue	 	Anaheim	 	CA	 	92801-6731	 	Leased	 	No
	 Hawaiian Gardens Dialysis Center, LLC
	 	Hawaiian Gardens	 	22437 Norwalk Blvd	 	Hawaiian Gardens	 	CA	 	90716-1510	 	Leased	 	No
	 Hazelton Dialysis, LLC
	 	Sunny Crest	 	1950 Sunny Crest Drive	 	Fullerton	 	CA	 	92835-3638	 	Leased	 	No
	 Hills Dialysis, LLC
	 	Carabello	 	757 East Washington Blvd	 	Los Angeles	 	CA	 	90021-3016	 	Leased	 	No
	 Hunter Dialysis, LLC
	 	Moorpark	 	883 Patriot Drive	 	Moorpark	 	CA	 	93021-3352	 	Leased	 	Yes
	 Huntington Park Dialysis, LLC
	 	Huntington Park	 	5942 Rugby Ave	 	Huntington Park	 	CA	 	90255-2803	 	Leased	 	No
	 Hyde Dialysis, LLC
	 	Calvine Home	 	8231 East Stockton Blvd.	 	Sacramento	 	CA	 	95828-8202	 	Leased	 	No
	 Kamiah Dialysis, LLC
	 	Pomona Valley	 	2703 S. Towne Avenue	 	Pomona	 	CA	 	91766-6206	 	Leased	 	No
	 Lighthouse Dialysis, LLC
	 	Lemoore	 	1345 W Bush Street	 	Lemoore	 	CA	 	93245-3303	 	Leased	 	No
	 Llano Dialysis, LLC
	 	El Cerrito	 	10690 San Pablo Avenue	 	El Cerrito	 	CA	 	94530-2620	 	Leased	 	Yes
	 Llano Dialysis, LLC
	 	Vallejo	 	121-123 Hospitaldrive	 	Vallejo	 	CA	 	94589-2562	 	Leased	 	Yes
	 Llano Dialysis, LLC
	 	GHc-Vallejo	 	125 Hospital Drive	 	Vallejo	 	CA	 	94589-2562	 	Owned	 	No
	 Llano Dialysis, LLC
	 	San Pablo	 	14020 San Pablo Ave	 	San Pablo	 	CA	 	94806-3604	 	Leased	 	Yes
	 Long Beach Dialysis Center, LLC
	 	Bixby Knolls	 	3744 Long Beach Blvd	 	Long Beach	 	CA	 	90807-3310	 	Leased	 	No
	 Manito Dialysis, LLC
	 	Glendora Foothills	 	750 West route 66	 	Glendora	 	CA	 	91740-4162	 	Leased	 	No
	 Marysville Dialysis Center, LLC
	 	Marysville	 	1015 8th Street	 	Marysville	 	CA	 	95901-5271	 	Leased	 	No
	 Mazonia Dialysis, LLC
	 	El Dorado	 	2977 Redondo Avenue	 	Long Beach	 	CA	 	90806-2445	 	Leased	 	No
	 Meridian Dialysis, LLC
	 	Anaheim	 	1324 S. Euclid Street	 	Anaheim	 	CA	 	92802-2002	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Orange County	 	12555 Garden Grove Blvd.	 	Garden Grove	 	CA	 	92843-1906	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Solano	 	127 Hospital Drive	 	Vallejo	 	CA	 	94589-2562	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline-Long Beach	 	16506 Lakewood Blvd	 	Bellflower	 	CA	 	90706-5165	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Inglewood	 	323 North Prairie Avenue	 	Inglewood	 	CA	 	90301-4501	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Riverside 1b	 	36955 Cook Street	 	Palm Desert	 	CA	 	92211-6066	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Riverside	 	4100 Latham Street	 	Riverside	 	CA	 	92501	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Fresno	 	568 E Herndon Ave	 	Fresno	 	CA	 	93720-2907	 	Leased	 	No

  
 Sch 4.8-12 

															
	 MGD-Medical Practice (Lifeline)
	 	San Diego	 	6402 El Cajon Boulevard	 	San Diego	 	CA	 	92115-2645	 	Leased	 	No
	 MGD-NAMG-Home Dialysis, LLC
	 	Riverside	 	3660 Park Sierra Dr	 	Riverside	 	CA	 	92505	 	Leased	 	No
	 MGD-NAMG-Home Dialysis, LLC
	 	Riverside Pd Central	 	3660 Park Sierra Dr	 	Riverside	 	CA	 	92505-3071	 	Leased	 	No
	 MGD-NAMG-Home Dialysis, LLC
	 	Riverside Pd	 	3660 Park Sierra Drive, Suite 108	 	Riverside	 	CA	 	92505-3071	 	Leased	 	No
	 Mulgee Dialysis, LLC
	 	Hawthorne	 	14204 Prairie Ave	 	Hawthorne	 	CA	 	90250-7908	 	Leased	 	No
	 Natomas Dialysis, LLC
	 	Natomas	 	30 Golden Land Ct	 	Sacramento	 	CA	 	95834-2423	 	Leased	 	No
	 Nuevo Dialysis, LLC
	 	Laguna Hills	 	25352 Cabot Road	 	Laguna Hills	 	CA	 	92653-5521	 	Leased	 	No
	 Olive Dialysis, LLC
	 	South Gate	 	9848 Atlantic Blvd	 	South Gate	 	CA	 	90280-5219	 	Leased	 	No
	 Orange Dialysis, LLC
	 	Whittier Hills	 	10055 Whittwood Drive	 	Whittier	 	CA	 	90603-2313	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Shine-Covina	 	65 N First Avenue	 	Arcadia	 	CA	 	91006-3207	 	Leased	 	No
	 Palomar Dialysis, LLC
	 	Livermore	 	3201 Doolan Rd, Suite 175	 	Livermore	 	CA	 	94551-9610	 	Leased	 	No
	 Percha Dialysis, LLC
	 	Daly City Home Training	 	74 Camaritas Ave	 	South San Francisco	 	CA	 	94080-3133	 	Leased	 	No
	 Plaine Dialysis, LLC
	 	Yuba City	 	1525 Plumas Court	 	Yuba City	 	CA	 	95991-2971	 	Leased	 	No
	 Pokagon Dialysis, LLC
	 	Bluff Rd	 	100 W. Washington Blvd.	 	Monebello	 	CA	 	90640-2170	 	Leased	 	No
	 Ponca Dialysis, LLC
	 	Tully Road Home Training	 	1290 Tully Road	 	San Jose	 	CA	 	95122-3069	 	Leased	 	No
	 Priday Dialysis, LLC
	 	Silicon Valley Home Training	 	725 Ridder Park Drive, Suites 50-70	 	San Jose	 	CA	 	95131-2431	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Long Beach Harbor (UCLA)	 	1075 East Pacific Coast Highway	 	Long Beach	 	CA	 	90806-5089	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Creekside	 	141 Parker Street	 	Vacaville	 	CA	 	95688-3921	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Clearlake	 	14400 Olympic Drive	 	Clearlake	 	CA	 	95422-8809	 	Leased	 	Yes
	 Renal Treatment Centers-California, Inc.
	 	Bellflower	 	15736 Woodruff Avenue	 	Bellflower	 	CA	 	90706-4018	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Santa Ana	 	1820 E Deere Ave.	 	Santa Ana	 	CA	 	92705-5721	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Ontario	 	1950 Grove Ave, Suites 101-105	 	Ontario	 	CA	 	91761-5693	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Santa Monica	 	2020 Santa Monica Blvd.	 	Santa Monica	 	CA	 	90404-2139	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Corona	 	2057 Compton Avenue, Bldg #6	 	Corona	 	CA	 	92881-7287	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Concord	 	2300 Stanwell Drive	 	Concord	 	CA	 	94520-4841	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	South Chico	 	2345 Forest Ave	 	Chico	 	CA	 	95928-7641	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Red Bluff	 	2455 Sister Mary Columba Drive	 	Red Bluff	 	CA	 	96080-4364	 	Leased	 	No

  
 Sch 4.8-13 

															
	 Renal Treatment Centers-California, Inc.
	 	Moreno Valley	 	26900 Cactus Ave.	 	Moreno Valley	 	CA	 	92555-3912	 	Leased	 	Yes
	 Renal Treatment Centers-California, Inc.
	 	Tokay	 	312 South Fairmont Ave, Suite A	 	Lodi	 	CA	 	95240-3840	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Rosemead	 	3212 Rosemead Blvd	 	El Monte	 	CA	 	91731-2807	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Napa	 	3900-C Bel Aire Plaza	 	Napa	 	CA	 	94558-2823	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Mountain Vista	 	4041 North University Parkway	 	San Bernadino	 	CA	 	92407-1823	 	Leased	 	Yes
	 Renal Treatment Centers-California, Inc.
	 	Temecula	 	40945 County Center Drive, Suite #E	 	Temecula	 	CA	 	92591-6006	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Imperial Care	 	4345 E. Imperial Highway	 	Lynwood	 	CA	 	90262-2318	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Riverside	 	4361 Latham Street	 	Riverside	 	CA	 	92501-1767	 	Leased	 	Yes
	 Renal Treatment Centers-California, Inc.
	 	Fairfield	 	4660 Central Way	 	Fairfield	 	CA	 	94534-1803	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Brea	 	595 Tamarack Avenue Suite A	 	Brea	 	CA	 	92821-3125	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Tokay Home Pd	 	777 South Ham Lane, Suite L	 	Lodi	 	CA	 	95242-3593	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Lakeport	 	804 - 11th Street, Suite 2	 	Lakeport	 	CA	 	95453-4102	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	San Bernardino II	 	894 Hardt Street	 	San Bernardino	 	CA	 	92408-2854	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Vacaville	 	941 Merchant Street	 	Vacaville	 	CA	 	95688-5315	 	Leased	 	No
	 Roose Dialysis, LLC
	 	Stockton Ca	 	1523 East March Lane, Suite 200	 	Stockton	 	CA	 	95210-5607	 	Leased	 	No
	 San Marcos Dialysis LLC
	 	San Marcos	 	2135 Montiel Road, Building B	 	San Marcos	 	CA	 	92069-3511	 	Leased	 	No
	 Santa Fe Springs Dialysis, LLC
	 	Santa Fe Springs	 	11149 Washington Blvd.	 	Whittier	 	CA	 	90606-3007	 	Leased	 	No
	 Sapelo Dialysis, LLC
	 	San Leandro	 	2551 Merced Street	 	San Leandro	 	CA	 	94577-4207	 	Leased	 	No
	 Seabay Dialysis, LLC
	 	San Bernardino	 	966 E. Hospitality Lane	 	San Bernardino	 	CA	 	92408-2818	 	Leased	 	No
	 Shadow Dialysis, LLC
	 	Antelope	 	6406 Tupelo Drive, Suite A	 	Citrus Heights	 	CA	 	95621-1780	 	Leased	 	No
	 Shayano Dialysis, LLC
	 	San Leandro	 	15555 E. 14th Street, Suite 520	 	San Leandro	 	CA	 	94578-1949	 	Leased	 	No
	 Skagit Dialysis, LLC
	 	Silicon Valley	 	725 Ridder Park Drive, Suite 10	 	San Jose	 	CA	 	95131-2431	 	Leased	 	No
	 Soledad Dialysis Center, LLC
	 	Soledad	 	901 Los Coches Drive	 	Soledad	 	CA	 	93960-2995	 	Leased	 	No
	 South Fork Dialysis, LLC
	 	Herndon	 	560 E. Herndon Avenue, Suite 101	 	Fresno	 	CA	 	93720-2907	 	Leased	 	No
	 Stewart Dialysis, LLC
	 	Richmond	 	4200 Mcdonald Avenue	 	Richmond	 	CA	 	94805-2315	 	Leased	 	No
	 Sunset Dialysis, LLC
	 	Sunset	 	3071 Gold Canal Drive	 	Rancho Cordova	 	CA	 	95670-6129	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mills Dialysis	 	100 S. San Mateo Drive	 	San Mateo	 	CA	 	94401-3805	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Palo Alto	 	1000 Marshall Street	 	Redwood City	 	CA	 	94063-2027	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Santa Fe Springs	 	10012 Norwalk Blvd	 	Santa Fe Springs	 	CA	 	90670-3345	 	Leased	 	No

  
 Sch 4.8-14 

															
	Total Renal Care, Inc.	 	San Luis Osbispo	 	1043 Marsh Street	 	San Luis Obispo	 	CA	 	93401-3629	 	Leased	 	No
	Total Renal Care, Inc.	 	UCLA	 	10630 Santa Monica	 	Los Angeles	 	CA	 	90025-4837	 	Leased	 	Yes
	Total Renal Care, Inc.	 	Silverado Dialysis	 	1100 Trancas Street	 	Napa	 	CA	 	94558-2921	 	Leased	 	No
	Total Renal Care, Inc.	 	Exeter	 	1116 W Visalia Road	 	Exeter	 	CA	 	93221-1482	 	Leased	 	No
	Total Renal Care, Inc.	 	Visalia At Home Pd	 	1120 N. Chinowth Street	 	Visalia	 	CA	 	93291-7896	 	Leased	 	No
	Total Renal Care, Inc.	 	Airport—Sunrise	 	11300 Hawthorne Blvd.	 	Hawthorne	 	CA	 	90304-2715	 	Leased	 	Yes
	Total Renal Care, Inc.	 	Coalinga	 	1147 Phelps Avenue	 	Coalinga	 	CA	 	93210-9662	 	Leased	 	No
	Total Renal Care, Inc.	 	Delta View	 	1150 E Leland Road	 	Pittsburg	 	CA	 	94565-5319	 	Leased	 	No
	Total Renal Care, Inc.	 	Downey Kaiser	 	11611 Bellflower Blvd	 	Downey	 	CA	 	90241-5408	 	Leased	 	No
	Total Renal Care, Inc.	 	Kenneth Hahn	 	11854 Wilmington Ave.	 	Willowbrook	 	CA	 	90059-3016	 	Leased	 	No
	Total Renal Care, Inc.	 	Norwalk II Ca	 	11913 Firestone Blvd.	 	Norwalk	 	CA	 	90650-2904	 	Leased	 	No
	Total Renal Care, Inc.	 	Walnut Creek West	 	1221 Rossmoor Parkway	 	Walnut Creek	 	CA	 	94596	 	Leased	 	No
	Total Renal Care, Inc.	 	Norwalk	 	12375 E. Imperial Hwy, D-3	 	Norwalk	 	CA	 	90650-3129	 	Leased	 	No
	Total Renal Care, Inc.	 	Vallejo	 	125 Corporate Place	 	Vallejo	 	CA	 	94590-6968	 	Leased	 	No
	Total Renal Care, Inc.	 	Anaheim Harbor	 	1260 N. Harbor Blvd	 	Anaheim	 	CA	 	92801	 	Leased	 	No
	Total Renal Care, Inc.	 	Belmont	 	1261 East Hillsdale Boulevard	 	Foster City	 	CA	 	94404-1236	 	Leased	 	No
	Total Renal Care, Inc.	 	Tully Road	 	1290 Tully Road	 	San Jose	 	CA	 	95122-3069	 	Leased	 	No
	Total Renal Care, Inc.	 	Sunrise	 	13039 Hawthorne Blvd	 	Hawthorne	 	CA	 	90304-2715	 	Leased	 	Yes
	Total Renal Care, Inc.	 	Carson	 	1309 E Carson St	 	Carson	 	CA	 	90745-1631	 	Leased	 	No
	Total Renal Care, Inc.	 	Templeton	 	1310 Las Tablas Rd	 	Templeton	 	CA	 	93465-9746	 	Leased	 	No
	Total Renal Care, Inc.	 	Alhambra	 	1315 Alahmbra Blvd	 	Sacramento	 	CA	 	95816-5245	 	Leased	 	No
	Total Renal Care, Inc.	 	East Bay Peritoneal	 	13939 E. 14th St., Suite# 110	 	San Leandro	 	CA	 	94578-2613	 	Leased	 	No
	Total Renal Care, Inc.	 	San Rafael	 	1415 3rd Street	 	San Rafael	 	CA	 	94901-2826	 	Leased	 	No
	Total Renal Care, Inc.	 	Hesperia	 	14163 Main Street	 	Hesperia	 	CA	 	92345-8097	 	Leased	 	No
	Total Renal Care, Inc.	 	Los Gatos	 	14251 Winchester Boulevard, Suite 100	 	Los Gatos	 	CA	 	95032-1811	 	Leased	 	No
	Total Renal Care, Inc.	 	West Glendale	 	1429 S. Glendale Avenue	 	Glendale	 	CA	 	91205-3313	 	Leased	 	Yes
	Total Renal Care, Inc.	 	San Francisco Home Training	 	1493 Webster Street	 	San Francisco	 	CA	 	94115-3705	 	Leased	 	No
	Total Renal Care, Inc.	 	Discovery Home Training (fka Santa Maria PD) (PD Only)	 	1503 East Main Street	 	Santa Maria	 	CA	 	93458	 	Leased	 	No

  
 Sch 4.8-15 

															
	 Total Renal Care, Inc.
	 	North Glendale	 	1505 Wilson Terrace, Suite 190	 	Glendale	 	CA	 	91206-4015	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Covina	 	1547 West Garvey Avenue North	 	West Covina	 	CA	 	91790-2139	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Gateway Plaza	 	1580 Rosecrans Avenue	 	Compton	 	CA	 	90220-1001	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lodi	 	1610 W. Kettleman Lane	 	Lodi	 	CA	 	95242-4210	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Joy Of Dixon	 	1640 North Lincoln Street	 	Dixon	 	CA	 	95620-9268	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Palmdale	 	1643 E. Palmdale Boulevard	 	Palmdale	 	CA	 	93550-4847	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Yosemite Street	 	1650 West Yosemite Avenue	 	Manteca	 	CA	 	95337-5193	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Artesia Home Training	 	16506 Lakewood Blvd	 	Bellflower	 	CA	 	90706-5165	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fountain Valley	 	17150 Euclid Ave	 	Fountain Valley	 	CA	 	92708-4092	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Burlingame Dialysis	 	1720 El Camino Real	 	Burlingame	 	CA	 	94010-3225	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Antelope Valley	 	1759 West Avenue J, #102	 	Lancaster	 	CA	 	93534-2703	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ceres	 	1768 Mitchell Road	 	Ceres	 	CA	 	95307-2156	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Valley	 	17815 Ventura Boulevard	 	Encino	 	CA	 	91316-3600	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Redding	 	1876 Park Marina Drive	 	Redding	 	CA	 	96001-0913	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Oxnard	 	1900 Outlet Center Drive	 	Oxnard	 	CA	 	93036-0677	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Cerritos	 	19222 Poineer Blvd	 	Cerritos	 	CA	 	90703-6601	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Boyle Heights	 	1934 East 1st Street	 	Los Angeles	 	CA	 	90033-3413	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Greater El Monte	 	1938 Tyler Avenue	 	South El Monte	 	CA	 	91733-3623	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cornerhouse	 	2005 Naglee	 	San Jose	 	CA	 	95128-4801	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Beverlywood	 	2080 Century Park East	 	Los Angeles	 	CA	 	90035	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Indian Wells Valley	 	212 South Richmond Road	 	Ridgecrest	 	CA	 	93555-4434	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Harbor UCLA	 	21600 S. Vermont Avenue	 	Torrance	 	CA	 	90502-1940	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hayward II	 	21615 Hesperian Blvd	 	Hayward	 	CA	 	94541-7026	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Colma	 	2201 Junipero Serra Boulevard	 	Daly City	 	CA	 	94014-1908	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Garfield Pd	 	228 N. Garfield Avenue	 	Monterey Park	 	CA	 	91754-1709	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pacific	 	2351 Clay St	 	San Francisco	 	CA	 	94115-1931	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Region	 	2420 Del Paso Road	 	Sacramento	 	CA	 	95834-9673	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Camarillo	 	2438 Ponderosa Drive	 	Camarillo	 	CA	 	93010-2465	 	Leased	 	Yes

  
 Sch 4.8-16 

															
	 Total Renal Care, Inc.
	 	Sanger	 	2517 Jensen Avenue Building B	 	Sanger	 	CA	 	93657-2251	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Santa Paula	 	253 March St	 	Santa Paula	 	CA	 	93060-2511	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Hayward	 	254 Jackson Street	 	Hayward	 	CA	 	94544-1907	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Monterey Park #D102	 	2560 Corp. Place, Suite #D102	 	Monterey Park	 	CA	 	91754-7612	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ash Tree	 	2666 N Grove Industrial Drive	 	Fresno	 	CA	 	93727-1552	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mission	 	2700 Geary Street	 	San Francisco	 	CA	 	94103	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ventura	 	2705 Loma Vista Road	 	Ventura	 	CA	 	93003-1596	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Silver Lake-Formerly 3163	 	2723 West Temple Street	 	Los Angeles	 	CA	 	90026-4723	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Simi Valley	 	2950 North Sycamore Dr Ste 100	 	Simi Valley	 	CA	 	93065-1210	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Archway	 	3001 Health Care Way, Building E	 	Modesto	 	CA	 	95356-8503	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Archway Modesto	 	3001 Health Care Way, Building E	 	Modesto	 	CA	 	95356-8503	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Antioch	 	3100 Delta Fair Blvd.	 	Antioch	 	CA	 	94509-4001	 	Leased	 	No
	 Total Renal Care, Inc.
	 	United	 	3111 Long Beach Blvd	 	Long Beach	 	CA	 	90807-5015	 	Leased	 	No
	 Total Renal Care, Inc.
	 	East San Jose	 	3162 S. White Road # 100	 	San Jose	 	CA	 	95148-4019	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Pismo Beach	 	320 James Way	 	Pismo Beach	 	CA	 	93449-2875	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Union City	 	32930 Alvarado Niles Road	 	Union City	 	CA	 	94587-8101	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Santa Clara	 	3572 Homestead Ave	 	Santa Clara	 	CA	 	95051-5118	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kidney Dialysis Care Unit	 	3600 E. Martin Luther King Blvd	 	Lynwood	 	CA	 	90262-2607	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Thousand Oaks	 	375 Rolling Oaks Drive	 	Thousand Oaks	 	CA	 	91361-1024	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Walnut Creek At Home	 	400 North Wiget Lane	 	Walnut Creek	 	CA	 	94598	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Manzanita Pd	 	4005 Manzanita Avenue	 	Carmichael	 	CA	 	95608-1779	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Clinic	 	4005 Manzanita Avenue	 	Carmichael	 	CA	 	95608-1779	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Walnut Creek	 	404 North Wiget Lane	 	Walnut Creek	 	CA	 	94598-2408	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Anaheim Hills	 	4201 E La Palma Ave	 	Anaheim	 	CA	 	92807-1815	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bakersfield Oak Street	 	422 Oak Street	 	Bakersfield	 	CA	 	93304-1744	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Oakland Chabot EBN	 	4242 - 4246 Broadway	 	Oakland	 	CA	 	94601	 	Leased	 	No
	 Total Renal Care, Inc.
	 	San Jose Hhd/Pd	 	4400 B & C Stevens Creek Boulevard	 	San Jose	 	CA	 	95129-1104	 	Leased	 	No

  
 Sch 4.8-17 

															
	 Total Renal Care, Inc.
	 	Davies	 	45 Castro Street	 	San Francisco	 	CA	 	94114-1032	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lakewood	 	4611 Silva Street	 	Lakewood	 	CA	 	90712-2512	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Merced East	 	464 E Yosemite Ave	 	Merced	 	CA	 	95340-8489	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sacramento Mobile Services Acute	 	4650 Northgate Blvd	 	Sacramento	 	CA	 	95834-1156	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Madera	 	501 East Almond Avenue	 	Madera	 	CA	 	93637-5661	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Montclair	 	5050 Palo Verde Street	 	Montclair	 	CA	 	91763-2329	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dinuba	 	510 E. North Way	 	Dinuba	 	CA	 	93618-1653	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bakersfield	 	5143 Office Park Drive	 	Bakersfield	 	CA	 	93309-0660	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Washington Plaza	 	516-522 E. Washington Blvd.	 	Los Angeles	 	CA	 	90015-3723	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Chico	 	530 Cohasset Road	 	Chico	 	CA	 	95926-2212	 	Leased	 	No
	 Total Renal Care, Inc.
	 	La Palma	 	5451 La Palma Ave	 	La Palma	 	CA	 	90623-1731	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Delta	 	555 West Benjamin Holt Drive	 	Stockton	 	CA	 	95207-3839	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fresno Pd	 	568 East Herndon Avenue	 	Fresno	 	CA	 	93720-2989	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pleasanton	 	5720 Stoneridge Mall Road	 	Pleasanton	 	CA	 	94588-2882	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Avalon	 	5807 S. Avalon Avenue	 	Los Angeles	 	CA	 	90047	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Nephron	 	5812-5820 Downey Ave	 	Long Beach	 	CA	 	90805-4517	 	Leased	 	No
	 Total Renal Care, Inc.
	 	San Rafael	 	650 Las Gallinas Blvd	 	San Rafael	 	CA	 	94903-3620	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Valley	 	6840 Sepulveda Blvd.	 	Van Nuys	 	CA	 	91405-4401	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Sacramento	 	7000 Franklin Blvd., Suite 880	 	Sacramento	 	CA	 	95823-1838	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Florin	 	7000 Stockton Blvd.	 	Sacramento	 	CA	 	95823-2312	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Premier	 	7612 Atlantic Ave	 	Cudahy	 	CA	 	90201-5020	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sierra Terrific Div.	 	7755 Pardee Lane	 	Oakland	 	CA	 	94621-3040	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Crescent Heights	 	8151 Beverly Blvd	 	Los Angeles	 	CA	 	90048-4514	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Paramount	 	8319 Alondra Blvd.	 	Paramount	 	CA	 	90723-4403	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Iowa Street	 	8333 Iowa Street	 	Downey	 	CA	 	90241-4994	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Downey	 	8600-8630 Florence Ave.	 	Downey	 	CA	 	90240-4017	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Arvin	 	902 Bear Mountain Blvd	 	Arvin	 	CA	 	93203-1317	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Montclair	 	9140 Monte Vista Avenue	 	Montclair	 	CA	 	91763-2329	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South San Francisco	 	925 El Camino Real	 	South San Francisco	 	CA	 	94080-3203	 	Leased	 	No

  
 Sch 4.8-18 

															
	 Total Renal Care, Inc.
	 	Salinas	 	955 Blanco Cir, Suite C	 	Salinas	 	CA	 	93901-4452	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Visalia Vineyard	 	TBD	 	Visalia	 	CA	 	93292-3643	 	Leased	 	No
	 Total Renal Care-Eaton Canyon Dialysis Center Partnership
	 	Eaton Canyon	 	2551 East Washington Blvd	 	Pasadena	 	CA	 	91107-1446	 	Leased	 	No
	 Turlock Dialysis Center, LLC
	 	Turlock	 	50 W Syracuse Avenue	 	Turlock	 	CA	 	95380-3143	 	Leased	 	Yes
	 Tustin Dialysis Center, LLC
	 	Tustin	 	2090 N. Tustin Ave	 	Santa Ana	 	CA	 	92705-7869	 	Leased	 	No
	 University Dialysis Center, LLC
	 	University	 	777 Campus Commons Drive	 	Sacramento	 	CA	 	95825-8344	 	Leased	 	No
	 USC-Davita Dialysis Center, LLC
	 	USC University Park	 	2310 Alcazar St.	 	Los Angeles	 	CA	 	90033-5327	 	Leased	 	No
	 VillageHealth DM, LLC
	 	Riverside	 	4361 Latham Street	 	Riverside	 	CA	 	92501-4332	 	Leased	 	No
	 Villanueva Dialysis, LLC
	 	Mojave Sage	 	17207 Jasmine St	 	Victorville	 	CA	 	92395-7786	 	Leased	 	No
	 Walcott Dialysis, LLC
	 	Newport Irvine	 	4300 Von Karman Ave	 	Newport Beach	 	CA	 	92660	 	Leased	 	No
	 Walker Dialysis, LLC
	 	Hayward III	 	1661 Industrial Parkway West	 	Hayword	 	CA	 	94544-7046	 	Leased	 	No
	 Walker Dialysis, LLC
	 	Fremont	 	2599 Stevenson Blvd	 	Fremont	 	CA	 	94538-2315	 	Leased	 	No
	 Walker Dialysis, LLC
	 	Fremont At Home	 	39355 California St	 	Fremont	 	CA	 	94538-1447	 	Leased	 	No
	 Walton Dialysis, LLC
	 	Colton Ranch	 	1405 West Valley Boulevard	 	Colton	 	CA	 	92324-1910	 	Leased	 	No
	 Weldon Dialysis, LLC
	 	Roseville	 	1836 Sierra Gardens Drive	 	Roseville	 	CA	 	95661-2943	 	Leased	 	No
	 West Elk Grove Dialysis LLC
	 	West Elk Grove	 	2208 Kausen Drive, Suite 100	 	Elk Grove	 	CA	 	95758-7174	 	Leased	 	No
	 West Sacramento Dialysis, LLC
	 	West Sacramento	 	3450 Industrial Blvd.	 	West Sacramento	 	CA	 	95691-5053	 	Leased	 	No
	 Yucaipa Dialysis, LLC
	 	Yucaipa	 	33487 Yucaipa Blvd	 	Yucaipa	 	CA	 	92399-2064	 	Leased	 	No
	 Brighton Dialysis Center, LLC.
	 	Brighton	 	4700 East Bromley Lane	 	Brighton	 	CO	 	80601-7821	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Casa Del Mundo Office	 	1551 Wewatta Street	 	Denver	 	CO	 	80202-5117	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Denver Headquarters	 	2000 16th Street	 	Denver	 	CO	 	80202	 	Owned	 	No
	 DaVita Healthcare Partners Inc.
	 	Wisdom Warehouse	 	2500 W 4th Avenue	 	Denver	 	CO	 	80202-5117	 	Leased	 	No
	 Durango Dialysis Center, LLC
	 	Durango	 	72 Suttle St	 	Durango	 	CO	 	81303-6829	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	APEX Hospital Svcs Region 01 Office	 	2369 South Trenton Way, Unit H	 	Denver	 	CO	 	80226	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Denver	 	130 Rampart Way	 	Denver	 	CO	 	80230-6404	 	Leased	 	No
	 Mountain West Dialysis Services, LLC
	 	Parker Co	 	10371 Parkglenn Way	 	Parker	 	CO	 	80138-3871	 	Leased	 	No

  
 Sch 4.8-19 

															
	 Mountain West Dialysis Services, LLC
	 	Lakewood Crossing	 	1057 Wadsworth Blvd #100	 	Lakewood	 	CO	 	80226-4361	 	Leased	 	No
	 Mountain West Dialysis Services, LLC
	 	North Metro	 	12365 Huron Street	 	Westminster	 	CO	 	80234-3498	 	Leased	 	No
	 Mountain West Dialysis Services, LLC
	 	Longmont	 	1700 Kylie Drive	 	Longmont	 	CO	 	80501-9617	 	Leased	 	No
	 Mountain West Dialysis Services, LLC
	 	Lakewood-Co	 	1750 Pierce Street	 	Lakewood	 	CO	 	80214-1434	 	Leased	 	Yes
	 Mountain West Dialysis Services, LLC
	 	Boulder	 	2880 Folsom Dr	 	Boulder	 	CO	 	80304-3769	 	Leased	 	No
	 Mountain West Dialysis Services, LLC
	 	Thornton	 	8800 Fox Drive	 	Thornton	 	CO	 	80260-6880	 	Leased	 	Yes
	 Mountain West Dialysis Services, LLC
	 	Arvada	 	9950 West 80th Avenue	 	Arvada	 	CO	 	80005-3914	 	Leased	 	No
	 North Colorado Springs Dialysis, LLC
	 	North Colorado Springs	 	6071 E Woodmen Rd	 	Colorado Springs	 	CO	 	80923-2610	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Mountain View Corporate Center	 	12202 Airport Way	 	Broomfield	 	CO	 	80021-2588	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Denver	 	1515 Wynkoop Street	 	Denver	 	CO	 	80202	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Vail Region 02	 	1700 Basset Street	 	Denver	 	CO	 	53005-6864	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	DPC Paladina Health Colorado Springs	 	6475 Wall Street, Suite 201	 	Colorado Springs	 	CO	 	80918-8337	 	Leased	 	No
	 Pible Dialysis, LLC
	 	West Lakewood	 	11700 West 2nd Place, St. Anthony’s Medical Plaza II	 	Lakewood	 	CO	 	80228-1704	 	Leased	 	No
	 Pible Dialysis, LLC
	 	Ne Aurora	 	509 N. Sable Blvd.	 	Aurora	 	CO	 	80011-0801	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Littleton	 	209 W County Line Road	 	Littleton	 	CO	 	80129-1901	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Denver-Downing	 	2900 Downing Street	 	Denver	 	CO	 	80205-4699	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Interstate	 	334 South 13th Street	 	Burlington	 	CO	 	80807-2414	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	South Denver	 	850 East Harvard Avenue	 	Denver	 	CO	 	80210-5030	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Westminster	 	9053 Harlan Street	 	Westminster	 	CO	 	80031-2908	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Aurora	 	Amc Ii, Suite# 100, 1411 S. Potomac	 	Aurora	 	CO	 	80012-4536	 	Leased	 	No
	 Rocky Mountain Dialysis Services, LLC
	 	East Aurora	 	482 S. Chambers Road	 	Aurora	 	CO	 	80017-2092	 	Leased	 	No
	 Rocky Mountain Dialysis Services, LLC
	 	Belcaro	 	755 S Colorado Boulevard	 	Denver	 	CO	 	80246-8005	 	Leased	 	No
	 Rocky Mountain Dialysis Services, LLC
	 	Lonetree	 	9777 Mt. Pyramid Court, Suite 140	 	Englewood	 	CO	 	80112-6017	 	Leased	 	No

  
 Sch 4.8-20 

															
	 Southern Colorado Joint Ventures, LLC
	 	Fountain	 	6910 Bandley Drive, Suite 100	 	Fountain	 	CO	 	80817-2617	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Loveland	 	1453 N Denver Ave	 	Loveland	 	CO	 	80538-5226	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pikes Peak	 	2002 Leleray Street	 	Colorado Springs	 	CO	 	80909-2804	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Printers Place	 	2802 International Circle	 	Colorado Springs	 	CO	 	80910-3127	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Englewood	 	3247 S. Lincoln St	 	Englewood	 	CO	 	80113-2505	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Black Canyon Montrose	 	3421 Rio Grande, Unit D	 	Montrose	 	CO	 	81401-4840	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Castle Rock	 	4348 Woodlands Blvd	 	Castle Rock	 	CO	 	80104-2800	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mesa County	 	561 25 Road	 	Grand Junction	 	CO	 	81505-1360	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sterling	 	603 Holly Drive	 	Sterling	 	CO	 	80751-4539	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Alamosa	 	62 El Rio Drive	 	Alamosa	 	CO	 	81101-8548	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Commerce	 	6320 Holly Street	 	Commerce City	 	CO	 	80022-3325	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grand Junction	 	710 Wellington Ave	 	Grand Junction	 	CO	 	81501-6100	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Centralized Patient	 	7173 S Havana Street	 	Centennial	 	CO	 	80112-3891	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lowry	 	7465 East 1st Ave	 	Denver	 	CO	 	80230-6877	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Southwest Denver	 	8601 W. Cross Drive	 	Littletown	 	CO	 	80123-2200	 	Leased	 	No
	 Total Renal Research, Inc
	 	Early Clinical Denver	 	11750 West 2nd Place, Levels 3 And 4 St Anthony’s Medical Plaza I	 	Lakewood	 	CO	 	80228	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Cortez	 	610 East Main, Suite C	 	Cortez	 	CO	 	81321-3308	 	Leased	 	No
	 Argyle Dialysis, LLC
	 	Enfield	 	51 Palomba Drive	 	Enfield	 	CT	 	6082	 	Leased	 	No
	 DVA Healthcare of New London, LLC
	 	New London	 	5 Shaws Cove Suite 100	 	New London	 	CT	 	06320-4974	 	Leased	 	No
	 DVA Healthcare of Norwich, LLC
	 	Norwich	 	113 Salem Turnpike	 	Norwich	 	CT	 	06360-6484	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Greater Waterbury	 	209 Highland Avenue	 	Waterbury	 	CT	 	06708-3026	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Milford	 	470 Bridgeport Avenue	 	Milford	 	CT	 	06460-4167	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Shelton	 	750 Bridgeport Avenue	 	Shelton	 	CT	 	06484-4734	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Bridgeport	 	900 Madison Avenue	 	Bridgeport	 	CT	 	06606-5534	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	New Haven	 	100 Church Street South	 	New Haven	 	CT	 	06519-1703	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Branford	 	249-251 West Main Street	 	Branford	 	CT	 	06405-4048	 	Leased	 	No

  
 Sch 4.8-21 

															
	 DVA Renal Healthcare, Inc.
	 	Bloomfield	 	29 Griffin Road South	 	Bloomfield	 	CT	 	06002-1351	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Stamford	 	30 Commerce Road	 	Stamford	 	CT	 	06902-4550	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	South Norwalk	 	31 Stevens Street	 	Norwalk	 	CT	 	06850-3805	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Hartford	 	675 Tower Avenue	 	Hartford	 	CT	 	6112	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Torrington	 	780 Litchfield	 	Torrington	 	CT	 	06790-6268	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Connecticut Acutes	 	93 Eastern Steel Road	 	Milford	 	CT	 	06460-2861	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	New Haven	 	96 Orange Street, Suite 2	 	New Haven	 	CT	 	06519-1703	 	Leased	 	No
	 Middlesex Dialysis Center, LLC
	 	Middlesex	 	100 Main Street	 	Middletown	 	CT	 	06457-3477	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Rocky Hill	 	30 Waterchase Drive	 	Rocky Hill	 	CT	 	06067-2110	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Hartford	 	11 South Road	 	Farmington	 	CT	 	06032-2483	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Danbury	 	111 Osborne St	 	Danbury	 	CT	 	06810-6031	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Waterbury	 	150 Mattatuck Heights Road	 	Waterbury	 	CT	 	06705-3893	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hamden	 	3000 Dixwell Avenue	 	Hamden	 	CT	 	06518-3522	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Windham	 	375c Tuckie Road1	 	Windham	 	CT	 	06256-1345	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Blackrock	 	427 Stillson Rd	 	Fairfield	 	CT	 	06824-3153	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Newington	 	445 Willard Ave	 	Newington	 	CT	 	06111-2318	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Vernon	 	460 Hartford Turnpike	 	Vernon	 	CT	 	06066-4847	 	Leased	 	No
	 Tross Dialysis, LLC
	 	Brookfield	 	164 Mount Pleasant Road	 	Newtown	 	CT	 	6804	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	North Capital	 	500 North Capitol Street, N.W.	 	Washington, D.C.	 	DC	 	90245-4814	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Brentwood	 	1225-1231 Brentwood Road Ne	 	Washington	 	DC	 	20018-1019	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Eighth Street	 	300 8th Street	 	Washington	 	DC	 	20002-6108	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Gwu N Street	 	2131 K Street Nw	 	Washington	 	DC	 	20037-1898	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Gwu Southeast	 	3857-A Pennsylvania Avenue Se	 	Washington	 	DC	 	20020-1309	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Grant Park	 	5000 Nannie Helen Burroughs Ave	 	Washington Dc	 	DC	 	20019-5506	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Lee Street	 	5155 Lee Street, Ne,	 	Washington	 	DC	 	20019-4051	 	Leased	 	No
	 Total Renal Care, Inc.
	 	International	 	1730 Hamlin Street Ne	 	Washington	 	DC	 	20018-1838	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Washington Nursing	 	2425 25th St Se	 	Washington	 	DC	 	20020-3409	 	Leased	 	No
	 TRC-Georgetown Regional Dialysis, LLC.
	 	Georgetown Home Training	 	2233 Wisconsin Ave	 	Washingotn	 	DC	 	20007-4119	 	Leased	 	No

  
 Sch 4.8-22 

															
	 TRC-Georgetown Regional Dialysis, LLC.
	 	Union Plaza	 	810 First St. Ne, Suite #100	 	Washington	 	DC	 	20002-4227	 	Leased	 	No
	 Anderson Kidney Dialysis, LLC
	 	Key West	 	1122 N Roosevelt Blvd	 	Key West	 	FL	 	33040-4076	 	Leased	 	No
	 Bright Dialysis, LLC
	 	Fort Pierce	 	1801 S 23rd St	 	Ft Pierce	 	FL	 	34950-4830	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	West Palm Beach	 	200 Butler Street	 	West Palm Beach	 	FL	 	90245-4814	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Dc Mcallister Office	 	4033 Tampa Road, Suite 102	 	Oldsmar	 	FL	 	90245-4814	 	Leased	 	No
	 DaVita Rx, LLC
	 	Davita Rx - Florida	 	2252 Commerce Park Drive	 	Orlando	 	FL	 	32819	 	Leased	 	No
	 DaVita Rx, LLC
	 	Davita Rx - Florida	 	2616 Commerce Park Drive	 	Orlando	 	FL	 	32819	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	New Smyrna Beach	 	110 South Orange Avenue	 	New Smyrna Beach	 	FL	 	32168-7153	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Lake Wales	 	1125 Bryn Mawr Ave	 	Lake Wales	 	FL	 	33853-4333	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Tampa Acutes	 	1130 Nikki View Drive	 	Brandon	 	FL	 	33511-4868	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Temple Terrace	 	11306 53rd St	 	Temple Terrace	 	FL	 	33617-2214	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Brandon East	 	114 E Brandon Blvd	 	Brandon	 	FL	 	33511-5219	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Perry	 	118 West Main Street	 	Perry	 	FL	 	32347-2656	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Bartow	 	1190 East Church Street	 	Bartow	 	FL	 	33830-4117	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Plant City	 	1211 W Reynolds Street	 	Plant City	 	FL	 	33563-4321	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Palm Coast	 	13 Kingswood Drive, Suite A	 	Palm Coast	 	FL	 	32137-4614	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Broward	 	1500 N Federal Highway	 	Ft Lauderdale	 	FL	 	33304-5600	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Greater Miami	 	160 Nw 176th Street	 	Miami	 	FL	 	33169-5023	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Tallahassee	 	1607 Physicians Drive	 	Tallahassee	 	FL	 	32308-4620	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Winter Haven	 	1625 Dr. Martin Luther King Drive	 	Winterhaven	 	FL	 	33881	 	Owned	 	No
	 DVA Healthcare Renal Care, Inc.
	 	South Beach	 	1711 Alton Road	 	Miami Beach	 	FL	 	33139-2411	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Daytona South	 	1801 S. Nova Road	 	Daytona Beach	 	FL	 	32119-1775	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lake Worth	 	2459 S. Congress Ave., Suite 100	 	West Palm Beach	 	FL	 	33406-7616	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Orange City	 	2575 S Volusia Ave	 	Orange City	 	FL	 	32763-9116	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lehigh Acres Dialysis	 	2814 Lee Boulevard	 	Lehigh Acres	 	FL	 	33971-1561	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Four Freedoms Dialysis	 	289a Sw Range Ave	 	Madison	 	FL	 	32340-2351	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Deland	 	346 E New York Ave	 	Deland	 	FL	 	32724-5510	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Brandenton	 	3501 Cortez Road W.	 	Bradenton	 	FL	 	34210-3104	 	Leased	 	Yes

  
 Sch 4.8-23 

															
	 DVA Healthcare Renal Care, Inc.
	 	Central Tampa	 	4204 N. Macdill Avenue	 	Tampa	 	FL	 	33607-6342	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Fort Myers	 	4220 Executive Circle, Suite 38	 	Fort Myers	 	FL	 	33916-7993	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Ormond Beach	 	431-495 South Nova Rd	 	Ormond Beach	 	FL	 	32174-8444	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	West Tampa	 	4515 George Road	 	Tampa	 	FL	 	33634-7300	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lakeland	 	515 E. Bella Vista Street	 	Lakeland	 	FL	 	33805-3005	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Daytona Beach	 	578 Health Boulevard	 	Daytona Beach	 	FL	 	32114-1492	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	West Tallahassee	 	5857 W Tennessee St	 	Tallahassee	 	FL	 	32304-9218	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Sun City	 	783 Cortaro Drive	 	Ruskin	 	FL	 	33573-6812	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Quincy	 	878 Strong Road	 	Quincy	 	FL	 	32351-5243	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Ft Myers South	 	8850 Gladiolus Dr	 	Fort Meyers	 	FL	 	33908-5102	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Ocoee	 	11140 West Colonial Drive	 	Ocoee	 	FL	 	34761-3300	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	St. Petersburg	 	1117 Arlington Avenue	 	St. Petersburg	 	FL	 	33705-1521	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Orlando	 	116 W Sturtevant Street	 	Orlando	 	FL	 	32806-2021	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Orlando East	 	11616 Lake Underhill Rd	 	Orlando	 	FL	 	32825-4466	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Miami East	 	1250 Nw 7th St Units 103-110	 	Miami	 	FL	 	33125-3744	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Sebastian	 	1424 U.S. Highway 1	 	Sebastian	 	FL	 	32958-1619	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Fort Myers North	 	16101 N Cleveland Avenue	 	North Fort Myers	 	FL	 	33903-2148	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Melbourne	 	2235 Babcock Street	 	Melbourne	 	FL	 	32901-5305	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Supernova Reg 7	 	2401 Pga Boulevard	 	Palm Beach Gardens	 	FL	 	33334-4806	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Tallahassee South	 	2410 South Adams Street	 	Tallahassee	 	FL	 	32301-6325	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	St Petersburg South	 	2850 34th Street South	 	St Petersburg	 	FL	 	33711-3817	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Miami Gardens	 	3363 Nw 167th Street	 	Miami Gardens	 	FL	 	33056-4254	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Lakeland South	 	5050 S Florida Ave	 	Lakeland	 	FL	 	33813-2181	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Orlando North	 	5135 Adanson Street	 	Orlando	 	FL	 	32804-1338	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Orlando Southwest	 	6925 Lake Ellenor Dr	 	Orlando	 	FL	 	32809-4670	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Plantation	 	7061 Cypress Road	 	Plantation	 	FL	 	33317-2243	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Miami North	 	860 Northeast 125th Street	 	North Miami	 	FL	 	33161-5743	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Bonita Springs	 	9132 & 9134 Bonita Beach Road	 	Bonita Springs	 	FL	 	34135-4281	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Miami Campus	 	Jackson Medical Tower	 	Miami	 	FL	 	33136-1121	 	Leased	 	Yes

  
 Sch 4.8-24 

															
	 East Ft. Lauderdale, LLC
	 	E Ft Lauderdale	 	1301 S Andrews Ave	 	Ft Lauderdale	 	FL	 	33316-1823	 	Leased	 	No
	 Fairfield Dialysis, LLC
	 	Jacksonville Arlington	 	929 University Blvd North	 	Jacksonville	 	FL	 	32211-5529	 	Leased	 	No
	 Fjords Dialysis, LLC
	 	Silver Springs Shores	 	9310 Spring Road	 	Ocala	 	FL	 	34472-2913	 	Leased	 	No
	 Flamingo Park Kidney Center, Inc.
	 	Le Jeune	 	3280 Ponce De Leon	 	Coral Gables	 	FL	 	33134-7252	 	Leased	 	Yes
	 Flamingo Park Kidney Center, Inc.
	 	Interamerican	 	7815 Coral Way	 	Miami	 	FL	 	33155-6541	 	Leased	 	No
	 Flamingo Park Kidney Center, Inc.
	 	Flamingo Park	 	901 East 10th Avenue	 	Hialeah	 	FL	 	33010-3762	 	Leased	 	No
	 Golden Sun Bear, LLC
	 	Lifeline Aaxess	 	13085 & 13087 Telecom Parkway North	 	Temple Terrace	 	FL	 	33637-0926	 	Leased	 	No
	 GreenLeaf Dialysis, LLC
	 	Gainesville Home Training	 	4960 West Newberry Road	 	Gainesville	 	FL	 	32607-2201	 	Leased	 	Yes
	 Indian River Dialysis Center, LLC
	 	Vero Beach	 	Pineapple Palm Plaza, 2150 45th Street Building C	 	Vero Beach	 	FL	 	32967-6281	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Collier County	 	6625 Hillway Circle	 	Naples	 	FL	 	34112-8756	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Manatee County	 	8470 Cooper Creek Boulevard	 	University Park	 	FL	 	34201-2020	 	Leased	 	No
	 Kavett Dialysis, LLC
	 	Palmetto	 	7150 West 20th Ave	 	Hialeah	 	FL	 	33016-5509	 	Leased	 	No
	 Las Olas De Sequoia, LLC
	 	Lifeline Fort Lauderdale	 	2271 - 2283 Sw 2nd St., Bldg. 9	 	Pompano Beach	 	FL	 	33069-3101	 	Leased	 	No
	 Lifeline Pensacola, LLC
	 	Lifeline Pensacola	 	1851 North 9th Avenue	 	Pensacola	 	FL	 	32503	 	Leased	 	Yes
	 Lifeline Vascular Center-Niceville, LLC
	 	Niceville	 	4585 Highway 20 East	 	Niceville	 	FL	 	32578	 	Leased	 	No
	 Lifeline Vascular Center-Orlando, LLC
	 	Lf Orlando North	 	337 South Northlake Boulevard	 	Altamonte Springs	 	FL	 	32701-5264	 	Leased	 	No
	 Lourdes Dialysis, LLC
	 	Lake Mary	 	39 Skyline Drive, Suite 1001	 	Lake Mary	 	FL	 	32746-7123	 	Leased	 	No
	 Lourdes Dialysis, LLC
	 	Oviedo	 	7560 Red Bug Lake Road	 	Oviedo	 	FL	 	32765-6591	 	Leased	 	No
	 Mammoth Dialysis, LLC
	 	Carrollwood	 	14358 N Dale Mabry Hwy	 	Tampa	 	FL	 	33618-2018	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Gainesville	 	932 N.W. 56th Terrace	 	Gainesville	 	FL	 	32605-4480	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Lake City	 	221 SW Stonegate Terrace	 	Lake City	 	FL	 	32024-3463	 	Leased	 	No
	 Okanogan Dialysis, LLC
	 	Lauderdale Lakes	 	2922 North State Road 7	 	Lauderdale Lakes	 	FL	 	33313-1912	 	Leased	 	No
	 Open Access Lifeline, LLC
	 	Lifeline Miami	 	16401 Nw 2nd Ave	 	Miami	 	FL	 	33169-6035	 	Leased	 	No
	 Reef Dialysis, LLC
	 	Home Options Of Pensacola	 	812 Creighton Rd	 	Pensacola	 	FL	 	32504-7028	 	Leased	 	No
	 Renal Life Link, Inc
	 	Davie	 	11011 Sheridan Street	 	Cooper City	 	FL	 	33026-1505	 	Leased	 	No
	 Renal Life Link, Inc
	 	Haines City II	 	Ridgeview Plaza Us Highway 27	 	Haines City	 	FL	 	33897-4519	 	Leased	 	No

  
 Sch 4.8-25 

															
	 Renal Treatment Centers-Southeast, LP
	 	Ocala South	 	13940 Us Hwy 441	 	Lady Lake	 	FL	 	32159-8908	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Amelia Island	 	1525 Lime Street	 	Fernandina Beach	 	FL	 	32034-3015	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Villages	 	1950 Laurel Manor Drive	 	The Villages	 	FL	 	32162-5603	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Aventura	 	22 Southwest 11th Street	 	Hallandale	 	FL	 	33009-7038	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Lake	 	221 North 1st Street	 	Leesburg	 	FL	 	34748-5150	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Ocala North	 	2620 W Hwy 316	 	Citra	 	FL	 	32113-3555	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Ocala Regional Kidney	 	2860 Se 1st Ave	 	Ocala	 	FL	 	34471-0406	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Ocala East	 	2870 Se 1st Avenue	 	Ocala	 	FL	 	34471-0406	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Marianna	 	2930 Optimist Dr	 	Marianna	 	FL	 	32448-7703	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	North Okaloosa	 	320 West Redstone Drive	 	Crestview	 	FL	 	32536-6433	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Santa Rosa	 	5819 Highway 90	 	Milton	 	FL	 	32583-1763	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Panama City	 	615 Highway 231	 	Panama City	 	FL	 	32405-4704	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Leesburg	 	801 E Dixie Ave	 	Leesburg	 	FL	 	34748-7699	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Venice	 	816 Pinebrook Road	 	Venice	 	FL	 	34285-7103	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	West Florida	 	8333 North Davis Highway	 	Pensacola	 	FL	 	32514-6050	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Chipley	 	877 3rd Street, Suite 2	 	Chipley	 	FL	 	32428-1855	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Ocala West	 	9401 Sw Hwy 200	 	Ocala	 	FL	 	34481-9612	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Mt Dora	 	County Road 19a	 	Mount Dora	 	FL	 	32757-3526	 	Leased	 	No
	 SafeHarbor Dialysis, LLC
	 	East Tampa	 	1701 9th Avenue	 	Tampa	 	FL	 	33605-3801	 	Leased	 	No
	 Sands Dialysis, LLC
	 	Boynton/North Delray	 	2655 West Atlantic Blvd	 	Delray Beach	 	FL	 	33445-4400	 	Leased	 	Yes
	 Sands Dialysis, LLC
	 	Boca Raton	 	998 Northwest 9th Court	 	Boca Raton	 	FL	 	33486-2214	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Poinciana	 	1002 Cypress Parkway	 	Poinciana	 	FL	 	34759-3328	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Celebration	 	1154 Celebration Blvd	 	Celebration	 	FL	 	34747-4605	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Kissimmee Home Training Pd	 	1203 North Central Avenue, Suite A	 	Kissimmee	 	FL	 	34741-4407	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Winter Garden	 	1222 Winter Garden Vineland Rd.	 	Winter Garden	 	FL	 	34787	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Orlando	 	14050 Town Loop Blvd	 	Orlando	 	FL	 	32837-6190	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Ocoee Home Training	 	1552 Boren Drive	 	Ocoee	 	FL	 	34761-4216	 	Leased	 	Yes
	 South Central Florida Dialysis Partners, LLC
	 	Buena Ventura Orlando	 	1998 Osceola Parkway	 	Kissimmee	 	FL	 	34743	 	Leased	 	No

  
 Sch 4.8-26 

															
	 South Central Florida Dialysis Partners, LLC
	 	St. Cloud	 	220 Kissimmee Park Road	 	St. Cloud	 	FL	 	34769-1430	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Orlando Park	 	5397 W Colonial Dr	 	Orlando	 	FL	 	32808-7647	 	Leased	 	No
	 South Central Florida Dialysis Partners, LLC
	 	Kissimmee	 	802 North John Young Parkway	 	Kissimmee	 	FL	 	34741-4912	 	Leased	 	No
	 Talimena Dialysis, LLC
	 	Miami Shores	 	15600 NW 15th Avenue	 	Miami Gardens	 	FL	 	33169-5609	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Defuniak Springs	 	1045 Us Hwy 331	 	Defuniak Springs	 	FL	 	32435-3375	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Tampa Fl	 	10770 N. 46th St.	 	Tampa	 	FL	 	33617-3465	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Coral Reef	 	11000 Sw 184th St	 	Miami	 	FL	 	33157-6602	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bay Breeze	 	11550 Ulmerton Road	 	Largo	 	FL	 	33778-1501	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Center For Kidney Disease	 	1190 Nw 95th St	 	Miami	 	FL	 	33150-2065	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pembroke Pines	 	12145 Pembroke Rd	 	Pembroke Pines	 	FL	 	33025-1727	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fort Lauderdale	 	1299 East Commerical Blvd	 	Oakland Park	 	FL	 	33334	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cape Coral	 	1315 Se 8th Terrace	 	Cape Coral	 	FL	 	33990-3213	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Arcadia	 	1341 East Oak Street	 	Arcadia	 	FL	 	34266-8902	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Columbia County-FL	 	1389 U.S. Highway 90 West, Suite 100A	 	Lake City	 	FL	 	32055-6130	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bayonet Point	 	14144 Nephron Ln	 	Hudson	 	FL	 	34667-6504	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Beach Boulevard Dialysis	 	14444 Beach Blvd	 	Jacksonville	 	FL	 	32250-2079	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Renovation Of Life	 	14505 Commerce Way	 	Miami Lakes	 	FL	 	33016-1530	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Miami Lakes	 	14600 Nw 60th Avenue	 	Miami Beach	 	FL	 	33014-2811	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Palm Breeze (Northport)	 	14942 Tamiami Trl	 	Northport	 	FL	 	34287-2705	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Jacksonville South	 	14965 Old St. Augustine Rd	 	Jacksonville	 	FL	 	32258-9481	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Gulf Breeze	 	1523 Main Street	 	Dunedin	 	FL	 	34698-4650	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Beach	 	16201 Panama City Beach Parkway	 	Panama City	 	FL	 	32413-5301	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Venture	 	16855 NE 2nd Avenue	 	N. Miami Beach	 	FL	 	33162-1744	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sanford	 	1701 W 1st St	 	Sanford	 	FL	 	32771-1605	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pine Island	 	1871 N Pine Island Rd	 	Plantation	 	FL	 	33322-5208	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Keys Gate	 	1982 NE 8th Street	 	Homestead	 	FL	 	33033-4704	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Deerfield Beach	 	1983 West Hillsboro Boulevard	 	Deerfield Beach	 	FL	 	33441-3026	 	Leased	 	No

  
 Sch 4.8-27 

															
	 Total Renal Care, Inc.
	 	Deerfield	 	200 Sw Natura Ave	 	Deerfield Beach, Fl	 	FL	 	33441-3026	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Miramar	 	2501 Sw 160th Ave	 	Miramar	 	FL	 	33027-4217	 	Leased	 	No
	 Total Renal Care, Inc.
	 	St. Augustine Home Training (PD/HHD)-FL	 	252 Southpark Circle East	 	St. Augustine	 	FL	 	32086-5137	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Central Orlando	 	2548 N Orange Blossom Trl	 	Orlando	 	FL	 	32804-4863	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Palm Beach	 	2611 North Dixie Hwy	 	W Palm Beach	 	FL	 	33407-5919	 	Leased	 	No
	 Total Renal Care, Inc.
	 	St Augustine	 	264 Southpark Circle East	 	St Augustine	 	FL	 	32086-5137	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hallendale	 	2655 Hollywood Blvd	 	Hollywodd	 	FL	 	33020-4840	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Palm Beach	 	2841 Pga Blvd	 	Palm Beach Gardens	 	FL	 	33410-2910	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pinnacle Of Boca Raton	 	2900 N. Military Trail	 	Boca Raton	 	FL	 	33431-6308	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hernando	 	2985 Landover Blvd	 	Spring Hill	 	FL	 	34608-7258	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cape Coral South	 	3046 Del Prado Blvd, Unit 4a To F	 	Cape Coral	 	FL	 	33904-7232	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake Vista	 	3187 Us Highway 98	 	Lakeland	 	FL	 	33805-2103	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Palatka	 	326 Zeagler Drive	 	Palatka	 	FL	 	32177-3817	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Gulf Coast	 	3300 Tamiami Trail Unit No.3	 	Port Charlotte	 	FL	 	33952-8054	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pinellas West Shore	 	3451 66th St. N	 	St. Petersburg	 	FL	 	33710-1568	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Winter Park	 	3727 North Goldenrod Road	 	Winter Park	 	FL	 	32792-8611	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Port Saint Joe	 	3871 Highway 98 E	 	Port Saint Joe	 	FL	 	32456-5318	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Memorial Plaza	 	3901 University Blvd S	 	Jacksonville	 	FL	 	32216-4374	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Team Endeavor Group Office Davert Lease	 	3985 NW Street	 	Pensacola	 	FL	 	28211	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake Griffin East	 	401 E North Ave	 	Leesburg	 	FL	 	34748-5262	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Winter Park Hemo	 	4100 Metric Dr	 	Winter Park	 	FL	 	32792-6832	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Port Charlotte	 	4300 Kings Highway	 	Port Charlotte	 	FL	 	33980	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Casselberry	 	4970 S Us Hwy 17/92	 	Casselberry	 	FL	 	32707-3888	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Coastal Kidney	 	510 Macarthur Avenue	 	Panama City	 	FL	 	32401-3636	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Florida Renal Center	 	5320 W Flagler St	 	Miami	 	FL	 	33134	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Immokalee	 	5340 Useppa Dr	 	Ave Maria	 	FL	 	34142-5051	 	Leased	 	No

  
 Sch 4.8-28 

															
	 Total Renal Care, Inc.
	 	Gateway	 	5705 Lee Boulevard	 	Lehigh Acres	 	FL	 	33971-6342	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Pensacola	 	598 North Fairfield	 	Pensacola	 	FL	 	32506-4320	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Pompano Beach	 	600 Sw 3rd Street	 	Pompano Beach	 	FL	 	33060-6932	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Apopka	 	640 Executive Park Ct	 	Apopka	 	FL	 	32703-6075	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Downtown Pensacola	 	700 E Cervantes St	 	Pensacola	 	FL	 	32501-3210	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Tamarac	 	7132, 7140, 7144 & 7148 W Mcnab Rd	 	Tamarac	 	FL	 	33321-5306	 	Leased	 	No
	 Total Renal Care, Inc.
	 	New Port Richey II	 	7421 Ridge Rd	 	Port Richey	 	FL	 	34668-6935	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sunrays Division	 	7421 Ridge Road	 	New Port Richey	 	FL	 	34677-3224	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Complete	 	7467-7475 West Sample Rd	 	Coral Springs	 	FL	 	33065-4754	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Doral	 	7705 Nw 48th St	 	Doral	 	FL	 	33166-5401	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Davie City	 	7950 Sw 30th St	 	Davie	 	FL	 	33328-1979	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kendall	 	8354 Mills Drive	 	Kendall	 	FL	 	33183-4806	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hialeah	 	8500 NW 103rd Street	 	Hialeah Gardens	 	FL	 	33016-4870	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Oakland Park	 	911 E Oakland Park Blvd	 	Oakland Park	 	FL	 	33334-2725	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dadeland	 	9175 Sw 87th Ave	 	Miami	 	FL	 	33176-2302	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Corp-Non Cbo	 	929 North Spring Garden Ave	 	Deland	 	FL	 	32720-0838	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Regency	 	9535 Regency Square Blvd	 	Jacksonville	 	FL	 	32225-8128	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Florida	 	One Oakwood Blvd	 	Hollywood	 	FL	 	33020-1937	 	Leased	 	No
	 Total Renal Care/Crystal River Dialysis, L.C.
	 	Crystal River	 	7415 West Gulf To Lake Highway	 	Crystal River	 	FL	 	34429-7834	 	Leased	 	No
	 Total Renal Laboratories, Inc.
	 	TRC LAB	 	1991 Industrial Drive	 	Deland	 	FL	 	32724-2039	 	Owned	 	No
	 Townsend Dialysis, LLC
	 	Plantation Home Training	 	8144 West Broward Blvd.	 	Plantation	 	FL	 	33324-2000	 	Leased	 	No
	 Wesley Chapel Dialysis, LLC
	 	Wesley Chapel	 	27401 Cashford Cir	 	Wesley Chapel	 	FL	 	33544-8183	 	Leased	 	No
	 Weston Dialysis Center, LLC
	 	Weston	 	2685 Executive Park	 	Weston	 	FL	 	33331-3651	 	Leased	 	No
	 Yargol Dialysis, LLC
	 	Winter Haven South	 	7190-7220 Cypress Gardens Boulevard	 	Winter Haven	 	FL	 	33884-3217	 	Leased	 	No
	 Ybor City Dialysis, LLC
	 	Greater Tampa Hhd/Pd	 	4204b N Macdill Ave	 	Tampa	 	FL	 	33607-6364	 	Leased	 	No
	 Zephyrhills Dialysis Center, LLC
	 	Zephyrhills	 	TBD	 	Zephyrhills	 	FL	 	33542-0001	 	Leased	 	No
	 Bayshore Dialysis, LLC
	 	Savannah Riverside	 	540 E. Oglethorpe Avenue	 	Savannah	 	GA	 	31401	 	Leased	 	No
	 Buford Dialysis, LLC
	 	Buford	 	1550 Buford Highway	 	Buford	 	GA	 	30518-3666	 	Leased	 	Yes

  
 Sch 4.8-29 

															
	 Bulfinch Dialysis, LLC
	 	Lake Hartwell	 	1065 East Franklin St	 	Hartwell	 	GA	 	30643	 	Leased	 	No
	 Burney Dialysis, LLC
	 	Valdosta Home	 	401 Northside Drive	 	Valdosta	 	GA	 	31602-1872	 	Leased	 	No
	 Carlsbad Dialysis, LLC
	 	South Fulton	 	1275 East Cleveland Avenue	 	East Point	 	GA	 	30344-3433	 	Leased	 	No
	 Central Georgia Dialysis, LLC
	 	Perry	 	1027 Keith Dr.	 	Perry	 	GA	 	31069-2948	 	Leased	 	No
	 Central Georgia Dialysis, LLC
	 	East Macon	 	165 Emery Highway	 	Macon	 	GA	 	31217-3666	 	Leased	 	No
	 Dialysis of North Atlanta, LLC
	 	Ellijay	 	449 Industrial Boulevard	 	Ellijay	 	GA	 	30540-6724	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Thomaston	 	1075 Hwy 19 N	 	Thomaston	 	GA	 	30286-2233	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	East Atlanta	 	1308 Moreland Avenue Se	 	Atlanta	 	GA	 	30316-3224	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Rome	 	15 John Maddox Drive	 	Rome	 	GA	 	30165-1413	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Athens West	 	1747 Langford Drive, Building 500	 	Bogart	 	GA	 	30622-2610	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Eastlake	 	1757 Candler Road	 	Decatur	 	GA	 	30032-3276	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Wylds Road	 	1815 Wylds Road	 	Augusta	 	GA	 	30909-4430	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Americus	 	227 Lee Street	 	Americus	 	GA	 	31709-3525	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	South Fulton	 	2685 Metropolitan Parkway Sw	 	Atlanta	 	GA	 	30315-7926	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Oak Street	 	2704 North Oak Street	 	Valdosta	 	GA	 	31602-1723	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	St. Mary’s	 	2714 Osborne Road	 	Saint Mary’S	 	GA	 	31558-4049	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Brunswick South	 	2930 Springdale Rd	 	Brunswick	 	GA	 	31520-4838	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Jesup	 	301 Peachtree Street	 	Jesup	 	GA	 	31545-0245	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Candler County	 	325 Cedar Street	 	Metter	 	GA	 	30439-4043	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Douglasville	 	3877 Longview Drive	 	Douglasville	 	GA	 	30135-1373	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hinesville	 	522 E G Mills Parkway	 	Hinesville	 	GA	 	31313-4021	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Brunswick	 	53 Scranton Connector	 	Brunswick	 	GA	 	31525-1862	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Piedmont	 	105 Collier Road	 	Atlanta	 	GA	 	30309-1730	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Montezuma	 	114 De Vaughn Street	 	Montezuma	 	GA	 	31063-1708	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Abercorn	 	11706 Mercy Blvd Bldg 9	 	Savannah	 	GA	 	31419-1751	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	North Fulton	 	1250 Northmeadow Parkway	 	Roswell	 	GA	 	30076-4914	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Fayetteville	 	1279 Highway 54 West, Suite 110	 	Fayetteville	 	GA	 	30214-4551	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Effingham North	 	1451 Hwy 21 South	 	Springfield	 	GA	 	31329-5244	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Loring Heights	 	1575 Northside Drive N W	 	Atlanta	 	GA	 	30318-4211	 	Leased	 	No

  
 Sch 4.8-30 

															
	 DVA Renal Healthcare, Inc.
	 	GHc-Decatur	 	1840 Southern Lane	 	Decatur	 	GA	 	30033	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	Douglas	 	191 West Side Drive	 	Douglas	 	GA	 	31533-3534	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Laurens County	 	2400 Bellevue Road	 	Dublin	 	GA	 	31021-2856	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Atlanta West	 	2538 Martin Luther King Drive	 	Atlanta	 	GA	 	30311-1779	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Williams Street	 	2812 Williams Street	 	Savannah	 	GA	 	31404-4134	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cedartown	 	325 West Avenue	 	Cedartown	 	GA	 	30125-3439	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Wrightsville	 	513 West Elm Street	 	Wrightsville	 	GA	 	31096-2016	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Derenne	 	5303 Montgomery Street	 	Savannah	 	GA	 	31405-5138	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Atlanta	 	567 North Avenue	 	Atlanta	 	GA	 	30308-2721	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Baxley	 	604 Fair Street	 	Baxley	 	GA	 	31513-0112	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cumming	 	911 Marketplace Blvd, Cumming Marketplace Blvd #3 Suites I-K	 	Cumming	 	GA	 	30041-7938	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Atlanta South	 	Tri Cities Plaza, 3158 East Main Street	 	East Point	 	GA	 	30344-4800	 	Leased	 	No
	 Elberton Dialysis Facility, Inc.
	 	Elberton	 	894 Elbert Street	 	Elberton	 	GA	 	30635-2628	 	Leased	 	No
	 Goldendale Dialysis, LLC
	 	Columbus Home Training	 	1200 Brookstone Centre	 	Columbus	 	GA	 	31904-2988	 	Leased	 	No
	 Heavener Dialysis, LLC
	 	Victory	 	2401 Shelby Street	 	Columbus	 	GA	 	31903	 	Leased	 	No
	 Honey Dialysis, LLC
	 	Snellville	 	2125 Main St E	 	Snellville	 	GA	 	30078-6424	 	Leased	 	No
	 Humboldt Dialysis, LLC
	 	Savannah Gateway	 	5973 Ogeechee Road	 	Savannah	 	GA	 	31419-8901	 	Leased	 	No
	 ISD Canton, LLC (fka DSI Canton, LLC)
	 	Northwest Georgia	 	260 Hospital Road	 	Canton	 	GA	 	30114-2409	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Greensboro	 	1220 Siloam Rd	 	Greensboro	 	GA	 	30642-2810	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Cartersville	 	203 N.Tennessee Street	 	Cartersville	 	GA	 	30120-3605	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Austell	 	3642 Marathon Circle	 	Austell	 	GA	 	30106-6821	 	Leased	 	No
	 Lapham Dialysis, LLC
	 	Ellijay	 	449 Industrial Boulevard	 	Ellijay	 	GA	 	30540-3772	 	Leased	 	Yes
	 MGD-Kidney Dialysis Center, LLC
	 	Kidney Dialysis Center	 	640 Martin Luther King Jr. Blvd	 	Macon	 	GA	 	31201-3206	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Albany	 	2300 Dawson Rd	 	Albany	 	GA	 	31707-2436	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Atlanta 2	 	3885 Princeton Way	 	Atlanta	 	GA	 	30331-7100	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Atlanta 2b	 	5461 Hillandale Dr	 	Lithonia	 	GA	 	30058-4842	 	Leased	 	No
	 Osage Dialysis, LLC
	 	Mcfarland	 	6225 Atlanta Hwy	 	Alpharetta	 	GA	 	30004-8799	 	Leased	 	No
	 Parker Dialysis, LLC
	 	Walton County	 	221 Plaza Drive	 	Monroe	 	GA	 	30655-3184	 	Leased	 	Yes

  
 Sch 4.8-31 

															
	 Renal Life Link, Inc
	 	Cobb	 	3865 Medical Park Drive	 	Austell	 	GA	 	30106-1109	 	Leased	 	Yes
	 Renal Life Link, Inc
	 	Paulding	 	4019 Johns Road	 	Dallas	 	GA	 	30132-3420	 	Leased	 	No
	 Renal Life Link, Inc
	 	Sweetwater	 	7117 S. Sweetwater Road	 	Lithia Springs	 	GA	 	30122-2446	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Buena Vista	 	100 Burhalter Ave	 	Buena Vista	 	GA	 	31803-9701	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Lake Hearn	 	1150 Lake Hearn Drive	 	Atlanta	 	GA	 	30342-1566	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	South Columbus	 	1216 Stark Avenue	 	Columbus	 	GA	 	31906-2500	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Jonesboro	 	129 King Street	 	Jonesboro	 	GA	 	30236-3656	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Northlake	 	1390 Montreal Road	 	Tucker	 	GA	 	30084-8144	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Spivey Pd	 	1423 Stockbridge Road, Unit 3 & 4 Suite B	 	Jonesboro	 	GA	 	30236-3740	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Moultrie	 	2419 S. Main St.	 	Moultrie	 	GA	 	31768-6531	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Newnan	 	242 Bullsboro Drive	 	Newnan	 	GA	 	30263-1295	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Lithonia	 	2485 Park Central Blvd	 	Lithonia	 	GA	 	30035-3903	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Gainsville	 	2545 Flintridge Road	 	Gaineville	 	GA	 	30501-7428	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Southern Crescent	 	275 Upper Riverdale Road	 	Riverdale	 	GA	 	30274-2556	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Cascade	 	3651 Bakers Ferry Rd Sw	 	Atlanta	 	GA	 	30331-3712	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Forest Park	 	380 Forest Parkway	 	Forest Park	 	GA	 	30297-2107	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Milledgeville	 	400 South Wayne Street	 	Milledgeville	 	GA	 	31061-3446	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	East Georgia	 	450 Georgia Avenue	 	Statesboro	 	GA	 	30458-5590	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Iris City	 	521 North Expressway Village, Suite #1509	 	Griffin	 	GA	 	30223-2073	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Fort Valley	 	557 Bluebird Blvd.	 	Fort Valley	 	GA	 	31030-5083	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Columbus	 	6228 Bradley Park Dr	 	Columbus	 	GA	 	31904-3604	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Jackson	 	Mcdonough Road	 	Jackson	 	GA	 	30233-1572	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	East Georgia Dialysis	 	TBD Stambuk Lane	 	Statesboro	 	GA	 	30458-5590	 	Leased	 	No
	 Royale Dialysis, LLC
	 	Kennestone	 	200 North Cobb Pkwy, Bldg. 300	 	Marietta	 	GA	 	30062-3558	 	Leased	 	No
	 Saddleback Dialysis, LLC
	 	Magnolia Oaks	 	2377 Hwy 196 W	 	Hinesville	 	GA	 	31313-8036	 	Leased	 	No
	 Seminole Dialysis, LLC
	 	Hiram	 	76 Highland Pavilion Court	 	Hiram	 	GA	 	30141-3170	 	Leased	 	No
	 Shone Dialysis, LLC
	 	Newton	 	Bypass Road and Highway 36	 	Covington	 	GA	 	30014-3651	 	Leased	 	No
	 Southwest Atlanta Dialysis Centers, LLC
	 	Linden	 	121 Linden Ave	 	Atlanta	 	GA	 	30308-2432	 	Leased	 	No

  
 Sch 4.8-32 

															
	 Southwest Atlanta Dialysis Centers, LLC
	 	Decatur	 	1987 Candler Road	 	Decatur	 	GA	 	30032-4212	 	Leased	 	No
	 Southwest Atlanta Dialysis Centers, LLC
	 	East Point	 	2669 Church Street	 	East Point	 	GA	 	30344	 	Leased	 	No
	 Southwest Atlanta Dialysis Centers, LLC
	 	Southwest Atlanta	 	3620 Martin Luther King Drive	 	Atlanta	 	GA	 	30331-3711	 	Leased	 	No
	 Southwest Atlanta Dialysis Centers, LLC
	 	Bakers Ferry	 	3645 Bakers Ferry Road	 	Atlanta	 	GA	 	30331-3712	 	Leased	 	No
	 Sugarloaf Dialysis, LLC
	 	Sugarloaf	 	1705 Belle Meade Court	 	Lawrenceville	 	GA	 	30043-5895	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cordele	 	1013 E. 16th Street	 	Cordele	 	GA	 	31015-1539	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Shamrock	 	1016 Claxton Dairy Road	 	Dublin	 	GA	 	31021-7971	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Medlock Bridge	 	10680 Medlock Bridge Road	 	Duluth	 	GA	 	30097-8420	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mcdonough	 	114 Dunn Ave.	 	Mcdonough	 	GA	 	30253-2347	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Troup County	 	140 Glenn Bass Road	 	Lagrange	 	GA	 	30240-5809	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sumter County	 	1432 E Forsyth St.	 	Americus	 	GA	 	31709-3808	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Washington	 	154 Washington Plaza	 	Washington	 	GA	 	30673-2074	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Piedmont 300b	 	1575 Northside Drive	 	Atlanta	 	GA	 	30318-4210	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Augusta	 	1631 Gordon Hwy Ste 1b	 	Augusta	 	GA	 	30906-2221	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Carrollton	 	195 Parkwood Circle	 	Carrollton	 	GA	 	30117-8756	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Mcafee	 	1987 Candler Road	 	Decatur	 	GA	 	30032-4212	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Athens	 	2026 South Millege Ave, Ste# A-2	 	Athens	 	GA	 	30605-6480	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Tri County	 	2540 Flat Shoals Road	 	Atlanta	 	GA	 	30349-4314	 	Leased	 	No
	 Total Renal Care, Inc.
	 	East Dekalb	 	2801 Candler Rd	 	Decatur	 	GA	 	30034-1421	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Peachtree City	 	2830 W. Highway 54, Building 100	 	Peachtree City	 	GA	 	30269-1026	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Powder Springs	 	2840 East West Connector	 	Austell	 	GA	 	30106-6813	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Waycross	 	308 Carswell Ave	 	Waycross	 	GA	 	31501-4762	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	GHc-Atlanta	 	400 Decatur Street (Retax Bill Also Shows 382 Decatur Street)	 	Atlanta	 	GA	 	30312	 	Owned	 	No
	 Total Renal Care, Inc.
	 	Tucker	 	4434 Hugh Howell Rd	 	Tucker	 	GA	 	30084-4905	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Statesboro	 	4b College Plaza Fair Road	 	Statesboro	 	GA	 	30458-4928	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Divisional - Glenlake	 	50 Glenlake Parkway	 	Atlanta	 	GA	 	30328-7242	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Middle Georgia	 	509 North Houston Road	 	Warner Robins	 	GA	 	31093-8844	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Locust Grove-GA	 	517-531 Stanley K. Tanger Boulevard	 	Locust Grove	 	GA	 	30248	 	Leased	 	No

  
 Sch 4.8-33 

															
	 Total Renal Care, Inc.
	 	Mountain Park	 	5235 Memorial Drive	 	Stone Mountain	 	GA	 	30083-3112	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Snapfinger	 	5255 Snapfinger Park Dr	 	Decatur	 	GA	 	30035-4066	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Pooler	 	54 Traders Way	 	Pooler	 	GA	 	31322	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Metropolitan	 	540 Central Avenue	 	Atlanta	 	GA	 	30312-2735	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Old National	 	5615 Old National Hwy	 	College Park	 	GA	 	30349-3811	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Henry	 	5627 N. Henry Blvd	 	Stockbridge	 	GA	 	30281-3244	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Darien	 	5873 Hwy 17 North	 	Darien	 	GA	 	31305-4003	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mcduffie	 	621 Mcneil Circle	 	Tomson	 	GA	 	30824-8060	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Tifton	 	636 Love Avenue	 	Tifton	 	GA	 	31794-4406	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Union City	 	6851 Shannon Pkwy.	 	Union City	 	GA	 	30291-2049	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Turner Hills	 	7301 Stonecrest Concourse	 	Lithonia	 	GA	 	30038-6902	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Macon-Middle Georgia	 	747 Second Street	 	Macon	 	GA	 	31201-6835	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Vidalia	 	906 E First St	 	Vidalia	 	GA	 	30474-4207	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Arbor Place	 	9559 Hwy 5 Ste 1	 	Douglasville	 	GA	 	30135-1573	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Meriwether Greenville	 	GA Highway 85	 	Warm Springs	 	GA	 	31830-2214	 	Leased	 	Yes
	 Wilder Dialysis, LLC
	 	Conyers	 	1501 Milstead Rd Ne	 	Conyers	 	GA	 	30012-3838	 	Leased	 	Yes
	 MGD-Rainbow Dialysis, LLC
	 	Rainbow Dialysis	 	305 Keawe Street	 	Lahaina	 	HI	 	96761-2734	 	Leased	 	No
	 Central Iowa Dialysis Partners, LLC
	 	Des Moines	 	1301 Penn Ave	 	Des Moines	 	IA	 	50316-2365	 	Leased	 	No
	 Davis Dialysis, LLC
	 	Sioux City	 	5865 Sunnybrook Drive	 	Sioux City	 	IA	 	51106-4203	 	Leased	 	No
	 Dialysis of Des Moines, LLC
	 	Des Moines	 	501 S.W. 7th Street	 	Des Moines	 	IA	 	50309-4538	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Council Bluffs	 	300 West Broadway, Suite 150	 	Council Bluffs	 	IA	 	51503-9077	 	Leased	 	No
	 Garner Dialysis, LLC
	 	Ames Mary Greeley	 	2322 E 13th St	 	Ames	 	IA	 	50010-5669	 	Leased	 	No
	 Garner Dialysis, LLC
	 	Marshalltown	 	3120 S 2nd St	 	Marshalltown	 	IA	 	50158-4614	 	Leased	 	No
	 Garner Dialysis, LLC
	 	Iowa Falls Mary Greeley	 	701 Washington Ave	 	Iowa Falls	 	IA	 	50126-2109	 	Leased	 	No
	 Geyser Dialysis, LLC
	 	Ankeny	 	2625 N. Ankeny Blvd.	 	Ankeny	 	IA	 	50023-4704	 	Leased	 	No
	 Green Country Dialysis, LLC
	 	Green Country Dialysis	 	5250 Utica Ridge Road	 	Davenport	 	IA	 	52807-3872	 	Leased	 	No
	 Honeyman Dialysis, LLC
	 	Five Seasons	 	1002 4th Avenue SE	 	Cedar Rapids	 	IA	 	52403-2425	 	Leased	 	No
	 Honeyman Dialysis, LLC
	 	Cedar Rapids	 	5945 Council St Ne	 	Cedar Rapids	 	IA	 	52402-5858	 	Leased	 	No
	 Kobuk Dialysis, LLC
	 	Ottumwa	 	1005 E Pennsylvania Ave	 	Ottumwa	 	IA	 	52501-6408	 	Leased	 	No

  
 Sch 4.8-34 

															
	 Renal Treatment Centers-Illinois, Inc.
	 	Grundy Center	 	101 East J Avenue	 	Grundy Center	 	IA	 	50638-2031	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Harlan	 	1213 Garfield Avenue	 	Harlan	 	IA	 	51537-2057	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Central Des Moines	 	1215 Pleasant Street	 	Des Moines	 	IA	 	50309-1409	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Atlantic Dialysis	 	1500 E 10th St	 	Atlantic	 	IA	 	50022-1935	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Buchanan	 	1600 1st St East	 	Independence	 	IA	 	50644-3155	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Cedar Valley	 	1661 W. Ridgeway	 	Waterloo	 	IA	 	50701-4541	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Creston	 	1700 West Townline Street	 	Creston	 	IA	 	50801-1054	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Newton	 	204 N 4th Street	 	Newton	 	IA	 	50208-3135	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Bremer County	 	220 10th St. S.W.	 	Waverly	 	IA	 	50677-2930	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Shenandoah	 	300 Pershing Avenue	 	Shenandoah	 	IA	 	51601-2355	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Black Hawk	 	3421 W 9th St	 	Waterloo	 	IA	 	50702-5401	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	West Union	 	405 Hwy 150 N	 	West Union	 	IA	 	52175-1003	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Perry	 	610 10th Street	 	Perry	 	IA	 	50220-2221	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	West Des Moines	 	6800 Lake Drive	 	Des Moines	 	IA	 	50266-2544	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Snake River	 	1491 Parkway Drive	 	Blackfoot	 	ID	 	83221-1667	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Twin Falls	 	1840 Canyon Crest Drive	 	Twin Falls	 	ID	 	83301-3042	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Gate City	 	2001 Bench Road	 	Pocatello	 	ID	 	83201-2033	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Moscow	 	212 Rodeo Dr	 	Moscow	 	ID	 	83843-9798	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Treasure Valley	 	3525 East Louise Dr	 	Meridian	 	ID	 	83642-6303	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Table Rock	 	5610 West Gage Street	 	Boise	 	ID	 	83706-1332	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Twin Falls	 	600 N. Poleline Road	 	Twin Falls	 	ID	 	83301-3042	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Burley	 	741 North Overland Drive	 	Burley	 	ID	 	83318-3440	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Caldwell	 	821 S Smeed Parkway	 	Caldwell	 	ID	 	83605-5130	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Nampa	 	846 Park Centre Way	 	Nampa	 	ID	 	83651-1790	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Idaho Falls	 	900 Pancheri Dr	 	Idaho Falls	 	ID	 	83402-3310	 	Leased	 	No
	 Camino Dialysis, LLC
	 	Barrington Creek At Home	 	28160 Northwest Hwy, Unit 111	 	Lake Barrington	 	IL	 	60010-2324	 	Leased	 	Yes
	 Camino Dialysis, LLC
	 	Barrington Creek	 	28160 Northwest Hwy, Unit 118	 	Lake Barrington	 	IL	 	60010	 	Leased	 	No
	 Chicago Heights Dialysis, LLC
	 	Chicago Heights	 	177 B West Joe Orr Road	 	Chicago Heights	 	IL	 	60411-1733	 	Leased	 	No
	 Cowell Dialysis, LLC
	 	Lawndale	 	3934 West 24th Street	 	Chicago	 	IL	 	60623-3371	 	Leased	 	No

  
 Sch 4.8-35 

															
	 Dialysis of Northern Illinois, LLC
	 	Gateway	 	2200 Gateway Drive	 	Sycamore	 	IL	 	60178-3113	 	Leased	 	Yes
	 Dialysis of Northern Illinois, LLC
	 	Crimson Ridge Home	 	2540 Hauser-Ross Dr	 	Sycamore	 	IL	 	60178-3171	 	Leased	 	No
	 Dialysis of Northern Illinois, LLC
	 	Roxbury	 	622 Roxbury Road	 	Rockford	 	IL	 	61107-5089	 	Leased	 	No
	 Dialysis of Northern Illinois, LLC
	 	Timber Creek	 	975 S Annie Gidden Road	 	Dekalb	 	IL	 	60115-8250	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Macon	 	1090 W. McKinley	 	Decatur	 	IL	 	62526	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Jacksonville	 	1515 W. Walnut	 	Jacksonville	 	IL	 	62650	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	Lincoln	 	2100 W 5th Street	 	Lincoln	 	IL	 	62656-9115	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Springfield Montvale	 	2930 South Montvale Drive	 	Springfield	 	IL	 	62704-5376	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Alton	 	3511 College Avenue	 	Alton	 	IL	 	62002-5009	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Illini Renal	 	507 East University	 	Champaign	 	IL	 	61820-3828	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Mattoon	 	6051 Development Drive	 	Charleston	 	IL	 	61920-9467	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Decatur East Wood	 	792 East Wood Street	 	Decatur	 	IL	 	62523-1155	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Taylorville	 	901 West Spresser Street	 	Taylorville	 	IL	 	62568-1831	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Effingham	 	904 Medical Park Drive	 	Effingham	 	IL	 	62401-2193	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Litchfield	 	915 St. Francis Way	 	Litchfield	 	IL	 	62056-1775	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Springfield	 	932 N Rutledge St	 	Springfield	 	IL	 	62702-3721	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Rushville	 	Route 2 Box 99a	 	Rushville	 	IL	 	62681-1293	 	Leased	 	No
	 Ebrea Dialysis, LLC
	 	South Suburban	 	19720 Governors Highway	 	Flossmoor	 	IL	 	60422-2075	 	Leased	 	No
	 Fenton Dialysis, LLC
	 	Harrisburg Home Training (PD-HHD)	 	303 South Commercial Street, Suite 15	 	Harrisburg	 	IL	 	62946-2125	 	Leased	 	No
	 Freeportbay Dialysis, LLC
	 	Driftwood	 	1808 S West Avenue	 	Freeport	 	IL	 	61032-6712	 	Leased	 	No
	 Holiday Dialysis, LLC
	 	Silverbridge Home Training	 	2410 Alft Lane	 	Elgin	 	IL	 	60124-7843	 	Leased	 	No
	 ISD Buffalo Grove, LLC fka DSI Buffalo Grove, LLC
	 	Buffalo Grove	 	1291 W Dundee Road	 	Buffalo Grove	 	IL	 	60089-4009	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Loop Renal	 	1101 S Canal Street	 	Chicago	 	IL	 	60607-4901	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	South Holland	 	16136 S Park Avenue	 	South Holland	 	IL	 	60473-1511	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Waukegan	 	1616 N Grand Avenue	 	Waukegan	 	IL	 	60085-3676	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Arlington Heights	 	17 W Golf Road	 	Arlington Heights	 	IL	 	60005-3905	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Evanston	 	1717 Central Street	 	Evanston	 	IL	 	60202-1016	 	Leased	 	No

  
 Sch 4.8-36 

															
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Evanston	 	1922 Dempster Street	 	Evanston	 	IL	 	60202-1016	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Markham	 	3053 W 159th Street	 	Markham	 	IL	 	60428-4003	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Waukegan	 	3350 West Grand Avenue	 	Waukegan	 	IL	 	60085-3676	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Hazel Crest	 	3470 W 183rd Street	 	Hazel Crest	 	IL	 	60429-2428	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Markham	 	4215 West 167th Street	 	Country Club Hills	 	IL	 	60428-4003	 	Leased	 	No
	 ISD Schaumburg, LLC fka DSI Schaumburg, LLC
	 	Schaumburg	 	1156 S Roselle Road	 	Schaumberg	 	IL	 	60193-4072	 	Leased	 	No
	 ISD Schaumburg, LLC fka DSI Schaumburg, LLC
	 	Schaumburg	 	1156 South Roselle Road, Suites A and B	 	Schaumburg	 	IL	 	60005-3905	 	Leased	 	No
	 Lincoln Park Dialysis Services, Inc.
	 	Lincoln Park	 	3155-57 North Lincoln Ave.	 	Chicago	 	IL	 	60657-3111	 	Leased	 	No
	 Lincoln Park Dialysis Services, Inc.
	 	Kennedy Home	 	5509 N. Cumberland Avenue, Ste 515	 	Chicago	 	IL	 	60656-4702	 	Leased	 	No
	 Lincoln Park Dialysis Services, Inc.
	 	Lincoln Park	 	7009 W Belmont	 	Chicago	 	IL	 	60634-4533	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Merrillville	 	100 W 86th Ave	 	Merrillville	 	IL	 	46410-7062	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Alsip	 	12250 S. Cicero Ave.	 	Alsip	 	IL	 	60803-2907	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Rolling Meadows	 	1545 Hicks Road	 	Rolling Meadows	 	IL	 	60008	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Woodbridge	 	Woodgrove Medical And Professional Center, 7425 Janes Ave. #101	 	Woodridge	 	IL	 	60517-2356	 	Leased	 	No
	 Nadell Dialysis, LLC
	 	Moline Home Training	 	4650 38th Ave	 	Moline	 	IL	 	61265-6706	 	Leased	 	No
	 Pekin Dialysis, LLC
	 	Tazewell County	 	1021 Court Street	 	Pekin	 	IL	 	61554-4817	 	Leased	 	No
	 Renal Life Link, Inc
	 	Benton	 	1151 Route 14 West	 	Benton	 	IL	 	62812-1500	 	Leased	 	No
	 Renal Life Link, Inc
	 	Olney	 	117 N. Boone St.	 	Olney	 	IL	 	62450-2109	 	Leased	 	No
	 Renal Life Link, Inc
	 	Centralia	 	1231 State Route 161 East	 	Centralia	 	IL	 	62801-6739	 	Leased	 	No
	 Renal Life Link, Inc
	 	Marion	 	324 South 4th Street	 	Marion	 	IL	 	62959-1241	 	Leased	 	No
	 Renal Life Link, Inc
	 	Mount Vernon	 	4102 North Water Tower Place	 	Mount Vernon	 	IL	 	62864-6295	 	Leased	 	No
	 Renal Life Link, Inc
	 	East Metro	 	5105 West Main Street	 	Belleville	 	IL	 	62226-4728	 	Leased	 	Yes
	 Renal Life Link, Inc
	 	Beverly	 	8111 S. Western Avenue	 	Chicago	 	IL	 	60620-5939	 	Leased	 	No
	 Renal Life Link, Inc
	 	Stony Creek	 	9115 S. Cicero Ave	 	Oak Lawn	 	IL	 	60453-1895	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Granite City	 	 #2-#9 American Village
 & 3305 Nameoki
Rd
	 	Granite City	 	IL	 	62040-3706	 	Leased	 	No

  
 Sch 4.8-37 

															
	 Renal Treatment Centers-Illinois, Inc.
	 	Freeport	 	1026 & 1028 Kunkle Blvd	 	Freeport	 	IL	 	61032-6914	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	Dixon	 	1131 N Galena Ave	 	Dixon	 	IL	 	61021-1015	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	Sauget	 	2061 Goose Lake Rd	 	Sauget	 	IL	 	62206-2822	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Maryville	 	2130 Vadalabene Drive	 	Maryville	 	IL	 	62062-5632	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Maryville	 	2136-B Vadalabene Dr	 	Maryville	 	IL	 	62062-5828	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Little Village	 	2335 W Cermak	 	Chicago	 	IL	 	60608-3811	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Whiteside	 	2600 North Locust	 	Sterling	 	IL	 	61081-4602	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	Rockford	 	3339 N Rockton Ave	 	Rockford	 	IL	 	61103-2839	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Greenwood	 	3401 W 111th Street	 	Chicago	 	IL	 	60655-3329	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Lake Villa	 	37809 N Il Route 59	 	Lake Villa	 	IL	 	60046-7332	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Churchview	 	417 Ware Avenue	 	Rockford	 	IL	 	61107-6413	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Kankakee	 	581 William Latham Drive Ste 104	 	Bourbonnais	 	IL	 	60914-2439	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Churchview	 	5970 Churchview Drive	 	Rockford	 	IL	 	61107-6413	 	Leased	 	No
	 RMS Lifeline, Inc.
	 	Lifeline Corp	 	Three Hawthorn Parkway	 	Vernon Hills	 	IL	 	60061-1450	 	Leased	 	No
	 Robinson Dialysis, LLC
	 	Robinson	 	1215 N Allen St	 	Robinson	 	IL	 	62454-1100	 	Leased	 	No
	 Seasons Dialysis, LLC
	 	Crystal Springs	 	720 Cog Circle	 	Crystal Lake	 	IL	 	60014-7301	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Quincy	 	1005 Broadway St	 	Quincy	 	IL	 	62301-4152	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Team Fusion Group Office	 	105 E 1st Street	 	Dixon	 	IL	 	55344	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Joliet	 	1051 Essington Rd	 	Joliet	 	IL	 	60435-2893	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Shiloh	 	1095 North Green Mount Rd	 	Belleville	 	IL	 	62221-3303	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Salem Home Training	 	1201 Ricker Drive	 	Salem	 	IL	 	62881	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Stonecrest	 	1302 East State St	 	Rockford	 	IL	 	61104-2228	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hickory Hills	 	13155 S. Lagrange Road	 	Orlando Park	 	IL	 	60462-1162	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Chicago Clinic	 	1333 North Kingsbury Street, Suite 100	 	Chicago	 	IL	 	60642-2687	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Skyline Division Office	 	1333 North Kingsbury Street, Suite 305	 	Chicago	 	IL	 	60642-7039	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Red Bud	 	1500 East Market Street	 	Red Bud	 	IL	 	62278	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Morris	 	1547, 1549, 1551 Creek Drive	 	Morris	 	IL	 	60450-6857	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Side	 	1600 West 13th Street, Unit 3	 	Chicago	 	IL	 	60608-1306	 	Leased	 	No

  
 Sch 4.8-38 

															
	 Total Renal Care, Inc.
	 	Belvidere-IL	 	1755 Henry Luckow Lane	 	Belvidere	 	IL	 	61008	 	Leased	 	No
	 Total Renal Care, Inc.
	 	New Lenox	 	1890 Silver Cross Blvd	 	New Lenox	 	IL	 	60451	 	Leased	 	No
	 Total Renal Care, Inc.
	 	New Lenox Home Training	 	1890 Silver Cross Boulevard, Suite 465	 	New Lenox	 	IL	 	60451	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Carpentersville	 	2203 Randall Road	 	Carpentersville	 	IL	 	60110-3355	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Edwardsville	 	235 S. Buchanan	 	Edwardsville	 	IL	 	62025-2108	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dnp Regional Office East	 	27475 Ferry Road	 	Warrenville	 	IL	 	60555	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Logan Square	 	2838 North Kimball Ave	 	Chicago	 	IL	 	60618-7524	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Springfield South	 	2930 South 6th St	 	Springfield	 	IL	 	62703-5944	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Danville Home Training	 	3 Poland Road	 	Danville	 	IL	 	61834-7463	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Vandalia	 	301 Mattes Road	 	Vandalia	 	IL	 	62471-2061	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fairfield	 	303 Nw 11th St	 	Fairfield	 	IL	 	62837-1203	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Downers Grove	 	3050 Finley Road	 	Downers Grove	 	IL	 	60515-1196	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Garfield Kennedy	 	3250 W Franklin Blvd	 	Chicago	 	IL	 	60624-1509	 	Owned	 	No
	 Total Renal Care, Inc.
	 	Lake Park	 	4253 South Cottage Grove Ave	 	Chicago	 	IL	 	60653-2929	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Woodlawn Home Pd	 	4253 South Cottage Grove Ave	 	Chicago	 	IL	 	60653	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Olympia Fields	 	4557b W Lincoln Hwy	 	Matteson	 	IL	 	60443-2385	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Woodlawn	 	5060 S State St	 	Chicago	 	IL	 	60609-5328	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Big Oaks	 	5623 W Touhy Ave	 	Niles	 	IL	 	60714-4019	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake County	 	565 Lakeview Parkway	 	Vernon Hills	 	IL	 	60061-1857	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Lake County At Home	 	565 Lakeview Parkway	 	Vernon Hills	 	IL	 	60061-1857	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pittsfield	 	640 W Washington St	 	Pittsfield	 	IL	 	62363-1350	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Lawn	 	7000 S. Pulaski Rd.	 	Chicago	 	IL	 	60629-5842	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Montclare	 	7009-11 W. Belmont Ave	 	Chicago	 	IL	 	60634-4533	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Emerald	 	710 W 43rd St	 	Chicago	 	IL	 	60609-3435	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grand Crossing	 	7319 S. Cottage Grove	 	Chicago	 	IL	 	60619-1909	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Woodridge Home	 	7425 Janes Ave	 	Woodridge	 	IL	 	60517-2335	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cobblestone	 	836 Dundee Ave & 851 Duncan Ave	 	Elgin	 	IL	 	60120-3068	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Stony Island	 	8721 South Stony Island	 	Chicago	 	IL	 	60617-2709	 	Leased	 	Yes

  
 Sch 4.8-39 

															
	 Total Renal Care, Inc.
	 	Marengo City	 	910 Greenlee	 	Marengo	 	IL	 	60152-8200	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Jerseyville	 	917 S State St	 	Jerseyville	 	IL	 	62052-2344	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Coal City	 	965 E. Division Street	 	Coal City	 	IL	 	60416-9483	 	Leased	 	No
	 TRC-Indiana, LLC.
	 	Crc East Chicago	 	4320 Fir Street	 	East Chicago	 	IL	 	46312-3078	 	Leased	 	No
	 Bridges Dialysis, LLC
	 	Fort Wayne South	 	302 East Pettit Avenue	 	Fort Wayne	 	IN	 	46806-3007	 	Leased	 	No
	 Bridges Dialysis, LLC
	 	Summit City	 	3101 East Coliseum Blvd	 	Fort Wayne	 	IN	 	46805-1561	 	Leased	 	No
	 Bridges Dialysis, LLC
	 	Fort Wayne Home	 	3124 E State Blvd	 	Fort Wayne	 	IN	 	46805-4763	 	Leased	 	No
	 Bridges Dialysis, LLC
	 	Fort Wayne West	 	4916 Illinois Rd	 	Fort Wayne	 	IN	 	46804-5116	 	Leased	 	No
	 Cardinal Dialysis, LLC
	 	Muncie	 	820-824 E. McGalliard Road	 	Muncie	 	IN	 	47303-2081	 	Leased	 	No
	 Damon Dialysis, LLC
	 	Avon	 	9210 Rockville Road	 	Indianapolis	 	IN	 	46234-2670	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Division	 	3021 East 98th Street	 	Indianapolis	 	IN	 	46280-1964	 	Leased	 	No
	 Gardenside Dialysis, LLC
	 	Scottsburg	 	1619 W. Mcclain Ave	 	Scottsburg	 	IN	 	47170-1161	 	Leased	 	No
	 Griffs Dialysis, LLC
	 	South Bend West	 	Blackthorn Office Park	 	South Bend	 	IN	 	46628-6205	 	Leased	 	No
	 ISD Plainfield, LLC fka DSI Plainfield, LLC
	 	Plainfield	 	8110 Network Drive	 	Plainfield	 	IN	 	46168-9024	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Central Fort Wayne	 	1940 Bluffton Road	 	Fort Wayne	 	IN	 	46809-1307	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Blue River Valley	 	2309 S Miller Street	 	Shelbyville	 	IN	 	46176-9350	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Huntington	 	3040 W Park Drive	 	Huntington	 	IN	 	46750-8956	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Lake Avenue	 	3525 Lake Avenue	 	Fort Wayne	 	IN	 	46805-5545	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Marion County	 	3834 S Emerson Avenue	 	Indianapolis	 	IN	 	46203-5902	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Quad Counties	 	528 N Grandstaff Dr	 	Auburn	 	IN	 	46706-1660	 	Leased	 	No
	 ISD Renal, Inc. fka DSI Renal, Inc.
	 	Lake Avenue Dialysis (P226, P227)	 	3525 Lake Avenue	 	Fort Wayne	 	IN	 	46816	 	Owned	 	No
	 ISD Renal, Inc. fka DSI Renal, Inc.
	 	CLSD-South Anthony Dialysis (P234)	 	7017 South Anthony	 	Fort Wayne	 	IN	 	46816	 	Owned	 	No
	 Lawrenceburg Dialysis, LLC
	 	Lawrenceburg	 	721 Rudolph Way	 	Greendale	 	IN	 	47025-8378	 	Leased	 	No
	 Lurleen Dialysis, LLC
	 	Jeffersonville	 	365 Quartermaster Court	 	Jeffersonville	 	IN	 	47130-3670	 	Leased	 	No
	 Mocca Dialysis, LLC
	 	Spring Street	 	1601 Spring Street	 	Jeffersonville	 	IN	 	47130	 	Leased	 	No
	 New Bay Dialysis, LLC
	 	Corydon	 	1937-B Old Highway 135 Nw	 	Corydon	 	IN	 	47112-2013	 	Leased	 	No
	 New Springs Dialysis, LLC
	 	Salem	 	1201 North Jim Day Rd	 	Salem	 	IN	 	47167-7219	 	Leased	 	No
	 Prings Dialysis, LLC
	 	Eagle Highlands	 	6925 Shore Terrace Drive	 	Indianapolis	 	IN	 	46254-4675	 	Leased	 	Yes

  
 Sch 4.8-40 

															
	 Renal Life Link, Inc
	 	North Evansville	 	1151 West Buena Vista Road	 	Evansville	 	IN	 	47710-3334	 	Leased	 	No
	 Renal Life Link, Inc
	 	East Evansville	 	1312 Professional Boulevard	 	Evansville	 	IN	 	47714-8007	 	Leased	 	Yes
	 Renal Life Link, Inc
	 	Daviess	 	310 NE 14th Street	 	Washington	 	IN	 	47501-2137	 	Leased	 	No
	 Renal Life Link, Inc
	 	Jasper	 	671 3rd Avenue, Suite A	 	Jasper	 	IN	 	47546-1856	 	Leased	 	No
	 Renal Life Link, Inc
	 	Vincennes	 	700 Willow Street	 	Vincennes	 	IN	 	47591-1028	 	Leased	 	Yes
	 Renal Life Link, Inc
	 	Jasper	 	721 W. 13th Street	 	Jasper	 	IN	 	47546-1856	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Franklin	 	1140 West Jefferson Street	 	Franklin	 	IN	 	46131-2101	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Madison	 	220 Clifty Drive Unit K	 	Madison	 	IN	 	47250-1669	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	Princeton - In	 	2227 Sherman Drive	 	Princeton	 	IN	 	47670-1062	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Batesville	 	232 State Road 129 South	 	Batesville	 	IN	 	47006-7694	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	New Albany	 	2669 E&F Charlestown Rd	 	New Albany	 	IN	 	47150-2573	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Westview	 	3749 Commercial Drive	 	Indianapolis	 	IN	 	46222-1676	 	Leased	 	No
	 Roushe Dialysis, LLC
	 	Mishawaka	 	Trinity Place, Lot 6	 	Mishawaka	 	IN	 	46545-5005	 	Leased	 	No
	 Santee Dialysis, LLC
	 	Elkhart	 	1401 N. Michigan Street	 	Elkhard	 	IN	 	46514-2633	 	Leased	 	No
	 Silverwood Dialysis, LLC
	 	Indy East	 	1208 North Arlington Avenue	 	Indianapolis	 	IN	 	46219-3203	 	Leased	 	No
	 Southwest Indiana Dialysis, LLC
	 	Bridge Point	 	1136 North Baldwin Avenue	 	Marion	 	IN	 	46952-2536	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Carmel Healthy Living	 	118 Medical Drive	 	Carmel	 	IN	 	46032-2923	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Brownsburg	 	124 E Northfield Drive	 	Brownsburg	 	IN	 	46112-2601	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Rushville	 	1400 N Cherry St	 	Rushville	 	IN	 	46173-1097	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hoosier Hills	 	143 S Kingston Dr	 	Bloomington	 	IN	 	47408-6342	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Greenburg	 	1531 North Commerce East Drive	 	Greensburg	 	IN	 	47240-3259	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Carmel	 	176-182 East Carmel Dr	 	Carmel	 	IN	 	46032-2633	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Vernon	 	2350 N State Hwy 7	 	North Vernon	 	IN	 	47265-7183	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Newburgh	 	4311 Highway 261	 	Newburgh	 	IN	 	47630-2653	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hl Region 6	 	5521 W. U.S. Highway 30	 	Schererville	 	IN	 	46307	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Paoli	 	555 West Longest Street	 	Paoli	 	IN	 	47454-9670	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Portage	 	5823 Us Route 6	 	Portage	 	IN	 	46368-4851	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Chesterton	 	711 Plaza Dr #6	 	Chesterton	 	IN	 	46304-5506	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Indy South	 	972 Emerson Parkway	 	Greenwood	 	IN	 	46143-6202	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Southbend Downtown	 	TBD	 	South Bend	 	IN	 	46601	 	Leased	 	No

  
 Sch 4.8-41 

															
	 Total Renal Care, Inc.
	 	St John	 	Units # 3-8	 	St. John	 	IN	 	46373-8777	 	Leased	 	Yes
	 TRC-Indiana, LLC.
	 	Tell City	 	1602 Main Street	 	Tell City	 	IN	 	47586-1310	 	Leased	 	Yes
	 TRC-Indiana, LLC.
	 	Hammond	 	222 Douglas	 	Hammond	 	IN	 	46320-1960	 	Leased	 	No
	 TRC-Indiana, LLC.
	 	Gary	 	4802 Broadway	 	Gary	 	IN	 	46408-4509	 	Leased	 	No
	 TRC-Indiana, LLC.
	 	Valparaiso	 	606 Lincoln Way	 	Valparaiso	 	IN	 	46383-5728	 	Leased	 	No
	 TRC-Indiana, LLC.
	 	Crc Munster	 	9100 A Calumet Ave	 	Munster	 	IN	 	46321-2806	 	Leased	 	No
	 TRC-Indiana, LLC.
	 	Merrillville	 	9223 Taft Street	 	Merrillville	 	IN	 	46410-6911	 	Leased	 	Yes
	 TRC-Indiana, LLC.
	 	Comprehensive Michigan City	 	9836 W 400 North	 	Michigan City	 	IN	 	46360-2910	 	Leased	 	Yes
	 Beals Dialysis, LLC
	 	Gardner-KS	 	324-328 East Main Street	 	Gardner	 	KS	 	66030-1314	 	Leased	 	No
	 Bladon Dialysis, LLC
	 	Hutchinson	 	1901 North Waldron	 	Hutchinson	 	KS	 	67502-1129	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Wyandotte West	 	11013 Haskell Ave	 	Kansas City	 	KS	 	66109-4404	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lenexa	 	8630 Halsey	 	Lenexa	 	KS	 	66215-2880	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Olathe	 	732 West Frontier	 	Olathe	 	KS	 	66061-7202	 	Leased	 	No
	 Joshua Dialysis, LLC
	 	Andover	 	626 S. Andover Road	 	Andover	 	KS	 	67002-8910	 	Leased	 	No
	 Kenai Dialysis, LLC
	 	Medical Plaza	 	10787 Nall	 	Leawood	 	KS	 	66211-1375	 	Leased	 	No
	 MGD-Maize Dialysis Center, LLC
	 	Maize	 	10001 W Grady Ave	 	Maize	 	KS	 	67101	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Kansas City	 	10 E. Cambridge Circle	 	Kansas City	 	KS	 	66103-1334	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Wichita	 	2630 N. Webb Rd, Bld. 100 Suite 200	 	Wichita	 	KS	 	67226-8110	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Newton	 	1223 Washington Road	 	Newton	 	KS	 	67114-4855	 	Leased	 	Yes
	 Renal Treatment Centers-West, Inc.
	 	Winfield	 	1315 East 4th Avenue	 	Winfield	 	KS	 	67156-2457	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Derby	 	250 W. Red Powell Drive	 	Derby	 	KS	 	67037-2626	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Ne Wichita	 	2630 N. Webb Rd, Bld. 100 Suite 200	 	Wichita	 	KS	 	67226-8174	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	East Wichita	 	320 North Hillside	 	Wichita	 	KS	 	67214-4918	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Garden City	 	401 N Main St	 	Garden City	 	KS	 	67846-6959	 	Leased	 	Yes
	 Renal Treatment Centers-West, Inc.
	 	Leavenworth	 	501 Oaks Street	 	Leavenworth	 	KS	 	66048-2646	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Wichita	 	909 North Topeka	 	Wichita	 	KS	 	67214-3620	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Parsons	 	Labette County Medical Center	 	Parsons	 	KS	 	67357	 	Leased	 	Yes

  
 Sch 4.8-42 

															
	 Renal Treatment Centers-West, Inc.
	 	Independence	 	 Mercy Hospital, 801 W. Myrtle
 PO Box
1233
	 	Independence	 	KS	 	67301-3239	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Johnson County	 	10453 W 84th Terrace	 	Lenexa	 	KS	 	66214-1641	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sabetha	 	106 North 12th Street	 	Sabetha	 	KS	 	66534-1810	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hiawatha	 	120 East Lodge Road	 	Hiawatha	 	KS	 	66434	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ottawa	 	1320 S. Ash	 	Ottawa	 	KS	 	66067-3413	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pratt	 	203 Watson	 	Pratt	 	KS	 	67124-3092	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Lawrence	 	330 Arkansas Street	 	Lawrence	 	KS	 	66044-1394	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wyandotte	 	5001 State Avenue	 	Kansas City	 	KS	 	66102-3459	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Topeka	 	634 Sw Mulvane Street	 	Topeka	 	KS	 	66606-1678	 	Leased	 	No
	 Windcreek Dialysis, LLC
	 	Paola	 	1605 E. Peoria Street	 	Paola	 	KS	 	66071-1893	 	Leased	 	No
	 Wyandotte Central Dialysis, LLC
	 	Wyandotte Central	 	3737 State Avenue	 	Kansas City	 	KS	 	66102-3830	 	Leased	 	No
	 Bluegrass Dialysis, LLC
	 	Williamstown	 	103 Barnes Road	 	Williamstown	 	KY	 	41097-9468	 	Leased	 	No
	 Bluegrass Dialysis, LLC
	 	12th Street Covington	 	1500 James Simpson Jr. Way	 	Covington	 	KY	 	41011	 	Leased	 	No
	 Caballo Dialysis, LLC
	 	Hi Hat	 	17721 Route 122	 	Hi Hat	 	KY	 	41636-6624	 	Leased	 	No
	 Caddo Dialysis, LLC
	 	General Butler	 	329 Floyd Drive	 	Carrollton	 	KY	 	41008-8258	 	Leased	 	No
	 Central Kentucky Dialysis Centers, LLC
	 	Radcliff	 	180 East Lincoln Trail Blvd	 	Radcliff	 	KY	 	40160-1254	 	Leased	 	No
	 Central Kentucky Dialysis Centers, LLC
	 	Bardstown	 	208/210 West John Fitch Avenue	 	Bardstown	 	KY	 	40004-1115	 	Leased	 	No
	 Central Kentucky Dialysis Centers, LLC
	 	Woodland	 	2807-2813 Ring Road	 	Elizabethtown	 	KY	 	42701-2795	 	Leased	 	No
	 Central Kentucky Dialysis Centers, LLC
	 	Woodland	 	912 Woodland Drive	 	Elizabethtown	 	KY	 	42701-2795	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Hopkinsville	 	1914 South Virginia Street	 	Hopkinsville	 	KY	 	42240	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Christian County	 	200 Burley Avenue	 	Hopkinsville	 	KY	 	42240-8725	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Crestview Hills	 	400 Centerview Blvd	 	Crestview Hills	 	KY	 	41017-3478	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	South Hill	 	525 Alexandria Pike	 	Southgate	 	KY	 	41071-3243	 	Leased	 	Yes
	 Grove Dialysis, LLC
	 	Warren County	 	391 Swannee Trail Street	 	Bowling Green	 	KY	 	42103-7956	 	Leased	 	No
	 Martin Dialysis, LLC
	 	Owensboro	 	3250 Kidron Valley Way	 	Owensboro	 	KY	 	42301-2398	 	Leased	 	No
	 New Bay Dialysis, LLC
	 	Lagrange	 	240 Parker Drive	 	Lagrange	 	KY	 	40031-1200	 	Leased	 	No
	 New Bay Dialysis, LLC
	 	Meadows East	 	2520 Six Mile Lane	 	Louiville	 	KY	 	40220-2934	 	Leased	 	No
	 New Bay Dialysis, LLC
	 	West Broadway	 	720 W Broadway	 	Louisville	 	KY	 	40202-2240	 	Leased	 	No
	 New Springs Dialysis, LLC
	 	Louisville	 	8037 Dixie Highway	 	Louisville	 	KY	 	40258-1344	 	Leased	 	Yes

  
 Sch 4.8-43 

															
	 Renal Life Link, Inc
	 	Springhurst	 	10201 Champion Farms Drive	 	Louisville	 	KY	 	40241-6150	 	Leased	 	No
	 Renal Life Link, Inc
	 	Gardenside	 	70 North Garden Mile Road	 	Henderson	 	KY	 	42420-5529	 	Leased	 	No
	 Renal Life Link, Inc
	 	Leitchfield	 	912 Wallace Avenue	 	Leitchfield	 	KY	 	42754-2405	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Owensboro	 	1930 East Parrish Ave	 	Owensboro	 	KY	 	42303-1443	 	Leased	 	No
	 River Valley Dialysis, LLC
	 	Turfway	 	11 Spiral Drive	 	Florence	 	KY	 	41042-1394	 	Leased	 	Yes
	 River Valley Dialysis, LLC
	 	Cold Springs	 	400 Cross Roads Drive	 	Cold Spring	 	KY	 	41076-2341	 	Leased	 	No
	 Sugarite Dialysis, LLC
	 	Shelbyville Road	 	4600 Shelbyville Rd	 	Louisville	 	KY	 	40207-3326	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Taylor Country	 	101 Kingwood Drive	 	Campbellsville	 	KY	 	42718-9634	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Eastern Kentucky	 	167 Weddington Branch Road	 	Pikeville	 	KY	 	41501-3204	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hamburg	 	1745 Alysheba Way	 	Lexington	 	KY	 	40509-9013	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Williamson	 	204 Appalachian Plz	 	South Williamson	 	KY	 	41503-9404	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Portland	 	2112-2122 Portland Avenue	 	Louisville	 	KY	 	40212	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bourbon County	 	213 Letton Dr	 	Paris	 	KY	 	40361-2251	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kentucky Home	 	2130 Nicholasville Road	 	Lexington	 	KY	 	40503-2520	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Louisa	 	2145 Highway 2565	 	Louisa	 	KY	 	41230-9166	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Madisonville	 	255 East North St.	 	Madisonville	 	KY	 	42431-1641	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Paintsville	 	4750 S Ky Route 321	 	Hagerhill	 	KY	 	41222-9012	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Versailles	 	480 Lexington Rd	 	Versailles	 	KY	 	40383-1918	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Raven Rock	 	483 Gateway Industrial Park	 	Jenkins	 	KY	 	41537-9209	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Maysville	 	489 Tucker Drive	 	Maysville	 	KY	 	41056-9111	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Shelby County KY	 	Churchview Street, Lot #6	 	Shelbyville	 	KY	 	40065	 	Leased	 	No
	 Verde Dialysis, LLC
	 	Shepherdsville	 	150 Brooks Hill Way	 	Brooks	 	KY	 	40109-6105	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Donaldsonville	 	101 Plimsol Street	 	Donaldsonville	 	LA	 	70346	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Magnolia	 	210 East Spillman Road	 	Gonzales	 	LA	 	70737-4604	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Chateau	 	720 Village Road	 	Kenner	 	LA	 	70065-2751	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	New Orleans Uptown	 	1401 Foucher Street	 	New Orleans	 	LA	 	70115-3515	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Deridder	 	239 East 1st Street	 	Deridder	 	LA	 	70634-4105	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Lake Charles	 	300 W. 18th	 	Lake Charles	 	LA	 	70601-7342	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Sulphur	 	944 S Beglis Parkway	 	Sulphur	 	LA	 	70663-5102	 	Leased	 	No

  
 Sch 4.8-44 

															
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Batonrouge	 	1333 O’Neal Lane	 	Baton Rouge	 	LA	 	70816-1957	 	Leased	 	No
	 ISD Renal, Inc. fka DSI Renal, Inc.
	 	Houma Dialysis (P175)	 	108 Picone Road	 	Houma	 	LA	 	70363	 	Owned	 	No
	 Pine Dialysis, LLC
	 	Westwego	 	1 Westbank Expressway	 	Westwego	 	LA	 	70094-4156	 	Leased	 	No
	 Renal Life Link, Inc
	 	Metairie	 	7110 Airline Drive	 	Metairie	 	LA	 	70003-5950	 	Leased	 	No
	 Renal Life Link, Inc.
	 	River Parishes Dialysis (aka La Place)	 	2880 West Airline Hwy	 	La Place	 	LA	 	70068-2922	 	Owned	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Northshore	 	106 Medical Center Drive	 	Slidell	 	LA	 	70461-5575	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Oakwood	 	148 Hector Avenue	 	Gretna	 	LA	 	70056-2531	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Hammond	 	15799 Professional Plaza	 	Hammond	 	LA	 	70403-1452	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Marrero	 	1908 Jutland Dr	 	Harvey	 	LA	 	70058-2359	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Covington	 	210 Greenbriar Blvd.	 	Covington	 	LA	 	70433-7235	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Bogalusa	 	2108 Avenue F	 	Bogalusa	 	LA	 	70427	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Slidell	 	662 Robert Blvd	 	Slidell	 	LA	 	70458-1648	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Washington Parish	 	724 Washington Street	 	Franklinton	 	LA	 	70438-1790	 	Leased	 	No
	 Total Renal Care, Inc.
	 	River Bend	 	1057 Paul Maillard Road	 	Luling	 	LA	 	70070-4349	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fremaux	 	1570 Shortcut Highway	 	Slidell	 	LA	 	70458-8126	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Broadmoor	 	1815 E. 70th	 	Shreveport	 	LA	 	71105-5301	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kenner Regional	 	200 West Esplanade Avenue	 	Kenner	 	LA	 	70065-2473	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Marigny	 	2345 St. Claude Avenue	 	New Orleans	 	LA	 	70117-8352	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Tri-Parish	 	2345 St. Claude Avenue	 	New Orleans	 	LA	 	70128-3450	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Galaxy Hospital Services Division Office	 	2400 Veterans Blvd.	 	Kenner	 	LA	 	70062	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Garden District	 	2620 Jena Street	 	New Orleans	 	LA	 	70115-6325	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Algiers	 	2924 General DeGaulle Drive	 	New Orleans	 	LA	 	70114-6440	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Youngsville	 	314 Youngsville Hwy	 	Lafayette	 	LA	 	70508-4524	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Westabank Chronic	 	3631 Behrman Place	 	New Orleans	 	LA	 	70114-0906	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Crescent City	 	3909 Bienville Street	 	New Orleans	 	LA	 	70119-5151	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Southern Heat Division Office	 	401 Whitney Ave	 	Gretna	 	LA	 	70056-2500	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Memorial	 	4427 S Robertson St	 	New Orleans	 	LA	 	70115-6308	 	Leased	 	No

  
 Sch 4.8-45 

															
	 Total Renal Care, Inc.
	 	Fleur De Lis	 	5555 Bullard Road	 	New Orleans	 	LA	 	70128-3450	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Nola	 	5646 Read Blvd, Suite 150	 	New Orleans	 	LA	 	70127-3106	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Baton Rouge	 	7703 Picardy Ave.	 	Baton Rouge	 	LA	 	70808-4338	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Red River Dialysis	 	9205 Linwood Avenue	 	Shreveport	 	LA	 	71106-7006	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Scotlandville	 	TBD	 	Baton Rouge	 	LA	 	70807-5583	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Wellington Circle	 	10 Cabot Road	 	Medford	 	MA	 	02155-5173	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Salem Northeast	 	10 Colonial Road, Suite 205	 	Salem	 	MA	 	01970-2947	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Woburn	 	23 Warren Ave.	 	Woburn	 	MA	 	01801-7906	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	New Bedford	 	237 State Road	 	Dartmouth	 	MA	 	02747-2612	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Burlington Regional	 	31 Mall Road	 	Burlington	 	MA	 	01803-4138	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	GHc-Brookline	 	322 Washington Street	 	Brookline	 	MA	 	2146	 	Owned	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Weymouth	 	330 Libbey Industrial Parkway	 	Weymouth	 	MA	 	02189-3122	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Boston	 	660 Harrison Ave	 	Boston	 	MA	 	02118-2304	 	Leased	 	No
	 DVA Healthcare of Massachusetts, Inc.
	 	Northeast Cambridge	 	799 Concord Avenue	 	Cambridge	 	MA	 	02138-1048	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	North Andover	 	201 Sutton Street	 	North Andover	 	MA	 	1845	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Amesbury	 	24 Morrill Place	 	Amesbury	 	MA	 	01913-3530	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Worcester	 	19 Glennie Street	 	Worcester	 	MA	 	01605-3918	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Fitchburg	 	551 Electric Avenue	 	Fitchburg	 	MA	 	01420-5371	 	Leased	 	Yes
	 Aberdeen Dialysis, LLC
	 	Forest Landing	 	2220 Commerce Road	 	Forest Hill	 	MD	 	21050-2560	 	Leased	 	No
	 Aberdeen Dialysis, LLC
	 	Aberdeen	 	780 W Bel Air Avenue	 	Aberdeen	 	MD	 	21001-2236	 	Leased	 	No
	 Brook Dialysis, LLC
	 	Waldorf	 	4475 Regency Place	 	White Plains	 	MD	 	20695-3072	 	Leased	 	No
	 Brownwood Dialysis, LLC
	 	Brownwood	 	5542 Norbeck Road	 	Rockville	 	MD	 	20853-2441	 	Leased	 	No
	 Carroll County Dialysis Facility Limited Partnership
	 	Carroll County	 	193 Stoner Ave	 	Westminster	 	MD	 	21157-5782	 	Leased	 	No
	 Clark Dialysis, LLC
	 	Annapolis	 	1127 West Street	 	Annapolis	 	MD	 	21401-3615	 	Leased	 	Yes
	 Cleburne Dialysis, LLC
	 	Coral Hills	 	4797 Marlboro Pike	 	Capitol Heights	 	MD	 	20743-5213	 	Leased	 	No
	 Creek Dialysis, LLC
	 	Calverton Md	 	4780 Corridor Pl	 	Beltsville	 	MD	 	20705-1165	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Whitesquare	 	1 Nashua Court	 	Baltimore	 	MD	 	21221-3131	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Lakeside	 	10401 Hospital Drive, Suite G02	 	Clinton	 	MD	 	20735-3113	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Falls Road	 	10753 Falls Road Suite 115	 	Lutherville	 	MD	 	21093-4572	 	Leased	 	No

  
 Sch 4.8-46 

															
	 DVA Healthcare of Maryland, Inc.
	 	Dundalk	 	14 Commerce Street	 	Dundalk	 	MD	 	21222-4307	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Frederick	 	140 Thomas Johnson Drive	 	Frederick	 	MD	 	21702-4475	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Bel Air	 	2225 Old Emmorton Road	 	Bel Air	 	MD	 	21015-6122	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Jb Zachary	 	333 Cassell Drive Suite 2300	 	Baltimore	 	MD	 	21224-6815	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Jhhs North Bond Street	 	412 North Bond Street	 	Baltimore	 	MD	 	21231-1003	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Pasadena	 	8037 A Governor Ritchie Highway	 	Pasadena	 	MD	 	21122-7608	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Silver Spring	 	8040 Georgia Ave	 	Silver Springs	 	MD	 	20910-4959	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Pasadena	 	8894 Fort Smallwood Road	 	Pasadena	 	MD	 	21122-7608	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	25th Street	 	920 East 25th Street	 	Baltimore	 	MD	 	21218-5503	 	Leased	 	No
	 DVA Healthcare of Maryland, Inc.
	 	Baltimore Geriatric & Rehab	 	Johns Hopkins Bayview Medical Ctr, 5th Floor Pavilion 4940 Eastern Avenue	 	Baltimore	 	MD	 	21224-2735	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Harbor Park	 	111 Cherry Hill Road	 	Baltimore	 	MD	 	21225-1392	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Landover	 	1200 Mercantile Lane Suite 105	 	Largo	 	MD	 	20774-5389	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Catonsville	 	1581 Sulphur Spring Road, Suite 111,112, And 116-118 Bldg A	 	Baltimore	 	MD	 	21227-2599	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Catonsville-Warehouse	 	1585 Sulphur Spring Road	 	Baltimore	 	MD	 	21227-2599	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Mercy	 	315 N Calvert St	 	Baltimore	 	MD	 	21202-3611	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Catonsville North	 	5401 Baltimore National Pike	 	Catonsville	 	MD	 	21229-2102	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Cedar Lane	 	6334 Cedar Lane	 	Columbia	 	MD	 	21044-3898	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Southern Maryland	 	9211 Stuart Lane	 	Clinton	 	MD	 	20735-2712	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Howard County	 	Suite E-100	 	Columbia	 	MD	 	21044-3023	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Atlantic Stars Division	 	4041 Powder Mill Road	 	Calverton	 	MD	 	20706-1872	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Maryland Deal Depot Corporate Office	 	600 Jefferson Street	 	Rockville	 	MD	 	20705-3106	 	Leased	 	No
	 Hagerstown Dialysis, LLC
	 	Washington County	 	1136 Opal Court	 	Hagerstown	 	MD	 	21740-5940	 	Leased	 	No
	 Limon Dialysis, LLC
	 	District Heights	 	5701 Silver Hill Road	 	District Heights	 	MD	 	20747-1102	 	Leased	 	No
	 Lord Baltimore Dialysis, LLC
	 	Woodlawn	 	2245 Rolling Run Drive	 	Baltimore	 	MD	 	21244-1858	 	Leased	 	Yes
	 Mason-Dixon Dialysis Facilities, Inc.
	 	Baltimore County	 	3689 Offutt Road	 	Randallstown	 	MD	 	21133-3515	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Baltimore 1b	 	1664-1670 Sulphur Spring Rd.	 	Baltimore	 	MD	 	21227	 	Leased	 	No

  
 Sch 4.8-47 

															
	 MGD-Medical Practice (Lifeline)
	 	Lf-Baltimore	 	2405 York Road	 	Timonium	 	MD	 	21093	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Washington Dc	 	4155 Bladensburg Rd	 	Colmar Manor	 	MD	 	20722-1928	 	Leased	 	No
	 Parkside Dialysis, LLC
	 	Pikesville	 	6609 Reisterstown Road	 	Baltimore	 	MD	 	21215-2662	 	Leased	 	No
	 Renal Care of Seat Pleasant, LLC
	 	Seat Pleasant	 	6274 Central Avenue	 	Seat Pleasant	 	MD	 	20743	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Chestertown	 	100 Brown St	 	Chestertown	 	MD	 	21620-1435	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Owings Mills	 	1121 Dolfield Blvd	 	Ownings Mills	 	MD	 	21117-3254	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Kidney Care Of Largo	 	1300 Mercantile Lane	 	Largo	 	MD	 	20774	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Laurel	 	14631 Laurel Bowie Road	 	Laurel	 	MD	 	20707	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Rockville	 	14915 Broschart Road, Suite# 100	 	Rockville	 	MD	 	20850-3367	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Takoma Park	 	1502 University Boulevard	 	Langley Park	 	MD	 	20783	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Germantown	 	20111 Century Blvd	 	Germantown	 	MD	 	20874-9165	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Cambridge	 	300 Byrn Street	 	Cambridge	 	MD	 	21613-1908	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Berlin	 	314 Franklin Ave., Suite #306	 	Berlin	 	MD	 	21811-1238	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Easton	 	402 Marvel Court	 	Easton	 	MD	 	21601-3857	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Lanham	 	4451 Parliament Place	 	Lanham	 	MD	 	20706-1872	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Seton Drive	 	4800 Seton Drive	 	Baltimore	 	MD	 	21215-3210	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Bowie	 	4861 Telsa Drive	 	Bowie	 	MD	 	20715-4318	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Easton	 	500 Cadmus Lane	 	Easton	 	MD	 	21601-3857	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Berlin	 	9952 North Main Street	 	Berlin	 	MD	 	21811-1238	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Wheaton	 	Wheaton Park Shopping, 11941 Georgia Ave. Suite # 100	 	Wheaton	 	MD	 	20902	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Midatlantic Operations Umbrella	 	11165 Crain Highway	 	Newburg	 	MD	 	21015-6129	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dulaney Towson	 	113 West Road, Suite #201	 	Towson	 	MD	 	21204-2318	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Middlebrook	 	12401 Middlebrook Rd	 	Germantown	 	MD	 	20874-1523	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Queen Anne County PD-MD	 	125 Shoreway Drive, Suite 330	 	Queenstown	 	MD	 	21658-1680	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bay City Lights Divisional Office	 	2245 Rolling Run Drive	 	Woodlawn	 	MD	 	21244-1858	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cotoctin Parking Lot	 	405 W 7th St	 	Frederick	 	MD	 	21701-4505	 	Leased	 	Yes

  
 Sch 4.8-48 

															
	 Total Renal Care, Inc.
	 	Catoctin	 	405 West Seventh St	 	Frederick	 	MD	 	21701-4505	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Greenspring	 	4701 Mt Hope Drive	 	Baltimore	 	MD	 	21215-3246	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Harford Road	 	5800 Harford Road	 	Baltimore	 	MD	 	21214-1847	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bertha Sirk	 	5820 York Rd	 	Baltimore	 	MD	 	21212-3620	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Deer Creek Pd	 	602 S. Atwood Rd	 	Bel Air	 	MD	 	21014-4198	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Downtown	 	821 N. Eutaw Street, Suite #401	 	Baltimore	 	MD	 	21201-6304	 	Leased	 	Yes
	 TRC-Georgetown Regional Dialysis, LLC.
	 	Rivertowne	 	6192 Oxon Hill Rd.	 	Oxon Hill	 	MD	 	20745-3114	 	Leased	 	No
	 Victory Dialysis, LLC
	 	Glen Burnie	 	6934 Aviation Boulevard	 	Glen Burnie	 	MD	 	21061-2593	 	Leased	 	No
	 Whitney Dialysis, LLC
	 	Oxon Hill	 	5432 St Barnabas Road	 	Oxon Hill	 	MD	 	20745-3622	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ellsworth	 	11 Short Street	 	Ellsworth	 	ME	 	04605-1718	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Lincoln	 	250 Enfield Rd	 	Lincoln	 	ME	 	04457-0367	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Bangor	 	925 Union Street	 	Bangor	 	ME	 	04401-3051	 	Leased	 	No
	 Acton Dialysis, LLC
	 	Bad Axe	 	 897 North Van Dyke Road,
 Spaces A, B, C,
& D
	 	Bad Axe	 	MI	 	48413-7912	 	Leased	 	No
	 Beachside Dialysis, LLC
	 	Harper Woods	 	19265 Vernier Rd	 	Harper Woods	 	MI	 	48225-1010	 	Leased	 	No
	 Blanco Dialysis, LLC
	 	Muskegon	 	2480 E. Apple Ave	 	Muskegon	 	MI	 	49442-4471	 	Leased	 	No
	 Bowan Dialysis, LLC
	 	Beltline Home	 	330 East Beltline Ave NE	 	Grand Rapids	 	MI	 	49506-1267	 	Leased	 	No
	 Clinton Township Dialysis, LLC
	 	Clinton Township	 	15918 Nineteen Mile Road	 	Clinton Township	 	MI	 	48038-1101	 	Leased	 	No
	 Commerce Township Dialysis Center, LLC
	 	Commerce Township	 	120-150 Commerce Road	 	Commerce Township	 	MI	 	48382-3915	 	Leased	 	No
	 DaVita Healthcare Partners Inc.
	 	Payor Contracting	 	27780 Novi Rd	 	Novi	 	MI	 	90245-4814	 	Leased	 	No
	 Downriver Centers, Inc.
	 	Down River	 	5600 Allen Park	 	Allen Park	 	MI	 	48101-2604	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Dearborn	 	1185 Monroe	 	Dearborn	 	MI	 	48124-2814	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Southgate	 	14752 Northline Road	 	Southgate	 	MI	 	48195-2467	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Schaeffer Drive	 	18100 Schafer Hwy	 	Detroit	 	MI	 	48235-2600	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Greenview	 	18544 Eight Mile Road	 	Southfield	 	MI	 	48075-4194	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Dearborn At Home	 	22030 Park St	 	Dearborn	 	MI	 	48124-2854	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Redford	 	22711 Grand River Avenue	 	Detroit	 	MI	 	48219-3113	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Kresge	 	4145 Cass Avenue	 	Detroit	 	MI	 	48201-1707	 	Leased	 	No

  
 Sch 4.8-49 

															
	 DVA Healthcare Renal Care, Inc.
	 	Motor City Home Training	 	4727 Saint Antoine	 	Detroit	 	MI	 	48201-1461	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Westland	 	5715 Venoy	 	Westland	 	MI	 	48185-2830	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Muskegon	 	1250 Mercy Drive	 	Muskegon	 	MI	 	49444-1830	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Newaygo County	 	1317 West Main St	 	Fremont	 	MI	 	49412-1478	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Romulus	 	31470 Ecorse Rd	 	Romulus	 	MI	 	48174-1963	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Supernova Region 02 Office	 	575 East Big Beaver Road, Suite 185	 	Troy	 	MI	 	48083-1366	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Ludington	 	7 Atkinson Drive	 	Ludington	 	MI	 	49431-1953	 	Leased	 	Yes
	 Everglades Dialysis, LLC
	 	Grayling Home	 	125 E. Michigan Avenue	 	Grayling	 	MI	 	49738-1740	 	Leased	 	Yes
	 Forester Dialysis, LLC
	 	Burton	 	4015 Davison Rd	 	Burton	 	MI	 	48509-1401	 	Leased	 	No
	 Fremont Dialysis, LLC
	 	Bloomfield Hills	 	42886 Woodward Ave	 	Bloomfield Hills	 	MI	 	48304-5033	 	Leased	 	No
	 GiveLife Dialysis, LLC
	 	Grosse Pointe	 	18000 E Warren Ave	 	Detroit	 	MI	 	48224-1336	 	Leased	 	No
	 Gordina Dialysis, LLC
	 	Starrwood (In-Center Hemo Only)	 	3425 Starr Road	 	Royal Oak	 	MI	 	48073	 	Leased	 	No
	 Gulch Dialysis, LLC
	 	Riverbend Commons	 	407 South Telegraph Road	 	Monroe	 	MI	 	48161-1611	 	Leased	 	No
	 Heideck Dialysis, LLC
	 	Roscommon MI	 	TBD	 	Roscommon	 	MI	 	48653	 	Leased	 	No
	 Ionia Dialysis, LLC
	 	Ionia	 	South State Road (M-66)	 	Ionia Township	 	MI	 	48846-8757	 	Leased	 	Yes
	 Kidney Centers of Michigan, L.L.C.
	 	Oak Park	 	13481 Ten Mile Road	 	Oak Park	 	MI	 	48237-4633	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Southfield	 	21900 Melrose Avenue	 	Southfield	 	MI	 	48075-7967	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Jackson	 	232 West Louis Glick Highway	 	Jackson	 	MI	 	49201-1326	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Cornerstone	 	23675 Greenfield Road	 	Southfield	 	MI	 	48075-3122	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Detroit	 	2674 E Jefferson Ave	 	Detroit	 	MI	 	48207-4129	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Ypsilanti	 	2766 Washtenaw Rd	 	Ypsilanti	 	MI	 	48197-1506	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Macomb	 	28295 Schoenherr	 	Warren	 	MI	 	48088-4300	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Grand Blanc	 	3625 Genesys Parkway	 	Grand Blanc	 	MI	 	48439-8070	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	North Oakland	 	450 N Telegraph Rd, Suite 600	 	Pontiac	 	MI	 	48341-1037	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Novi	 	47250 W 10 Mile Rd	 	Novi	 	MI	 	48374-2932	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Clarkston	 	6770 Dixie Hwy, Suite #205	 	Clarkston	 	MI	 	48346-2089	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	New Center	 	7700 Second Ave	 	Detroit	 	MI	 	48202-2411	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	North Oakland	 	7960 W Grand River Avenue, Suite 174	 	Brighton	 	MI	 	48341-1037	 	Leased	 	No

  
 Sch 4.8-50 

															
	 Kidney Centers of Michigan, L.L.C.
	 	Brighton	 	7960 West Grand River	 	Brighton	 	MI	 	48114-7336	 	Leased	 	No
	 Kidney Centers of Michigan, L.L.C.
	 	Grand Blanc	 	One Genesys Parkway	 	Grand Blanc	 	MI	 	48439-8070	 	Leased	 	No
	 Lassen Dialysis, LLC
	 	Riverview	 	18236 Fort St	 	Riverview	 	MI	 	48193-7439	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Detroit III	 	16507 Southfield Road	 	Allen Park	 	MI	 	48101-2503	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Rochester Hills	 	1886 W. Auburn Road	 	Rochester Hills	 	MI	 	48309-3858	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Detroit II	 	22201 Moross	 	Detroit	 	MI	 	48236-2114	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Detroit	 	26225 Greenfield Road	 	Southfield	 	MI	 	48076	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Ypsilanti	 	2892 Washtenaw Ave	 	Ypsilanti	 	MI	 	48197-1507	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Detroit 4	 	7633 E Jefferson Ave	 	Detroit	 	MI	 	48214-2513	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Grand Rapids East	 	1230 Elkhart Street Southeast	 	Grand Rapids	 	MI	 	49503-1372	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Grand Haven	 	16964 Robbins Road	 	Grand Haven	 	MI	 	49417-2796	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Cadieux	 	6150 Cadieux	 	Detroit	 	MI	 	48224-2006	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Highland Park	 	64 Victor	 	Highland Park	 	MI	 	48203-3128	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Grand Rapids	 	801 And 817 Cherry Street Se	 	Grand Rapids	 	MI	 	49506-1440	 	Leased	 	No
	 Portola Dialysis, LLC
	 	Town Center	 	323 North Michigan Ave	 	Saginaw	 	MI	 	48602-4240	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Davison	 	1011 So. State Rd.	 	Davison	 	MI	 	48423-1903	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	East Dearborn	 	13200 West Warren Avenue	 	Dearborn	 	MI	 	48126-2410	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Chelsea	 	1620 Commerce Park Drive	 	Chelsea	 	MI	 	48118-2136	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Battle Creek	 	220 Goodale Avenue East	 	Battle Creek	 	MI	 	49037-2728	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	West Flint	 	2262 S. Ballenger	 	Flint	 	MI	 	48503-3447	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Saginaw	 	311 Hoyt Avenue	 	Saginaw	 	MI	 	48607-1105	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Flushing	 	3469 Pierson Place	 	Flushing	 	MI	 	48433-2413	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Canton	 	3658 Ford Road	 	Westland	 	MI	 	48185-3769	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Hallwood	 	4929 Clio Rd	 	Flint	 	MI	 	48504-1886	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Park Plaza	 	G-1075 N. Ballenger Hwy	 	Flint	 	MI	 	48504-4431	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Flint	 	Two Hurley Plaza	 	Flint	 	MI	 	48503-5904	 	Leased	 	No
	 Rochester Dialysis Center, LLC
	 	Rochester Hills	 	1886 W. Auburn Road	 	Rochester Hills	 	MI	 	48309-3865	 	Leased	 	No
	 Tel-Huron Dialysis, LLC
	 	Tel Huron Mi	 	225 Summit Drive	 	Waterford	 	MI	 	48328-3364	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Greenville Dialysis	 	101 S Greenville West Drive	 	Greenville	 	MI	 	48838-1598	 	Leased	 	No

  
 Sch 4.8-51 

															
	 Total Renal Care, Inc.
	 	Kalamazoo West	 	1040 North 10th Street	 	Kalamazoo	 	MI	 	49009-6149	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lansing At Home	 	1675 Watertower Place	 	East Lansing	 	MI	 	48823-6397	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Alma	 	1730-1750 Wright Avenue	 	Alma	 	MI	 	48801-1024	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fenton	 	17420 Silver Parkway	 	Fenton	 	MI	 	48430-4429	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Rogers City	 	194 East Erie St	 	Rogers City	 	MI	 	49779-1612	 	Leased	 	No
	 Total Renal Care, Inc.
	 	State Fair	 	19800 Woodward Avenue	 	Detroit	 	MI	 	48203-5102	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Gaylord	 	1989 Walden Drive	 	Gaylord	 	MI	 	49735-8241	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Walker	 	2680 Walker Ave Nw, Suite A	 	Walker	 	MI	 	49544-1385	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Alpena	 	301 Oxbow Drive	 	Alpena	 	MI	 	49707-1447	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ann Arbor	 	3147 Oak Valley Drive	 	Ann Arbor	 	MI	 	48103-9248	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bay City	 	3170 S Professional Drive	 	Bay City	 	MI	 	48706-2839	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Alma	 	330 E Warwick Dr	 	Alma	 	MI	 	48801-1024	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Starrwood Home Training (PD-HHD)	 	3425 Starr Road	 	Royal Oak	 	MI	 	48067	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mt Pleasant	 	404 S Crapo Street	 	Mt Pleasant	 	MI	 	48858-2944	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lansing	 	4530 S. Hagadorn Road	 	Okemos	 	MI	 	48906	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Midland	 	4901 Midland Center	 	Jefferson	 	MI	 	48640-2905	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Central Kalamazoo	 	535 South Burdick Street	 	Kalamazoo	 	MI	 	49007-5261	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Branch	 	599 Court Street	 	West Branch	 	MI	 	48661-9310	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Bloomfield	 	6010 W Maple Rd	 	West Bloomfield	 	MI	 	48322-4406	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Flint	 	6141 N. Saginaw St	 	Mt. Morris	 	MI	 	48458-2403	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Gladwin	 	673 Quarter Street	 	Gladwin	 	MI	 	48624-1954	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cass City	 	6757 Main Street	 	Cass City	 	MI	 	48726-1556	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Region	 	7960 West Grand River	 	Brighton	 	MI	 	49506-1267	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grand Blanc Home Training	 	8195 S. Saginaw Street	 	Grand Blanc	 	MI	 	48439	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Norton Shores	 	955 Seminole Road	 	Muskegon	 	MI	 	49441-4341	 	Leased	 	No
	 Tree City Dialysis, LLC
	 	Riverwood	 	24467 W 10 Mile Rd	 	Southfield	 	MI	 	48033-2931	 	Leased	 	No
	 Atlantic Dialysis, LLC
	 	Alpha	 	2004 Jefferson Road	 	Northfield	 	MN	 	55057-3253	 	Leased	 	No
	 Fanthorp Dialysis, LLC
	 	Mankato	 	1400 Madison Avenue	 	Mankato	 	MN	 	56001-5476	 	Leased	 	No

  
 Sch 4.8-52 

															
	 Hardy Dialysis, LLC
	 	Glencoe	 	1123 Hennepin Avenue N	 	Glencoe	 	MN	 	55336	 	Leased	 	No
	 Lincolnton Dialysis, LLC
	 	Central Avenue	 	10994 Baltimore Street NE	 	Blaine	 	MN	 	55449-4601	 	Leased	 	No
	 Maple Grove Dialysis, LLC
	 	Maple Grove	 	15655 Grove Circle N	 	Maple Grove	 	MN	 	55369-4489	 	Leased	 	No
	 Neff Dialysis, LLC
	 	Moorhead	 	1710 Center Ave W	 	Dilworth	 	MN	 	56529-1309	 	Leased	 	No
	 Nisene Dialysis, LLC
	 	Park Rapids	 	110 7th St. W.	 	Park Rapids	 	MN	 	56470-1872	 	Leased	 	No
	 Pearl Dialysis, LLC
	 	Apple Valley	 	14050 Pilot Knob Road	 	Apple Valley	 	MN	 	55124-6647	 	Leased	 	No
	 Renal Life Link, Inc
	 	Golden Valley	 	5600 International Parkway	 	New Hope	 	MN	 	55428-3047	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Minneapolis	 	1049 10th Ave. Se	 	Minneapolis	 	MN	 	55414-1312	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Eden Prairie	 	14852 Scenic Heights Road	 	Eden Prairie	 	MN	 	55344-2320	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Eagan	 	2750 Blue Water Road	 	Eagan	 	MN	 	55121-1400	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	St Louis Park	 	3501 St Louisiana Avenue South	 	St Louis Park	 	MN	 	55426-4121	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Richfield	 	6601 Lyndale Avenue South	 	Richfield	 	MN	 	55423-2490	 	Leased	 	No
	 Rio Dialysis, LLC
	 	Robbinsdale	 	3501 West Broadway	 	Robbinsdale	 	MN	 	55422-2955	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Redwood Falls	 	100 Fallwood Road	 	Redwood Falls	 	MN	 	56283-1828	 	Leased	 	No
	 Total Renal Care, Inc.
	 	University	 	1045 Westgate Drive	 	Saint Paul	 	MN	 	55114-1079	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Team Fusion Group Office	 	11010 Prairie Lakes Dr	 	Eden Prairie	 	MN	 	55344	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pine City	 	129 East 6th Ave	 	Pine City	 	MN	 	55063-1913	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Governor Home Training (PD/HHD) MN	 	1420 College Drive East, Suite 900	 	Marshall	 	MN	 	56258	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West St. Paul	 	1555 Livingston Ave	 	West St. Paul	 	MN	 	55118-3411	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Highland Park	 	1559 West 7th Street	 	Minneapolis	 	MN	 	55102-4243	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sun Ray	 	1758 Old Hudson Rd	 	St. Paul	 	MN	 	55106-6118	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Minnetonka	 	17809 Hutchins Drive	 	Minnetonka	 	MN	 	55345-4100	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Historical Hastings	 	1828 Market Blvd.	 	Hastings	 	MN	 	55033-3494	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Woodbury	 	1850 3 Weir Drive	 	Woodbury	 	MN	 	55125-2260	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lakeview Suite 500	 	1970 Northwestern Avenue	 	Stillwater	 	MN	 	55082-6567	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Faribault	 	201 South Lyndale Ave	 	Faribault	 	MN	 	55021-5758	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Maplewood	 	2785 White Bear Ave	 	Maplewood	 	MN	 	55109-1320	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Marshall	 	300 So. Bruce St.	 	Marshall	 	MN	 	56258-1934	 	Leased	 	No

  
 Sch 4.8-53 

															
	 Total Renal Care, Inc.
	 	Red Wing	 	3028 North Service Drive	 	Red Wing	 	MN	 	55066-1921	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Uptown Minneapolis	 	3601 Lyndale Avenue South	 	Minneapolis	 	MN	 	55409-1103	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Arden Hills	 	3900 Northwoods Drive	 	Arden Hills	 	MN	 	55112-6911	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Coon Rapids	 	3960 Coon Rapids Blvd	 	Coon Rapids	 	MN	 	55433-2598	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Burnsville	 	501 East Nicollet Blvd	 	Burnsville	 	MN	 	55337-6784	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fridley	 	5301 E River Rd Ne	 	Fridley	 	MN	 	55421-3778	 	Leased	 	No
	 Total Renal Care, Inc.
	 	St Paul	 	555 Park St	 	St Paul	 	MN	 	55103-2192	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wyoming	 	5657 257th Street	 	Wyoming	 	MN	 	55092-8072	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cass Lake	 	606 Grant Utley Ave	 	Cass Lake	 	MN	 	56633-0757	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Edina	 	6550 York Ave South Suite 100	 	Edina	 	MN	 	55435-2332	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Scott County	 	7450 South Park Drive	 	Savage	 	MN	 	55378-3635	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Excelsior	 	7525 Wayzata Blvd	 	St. Louis Park	 	MN	 	55426-1621	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Montevideo	 	824 N. 11th St	 	Montevideo	 	MN	 	56265-1629	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hl Division	 	825 South 8th Street	 	Minneapolis	 	MN	 	55404-1208	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cottage Grove	 	8800 East Point Douglas Road	 	Cottage Grove	 	MN	 	55016-4160	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pipestone	 	911 5th Ave. S.W	 	Pipestone	 	MN	 	56164-1890	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bloomington	 	Lyndale Ave South	 	Bloomington	 	MN	 	55420-2237	 	Leased	 	No
	 Total Renal Research, Inc
	 	Total Renal Research	 	825 South 8th St	 	Minneapolis	 	MN	 	55404-1212	 	Leased	 	No
	 Catello Dialysis, LLC
	 	Trenton	 	1705 E 9th St	 	Trenton	 	MO	 	64683-2641	 	Leased	 	No
	 Colleton Dialysis, LLC
	 	Kansas Avenue	 	604 Kansas Ave	 	Clinton	 	MO	 	64735-3069	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lake St. Louis	 	200 Brevco Plaza	 	Late St. Louis	 	MO	 	63367-2950	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	St. Charles	 	2103 Bluestone Drive	 	St. Charles	 	MO	 	63303-6704	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Liberty	 	2525 Glen Hendren Drive	 	Liberty	 	MO	 	64068-9625	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Northland	 	2750 Clay Edwards Drive	 	North Kansas City	 	MO	 	64116-3257	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	St. Peters	 	300 First Executive Avenue	 	St. Peters	 	MO	 	63376-1655	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cameron	 	1003 W. Fourth Street	 	Cameron	 	MO	 	64429-1466	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Florissant Dialysis	 	10887 W Florissant Ave	 	Ferguson	 	MO	 	63136-2405	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Washington Square	 	1110 Washington Square	 	Washington	 	MO	 	63090-5336	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Rolla	 	1503 E 10th St	 	Rolla	 	MO	 	65401-3696	 	Leased	 	No

  
 Sch 4.8-54 

															
	 DVA Renal Healthcare, Inc.
	 	Hospital Hill	 	2250 Holmes St	 	Kansas City	 	MO	 	64108-2639	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Riverside Reprocessing	 	408 Nw Business Park Lane	 	Riverside	 	MO	 	64150-9572	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	St. Joseph	 	5514 Corporate Drive, Suite 100	 	St. Joseph	 	MO	 	64507-7754	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Chillicothe	 	588 East Business Route 36	 	Chillicothe	 	MO	 	64601-3721	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Hazelwood	 	637 Dunn Road Ste 199	 	Hazelwood	 	MO	 	63042-1757	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Shrewsbury	 	7303 Watson Road	 	Shrewsbury	 	MO	 	63119-4405	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Platte Woods	 	7667 Northwest Prairie View Road	 	Kansas City	 	MO	 	64151-1544	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	St Louis West At Home	 	9632 Olive Boulevard	 	Olivette	 	MO	 	63132-3002	 	Leased	 	No
	 DVA/Washington University Healthcare of Greater St. Louis, LLC
	 	St Louis	 	324 Debaliviere Ave	 	St. Louis	 	MO	 	63112-1804	 	Leased	 	No
	 DVA/Washington University Healthcare of Greater St. Louis, LLC
	 	St Louis West	 	400 N Lindbergh Blvd	 	St Louis	 	MO	 	63141-7814	 	Leased	 	No
	 ISD Kansas City, LLC fka DSI Kansas City, LLC
	 	Westport	 	3947 Broadway Street	 	Kansas City	 	MO	 	64111-2516	 	Leased	 	No
	 ISD Lees Summit, LLC fka DSI Lees Summit, LLC
	 	Lees Summit	 	100 Ne Missouri Road	 	Lee’S Summit	 	MO	 	64086-4702	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Harrisonville	 	308 Galaxie Avenue	 	Harrisonville	 	MO	 	64701-2084	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Marshall	 	359 W Morgan	 	Marshall	 	MO	 	65340-1929	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Kansas City	 	4333 Madison Avenue	 	Kansas City	 	MO	 	64111-3429	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Butler	 	601 W Nursery	 	Butler	 	MO	 	64730-1872	 	Leased	 	No
	 Leasburg Dialysis, LLC
	 	Town And Country West	 	12855 North Forty Drive	 	St Louis	 	MO	 	63141-8657	 	Leased	 	No
	 Leasburg Dialysis, LLC
	 	Town And Country West At Home	 	12855 North Forty Drive	 	St Louis	 	MO	 	63141-8657	 	Leased	 	No
	 Lone Dialysis, LLC
	 	Swope Dialysis	 	4407 E 50th Terr	 	Kansas City	 	MO	 	64130-2855	 	Leased	 	No
	 Loup Dialysis, LLC
	 	Bowles Avenue	 	1011 Bowles Ave	 	St Louis	 	MO	 	63026-2387	 	Leased	 	No
	 Pacheco Dialysis, LLC
	 	Springfield	 	1007 E Kearney St	 	Springfield	 	MO	 	65803-3433	 	Leased	 	No
	 Palmetto Dialysis, LLC
	 	Arnold	 	100 Richardson Crossing	 	Arnold	 	MO	 	63010-6023	 	Leased	 	No
	 Rainer Dialysis, LLC
	 	South City	 	3740 South Jefferson Ave	 	St. Louis	 	MO	 	63118-3905	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Hope Again	 	1207 State Route W	 	Kennett	 	MO	 	63857-3823	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Lamplighter Plaza	 	12354 Lightlighter Square	 	St Louis	 	MO	 	63128-2746	 	Leased	 	No

  
 Sch 4.8-55 

															
	 Renal Treatment Centers-Illinois, Inc.
	 	Hampton	 	1425 Hampton Avenue	 	St Louis	 	MO	 	63139-3115	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Columbia	 	1701 East Broadway	 	Columbia	 	MO	 	65201-8029	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Bluff City II	 	2400 Lucy Lee Parkway, Suite E&D	 	Poplar Bluff	 	MO	 	63901-2429	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	St Louis	 	2610 Clark Ave.	 	St Louis	 	MO	 	63103-2502	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	Crestwood	 	9560 Watson Rd	 	Crestwood	 	MO	 	63126-1541	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Crystal City	 	960 S. Truman Boulevard	 	Crystal City	 	MO	 	63019-1329	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Washington Home Training	 	1038-1040 Washington Square	 	Washington	 	MO	 	63090-5302	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Villa Of Wentzville	 	1126 W Pearce Blvd	 	Wentzville	 	MO	 	63385-1053	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Timberlake	 	12110 Holmes Rd	 	Kansas City	 	MO	 	64145-1707	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North St.Louis	 	13119 New Halls Ferry Rd	 	Florissant	 	MO	 	63033-3228	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sikeston	 	135 Plaza Drive	 	Sikestown	 	MO	 	63801-5148	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grandview	 	13812 South 71 Highway	 	Grandview	 	MO	 	64030-3685	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Excelsior Springs	 	1745 W. Jesse James Road	 	Excelsior Springs	 	MO	 	64024-1801	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Eastland	 	19101 E Valley View Parkway, Ste E	 	Independence	 	MO	 	64055-6907	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dexter	 	2010 North Outer Road	 	Dexter	 	MO	 	63841-8001	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake St. Louis	 	202 Brevco Plaza	 	Lake St. Louis	 	MO	 	63367-2950	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Great Falls	 	2800 11th Avenue South	 	Great Falls	 	MO	 	59405-5263	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Discovery Division	 	300 First Executive Ave	 	St Peters	 	MO	 	63376-1655	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hannibal	 	3140 Palmyra Road	 	Hannibal	 	MO	 	63401-2204	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Columbia Home Training	 	3320 Bluff Creek Drive	 	Columbia	 	MO	 	65201-3501	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South County	 	4145 Union Road	 	St. Louis	 	MO	 	63129-1064	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Eureka	 	419 Meramec Boulevard	 	Eureka	 	MO	 	63025-3906	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Maple Valley Plaza	 	649 Maple Valley Drive	 	Farmington	 	MO	 	63640-1993	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Villa At St. John	 	9030 Saint Charles Rock Rd	 	St. Louis	 	MO	 	63114-4246	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Villa Of Waterbury	 	929-931 Waterbury Falls Dr	 	O’Fallon	 	MO	 	63368-2202	 	Leased	 	No
	 Tugman Dialysis, LLC
	 	Chambers Dialysis	 	10241 Lewis And Clark Blvd	 	Saint Louis	 	MO	 	63136-5505	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Ocean Springs	 	13150 Ponce De Leon	 	Ocean Springs	 	MS	 	39564-2460	 	Leased	 	No

  
 Sch 4.8-56 

															
	 DVA Healthcare Renal Care, Inc.
	 	Singing River	 	4907 Telephone Road	 	Pascagoula	 	MS	 	39567-1823	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lucedale	 	652 Manilla Street	 	Lucedale	 	MS	 	39452-5962	 	Leased	 	No
	 ISD Brandon, LLC fka DSI Brandon, LLC
	 	Brandon	 	101 Christian Drive	 	Brandon	 	MS	 	39042-2678	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Jackson Southwest	 	1828 Raymond Road	 	Jackson	 	MS	 	39204-4126	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Hazlehurst	 	201 N Haley Street	 	Hazlehurst	 	MS	 	39083-3111	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Lexington	 	22579 Depot Street	 	Lexington	 	MS	 	39095-7339	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Carthage	 	312 Ellis Street	 	Carthage	 	MS	 	39051-3809	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Jackson North	 	571 Beasley Road	 	Jackson	 	MS	 	39206-3042	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Canton	 	620 E Peace Street	 	Canton	 	MS	 	39046-4729	 	Leased	 	No
	 ISD Renal, Inc. fka DSI Renal, Inc.
	 	Jackson South Dialysis (P182)	 	1015 I-20 Frontage Road	 	Jackson	 	MS	 	39204	 	Owned	 	No
	 Total Renal Care, Inc.
	 	Great Falls Dialysis	 	2800 11th Avenue South, Suite 22	 	Great Falls	 	MT	 	59405-5263	 	Leased	 	No
	 Central Carolina Dialysis Centers, LLC
	 	Copperfield	 	1030 Brinehaven Dr	 	Concord	 	NC	 	28025-2438	 	Leased	 	No
	 Central Carolina Dialysis Centers, LLC
	 	Rowan County-Kannapolis	 	1607 North Main Street	 	Kannapolis	 	NC	 	28081-2317	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Mint Hill	 	11308 Hawthorn Drive	 	Mint Hill	 	NC	 	28227-9300	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Ahoskie	 	129 Hertford County High Road	 	Ahoskie	 	NC	 	27910-8131	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Elizabeth City	 	1840 West City Drive	 	Elizabeth City	 	NC	 	27909-9632	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Charlotte	 	2321 W Morehead St	 	Charlotte	 	NC	 	28208-5145	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Charlotte East	 	5627 Albemarle Road	 	Charlotte	 	NC	 	28212-3611	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Union County	 	615 Comfort Ln	 	Monroe	 	NC	 	28112-5599	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	South Charlotte	 	6450 Bannington Rd	 	Charlotte	 	NC	 	28226-1327	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	North Charlotte	 	6620 Old Statesville Road	 	Charlotte	 	NC	 	28269	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Edenton	 	703 Luke Street	 	Edenton	 	NC	 	27932-9694	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Marshville1	 	7260 East Marshville Blvd	 	Marshville	 	NC	 	28103-1191	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Roxboro	 	1005 Ridge Road	 	Roxboro	 	NC	 	27573-4513	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Mt Olive	 	105 Michael Martin Road	 	Mt. Olive	 	NC	 	28365	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	Wilson	 	1605 Medical Park Drive	 	Wilson	 	NC	 	27893-8611	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Goldsboro South	 	1704 Wayne Memorial Drive	 	Goldsboro	 	NC	 	27534-2240	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	Durham	 	200 Hood Street	 	Durham	 	NC	 	27701-3715	 	Leased	 	No

  
 Sch 4.8-57 

															
	 DVA Renal Healthcare, Inc.
	 	Goldsboro	 	2609 Hospital Road	 	Goldsboro	 	NC	 	27534-9424	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Forest Hills	 	2693 Forest Hills Road	 	Wilson	 	NC	 	27893-8611	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Wilson	 	2833 Wooten Boulevard	 	Wilson	 	NC	 	27893	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Durham South	 	415 W. Hwy 54	 	Durham	 	NC	 	27713-7516	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	West Durham	 	4307 Western Park Pl	 	Durham	 	NC	 	27705-1204	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Durham West	 	4307 Western Park Place	 	Durham	 	NC	 	27705-1204	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Vance County	 	854 Beckford Dr	 	Henderson	 	NC	 	27536-3487	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Burlington	 	873 Heather Road	 	Burlington	 	NC	 	27215-6288	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Biltmore Home	 	10 McDowell Street	 	Asheville	 	NC	 	28801-4104	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Martin County	 	100 Medical Drive	 	Williamston	 	NC	 	27892-2156	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Mcdowell County	 	100 Spaulding Drive	 	Marion	 	NC	 	28752-5116	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Elizabethtown	 	101 Dialysis Center Drive	 	Elizabethtown	 	NC	 	28337-9048	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Transylvania	 	102 College Station Drive	 	Brevard	 	NC	 	28712-3355	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Green County	 	1025 Kingold Boulevard	 	Snow Hill	 	NC	 	28580-1616	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Waynesville	 	11 Park Terrace Drive	 	Clyde	 	NC	 	28721-7445	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Wake Forest	 	11001 Ingleside Place	 	Raleigh	 	NC	 	27614-8577	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Lumbee River	 	11016 Red Springs Road	 	Red Springs	 	NC	 	28377-8060	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Rowan County	 	111 Dorsett Drive	 	Salisbury	 	NC	 	28144-2278	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Reidsville	 	1307 Freeway Drive	 	Reidsville	 	NC	 	27320-7104	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Jacksonville	 	14 Office Park Drive	 	Jacksonville	 	NC	 	28546-7325	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Southport	 	1513 Howe St. Suite 15	 	Southport	 	NC	 	28461-2770	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Moore County	 	16 Regional Drive	 	Pinehurst	 	NC	 	28374-8850	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Asheville	 	1600 Centerpark Drive	 	Asheville	 	NC	 	28805-6206	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Smoky Mountain	 	1611 Andrews Rd.	 	Murphy	 	NC	 	28906-5100	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Carthage	 	165 Savannah Gardens Dr	 	Carthage	 	NC	 	28327	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Franklin County	 	1706 North Carolina Hwy 39 N	 	Louisburg	 	NC	 	27549-8329	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Southern Pines	 	209 Windstar Place	 	Southern Pines	 	NC	 	28387-7086	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Chadbourn	 	210 East Strawberry Blvd	 	Chadbourn	 	NC	 	28431-1418	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Wilmington	 	2215 Yaupon Drive	 	Wilmington	 	NC	 	28401-7334	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Rutherford County	 	226 Commercial Drive	 	Forest City	 	NC	 	28043-2851	 	Leased	 	No

  
 Sch 4.8-58 

															
	 Total Renal Care Of North Carolina, LLC
	 	Rockingham County	 	251 West Kings Highway	 	Eden	 	NC	 	27288-5009	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Cape Fear	 	3005 Enterprise Dr	 	Wilmington	 	NC	 	28405-2181	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Kenansville	 	305 Beasley Street	 	Kenansville	 	NC	 	28349-8798	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Edgecomb County	 	3206 Western Blvd	 	Tarboro	 	NC	 	27886-1828	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Montgomery County	 	323 W. Main Street	 	Biscoe	 	NC	 	27209-9528	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Weaverville	 	329 Merrimon Ave.	 	Weaverville	 	NC	 	28787-9253	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Harrisburg	 	3310 Perry St.	 	Concord	 	NC	 	28027-3901	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Hoke	 	403 South Main Street	 	Raeford	 	NC	 	28376-3222	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Shallote	 	4740 Shallotte Avenue	 	Shallotte	 	NC	 	28470-6596	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Hendersonville	 	500 Beverly Hanks Ctr	 	Hendersonville	 	NC	 	28792	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	St. Pauls	 	564 W Mclean Street	 	St. Pauls	 	NC	 	28384-1421	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Wallace	 	5650 S Nc 41 Highway	 	Wallace	 	NC	 	28466-6094	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Mayland	 	575 Altapass Highway	 	Spruce Pine	 	NC	 	28777-3012	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Whiteville	 	608 Pecan Lane	 	Whiteville	 	NC	 	28472-2949	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Sylva Dialysis Center	 	655 Asheville Rd	 	Sylva	 	NC	 	28779-2747	 	Leased	 	Yes
	 Total Renal Care Of North Carolina, LLC
	 	Burgawnc	 	704 S Dickerson St	 	Burgaw	 	NC	 	28425-4904	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Richmond County	 	771 Chaeran Highway	 	Hamlett	 	NC	 	28345-7158	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Franklin Township	 	80 Westgate Plaza	 	Franklin	 	NC	 	28734-1422	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Sandhills	 	809 S Long Drive	 	Rockingham	 	NC	 	28379-4317	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Anson County	 	923 East Caswell	 	Wadesboro	 	NC	 	28170-2305	 	Leased	 	No
	 Total Renal Care Of North Carolina, LLC
	 	Cherokee	 	 Sevan Clans Building,
 53 Echota Church
Rd
	 	Cherokee	 	NC	 	28719-9702	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	New River (aka Onslow County)-NC	 	111 Yopp Road	 	Jacksonville	 	NC	 	28546	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Burlington	 	1909 N. Church Street	 	Burlington	 	NC	 	27217	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Team Endeavor Group Office	 	2700 Coltsgate Rd, Suite 202	 	Charlotte	 	NC	 	28211	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Division	 	559 Davidson Gateway Drive	 	Davidson	 	NC	 	28208-5145	 	Leased	 	No
	 DaVita Dakota Dialysis Center, LLC
	 	Fargo	 	2350 45th St Sw	 	Fargo	 	ND	 	58104-8795	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Oakes	 	413 S 7th St	 	Oakes	 	ND	 	58474-1920	 	Leased	 	No

  
 Sch 4.8-59 

															
	 DVA Renal Healthcare, Inc.
	 	Omaha West	 	13010-26 West Dodge Road	 	Omaha	 	NE	 	68154-2148	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Omaha Central	 	144 South 40th Street	 	Omaha	 	NE	 	68131-3004	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Dodge County	 	1949 E 23rd Ave S	 	Fremont	 	NE	 	68025-2452	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Omaha South	 	3427 L Street	 	Omaha	 	NE	 	68107-2577	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Papillion	 	505 Cornhusker Rd	 	Bellevue	 	NE	 	68005-7911	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Omaha North	 	6212 N 73rd Plaza	 	Omaha	 	NE	 	68134-1801	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Dnp Grand Island	 	638 N Webb Rd	 	Grand Island	 	NE	 	68803	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Hastings Ne	 	715 N Kansas Ave	 	Hastings	 	NE	 	68901-4446	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Ne Nebraska	 	1603 W Prospect Ave	 	Norfolk	 	NE	 	68701-3683	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Hastings	 	1900 North Saint Joseph Ave.	 	Hastings	 	NE	 	68901-2652	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Grand Island Dialysis	 	203 E Stolley Park Rd	 	Grand Island	 	NE	 	68801-8256	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Capital City	 	307 North 46th Street	 	Lincoln	 	NE	 	68503-3714	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	South Lincoln	 	3401 Plantation Drive	 	Lincoln	 	NE	 	68516-4712	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Omaha Lavista	 	6610 S 168th St	 	Omaha	 	NE	 	68135-5412	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Omaha Florence	 	7428 North 30th St	 	Omaha	 	NE	 	68112-2722	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Mccook	 	801 West C Street	 	Mccook	 	NE	 	69001-3592	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Omaha Home Training	 	8021 Cass Street	 	Omaha	 	NE	 	68114-3525	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Scottsbluff	 	3812 Avenue B	 	Scottsbluff	 	NE	 	69361-4780	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Nashua	 	38 Tyler Street	 	Nashua	 	NH	 	03060-2912	 	Leased	 	No
	 Steam Dialysis, LLC
	 	Derry	 	8 Action Blvd	 	Londonderry	 	NH	 	03053-3428	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Manchester	 	15 Constitution Drive	 	Bedford	 	NH	 	03110-6002	 	Leased	 	No
	 Versailles Dialysis, LLC
	 	Rockingham County	 	18 Pelham Road	 	Salem	 	NH	 	03079-4818	 	Leased	 	No
	 Caverns Dialysis, LLC
	 	Fair Lawn	 	15-00 Pollitt Drive	 	Fair Lawn	 	NJ	 	07410-2732	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Burlington North	 	1164 Route 130 North	 	Burlington	 	NJ	 	08016-2954	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hainesport	 	1261 Route 38	 	Hainesport	 	NJ	 	08036-2702	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lumberton	 	668 Main Street	 	Mt Holly	 	NJ	 	08036-2702	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Holmdel	 	668 North Beers Street	 	Holmdel	 	NJ	 	07733-1526	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Delran	 	8008 Route 130 North	 	Delran	 	NJ	 	08075-1869	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cherry Hill	 	1030 North Kings Highway	 	Cherry Hill	 	NJ	 	08034-1907	 	Leased	 	Yes

  
 Sch 4.8-60 

															
	 DVA Renal Healthcare, Inc.
	 	Summit	 	1139 Spruce Drive	 	Mountainside	 	NJ	 	07092-2221	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Plainfield	 	1200 Randolph Road	 	Plainfield	 	NJ	 	07060-3361	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	East Orange	 	14-20 Prospect Street	 	East Orange	 	NJ	 	07017-2238	 	Owned	 	No
	 DVA Renal Healthcare, Inc.
	 	Willingboro	 	230 Van Sciver Parkway	 	Willingboro	 	NJ	 	08046-1131	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Edison	 	29 Meridian Road	 	Edison	 	NJ	 	08820-2823	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Old Bridge	 	3 Hospital Plaza	 	Old Bridge	 	NJ	 	08857-3084	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Central Jersey Acutes	 	3001 Hadley Road	 	South Plainfield	 	NJ	 	07080-1109	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Perth Amboy	 	530 New Brunswick Ave	 	Perth Amboy	 	NJ	 	08861-3654	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-East Orange	 	90 Washington Street, Basement - Condo Units 109-113	 	East Orange	 	NJ	 	07017-1050	 	Leased	 	No
	 Eufaula Dialysis, LLC
	 	Elmwood Park	 	680 Broadway	 	Paterson	 	NJ	 	07514-1524	 	Leased	 	No
	 Eufaula Dialysis, LLC
	 	Haledon	 	953 Belmont Avenue	 	North Haledon	 	NJ	 	07508-2548	 	Leased	 	No
	 Freehold Artificial Kidney Center, LLC
	 	Freehold	 	300 Craig Rd	 	Manalapan	 	NJ	 	07726-8742	 	Leased	 	No
	 Ganois Dialysis, LLC
	 	Wall Township Home Training	 	5100 Belmar Boulevard	 	Wall Township	 	NJ	 	7727	 	Leased	 	No
	 ISD Trenton, LLC fka DSI Trenton, LLC
	 	Lawrenceville	 	1840 Princeton Avenue	 	Lawrenceville	 	NJ	 	08648-4518	 	Leased	 	No
	 Magoffin Dialysis, LLC
	 	Browns Mills	 	107 Trenton Road	 	Browns Mills	 	NJ	 	8015	 	Leased	 	No
	 Marlton Dialysis Center, LLC
	 	Marlton	 	796 E Route 70	 	Marlton	 	NJ	 	08053-2361	 	Leased	 	Yes
	 MGD-Renal Centers or North Jersey, LLC
	 	Lincoln Park	 	6 “A” Frassetto Way	 	Lincoln Park	 	NJ	 	07035-2055	 	Leased	 	No
	 Navarro Dialysis, LLC
	 	Marlboro	 	762 Highway 34	 	Matawan	 	NJ	 	07747-6614	 	Leased	 	No
	 Neptune Artificial Kidney Center, LLC
	 	Neptune	 	300 W Sylvania	 	Neptune City	 	NJ	 	07753-6017	 	Leased	 	No
	 Redcliff Dialysis, LLC
	 	Millburn	 	25 East Willow Street	 	Millburn	 	NJ	 	07041-1416	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Bridgewater	 	2121 Route 22 West	 	Bound Brook	 	NJ	 	08805-1546	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Hackettstown	 	657 Willow Grove Street	 	Hackettstown	 	NJ	 	07840-1713	 	Leased	 	No
	 Shining Star Dialysis, Inc.
	 	Neptune	 	2180 Bradley Ave	 	Neptune	 	NJ	 	07753-4427	 	Leased	 	No
	 Shining Star Dialysis, Inc.
	 	Somerset	 	240 Churchill Ave	 	Somerset	 	NJ	 	08873-3451	 	Leased	 	No
	 Shining Star Dialysis, Inc.
	 	Middletown	 	500 Route 35	 	Middletown	 	NJ	 	07701-5038	 	Leased	 	No
	 Shining Star Dialysis, Inc.
	 	Bricktown	 	525 Jack Martin Blvd	 	Bricktown	 	NJ	 	08724-7737	 	Leased	 	No
	 Simeon Dialysis, LLC
	 	St Josephs Paterson	 	11 Getty Ave	 	Paterson	 	NJ	 	07503-2621	 	Leased	 	No
	 Simeon Dialysis, LLC
	 	St Josephs Wayne	 	57 Willowbrook Blvd	 	Wayne	 	NJ	 	07470-7045	 	Leased	 	No

  
 Sch 4.8-61 

															
	 Simeon Dialysis, LLC
	 	St Josephs Sjrmc	 	703 Main St	 	Paterson	 	NJ	 	07503-2621	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hackensack	 	113 Essex Street	 	Maywood	 	NJ	 	07607-1020	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Jersey City	 	1310 5th St	 	North Bergen	 	NJ	 	07047-1710	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hillside	 	1529 North Broad St	 	Hillside	 	NJ	 	07205-1603	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fair Lawn Dialysis	 	18-01 Pollitt Drive	 	Fair Lawn	 	NJ	 	07410-2813	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Plainfield South	 	241-261 Durham Ave	 	Plainfield	 	NJ	 	07080-2504	 	Leased	 	No
	 Total Renal Care, Inc.
	 	New Brunswick	 	303 George Street	 	New Brunswick	 	NJ	 	08901-2020	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Orange	 	375 Mt Pleasant Ave	 	West Orange	 	NJ	 	07052-2724	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Teterboro	 	502 Route 46	 	Teterboro	 	NJ	 	07608-1118	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Woodbridge	 	541 Main Street	 	Woodbridge	 	NJ	 	07095-1104	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Parkside	 	580 Frelinghuysen Ave	 	Newark	 	NJ	 	07114-1361	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Atlantic Artificial	 	6 Industrial Way West	 	Eatontown	 	NJ	 	07724-2258	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pennsauken	 	7020, 7022, & 7024 Kaighn Ave, Pennsauken Township Lot 2 Block 6301	 	Pennsauken	 	NJ	 	08109-4417	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Princeton	 	88 Princeton Hightstown Rd	 	Princeton Junction	 	NJ	 	08550-1100	 	Leased	 	No
	 Tyler Dialysis, LLC
	 	Lourdes Mt Laurel	 	130 Gaither Dr	 	Mount Laurel	 	NJ	 	08054-1715	 	Leased	 	No
	 Tyler Dialysis, LLC
	 	Lourdes Camden	 	1601 Haddon Ave	 	Camden	 	NJ	 	08103-3109	 	Leased	 	No
	 Tyler Dialysis, LLC
	 	Lourdes Innova	 	3716 Church Rd	 	Mount Laurel	 	NJ	 	08054-1104	 	Leased	 	No
	 Unicoi Dialysis, LLC
	 	East Brunswick	 	629 Cranbury Road	 	East Brunswick	 	NJ	 	08816-4031	 	Leased	 	No
	 Foss Dialysis, LLC
	 	Mesilla Valley	 	2550 S. Telshor Boulevard	 	Las Cruces	 	NM	 	88011-4907	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Las Cruces	 	3961 E Lohman Avenue	 	Las Cruces	 	NM	 	88011-8272	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Artesia	 	702 N 13th Street	 	Artesia	 	NM	 	88210-1166	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Region	 	817 West Broadway, Suite #104	 	Farmington	 	NM	 	87401-5699	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Four Corners	 	801 W Broadway	 	Farmington	 	NM	 	87401-5650	 	Leased	 	No
	 TRC Four Corners Dialysis Clinics, LLC. (Bevan Partnership)
	 	Shiprock	 	Us Highway 491 North, Po Box 2156	 	Shiprock	 	NM	 	87420-2156	 	Leased	 	No
	 Centennial LV, LLC
	 	Centennial	 	8775 W Deer Springs Way	 	Las Vegas	 	NV	 	89149-0416	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Anthem Village	 	2530 Anthem Village Drive	 	Henderson	 	NV	 	89052-5548	 	Leased	 	No

  
 Sch 4.8-62 

															
	 DVA Renal Healthcare, Inc.
	 	Mountain View	 	2881 Business Park Court	 	Las Vegas	 	NV	 	89128-9019	 	Leased	 	No
	 Five Star Dialysis, LLC
	 	Las Vegas Multicare	 	2400 Tech Center Ct	 	Las Vegas	 	NV	 	89128-0804	 	Leased	 	No
	 Greater Las Vegas Dialysis, LLC
	 	Las Vegas	 	150 South Valley View Boulevard	 	Las Vegas	 	NV	 	89107	 	Leased	 	No
	 Greater Las Vegas Dialysis, LLC
	 	North Las Vegas	 	2065 North Las Vegas Blvd	 	North Las Vegas	 	NV	 	89030-5801	 	Leased	 	No
	 Greater Las Vegas Dialysis, LLC
	 	South Las Vegas	 	2250 South Rancho Drive	 	Las Vegas	 	NV	 	89102-4456	 	Leased	 	No
	 Greater Las Vegas Dialysis, LLC
	 	Summerlin	 	653 North Town Center Drive	 	Las Vegas	 	NV	 	89144-0503	 	Leased	 	Yes
	 Green Desert Dialysis, LLC
	 	Desert Springs	 	2110 East Flamingo Road	 	Las Vegas	 	NV	 	89119-5191	 	Leased	 	No
	 ISD Las Vegas, LLC fka DSI Las Vegas, LLC
	 	Green Valley	 	1489 W Warm Springs Road	 	Henderson	 	NV	 	89014-7637	 	Leased	 	No
	 ISD Las Vegas, LLC fka DSI Las Vegas, LLC
	 	Las Vegas	 	2333 Rennaissance Drive	 	Las Vegas	 	NV	 	89119-6191	 	Leased	 	No
	 ISD Spring Valley, LLC fka DSI Spring Valley, LLC
	 	Spring Valley	 	3855 S. Jones	 	Las Vegas	 	NV	 	89103-2296	 	Leased	 	No
	 Las Vegas Pediatric Dialysis, LLC
	 	DaVita Pediatrics	 	7271 W. Sahara Avenue	 	Las Vegas	 	NV	 	89117-2862	 	Leased	 	No
	 Lockhart Dialysis, LLC
	 	Pahrump	 	330 South Lola Lane	 	Pahrump	 	NV	 	89048-0884	 	Leased	 	No
	 Renal Treatment Centers-California, Inc.
	 	Las Vegas Acutes Ste D	 	7330 Smoke Ranch Road	 	Las Vegas	 	NV	 	89128-1043	 	Leased	 	No
	 Routt Dialysis, LLC
	 	Reno Nv	 	10085 Double R Blvd	 	Reno	 	NV	 	89521-4867	 	Leased	 	No
	 Routt Dialysis, LLC
	 	Reno Nv	 	1500 East Second Street	 	Reno	 	NV	 	89502-1189	 	Leased	 	No
	 Routt Dialysis, LLC
	 	Carson City	 	3246 N. Carson Street	 	Carson City	 	NV	 	89706-0248	 	Leased	 	No
	 Routt Dialysis, LLC
	 	Sparks	 	4860 Vista Boulrvard	 	Sparks	 	NV	 	89436-2817	 	Leased	 	No
	 Routt Dialysis, LLC
	 	Sierra Rose	 	685 Sierra Rose Drive	 	Reno	 	NV	 	89511-2060	 	Leased	 	No
	 Sherman Dialysis, LLC
	 	Cheyenne	 	3291 N Buffalo Drive, Bldg. A	 	Las Vegas	 	NV	 	89129-7441	 	Leased	 	No
	 Siena Dialysis Center, LLC
	 	Siena Henderson	 	2865 Siena Heights Drive	 	Las Vegas	 	NV	 	89052-4168	 	Leased	 	No
	 Southern Hills Dialysis Center, LLC
	 	Southern Hills	 	9280 West Sunset Road, Suite 110	 	Las Vegas	 	NV	 	89148-4861	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fallon	 	1103 New River Pkwy	 	Fallon	 	NV	 	89406-6899	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Winnemucca	 	830 Fairgrounds Road	 	Winnemucca	 	NV	 	89445-2011	 	Leased	 	No
	 Valley Springs Dialysis, LLC
	 	The Nevada	 	1510 West Warm Springs Road	 	Henderson	 	NV	 	89014-3586	 	Leased	 	No
	 Empire State DC, Inc.
	 	Utica Avenue	 	1305 Utica Avenue	 	Brooklyn	 	NY	 	11203-5911	 	Leased	 	No
	 Empire State DC, Inc.
	 	Ithaca	 	201 Dates Drive	 	Ithaca	 	NY	 	14850-1345	 	Leased	 	Yes
	 Empire State DC, Inc.
	 	Columbia University	 	60 Haven Street	 	New York	 	NY	 	10032-2604	 	Leased	 	No
	 Enchanted Dialysis, LLC
	 	Newark Wayne	 	1120 South Main St.	 	Newark	 	NY	 	14513-2171	 	Leased	 	No

  
 Sch 4.8-63 

															
	 Huntington Artificial Kidney Center, Ltd.
	 	Medford	 	1725 North Ocean Avenue	 	Medford	 	NY	 	11763-2649	 	Leased	 	No
	 Huntington Artificial Kidney Center, Ltd.
	 	Huntington Station	 	256 Broadway	 	Huntington Station	 	NY	 	11746-1403	 	Leased	 	No
	 Huntington Artificial Kidney Center, Ltd.
	 	Freeport	 	267 West Merrick Road	 	Freeport	 	NY	 	11520-3346	 	Leased	 	No
	 Huntington Artificial Kidney Center, Ltd.
	 	Freeport	 	351 S. Main Street	 	Freeport	 	NY	 	11520-3346	 	Leased	 	No
	 Huntington Artificial Kidney Center, Ltd.
	 	Syosset	 	One Locust Lane	 	Syosset	 	NY	 	11791-4834	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Orange	 	100 Crystal Run Road, Suite 102	 	Middletown	 	NY	 	10941-4042	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Garden City	 	1100 Stewart Ave	 	Garden City	 	NY	 	11530-4839	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Staten Island	 	1139-1141 Hylan Blvd.	 	Staten Island	 	NY	 	10305-2061	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Queens	 	118-01 Guy Brewer Blvd.	 	Queens	 	NY	 	11434-2101	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Richmond	 	1366 Victory Blvd	 	Staten Island	 	NY	 	10301-3907	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Catskill	 	139 Forestburgh Road	 	Monticello	 	NY	 	12701-2348	 	Leased	 	Yes
	 Knickerbocker Dialysis, Inc.
	 	Lynbrook	 	147 Scranton Ave	 	Lynbrook	 	NY	 	11563-2808	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Suburban	 	1542 Maple Road	 	Amherst	 	NY	 	14221-3625	 	Leased	 	Yes
	 Knickerbocker Dialysis, Inc.
	 	Bronx	 	1615 Eastchester Road	 	Bronx	 	NY	 	10461-2603	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Soundview	 	1622-24 Bruckner Blvd.	 	Bronx	 	NY	 	10473-4553	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Riverdale	 	170 West 233rd Street	 	Bronx	 	NY	 	10463-5639	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Bronx	 	1733 Eastchester Road	 	Bronx	 	NY	 	10461-2315	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	South Bronx	 	1940 Webster Ave	 	Bronx	 	NY	 	10457-4261	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Womens Christian Association Hospital	 	207 Foote Ave	 	Jamestown	 	NY	 	14701-7077	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Queens Village	 	222-02 Hempstead Ave.	 	Queens	 	NY	 	11429-2123	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Coney Island	 	26 Thru 48 Brighton 11th Street	 	Brooklyn	 	NY	 	11235-5304	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Long Island	 	3460 Great Neck Road	 	Amityville	 	NY	 	11701-1915	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Williamsbridge	 	3525 White Plains Road	 	Bronx	 	NY	 	10461-5705	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Orchard Park	 	3801 Taylor Rd	 	Orchard Park	 	NY	 	14127-2232	 	Leased	 	Yes
	 Knickerbocker Dialysis, Inc.
	 	Boston Post	 	4026 Boston Post Road	 	Bronx	 	NY	 	10475-1122	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Northtowns	 	4041 Delaware Avenue	 	Tonawanda	 	NY	 	14150-6850	 	Leased	 	Yes
	 Knickerbocker Dialysis, Inc.
	 	Port Washington	 	50 Seaview Boulevard	 	Port Washington	 	NY	 	11050-4615	 	Leased	 	Yes
	 Knickerbocker Dialysis, Inc.
	 	Peekskill	 	500 Pike Plaza Route 6	 	Cortland Manor	 	NY	 	10567-2502	 	Leased	 	No

  
 Sch 4.8-64 

															
	 Knickerbocker Dialysis, Inc.
	 	Yonkers	 	575 Yonkers Avenue	 	Yonkers	 	NY	 	10704-2601	 	Leased	 	No
	 Knickerbocker Dialysis, Inc.
	 	Central New York	 	910 Erie Blvd E	 	Syracuse	 	NY	 	13210-1060	 	Leased	 	No
	 Liberty RC, Inc.
	 	Dyker Heights	 	1435 86th St.	 	Brooklyn	 	NY	 	11228-3435	 	Leased	 	Yes
	 Liberty RC, Inc.
	 	Cleve Hill	 	1461 Kensington Avenue	 	Buffalo	 	NY	 	14215-1436	 	Leased	 	No
	 Liberty RC, Inc.
	 	Hudson Valley	 	155 White Plains Rd	 	Tarrytown	 	NY	 	10591-5523	 	Leased	 	No
	 Liberty RC, Inc.
	 	Eastchester Road	 	1615-1617 Eastchester Road	 	Bronx	 	NY	 	10461-2606	 	Leased	 	No
	 Liberty RC, Inc.
	 	White Plains	 	200 Hamilton Avenue, Suite# 13b	 	White Plains	 	NY	 	10601-1859	 	Leased	 	No
	 Liberty RC, Inc.
	 	Niagara Falls	 	2932 Military Road	 	Niagara Falls	 	NY	 	14304-1252	 	Leased	 	No
	 Liberty RC, Inc.
	 	Bedford Park	 	3119 Webster Avenue	 	Bronx	 	NY	 	10467-4905	 	Leased	 	No
	 Liberty RC, Inc.
	 	Port Chester	 	38 Bulkley Avenue	 	Port Chester	 	NY	 	10573-3902	 	Leased	 	No
	 Liberty RC, Inc.
	 	South Brooklyn	 	3915 Avenue V	 	Brooklyn	 	NY	 	11234-5150	 	Leased	 	No
	 Liberty RC, Inc.
	 	Southtowns	 	4910 Camp Road	 	Hamburg	 	NY	 	14075-2617	 	Leased	 	No
	 Liberty RC, Inc.
	 	Yonkers II	 	5 Odell Plaza	 	Yonkers	 	NY	 	10701-1406	 	Leased	 	No
	 Liberty RC, Inc.
	 	Buffalo	 	550 Orchard Park Road	 	West Seneca	 	NY	 	14224-2646	 	Leased	 	No
	 Liberty RC, Inc.
	 	Niagara Falls Memorial	 	621 10th St	 	Niagara Falls	 	NY	 	14301-1813	 	Leased	 	No
	 Liberty RC, Inc.
	 	Lowville	 	7785 North State Street	 	Lowville	 	NY	 	13367-1229	 	Leased	 	No
	 Liberty RC, Inc.
	 	Celia Dill	 	Barns Office Center, Suite #206	 	Carmel	 	NY	 	10512-2454	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Brooklyn	 	621-625 Degraw Street	 	Brooklyn	 	NY	 	11217-3120	 	Leased	 	No
	 TRC of New York, Inc.
	 	NE Divisional Vp Office	 	333 Westchester Avenue	 	White Plains	 	NY	 	10604-2910	 	Leased	 	No
	 Alomie Dialysis, LLC
	 	Pike County Dialysis	 	609 W. Emmitt Avenue	 	Waverly	 	OH	 	45690-1013	 	Leased	 	No
	 Barrington Dialysis, LLC
	 	Steubenville Home Training	 	1799 Sinclair Avenue	 	Steubenville	 	OH	 	43953-3328	 	Leased	 	No
	 Basin Dialysis, LLC
	 	Buckeye	 	3040 S Dixie Drive	 	Kettering	 	OH	 	45409-1516	 	Leased	 	No
	 Bastrop Dialysis, LLC
	 	Darke County	 	1111 Sweitzer St	 	Greenville	 	OH	 	45331-1189	 	Leased	 	No
	 Bastrop Dialysis, LLC
	 	Upper Valley Kidney	 	3130 N County Rd 25a	 	Troy	 	OH	 	45373-1337	 	Leased	 	No
	 Bastrop Dialysis, LLC
	 	Dayton North	 	455 Turner Road	 	Dayton	 	OH	 	45415-3630	 	Leased	 	No
	 Beck Dialysis, LLC
	 	Atrium	 	4421 Roosevelt Blvd	 	Middletown	 	OH	 	45044-9024	 	Leased	 	Yes
	 Birch Dialysis, LLC
	 	Hilliard	 	19133 Hilliard Boulevard	 	Rocky River	 	OH	 	44116-2907	 	Leased	 	Yes
	 Birch Dialysis, LLC
	 	Center Ridge	 	38600 Center Ridge Road	 	North Ridgeville	 	OH	 	44039-2837	 	Leased	 	No
	 Birch Dialysis, LLC
	 	Parma Heights	 	9050 North Church Drive	 	Parma	 	OH	 	44130-4701	 	Leased	 	Yes

  
 Sch 4.8-65 

															
	 Borrego Dialysis, LLC
	 	Harrison	 	 10475, 10473, 10471
 & 10469 Harrison
Avenue
	 	Harrison	 	OH	 	45030-1941	 	Leased	 	No
	 Columbus-RNA-DaVita, LLC
	 	Columbus	 	226 Graceland Boulevard, Suite 3-09A	 	Columbus	 	OH	 	43214-5404	 	Leased	 	No
	 Columbus-RNA-DaVita, LLC
	 	Columbus East	 	299 Outerbelt Street	 	Columbus	 	OH	 	43213-1529	 	Leased	 	No
	 Columbus-RNA-DaVita, LLC
	 	Columbus	 	3830 Olentangy River Road	 	Columbus	 	OH	 	43214-5404	 	Leased	 	No
	 Columbus-RNA-DaVita, LLC
	 	Columbus Downtown	 	415 East Mound Street	 	Columbus	 	OH	 	43215-5512	 	Leased	 	No
	 Court Dialysis, LLC
	 	Adena	 	1800 North Bridge Street	 	Chillicothe	 	OH	 	45601-1793	 	Leased	 	No
	 DeSoto Dialysis, LLC
	 	Lucas County Home	 	2702 Navarra Ave	 	Oregon	 	OH	 	43616-3224	 	Leased	 	No
	 Dome Dialysis, LLC
	 	Westerville	 	241 West Schrock Road	 	Westerville	 	OH	 	43081-2874	 	Leased	 	Yes
	 DVA Healthcare - Southwest Ohio, LLC
	 	Blue Ash	 	10600 Mckinley Road	 	Cincinnati	 	OH	 	45242-3716	 	Leased	 	No
	 DVA Healthcare - Southwest Ohio, LLC
	 	Fairfield	 	1210 Hicks Boulevard	 	Fairfield	 	OH	 	45014-1921	 	Leased	 	Yes
	 DVA Healthcare - Southwest Ohio, LLC
	 	Mt. Auburn	 	2109 Reading Road	 	Cincinnati	 	OH	 	45202-1417	 	Leased	 	No
	 DVA Healthcare - Southwest Ohio, LLC
	 	Western Hills	 	3267 Westbourne Drive	 	Cincinnati	 	OH	 	45248-5130	 	Leased	 	No
	 DVA Healthcare - Southwest Ohio, LLC
	 	Butler County	 	3497 South Dixie Highway	 	Franklin	 	OH	 	45005-5717	 	Leased	 	Yes
	 DVA Healthcare - Southwest Ohio, LLC
	 	Winton Road	 	6550 Winton Road	 	Cincinnati	 	OH	 	45224-1327	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Toledo	 	1614 S, Byrne Road	 	Toledo	 	OH	 	43614-3464	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Ashtabula	 	1614 West 19th Street	 	Ashtabula	 	OH	 	44004-3036	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hubbard Road	 	1963 Hubbard Road	 	Madison	 	OH	 	44057-2105	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Toledo	 	5325 Airport Highway	 	Toledo	 	OH	 	43614-3464	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Toledo At Home	 	5325 Airport Highway	 	Toledo	 	OH	 	43614-3464	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Northwood	 	605 Lemoyne Road	 	Northwood	 	OH	 	43619-1811	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hubbard Road	 	6800 North Ridge Road	 	Madison	 	OH	 	44057-2105	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Marietta	 	1019 Pike Street	 	Marietta	 	OH	 	45750-3500	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Coshocton	 	1404 Chestnut Street East	 	Coshocton	 	OH	 	43812-1401	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Urbana	 	1880 E Us Highway 36	 	Urbana	 	OH	 	45503-2692	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Belpre	 	2906 Washington Blvd	 	Belpre	 	OH	 	45714-1848	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Zanesville	 	3120 Newark Road	 	Zanesville	 	OH	 	43701-9659	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Buckaneers Region 3 Office	 	5554 Cheviot Rd Ste C	 	Cincinnati	 	OH	 	45247	 	Leased	 	No
	 Fields Dialysis, LLC
	 	Norwood	 	2300 Wall Street	 	Cincinnati	 	OH	 	45212-2781	 	Leased	 	No

  
 Sch 4.8-66 

															
	 Fields Dialysis, LLC
	 	Milford	 	5901 Montclair Blvd	 	Milford	 	OH	 	45150-2547	 	Leased	 	No
	 Fort Dialysis, LLC
	 	Massillon	 	2112 Lincoln Way East	 	Massillon	 	OH	 	44646-7034	 	Leased	 	No
	 Garrett Dialysis, LLC
	 	Brunswick	 	3812 Center Road	 	Brunswick	 	OH	 	44212-3025	 	Leased	 	Yes
	 Goza Dialysis, LLC
	 	Ross	 	3825 Kraus Lane	 	Fairfield	 	OH	 	45014-5867	 	Leased	 	No
	 Heyburn Dialysis, LLC
	 	Hilliard Station	 	2447 Hilliard Rome Road	 	Hilliard	 	OH	 	43026-8194	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Akron	 	525 E Market Street	 	Akron	 	OH	 	44304-1619	 	Leased	 	Yes
	 ISD Summit Renal Care, LLC fka Summit Renal Care, LLC
	 	Munroe Falls	 	265 N Main Street	 	Munroe Falls	 	OH	 	44262-1090	 	Leased	 	No
	 ISD Summit Renal Care, LLC fka Summit Renal Care, LLC
	 	White Ponds	 	534 White Pond Drive	 	Akron	 	OH	 	44320-1100	 	Leased	 	No
	 ISD Summit Renal Care, LLC fka Summit Renal Care, LLC
	 	Summit	 	73 Massillon Road	 	Akron	 	OH	 	44312-1028	 	Leased	 	No
	 Kinswa Dialysis, LLC
	 	Freemont	 	100 Pinnacle Dr	 	Fremont	 	OH	 	43420-7400	 	Leased	 	No
	 Lakeshore Dialysis, LLC
	 	Dayton North	 	4750 North Main Street	 	Dayton	 	OH	 	45405-5021	 	Leased	 	No
	 Lory Dialysis, LLC
	 	Premiere Kidney Center	 	65 South Terrace Avenue	 	Newark	 	OH	 	43055-1355	 	Leased	 	No
	 Los Arcos Dialysis, LLC
	 	Amherst	 	3200 Cooper Foster Park Rd W	 	Lorain	 	OH	 	44053-3654	 	Leased	 	No
	 Mahoney Dialysis, LLC
	 	Meadowhawk	 	491 Coleman’s Crossing Blvd.	 	Marysville	 	OH	 	43040-7068	 	Leased	 	No
	 Manzano Dialysis, LLC
	 	Midwest Fairborn	 	1266 N. Broad St	 	Fairborn	 	OH	 	45324-5549	 	Leased	 	Yes
	 Mermet Dialysis, LLC
	 	East Hamilton OH	 	77 W Voice of Americas Park Dr	 	West Chester	 	OH	 	45069	 	Leased	 	No
	 Mermet Dialysis, LLC
	 	Mt Healthy	 	7702 Affinity Place	 	Mt Healthy	 	OH	 	45231-3566	 	Leased	 	No
	 Mesilla Dialysis, LLC
	 	Midwest Urbana	 	1430 East U.S. Highway 36	 	Urbana	 	OH	 	43078-9112	 	Leased	 	Yes
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Dayton	 	2016 Springboro West	 	Moraine	 	OH	 	45439-1648	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Cincinnati	 	4623 Wesley Avenue	 	Norwood	 	OH	 	45212	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Cincinnati	 	7335 Yankee Road	 	Liberty Township	 	OH	 	45044-9168	 	Leased	 	Yes
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Columbus	 	815 West Broad Street	 	Columbus	 	OH	 	43222-1478	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Youngstown	 	8423 Market Street	 	Boardman	 	OH	 	44512-6725	 	Leased	 	No
	 Milo Dialysis, LLC
	 	Twinsburg	 	2592 E. Aurora Road	 	Twinsburg	 	OH	 	44087-2148	 	Leased	 	No
	 Milo Dialysis, LLC
	 	Painesville	 	7611 Auburn Road	 	Concord	 	OH	 	44077-9608	 	Leased	 	No
	 Morro Dialysis, LLC
	 	Miamisburg	 	290 Alexandersville Rd	 	Miamisburg	 	OH	 	45342-3611	 	Leased	 	No

  
 Sch 4.8-67 

															
	 National Trail Dialysis, LLC
	 	National Trail	 	167 Tuttle Road	 	Springfield	 	OH	 	45505-1560	 	Leased	 	No
	 Pendster Dialysis, LLC
	 	New Carlisle OH	 	7769 Old Country Court	 	Huber Heights	 	OH	 	45424	 	Leased	 	No
	 Powerton Dialysis, LLC
	 	University Toledo	 	2900 Carskaddon Avenue	 	Toledo	 	OH	 	43606-1601	 	Leased	 	No
	 Rancho Dialysis, LLC
	 	Dover	 	899 East Iron Blvd	 	Dover	 	OH	 	44622-2097	 	Leased	 	No
	 Renal Life Link, Inc
	 	Willow	 	1675 Alex Drive	 	Wilmington	 	OH	 	45177-2446	 	Leased	 	Yes
	 Renal Life Link, Inc
	 	Fairborne	 	3070 Presidential Drive	 	Fairborn	 	OH	 	45324-6273	 	Leased	 	No
	 Renal Life Link, Inc
	 	Kettering	 	5721 Bigger Road	 	Kettering	 	OH	 	45440-2752	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Eaton	 	105 E Washington Jackson Road	 	Eaton	 	OH	 	45320-9789	 	Leased	 	Yes
	 Renal Treatment Centers-Illinois, Inc.
	 	Ohio Pike	 	1761 St. Route 125	 	Amelia	 	OH	 	45102-2039	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Rocky River	 	20220 Center Ridge Road	 	Rocky River	 	OH	 	44116-3567	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	South West Ohio	 	215 South Allison St	 	Xenia	 	OH	 	45385-3694	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	East Galbraith	 	3877 E. Galbraith Rd., Bldg. C	 	Cincinnati	 	OH	 	45236-1500	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Batavia	 	4000 Golden Age Drive	 	Batavia	 	OH	 	45103-1913	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Point Place	 	4747 Suder Avenue	 	Toledo	 	OH	 	43611-2869	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Rockside	 	4801 Acorn Dr	 	Independence	 	OH	 	44131-2566	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Andover	 	488 South Main Street	 	Andover	 	OH	 	44003-9602	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Parma	 	6713 Ames Road	 	Parma	 	OH	 	44129-5601	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Middleburg Heights	 	7360 Engle Rd	 	Middleburg Hts	 	OH	 	44130	 	Leased	 	No
	 Renal Treatment Centers-Illinois, Inc.
	 	Cincinnati	 	Eastgate Professional Office Park, 4435 Aicholtz Road	 	Cincinnati	 	OH	 	45245-1690	 	Leased	 	Yes
	 River Valley Dialysis, LLC
	 	Delhi	 	5052-5040 Delhi Pike	 	Cincinnati	 	OH	 	45238-5388	 	Leased	 	No
	 River Valley Dialysis, LLC
	 	White Oak	 	5520 Cheviot Road	 	Cincinnati	 	OH	 	45247-7069	 	Leased	 	Yes
	 River Valley Dialysis, LLC
	 	Silverton	 	6929 Silverton Avenue	 	Cincinnati	 	OH	 	45236-3701	 	Leased	 	Yes
	 River Valley Dialysis, LLC
	 	Anderson	 	7502 State Road	 	Cincinnati	 	OH	 	45255	 	Leased	 	No
	 River Valley Dialysis, LLC
	 	Lebanon	 	916 Columbus Avenue	 	Lebanon	 	OH	 	45036-1402	 	Leased	 	No
	 RNA - DaVita Dialysis, LLC
	 	Columbus West	 	1395 Georgesville Road	 	Columbus	 	OH	 	43228-3611	 	Leased	 	No
	 RNA - DaVita Dialysis, LLC
	 	Dublin	 	6770 Perimeter Drive	 	Dublin	 	OH	 	43016-8063	 	Leased	 	No
	 Sandusky Dialysis, LLC
	 	Sandusky	 	211 Lakeside Park	 	Sandusky	 	OH	 	44870-8639	 	Leased	 	No
	 Seneca Dialysis, LLC
	 	Seneca County	 	10 St Lawrence Drive	 	Tiffin	 	OH	 	44883-8310	 	Leased	 	No
	 St. Luke’s Dialysis Center, LLC
	 	Shaker Square	 	12800 Shaker Boulevard	 	Cleveland	 	OH	 	44120-2004	 	Leased	 	No

  
 Sch 4.8-68 

															
	 Steele Dialysis, LLC
	 	Galion	 	865 Harding Way West	 	Galion	 	OH	 	44833-1637	 	Leased	 	No
	 Storrie Dialysis, LLC
	 	Midwest Springfield	 	2200 N. Limestone St	 	Springfield	 	OH	 	45503-2692	 	Leased	 	No
	 Strongsville Dialysis, LLC
	 	Strongsville	 	17792 Pearl Road	 	Strongsville	 	OH	 	44136-6909	 	Leased	 	No
	 Total Renal Care, Inc.
	 	River’s Edge	 	1004 E State St	 	Athens	 	OH	 	45701-2158	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Forest Fair	 	1145 Kemper Meadow Drive	 	Forest Park	 	OH	 	45240-4118	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Highland County	 	120 Roberts Ln	 	Hillsboro	 	OH	 	45133-7608	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Heart of Marion	 	1221 Delaware Avenue	 	Marion	 	OH	 	43302	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Merrcy Canton	 	1320 Mercy Drive Nw	 	Canton	 	OH	 	44708-2614	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Columbus West	 	1391 Georgesville Road	 	Columbus	 	OH	 	43228-3611	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Northcoast Dialysis	 	14050 Madison Ave	 	Lakewood	 	OH	 	44107-4530	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Knox County	 	1485 Coshocton Ave	 	Mount Vernon	 	OH	 	43050-1544	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Cherry Valley	 	1627 W. Main St	 	Newark	 	OH	 	43055-1345	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Millersburg	 	1649 South Washington Street	 	Millersburg	 	OH	 	44654	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fairview	 	19050 Lorain Road	 	Fairview Park	 	OH	 	44126-1915	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wadsworth	 	195 Wadsworth Road	 	Wadsworth	 	OH	 	44281-9504	 	Leased	 	No
	 Total Renal Care, Inc.
	 	The Christ Hospital Dialysis	 	2139 Auburn Ave.	 	Cincinnati	 	OH	 	45219-2906	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Olmsted	 	22710 Fairview Center Dr	 	Fairview Park	 	OH	 	44126-3607	 	Leased	 	No
	 Total Renal Care, Inc.
	 	St V Quadrangle	 	2302 Community College Avenue	 	Cleveland	 	OH	 	44115-3117	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Alliance Community	 	270 East State Street	 	Alliance	 	OH	 	44601-4309	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Westlake	 	29000 Center Ridge Rd	 	Westlake	 	OH	 	44145-5293	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Barberton	 	3235 Manchester Road, Ste 9	 	Akron	 	OH	 	44319-1458	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Maumee Bay	 	3310 Dustin Road	 	Oregon	 	OH	 	43616-3302	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Southland	 	3401 Glendale Avenue	 	Toledo	 	OH	 	43614-2490	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Ridgeville	 	35143 Center Ridge Road	 	North Ridgeville	 	OH	 	44039-3089	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Red Bank	 	3960 Red Bank Road Ste 160	 	Fairfax	 	OH	 	45227-3421	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grove City	 	4155 Kelnor Drive	 	Grove City	 	OH	 	43123-2960	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Us Grant	 	458 Home Street	 	Georgetown	 	OH	 	45121-1408	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Belden	 	4685 Fulton Dr Nw	 	Canton	 	OH	 	44718-2379	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Dayton South	 	4700 Springboro Pike	 	Moraine	 	OH	 	45439-1964	 	Leased	 	No

  
 Sch 4.8-69 

															
	 Total Renal Care, Inc.
	 	Mccarthy Lane	 	500 Mccarty Ln	 	Jackson	 	OH	 	45640-7019	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Flower	 	5308 Harroun Road	 	Sylvania	 	OH	 	43560-2114	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ashtabula	 	5740 Dibble Road	 	Kingsville	 	OH	 	44048-9809	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Detroit Road	 	7901 Detroit Avenue	 	Cleveland	 	OH	 	44102-2828	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lorain County	 	824 East Broad Street	 	Elyria	 	OH	 	44035-6559	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kenton	 	East Columbus Street	 	Kenton	 	OH	 	43326-1760	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Logan	 	Grey Street	 	Logan	 	OH	 	43138-9638	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pataskala	 	Hazelwood Plaza Phase II, 642-658 East Broad Street	 	Pataskala	 	OH	 	43062-7627	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dayton	 	One Elizabeth Place	 	Dayton	 	OH	 	45417-3474	 	Leased	 	No
	 Vogel Dialysis, LLC
	 	Canal	 	3568 Gender Road	 	Canal Winchester	 	OH	 	43110-8007	 	Leased	 	No
	 Wallowa Dialysis, LLC
	 	Ontario	 	2148 West 4th Street	 	Ontario	 	OH	 	44906-1200	 	Leased	 	No
	 Wauseon Dialysis, LLC
	 	Wauseon	 	721 South Shoop Avenue	 	Wauseon	 	OH	 	43567-1729	 	Leased	 	No
	 Bliss Dialysis, LLC
	 	Berkshire Home Training	 	4800 W. San Antonio	 	Broken Arrow	 	OK	 	74012-6127	 	Leased	 	No
	 Bottle Dialysis, LLC
	 	Midwest City	 	1405 S. Douglas Blvd.	 	Midwest City	 	OK	 	73130-5240	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Oklahoma City South	 	5730 S May Ave	 	Oklahoma City	 	OK	 	73119-5604	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Heartland	 	925 Northeast 8th Street	 	Oklahoma City	 	OK	 	73104-5800	 	Leased	 	No
	 Greenwood Dialysis, LLC
	 	Greenwood	 	1345 N Lansing Avenue	 	Tulsa	 	OK	 	74106-5911	 	Leased	 	No
	 Jacinto Dialysis, LLC
	 	Ardmore Ranch	 	2617 Crossroads Drive	 	Ardmore	 	OK	 	73401	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline-Tulsa	 	4800 W San Antonio St	 	Broken Arrow	 	OK	 	74012	 	Leased	 	No
	 Owasso Dialysis, LLC
	 	Owasso	 	9521 N Owasso E. Expressway	 	Owasso	 	OK	 	74055-5414	 	Leased	 	Yes
	 Platte Dialysis, LLC
	 	Tahlequah	 	1373 East Boone St	 	Tahlequah	 	OK	 	74464-3330	 	Leased	 	No
	 Platte Dialysis, LLC
	 	Muskogee	 	2316 W. Shawnee Bypass	 	Muskogee	 	OK	 	74401-2228	 	Leased	 	Yes
	 Platte Dialysis, LLC
	 	Platte	 	305 S Jt Stites St	 	Sallisaw	 	OK	 	74955-9302	 	Leased	 	No
	 Platte Dialysis, LLC
	 	Stilwell	 	319 N 2nd Street	 	Stilwell	 	OK	 	74960-1636	 	Leased	 	Yes
	 Renal Life Link, Inc
	 	Okc South	 	3905 S. Western	 	Oklahoma City	 	OK	 	73109-3405	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Central Tulsa	 	1124 South St. Louis	 	Tulsa	 	OK	 	74120-5413	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Oklahoma City Acutes	 	1301 Cornell Parkway	 	Oklahoma City	 	OK	 	73108-1822	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Clinton	 	150 South 31st Street	 	Clinton	 	OK	 	73601-9118	 	Leased	 	No

  
 Sch 4.8-70 

															
	 Renal Treatment Centers-West, Inc.
	 	Elk City	 	1601 West 2nd Street	 	Elk City	 	OK	 	73644-4427	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Norman	 	1818 W. Lindsey Street, Building B	 	Norman	 	OK	 	73069-4184	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Claremore	 	202 East Blue Starr Drive	 	Claremore	 	OK	 	74017-4223	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Altus	 	205 S. Park Lane	 	Altus	 	OK	 	73521-5756	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Chickasha	 	228 South 29th Street	 	Chickasha	 	OK	 	73018-2502	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Miami	 	2510 North Main	 	Miami	 	OK	 	74354-1602	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Duncan	 	2645 W. Elk	 	Duncan	 	OK	 	73533-1572	 	Owned	 	No
	 Renal Treatment Centers-West, Inc.
	 	Stillwater	 	406 East Hall Of Fame Ave	 	Stillwater	 	OK	 	74075-5447	 	Leased	 	Yes
	 Renal Treatment Centers-West, Inc.
	 	Durant	 	411 Westside Drive	 	Durant	 	OK	 	74701-2932	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Anadarko	 	412 East 11th Street	 	Anadarko	 	OK	 	73005-4442	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Shawnie	 	4409 N Kickapoo Ave	 	Shawnee	 	OK	 	74804-1224	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Tulsa	 	4436 South Harvard	 	Tulsa	 	OK	 	74135-2605	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Dream Catchers Region 04 Office	 	4800 W. San Antonio	 	Broken Arrow	 	OK	 	74012-6127	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Edmond	 	50 South Baumann Avenue	 	Edmond	 	OK	 	73034-5676	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Region-Park Towers	 	5314 South Yale	 	Tulsa	 	OK	 	74012-6127	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Midwest City	 	7221 East Reno Avenue	 	Midwest City	 	OK	 	73110-4474	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	NW Bethany	 	7800 Nw 23rd St	 	Bethany	 	OK	 	73008-4948	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Okmulgee	 	East 7th And South Delaware	 	Okmulgee	 	OK	 	74447-5528	 	Leased	 	No
	 Rusk Dialysis, LLC
	 	Cleveland	 	1059 Se 82nd St	 	Oklahoma City	 	OK	 	73149-2999	 	Leased	 	No
	 Southcrest Dialysis, LLC
	 	Southcrest	 	9001 S 101st E Ave, Suite #110	 	Tulsa	 	OK	 	74133-5799	 	Leased	 	No
	 Southlake Dialysis, LLC
	 	Broken Arrow	 	1710 N 9th St	 	Broken Arrow	 	OK	 	74012-8283	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grove	 	1111 North E O Loop	 	Grove	 	OK	 	74344-6046	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sooner	 	1561 North Porter Ave	 	Norman	 	OK	 	73071-6621	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Region	 	7806 Nw 23rd Street	 	Bethany	 	OK	 	73008-4948	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Rose Rock	 	9913 East Reno Avenue	 	Midwest City	 	OK	 	73130-3505	 	Leased	 	No
	 Tulsa Dialysis, LLC
	 	Sapulpa	 	9647 Ridgeview Street	 	Tulsa	 	OK	 	74131-6205	 	Leased	 	No
	 Wyler Dialysis, LLC
	 	Pryor	 	309 East Graham Avenue	 	Pryor	 	OK	 	74361-2434	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Salem North	 	1220 Liberty Street Ne	 	Salem	 	OR	 	97301-7330	 	Leased	 	No

  
 Sch 4.8-71 

															
	 DVA Healthcare Renal Care, Inc.
	 	Woodburn	 	1840 Newburg Hwy	 	Woodburn	 	OR	 	97071-3187	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Roseburg	 	2410 Nw Edenbower Blvd	 	Roseburg	 	OR	 	97471-8830	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Salem	 	3550 Liberty Road South	 	Salem	 	OR	 	97302-5700	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Beaverton	 	15050 Sw Koll Pkwy	 	Beaverton	 	OR	 	97006-6002	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Willamette Valley	 	1510 Division Street	 	Oregon City	 	OR	 	97045-1572	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Dialysis Care Of Portland	 	5318 Ne Irving	 	Portland	 	OR	 	97213-3158	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Sunnyside	 	6902 Se Lake Road	 	Milwaukie	 	OR	 	97267-2148	 	Leased	 	Yes
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Northeast Portland	 	703 Ne Hancock Street	 	Portland	 	OR	 	97212-3955	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	NPS Portland	 	15895 SW 72nd	 	Portland	 	OR	 	97224-7966	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Mcminnville	 	220 NE Norton Lane	 	Mcminnville	 	OR	 	97224-7966	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Oregon Kidney	 	9155 SW Barnes Rd	 	Portland	 	OR	 	97224-7966	 	Leased	 	No
	 Nephrology Medical Associates of Georgia, LLC
	 	Dnp.Newberg Timeshare	 	Providence Newberg Medical Center, 1003 Providence Drive Suite 315	 	Portland	 	OR	 	97224-7966	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Hermiston	 	1155 W Linda Ave.	 	Hermiston	 	OR	 	97838-9601	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Sherwood	 	Highway 99 & Edy Road	 	Sherwood	 	OR	 	97140-8062	 	Leased	 	No
	 Star Dialysis, LLC
	 	Grants Pass	 	1055 Redwood Avenue	 	Grants Pass	 	OR	 	97527-5525	 	Leased	 	No
	 Star Dialysis, LLC
	 	Redwood	 	201 SW L Street	 	Grants Pass	 	OR	 	97526-2913	 	Leased	 	No
	 Star Dialysis, LLC
	 	Rogue Valley	 	760 Golf View Drive, Unit 100	 	Medford	 	OR	 	97504-9685	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Linn	 	18900 Willamette Drive	 	West Linn	 	OR	 	97068-1715	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake Oswego	 	19255 SW 65th Avenue	 	Tualatin	 	OR	 	97062-9712	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mcminneville	 	200 NE Norton Lane	 	Mcminneville	 	OR	 	97128-8470	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Acq Klamath Falls	 	2230 El Dorado Drive	 	Klamath Falls	 	OR	 	97601-6418	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hillsboro	 	2500 Nw 229th Avenue	 	Hillsboro	 	OR	 	97124-7516	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Portland MLK	 	2737 NE Martin Luther King Blvd.	 	Portland	 	OR	 	97227	 	Leased	 	No
	 Total Renal Care, Inc.
	 	NE Salem	 	4792 Portland Road NE	 	Salem	 	OR	 	97305-3920	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Four Rivers	 	515 East Lane	 	Ontario	 	OR	 	97914-3953	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Portland Gateway	 	9932 NE Halsey Street	 	Portland	 	OR	 	97220-4495	 	Leased	 	No

  
 Sch 4.8-72 

															
	 Total Renal Care, Inc.
	 	Blue Mountain	 	Coyote Business Park North Lot 11	 	Pendleton	 	OR	 	97801-1002	 	Leased	 	Yes
	 Able Dialysis, LLC
	 	Providence Square Home Training (PD)	 	831 Providence Road	 	Secane	 	PA	 	19018-2921	 	Leased	 	No
	 Campton Dialysis, LLC
	 	Swarthmore	 	1310 MacDade Boulevard	 	Woodlyn	 	PA	 	19078	 	Leased	 	No
	 Cedar Dialysis, LLC
	 	Paxton	 	479 Port View Drive	 	Harrisburg	 	PA	 	17111	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Mckeesport	 	101 9th Street	 	Mckeesport	 	PA	 	15132-3953	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	GHc-Waynesburg	 	248 Elm Drive	 	Waynesburg	 	PA	 	15370	 	Owned	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Radnor	 	250 King Of Prussia Road	 	Radnor	 	PA	 	19087-5235	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Paris	 	32 Steubenville Pike	 	Paris	 	PA	 	15021-8529	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Philadelphia Market Street	 	3701 Market Street	 	Philadelphia	 	PA	 	19104-5503	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Philadelphia PMC	 	3817-39 Market Street	 	Philadelphia	 	PA	 	19104-3145	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Philadelphia 42nd Street	 	4126-38 Walnut Street	 	Philadelphia	 	PA	 	19104-3511	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Pittsburg	 	4312 Penn Avenue	 	Pittsburg	 	PA	 	15224-1310	 	Leased	 	No
	 DVA Healthcare of Pennsylvania, Inc.
	 	Philadelphia Pmc	 	51 North 39th Street	 	Philadelphia	 	PA	 	19104-3145	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Elkins Park	 	1000 Easton Rd	 	Cheltenham	 	PA	 	19095-2934	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Northumberland	 	101 West State Route 61	 	Mt. Carmel	 	PA	 	17851-2539	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Selinsgrove	 	1030 North Susquehanna Trail	 	Selinsgrove	 	PA	 	17870-7767	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Jefferson	 	14 Clairton Boulevard	 	Pittsburgh	 	PA	 	15236-3911	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Cobbs Creek	 	1700 South 60th Street	 	Philadelphia	 	PA	 	19142-1404	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Meadville	 	19050 Park Avenue Plaza	 	Meadville	 	PA	 	16335-4012	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Mckeesport	 	2001 Lincoln Way, Oak Park Mall	 	Mckeesport	 	PA	 	15131-2419	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Elizabeth	 	201 Mckeesport Road	 	Elizabeth	 	PA	 	15037-1623	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Homestead	 	207 West 7th Avenue	 	West Homestead	 	PA	 	15120-1002	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Corry	 	300 York Street	 	Corry	 	PA	 	16407-1420	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Erie	 	350 East Bayfront Pkway	 	Erie	 	PA	 	16507-2410	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Abington	 	3940 Commerce Avenue	 	Willow Grove	 	PA	 	19090-1705	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Roxborough	 	5003 Umbria Street	 	Philadelphia	 	PA	 	19128-4301	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Roxborough Dialysis	 	5003 Umbria Street	 	Philadelphia	 	PA	 	19127	 	Owned	 	No

  
 Sch 4.8-73 

															
	 DVA Healthcare Renal Care, Inc.
	 	Bradford	 	665 East Main Street	 	Bradford	 	PA	 	16701-1816	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	West Philadelphia	 	7607-7609 Lindbergh Boulevard	 	Philadelphia	 	PA	 	19153-2301	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Huntingdon Valley	 	769 Huntingdon Pike	 	Philadelphia	 	PA	 	19006-8362	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Elizabethtown	 	844 North Hanover Street	 	Elizabethtown	 	PA	 	17022-1303	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Clearfield	 	Sj Waterworth Med Bldg	 	Clearfield	 	PA	 	16830-3061	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Waverly	 	Waverly Square	 	Morton	 	PA	 	19070-1042	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Avanti Group Office	 	447 West Moreland Drive	 	Willow Grove	 	PA	 	19355	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Team Avanti Group Office	 	676 Swedesford Rd	 	Wayne	 	PA	 	19355	 	Leased	 	Yes
	 Etowah Dialysis, LLC
	 	St. Luke’s Quakertown	 	1021 Park Avenue	 	Quakertown	 	PA	 	18951-1573	 	Leased	 	No
	 Etowah Dialysis, LLC
	 	St. Luke’s Bethlehem	 	1425 8th Ave.	 	Bethlehem	 	PA	 	18018-2256	 	Leased	 	No
	 Etowah Dialysis, LLC
	 	St. Luke’s Allentown	 	1736 Hamilton Blvd	 	Allentown	 	PA	 	18104-5656	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Memphis Street	 	3310 - 28 Memphisstreet	 	Philadelphia	 	PA	 	19134-4510	 	Leased	 	No
	 ISD Renal, Inc. fka DSI Renal, Inc.
	 	Northern Philadelphia Dialysis (P244)	 	5933 Broad Street	 	Philadelphia	 	PA	 	19141	 	Owned	 	No
	 Kimball Dialysis, LLC
	 	Moosic	 	3409 Birney Avenue	 	Moosic	 	PA	 	18507-1505	 	Leased	 	No
	 Kimball Dialysis, LLC
	 	Scranton	 	920 South Washington Ave	 	Scranton	 	PA	 	18505-3810	 	Leased	 	No
	 Landing Dialysis, LLC
	 	Bayview Home Training	 	2563 W 8th	 	Erie	 	PA	 	16505-4430	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Lehigh	 	2014 City Line Rd	 	Bethlehem	 	PA	 	18017-2126	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Pittsburgh	 	2030 Ardmore Boulevard, 2 Parkway Center East Bldg Suite 125	 	Pittsburgh	 	PA	 	15221-4652	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Philadelphia 2a	 	235-237 North Broad Street	 	Philadelphia	 	PA	 	19107-1511	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Philadelphia	 	250 Yorktown Plaza	 	Elkins Park	 	PA	 	19027-1424	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Johnstown	 	344 Budfield Street	 	Johnstown	 	PA	 	15904-3214	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Ebensburg	 	429 Manor Drive, Ste 6	 	Ebensburg	 	PA	 	15931-4917	 	Leased	 	No
	 Physicians Dialysis Acquisitions, Inc.
	 	Pdi Walnut Towers	 	830 Walnut Street	 	Philadelphia	 	PA	 	19107-5109	 	Leased	 	Yes
	 Physicians Dialysis of Lancaster, LLC
	 	Pdi Lancaster	 	1412 E. King Street	 	Lancaster	 	PA	 	17602-3240	 	Leased	 	No
	 Physicians Dialysis of Lancaster, LLC
	 	Manhiem Pike	 	1650 Manheim Pike	 	Lancaster	 	PA	 	17601-3056	 	Leased	 	No
	 Physicians Dialysis of Lancaster, LLC
	 	Suburban Campus	 	2100 Harrisburg Pike	 	Lancaster	 	PA	 	17601-2644	 	Leased	 	No
	 Physicians Dialysis of Lancaster, LLC
	 	Pdi Ephrata	 	67 West Church St	 	Stevens	 	PA	 	17578-9203	 	Leased	 	No

  
 Sch 4.8-74 

															
	 Pittsburgh Dialysis Partners, LLC
	 	Monroeville	 	2690 Monroeville Blvd	 	Monroeville	 	PA	 	15146-2302	 	Leased	 	No
	 Pittsburgh Dialysis Partners, LLC
	 	Pittsburgh	 	401 Liberty Ave	 	Pittsburgh	 	PA	 	15235-3337	 	Leased	 	No
	 Pittsburgh Dialysis Partners, LLC
	 	Bloomfield-Pittsburg	 	5171 Liberty Ave	 	Pittsburg	 	PA	 	15224-2254	 	Leased	 	No
	 Pittsburgh Dialysis Partners, LLC
	 	Pittsburg At Home	 	5171 Liberty Ave	 	Pittsburg	 	PA	 	15224-2254	 	Leased	 	No
	 Pittsburgh Dialysis Partners, LLC
	 	Bethel Park	 	60 Highland Ave	 	Bethel Park	 	PA	 	15102-1806	 	Leased	 	Yes
	 Pittsburgh Dialysis Partners, LLC
	 	East End Pittsburgh	 	7714 Penn Avenue	 	Pittsburgh	 	PA	 	15221	 	Leased	 	No
	 Pittsburgh Dialysis Partners, LLC
	 	Harmarville	 	791 Freeport Road	 	Cheswick	 	PA	 	15024-1201	 	Leased	 	No
	 Prineville Dialysis, LLC
	 	Eagle Valley	 	166 Eagle’s Glen Plaza	 	East Stroudsburg	 	PA	 	18301-1349	 	Leased	 	No
	 Prineville Dialysis, LLC
	 	Pocono Home	 	3361 Route 611	 	Bartonsville	 	PA	 	18321-7821	 	Leased	 	No
	 Red Willow Dialysis, LLC
	 	Willow Grove	 	1849 Davisville Road	 	Willow Grove	 	PA	 	19090-4111	 	Leased	 	No
	 Red Willow Dialysis, LLC
	 	Castor	 	7198 Castor Ave	 	Philadephia	 	PA	 	19149-1105	 	Leased	 	No
	 Red Willow Dialysis, LLC
	 	Warminster	 	720 Johnsville Blvd	 	Warminster	 	PA	 	18974-3546	 	Leased	 	No
	 Renal Life Link, Inc
	 	Childs	 	101 South Main Street	 	Childs	 	PA	 	18407-2614	 	Leased	 	No
	 Renal Life Link, Inc
	 	Dunmore	 	1212 O’Neil Highway	 	Dunmore	 	PA	 	18512-1717	 	Leased	 	No
	 Renal Life Link, Inc
	 	Old Forge	 	325 S. Main Street	 	Old Forge	 	PA	 	18518-1677	 	Leased	 	No
	 Renal Life Link, Inc
	 	Scranton	 	475 Morgan Highway	 	Scranton	 	PA	 	18508-2605	 	Leased	 	No
	 Renal Life Link, Inc
	 	Tunkhannock	 	5950 Sr 6	 	Tunkhannock	 	PA	 	18657-7905	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Upland	 	1 Medical Center Boulevard	 	Upland	 	PA	 	19013-3902	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Mt.Pocono	 	100 Community Drive, Ste 106	 	Tobyhanna	 	PA	 	18466-8986	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Jennersville	 	10111 West Baltimore Pike, Suite #107	 	West Grove	 	PA	 	19390-9446	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	South Philadelphia	 	109 Dickenson Street	 	Philadelphia	 	PA	 	19147-6107	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	South Philadelphia II - Pa	 	1172-74 S Broad Street	 	Philadelphia	 	PA	 	19146-3142	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Palmerton	 	185c Delaware Avenue	 	Palmerton	 	PA	 	18071-1716	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Palmer	 	30 Community Drive	 	Easton	 	PA	 	18045-2658	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Thorndale	 	3243 E. Lincoln Highway	 	Thorndale	 	PA	 	19372-1012	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Pocono	 	447 Office Plaza, 100 Plaza Ct Suite B	 	East Stroudsburg	 	PA	 	18301-8258	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	NE Philadelphia	 	518 Knorr Street	 	Philadelphia	 	PA	 	19111-4604	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Lewistown	 	611 Electric Avenue	 	Lewiston	 	PA	 	17044-1128	 	Leased	 	No

  
 Sch 4.8-75 

															
	 Renal Treatment Center-Northeast, Inc.
	 	Camp Hill	 	Plaza 21 Bldg, 1st Floor	 	Camp Hill	 	PA	 	17011-2223	 	Leased	 	No
	 Renal Treatment Center-Northeast, Inc.
	 	Upland	 	Professional Office Building II	 	Chester	 	PA	 	19013-3902	 	Leased	 	No
	 Renal Treatment Centers, Inc.
	 	Berwyn Business Office	 	2476 Swedesford Road	 	Malvern	 	PA	 	19355-1456	 	Leased	 	No
	 Riddle Dialysis, LLC
	 	Riddle	 	100 Granite Drive	 	Media	 	PA	 	19063-5134	 	Leased	 	No
	 Sahara Dialysis, LLC
	 	Cheltenham	 	133-135 Cheltenham Avenue	 	Cheltenham	 	PA	 	19012-1301	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Franklin	 	101 Public Ledger Building	 	Philadelphia	 	PA	 	19106-3413	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Delaware Valley	 	102 Davita Drive	 	Milford	 	PA	 	18337-9390	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Thorn Run	 	1136 Thorn Run Rd	 	Moon Township	 	PA	 	15108-4301	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Lincoln Way	 	1303 Lincoln Way	 	White Oak	 	PA	 	15131-1603	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Allegheny Valley	 	1620 Pacific Ave	 	Natrona Heights	 	PA	 	15065-2101	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Erie	 	1641 Sassafras Street	 	Erie	 	PA	 	16502-1858	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fayette County	 	201 Mary Higginson Lane	 	Uniontown	 	PA	 	15401-2658	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Somerset County	 	229 South Kimberly Ave	 	Somerset	 	PA	 	15501-2022	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Broomall	 	2835 West Chester Pike	 	Broomall	 	PA	 	19008-1833	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Franklin At Home	 	301 Callowhill St	 	Philadelphia	 	PA	 	19123-4117	 	Leased	 	No
	 Total Renal Care, Inc.
	 	University City	 	3020-52 Market St	 	Philadelphia	 	PA	 	19104-2999	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Callowhill	 	309-315 Callowhill Street	 	Philadelphia	 	PA	 	19123-4103	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Budfield Street	 	350 Budfield St.	 	Johnstown	 	PA	 	15904-3214	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lebanon County	 	440 Oak Street	 	Lebanon	 	PA	 	17042-6243	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Drexel	 	449 North Broad St	 	Philadelphia	 	PA	 	19123-3628	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Dnvo-Fairmount	 	4508 City Line Avenue	 	Philadelphia	 	PA	 	19131-1509	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	State College	 	500 Science Park Drive	 	State College	 	PA	 	16803-2218	 	Leased	 	No
	 Total Renal Care, Inc.
	 	St. Mary	 	60 Blacksmith Road	 	Newtown	 	PA	 	18940-1847	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Quincy Ave	 	700 Quincy Avenue	 	Scranton	 	PA	 	18510-1724	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Oak Springs	 	764 Locust Dr.	 	Washington	 	PA	 	15301-2756	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Westtown	 	800 E. Market Street	 	West Chester	 	PA	 	19382-8902	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Frackville	 	801 Schuylkill Mall	 	Frackville	 	PA	 	17931-2524	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Side	 	930 Madison Ave	 	Pittsburgh	 	PA	 	15212-4937	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Oxford Court	 	930 Town Drive	 	Langehorne	 	PA	 	19047-4260	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grant One	 	9475 Roosevelt Blvd	 	Philadelphia	 	PA	 	19114-2212	 	Leased	 	No

  
 Sch 4.8-76 

															
	 Total Renal Care, Inc.
	 	Honesdale	 	Stourbridge Mall	 	Honesdale	 	PA	 	18431-1459	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Warren	 	Two Crescent Park West	 	Warren	 	PA	 	16365-2111	 	Leased	 	Yes
	 Wooten Dialysis, LLC
	 	Carlisle	 	419 Village Drive	 	Carlisle	 	PA	 	17015-6943	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-San Juan	 	Hospital Auxilo Mutuo, Avenida Ponce De Leon Parada 37 1/2	 	San Juan	 	PR	 	918	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Mayaguez	 	Office Park II, 357 Ave Hostos Suite 203	 	Mayaguez	 	PR	 	00680-1507	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	North Providence	 	1635 Mineral Spring Avenue	 	North Providence	 	RI	 	02904-4025	 	Leased	 	No
	 Curlew Dialysis, LLC
	 	McColl	 	3595 Hwy 15-401 E	 	McColl	 	SC	 	29570-5918	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	South Orangeburg2	 	1080 Summers Ave	 	Orangeburg	 	SC	 	29115-4920	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Greenwood	 	109 Overland Drive	 	Greenwood	 	SC	 	29646-4053	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lancaster County	 	1100 West Meeting Street	 	Lancaster	 	SC	 	29720-2251	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	North Orangeburg	 	124 Fire Tower Rd	 	Orangeburg	 	SC	 	29118-1443	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Allendale County	 	1241 Boundary Street West	 	Fairfax	 	SC	 	29827-3611	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Santee	 	228 Bradford Blvd	 	Santee	 	SC	 	29142-8677	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Walterboro	 	302 Ruby Street	 	Walterboro	 	SC	 	29488-2758	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Central Bamberg	 	67 Sunset Drive	 	Bamberg	 	SC	 	29003-1181	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Aiken	 	775 Medical Park Drive	 	Aiken	 	SC	 	29801-6306	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Pageland	 	505a South Pearl Street	 	Pageland	 	SC	 	29728-2222	 	Leased	 	No
	 Givhan Dialysis, LLC
	 	Cypress Gardens	 	526 Broad Street	 	Sumter	 	SC	 	29150-3306	 	Leased	 	No
	 Jedburg Dialysis, LLC
	 	Jedburg	 	2897 W 5th North St	 	Summerville	 	SC	 	29483-9674	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	DPC Netherby Clinic	 	5401 Netherby Lane	 	North Charleston	 	SC	 	29420-7363	 	Leased	 	No
	 Pointe Dialysis, LLC
	 	West Ashley	 	1964 Ashley River Road	 	Charleston	 	SC	 	29407-4737	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Clemson	 	7703 Highway 76	 	Pendleton	 	SC	 	29670-1818	 	Leased	 	No
	 Shoals Dialysis, LLC
	 	Bluffton	 	Lot S-2	 	Bluffton	 	SC	 	29909-7547	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hartsville	 	1015 South 4th Street	 	Hartsville	 	SC	 	29550-5791	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Goose Creek	 	109 Greenland Drive	 	Goose Creek	 	SC	 	29445-5354	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ridgeland	 	112 Weathersbee Street	 	Ridgeland	 	SC	 	29936-9514	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Market Commons	 	1350 Farrow Parkway, Suite 100	 	Myrtle Beach	 	SC	 	29577-1668	 	Leased	 	No

  
 Sch 4.8-77 

															
	 Total Renal Care, Inc.
	 	Pamplico	 	1520 Flag Drive	 	Florence	 	SC	 	29505-6012	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Fort Mill	 	1975 Carolina Place	 	Ft. Mill	 	SC	 	29708-6922	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Greer	 	211 Village Drive	 	Greer	 	SC	 	29651-1238	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Low Country Home Training	 	25 Hospital Center Blvd.	 	Hilton Head	 	SC	 	29926-2735	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Greenville West End	 	297 Pete Hollis Blvd.	 	Greenville	 	SC	 	29601-1143	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fountain Inn	 	298 Chapman Rd	 	Fountain Inn	 	SC	 	29644-6129	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Upstate	 	308 Mills Ave	 	Greenville	 	SC	 	29605-4022	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Palmetto	 	317 Professional Park Rd	 	Clinton	 	SC	 	29325-7625	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Greer South	 	3254 Brushy Creek Road	 	Greer	 	SC	 	29650-1000	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Faber Place	 	3801 Faber Place Drive	 	North Charleston	 	SC	 	29405-8533	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Myrtle Beach	 	3919 Mayfair Street	 	Myrtle Beach	 	SC	 	29577-5773	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Charleston	 	4937 Fargo St.	 	North Charleston	 	SC	 	29406-6054	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Gaston	 	5224 Highway 321	 	Gaston	 	SC	 	29053-9194	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Longs	 	90 Cloverleaf Dr	 	Longs	 	SC	 	29568-9262	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Abbeville	 	904 W Greenwood St	 	Abbeville	 	SC	 	29620-5687	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Rosebud	 	1 Soldier Creek Rd., Po Box 950	 	Rosebud	 	SD	 	57570-0610	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sioux Falls	 	2210 W. 69th Street	 	Sioux Falls	 	SD	 	57108-5600	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mitchell	 	525 North Foster	 	Mitchell	 	SD	 	57301-2966	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mitchell Dialysis	 	Lot 2 Menard’s Addition	 	Mitchell	 	SD	 	57301-2966	 	Leased	 	No
	 Capelville Dialysis, LLC
	 	Capelville	 	7008 E Shelby Dr	 	Memphis	 	TN	 	38125-3416	 	Leased	 	No
	 Cerito Dialysis Partners, LLC
	 	Wolf River	 	7990 Trinity Place	 	Cordova	 	TN	 	38018-7731	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Tipton County	 	107 Tennessee Avenue	 	Covington	 	TN	 	38019-3902	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Dyersburg	 	1575 Parr Avenue	 	Dyersburg	 	TN	 	38024-3151	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Whitebridge	 	103 Whitebridge Road	 	Nashville	 	TN	 	37209-4539	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Memphis South	 	1205 Marlin Road	 	Memphis	 	TN	 	38116-5812	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Murfreesboro	 	1346 Dow Street	 	Murfreesboro	 	TN	 	37130-2470	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Columbia	 	1705 Grove Street	 	Columbia	 	TN	 	38401	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Nasville Home	 	1919 Charlotte Ave	 	Nashville	 	TN	 	37203-2245	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Lawrenceburg	 	2022 North Locust Avenue	 	Lawrenceburg	 	TN	 	38464-2336	 	Leased	 	No

  
 Sch 4.8-78 

															
	 DVA Renal Healthcare, Inc.
	 	GHc-Clarksville	 	231 Hillcrest Drive	 	Clarksville	 	TN	 	37403-5093	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Sumner	 	300 Steam Plant Road	 	Gallatin	 	TN	 	37066-3019	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cookeville	 	320 North Willow Ave	 	Cookeville	 	TN	 	38501-2337	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Williamson County	 	4211 South Carothers Road	 	Franklin	 	TN	 	37067-5936	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Dsi Corporate Office	 	424 Church St, Ste 1900	 	Nashville	 	TN	 	37027-7569	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Brentwood Corp Office	 	5200 Virginia Way	 	Brentwood	 	TN	 	37027-7569	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cumberland	 	5500 Old Hickory Blvd	 	Hermitage	 	TN	 	37076-2576	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Memphis East	 	6029 Walnut Grove Road	 	Memphis	 	TN	 	38120-2112	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Brentwood Corp Office	 	800 Crescent Centre Drive	 	Franklin	 	TN	 	37027-7569	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Memphis Central	 	889 Linden Avenue	 	Memphis	 	TN	 	38126-2412	 	Leased	 	No
	 ISD Bartlett, LLC fka DSI Bartlett, LLC
	 	Bartlett	 	2920 Covington Pike	 	Memphis	 	TN	 	38128-6007	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Renal Care Of Memphis Central	 	1331 Union Avenue	 	Memphis	 	TN	 	38104-7559	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Whitehaven	 	3420 Elvis Presley Boulevard	 	Memphis	 	TN	 	38116-3260	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Memphis Graceland	 	4180 Auburn Road	 	Memphis	 	TN	 	38116-6202	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Rc Of Memphis North	 	4913 Raleigh Commons Drive	 	Memphis	 	TN	 	38128-2485	 	Leased	 	No
	 Latrobe Dialysis, LLC
	 	Smokie Mountain	 	101 Med Tech Parkway	 	Johnson City	 	TN	 	37604-4000	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Jackson	 	213 Sterling Farm Drive	 	Jackson	 	TN	 	38305-5727	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Memphis	 	2200 Union Avenue	 	Memphis	 	TN	 	38104-4205	 	Leased	 	No
	 Ripley Dialysis, LLC
	 	Ripley	 	854 Highway 51 South	 	Ripley	 	TN	 	38063-5536	 	Leased	 	No
	 Sandlin Dialysis, LLC
	 	Greenville	 	110 Heritage Ct	 	Greeneville	 	TN	 	37743-2081	 	Leased	 	No
	 Somerville Dialysis Center, LLC
	 	Somerville	 	12485 Highway 64	 	Somerville	 	TN	 	38068-6029	 	Leased	 	No
	 Somerville Dialysis Center, LLC
	 	SW Tennessee	 	9045 US Highway 64	 	Lakeland	 	TN	 	38002-8394	 	Leased	 	No
	 Tannor Dialysis, LLC
	 	Farragut	 	111 S. Campbell Station Road	 	Farragut	 	TN	 	37934-2845	 	Leased	 	No
	 Tennessee Valley Dialysis Center, LLC
	 	Tennessee Valley	 	107 Woodlawn Drive	 	Johnson City	 	TN	 	37604-6287	 	Leased	 	No
	 Tortugas Dialysis, LLC
	 	State Line	 	2049 East Shelby Drive	 	Memphis	 	TN	 	38116-7639	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Etowah	 	109 Grady Road	 	Etowah	 	TN	 	37331-1903	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Pickwick	 	112 N Pickwick	 	Savannah	 	TN	 	38372-1953	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Morristown	 	120 Pearce Drive	 	Morristown	 	TN	 	37814-3649	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sparta	 	150 Sam Walton Drive	 	Sparta	 	TN	 	38583-8818	 	Leased	 	No

  
 Sch 4.8-79 

															
	 Total Renal Care, Inc.
	 	Camden	 	166 West Main Street	 	Camden	 	TN	 	38320-1767	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Memphis Southeast	 	1805 Moriah Woods Boulevard	 	Memphis	 	TN	 	38117-7119	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Memphis Downtown	 	2076 Union Avenue	 	Memphis	 	TN	 	38104-4138	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Stonegate	 	217 Sterling Farms Dr.	 	Jackson	 	TN	 	38305-5727	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Humboldt	 	2214 Osborne Avenue	 	Humboldt	 	TN	 	38343-3044	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Selmer	 	251 Oak Grove Road	 	Selmer	 	TN	 	38375-1881	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Knoxville	 	2909 East Magnolia Ave	 	Knoxville	 	TN	 	37914-4516	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Clarksville North	 	3071 Clay Lewis Rd	 	Clarksville	 	TN	 	37040-5141	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Livingston	 	308 Oak St	 	Livingston	 	TN	 	38570-1729	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Memphis Midtown	 	3430 Summer Ave	 	Memphis	 	TN	 	38122-3610	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Brownsville	 	380 Dupree	 	Brownsville	 	TN	 	38012-2332	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lexington	 	390 S Broad St	 	Lexington	 	TN	 	38351-2257	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Jackson	 	46 Harts Bridge Road West	 	Jackson	 	TN	 	38301-7512	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Appalachian	 	503 Elm Ave	 	New Tazewell	 	TN	 	37825-7525	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bolivar	 	515 Pecan Drive	 	Bolivar	 	TN	 	38008-1611	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Smyrna	 	537 Stonecrest Pkwy	 	Smyrna	 	TN	 	37167-6884	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Clinch River	 	702 North Main St	 	Clinton	 	TN	 	37716-3143	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Blount	 	714 East Harper Ave	 	Maryville	 	TN	 	37804-4028	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Collierville	 	791 West Popular Avenue	 	Collierville	 	TN	 	38017-2543	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Tiptonville	 	795 Hamra Street	 	Tiptonville	 	TN	 	38079-1663	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Millington	 	8510 New Wilkinsonville Rd	 	Millington	 	TN	 	38053-1537	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Knoxville Central - Tn	 	9141 Cross Park Dr	 	Knoxville	 	TN	 	37923-4557	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Galleria	 	9160 Highway 64	 	Memphis	 	TN	 	38002-4766	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Rocky Top	 	921 New Hwy 68	 	Sweetwater	 	TN	 	37874-2726	 	Leased	 	No
	 Alamosa Dialysis, LLC
	 	Port Lavaca	 	1300 N Virginia St	 	Port Lavaca	 	TX	 	77979-2512	 	Leased	 	No
	 Astro, Hobby, West MT Renal Care Limited Partnership
	 	Lone Star	 	8560 Monroe Road	 	Houston	 	TX	 	77061-4815	 	Leased	 	No
	 Austin Dialysis Centers, L.P.
	 	Hill Country Dialysis Center of San Marcos	 	1250 Dacy Lane	 	Kyle	 	TX	 	78666-7407	 	Leased	 	No
	 Austin Dialysis Centers, L.P.
	 	Waterloo	 	5310 Burnet Rd	 	Austin	 	TX	 	78756-2003	 	Leased	 	Yes

  
 Sch 4.8-80 

															
	 Austin Dialysis Centers, L.P.
	 	South Austin	 	6114 South First Street	 	Austin	 	TX	 	78745-4008	 	Leased	 	No
	 Austin Dialysis Centers, L.P.
	 	El Milagro	 	Fountain Park Plaza III Bldg., 2800 South Ih-35 Ste #120, 130, 133 & 136	 	Austin	 	TX	 	78704-5700	 	Leased	 	No
	 Austin Dialysis Centers, L.P.
	 	Hill Country Of San Marcos	 	Tdc Plaza	 	San Marcos	 	TX	 	78666-7407	 	Leased	 	No
	 Bainbridge Dialysis, LLC
	 	Fort Worth	 	1000 St. Louis Ave	 	Fort Worth	 	TX	 	76104-3377	 	Leased	 	No
	 Bannon Dialysis, LLC
	 	McKiney North	 	5341 W. University	 	McKinney	 	TX	 	75071	 	Leased	 	No
	 Barnell Dialysis, LLC
	 	Pine Park	 	3333 Bayshore Blvd	 	Pasadena	 	TX	 	77504-1952	 	Leased	 	No
	 Beacon Dialysis, LLC
	 	Sugar Land Pd	 	1447 Highway 6	 	Sugar Land	 	TX	 	77478-5094	 	Leased	 	No
	 Bear Creek Dialysis Center, L.P.
	 	Bear Creek	 	4978 N. Highway 6	 	Houston	 	TX	 	77084-5282	 	Leased	 	No
	 Belfair Dialysis, LLC
	 	Harlingen	 	1629 Treasure Hills Blvd	 	Harlingen	 	TX	 	78550-8907	 	Leased	 	No
	 Bellevue Dialysis, LLC
	 	Horizon	 	2222 Greenhouse Road	 	Houston	 	TX	 	77084	 	Leased	 	No
	 Bidwell Dialysis, LLC
	 	North Plano	 	201 South Jupiter Road	 	Allen	 	TX	 	75002-3035	 	Leased	 	No
	 Brantley Dialysis, LLC
	 	Ridgecrest	 	12249 Rojas Drive	 	El Paso	 	TX	 	79936-7750	 	Leased	 	No
	 Brownsville Kidney Center, Ltd.
	 	Brownsville	 	2945 Central Boulevard	 	Brownsville	 	TX	 	78520-8958	 	Leased	 	No
	 Cascades Dialysis, LLC
	 	Champions	 	4427 Fm 1960 W.	 	Houston	 	TX	 	77068-3409	 	Leased	 	No
	 Chadron Dialysis, LLC
	 	Ace	 	14512 Lee Road	 	Humble	 	TX	 	77396-3425	 	Leased	 	No
	 Churchill Dialysis, LLC
	 	Harlingen	 	2220 Haine Dr	 	Harlingen	 	TX	 	78550-8584	 	Leased	 	No
	 Churchill Dialysis, LLC
	 	Raymondville	 	894 Farm To Market Road 3168	 	Raymondville	 	TX	 	78580-4519	 	Leased	 	No
	 Clayton Dialysis, LLC
	 	North Arlington	 	642 Lincoln Square	 	Arlington	 	TX	 	76011-4896	 	Leased	 	No
	 Clifton Dialysis, LLC
	 	South Shore Annex (FKA Clear Lake)	 	16750 Highway 3	 	Webster	 	TX	 	77598-2000	 	Leased	 	No
	 Dallas-Fort Worth Nephrology II, LLC
	 	Garland	 	776 E Centerville Rd	 	Garland	 	TX	 	75041-4640	 	Leased	 	No
	 Dallas-Fort Worth Nephrology, L.P.
	 	Arlington	 	1250 E. Pioneer Parkway	 	Arlington	 	TX	 	76010-6423	 	Leased	 	No
	 Dallas-Fort Worth Nephrology, L.P.
	 	Grapevine	 	1600 W North Highway	 	Grapevine	 	TX	 	76051-8131	 	Leased	 	No
	 Dallas-Fort Worth Nephrology, L.P.
	 	Grapevine Dialysis	 	1651 W. North Highway	 	Grapevine	 	TX	 	76051-8131	 	Leased	 	No
	 DaVita EL Paso East, L.P.
	 	Labamba	 	11989 Pellicano Drive	 	El Paso	 	TX	 	79936-6287	 	Leased	 	No
	 DaVita Rx, LLC
	 	Davita Rx Texas	 	1234 Lakeshore Drive	 	Coppell	 	TX	 	75019-4971	 	Leased	 	No
	 Diablo Dialysis, LLC
	 	Lubbock	 	1923 Marsha Sharp Freeway	 	Lubbock	 	TX	 	79415-4036	 	Leased	 	No
	 Dialysis Specialists of Dallas, Inc.
	 	Brookriver	 	8101 North Brookriver Drive	 	Dallas	 	TX	 	75247-4003	 	Leased	 	No

  
 Sch 4.8-81 

															
	 Downtown Houston Dialysis Center, L.P.
	 	Downtown Houston	 	2207 Crawford Street	 	Houston	 	TX	 	77002-8915	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Sagemont	 	10851 Scarsdale Blvd	 	Houston	 	TX	 	77089-5738	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	San Jacinto	 	11430 East Freeway # 330	 	Houston	 	TX	 	77029-1959	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Pearsall	 	1305 North Oak	 	Pearsall	 	TX	 	78061-3414	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Southwest San Antonio	 	1620 Somerset Road	 	San Antonio	 	TX	 	78211-3021	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	San Antonio West	 	4530 Callaghan Road	 	San Antonio	 	TX	 	78228	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Kerrville	 	515 Granada Place	 	Kerrville	 	TX	 	78028-5992	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Central Houston	 	610 South Wayside, #B	 	Houston	 	TX	 	77011-4605	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Houston	 	7543 South Freeway	 	Houston	 	TX	 	77021-5928	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Channelview	 	777 Sheldon Road	 	Channelview	 	TX	 	77530-3509	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Houston	 	900 South Loop West, Suites 100 & 110	 	Houston	 	TX	 	77021-5928	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	GHc-Katy JV	 	1265 Rock Canyon Road	 	Katy	 	TX	 	77450-3831	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Reliant	 	1335 La Concha	 	Houston	 	TX	 	77054-1809	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Rock Prairie Road	 	1605 Rock Prairie Road	 	College Station	 	TX	 	77845-8358	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Mainland	 	2600 Gulf Freeway	 	La Marque	 	TX	 	77568-4922	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Brenham	 	2815 Highway 36 S	 	Brenham	 	TX	 	77833-8143	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Huntsville	 	521 I-45 South	 	Huntsville	 	TX	 	77340-5651	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Island	 	5920 Broadway	 	Galveston	 	TX	 	77551-4305	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Bryan	 	701 University Drive East	 	College Station	 	TX	 	77840-1866	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	North Loop East	 	7135 North Loop East	 	Houston	 	TX	 	77028-5903	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Eagle Div Office	 	731 Carnoustie Dr.	 	San Antonio	 	TX	 	78258-4294	 	Leased	 	No
	 Dworsher Dialysis, LLC
	 	Green Oak	 	1420-1450 Kingwood Drive	 	Kingwood	 	TX	 	77339-3040	 	Leased	 	No
	 East Houston Kidney Center, L.P.
	 	Jacinto	 	11515 Market Street	 	Jacinto City	 	TX	 	77029-2305	 	Leased	 	No
	 Elgin Dialysis, LLC
	 	Dumas	 	107 Binkley Ave.	 	Dumas	 	TX	 	79029-3825	 	Leased	 	No
	 Elgin Dialysis, LLC
	 	Muleshoe	 	1100 West Avenue J.	 	Muleshoe	 	TX	 	79347-4424	 	Leased	 	No
	 Elgin Dialysis, LLC
	 	Colorado City	 	1546 Chestnut St.	 	Colorado City	 	TX	 	79512-3925	 	Leased	 	No
	 Elgin Dialysis, LLC
	 	Fort Stockton	 	387 W. Ih-10, Suite B	 	Fort Stockton	 	TX	 	79735-2700	 	Leased	 	No
	 Elgin Dialysis, LLC
	 	Brownfield	 	710 East Felt St.	 	Brownfield	 	TX	 	79316-3440	 	Leased	 	No
	 Gertrude Dialysis, LLC
	 	Grand Prairie	 	402 N Carrier, Suite 102	 	Grand Prairie	 	TX	 	75050-5426	 	Leased	 	No

  
 Sch 4.8-82 

															
	 Glacier Dialysis, LLC
	 	North Park	 	324 Fm 1960 Road E	 	Houston	 	TX	 	77073-1887	 	Leased	 	No
	 Golden Dialysis, LLC
	 	Balch Springs	 	12001 Elam Road	 	Balch Springs	 	TX	 	75180-2822	 	Leased	 	No
	 Great Dialysis, LLC
	 	McKinney	 	4717 Medical Center Drive	 	Mckinney	 	TX	 	75069-1870	 	Leased	 	No
	 Headlands Dialysis, LLC
	 	Southwest Fort Worth	 	5832 Hulen Street	 	Fort Worth	 	TX	 	76132-2684	 	Leased	 	No
	 Higbee Dialysis, LLC
	 	Cottage	 	1902 Hospital Blvd	 	Gainesville	 	TX	 	76240-2008	 	Leased	 	No
	 Hochatown Dialysis, LLC
	 	Odessa	 	6005 Eastridge Rd	 	Odessa	 	TX	 	79762-5019	 	Leased	 	No
	 Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership
	 	Northwest Houston	 	11029 N.W. Freeway	 	Houston	 	TX	 	77092-7305	 	Leased	 	No
	 Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership
	 	North Houston Kidney	 	380 West Little York Rd.	 	Houston	 	TX	 	77076-1303	 	Leased	 	No
	 Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership
	 	Cypress Station	 	72 Fm 1960 West	 	Houston	 	TX	 	77090-3538	 	Leased	 	No
	 Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership
	 	Houston Kidney Center Southwest	 	9980 W Sam Houston Parkway S.	 	Houston	 	TX	 	77099-5104	 	Leased	 	No
	 Hunts Dialysis, LLC
	 	Round Rock	 	1800 Round Rock	 	Round Rock	 	TX	 	78681	 	Leased	 	No
	 ISD Corpus Christi, LLC (fka DSI Corpus Christi, LLC)
	 	Greenwood Holly	 	1533 Holly Road	 	Corpus Christi	 	TX	 	78417-2010	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Riverside Renal	 	13434 Leopard Street	 	Corpus Christi	 	TX	 	78410-4466	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Beeville	 	1950 Nw. Frontage	 	Beeville	 	TX	 	78102-2954	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Morgan Avenue	 	2222 S Morgan Avenue	 	Corpus Christi	 	TX	 	78405-1992	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Alice	 	2345 Alice Regional Boulevard	 	Alice	 	TX	 	78332-7291	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Edinburg	 	3894 S Jackson Rd	 	Edinburg	 	TX	 	78539-6676	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Dc Of Mcallen	 	411 Lindberg Avenue	 	Mcallen	 	TX	 	78501-2921	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	South Texas	 	4300 S Padre Island Drive	 	Corpus Christi	 	TX	 	78411-4433	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Dialysis Care Of Greenville	 	4805 Wesley Street	 	Greenville	 	TX	 	75401-5649	 	Leased	 	Yes

  
 Sch 4.8-83 

															
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Weslaco	 	910 S Utah Avenue	 	Weslaco	 	TX	 	78596-4270	 	Leased	 	No
	 Kearn Dialysis, LLC
	 	Georgetown	 	201 Fm 971	 	Georgetown	 	TX	 	78626-4546	 	Leased	 	No
	 Lathrop Dialysis, LLC
	 	North Fort Worth	 	3812 Belknap	 	Fort Worth	 	TX	 	76111-6012	 	Leased	 	No
	 Madison Dialysis, LLC
	 	Balcones	 	11150 Research Boulevard	 	Austin	 	TX	 	78759	 	Leased	 	No
	 Manchester Dialysis, LLC
	 	Southeast Fort Worth	 	3845-3851 E. Loop 820 S	 	Fort Worth	 	TX	 	76119	 	Leased	 	No
	 Memorial Dialysis Center, L.P.
	 	Memorial II	 	11621 Katy Freeway	 	Houston	 	TX	 	77079-1801	 	Leased	 	No
	 Mendocino Dialysis, LLC
	 	North Conroe	 	3211 Interstate 45 North	 	Conroe	 	TX	 	77304-2180	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline El Paso 2	 	11989 Pellicano Dr.	 	El Paso	 	TX	 	79936-6288	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf Dallas	 	1222 N. Bishop Avenue	 	Dallas	 	TX	 	75208-4178	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Sw Nephrology Of Houston	 	1570 S Dairy Ashford St	 	Houston	 	TX	 	77077-3820	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-San Antonio	 	7114 San Pedro	 	San Antonio	 	TX	 	78216-6218	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Houston 1 North	 	7272 North Shepherd, Bldg. B	 	Houston	 	TX	 	77091-2435	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Tyler	 	807 East First Street	 	Tyler	 	TX	 	75701-3304	 	Leased	 	No
	 Minam Dialysis, LLC
	 	Amarillo	 	8604 South Coulter	 	Amarillo	 	TX	 	79119-7379	 	Leased	 	No
	 Mission Dialysis Services, LLC
	 	Denton	 	Unicorn Lake Boulevard at Shoreline Dr	 	Denton	 	TX	 	76201	 	Leased	 	No
	 Moncrief Dialysis Center/Total Renal Care Limited Partnership
	 	Moncrief Partners	 	800 West 34th Street, Suite #101	 	Austin	 	TX	 	78705-1144	 	Leased	 	Yes
	 Nolia Dialysis, LLC
	 	Saginaw	 	900 N. Bluemound Rd.	 	Saginaw	 	TX	 	76131-8828	 	Leased	 	No
	 North Austin Dialysis, LLC
	 	Cedar Park	 	1702 East Whitestone	 	Cedar Park	 	TX	 	78613-7640	 	Leased	 	No
	 Oasis Dialysis, LLC
	 	Binz	 	1213 Hermann Dr	 	Houston	 	TX	 	77004-7018	 	Leased	 	No
	 Peaks Dialysis, LLC
	 	West Oaks	 	14800 Westheimer Road, Suite A	 	Houston	 	TX	 	77082	 	Leased	 	No
	 Pfeiffer Dialysis, LLC
	 	West Houston	 	12051 Westpark Drive	 	Houston	 	TX	 	77082-6604	 	Leased	 	No
	 Physicians Dialysis of Houston LLP
	 	Pdi South Houston	 	5989 South Loop East	 	Houston	 	TX	 	77033-1017	 	Leased	 	No
	 Physicians Dialysis of Houston LLP
	 	Pdi North Houston	 	7115 North Loop East	 	Houston	 	TX	 	77028-5948	 	Leased	 	No
	 Pike Dialysis, LLC
	 	Sagemeadow	 	10923 Scarsdale Boulevard	 	Houston	 	TX	 	77089-6024	 	Leased	 	No
	 Pobello Dialysis, LLC
	 	West Bellfort	 	21026 West Bellfort Street	 	Richmond	 	TX	 	77406-1685	 	Leased	 	No
	 Ponderosa Dialysis, LLC
	 	Victory Lakes	 	3290 Gulf Freeway	 	League City	 	TX	 	77539-4542	 	Leased	 	No
	 Rayburn Dialysis, LLC
	 	Midland	 	705 West Wadley Avenue	 	Midland	 	TX	 	79705-5351	 	Leased	 	No

  
 Sch 4.8-84 

															
	 Renal Clinic of Houston, LLC
	 	Sealy	 	2242 Championship Drive	 	Sealy	 	TX	 	77474-8026	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Hearne Tx	 	106 Cedar St	 	Hearne	 	TX	 	77859-2523	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Cuero Lakeview	 	1105 E Broadway St	 	Cuero	 	TX	 	77954	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	North Dallas	 	11886 Greenville Ave Suite 100d	 	Dallas	 	TX	 	75243-0584	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Granbury	 	1200 Paluxy Medical Circle	 	Granbury	 	TX	 	76048-5696	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Denison	 	1220 Reba McEntire Lane	 	Denison	 	TX	 	75020-9057	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Mid-Cities	 	125 Harwood Road	 	Hurst	 	TX	 	76054-3043	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Woodforest	 	12626 Woodforest	 	Houston	 	TX	 	77015-3425	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Central Plano-TX	 	1301 Custer Road	 	Plano	 	TX	 	75075	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Marshall Tx	 	1301 South Washington	 	Marshall	 	TX	 	75670-6215	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	West Houston Home Center of Excellence	 	1319 West Sam Houston Parkway North, Suite 130	 	Houston	 	TX	 	77043	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Gonzales	 	1404 Sarah Dewitt Drive	 	Gonzales	 	TX	 	78629-2702	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Victoria	 	1405 Victoria Station	 	Victoria	 	TX	 	77901-3092	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Spring Branch	 	1425 Blalock	 	Houston	 	TX	 	77055-4446	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	First Colony	 	1447 Hwy 6	 	Sugarland	 	TX	 	77478-5094	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Cypress Fairfield-TX	 	15103 Mason Road, Suite D5	 	Cypress	 	TX	 	77433	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Carrollton	 	1544 Valwood Parkway	 	Carrollton	 	TX	 	75006-8425	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Magnolia	 	17649 Fm 1488 Rd	 	Magnolia	 	TX	 	77354-5235	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Tc Jester	 	1800 W 26th St	 	Houston	 	TX	 	77008-1419	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Heb Dialysis Center	 	1809 Forest Ridge Road	 	Bedford	 	TX	 	76022-7961	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Fort Brown	 	2000 Boca Chica Boulevard	 	Brownsville	 	TX	 	78521	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Meridian	 	201 W Fairmont Parkway, Suite A	 	La Porte	 	TX	 	77571-6303	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Greatwood	 	20333 Southwest Freeway B	 	Sugarland	 	TX	 	77479-6183	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Sherman	 	205 West Lamberth Road	 	Sherman	 	TX	 	75092-2659	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Livingston	 	209 West Park Place	 	Livingston	 	TX	 	77351-7020	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Kingwood	 	2300 Green Oak Drive, Suite 500	 	Kingwood	 	TX	 	77339-2053	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Rockwall	 	2455 Ridge Rd	 	Rockwall	 	TX	 	75087-5530	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Gracias	 	2506-A W. Mount Houston Road	 	Houston	 	TX	 	77038	 	Leased	 	No

  
 Sch 4.8-85 

															
	 Renal Treatment Centers-Southeast, LP
	 	Cedar Hill	 	270 E. Highway 67	 	Duncanville	 	TX	 	75137-4428	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Dallas Central Reuse	 	2703 W. Mockingbird Lane	 	Dallas	 	TX	 	75204-6223	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Tomball	 	27720-A Tomball Parkway	 	Tomball	 	TX	 	77375	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Spring II-TX	 	2828 FM 2920	 	Spring	 	TX	 	77090	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Kaufman	 	2851 Millennium Dr	 	Kaufman	 	TX	 	75142-8865	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Spring Creek	 	301 East Airline Rd	 	Victoria	 	TX	 	77901-3901	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Downtown Dallas	 	3515 Swiss Avenue	 	Dallas	 	TX	 	75204-6223	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Austin Music City	 	3601 Manor Rd	 	Austin	 	TX	 	78723-5816	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Longview	 	425 N. Fredonia St.	 	Longview	 	TX	 	75601-6464	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Baytown	 	4665 Garth Road	 	Baytown	 	TX	 	77521-2261	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Plano	 	481 Shiloh Rd	 	Plano	 	TX	 	75074-7231	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Conroe	 	500 Medical Center Blvd	 	Conroe	 	TX	 	77304-2899	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Gilmer	 	505 N Wood	 	Gilmer	 	TX	 	75644-7651	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Med Center	 	5610 Alameda Ave.	 	Houston	 	TX	 	77004	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Cleveland-Tx	 	600 E. Houston, Suite #630 Croley Center	 	Cleveland	 	TX	 	77327-4689	 	Leased	 	Yes
	 Renal Treatment Centers-Southeast, LP
	 	Lufkin	 	603 Largent Street	 	Lufkin	 	TX	 	75904-3145	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Fort Worth Tx	 	6260 Southwest Blvd	 	Benbrook	 	TX	 	76109-6906	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	West Park	 	6400 Southwest Freeway	 	Houston	 	TX	 	77074-2213	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Americas	 	715 N Americas Ave	 	El Paso	 	TX	 	79907-7003	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Eagle Central Registration	 	731 Carnoustie Dr	 	San Antonio	 	TX	 	78258-4294	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Southwest San Antonio	 	7515 Barlite Blvd	 	San Antonio	 	TX	 	78224-1311	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Med-Center At Home	 	7580 Fannin Professional Building, 7580 Fannin Suite 230	 	Houston	 	TX	 	77054-1939	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	North Hills	 	7927 Grapevine Highway 26	 	North Richland Hills	 	TX	 	76180-7103	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Lake Cliff	 	805 N Beckley Ave	 	Dallas	 	TX	 	75203-1612	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	North Houstons	 	8621 Fulton	 	Houston	 	TX	 	77022-2021	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Jersey Village	 	8787 Fallbrook Drive	 	Houston	 	TX	 	77064	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Pinecrest	 	913 Pinecrest Drive	 	Marshall	 	TX	 	75670-7309	 	Leased	 	Yes

  
 Sch 4.8-86 

															
	 Renal Treatment Centers-Southeast, LP
	 	LA Central	 	916 Houston Street	 	Laredo	 	TX	 	78040-8015	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Omni	 	9350 Kirby Drive	 	Houston	 	TX	 	77054-2528	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Central Dallas	 	9500 North Central Expressway	 	Dallas	 	TX	 	75231-5139	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Mansfield	 	987 N. Walnut Creek Drive	 	Mansfield	 	TX	 	76063-8016	 	Leased	 	No
	 Renal Treatment Centers-Southeast, LP
	 	Cross Timbers	 	Northline Commons	 	Houston	 	TX	 	77022-3604	 	Leased	 	No
	 Rickwood Dialysis, LLC
	 	Richmond Tx	 	6952 Industrial Parkway	 	Rosenburg	 	TX	 	77471-5656	 	Leased	 	No
	 RMS Lifeline, Inc.
	 	Lifeline Divisional	 	7607 Eastmark Drive	 	College Station	 	TX	 	60061-1450	 	Leased	 	No
	 Russell Dialysis, LLC
	 	Wylie Tx	 	941 S. Westgate Way	 	Wylie	 	TX	 	75098-4947	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Rivercenter	 	1123 North Main Avenue	 	San Antonio	 	TX	 	78212-4738	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	South San Antonio	 	1313 Se Military Drive #111	 	San Antonio	 	TX	 	78214-2850	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Boerne	 	1361 Main Street	 	Boerne	 	TX	 	78006-2860	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Marymont	 	2391 Ne Loop 410	 	San Antonio	 	TX	 	78217-5675	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Southcross	 	4602 E Southcross	 	San Antonio	 	TX	 	78222-4911	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	NW Medical Center	 	5284 Medical Drive, Suite 135	 	San Antonio	 	TX	 	78229-4849	 	Leased	 	Yes
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Floresville	 	543 10th Street	 	Floresville	 	TX	 	78114-3107	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Downtown San Antonio	 	615 E. Quincy	 	San Antonio	 	TX	 	78215-1600	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Seguin	 	618 E. Court Street	 	Seguin	 	TX	 	78155-5714	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Live Oak	 	6700 Randolph Blvd, Ste 101	 	Live Oak	 	TX	 	78233-4222	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Stone Oak	 	731 Carnoustie Drive	 	San Antonio	 	TX	 	78258	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Las Palmas	 	803 Castroville Road, Suite 415	 	San Antonio	 	TX	 	78237-3148	 	Leased	 	Yes
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	New Braunfels	 	900 Loop 337 North	 	New Braunfels	 	TX	 	78130-3555	 	Leased	 	No
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	Floyd Curl San Antonio	 	9238 Floyd Curl	 	San Antonio	 	TX	 	78240-1691	 	Leased	 	Yes
	 SAKDC-DaVita Dialysis Partners, L.P.
	 	San Antonio	 	9846 Westover Hills Blvd	 	San Antonio	 	TX	 	78251-4125	 	Leased	 	No
	 Santiam Dialysis, LLC
	 	Houston Galleria	 	5923 Westheimer Road	 	Houston	 	TX	 	77057-7603	 	Leased	 	No
	 Shelby Dialysis, LLC
	 	Cloverleaf	 	13535A I-10 East Freeway	 	Houston	 	TX	 	77015	 	Leased	 	No
	 South Shore Dialysis Center, L.P.
	 	South Shore	 	212 Gulf Freeway, Suite G3	 	League City	 	TX	 	77573-3956	 	Leased	 	Yes
	 Springs Dialysis, LLC
	 	Highland Village	 	2700 Village Pkwy	 	Highland Village	 	TX	 	75077-3286	 	Leased	 	No
	 Summit Dialysis Center, L.P.
	 	Summit	 	3150 Polk Street	 	Houston	 	TX	 	77003-4631	 	Leased	 	No
	 Taylor Dialysis, LLC
	 	Taylor	 	3100 West 2nd Street	 	Taylor	 	TX	 	76574	 	Leased	 	No
	 Teton Dialysis, LLC
	 	Texas City Pd	 	13003 Delaney	 	La Marque	 	TX	 	77568-2506	 	Leased	 	No

  
 Sch 4.8-87 

															
	 The Woodlands Dialysis Center, LP
	 	Woodlands	 	9303 Pinecroft Dr	 	The Woodlands	 	TX	 	77380-3178	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Henderson	 	1002 Highway 79 North	 	Henderson	 	TX	 	75652-6008	 	Leased	 	Yes
	 Total Renal Care Texas Limited Partnership
	 	Hanson	 	10655 Eastex Freeway	 	Houston	 	TX	 	77093-4323	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Central City	 	1300 Murchison Dr. Suite #320	 	El Paso	 	TX	 	79902-4840	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Pin Oak	 	1302 Pin Oak Road	 	Katy	 	TX	 	77494-6848	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Central City	 	1310 Murchison Drive	 	El Paso	 	TX	 	79902-4840	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Oak Cliff	 	2000 Llewelyn Avenue	 	Dallas	 	TX	 	75224-1804	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Bonham	 	201 West 5th Street	 	Bonham	 	TX	 	75418-4302	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	River Park	 	2010 South Loop 336 West	 	Conroe	 	TX	 	77304-3313	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Hillsboro	 	207 Nw I-35	 	Hillsboro	 	TX	 	76645-2658	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Kilgore	 	209 Powder Horn	 	Kilgore	 	TX	 	75662-5554	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Mesa Vista	 	2400 North Oregon	 	El Paso	 	TX	 	79902-3135	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Lancaster	 	2424 W Pleasant Run Road	 	Lancaster	 	TX	 	75146-4005	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Mission Hills	 	2700 North Stanton	 	El Paso	 	TX	 	79902-2500	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Fourth Street	 	3101 North Fourth Street	 	Longview	 	TX	 	75605-5146	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Katy III	 	403 W Grand Parkway South	 	Katy	 	TX	 	77494-8358	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Brookhollow	 	4918 West 34th Street	 	Houston	 	TX	 	77092-6606	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	West Texas	 	5595 B Alameda Avenue	 	El Paso	 	TX	 	79905-2915	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Sun City	 	600 Newman	 	El Paso	 	TX	 	79902-5543	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Spring	 	607 Timberdale Lane, Suite 100	 	Houston	 	TX	 	77090-3043	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Pearland	 	6516 Broadway	 	Pearland	 	TX	 	77581-7879	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Cielo Vista	 	7200 Gateway East, Suite #B	 	El Paso	 	TX	 	79915-1301	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Cyfair	 	9110 Jones Road #110	 	Houston	 	TX	 	77065-4489	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Deerbrook	 	9660 Fm 1960 Bypass	 	Humble	 	TX	 	77338-4039	 	Leased	 	No
	 Total Renal Care Texas Limited Partnership
	 	Edna	 	Ne Corner Of Wells St & Hwy 59	 	Edna	 	TX	 	77957-2153	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mission Hills	 	1203 St Claire Blvd	 	Mission	 	TX	 	78572-6601	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Odyssey Region 04 Office	 	1380 Lomaland Drive	 	El Paso	 	TX	 	79935-5204	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Silver Spurs Division Office	 	1701 Directors Boulevard, Suite 530	 	Austin	 	TX	 	76574-4647	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lone Star Region 2	 	3211 Interstate 45 North	 	Conroe	 	TX	 	77304-2187	 	Leased	 	No

  
 Sch 4.8-88 

															
	 Total Renal Care, Inc.
	 	Northeast Texas Dialysis	 	413B U.S. 59	 	Atlanta	 	TX	 	75551-2015	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Texarkana	 	4800 Texas Blvd	 	Texarkana	 	TX	 	75503-3033	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Division	 	600 Rockmead Dr, Suite #211	 	Kingwood	 	TX	 	77339-2193	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sierra Acute	 	6000 Welch, Suite 17 & 18	 	El Paso	 	TX	 	79905-1814	 	Leased	 	No
	 Transmountain Dialysis, L.P.
	 	Transmountain	 	5255 Woodrow Bean	 	El Paso	 	TX	 	79924-3832	 	Leased	 	No
	 Transmountain Dialysis, L.P.
	 	Transmountain	 	5800 Woodrow Bean Transmountain Dr	 	El Paso	 	TX	 	79924-3832	 	Leased	 	No
	 TRC EL Paso Limited Partnership (N Facility)
	 	Loma Vista	 	1382 Lomaland Drive	 	El Paso	 	TX	 	79935-5204	 	Leased	 	No
	 Tumalo Dialysis, LLC
	 	San Angelo	 	3518 Knickerbocker Road	 	San Angelo	 	TX	 	76904-7611	 	Leased	 	No
	 Ukiah Dialysis, LLC
	 	Woodlands II	 	17191 St. Lukes Way	 	The Woddlands	 	TX	 	77384-8042	 	Leased	 	No
	 Upper Valley Dialysis, L.P.
	 	Upper Valley	 	7933 N. Mesa	 	El Paso	 	TX	 	79932-1699	 	Leased	 	No
	 UT Southwestern DVA Healthcare LLP
	 	SW Dallas Airport Fwy	 	204 E. Airport Freeway	 	Irving	 	TX	 	75062-6305	 	Leased	 	No
	 UT Southwestern DVA Healthcare LLP
	 	Dallas East	 	3312 N Buckner Blvd #123	 	Dallas	 	TX	 	75228-5642	 	Leased	 	No
	 UT Southwestern DVA Healthcare LLP
	 	Ut Southwestern-Oakcliff	 	608/610 Wynnewood Village	 	Dallas	 	TX	 	75224	 	Leased	 	No
	 Willowbrook Dialysis Center, L.P.
	 	Willowbrook	 	12220 Jones Rd, Suite D	 	Houston	 	TX	 	77070-5280	 	Leased	 	No
	 Winds Dialysis, LLC
	 	West Plano	 	5036 Tennyson Pkwy	 	Plano	 	TX	 	75024-3002	 	Leased	 	No
	 Wood Dialysis, LLC
	 	Cypress Woods	 	20320 Northwest Freeway	 	Houston	 	TX	 	77065	 	Leased	 	No
	 American Fork Dialysis, LLC
	 	Lone Peak	 	1175 E 50 S	 	American Fork	 	UT	 	84003-2845	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Utah Valley	 	1055 North 500 West	 	Provo	 	UT	 	84604-3305	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ogden	 	1920 W 250 N. Suites 5 - 8	 	Marriott-Slaterville	 	UT	 	84404-9233	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Bountiful	 	724 West 500 South, Suite 300	 	West Bountiful	 	UT	 	84087-1471	 	Leased	 	No
	 CDC of Springfield-Fairfax, Inc.
	 	Alexandria	 	5999 Stevenson Ave	 	Alexandria	 	VA	 	22304-3302	 	Leased	 	No
	 CDC of Springfield-Fairfax, Inc.
	 	Fairfax	 	8350 A Traford Lane	 	Springfield	 	VA	 	22152-1664	 	Leased	 	Yes
	 Continental Dialysis Center, Inc.
	 	Manassas	 	10651 Lomond Drive	 	Manassas	 	VA	 	20109-2877	 	Leased	 	No
	 Continental Dialysis Center, Inc.
	 	Woodbridge	 	2751 Killarney Drive	 	Woodbridge	 	VA	 	22192-4119	 	Leased	 	Yes
	 Continental Dialysis Center, Inc.
	 	Sterling	 	46396 Benedict Dr	 	Sterling	 	VA	 	20164-6626	 	Leased	 	Yes
	 DaVita Tidewater, LLC
	 	Leigh-Kempsville	 	420 North Center Drive	 	Norfolk	 	VA	 	23502-4019	 	Leased	 	No
	 DaVita Tidewater-Virginia Beach, LLC
	 	Camelot	 	1800 Camelot Drive	 	Virginia Beach	 	VA	 	23454-2440	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Chester Dialysis	 	10360 Ironbridge Rd	 	Chester	 	VA	 	23831-1426	 	Leased	 	No

  
 Sch 4.8-89 

															
	 DVA Healthcare Renal Care, Inc.
	 	Midlothian	 	14281 Midlothian Turnpike Bldg B	 	Midlothian	 	VA	 	23113-6560	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Amelia	 	15151 Patrick Henry Highway	 	Amelia	 	VA	 	23002-4700	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Central Virginia Acutes	 	2161 Tomlynn Street	 	Richland	 	VA	 	23230-3316	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Covington	 	2504 Valley Ridge Road	 	Covington	 	VA	 	24426	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	GHc-Staunton	 	29 Idlewood Blvd Hwy 250	 	Staunton	 	VA	 	24401-9355	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Culpeper	 	430 Southridge Parkway	 	Culpeper	 	VA	 	22701-3791	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Arlington	 	4805 First Street	 	Arlington	 	VA	 	22203-2603	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hioaks	 	671 Hioaks Rd	 	Richmond	 	VA	 	23225-4072	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Hioaks Pd	 	681 Hioaks Road	 	Richmond	 	VA	 	23225-4043	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Lexington	 	756 North Lee Highway	 	Lexington	 	VA	 	24450-3724	 	Leased	 	Yes
	 DVA Healthcare Renal Care, Inc.
	 	Mechanicsville	 	8191 Atlee Road	 	Mechanicsville	 	VA	 	23116-1807	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Tyson’S Corner	 	8391 Old Courthouse Rd #160	 	Vienna	 	VA	 	22182-3819	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Harrisonburg	 	871 Cantrell Avenue Suite 100	 	Harrisonburg	 	VA	 	22801-4323	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Dabney	 	8813 Three Chopt Rd	 	Richmond	 	VA	 	23229-4774	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Martinsville	 	Market Street & Bridge Street	 	Martinsville	 	VA	 	24112-6214	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Charlottesville	 	1450 Pantops Mountain Place	 	Charlottesville	 	VA	 	22911-4600	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Charlottesville North	 	1800 Timberwood Blvd	 	Charlottesville	 	VA	 	22911-7544	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Alexandria	 	5150 Duke Street	 	Alexandria	 	VA	 	22304-2906	 	Leased	 	Yes
	 DVA Renal Healthcare, Inc.
	 	Henrico County	 	5270 Chamberlyne Road	 	Richmond	 	VA	 	23227-2950	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Radford	 	600 East Main Street	 	Radford	 	VA	 	24141-1826	 	Leased	 	No
	 East End Dialysis Center, Inc.
	 	East End	 	2201 East Main St.	 	Richmond	 	VA	 	23223-7071	 	Leased	 	No
	 Landsford Dialysis, LLC
	 	Princess Anne	 	3973 Holland Road	 	Virginia Beach	 	VA	 	23452-2804	 	Leased	 	No
	 Livingston Dialysis, LLC
	 	Forest Hill Avenue	 	4900 Forest Hill Avenue	 	Richmond	 	VA	 	23225-3146	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Fairfax	 	13135 Lee Jackson Hwy	 	Fairfax	 	VA	 	22033-1904	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Hampton	 	501 Butler Farm Road	 	Hampton	 	VA	 	23666-1777	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lf-Richmond	 	6031 Staples Mill Road	 	Richmond	 	VA	 	23228-4923	 	Leased	 	No
	 MGD-Medical Practice (Lifeline)
	 	Lifeline Norfolk	 	814 Kempsville Road	 	Norfolk	 	VA	 	23502-4001	 	Leased	 	No
	 Monahans Dialysis, LLC
	 	Royal Oak	 	1587 N Main Street	 	Marion	 	VA	 	24354-4317	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	First Colonial At Home	 	1157 First Colonial Road	 	Virgina Beach	 	VA	 	23454-2432	 	Leased	 	Yes

  
 Sch 4.8-90 

															
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Haymarket	 	14662 Gap Way	 	Gainesville	 	VA	 	20155-1683	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Portsmouth	 	2000 High Street	 	Portsmouth	 	VA	 	23704-3012	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Midtowne Norfolk	 	2201 Colonial Ave	 	Norfolk	 	VA	 	23517-1928	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	St. Francis	 	2312 Colony Crossing Place	 	Midlothina	 	VA	 	23112-4280	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Hopewell	 	301 West Broadway	 	Hopewell	 	VA	 	23860-2645	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Greater Portsmouth	 	3516 Queen Street	 	Portsmouth	 	VA	 	23707-3238	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Fair Oaks	 	3955 Pender Drive	 	Fairfax	 	VA	 	22030-6091	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Williamsburg	 	500 Sentara Circle	 	Williamsburg	 	VA	 	23188-5727	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Reston	 	530 Huntmar Park Drive	 	Herndon	 	VA	 	20170-5144	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Franconia	 	5695 King Centre Drive	 	Kingstowne	 	VA	 	22315-5746	 	Leased	 	Yes
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Newport News	 	711 79th Street	 	Newport News	 	VA	 	23605-2767	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Peninsula	 	716 Denbigh Boulevard	 	Newport News	 	VA	 	23608-4414	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Virgina Beach	 	740 Independence Circle	 	Virginia Beach	 	VA	 	23455-6438	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Norfolk	 	962 Norfolk Square	 	Norfolk	 	VA	 	23502-3235	 	Leased	 	No
	 Renal Treatment Centers-Mid-Atlantic, Inc.
	 	Chesapeake	 	Crossway 11, Suite #106	 	Chesapeake	 	VA	 	23320-2839	 	Leased	 	No
	 Rye Dialysis, LLC
	 	Giles County	 	377 Boxwood Lane	 	Pearisburg	 	VA	 	24134-1166	 	Leased	 	Yes
	 Stines Dialysis, LLC
	 	Leigh Home Training	 	230 Clearfield Ave, Suite 106	 	Virginia Beach	 	VA	 	23462-1832	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Harbour View	 	1039 Champions Way, Suite 500	 	Suffolk	 	VA	 	23435-3771	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Jefferson Ave	 	11234 Jefferson Ave	 	Newport News	 	VA	 	23601-2207	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Front Royal	 	1360 N Shenandoah Ave	 	Front Royal	 	VA	 	22630-3636	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Little Creek	 	1817 East Little Creek Road	 	Norfolk	 	VA	 	23518-4203	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Meherrin	 	201-A Weaver Avenue	 	Emporia	 	VA	 	23847-1248	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lynchburg Home Training	 	2091 Langhorne Road	 	Lynchburg	 	VA	 	24501-1443	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Leesburg	 	224d Cornwall St Nw	 	Leesburg	 	VA	 	20176-2700	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Winchester	 	2275 Valor Drive	 	Winchester	 	VA	 	22601-6111	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lansdowne	 	44084 Riverside Parkway	 	Lansdowne	 	VA	 	20176-5102	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Butler Farm	 	501 Butler Farm Road	 	Hampton	 	VA	 	23666-1777	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Garrisonville	 	70 Doc Stone Road	 	Stafford	 	VA	 	22556-4628	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Great Bridge	 	745 North Battlefield Blvd	 	Chesapeake	 	VA	 	23320-0305	 	Leased	 	Yes

  
 Sch 4.8-91 

															
	 Total Renal Care, Inc.
	 	Fairfax	 	8501 Arlington Blvd	 	Fairfax	 	VA	 	22031-4625	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Richmond Community Hospital	 	913 North 25th St	 	Richmond	 	VA	 	23223-6562	 	Leased	 	No
	 TRC-Petersburg, LLC (Appomatox)
	 	Appomattox	 	15 West Old Street	 	Petersburg	 	VA	 	23803-3221	 	Leased	 	No
	 TRC-Petersburg, LLC (Appomatox)
	 	Appomattox	 	20 Medical Park Boulevard	 	Petersburg	 	VA	 	23803-3221	 	Leased	 	No
	 Zara Dialysis, LLC
	 	Hampton Road Home Training (PD/HHD)	 	11234 Jefferson Avenue, Suite B	 	Newport News	 	VA	 	23601-2207	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Spokane Valley	 	12610 East Mirabeau Parkway	 	Spokane Valley	 	WA	 	99216	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	Downtown Spokane	 	601 W 5th Street	 	Spokane	 	WA	 	99204-2708	 	Leased	 	No
	 ISD Renal, Inc fka DSI Renal, Inc.
	 	North Spokane	 	7407 N Division Street, Suite F	 	Spokane	 	WA	 	99208-5689	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Paladina Health	 	1250 Pacific Ave	 	Tacoma	 	WA	 	98402	 	Leased	 	No
	 Refuge Dialysis, LLC
	 	Marysville	 	1250 State Avenue	 	Marysville	 	WA	 	98270	 	Leased	 	No
	 Refuge Dialysis, LLC
	 	Snohomish 2	 	8130 Evergreen Way	 	Everett	 	WA	 	98203-6419	 	Leased	 	No
	 Renal Life Link, Inc
	 	Tacoma	 	3401 So 19th St	 	Tacoma	 	WA	 	98405-1909	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Yakima	 	1221 North 16th Ave	 	Yakima	 	WA	 	98902-1347	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Union Gap	 	1236 Ahtanum Ridge Dr.	 	Union Gap	 	WA	 	98903-1813	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Westwood	 	2600 S.W Barton Street, Unit K-1 Westwood Village Shopping Center	 	Seattle	 	WA	 	98126-3745	 	Leased	 	No
	 Renal Treatment Centers-West, Inc.
	 	Bellevue	 	3535 Factoria Blvd Se	 	Bellevue	 	WA	 	98006-1293	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Federal Way	 	1015 S 348th	 	Federal Way	 	WA	 	98003-7078	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Graham Wa	 	10305 196th St Ct E	 	Graham	 	WA	 	98338-7792	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wenatchee Valley	 	116 Olds Station Road	 	Wenatchee	 	WA	 	98801-5936	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Richland	 	1315 Aaron Drive	 	Richland	 	WA	 	99352-4678	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Parkland	 	13818 Pacific Ave S	 	Tacoma	 	WA	 	98444	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Tacoma Tower	 	1423 Pacific Ave	 	Tacoma	 	WA	 	98402-4203	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Tower Outback	 	1441 Court A	 	Tacoma	 	WA	 	98402-4203	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Seaview	 	1800 Pacific South	 	Long Beach	 	WA	 	98631-2500	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mill Creek	 	18001 Bothell Everett Highway	 	Bothell	 	WA	 	98012-1661	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Ranier View-WA	 	1822 112th Street East, Suite A	 	Tacoma	 	WA	 	98444	 	Leased	 	No

  
 Sch 4.8-92 

															
	 Total Renal Care, Inc.
	 	Ellensburg	 	2101 West Dollarway Road	 	Ellensburg	 	WA	 	98926-7846	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kent	 	21851 - 84th Avenue So.	 	Kent	 	WA	 	98032-1958	 	Leased	 	No
	 Total Renal Care, Inc.
	 	East Wenatchee	 	295 - 3rd Street Ne	 	East Wenatchee	 	WA	 	98802-3800	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Olympia	 	315 Cooper Point Rd Nw	 	Olympia	 	WA	 	98502-4436	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Olympia	 	315 Cooper Point Rd Nw	 	Olympia	 	WA	 	98502-4436	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Kennewick	 	3208 W 19th Ave	 	Kennewick	 	WA	 	99337-2318	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Star Reg 08 Office	 	3208 W 19th Ave, Suite 102	 	Kennewick	 	WA	 	99337	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mt Adams	 	3220 Picard Place	 	Sunnyside	 	WA	 	98944-8400	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Team Evergreen North	 	32275 32nd Avenue South	 	Federal Way	 	WA	 	98001	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	Whidbey Island	 	32650 State Route 20	 	Oak Harbor	 	WA	 	98277-2641	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lakewood	 	5919 Lakewood Towne Center Blvd Sw #A	 	Lakewood	 	WA	 	98499-6513	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Mid Columbia	 	6825 Burden Blvd, Suite A	 	Pasco	 	WA	 	99301-9584	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Puyallup	 	716 South Hill Park Drive	 	Puyallup	 	WA	 	98373-1445	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Zillah Toppenish	 	823 Zillah West Road	 	Zillah	 	WA	 	98953-9548	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Vancouver	 	9120 NE Vancouver Mall Drive, Suite 160	 	Vancouver	 	WA	 	98662-9401	 	Leased	 	No
	 Total Renal Care, Inc.
	 	North Star Division Office	 	TBD	 	Goldendale	 	WA	 		 	Leased	 	No
	 Amery Dialysis, LLC
	 	Amery	 	970 Elden Ave	 	Amery	 	WI	 	54001-1448	 	Leased	 	No
	 Blake Dialysis, LLC
	 	Milwaukee	 	Midtown Center, 4176 North 56th Street	 	Milwaukee	 	WI	 	53216-1276	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	River Center	 	117 North Jefferson Street	 	Milwaukee	 	WI	 	53202-6160	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Janesville	 	1305 Woodman Road	 	Janesville	 	WI	 	53545-1068	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Brookfield	 	19395 W Capital Drive Building C	 	Brookfield	 	WI	 	53045-2736	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Wisconsin Avenue	 	3801 West Wisconsin Avneue	 	Milwaukee	 	WI	 	53208-3155	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Loomis Road	 	4120 W Loomis Road	 	Greenfield	 	WI	 	53221-2052	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Cedarburg	 	N52 West 6135 Mill Street	 	Cedarburg	 	WI	 	53012-2021	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Steelcraft	 	1023 W State St	 	Hartford	 	WI	 	53027-2726	 	Leased	 	No

  
 Sch 4.8-93 

															
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Green Bay	 	124 Siegler Street	 	Green Bay	 	WI	 	42459	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	DPC Eastbrook	 	12720 West North Ave	 	Brookfield	 	WI	 	53005-4637	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Vail Region 2	 	16800 West Greenfield Avenue	 	Brookfield	 	WI	 	53005-6864	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	DPC Metalcraft-Beaver Dam	 	215 Corporate Drive	 	Beaver Dam	 	WI	 	53916	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc King-Milwaukee	 	2350 North Lake Drive	 	Milwaukee	 	WI	 	53211-4414	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Geiger-Cedarburg	 	2410 S Main St., Suite F	 	West Bend	 	WI	 	53012	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Dr Jody Ritter	 	510 Hartbrook Drive	 	Hartland	 	WI	 	53029-1401	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Giles Waukesha	 	N4 W23370 Bluemound Rd	 	Waukesha	 	WI	 	53186	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc Dr. Washburne	 	N84 W15787 Menomonee Ave	 	Menomonee Falls	 	WI	 	53051	 	Leased	 	No
	 Paladina Health, LLC (fka DaVita DPC Management Company, LLC)
	 	Dpc King-Milwaukee	 	Prohealth Care Professional Building - New Berlin	 	New Berlin	 	WI	 	53211-4414	 	Leased	 	No
	 Renal Life Link, Inc
	 	Titletown	 	120 Siegler Street	 	Green Bay	 	WI	 	54303-2636	 	Leased	 	No
	 Renal Life Link, Inc
	 	Fox River	 	1910 Riverside Drive	 	Green Bay	 	WI	 	54301-2319	 	Leased	 	No
	 Renal Life Link, Inc
	 	Northwoods	 	West 7305 Elm Avenue	 	Shawano	 	WI	 	54166-1024	 	Leased	 	Yes
	 Total Renal Care, Inc.
	 	West Appleton	 	10130 W. Appleton Avenue	 	Milwaukee	 	WI	 	53225-2579	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wisconsin Rapids	 	1041b Hill Street	 	Wisconsin Rapids	 	WI	 	54494-5221	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sturgeon Bay	 	108 S 10th Ave	 	Sturgeon Bay	 	WI	 	54235-1802	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Stevens Point	 	1100 Meridian Drive	 	Plover	 	WI	 	54467-2385	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Meadow Lane	 	1120 Pine Street	 	Standley	 	WI	 	54768-1297	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Willow Creek Dialysis	 	1139 Warwick Way	 	Racine	 	WI	 	53406-5661	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Marshfield	 	123 Northridge St.	 	Marshfield	 	WI	 	54449-8341	 	Leased	 	No

  
 Sch 4.8-94 

															
	 Total Renal Care, Inc.
	 	Rhinelander	 	1306 Lincoln St.	 	Rhinelander	 	WI	 	54501-3664	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Sheboygan	 	1338 North Taylor Drive	 	Sheboygan	 	WI	 	53081-3042	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Green Bay	 	1751 Deckner Ave	 	Green Bay	 	WI	 	54302-2630	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grand Seasons	 	190 Grand Season Dr.	 	Waupaca	 	WI	 	54981-2200	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Fond Du Lac	 	210 Wisconsin American Dr	 	Fond Du Lac	 	WI	 	54937-2999	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Humboldt Ridge	 	2211 N. Humboldt Avenue	 	Milwaukee	 	WI	 	53212-3507	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wausau	 	2600 Stewart Ave.	 	Wausau	 	WI	 	54401-1403	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Marinette	 	2706 Cahill Road	 	Marinette	 	WI	 	54143-3886	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Northern Star	 	311 Elm Street	 	Woodruff	 	WI	 	54568-9190	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake Hallie	 	3636 Melby Street	 	Eau Claire	 	WI	 	54729-8392	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bay Shore	 	5650 N Green Bay Ave	 	Glendale	 	WI	 	53209-4449	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bluemound At Home	 	601 North 99th St	 	Wauwatosa	 	WI	 	53226-4362	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bluemound Pd	 	601 North 99th St	 	Wauwatosa	 	WI	 	53226-4362	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Bluemound	 	601 North 99th Street	 	Wauwatosa	 	WI	 	53226-4362	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Manitowoc	 	601 Reed Ave	 	Manitowoc	 	WI	 	54220-2026	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Prairie River	 	601 South Center Ave.	 	Merrill	 	WI	 	54452-3404	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Lake Geneva	 	650 N. Edwards Blvd.	 	Lake Geneva	 	WI	 	53147-4595	 	Leased	 	No
	 Total Renal Care, Inc.
	 	St Croix Falls	 	744 Louisiana East	 	St. Croix Falls	 	WI	 	54024-9501	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Ridge	 	7740 W. Layton Street	 	Greenfield	 	WI	 	53220-3707	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Harbor View Dialysis	 	816 6th Street	 	Racine	 	WI	 	53403-1176	 	Leased	 	No
	 Total Renal Care, Inc.
	 	South Milwaukee	 	8201 S Howell Ave	 	Oak Creek	 	WI	 	53154-8336	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Oshkosh West	 	855 N Westhaven Dr	 	Oshkosh	 	WI	 	54904-7668	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Wautoma	 	900 East Division Street	 	Wautoma	 	WI	 	54982-6944	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Grand Seasons	 	930 Furman Drive	 	Waupaca	 	WI	 	54981-2200	 	Leased	 	No
	 Beverly Dialysis, LLC
	 	Mountaineer	 	2958 Robert C. Byrd Drive	 	Beckley	 	WV	 	25801-4448	 	Leased	 	No
	 DVA Healthcare Renal Care, Inc.
	 	Greenbrier	 	129 Seneca Trail	 	Lewisburg	 	WV	 	24901-1564	 	Leased	 	No
	 DVA Renal Healthcare, Inc.
	 	Grand Central	 	800 Grand Central Mall	 	Vienna	 	WV	 	26105-4100	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Hillsboro	 	1487 North High St, Unit 1a	 	Hillsboro	 	WV	 	45133-8496	 	Leased	 	No
	 Total Renal Care, Inc.
	 	West Virginia	 	300 Prosperity Lane	 	Logan	 	WV	 	25601-3494	 	Leased	 	No
	 Total Renal Care, Inc.
	 	Point Pleasant	 	4683 Ohio River Road	 	Point Pleasant	 	WV	 	25550-9244	 	Leased	 	Yes

  
 Sch 4.8-95 

															
	 HCP
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 Entity
	 	 Center Name
	 	 Address
	 	 City
	 	 St
	 	 Zip
	 	 Owned/Leased
	 	 Subleased

	 Arizona Integrated Physicians, Inc.
	 	Peoria Administrative Office	 	16155 North 83rd Avenue, Suite 201	 	Peoria	 	AZ	 	85382	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Camelback Administrative Office	 	4745 N. 7th Street, Suite 140	 	Phoenix	 	AZ	 	85014	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Alhambra	 	55 S. Raymond, Suite 200	 	Alhambra	 	CA	 	91801	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Anaheim	 	1236 N. Magnolia	 	Anaheim	 	CA	 	92801	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Arcadia	 	450 E. Huntington Drive	 	Arcadia	 	CA	 	91006	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Administrative Office	 	440 E. Huntington Drive	 	Arcadia	 	CA	 	91006	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Bellflower	 	10132-36 Rosecrans Avenue	 	Bellflower	 	CA	 	90706	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Burbank (Magnolia) 2	 	2211 W. Magnolia, Suite 2211	 	Burbank	 	CA	 	91506	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Carson	 	824 E. Carson Street, Suite 104	 	Carson	 	CA	 	90745	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Chatsworth	 	9301 Oakdale Avenue, Suite 200	 	Chatsworth	 	CA	 	91311	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Compton	 	818 W. Alondra	 	Compton	 	CA	 	90220	 	Leased	 	Yes
	 The Camden Group
	 	Office Use	 	3080 Bristol Street, Suite 150	 	Costa Mesa	 	CA	 	92626	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	1665 Scenic Avenue	 	Costa Mesa	 	CA	 	92626	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Downey	 	8311 E. Florence Avenue	 	Downey	 	CA	 	90240	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	El Monte	 	3144 Santa Anita Avenue	 	El Monte	 	CA	 	91733	 	Leased	 	No
	 The Camden Group
	 	Office Use	 	100 N. Sepulveda, Suite 600	 	El Segundo	 	CA	 	90245	 	Leased	 	No
	 The Camden Group
	 	Storage	 	100 N. Sepulveda, Unit ABL-32	 	El Segundo	 	CA	 	90245	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Fountain Valley	 	9930 Talbert Avenue	 	Fountain Valley	 	CA	 	92708	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Gardena	 	1045 W. Redondo Beach Blvd.	 	Gardena	 	CA	 	90247	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Gardena	 	1141 Redondo Beach Blvd., Suite 311	 	Gardena	 	CA	 	90247	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Glendale/ASMG	 	1808 Verdugo Blvd., Suite 305	 	Glendale	 	CA	 	91208	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Glendale	 	225 West Broadway	 	Glendale	 	CA	 	91204	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Glendora Specialty	 	1377 S. Grand Avenue	 	Glendora	 	CA	 	91740	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Glendora	 	2025 Alosta Avenue	 	Glendora	 	CA	 	91740	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Manhattan Beach	 	5400 Rosecrans Avenue	 	Hawthorne	 	CA	 	90250	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Huntington Beach	 	19066 Magnolia Avenue	 	Huntington Beach	 	CA	 	92646	 	Leased	 	Yes

  
 Sch 4.8-96 

															
	 HealthCare Partners, LLC
	 	Springdale	 	17071 Springdale Street	 	Huntington Beach	 	CA	 	92649	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Talbert Surgical Associates	 	7677 Center Drive, Suite 104	 	Huntington Beach	 	CA	 	92647	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Huntington Park	 	2750 E. Slauson Avenue	 	Huntington Park	 	CA	 	90255	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	3333/3355 Michaelson Drive	 	Irvine	 	CA	 	92612	 	Leased	 	No
	 HealthCare Partners, LLC
	 	La Palma	 	7872 Walker Street, Suite 100	 	La Palma	 	CA	 	90623	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Lakewood	 	3650 E. South Street, Suite 303	 	Lakewood	 	CA	 	90712	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Lakewood	 	5001 Lakewood Blvd.	 	Lakewood	 	CA	 	90712	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	14829 Hawthorne Blvd., Suites 201 & 202	 	Lawndale	 	CA	 	90260	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Willow	 	2600 Redondo Boulevard	 	Long Beach	 	CA	 	90806	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Long Beach	 	2699 Atlantic Avenue	 	Long Beach	 	CA	 	90806	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Long Beach Plaza	 	2921-2923 N. Palo Verde Avenue	 	Long Beach	 	CA	 	90815	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Long Beach Plaza	 	2925-2933 N. Palo Verde Avenue	 	Long Beach	 	CA	 	90815	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Long Beach	 	300 W Ocean Blvd., Suite A	 	Long Beach	 	CA	 	90802	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Long Beach	 	3932 Long Beach Blvd., Unit B	 	Long Beach	 	CA	 	90807	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Long Beach	 	4401 North Atlantic Avenue	 	Long Beach	 	CA	 	90807	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Long Beach Downtown	 	500 Alamitos Avenue	 	Long Beach	 	CA	 	90802	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Long Beach	 	 6226 East Spring Street,
 Suites 100,150
& 175
	 	Long Beach	 	CA	 	90815	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Los Alamitos	 	4281 Katella Avenue, Suite 220	 	Los Alamitos	 	CA	 	90720	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Los Angeles - Crenshaw	 	5141 Crenshaw Blvd.	 	Los Angeles	 	CA	 	90043	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Los Angeles	 	929 W. Olympic Blvd.	 	Los Angeles	 	CA	 	90015	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	1025 W. Olympic Blvd.	 	Los Angeles	 	CA	 	90015	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Administrative Office	 	1109 W. 190th Street, Unit F	 	Gardena	 	CA	 	90248	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Mission Hills	 	11600 Indian Hills Road, Suite 300	 	Mission Hills	 	CA	 	91345	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Monrovia	 	831 East Huntington Drive	 	Monrovia	 	CA	 	91016	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Montebello	 	2301 West Via Campo & FS5	 	Montebello	 	CA	 	91016	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Monterey Park	 	880 S. Atlantic Blvd.	 	Monterey Park	 	CA	 	91754	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Roscoe Tower	 	18350 Roscoe Blvd., Suite 207	 	Northridge	 	CA	 	91325	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Northridge	 	18433 Roscoe Blvd.	 	Northridge	 	CA	 	91325	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Roscoe Tower West	 	18546 Roscoe Blvd., Suites 300 & 307	 	Northridge	 	CA	 	91325	 	Leased	 	No

  
 Sch 4.8-97 

															
	 HealthCare Partners, LLC
	 	Pasadena/ASMG	 	301 S. Fair Oaks, Suite 101	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Pasadena/ASMG	 	301 S. Fair Oaks, Suite 301	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Pasadena - ICC	 	401 S. Fair Oaks	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Pasadena-OB/GYN	 	50 Alessandro Place, Suite 440	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Pasadena - Dermatology	 	50 Bellefontaine Street, Suite 104	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Pasadena Main	 	675 S. Arroyo Pkwy Pasadena	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Glen Oaks	 	988 S. Fair Oaks Avenue	 	Pasadena	 	CA	 	91105	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Sunny Bay Pharmacy	 	502 Torrance Blvd.	 	Redondo Beach	 	CA	 	90277	 	Owned	 	Yes
	 HealthCare Partners, LLC
	 	Redondo Beach	 	601 Torrance Blvd.	 	Redondo Beach	 	CA	 	90277	 	Owned	 	Yes
	 HealthCare Partners, LLC
	 	San Pedro	 	1294 W. 6th Street, Suite 200	 	San Pedro	 	CA	 	90732	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Santa Ana	 	1002 N. Fairview Street	 	Santa Ana	 	CA	 	92703	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Temple City/Las Tunas	 	9810 Las Tunas Drive	 	Temple City	 	CA	 	91780	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Torrance	 	19148 South Van Ness Avenue	 	Torrance	 	CA	 	90504	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Torrance	 	2228 W. Sepulveda Blvd.	 	Torrance	 	CA	 	90501	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Torrance	 	23430 Hawthorne, Suite 100	 	Torrance	 	CA	 	90505	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Torrance	 	23430 Hawthorne, Suite 105	 	Torrance	 	CA	 	90505	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Torrance	 	3242 Sepulveda Blvd.	 	Torrance	 	CA	 	90505	 	Owned	 	No
	 HealthCare Partners, LLC
	 	Torrance	 	3565 Del Amo Blvd. (Specialty Site)	 	Torrance	 	CA	 	90503	 	Leased	 	Yes
	 HealthCare Partners, LLC
	 	Administrative Office	 	19601 Mariner Avenue	 	Torrance	 	CA	 	90503	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	2761 Plaza Del Amo	 	Torrance	 	CA	 	90503	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	22301 S. Western Avenue	 	Torrance	 	CA	 	90501	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	19191 S. Vermont Avenue Suites 200, 350, 565, 750	 	Torrance	 	CA	 	90502	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	2160 W. 190th Street	 	Torrance	 	CA	 	90501	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	2158 W. 190th Street	 	Torrance	 	CA	 	90501	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	2150 W. 190th Street	 	Torrance	 	CA	 	90501	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	19191 S. Vermont Avenue, Suite 540	 	Torrance	 	CA	 	90502	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Administrative Office	 	20280 S. Vermont Avenue	 	Torrance	 	CA	 	90502	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Tujunga	 	6673 Foothill Blvd	 	Tujunga	 	CA	 	91042	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Tustin	 	14591 Newport Avenue, Suite 206	 	Tustin	 	CA	 	97280	 	Leased	 	No

  
 Sch 4.8-98 

															
	 HealthCare Partners, LLC
	 	Santa Clarita/Valencia	 	23501 Cinema Drive	 	Valencia	 	CA	 	91355	 	Leased	 	No
	 HealthCare Partners, LLC
	 	Van Nuys	 	14600 Sherman Way, Suite 300	 	Van Nuys	 	CA	 	91405	 	Leased	 	No
	 HealthCare Partners, LLC
	 	West Hills	 	7301 Medical Center Drive, Suite 500	 	West Hills	 	CA	 	91307	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Orlando Satellite	 	217 N. Westmonte Drive, Suite 1005	 	Altamonte Springs	 	FL	 	32714	 	Leased	 	No
	 JSA Healthcare Corporation
	 	North Westmonte	 	220 N. Westmonte Drive, Suite B	 	Altamonte Springs	 	FL	 	32714	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Apopka Family Medicine	 	201 N. Park Avenue, Suite 200	 	Apopka	 	FL	 	32703	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Riverfront	 	2424 W. Manatee Avenue, Suite 100	 	Bradenton	 	FL	 	34205	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Bradenton	 	5534 Cortez Road West	 	Bradenton	 	FL	 	34210	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Valrico	 	1082 E. Brandon Blvd.	 	Brandon	 	FL	 	33511	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Brandon	 	1933 W. Lumsden Road	 	Brandon	 	FL	 	33511	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Brandon Pharmacy	 	1933 W. Lumsden Road	 	Brandon	 	FL	 	33511	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Woodlands	 	2326 S. Parsons Avenue	 	Brandon	 	FL	 	33510	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Bloomingdale	 	406 W. Bloomingdale Avenue	 	Brandon	 	FL	 	33511	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Oak Park	 	427 South Parsons Avenue, Suite 118	 	Brandon	 	FL	 	33511	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Parsons	 	908 South Parsons Avenue, Suite A	 	Brandon	 	FL	 	33511	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Lamar Avenue	 	605 Lamar Avenue	 	Brooksville	 	FL	 	34601	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Fort Harrison	 	1100 S. Fort Harrison	 	Clearwater	 	FL	 	33756	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Ponce Deleon	 	1180 Ponce De Leon Blvd., Suite 401	 	Clearwater	 	FL	 	33756	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Gulf to Bay	 	1660 Gulf to Bay Blvd., Suite 137	 	Clearwater	 	FL	 	33755	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Clearwater	 	2465 McMullen Booth Road	 	Clearwater	 	FL	 	33759	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Clermont/South Lakes	 	1920 Don Wickham Drive, Suite 300	 	Clermont	 	FL	 	34711	 	Leased	 	No
	 Healthcare Partners of South Florida
	 	Administrative Office	 	1401 N. University Drive, Suite 401	 	Coral Springs	 	FL	 	33071	 	Leased	 	No
	 Healthcare Partners of South Florida
	 	Rosalyn J. Norensbureg	 	8327 W. Atlantic Blvd.	 	Coral Springs	 	FL	 	33071	 	Leased	 	Yes
	 Healthcare Partners of South Florida
	 	Dr. Jablon	 	8328 W. Atlantic Blvd.	 	Coral Springs	 	FL	 	33071	 	Leased	 	Yes
	 Healthcare Partners of South Florida
	 	Coral Springs	 	9750 NW 33rd St, Suite 212	 	Coral Springs	 	FL	 	33065	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Dunedin	 	1460 Beltress Street, Suite 1	 	Dunedin	 	FL	 	34698	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Virginia St	 	646 Virginia Street, Suite 427	 	Dunedin	 	FL	 	34698	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	1102 S. Ft Harrison Avenue	 	Fort Harrison	 	FL	 	33756	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Holiday	 	3314 US Highway 19	 	Holiday	 	FL	 	34691	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Lake Mary Family Medicine	 	109 Timberlachen Circle	 	Lake Mary	 	FL	 	32746	 	Leased	 	No

  
 Sch 4.8-99 

															
	 JSA Healthcare Corporation
	 	Largo Pharmacy	 	11920 Seminole Blvd	 	Largo	 	FL	 	33788	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Largo	 	1345 W. Bay Drive, Suite 202	 	Largo	 	FL	 	33770	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Bryan Dairy	 	8839 Bryan Dairy Road, Suite 115	 	Largo	 	Fl	 	33777	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Associated Family Medicine Sabal Palm	 	320 Sabal Palm Suite 200	 	Longwood	 	FL	 	32779	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	320 Sabal Palm Suite 300	 	Longwood	 	FL	 	32779	 	Leased	 	No
	 JSA Healthcare Corporation
	 	South Seminole Family Medicine	 	515 W. State Road 434, Suite 110	 	Longwood	 	FL	 	32750	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Lutz	 	23532 State Road 54	 	Lutz	 	FL	 	33559	 	Leased	 	No
	 Healthcare Partners of South Florida
	 	Margate	 	2825 North State Road 7, Suite 204	 	Margate	 	FL	 	33063	 	Leased	 	No
	 JSA Healthcare Corporation
	 	New Port Richey Rx	 	4757 US 19	 	New Port Richey	 	FL	 	34652	 	Leased	 	No
	 JSA Healthcare Corporation
	 	New Port Richey	 	4759 US 19	 	New Port Richey	 	FL	 	34652	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Hunter’s Creek	 	2000 Cypress Crossing, Suite A	 	Orlando	 	FL	 	32837	 	Leased	 	No
	 JSA Healthcare Corporation
	 	West Colonial	 	7240 W. Colonial Drive	 	Orlando	 	FL	 	32818	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Lucerne	 	810 Lucerne Terrace	 	Orlando	 	FL	 	32801	 	Owned	 	No
	 JSA Healthcare Corporation
	 	Park Place	 	882 S. Kirkman Road	 	Orlando	 	FL	 	32811	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Palm Harbor	 	2122 Alternate 19, Suite B	 	Palm Harbor	 	FL	 	34683	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Palmetto	 	931 Tenth Street East	 	Palmetto	 	FL	 	34221	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Parrish	 	8342 US Hwy 301 North	 	Parrish	 	FL	 	34219	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Mainlands	 	9165 US Hwy 19 North	 	Pinellas Park	 	FL	 	33782	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Plant City	 	1001 E. Baker Street, Suite 400	 	Plant City	 	FL	 	33563	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Port Richey	 	10435 US Hwy 19	 	Port Richey	 	FL	 	34668	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Saint Cloud	 	2301 13th Street	 	Saint Cloud	 	FL	 	34769	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Northside Family Practice	 	1718 Lexington Green Lane	 	Sanford	 	FL	 	32771	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Sanford	 	920 Lexington Green Lane	 	Sanford	 	FL	 	32771	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Seffner (M.L. King)	 	770 Dr. MLK Jr. Blvd.	 	Seffner	 	FL	 	33584	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	10051 5th Street North, Suite 200	 	St. Petersburg	 	FL	 	33702	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Skyway	 	1100 62nd Avenue South	 	St. Petersburg	 	FL	 	33705	 	Leased	 	No
	 JSA Healthcare Corporation
	 	49th Street	 	2150 49th Street North, Suite A	 	St. Petersburg	 	FL	 	33710	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Bayway	 	2816 54th Avenue South	 	St. Petersburg	 	FL	 	33712	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Marina Village	 	4901 34th Street South	 	St. Petersburg	 	FL	 	33771	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Pasadena	 	508 Pasadena Avenue South	 	St. Petersburg	 	FL	 	33707	 	Leased	 	No

  
 Sch 4.8-100 

															
	 JSA Healthcare Corporation
	 	Point Brittany	 	5101 Brittany Drive South	 	St. Petersburg	 	FL	 	33715	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Tyrone Gardens	 	5838 9th Avenue North	 	St. Petersburg	 	FL	 	33710	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Gateway Pcc	 	710 94th Avenue North	 	St. Petersburg	 	FL	 	33702	 	Leased	 	No
	 JSA Healthcare Corporation
	 	9th Street Pharmacy	 	7601 Dr. MLK Jr. Street North, Suite C	 	St. Petersburg	 	FL	 	33702	 	Leased	 	No
	 JSA Healthcare Corporation
	 	9th Street	 	7601 Dr. MLK Jr. Street North, Suite E	 	St. Petersburg	 	FL	 	33702	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Tyrone	 	7655 38th Avenue North, Suite 101	 	St. Petersburg	 	FL	 	33710	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Pinellas Park	 	7800 66th Street North, Suite 101	 	St. Petersburg	 	FL	 	33781	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Northeast	 	8950 Dr. MLK Jr. Street North	 	St. Petersburg	 	FL	 	33702	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Cypress Creek	 	781 Cypress Village Blvd.	 	Sun City	 	FL	 	33573	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Sun City	 	787 Cortaro Drive	 	Sun City	 	FL	 	33573	 	Leased	 	No
	 JSA Healthcare Corporation
	 	North Tampa	 	14451 University Cove Place	 	Tampa	 	FL	 	33613	 	Leased	 	No
	 JSA Healthcare Corporation
	 	City Ctr - Retail Pharmacy	 	2727 W. Dr. MLK Jr. Blvd., Ste 100	 	Tampa	 	FL	 	33607	 	Leased	 	No
	 JSA Healthcare Corporation
	 	City Center	 	2727 W. Dr. MLK Jr. Blvd., Ste 850	 	Tampa	 	FL	 	33607	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Hyde Park	 	2835 W. De Leon Street, Suite 203	 	Tampa	 	FL	 	33609	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Quimbayo	 	3201 W. Waters Avenue, Suite A	 	Tampa	 	FL	 	33614	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Fountain Oaks	 	3663 W. Waters Avenue	 	Tampa	 	FL	 	33614	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Palma Ceia	 	3838 Neptune Avenue, Suite D5	 	Tampa	 	FL	 	33629	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Sheldon	 	5537 Sheldon Road, Suite K	 	Tampa	 	FL	 	33615	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Silver Lakes	 	7524 N. Himes Avenue	 	Tampa	 	FL	 	33614	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Hanley Road	 	8316 Hanley Road, Suite 1	 	Tampa	 	FL	 	33634	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Tarpon South	 	1200 S. Pinellas Avenue, Suite 11	 	Tarpon Springs	 	FL	 	34689	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Tarpon Springs	 	713 S. Pinellas Avenue, Suite A-1	 	Tarpon Springs	 	FL	 	34689	 	Leased	 	No
	 JSA Healthcare Corporation
	 	South Dillard	 	1002 S. Dillard Street, Suite 122	 	Winter Garden	 	FL	 	34787	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Tuskawilla Family Medicine	 	1301 Sundial Point	 	Winter Springs	 	FL	 	32708	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Zephyrhills	 	5528 Gall Blvd	 	Zephyrhills	 	FL	 	33542	 	Leased	 	No
	 Healthcare Partners of Georgia
	 	West End	 	1188 Ralph David Abernathy Blvd.	 	Atlanta	 	GA	 	30310	 	Leased	 	No
	 Healthcare Partners of Georgia
	 	Boulevard	 	315 Boulevard NE	 	Atlanta	 	GA	 	30312	 	Leased	 	No
	 The Camden Group
	 	Office Use	 	155 N. Wacker Drive, Suite 3660	 	Chicago	 	IL	 	60606	 	Leased	 	No
	 The Camden Group
	 	Office Use	 	155 Federal Street	 	Boston	 	MA	 	02110	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Tramway Clinic	 	13071 Encantado NE	 	Albuquerque	 	NM	 	87123	 	Owned	 	Yes

  
 Sch 4.8-101 

															
	 ABQ Health Partners, LLC
	 	Juan Tabo North Clinic	 	2121 Juan Tabo NE	 	Albuquerque	 	NM	 	87112	 	Owned	 	Yes
	 ABQ Health Partners, LLC
	 	Carlisle Clinic	 	3901 Carlisle NE	 	Albuquerque	 	NM	 	87107	 	Owned	 	Yes
	 ABQ Health Partners, LLC
	 	Quest Diagnostics Incorporated	 	5150 Journal Center Blvd.	 	Albuquerque	 	NM	 	87109	 	Owned	 	Yes
	 ABQ Health Partners, LLC
	 	Journal Center Clinic, Urgent Care	 	5150 Journal Center Blvd.	 	Albuquerque	 	NM	 	87109	 	Owned	 	Yes
	 ABQ Health Partners, LLC
	 	Administrative Office	 	5400 Gibson Blvd. SE	 	Albuquerque	 	NM	 	87108	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Family Practice/Ortho/Podiatry Clinics	 	10511 Golf Course Rd NW, Suite #103	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	ENT/Audiology Clinic	 	10511 Golf Course Rd NW, Suite #105	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Urology Clinic	 	10511 Golf Course Rd NW, Suite #201	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Pain Clinic	 	10511 Golf Course Rd NW, Suite #202	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	General Surgery	 	10511 Golf Course Rd NW, Suite #203	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	OB/GYN	 	10511 Golf Course Rd NW, Suite #204	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Rio Rancho Family, Pediatrics & Urgent Care	 	1721 Rio Rancho Blvd.	 	Albuquerque	 	NM	 	87124	 	Leased	 	Yes
	 ABQ Health Partners, LLC
	 	Juan Tabo South Family Clinic	 	1901 Juan Tabo NE	 	Albuquerque	 	NM	 	87112	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Rio Bravo Clinic	 	200 Rio Bravo SE	 	Albuquerque	 	NM	 	87105	 	Leased	 	Yes
	 ABQ Health Partners, LLC
	 	OB/GYN	 	4010 Montgomery NE	 	Albuquerque	 	NM	 	87109	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Sleep Center	 	4700 Jefferson St NE	 	Albuquerque	 	NM	 	87109	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Westside Cardiology & Pulmonary	 	4801 McMahon	 	Albuquerque	 	NM	 	87114	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Pain Clinic	 	5310 Homestead Rd NE, Suite 201	 	Albuquerque	 	NM	 	87110	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Montgomery Family Clinic & Urgent Care	 	9101 Montgomery Blvd. NE	 	Albuquerque	 	NM	 	87111	 	Leased	 	Yes
	 ABQ Health Partners, LLC
	 	Pulmonary	 	Downtown - 500 Walter, 2nd Floor	 	Albuquerque	 	NM	 	87102	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Clinical Thrombosis	 	Downtown - 500 Walter, 3rd Floor	 	Albuquerque	 	NM	 	87102	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Cardiology	 	Downtown - 500 Walter, 4th Floor	 	Albuquerque	 	NM	 	87102	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	General Surgery & Vascular	 	 Downtown - 715 Martin Luther King,
 3rd
Flr
	 	Albuquerque	 	NM	 	87102	 	Leased	 	No
	 ABQ Health Partners, LLC
	 	Westside Clinic	 	 Executive West Building,
 2929 Coors Blvd.
NW
	 	Albuquerque	 	NM	 	87120	 	Leased	 	No
	 HealthCare Partners Nevada, LLC
	 		 	595 W. Lake Mead Pkwy	 	Henderson	 	NV	 	89015	 	Owned	 	No
	 HealthCare Partners Nevada, LLC
	 	SMG-Corp; N Rainbow	 	1000 S. Rainbow Blvd.	 	Las Vegas	 	NV	 	89145	 	Owned	 	No

  
 Sch 4.8-102 

															
	 JSA Healthcare Corporation
	 	Administrative Office	 	700 E. Warm Springs, Suite110	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	770 E. Warm Springs, Suite 260	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	770 E. Warm Springs, Suite 240	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	700 E. Warm Springs, Suite 280	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	650 White Drive, Suite 280	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Administrative Office	 	2951 Marion Drive	 	Las Vegas	 	NV	 	89115	 	Leased	 	No
	 HealthCare Partners Nevada, LLC
	 	IT Server Storage	 	7185 Pollock Drive	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 HealthCare Partners Nevada, LLC
	 	Parkway-Clinic	 	100 N. Green Valley Pkwy, Suite 240	 	Henderson	 	NV	 	89074	 	Leased	 	No
	 HealthCare Partners Nevada, LLC
	 	Cardiology - Summerlin-Clinic	 	10105 Banburry Cross Drive, Suite 250	 	Las Vegas	 	NV	 	89144	 	Leased	 	No
	 RMCC Cancer Center
	 	HWY 160-Clinic	 	1151 S. Hwy 160	 	Boulder City	 	NV	 	89005	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	W Calvada; Diagnostics	 	1279 Calvada (Trailer)	 	Pahrump	 	NV	 	89048	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	W Calvada; Diagnostics	 	1280 Calvada	 	Pahrump	 	NV	 	89048	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Henderson-Clinic	 	129 W. Lake Mead, Suite 10	 	Henderson	 	NV	 	89015	 	Leased	 	No
	 HealthCare Partners Nevada, LLC
	 	NV Hwy-Clinic	 	1297 Nevada Highway, Suite A	 	Las Vegas	 	NV	 	89005	 	Leased	 	Yes
	 JSA Healthcare Corporation
	 	Golden Triange-Clinic	 	1302 W. Craig Road	 	Las Vegas	 	NV	 	89032	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Galleria-Clinic	 	1397 Galleria Drive	 	Henderson	 	NV	 	89014	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Redrock Peds	 	1430 E. Calvada, Suite 200	 	Henderson	 	NV	 	89074	 	Leased	 	No
	 Medical Systems Management, a Nevada Professional Corp./JSAHC (Sublease)
	 	E Calvada-Clinic	 	1501 E. Calvada	 	Pahrump	 	NV	 	89048	 	Leased	 	Yes
	 Fremont Primary Care Limited Partnership
	 	Wigwam-Clinic	 	1505 Wigwam Pkwy, Suite 230	 	Henderson	 	NV	 	89074	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Buffalo-Clinic	 	1700 N. Buffalo Drive	 	Las Vegas	 	NV	 	89128	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Summerlin-Clinic	 	2035 Village Center Circle, Suite 111	 	Las Vegas	 	NV	 	89134	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Virgin Valley	 	210 N. Sandhill	 	Mesquite	 	NV	 	89027	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Civic Center-Clinic	 	2225 Civic Center Drive	 	N. Las Vegas	 	NV	 	89030	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	UC;Endo;Derma 1/3	 	2285 E. Flamingo Road, Suite 105	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Pecos-Clinic	 	283 N. Pecos Road	 	Henderson	 	NV	 	89074	 	Leased	 	No
	 JSA Professional Association
	 	Siena-Clinic	 	2825 Siena Heights Drive	 	Henderson	 	NV	 	89052	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Tenaya-Clinic	 	2851 Business Park Court, Suite 100	 	Las Vegas	 	NV	 	89128	 	Leased	 	No
	 Fremont Primary Care Limited Partnership
	 	Oncology - Tenaya	 	2851 N. Tenaya, Suite 101	 	Las Vegas	 	NV	 	89128	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Cardiology - Green Valley; Corp/Clinic	 	2865 Siena Heights, Suite 331	 	Henderson	 	NV	 	89052	 	Leased	 	No

  
 Sch 4.8-103 

															
	 Fremont Primary Care Limited Partnership
	 	Oncology - Maryland	 	3006 South Maryland	 	Las Vegas	 	NV	 	89109	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Cardiology - La Canada-Clinic	 	3131 La Canada, Suite 200	 	Las Vegas	 	NV	 	89169	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Tenaya Peds-Clinic	 	3150 N. Tenaya, Suite 260	 	Las Vegas	 	NV	 	89128	 	Leased	 	No
	 Fremont Primary Care Limited Partnership
	 	Sunrise-Clinic	 	3201 S. Maryland Pkwy	 	Las Vegas	 	NV	 	89109	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Desert View	 	330 South Lola Lane	 	Pahrump	 	NV	 	89048	 	Leased	 	No
	 Fremont Primary Care Limited Partnership
	 	W Craig	 	3960 W. Craig Road, Suite 101	 	N. Las Vegas	 	NV	 	89032	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Valley-Clinic	 	400 Shadow Lane, Suite 207	 	Las Vegas	 	NV	 	89106	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Flamingo	 	4275 S. Burnham, Suite 105	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Burnham-Clinic	 	4275 S. Burnham, Suite 255	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Cardiology Burnham	 	4275 S. Burnham, Suite 335	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Central Valley-Clinic	 	4275 S. Burnham, Suite 365	 	Las Vegas	 	NV	 	89119	 	Leased	 	No
	 Fremont Primary Care Limited Partnership
	 	Oncology - Centennial	 	4722 N. 24th, Suite 400	 	Las Vegas	 	NV	 	89149	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Wynn-Clinic	 	4880 S. Wynn Road	 	Las Vegas	 	NV	 	89103	 	Leased	 	Yes
	 HealthCare Partners of Nevada
	 	Lone Mountain-Clinic	 	4920 Lone Mountain	 	Las Vegas	 	NV	 	89130	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Spring Valley-Clinic	 	5320 S. Rainbow, Suite 101	 	Las Vegas	 	NV	 	89118	 	Leased	 	No
	 Solari Hospice Care, LLC/HealthCare Partners Nevada, LLC
	 	Solari Hospice	 	5530 South Jones Blvd.	 	Las Vegas	 	NV	 	89118	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Durango-Clinic	 	5575 S. Durango	 	Las Vegas	 	NV	 	89148	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Medical Group - Corp; WR-Clinic/Admin	 	600 N. Whitney Ranch, Suits B6, B9	 	Henderson	 	NV	 	89014	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Centennial Hills-Clinic	 	6850 N. Durango Drive, Suite 208	 	Las Vegas	 	NV	 	89149	 	Leased	 	No
	 HealthCare Partners of Nevada (Sublesee)
	 	Cardiology - Centennial Hills-Clinic	 	6850 N. Durango Drive, Suite 211	 	Las Vegas	 	NV	 	89149	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Nellis-Clinic	 	821 N. Nellis	 	Las Vegas	 	NV	 	89110	 	Leased	 	No
	 Fremont Primary Care Limited Partnership
	 	Oncology - San Martin	 	8285 W. Arby, Suite 100	 	Las Vegas	 	NV	 	89113	 	Leased	 	No
	 JSA Healthcare Corporation
	 	Green Valley-Clinic	 	9077 S. Pecos Road, Suite 4500	 	Las Vegas	 	NV	 	89074	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Cardiology-Clinic	 	9280 W. Sunset Road, Suite 320	 	Las Vegas	 	NV	 	89148	 	Leased	 	No
	 HealthCare Partners of Nevada
	 	Southern Hills-Clinic	 	9280 W. Sunset Road, Suite 420	 	Las Vegas	 	NV	 	89148	 	Leased	 	No
	 Fremont Primary Care Limited Partnership
	 	W Charleston-Clinic	 	9499 W. Charleston Blvd., Suite 150	 	Las Vegas	 	NV	 	89117	 	Leased	 	No
	 The Camden Group
	 	Office Use	 	1882 S. Winton Road, Suite 8	 	Rochester	 	NY	 	14618	 	Leased	 	No

  
 Sch 4.8-104 

 Schedule 7.1(c) 

Existing Liens 
  

											
	 Debtor
	 	 Jurisdiction
	 	 Secured Party
	 	 Original File

Date
	 	 Original File

Number
	 	 Collateral
Description

	 ABQ Health Partners, LLC
	 	Delaware	 	Creekridge Capital LLC	 	11/8/2007 and continued on 09/12/2012	 	20074265491	 	Leased Equipment
	 ABQ Health Partners, LLC
	 	Delaware	 	De Lage Landen Financial Services, Inc.	 	9/24/2008 and continued on 09/04/2013	 	20083236385	 	Specific Equipment.
	 ABQ Health Partners, LLC
	 	Delaware	 	KONICA MINOLTA BUSINESS SOLUTIONS USA INC	 	9/21/2012	 	20123645704	 	Leased Equipment
	 ABQ Health Partners, LLC
	 	Bernalillo County, New Mexico	 	Audrey Neuson-Medina, Plaintiff	 	1/21/2009	 	D-202-CV-2009-00546	 	Civil Law Suit
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	North American Communications Resource, Inc.	 	10/23/2013	 	2013 4151305	 	Leased Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	North American Communications Resource, Inc.	 	10/23/2013	 	2013 4151495	 	Leased Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	Lease Corporation of America	 	3/3/2014	 	2014 0802249	 	Leased Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	Apple Financial Services	 	5/8/2014	 	2014 1811777	 	Leased Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	U.S. Bank Equipment Finance	 	5/15/2014	 	2014 1933209	 	Specific Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	U.S. Bank Equipment Finance	 	5/15/2014	 	2014 1933233	 	Specific Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	Apple Financial Services	 	5/28/2014	 	2014 2070522	 	Leased Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	U.S. Bank Equipment Finance	 	5/30/2014	 	2014 2121788	 	Specific Equipment
	 DaVita HealthCare Partners Inc.
	 	Delaware	 	Apple Financial Services	 	3/3/2014	 	2014 2142206	 	Leased Equipment

											
	 DNH MEDICAL MANAGEMENT, INC.
	 	California	 	Webbank	 	7/9/2012	 	12-7320028267	 	Leased Equipment
	 DVA Healthcare Renal Care, Inc.
	 	Nevada	 	U.S. Bancorp	 	12/30/2011	 	2011035141-4	 	Specific Equipment
	 DVA Healthcare Renal Care, Inc.
	 	Nevada	 	U.S. Bancorp	 	2/15/2012	 	2012004204-3	 	Specific Equipment
	 DVA Renal Healthcare, Inc.
	 	Tennessee	 	Macquarie Equipment Finance, LLC	 	03/28/2008 and continued on 02/27/2013	 	208-015426	 	Leased Equipment
	 DVA Renal Healthcare, Inc.
	 	Tennessee	 	US Bancorp	 	10/8/2010	 	310-059773	 	Specific Equipment
	 DVA Laboratory Services, Inc.
	 	Florida	 	Siemens Healthcare Diagnostics Inc.	 	3/22/2010	 	201002208422	 	Specific Equipment
	 HealthCare Partners Nevada, LLC and Frank Toppo MD Inc.
	 	Nevada	 	Baycap, LLC	 	2/5/2010)	 	2010003258-1	 	Specific Equipment.
	 HealthCare Partners Nevada, LLC
	 	Nevada	 	Les Olson Company	 	8/7/2012	 	2012021267-6	 	Specific Equipment.
	 HealthCare Partners Nevada, LLC
	 	Nevada	 	Cardinal Health	 	5/29/2013	 	2013013696-7	 	Equipment finance and lien
	 HealthCare Partners, LLC
	 	California	 	Amerisourcebergen Drug Corporation	 	2/25/2011	 	11-7261836388	 	Equipment finance and lien
	 JSA HealthCare Corporation
	 	Delaware	 	ASD Speciality Healthcare Inc.	 	10/16/2013	 	2013 4061298	 	Equipment finance and lien
	 Physicians Management, LLC
	 	Delaware	 	Var Resources, Inc.	 	11/2/2009	 	2009 3155076	 	Leased Equipment
	 Renal Treatment Centers – Southeast LP
	 	Delaware	 	Macquarie Equipment Finance, LLC	 	03/27/2008 and continued on 03/26/2013	 	2008 1075983	 	Leased Equipment
	 RMS Lifeline, Inc.
	 	Delaware	 	Summit Funding Group, Inc.	 	3/20/2014	 	2014 1221720	 	Leased Equipment
	 Total Renal Care, Inc.
	 	California	 	Macquarie Equipment Finance, LLC	 	03/27/2008 and continued on 02/26/2013	 	08-7152082265	 	Leased Equipment
	 Total Renal Laboratories, Inc.
	 	Florida	 	Leaf Funding, Inc.	 	09/24/2004 and continued on 03/31/2009	 	200407942562	 	Specific Equipment
	 Total Renal Laboratories, Inc.
	 	Florida	 	Siemens Healthcare Diagnostics Inc.	 	6/18/2013	 	201308280619	 	Specific Equipment

  
 Sch 7.1(c)-2 

											
	 DaVita-3SBio Healthcare Management (Liaoning) Co., Ltd.
	 	China	 	Liaoning Sunshine Science and Technology Co,.Ltd	 	2/9/14	 		 	Note
	 Basin Dialysis, LLC
	 	Ohio	 	Blackhawk Bank	 	8/2013	 		 	Note
	 Clover Dialysis, LLC
	 	California	 	City National Bank	 	7/2014	 		 	Note
	 Cowell Dialysis, LLC
	 	Illinois	 	Blackhawk Bank	 	2/2013	 		 	Note
	 Damon Dialysis, LLC
	 	Indiana	 	Blackhawk Bank	 	8/2011	 		 	Note
	 DaVita Lehbi Cayman
	 	Cayman Islands	 	Dr. Ali Mohammed Hamdan Allehbi	 	3/19/13	 		 	Note
	 Dialysis of Northern Illinois, LLC
	 	Illinois	 	Blackhawk Bank	 	6/2011	 		 	Note
	 Dolores Dialysis, LLC
	 	California	 	Well Fargo Equipment Finance	 	1/2012	 		 	Note
	 DSI Plainfield, LLC
	 	Indiana	 	National Bank of Inianapolis	 	1/2011	 		 	Note
	 East Ft Lauderdale, LLC
	 	Florida	 	City National Bank	 	5/2013	 		 	Note
	 Four Corners Dialysis Clinics
	 	New Mexico	 	Four Corners Community Bank	 	10/2011	 		 	Note
	 Geyser Dialysis, LLC
	 	Iowa	 	City National Bank	 	6/2013	 		 	Note
	 Golden Dialysis, LLC
	 	Texas	 	City National Bank	 	8/2013	 		 	Note
	 Goldendale Dialysis, LLC
	 	Georgia	 	City National Bank	 	8/2013	 		 	Note
	 Great Dialysis, LLC
	 	Texas	 	JPMorgan	 	7.2011	 		 	Note
	 Greater Las Vegas Dialysis, LLC
	 	Nevada	 	City National Bank	 	12/2012	 		 	Note
	 Honeyman Dialysis, LLC
	 	Iowa	 	Blackhawk Bank	 	12/2013	 		 	Note
	 DSI Spring Valley, LLC (was ISD)
	 	Nevada	 	City National Bank	 	4/2013	 		 	Note
	 Lathrop Dialysis, LLC
	 	Texas	 	City National Bank	 	5/2013	 		 	Note
	 Leaseburg Dialysis, LLC
	 	Missouri	 	Blackhawk Bank	 	12/2011	 		 	Note
	 Lincolnton Dialysis, LLC
	 	Minnesota	 	City National Bank	 	4/2014	 		 	Note
	 Loup Dialysis, LLC
	 	Missouri	 	Parkside Dinancial Bank & Trust	 	4/2012	 		 	Note
	 Okanogan Dialysis, LLC
	 	Florida	 	City National Bank	 	5/2013	 		 	Note
	 Palmetto Dialysis, LLC
	 	Missouri	 	Parkside Dinancial Bank & Trust	 	4/2012	 		 	Note
	 Patoka Dialysis, LLC
	 	Florida	 	Blackhawk Bank	 	4/2013	 		 	Note
	 Pearl Dialysis, LLC
	 	Minnesota	 	City National Bank	 	12/2013	 		 	Note
	 Pittsburgh Dialysis, LLC
	 	Pennsylvania	 	Colorado Business Bank DTC	 	12/2012	 		 	Note
	 Priday Dialysis, LLC
	 	California	 	City National Bank	 	5/2013	 		 	Note
	 Redcliff Dialysis, LLC
	 	New Jersey	 	City National Bank	 	12/2013	 		 	Note
	 Rio Dialysis, LLC
	 	Minnesota	 	Blackhawk Bank	 	10/2011	 		 	Note
	 Russel Dialysis, LLC
	 	Texas	 	City National Bank	 	5/2012	 		 	Note
	 Sands Dialysis, LLC
	 	Florida	 	Blackhawk Bank	 	2/2012	 		 	Note
	 Sapelo Dialysis, LLC
	 	California	 	City National Bank	 	5/2014	 		 	Note
	 Dr. Ali Lehbi Medical Center (aka Ali Mohammed Al Lehbi Medical Center Company)
	 	Saudi Arabia	 	Saudi Credit & Savings Bank	 	5/14/08	 		 	Note

  
 Sch 7.1(c)-3 

											
	 Shone Dialysis, LLC
	 	Georgia	 	Well Fargo Equipment Finance	 	5/2014	 		 	Note
	 Townsend
	 	Florida	 	City National Bank	 	12/2013	 		 	Note
	 Tugman Dialysis, LLC
	 	Missouri	 	Parkside Dinancial Bank & Trust	 	4/2012	 		 	Note
	 Tumalo Dialysis, LLC
	 	Texas	 	Bank of Texas	 	9/2011	 		 	Note
	 Victory Dialysis, LLC
	 	Maryland	 	Colorado Business Bank DTC	 	4/2011	 		 	Note
	 Villanueva Dialysis, LLC
	 	California	 	City National Bank	 	2/2013	 		 	Note
	 Walker Dialysis, LLC
	 	California	 	Umpqua Bank	 	6/2011	 		 	Note

 Liens with respect to operating leases and equipment financings incurred by each of the Subsidiaries. 

  
 Sch 7.1(c)-4 

 Schedule 7.2(b) 

Existing Debt as of 5/31/141 

 

									
	 Bank / Institution
	  	 Entity
	  	 Type
	  	 Amount
	 
	 Colorado Business Bank DTC
	  	Victory Dialysis, LLC	  	Note	  	$	963,026	  
	 Well Fargo Equipment Finance
	  	Dolores Dialysis, LLC	  	Note	  	$	1,457,106	  
	 Well Fargo Equipment Finance
	  	Shone Dialysis, LLC	  	Note	  	$	1,380,000	  
	 Umpqua Bank
	  	Walker Dialysis, LLC	  	Note	  	$	4,147,665	  
	 JPMorgan
	  	Great Dialysis, LLC	  	Note	  	$	1,180,000	  
	 Four Corners Community Bank
	  	Four Corners Dialysis Clinics	  	Note	  	$	423,061	  
	 National Bank of Indianapolis
	  	DSI Plainfield, LLC	  	Note	  	$	60,000	  
	 Parkside Financial Bank & Trust
	  	Palmetto Dialysis, LLC	  	Note	  	$	640,316	  
	 Parkside Financial Bank & Trust
	  	Loup Dialysis, LLC	  	Note	  	$	1,219,140	  
	 Parkside Financial Bank & Trust
	  	Tugman Dialysis, LLC	  	Note	  	$	859,864	  
	 Bank of Texas
	  	Tumalo Dialysis, LLC	  	Note	  	$	273,226	  
	 Blackhawk Bank
	  	Dialysis of Northern Illinois, LLC	  	Note	  	$	233,081	  
	 Blackhawk Bank
	  	Honeyman Dialysis, LLC	  	Note	  	$	1,936,392	  
	 Blackhawk Bank
	  	Leaseburg Dialysis, LLC	  	Note	  	$	2,019,882	  
	 Blackhawk Bank
	  	Rio Dialysis, LLC	  	Note	  	$	494,129	  
	 Blackhawk Bank
	  	Sands Dialysis, LLC	  	Note	  	$	1,208,967	  
	 Blackhawk Bank
	  	Damon Dialysis, LLC	  	Note	  	$	933,682	  
	 Blackhawk Bank
	  	Cowell Dialysis, LLC	  	Note	  	$	1,014,777	  
	 Blackhawk Bank
	  	Basin Dialysis, LLC	  	Note	  	$	400,000	  
	 Blackhawk Bank
	  	Patoka Dialysis, LLC	  	Note	  	$	714,000	  

  

	1 	Certain of the below are associated with operating leases for the equipment. 

									
	 Bank / Institution
	  	 Entity
	  	 Type
	  	 Amount
	 
	 Colorado Business Bank DTC
	  	Pittsburgh Dialysis, LLC	  	Note	  	$	12,750,000	  
	 City National Bank
	  	Russel Dialysis, LLC	  	Note	  	$	1,397,464	  
	 City National Bank
	  	Greater Las Vegas Dialysis, LLC	  	Note	  	$	1,305,644	  
	 City National Bank
	  	Villanueva Dialysis, LLC	  	Note	  	$	1,666,115	  
	 City National Bank
	  	Okanogan Dialysis, LLC	  	Note	  	$	1,150,000	  
	 City National Bank
	  	ISD Spring Valley, LLC	  	Note	  	$	386,667	  
	 City National Bank
	  	East Ft Lauderdale, LLC	  	Note	  	$	239,999	  
	 City National Bank
	  	Lathrop Dialysis, LLC	  	Note	  	$	1,295,000	  
	 City National Bank
	  	Priday Dialysis, LLC	  	Note	  	$	500,000	  
	 City National Bank
	  	Geyser Dialysis, LLC	  	Note	  	$	1,600,000	  
	 City National Bank
	  	Goldendale Dialysis, LLC	  	Note	  	$	797,000	  
	 City National Bank
	  	Golden Dialysis, LLC	  	Note	  	$	1,100,000	  
	 City National Bank
	  	Pearl Dialysis, LLC	  	Note	  	$	1,600,000	  
	 City National Bank
	  	Townsend	  	Note	  	$	538,000	  
	 City National Bank
	  	Clover Dialysis, LLC	  	Note	  	$	800,000	  
	 City National Bank
	  	Redcliff Dialysis, LLC	  	Note	  	$	952,133	  
	 City National Bank
	  	Lincolnton Dialysis, LLC	  	Note	  	$	1,100,000	  
	 City National Bank
	  	Sapelo Dialysis, LLC	  	Note	  	$	1,900,000	  
	 Dr. Ali Mohammed Hamdan Allehbi
	  	DaVita Lehbi Cayman	  	Note	  	$	439,466	  
	 Liaoning Sunshine Sscience and Technology Co,.Ltd
	  	DaVita-3SBio Healthcare Management (Liaoning) Co., Ltd.	  	Note	  	$	1,750,142	  
	 Saudi Credit & Savings Bank
	  	Dr. Ali Lehbi Medical Center (aka Ali Mohammed Al Lehbi Medical Center Company)	  	Note	  	$	519,653	  
	 VGCMD, LLC
	  	Hills Dialysis, LLC	  	Lease	  	$	817,899	  
	 Saga Realty-Shaker Square
	  	St. Luke’s Dialysis, LLC	  	Lease	  	$	415,307	  

  
 Sch 7.2(b)-2 

									
	 Bank / Institution
	  	 Entity
	  	 Type
	  	 Amount
	 
	 Mercy Medical Center of Durango
	  	Durango	  	Equipment lease	  	$	13,692	  
	 Well Fargo Equipment Finance
	  	Conyers	  	Equipment lease	  	$	277,862	  
	 Capital Partners
	  	Access Care	  	Equipment lease	  	$	227,754	  
	 Various
	  	Various	  	Capital leases	  	$	175,093,369	  
	 Central WA holdback
	  	Total Renal Care, Inc	  	Deferred purchase	  	$	655,000	  
	 Jackson
	  	Total Renal Care, Inc	  	Deferred purchase	  	$	3,000	  
	 Long Island Renal Care
	  	Knickerbocker Dialysis, Inc	  	Deferred purchase	  	$	12,792	  
	 Malaysia Office
	  	DVA (Malaysia) SDN. BHD.	  	Deferred purchase	  	$	155,569	  
	 Renovation of Life
	  	Total Renal Care, Inc	  	Deferred purchase	  	$	50,000	  
	 Crown
	  	Total Renal Care, Inc	  	Deferred purchase	  	$	175,000	  
	 Greenfield
	  	Total Renal Care, Inc	  	Deferred purchase	  	$	3,050,000	  
	 Garfield
	  	Total Renal Care, Inc	  	Deferred purchase	  	$	250,000	  
	 Ratingen
	  	MVZ DaVita Karlstrasse GmbH	  	Deferred purchase	  	$	897,698	  
	 Heerdt
	  	MVZ DaVita Karlstrasse GmbH	  	Deferred purchase	  	$	1,814,708	  
	 Sued
	  	MVZ DaVita Karlstrasse GmbH	  	Deferred purchase	  	$	617,080	  
	 Karlstrasse
	  	MVZ DaVita Karlstrasse GmbH	  	Deferred purchase	  	$	5,798,894	  
	 Gerresheim
	  	MVZ DaVita Karlstrasse GmbH	  	Deferred purchase	  	$	766,799	  
	 Total:
	  		  		  	$	246,438,020	  
				
	 Sumitomo
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	1,318,707	  
	 Wells Fargo
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	362,847	  
	 Credit Agricole
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	358,619	  
	 Royal Bank of Canada
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	359,116	  

  
 Sch 7.2(b)-3 

									
	 Bank / Institution
	  	 Entity
	  	 Type
	  	 Amount
	 
	 Bank of Nova Scotcia
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	272,135	  
	 Barclays Bank
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	270,270	  
	 Suntrust Bank
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	272,135	  
	 Union Bank
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	180,180	  
	 JPMorgan
	  	 DaVita HealthCare
 Partners Inc.
	  	Swap	  	$	179,807	  
	 Total:
	  		  		  	$	3,573,816	  
	
	Operating leases and equipment financings incurred by each of the Subsidiaries.	  

  
 Sch 7.2(b)-4 

 Schedule 7.6 

Investments as of 5/31/14 
  

									
	 Parent
	  	 Partnership
	  	 Ownership
	  	 Amount
	 
	 Total Renal Care, Inc.
	  	Total Renal Care / Crystal River Dialysis , L.C.	  	33.33%	  	$	253,693	  
	 Total Renal Care, Inc.
	  	Southwest Kidney-DaVita Dialysis Partners, LLC	  	50%	  	$	24,508,804	  
	 Total Renal Care, Inc.
	  	Southwest Kidney-DaVita Dialysis Partners II, LLC	  	50%	  	$	1,119,299	  
	 Renal Treatment Centers - West, Inc.
	  	Routt Dialysis, LLC	  	40%	  	$	2,668,402	  
	 East End Dialysis Center, Inc.
	  	MD Investments	  	50%	  	$	240,003	  
	 TRC of New York, Inc.
	  	MHS-XV, LLC (IHS of New York, Inc.)	  	15%	  	$	—  	  
	 TRC of New York, Inc.
	  	MHS-XIV,LLC (IHS of New York, Inc.)	  	15%	  	$	—  	  
	 DaVita HealthCare Partners Inc.
	  	CVRx, Inc.	  	Pref Stock	  	$	5,000,001	  
	 HealthCare Partners Affiliates Medical Group
	  	Magan Medical Group	  	50%	  	$	5,244,173	  
	 HealthCare Partners, LLC
	  	California Medical Group, Inc.	  	67%	  	$	3,088,728	  
	 Arizona Integrated Physicians, Inc.
	  	Banner Health Network	  	25%	  	$	7,600,000	  
	 HCP Explorer
	  	Tandigm Health, LLC	  	50%	  	$	4,749,500	  
				
		  		  		  	$	54,472,603	  

 EXHIBIT A 

[RESERVED] 

 EXHIBIT B 

[Form of] 
 COMPLIANCE
CERTIFICATE 
 I,
[                    ], the [Chief Financial Officer] of DaVita HealthCare Partners Inc. (in such capacity and not in my individual capacity), hereby
certify that, with respect to that certain Credit Agreement, dated as of June 24, 2014 (as it may be amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”); all of the
defined terms in the Credit Agreement are incorporated herein by reference) among DaVita HealthCare Partners Inc., a Delaware corporation, as borrower (the “Borrower”), the Guarantors party thereto, the Lenders party thereto,
JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto: 
 a. Attached
hereto as Schedule 1 are detailed calculations1 demonstrating compliance by Borrower with Sections 7.6(e), 7.12 and 7.16 of the Credit Agreement and showing a reconciliation of
Consolidated EBITDA to net income. Borrower is in compliance with such Sections as of the date hereof. [Attached hereto as Schedule 2 are detailed calculations setting forth (i) the Borrower’s Excess Cash Flow, (ii) the
Available Amount and (iii) that portion of the Available Amount that has been utilized pursuant to Sections 7.6(k)(ii), 7.7(d)(ii) and 7.9(a)(ii)(y) of the Credit Agreement.]2 [Attached
hereto as Schedule 3 is the report of [accounting firm.]]3 
 b.
The Borrower was in compliance with each of the covenants set forth in Sections 7.12 and 7.16 of the Credit Agreement at all times during and since
[                    ]. 

c. No Default has occurred under the Credit Agreement which has not been previously disclosed, in writing, to the
Administrative Agent pursuant to a Compliance Certificate.4 
  

 

	1	Which calculations shall be in reasonable detail satisfactory to the Administrative Agent and shall include, among other things, an explanation of the methodology used in such calculations and a breakdown of the
components of such calculations. 

	2	To accompany annual financial statements only, commencing with the Fiscal Year ending December 31, 2015. 

	3	To accompany annual financial statements only. The report must opine or certify that, with respect to its regular audit of such financial statements, which audit was conducted in accordance with GAAP, the accounting
firm obtained no knowledge that any Default has occurred or, if in the opinion of such accounting firm such a Default has occurred, specifying the nature and extent thereof. 

	4	If a Default shall have occurred, an explanation specifying the nature and extent of such Default shall be provided on a separate page together with an explanation of the corrective action taken or proposed to be taken
with respect thereto (include, as applicable, information regarding actions, if any, taken since prior certificate). 

 Dated this [    ] day of
[            ], 20[    ]. 
  

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	[Chief Financial Officer]

  
 Exh B-2 

 SCHEDULE 1 

Financial Covenants 
  

											
	 (A)
	  	 Maximum Leverage Ratio: Debt to Consolidated EBITDA
	  	
					
	 1.
	  	 Debt calculation:
	  		  		  	
			
	 (i)         Funded Debt of Borrower and its Subsidiaries, including debt in respect of Specified Letters
of Credit outstanding as of such date (assuming that the maximum amount of any such Specified Letters of Credit are fully drawn)
	  		  	
		  		    	   [explanation of differences from balance sheet debt]
	  	  
	  	
					
		  		    	 (i) includes:
	  		  	
		  		    	 Government Reimbursement Program

Costs (exclusive of those paid in such

period)
	  	  
	  		  	
		  		    	 Loans
	  	  
	  		  	
		  		    	 Receivables Transaction Amounts
	  	  
	  		  	
		  		    	 preferred Capital Stock obligations5
	  	  
	  		  	
					
	 Plus
	  		    		  		  	
					
		  	 (ii)
	    	 Letters of Credit (to the extent not included in (i));
	  	  
	  	
					
	 Minus
	  		    		  		  	
					
		  	 (iii)
	    	 cash and Cash Equivalents of Borrower and its Subsidiaries
	  	  
	  	
			
	 Debt for the Measurement Period:
	  	  
	  	
				
	 2.
	  	 Consolidated EBITDA calculation:
	  	  
	  	
						
		  	 (i)
	    	 Consolidated EBITDA
	  		  		  	
					
		  		    	 (a)    Consolidated Net Income of Borrower and its Subsidiaries
	  	  
	  	
				
	 plus (each of (b) — (m) to the extent deducted from Consolidated Net Income for such period)
	  		  		  	
					
		  		    	 (b)    Consolidated Interest Expense of Borrower and its Subsidiaries (including any cash charges for refinancing
any of the Obligations)
	  	  
	  	

  

	5 	 But excludes Contingent Obligations permitted under Section 7.2 of the Credit Agreement.

  
 Sch 1-1 

											
					
		  		    	 (c)    income tax expense of BorLP12rower and its Subsidiaries
	  	  
	  	
					
		  		    	 (d)    depreciation expense of Borrower and its Subsidiaries
	  	  
	  	
					
		  		    	 (e)    amortization expense of Borrower and its Subsidiaries
	  	  
	  	
					
		  		    	 (f)     cash fees, expenses, charges, debt extinguishment costs and other costs incurred in connection with
the Transactions
	  	  
	  	
					
		  		    	 (g)    other non-cash charges reducing Consolidated Net Income (excluding any non-cash charge that results in an
accrual of a reserve for cash charges in any future period or amortization of a prepaid cash expense that was paid in a prior period) (excluding write-offs of current assets of Borrower and its Subsidiaries)
	  	  
	  	
					
		  		    	 (h)    consolidated expenses for valuation adjustments or impairment charges
	  	  
	  	
					
		  		    	 (i)     expenses and charges relating to non-controlling interests and equity income in Subsidiaries
	  	  
	  	
					
		  		    	 (j)     extraordinary losses subtracted in determining Consolidated Net Income
	  	  
	  	
					
		  		    	 (k)    any losses of a Person (other than a Subsidiary) in which the Borrower or any of its Subsidiaries has an
ownership interest that is accounted for using the equity method
	  	  
	  	
					
		  		    	 (l)     cash fees, expenses, charges, debt extinguishment costs and other costs incurred in connection with
any Investments permitted by Section 7.6(e), (f), (j), (k) or (m)
	  	  
	  	
					
		  		    	 (m)   unusual or nonrecurring losses or charges for such period
	  	  
	  	
					
	 Minus
	  		    		  		  	
					
		  		    	 (n)    extraordinary gains added in determining Consolidated Net Income of Borrower and its Subsidiaries
	  	  
	  	

  
 Sch 1-2 

											
					
	Minus	  		    		  		  	
					
		  		    	 (o)    aggregate amount of all non-cash items increasing Consolidated Net Income (other than accrual of revenue or
recording of receivables in the ordinary course of business)
	  	  
	  	
					
	 Minus
	  		    		  		  	
					
		  		    	 (p)    unusual or nonrecurring gains for such period
	  	  
	  	
			
	Consolidated EBITDA for Measurement Period:	  	  
	  	
			
	 Leverage Ratio for Measurement Period:
	  	[     ] to 1.00	  	
			
	 Covenant Requirement for Measurement Period:
	  	[     ] to 1.00	  	

  
 Sch 1-3 

 EXHIBIT C 

[Form of] 
 SOLVENCY
CERTIFICATE 
 I, the undersigned, the chief financial officer of DaVita HealthCare Partners Inc., a Delaware corporation
(“Borrower”), DO HEREBY CERTIFY on behalf of Borrower that: 
 1. This Certificate is furnished
pursuant to Section 5.1(f) of the Credit Agreement, (as in effect on the date of this Certificate); the capitalized terms defined therein being used herein as therein defined, dated as of June 24, 2014 among DaVita HealthCare Partners
Inc., a Delaware corporation (“Borrower”), the Guarantors, the Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto (as from time to time in effect, the “Credit
Agreement”). 
 2. Immediately following the consummation of the Transactions and immediately following the making
of each Loan on the date hereof and after giving effect to the application of the proceeds of each Loan on the date hereof; (a) the amount of the “present fair saleable value” of the assets of each Loan Party (individually and on a
Consolidated basis with its Subsidiaries) will exceed the amount of all “liabilities of such Loan Party, contingent or otherwise”, as such quoted terms are determined in accordance with applicable federal and state laws governing
determinations of the insolvency of debtors; (b) the present fair saleable value of the assets of each Loan Party will be greater than the amount that will be required to pay the liability of such Loan Party on its debts as such debts become
absolute and matured; (c) each Loan Party will not have an unreasonably small amount of capital with which to conduct its business; and (d) each Loan Party will be able to pay its debts as they mature. For purposes of this certificate,
(i) “debt” means liability on a “claim,” and (ii) “claim” means any (x) right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured,
unmatured, disputed, undisputed, legal, equitable, secured or unsecured or (y) right to an equitable remedy for breach of performance if such breach gives rise to a right to payment, whether or not such right to an equitable remedy is reduced
to judgment, fixed, contingent, matured or unmatured, disputed, undisputed, secured or unsecured. 
 [Signature Page Follows] 

  
 C-1 

 IN WITNESS WHEREOF, I have hereunto set my hand this [    ]th day of
[            ]. 
  

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	[Chief Financial Officer]

  
 C-2 

 EXHIBIT D 

[Reserved] 

  
 D-1 

 EXHIBIT E 

[Form of] 
 ASSIGNMENT AND
ASSUMPTION 
 This Assignment and Assumption (the “Assignment and Assumption”) is dated as of the Effective Date set
forth below and is entered into by and between [Insert name of Assignor] (the “Assignor”) and [Insert name of Assignee] (the “Assignee”). Capitalized terms used but not defined herein shall have the
meanings given to them in the Credit Agreement defined below, receipt of a copy of which is hereby acknowledged by the Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated
herein by reference and made a part of this Assignment and Assumption as if set forth herein in full. 
 For an agreed consideration, the
Assignor hereby irrevocably sells and assigns to the Assignee, and the Assignee hereby irrevocably purchases and assumes from the Assignor, subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the
Effective Date inserted by the Administrative Agent as contemplated below, (i) all of the Assignor’s rights and obligations in its capacity as a Lender under the Credit Agreement and any other documents or instruments delivered pursuant
thereto to the extent related to the amount and percentage interest identified below of all of such outstanding rights and obligations of the Assignor under the respective facilities identified below (including participations in any Letters of
Credit and Swingline Loans included in such facilities) and (ii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the Assignor (in its capacity as a Lender) against any
person, whether known or unknown, arising under or in connection with the Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the
foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (i) above (the
rights and obligations sold and assigned pursuant to clauses (i) and (ii) above being referred to herein collectively as, the “Assigned Interest”). Such sale and assignment is without recourse to the Assignor and, except
as expressly provided in this Assignment and Assumption, without representation or warranty by the Assignor. 
  

					
	1.	  	Assignor:	  	                                      
                                         
         
			
	2.	  	Assignee:	  	                                      
                                         
         
		  		  	[and is an Affiliate/Approved Fund of [identify Lender]6 ]
			
	3.	  	Borrower(s):	  	DaVita HealthCare Partners Inc.
			
	4.	  	Administrative Agent:	  	JPMorgan Chase Bank, N.A., as the administrative agent under the Credit Agreement
		
	5.	  	Credit Agreement: The Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) among DaVita HealthCare
Partners Inc., a Delaware corporation (“Borrower”), the Guarantors (such term and each other capitalized term used but not defined herein having the meaning given it in Section 1 of the Credit Agreement), the Lenders, JPMorgan
Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto.

  

	6 	Select as applicable. 

  
 E-1 

					
	6.	  	Assigned Interest:	  	

  

													
	 Facility Assigned
	  	Aggregate Amount of
Commitment/
Loans for all Lenders	 	  	Amount of
Commitment/
Loans Assigned	 	  	Percentage
Assigned of
Commitment/Loans7	 
	 Tranche A Term Facility
	  	$	            	  	  	$	            	  	  	 	        	% 
	 Tranche B Term Facility
	  	$	            	  	  	$	            	  	  	 	        	% 
	 Dollar Revolving Facility
	  	$	            	  	  	$	            	  	  	 	        	% 
	 Alternative Currency Revolving Facility
	  	$	            	  	  	$	            	  	  	 	        	% 

 [Page break] 

 

	7 	Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder. 

  
 E-2 

 Effective Date:             
    , 20     [TO BE INSERTED BY ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.]8 

The terms set forth in this Assignment and Assumption are hereby agreed to: 

 

			
	ASSIGNOR
	
	[NAME OF ASSIGNOR]
		
	By:	 	  

	Title:	 	
	
	ASSIGNEE
	
	[NAME OF ASSIGNEE]
		
	By:	 	  

	Title:	 	

  

			
	Consented to and Accepted:
	
	[DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	 Title:    ]9

  
  

	8 	This date may not be fewer than 5 Business days after the date of assignment unless the Administrative Agent otherwise agrees. 

	9 	To be completed to the extent consent is required under Section 11.6(b) of the Credit Agreement. 

  
 E-3 

			
	[JPMORGAN CHASE BANK, N.A.,
	     as [Administrative Agent]10 [Issuing Lender and

    SwinglineLender]11

		
	By:	 	  

	Name:
	Title:    ]

  
  

	10 	To be completed to the extent consent is required under Section 11.6(b) of the Credit Agreement. 

	11 	Reference to Issuing Lender and Swingline Lender required for an assignment of Revolving Commitments. 

  
 E-4 

 ANNEX 1 to Assignment and Assumption 

DAVITA HEALTHCARE PARTNERS INC. 

CREDIT AGREEMENT 
 STANDARD TERMS
AND CONDITIONS FOR 
 ASSIGNMENT AND ASSUMPTION 

1. Representations and Warranties. 

1.1 Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned
Interest, (ii) the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim and (iii) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and Assumption and
to consummate the transactions contemplated hereby; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with the Credit Agreement or any other Loan Document,
(ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Loan Documents or any collateral thereunder, (iii) the financial condition of the Borrower, any of their Subsidiaries or Affiliates or any
other person obligated in respect of any Loan Document or (iv) the performance or observance by the Borrower, any of their Subsidiaries or Affiliates or any other person of any of their respective obligations under any Loan Document. 

1.2. Assignee. The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action
necessary, to execute and deliver this Assignment and Assumption and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it meets all requirements of an eligible assignee under the Credit
Agreement (subject to receipt of such consents as may be required under the Credit Agreement), (iii) from and after the Effective Date, it shall be bound by the provisions of the Credit Agreement as a Lender thereunder and, to the extent of the
Assigned Interest, shall have the obligations of a Lender thereunder, (iv) it has received a copy of the Credit Agreement, together with copies of the most recent financial statements referred to in Section 4.7 thereof or delivered
pursuant to Section 6.1 thereof, as applicable, and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and Assumption and to purchase the Assigned
Interest on the basis of which it has made such analysis and decision independently and without reliance on the Administrative Agent, the Assignor or any other Lender, (v) if it is not already a Lender under the Credit Agreement, attached to
the Assignment and Assumption an Administrative Questionnaire, (vi) the Administrative Agent has received a processing and recordation fee of $3,500 as of the Effective Date, (vii) if it is a Non-U.S. Lender, attached to the Assignment and
Assumption is any documentation required to be delivered by it pursuant to Section 2.19 of the Credit Agreement, duly completed and executed by the Assignee and (viii) it is not a Disqualified Lender or an affiliate of a Disqualified
Lender; and (b) agrees that (i) it will, independently and without reliance on the Administrative Agent, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to
make its own credit decisions in taking or not taking action under the Loan Documents, and (ii) it will perform in accordance with their terms all of the obligations that by the terms of the Loan Documents are required to be performed by it as
a Lender. 

  
 E-5 

 2. Payments. From and after the Effective Date, the Administrative Agent shall make all
payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) to the Assignor for amounts that have accrued to but excluding the Effective Date and to the Assignee for amounts that have accrued from
and after the Effective Date. 
 3. General Provisions. This Assignment and Assumption shall be binding upon, and inure to the
benefit of, the parties hereto and their respective successors and assigns. This Assignment and Assumption may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an executed counterpart of a
signature page of this Assignment and Assumption by telecopy shall be effective as delivery of a manually executed counterpart of this Assignment and Assumption. This Assignment and Assumption shall be construed in accordance with and governed by,
the law of the State of New York (including, without limitation, Sections 5-1401 and 5-1402 of the New York General Obligations Law, but otherwise without regard to conflicts of laws principles thereof). 

  
 E-6 

 EXHIBIT F 

[Reserved] 

  
 F-1 

 EXHIBIT G 

[Form of] 

PREPAYMENT OPTION NOTICE 

[Lenders] 
 Re: DaVita HealthCare Partners
Inc.  
 [Date] 
 Ladies and Gentlemen: 

Reference is made to the Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise
modified from time to time, the “Credit Agreement”) among DaVita HealthCare Partners Inc., a Delaware corporation, as borrower (the “Borrower”), the Guarantors (such term and each other capitalized term used but not
defined herein having the meaning given it in the Credit Agreement), the Lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto. Borrower has provided us with notice
pursuant to Section 2.11(e) of the Credit Agreement that it shall be making a prepayment of Tranche B Term Loans under the Credit Agreement. 

This Prepayment Option Notice constitutes an offer by the Borrower to prepay Tranche B Term Loans in the amount listed below on the 10th
Business Day following the date hereof. 
 Please notify the Administrative Agent in writing within [    ] days whether
you accept or decline this offer. Please note that failure to respond to this notice shall be deemed an acceptance of the prepayment offered to be repaid, as listed below. 

Pursuant to Section 2.11(e) of the Credit Agreement. Borrower shall pay (i) to the relevant Tranche B Lenders the aggregate amount
necessary to prepay that portion of the outstanding relevant Term Loans in respects of which such Lenders have accepted prepayment and (ii) to the Tranche A Lenders an amount equal to the portion of the Tranche B Prepayment Amount not accepted
by Tranche B Term Lenders, and such amount shall be applied to the prepayment of the Tranche A Term Loans; provided that if after the application of amounts pursuant to clause (ii), any portion of the Tranche B Prepayment Amount not accepted
by the Tranche B Term Loan Lenders shall remain, such amount shall be used to prepay the Tranche B Term Loans on a pro rata basis. 
  

					
	 (A)   Facility and Type of Loan being offered to be prepaid
	    	Tranche B Term Loan	  	
			
	 (B)   Percentage of all Tranche B Term Loans offered to be prepaid
	    	  
	  	
			
	 (C)   Principal amount of your
Tranche B Term Loans offered to be prepaid
	    	  
	  	
			
	 (D)   Date of prepayment
(which is a Business Day)
	    	  
	  	

  
 G-1 

 [Signature Page Follows] 

 

			
	JPMORGAN CHASE BANK, N.A.,
as Administrative Agent
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 G-2 

 EXHIBIT H 

[Form of] 
 BORROWING REQUEST

 JPMorgan Chase Bank, N.A. 
 as
Administrative Agent for 
 the Lenders referred to below, 
 c/o
JPMorgan Chase Bank, [Loan and Agency Services Group] 
 500 Stanton Christiana Road 

Floor 3, Ops 2 
 Newark, DE 19713 

Attention: Tesfaye Anteneh 
 Fax: 302-634-1417 

with a copy to: 
 JPMorgan Chase Bank, N.A. 

383 Madison Avenue 
 New York, New York 10179 

Attention: Dawn Lee Lum 
 Fax: 212-270-3279 

Re: DaVita HealthCare Partners Inc. 

[Date] 
 Ladies and Gentlemen: 

Reference is made to the Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise
modified from time to time, the “Credit Agreement”) among DaVita HealthCare Partners Inc., a Delaware corporation (“Borrower”), the Guarantors (such term and each other capitalized term used but not defined herein
having the meaning given it in Section 1 of the Credit Agreement), the Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto. Borrower hereby gives you notice that it requests a
Credit Extension pursuant to Section [2.2] [2.5] [2.7] of the Credit Agreement, and in that connection sets forth below the terms on which such Credit Extension is requested to be made: 

 

					
	 (A)   Facility of Credit Extension
	    	 [Dollar Revolving Facility]
 [Alternative
Currency Revolving Facility]
 [Tranche A Term Facility]

[Tranche B Term Facility]
 [Swingline Loan]
	  	
			
	 (B)   Principal amount of
      Credit Extension12
	    	  
	  	

  

	12 	Each borrowing under the Dollar Revolving Commitments and each borrowing of Alternative Currency Revolving Loans denominated in Dollars shall be in an amount equal to (x) in the case of ABR Loans, $1,000,000 or a
whole multiple thereof (or, if the then aggregate Available Dollar Revolving Commitments or Available Alternative Currency Revolving Commitments, as applicable, are less than $1,000,000, such lesser amount) and (y) in the case of Eurodollar
Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof. Each borrowing under the Alternative Currency Revolving Commitments (other than borrowings denominated in Dollars) should be in an amount equal to the Alternative Currency
Equivalent of $5,000,000 or a whole multiple of $1,000,000 in excess thereof. 

  
 H-1 

					
	 (D)   Currency
	    		  	
			
	 (D)   Date of Credit Extension
        (which is a Business Day)
	    	  
	  	
			
	 (E)   Type of Credit Extension
	    	[ABR] [Eurodollar]13	  	
			
	 (F)    Interest Period and the last day thereof14
	    	  
	  	
		
	 (G)   Funds are requested to be disbursed to Borrower’s account with
JPMorgan Chase Bank, N.A.
(Account No. ).
	  	

 Borrower hereby represents and warrants that the conditions to lending specified in Sections 5.2(b) and
(c) of the Credit Agreement are satisfied as of the date hereof. 
 [Signature Page Follows] 

 

	13 	Shall be ABR for Swingline Loans. 

	14 	Shall be subject to the definition of “Interest Period” in the Credit Agreement. 

  
 H-2 

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	[Responsible Officer]

  
 H-3 

 EXHIBIT I 

[RESERVED] 

  
 J-1 

 EXHIBIT J 

[Form of] 
 EXEMPTION
CERTIFICATE 
 Reference is made to the Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated,
supplemented or otherwise modified from time to time, the “Credit Agreement”) among DaVita HealthCare Partners Inc., a Delaware corporation (“Borrower”), the Guarantors (such term and each other capitalized term
used but not defined herein having the meaning given it in Section 1 of the Credit Agreement), the Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto. 

The undersigned is not (i) a bank (as such term is used in Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended
(the “Code”)), (ii) a “10-percent shareholder” of Borrower within the meaning of section 881(c)(3)(B) of the Code, or (C) a “controlled foreign corporation” described in section 881(c)(3)(C) of the
Code. 
  

			
	[NAME OF LENDER]
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	[ADDRESS]

 Dated:
                    , 20    . 

  
 J-1 

 EXHIBIT K 

[RESERVED] 

  
 K-2-1 

 EXHIBIT L 

[Form of] 
 JOINDER AGREEMENT

 Reference is made to the Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or
otherwise modified from time to time, the “Credit Agreement”) among DaVita HealthCare Partners Inc., a Delaware corporation (“Borrower”), the Guarantors (such term and each other capitalized term used but not
defined herein having the meaning given to it in Section 1 of the Credit Agreement), the Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto. 

W I T N E S S E T H: 

WHEREAS, the Guarantors have entered into the Credit Agreement and the Security Agreement in order to induce the Lenders to make the Loans and
the Issuing Lender to issue Letters of Credit to or for the benefit of Borrower; 
 WHEREAS, pursuant to Section 6.12(b) of the Credit
Agreement, Subsidiaries of Borrower are generally required to become Guarantors under the Credit Agreement. The undersigned Subsidiary (the “New Guarantor”) is executing this joinder agreement (“Joinder Agreement”)
to the Credit Agreement in order to induce the Lenders to make additional Revolving Loans and the Issuing Lender to issue Letters of Credit and as consideration for the Loans previously made [and Letters of Credit previously issued]. 

NOW, THEREFORE, the Administrative Agent, Collateral Agent and the New Guarantor hereby agree as follows: 

1. Guarantee. In accordance with Section 6.12(b) of the Credit Agreement, the New Guarantor by its signature below becomes a
Guarantor under the Credit Agreement with the same force and effect as if originally named therein as a Guarantor. 
 2. Representations
and Warranties. The New Guarantor hereby (a) agrees to all the terms and provisions of the Credit Agreement applicable to it as a Guarantor thereunder and (b) represents and warrants that the representations and warranties made by it
as a Guarantor thereunder are true and correct in all material respects (except that any representation and warranty that is qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects) on
and as of the date hereof. Each reference to a Guarantor in the Credit Agreement shall be deemed to include the New Guarantor. The New Guarantor hereby attaches supplements to each of the schedules to the Credit Agreement applicable to it. 

3. Severability. Any provision of this Joinder Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable
such provision in any other jurisdiction. 
 4. Counterparts. This Joinder Agreement may be executed in counterparts, each of which
shall constitute an original. Delivery of an executed signature page to this Joinder Agreement by facsimile transmission shall be as effective as delivery of a manually executed counterpart of this Joinder Agreement. 

  
 L-1 

 5. No Waiver. Except as expressly supplemented hereby, the Credit Agreement shall remain
in full force and effect. 
 6. Notices. All notices, requests and demands to or upon the New Guarantor, any Agent or any Lender
shall be governed by the terms of Section 11.2 of the Credit Agreement. 
 7. Governing Law. THIS AGREEMENT AND THE RIGHTS AND
OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAW OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT
REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF. 
 [Signature Page Follows] 

  
 L-2 

 IN WITNESS WHEREOF, the undersigned have caused this Joinder Agreement to be duly executed and
delivered by their duly authorized officers as of the day and year first above written. 
  

			
	[NEW GUARANTOR]
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	Address for Notices:
	
	JPMORGAN CHASE BANK, N.A., as
	     Administrative Agent and Collateral Agent
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 L-3 

 [Note: Schedules to be attached.] 

  
 L-4 

 EXHIBIT M 

[Form of] 
 INTERCOMPANY NOTE

 New York, New York 
 [date]

 FOR VALUE RECEIVED, each of the undersigned, to the extent a borrower from time to time from any other entity listed on the signature
page hereto (each, in such capacity, a “Payor”), hereby promises to pay on demand to the order of such other entity listed below (each, in such capacity, a “Payee”), in lawful money of the United States of America
in immediately available funds, at such location in the United States of America as a Payee shall from time to time designate, the unpaid principal amount of all loans and advances (including trade payables) made by such Payee to such Payor. Each
Payor promises also to pay interest on the unpaid principal amount of all such loans and advances in like money at said location from the date of such loans and advances until paid at such rate per annum as shall be agreed upon from time to time by
such Payor and such Payee. 
 This note (“Note”) is the Intercompany Note referred to in the Credit Agreement, dated as of
June 24, 2014 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) among DaVita HealthCare Partners Inc., a Delaware corporation, the Guarantors (such term and each
other capitalized term used but not defined herein having the meaning given it in Section 1 of the Credit Agreement), the Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto, and
is subject to the terms thereof, and shall be pledged by each Payee pursuant to the Security Agreement, to the extent required pursuant to the terms thereof. Each Payee hereby acknowledges and agrees that the Administrative Agent may exercise all
rights provided in the Credit Agreement and the Security Agreement with respect to this Note. 
 Anything in this Note to the contrary
notwithstanding, the indebtedness evidenced by this Note owed by any Payor that is Borrower or a Guarantor to any Payee other than Borrower shall be subordinate and junior in right of payment, to the extent and in the manner hereinafter set forth,
to all Obligations of such Payor under the Credit Agreement, including, without limitation, where applicable, under such Payor’s guarantee of the Obligations under the Credit Agreement (such Obligations and other indebtedness and obligations in
connection with any renewal, refunding, restructuring or refinancing thereof, including interest thereon accruing after the commencement of any proceedings referred to in clause (i) below, whether or not such interest is an allowed claim in
such proceeding, being hereinafter collectively referred to as “Senior Indebtedness”): 
 11.19.a.i.A.1.1 In
the event of any insolvency or bankruptcy proceedings, and any receivership, liquidation, reorganization or other similar proceedings in connection therewith, relative to any Payor or to its creditors, as such, or to its property, and in the event
of any proceedings for voluntary liquidation, dissolution or other winding up of such Payor, whether or not involving insolvency or bankruptcy, then (x) the holders of Senior Indebtedness shall be paid in full in cash in respect of all amounts
constituting Senior Indebtedness before any Payee is entitled to receive (whether directly or indirectly), or make any demands for, any payment on account of this Note and (y) until the holders of Senior Indebtedness are paid in full in cash in
respect of all amounts constituting Senior Indebtedness, any payment or distribution to which such Payee would otherwise be entitled (other than debt securities of such Payor that are subordinated, to at

  
 M-1 

 
least the same extent as this Note, to the payment of all Senior Indebtedness then outstanding (such securities being hereinafter referred to as “Restructured Debt Securities”))
shall be made to the holders of Senior Indebtedness; 
 11.19.a.i.A.1.2 if any Event of Default occurs and is continuing with
respect to any Senior Indebtedness (including any Default under the Credit Agreement), then no payment or distribution of any kind or character shall be made by or on behalf of the Payor or any other Person on its behalf with respect to this Note;
and 
 11.19.a.i.A.1.3 if any payment or distribution of any character, whether in cash, securities or other property (other
than Restructured Debt Securities), in respect of this Note shall (despite these subordination provisions) be received by any Payee in violation of clause (i) or (ii) before all Senior Indebtedness shall have been paid in full in cash,
such payment or distribution shall be held in trust for the benefit of, and shall be paid over or delivered to, the holders of Senior Indebtedness (or their representatives), ratably according to the respective aggregate amounts remaining unpaid
thereon, to the extent necessary to pay all Senior Indebtedness in full in cash. 
 To the fullest extent permitted by law, no present or
future holder of Senior Indebtedness shall be prejudiced in its right to enforce the subordination of this Note by any act or failure to act on the part of any Payor or by any act or failure to act on the part of such holder or any trustee or agent
for such holder. Each Payee and each Payor hereby agree that the subordination of this Note is for the benefit of the Administrative Agent, the Issuing Lender and the Lenders and the Administrative Agent, the Issuing Lender and the Lenders are
obligees under this Note to the same extent as if their names were written herein as such and the Administrative Agent may, on behalf of the itself, the Issuing Lender and the Lenders, proceed to enforce the subordination provisions herein. 

The indebtedness evidenced by this Note owed by any Payor that is not Borrower or a Guarantor shall not be subordinated to, and shall rank
pari passu in right of payment with, any other obligation of such Payor. 
 Nothing contained in the subordination provisions set
forth above is intended to or will impair, as between each Payor and each Payee, the obligations of such Payor, which are absolute and unconditional, to pay to such Payee the principal of and interest on this Note as and when due and payable in
accordance with its terms, or is intended to or will affect the relative rights of such Payee and other creditors of such Payor other than the holders of Senior Indebtedness. 

Each Payee is hereby authorized to record all loans and advances made by it to any Payor (all of which shall be evidenced by this Note), and
all repayments or prepayments thereof, in its books and records, such books and records constituting prima facie evidence of the accuracy of the information contained therein. 

Each Payor hereby waives presentment, demand, protest or notice of any kind in connection with this Note. All payments under this Note shall
be made without offset, counterclaim or deduction of any kind. 

  
 M-2 

 THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW
YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF). 

 

			
	[List Borrower and All Subsidiaries]
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 M-3 

 EXHIBIT N-1 

[Form of] 
 REVOLVING
LOAN NOTE 
  

			
	$        	 	New York, New York
		 	[Date]

 FOR VALUE RECEIVED, the undersigned, DaVita HealthCare Partners Inc., a Delaware corporation
(“Borrower”), hereby promises to pay to the order of [                    ] (the “Lender”) on the Revolving
Termination Date, in lawful money of the United States or such other Alternative Currency in which a relevant Revolving Loan was made and in immediately available funds the aggregate unpaid principal amount of all Revolving Loans of the Lender
outstanding under the Credit Agreement referred to below. Borrower further agrees to pay interest in like money at such office specified in Section 2.17(d) of the Credit Agreement on the unpaid principal amount hereof from time to time from the
date hereof at the rates, and on the dates, specified in Section 2.14 of such Credit Agreement. 
 The holder of this Note may endorse
and attach a schedule to reflect the date, Type, currency and amount of each Revolving Loan of the Lender outstanding under the Credit Agreement, the date and amount of each payment or prepayment of principal hereof, and the date of each interest
rate conversion or continuation pursuant to Section 2.12 of the Credit Agreement and the principal amount subject thereto; provided that the failure of the Lender to make any such recordation (or any error in such recordation) shall not
affect the obligations of Borrower hereunder or under the Credit Agreement. 
 This Note is one of the Notes referred to in the Credit
Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Borrower, the Guarantors, the Lenders, JPMorgan Chase Bank, N.A., as
Administrative Agent and Collateral Agent, and the other agents party thereto, is subject to the provisions thereof and is subject to optional and mandatory prepayment in whole or in part as provided therein. Terms used herein which are defined in
the Credit Agreement shall have such defined meanings unless otherwise defined herein or unless the context otherwise requires. 
 This Note
is secured and guaranteed as provided in the Credit Agreement and the Security Documents. Reference is hereby made to the Credit Agreement and the Security Documents for a description of the properties and assets in which a security interest has
been granted, the nature and extent of the security and guarantees, the terms and conditions upon which the security interest and each guarantee was granted and the rights of the holder of this Note in respect thereof. 

Upon the occurrence of any one or more of the Events of Default specified in the Credit Agreement, all amounts then remaining unpaid on this
Note shall become, or may be declared to be, immediately due and payable, all as provided therein. 
 All parties now and hereafter liable
with respect to this Note, whether maker, principal, surety, guarantor, endorser or otherwise, hereby waive presentment, demand, protest and all other notices of any kind. 

THIS NOTE MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS OF THE CREDIT AGREEMENT. TRANSFERS OF THIS NOTE MUST BE RECORDED IN
THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF THE CREDIT AGREEMENT. 

  
 N-1-1 

 THIS NOTE SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW
YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF). 

[Signature Page Follows] 

  
 N-1-2 

 
			
	 DAVITA HEALTHCARE PARTNERS INC.,

	    as Borrower
		
	 By:
	 	  

	 Name:
	 	
	 Title:
	 	

  
 N-1-3 

 EXHIBIT N-2 

[Form of] 
 TRANCHE A
TERM LOAN NOTE 
  

			
	$        	 	New York, New York
		 	[Date]

 FOR VALUE RECEIVED, the undersigned, DaVita HealthCare Partners Inc., a Delaware corporation
(“Borrower”), hereby promises to pay to the order of [                    ] (the “Lender”) on [maturity date] in
lawful money of the United States and in immediately available funds, the principal amount of                 DOLLARS
($        ), or, if less, the aggregate unpaid principal amount of all Tranche A Term Loans of the Lender outstanding under the Credit Agreement referred to below, which sum shall be due and payable in such
amounts and on such dates as are set forth in the Credit Agreement. Borrower further agrees to pay interest in like money at such office specified in Section 2.17(d) of the Credit Agreement on the unpaid principal amount hereof from time to
time from the date hereof at the rates, and on the dates, specified in Section 2.14 of such Credit Agreement. 
 The holder of this
Note may endorse and attach a schedule to reflect the date, Type and amount of each Tranche A Term Loan of the Lender outstanding under the Credit Agreement, the date and amount of each payment or prepayment of principal hereof, and the date of each
interest rate conversion or continuation pursuant to Section 2.12 of the Credit Agreement and the principal amount subject thereto; provided that the failure of the Lender to make any such recordation (or any error in such recordation)
shall not affect the obligations of Borrower hereunder or under the Credit Agreement. 
 This Note is one of the Notes referred to in the
Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Borrower, the Guarantors, the Lenders, JPMorgan Chase Bank,
N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto, is subject to the provisions thereof and is subject to optional and mandatory prepayment in whole or in part as provided therein. Terms used herein which are
defined in the Credit Agreement shall have such defined meanings unless otherwise defined herein or unless the context otherwise requires. 

This Note is secured and guaranteed as provided in the Credit Agreement and the Security Documents. Reference is hereby made to the Credit
Agreement and the Security Documents for a description of the properties and assets in which a security interest has been granted, the nature and extent of the security and guarantees, the terms and conditions upon which the security interest and
each guarantee was granted and the rights of the holder of this Note in respect thereof. 
 Upon the occurrence of any one or more of the
Events of Default specified in the Credit Agreement, all amounts then remaining unpaid on this Note shall become, or may be declared to be, immediately due and payable all as provided therein. 

All parties now and hereafter liable with respect to this Note, whether maker, principal, surety, guarantor, endorser or otherwise, hereby
waive presentment, demand, protest and all other notices of any kind. 

  
 N-2-1 

 THIS NOTE MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS OF THE CREDIT AGREEMENT.
TRANSFERS OF THIS NOTE MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF THE CREDIT AGREEMENT. 

THIS NOTE SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS
5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF). 

[Signature Page Follows] 

  
 N-2-2 

 
			
	DAVITA HEALTHCARE PARTNERS INC.,
	    as Borrower
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 N-2-3 

 EXHIBIT N-3 

[Form of] 
 TRANCHE B
TERM LOAN NOTE 
  

			
	$        	 	New York, New York
		 	[Date]

 FOR VALUE RECEIVED, the undersigned, DaVita HealthCare Partners Inc., a Delaware corporation
(“Borrower”), hereby promises to pay to the order of [                    ] (the “Lender”) on the Tranche B Term
Loan Maturity Date, in lawful money of the United States and in immediately available funds, the principal amount of                 DOLLARS
($        ), or if less, the aggregate unpaid principal amount of all Tranche B Term Loans of the Lender outstanding under the Credit Agreement referred to below, which sum shall be due and payable in such
amounts and on such dates as are set forth in the Credit Agreement. Borrower further agrees to pay interest in like money at such office specified in Section 2.17(d) of the Credit Agreement on the unpaid principal amount hereof from time to
time from the date hereof at the rates, and on the dates, specified in Section 2.14 of such Credit Agreement. 
 The holder of this
Note may endorse and attach a schedule to reflect the date, Type and amount of each Tranche B Term Loan of the Lender outstanding under the Credit Agreement, the date and amount of each payment or prepayment of principal hereof, and the date of each
interest rate conversion or continuation pursuant to Section 2.12 of the Credit Agreement and the principal amount subject thereto; provided that the failure of the Lender to make any such recordation (or any error in such recordation)
shall not affect the obligations of Borrower hereunder or under the Credit Agreement. 
 This Note is one of the Notes referred to in the
Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Borrower, the Guarantors, the Lenders, JPMorgan Chase Bank,
N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto, is subject to the provisions thereof and is subject to optional and mandatory prepayment in whole or in part as provided therein. Terms used herein which are
defined in the Credit Agreement shall have such defined meanings unless otherwise defined herein or unless the context otherwise requires. 

This Note is secured and guaranteed as provided in the Credit Agreement and the Security Documents. Reference is hereby made to the Credit
Agreement and the Security Documents for a description of the properties and assets in which a security interest has been granted, the nature and extent of the security and guarantees, the terms and conditions upon which the security interest and
each guarantee was granted and the rights of the holder of this Note in respect thereof. 
 Upon the occurrence of any one or more of the
Events of Default specified in the Credit Agreement, all amounts then remaining unpaid on this Note shall become, or may be declared to be, immediately due and payable as provided therein. 

All parties now and hereafter liable with respect to this Note, whether maker, principal, surety, guarantor, endorser or otherwise, hereby
waive presentment, demand, protest and all other notices of any kind. 

  
 N-3-1 

 THIS NOTE MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS OF THE CREDIT AGREEMENT.
TRANSFERS OF THIS NOTE MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF THE CREDIT AGREEMENT. 

THIS NOTE SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS
5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF). 

[Signature Page Follows] 

  
 N-3-2 

 
			
	DAVITA HEALTHCARE PARTNERS INC.,
	    as Borrower
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 N-3-3 

 EXHIBIT N-4 

[Form of] 
 SWINGLINE
NOTE 
  

			
	$        	 	New York, New York
		 	[Date]

 FOR VALUE RECEIVED, the undersigned, DaVita HealthCare Partners Inc., a Delaware corporation
(“Borrower”), hereby promises to pay to the order of [                    ] (the “Lender”) on the Revolving
Termination Date, in lawful money of the United States and in immediately available funds, the principal amount of the lesser of
(a)                 ($        ) and (b) the aggregate unpaid principal amount of all Swingline Loans made by Lender to
the undersigned pursuant to Sections 2.6 and 2.7 of the Credit Agreement referred to below. Borrower further agrees to pay interest on the unpaid principal amount hereof in like money at such office specified in Section 2.17(d) of the Credit
Agreement from time to time from the date hereof at the rates and on the dates specified in Section 2.14 of the Credit Agreement. 

The holder of this Note may endorse and attach a schedule to reflect the date, the amount of each Swingline Loan and the date and amount of
each payment or prepayment of principal thereof; provided that the failure of Lender to make such recordation (or any error in such recordation) shall not affect the obligations of Borrower hereunder or under the Credit Agreement. 

This Note is one of the Notes referred to in the Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated,
supplemented or otherwise modified from time to time, the “Credit Agreement”), among Borrower, the Guarantors, the Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party
thereto, is subject to the provisions thereof and is subject to optional and mandatory prepayment in whole or in part as provided therein. Terms used herein which are defined in the Credit Agreement shall have such defined meanings unless otherwise
defined herein or unless the context otherwise requires. 
 This Note is secured and guaranteed as provided in the Credit Agreement and the
Security Documents. Reference is hereby made to the Credit Agreement and the Security Documents for a description of the properties and assets in which a security interest has been granted, the nature and extent of the security and guarantees, the
terms and conditions upon which the security interest and each guarantee was granted and the rights of the holder of this Note in respect thereof. 

Upon the occurrence of any one or more of the Events of Default specified in the Credit Agreement, all amounts then remaining unpaid on this
Note may become, or may be declared to be, immediately due and payable as provided in the Credit Agreement. 
 All parties now and hereafter
liable with respect to this Note, whether maker, principal, surety, guarantor, endorser or otherwise, hereby waive presentment, demand, protest and all other notices of any kind. 

  
 N-4-1 

 THIS NOTE MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS OF THE CREDIT AGREEMENT.
TRANSFERS OF THIS NOTE MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF THE CREDIT AGREEMENT. 

THIS NOTE SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS
5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF). 

[Signature Page Follows] 

  
 N-4-2 

			
	DAVITA HEALTHCARE PARTNERS INC.,
	    as Borrower
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 N-4-3 

 EXHIBIT O 

[Form of] 
 LC REQUEST

 Dated [                ] 

JPMorgan Chase Bank, N.A., as Administrative Agent under the Credit Agreement, dated as of June 24, 2014 (as amended, amended and
restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among DaVita HealthCare Partners Inc., a Delaware corporation, the Lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as
Administrative Agent and Collateral Agent, and the other agents party thereto. 
 JPMorgan Chase Bank, N.A., 

    as Administrative Agent for 
 the Lenders
referred to below, 
 c/o JPMorgan Chase Bank, Loan and Agency Services Group 

500 Stanton Christiana Road 
 Floor 3, Ops 2 

Newark, DE 19713 
 Attention: Tesfaye Anteneh 

Fax: 302-634-1417 
 with a copy to: 

JPMorgan Chase Bank, N.A. 
 270 Park Avenue 

New York, NY 10017 
 Attention: Dawn Lee Lum 

Fax: 212-270-3279 
 Ladies and Gentlemen: 

We hereby request that [name of proposed Issuing Lender], as Issuing Lender under the Credit Agreement, [issue] [amend] [renew] [extend] [a]
[an existing] Letter of Credit for the account of the undersigned on [                ] (the “Date of [Issuance] [Amendment] [Renewal] [Extension]”) in the
aggregate stated amount of [        ]15. [Such Letter of Credit was originally issued on [date].] The requested Letter of Credit shall be a [Dollar Letter
of Credit] [Alternative Currency Letter of Credit]. The requested Letter of Credit [shall be] [is] denominated in [    ]16. 

For purposes of this LC Request, unless otherwise defined herein, all capitalized terms used herein which are defined in the Credit Agreement
shall have the respective meaning provided therein. 
  
  

	15 	Aggregate initial stated amount of Letter of Credit. 

	16 	Currency in which the Letter of Credit shall be denominated (which, in the case of a Dollar Letter of Credit, shall be in Dollars, and, in the case of an Alternative Currency Letter of Credit, shall be in Dollars or any
other Alternative Currency). 

  
 O-1 

 The beneficiary of the requested Letter of Credit [will be] [is]
[            ], and such Letter of Credit [will be] [is] in support of (17) and [will have] [has] a stated expiration date of
[            ]18. [Describe the nature of the amendment, renewal or extension.] 

We hereby certify that: 

(1) Each of Borrower and each other Loan Party is in compliance in all material respects with all the terms and provisions set
forth in each Loan Document on its part to be observed or performed, and, as of today and at the time of and immediately after giving effect to the [issuance] [amendment] [renewal] [extension] of the Letter of Credit requested herein, no Default has
or will have occurred and be continuing. 
 (2) Each of the representations and warranties made by any Loan Party set forth
in any Loan Document are true and correct in all material respects (except that any representation and warranty that is qualified as to “materiality” or “Material Adverse Effect” is true and correct in all respects) on and as of
today’s date and with the same effect as though made on and as of today’s date, except to the extent such representations and warranties expressly relate to an earlier date. 

(3) No order, judgment or decree of any Governmental Authority purports to restrain any Lender from taking any actions to be
made hereunder or from making any Loans to be made by it. No injunction or other restraining order has been issued, is pending or noticed with respect to any action, suit or proceeding seeking to enjoin or otherwise prevent the consummation of, or
to recover any damages or obtain relief as a result of, the transactions contemplated by this LC Request, the Credit Agreement or the making of Loans thereunder. 

(4) [After giving effect to the request herein, the LC Obligations will not exceed the LC Commitment, the Available Dollar
Revolving Commitments will not be less than zero and the Dollar LC Obligations with respect to any Issuing Lender will not exceed the applicable Specified Dollar LC Sublimit of such Issuing Lender then in effect.] [After giving effect to the request
herein, the LC Obligations will not exceed the LC Commitment, the Alternative Currency LC Obligations will not be less than zero and the Alternative Currency LC Obligations with respect to any Issuing Lender will not exceed the applicable Specified
Alternative Currency LC Sublimit of such Issuing Lender then in effect.] 
  

 

	17 	Insert description of the obligation to which it relates in the case of standby Letters of Credit and a description of the commercial transaction which is being supported in the case of commercial Letters of Credit.

	18 	Each Letter of Credit shall expire no later than the earlier of (x) the first anniversary of its date of issuance and (y) the date that is fifteen Business Days prior to the Revolving Termination Date (or with
respect to any Letters of Credit outstanding with respect to an Extended Revolving Commitment, the Maturity Date applicable thereto), provided that any Letter of Credit with a one-year term may provide for the renewal thereof for additional
one-year periods (which shall in no event extend beyond the date referred to in clause (y) above). 

  
 O-2 

 Copies of all relevant documentation with respect to the supported transaction are attached
hereto. 
  

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 O-3 

 EXHIBIT P 

[Form of] 
 INTEREST ELECTION
REQUEST 
 JPMorgan Chase Bank, N.A., 

    as Administrative Agent for 
 the Lenders
referred to below, 
 c/o JPMorgan Chase Bank, Loan and Agency Services Group 

500 Stanton Christiana Road 
 Floor 3, Ops 2 

Newark, DE 19713 
 Attention: Tesfaye Anteneh 

Fax: 302-634-1417 
 with a copy to: 

JPMorgan Chase Bank, N.A. 
 270 Park Avenue 

New York, NY 10017 
 Attention: Dawn Lee Lum 

Fax: 212-270-3279 
 [Date] 

Re: DaVita HealthCare Partners Inc. 

Ladies and Gentlemen: 
 This Interest Election
Request is delivered to you pursuant to Section 2.12 of the Credit Agreement, dated as of June 24, 2014 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) among
DaVita HealthCare Partners Inc., a Delaware corporation (“Borrower”), the Subsidiary Guarantors (such term and each other capitalized term used but not defined herein having the meaning given it in Section 1 thereof), the
Lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other agents party thereto. 

  
 P-1 

 Borrower hereby requests that on
[            ]20 (the “Interest Election Date”), 

1. $[        ] of the presently outstanding principal amount of the Loans originally
made on [                    ], 

2. and all presently being maintained as [ABR Loans] [Eurodollar Loans], 

3. be [converted into] [continued as], 

4. [Eurodollar Loans having an Interest Period of [one/two/three/six/twelve] months] [ABR Loans]. 

The undersigned hereby certifies that the following statements are true on the date hereof, and will be true on the proposed Interest Election
Date, both before and after giving effect thereto and to the application of the proceeds therefrom: 
 (a) the foregoing
[conversion] [continuation] complies with the terms and conditions of the Credit Agreement (including, without limitation, Section 2.12 of the Credit Agreement); 

(b) no Default has occurred and is continuing, or would result from such proposed [conversion] [continuation]. 

[Signature Page Follows] 
  

 

	20 	Shall be a Business Day that is (a) the next Business Day following the date hereof in the case of a conversion into ABR Loans to the extent this Interest Election Request is delivered to the Administrative Agent
prior to 2:00 p.m., New York City time on the date hereof, otherwise the second Business Day following the date of delivery hereof or (b) three Business Days following the date hereof in the case of a conversion into Eurodollar Loans
denominated in Dollars to the extent this Interest Election Request is delivered to the Administrative Agent prior to 2:00 p.m. New York City time on the date hereof, otherwise the fourth Business Day following the date of delivery hereof. Notices
of continuation of any Eurodollar Loan shall be delivered to the Administrative Agent not later than 11:00 A.M. Local Time, three Business Days prior to the last day of the then current Interest Period with respect thereto. 

  
 P-2 

 Borrower has caused this Interest Election Request to be executed and delivered by its duly
authorized officer as of the date first written above. 
  

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 P-3 

 EXHIBITQ 

[FORM OF] 
 FIRST-LIEN
INTERCREDITOR AGREEMENT 
 Among 

DAVITA HEALTHCARE PARTNERS INC., 

as Borrower, 
 the other Grantors
party hereto, 
 JPMORGAN CHASE BANK, N.A., 

as Credit Agreement Collateral Agent for the Credit Agreement Secured Parties 

JPMORGAN CHASE BANK, N.A., 
 as
Authorized Representative for the Credit Agreement Secured Parties, 

[                    ] 

as the Initial Additional Authorized Representative, 

and 
 each additional Authorized
Representative from time to time party hereto 
 dated as of [            ],
201[  ] 

 FIRST-LIEN INTERCREDITOR AGREEMENT, dated as of
[            ], 201[    ] (as amended, restated, amended and restated, extended, supplemented or otherwise modified from time to time, this
“Agreement”), among DAVITA HEALTHCARE PARTNERS INC. a Delaware corporation (the “Borrower”), the other Grantors (as defined below) from time to time party hereto, JPMORGAN CHASE BANK, N.A.,, as administrative agent
for the Credit Agreement Secured Parties (as defined below) (in such capacity and together with its successors in such capacity, the “Credit Agreement Collateral Agent”), JPMORGAN CHASE BANK, N.A., as Authorized Representative for
the Credit Agreement Secured Parties (as each such term is defined below), the Notes Collateral Agent (as defined below) and Authorized Representative for the Initial Additional First-Lien Secured Parties (as defined below) (in such capacity and
together with its successors in such capacity, the “Initial Additional Authorized Representative”) and each additional Authorized Representative from time to time party hereto for the other Additional First-Lien Secured Parties of
the Series (as defined below) with respect to which it is acting in such capacity. 
 In consideration of the mutual agreements herein
contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Administrative Agent, the Credit Agreement Collateral Agent (for itself and on behalf of the Credit Agreement Secured Parties),
the Initial Additional Authorized Representative (for itself and on behalf of the Initial Additional First-Lien Secured Parties) and each additional Authorized Representative (for itself and on behalf of the Additional First-Lien Secured Parties of
the applicable Series) agree as follows: 
 ARTICLE I 

Definitions 
 SECTION 1.01
Certain Defined Terms. Capitalized terms used but not otherwise defined herein have the meanings set forth in the Credit Agreement or, if defined in the New York UCC, the meanings specified therein. As used in this Agreement, the following
terms have the meanings specified below: 
 “Additional First-Lien Documents” means, with respect to the Initial Additional
First-Lien Obligations or any other Additional First-Lien Obligations, the notes, indentures, security documents and other operative agreements evidencing or governing such Indebtedness and the Liens securing such Indebtedness, including the Initial
Additional First-Lien Documents and the Additional First-Lien Security Documents and each other agreement entered into for the purpose of securing the Initial Additional First-Lien Obligations or any other Additional First-Lien Obligations. 

“Additional First-Lien Obligations” means collectively (1) the Initial Additional First-Lien Obligations and
(2) all amounts owing pursuant to the terms of any Series of Additional Senior Class Debt designated as Additional First-Lien Obligations pursuant to Section 5.13 hereof after the date hereof, including, without limitation, the obligation
(including guarantee obligations) to pay principal, interest (including interest that accrues after the commencement of a Bankruptcy Case, regardless of whether such interest is an allowed claim under such Bankruptcy Case), letter of credit
commissions, reimbursement obligations, charges, expenses, fees, attorneys costs, indemnities and other amounts payable by a Grantor under any Additional First-Lien Document. 

“Additional First-Lien Secured Party” means the holders of any Additional First-Lien Obligations and any Authorized
Representative with respect thereto, and shall include the Initial Additional First-Lien Secured Parties. 
 “Additional First-Lien
Security Document” means any collateral agreement, security agreement or any other document now existing or entered into after the date hereof that creates Liens on any assets or properties of any Grantor to secure the Additional First-Lien
Obligations. 

 “Additional Senior Class Debt” has the meaning assigned to such term in
Section 5.13. 
 “Additional Senior Class Debt Parties” has the meaning assigned to such term in Section 5.13.

 “Additional Senior Class Debt Representative” has the meaning assigned to such term in Section 5.13. 

“Administrative Agent” has the meaning assigned to such term in the definition of “Credit Agreement” and shall
include any successor administrative agent (including as a result of any Refinancing or other modification of the Credit Agreement permitted by Section 2.08). 

“Agreement” has the meaning assigned to such term in the introductory paragraph of this Agreement. 

“Applicable Authorized Representative” means at any time from and after the time that the Notes Collateral Agent becomes the
Controlling Collateral Agent, the Major Non-Controlling Authorized Representative. 
 “Authorized Representative” means, at
any time, (i) in the case of any Credit Agreement Obligations or the Credit Agreement Secured Parties, the Administrative Agent, (ii) in the case of the Initial Additional First-Lien Obligations or the Initial Additional First-Lien Secured
Parties, the Initial Additional Authorized Representative, and (iii) in the case of any other Series of Additional First-Lien Obligations or Additional First-Lien Secured Parties that become subject to this Agreement after the date hereof, the
collateral agent named as authorized representative for such Series in the applicable Joinder Agreement. 
 “Bankruptcy
Case” has the meaning assigned to such term in Section 2.05(b). 
 “Bankruptcy Code” means Title 11 of the
United States Code, as amended, or any similar federal or state law for the relief of debtors. 
 “Bankruptcy Law” means
the Bankruptcy Code and any similar federal, state or foreign law for the relief of debtors. 
 “Borrower” has the meaning
assigned to such term in the introductory paragraph of this Agreement. 
 “Collateral” means all assets and properties
subject to Liens created pursuant to any First-Lien Security Document to secure one or more Series of First-Lien Obligations. 

“Collateral Agent” means (i) in the case of any Credit Agreement Obligations, the Credit Agreement Collateral Agent,
(ii) in the case of the Initial Additional First-Lien Obligations, the Notes Collateral Agent and (iii) in the case of any other Series of Additional First-Lien Obligations, the collateral agent named as Authorized Representative for such
Series in the applicable Joinder Agreement. 
 “Controlling Collateral Agent” means (i) until the earlier of
(x) the Discharge of Credit Agreement Obligations and (y) the Non-Controlling Authorized Representative Enforcement Date, the Credit Agreement Collateral Agent and (ii) from and after the earlier of (x) the Discharge of Credit
Agreement Obligations and (y) the Non-Controlling Authorized Representative Enforcement Date, the Notes Collateral Agent (acting on the instructions of the Applicable Authorized Representative). 

  
 -2- 

 “Controlling Secured Parties” means, with respect to any Shared Collateral,
(i) at any time when the Credit Agreement Collateral Agent is the Controlling Collateral Agent, the Credit Agreement Secured Parties and (ii) at any other time, the Series of First-Lien Secured Parties whose Authorized Representative is
the Applicable Authorized Representative for such Shared Collateral. 
 “Credit Agreement” means that certain Credit
Agreement, dated as of June 24, 2014, among Borrower, the lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (in such capacity and together with its successors in such capacity, the
“Administrative Agent”) and the other parties thereto, as further amended, restated, amended and restated, extended, supplemented or otherwise modified from time to time. 

“Credit Agreement Collateral Agent” has the meaning assigned to such term in the introductory paragraph of this Agreement.

 “Credit Agreement Obligations” means all “Obligations” as defined in the Credit Agreement. 

“Credit Agreement Secured Parties” means the “Secured Parties” as defined in the Credit Agreement. 

“Credit Agreement Security Documents” means the Security Agreement, the other Security Documents (as defined in the Credit
Agreement) and each other agreement entered into in favor of the Credit Agreement Collateral Agent for the purpose of securing any Credit Agreement Obligations. 

“DIP Financing” has the meaning assigned to such term in Section 2.05(b). 

“DIP Financing Liens” has the meaning assigned to such term in Section 2.05(b). 

“DIP Lenders” has the meaning assigned to such term in Section 2.05(b). 

“Discharge” means, with respect to any Shared Collateral and any Series of First-Lien Obligations, the date on which such
Series of First-Lien Obligations is no longer secured by such Shared Collateral. The term “Discharged” shall have a corresponding meaning. 

“Discharge of Credit Agreement Obligations” means, with respect to any Shared Collateral, the Discharge of the Credit
Agreement Obligations with respect to such Shared Collateral; provided that the Discharge of Credit Agreement Obligations shall not be deemed to have occurred in connection with a Refinancing of such Credit Agreement Obligations with
additional First-Lien Obligations secured by such Shared Collateral under an Additional First-Lien Document which has been designated in writing by the Administrative Agent (under the Credit Agreement so Refinanced) to the Notes Collateral Agent and
each other Authorized Representative as the “Credit Agreement” for purposes of this Agreement. 
 “Event of
Default” means an “Event of Default” (or similarly defined term) as defined in any Secured Credit Document. 

“First-Lien Obligations” means, collectively, (i) the Credit Agreement Obligations and (ii) each Series of
Additional First-Lien Obligations. 
 “First-Lien Secured Parties” means (i) the Credit Agreement Secured Parties and
(ii) the Additional First-Lien Secured Parties with respect to each Series of Additional First-Lien Obligations. 

  
 -3- 

 “First-Lien Security Documents” means, collectively, (i) the Credit
Agreement Security Documents and (ii) the Additional First-Lien Security Documents. 
 “Grantors” means the Borrower
and each of the Guarantors (as defined in the Credit Agreement) which has granted a security interest pursuant to any First-Lien Security Document to secure any Series of First-Lien Obligations. The Grantors existing on the date hereof are set forth
in Annex I hereto. 
 “Impairment” has the meaning assigned to such term in Section 1.03. 

“Initial Additional Authorized Representative” has the meaning assigned to such term in the introductory paragraph of this
Agreement. 
 “Initial Additional First-Lien Agreement” mean that certain [Indenture] [Other Agreement], dated as of
[            ], among the Borrower, [the Guarantors identified therein,] and
[                    ], as [trustee], as amended, restated, amended and restated, extended, supplemented or otherwise modified from time to time.

 “Initial Additional First-Lien Documents” means the Initial Additional First-Lien Agreement, the debt securities issued
thereunder, the Initial Additional First-Lien Security Agreement and any security documents and other operative agreements evidencing or governing the Indebtedness thereunder, and the Liens securing such Indebtedness. 

“Initial Additional First-Lien Obligations” means the [Obligations] as such term is defined in the Initial Additional
First-Lien Security Agreement. 
 “Initial Additional First-Lien Secured Parties” means the Notes Collateral Agent, the
Initial Additional Authorized Representative and the holders of the Initial Additional First-Lien Obligations issued pursuant to the Initial Additional First-Lien Agreement. 

“Initial Additional First-Lien Security Agreement” means the security agreement, dated as of the date hereof, among the
Borrower, the Notes Collateral Agent and the other parties thereto, as amended, restated, amended and restated, extended, supplemented or otherwise modified from time to time. 

“Insolvency or Liquidation Proceeding” means: 

(1) any case commenced by or against the Borrower or any other Grantor under any Bankruptcy Law, any other proceeding for the
reorganization, recapitalization or adjustment or marshalling of the assets or liabilities of the Borrower or any other Grantor, any receivership or assignment for the benefit of creditors relating to the Borrower or any other Grantor or any similar
case or proceeding relative to the Borrower or any other Grantor or its creditors, as such, in each case whether or not voluntary; 

(2) any liquidation, dissolution, marshalling of assets or liabilities or other winding up of or relating to the Borrower or
any other Grantor, in each case whether or not voluntary and whether or not involving bankruptcy or insolvency; or 
 (3) any
other proceeding of any type or nature in which substantially all claims of creditors of the Borrower or any other Grantor are determined and any payment or distribution is or may be made on account of such claims. 

“Intervening Creditor” has the meaning assigned to such term in Section 2.01(a). 

  
 -4- 

 “Joinder Agreement” means a joinder to this Agreement substantially in the form
of Annex II hereto. 
 “Lien” means any mortgage, deed of trust, pledge, hypothecation, assignment, deposit arrangement,
encumbrance, lien (statutory or other), charge, or preference, priority or other security interest or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement, any easement, right
of way or other encumbrance on title to real property, and any Capitalized Lease having substantially the same economic effect as any of the foregoing). 

“Major Non-Controlling Authorized Representative” means, with respect to any Shared Collateral, (i) at any time when the
Credit Agreement Collateral Agent is the Controlling Collateral Agent, the Authorized Representative of the Series of Additional First-Lien Obligations, if any, that constitutes the largest outstanding principal amount of any then outstanding Series
of First-Lien Obligations (including the Credit Agreement Obligations) and (ii) at any time when the Notes Collateral Agent is the Controlling Collateral Agent, the Authorized Representative of the Series of Additional First-Lien Obligations
that constitutes the largest outstanding principal amount of any then outstanding Series of First-Lien Obligations (other than Credit Agreement Obligations) with respect to such Shared Collateral. 

“New York UCC” means the Uniform Commercial Code as from time to time in effect in the State of New York. 

“Non-Controlling Authorized Representative” means, at any time with respect to any Shared Collateral, any Authorized
Representative that is not the Applicable Authorized Representative at such time with respect to such Shared Collateral. 

“Non-Controlling Authorized Representative Enforcement Date” means, with respect to any Non-Controlling Authorized
Representative, the date which is [180] days (throughout which [180] day period such Non-Controlling Authorized Representative was the Major Non-Controlling Authorized Representative) after the occurrence of both (i) an Event of Default (under
and as defined in the Additional First-Lien Document under which such Non-Controlling Authorized Representative is the Authorized Representative) and (ii) each Collateral Agent’s and each other Authorized Representative’s
receipt of written notice from such Non-Controlling Authorized Representative certifying that (x) such Non-Controlling Authorized Representative is the Major Non-Controlling Authorized Representative and that an Event of Default (under and as
defined in the Additional First-Lien Document under which such Non-Controlling Authorized Representative is the Authorized Representative) has occurred and is continuing and (y) the Additional First-Lien Obligations of the Series with respect
to which such Non-Controlling Authorized Representative is the Authorized Representative are currently due and payable in full (whether as a result of acceleration thereof or otherwise) in accordance with the terms of the applicable Additional
First-Lien Document; provided that the Non-Controlling Authorized Representative Enforcement Date shall be stayed and shall not occur and shall be deemed not to have occurred with respect to any Shared Collateral (1) at any time the
Administrative Agent or the Credit Agreement Collateral Agent has commenced and is diligently pursuing any enforcement action with respect to such Shared Collateral or (2) at any time the Grantor which has granted a security interest in such
Shared Collateral is then a debtor under or with respect to (or otherwise subject to) any Insolvency or Liquidation Proceeding. 

“Non-Controlling Secured Parties” means, with respect to any Shared Collateral, the First-Lien Secured Parties which are not
Controlling Secured Parties with respect to such Shared Collateral. 
 “Notes Collateral Agent” means (a) prior to the
Discharge of the Initial Additional First-Lien Obligations, [                     ] and (b) after the Discharge of the Initial Additional
First-Lien Obligations, the Authorized Representative for the Series of Additional First-Lien Obligations that constitutes the largest outstanding principal amount of any then outstanding Series of Additional First-Lien Obligations. 

  
 -5- 

 “Possessory Collateral” means any Shared Collateral in the possession of a
Collateral Agent (or its agents or bailees), to the extent that possession thereof perfects a Lien thereon under the Uniform Commercial Code of any jurisdiction. Possessory Collateral includes, without limitation, any Certificated Securities,
Promissory Notes, Instruments, and Chattel Paper, in each case, delivered to or in the possession of the Collateral Agent under the terms of the First-Lien Security Documents. 

“Proceeds” has the meaning assigned to such term in Section 2.01(a). 

“Refinance” means, in respect of any indebtedness, to refinance, extend, renew, defease, amend, increase, modify, supplement,
restructure, refund, replace or repay, or to issue other indebtedness or enter into alternative financing arrangements, in exchange or replacement for such indebtedness (in whole or in part), including by adding or replacing lenders, creditors,
agents, borrowers and/or guarantors, and including in each case, but not limited to, after the original instrument giving rise to such indebtedness has been terminated and including, in each case, through any credit agreement, indenture or other
agreement. “Refinanced” and “Refinancing” have correlative meanings. 
 “Secured Credit
Document” means (i) the Credit Agreement and each Loan Document (as defined in the Credit Agreement), (ii) each Initial Additional First-Lien Document, and (iii) each Additional First-Lien Document for Additional First-Lien
Obligations incurred after the date hereof. 
 “Security Agreement” means the Security Agreement, dated as of June 24,
2014, among Borrower, the Administrative Agent and the other parties thereto, as amended, restated, amended and restated, extended, supplemented or otherwise modified from time to time. 

“Series” means (a) with respect to the First-Lien Secured Parties, each of (i) the Credit Agreement Secured Parties
(in their capacities as such), (ii) the Initial Additional First-Lien Secured Parties (in their capacities as such), and (iii) the Additional First-Lien Secured Parties (in their capacities as such) that become subject to this Agreement
after the date hereof that are represented by a common Authorized Representative (in its capacity as such for such Additional First-Lien Secured Parties) and (b) with respect to any First-Lien Obligations, each of (i) the Credit Agreement
Obligations, (ii) the Initial Additional First-Lien Obligations, and (iii) the Additional First-Lien Obligations incurred after the date hereof pursuant to any Additional First-Lien Document, which pursuant to any Joinder Agreement, are to
be represented hereunder by a common Authorized Representative (in its capacity as such for such Additional First-Lien Obligations). 

“Shared Collateral” means, at any time, Collateral in which the holders of two or more Series of First-Lien Obligations hold
a valid and perfected security interest at such time. If more than two Series of First-Lien Obligations are outstanding at any time and the holders of less than all Series of First-Lien Obligations hold a valid and perfected security interest in any
Collateral at such time, then such Collateral shall constitute Shared Collateral for those Series of First-Lien Obligations that hold a valid security interest in such Collateral at such time and shall not constitute Shared Collateral for any Series
which does not have a valid and perfected security interest in such Collateral at such time. 
 SECTION 1.02 Terms Generally. The
definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”,
“includes” and “including” shall be deemed to be followed by the phrase “without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. Unless the
context requires otherwise, 

  
 -6- 

 
(i) any definition of or reference to any agreement, instrument, other document, statute or regulation herein shall be construed as referring to such agreement, instrument, other document,
statute or regulation as from time to time amended, supplemented or otherwise modified, (ii) any reference herein to any Person shall be construed to include such Person’s successors and assigns, but shall not be deemed to include the
subsidiaries of such Person unless express reference is made to such subsidiaries, (iii) the words “herein”, “hereof” and “hereunder”, and words of similar import, shall be construed to refer to this Agreement in
its entirety and not to any particular provision hereof, (iv) all references herein to Articles, Sections and Annexes shall be construed to refer to Articles, Sections and Annexes of this Agreement, (v) unless otherwise expressly qualified
herein, the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights
and (vi) the term “or” is not exclusive. 
 SECTION 1.03 Impairments. It is the intention of the First-Lien Secured
Parties of each Series that the holders of First-Lien Obligations of such Series (and not the First-Lien Secured Parties of any other Series) bear the risk of (i) any determination by a court of competent jurisdiction that (x) any of the
First-Lien Obligations of such Series are unenforceable under applicable law or are subordinated to any other obligations (other than another Series of First-Lien Obligations), (y) any of the First-Lien Obligations of such Series do not have an
enforceable security interest in any of the Collateral securing any other Series of First-Lien Obligations and/or (z) any intervening security interest exists securing any other obligations (other than another Series of First-Lien Obligations)
on a basis ranking prior to the security interest of such Series of First-Lien Obligations but junior to the security interest of any other Series of First-Lien Obligations or (ii) the existence of any Collateral for any other Series of
First-Lien Obligations that is not Shared Collateral (any such condition referred to in the foregoing clauses (i) or (ii) with respect to any Series of First-Lien Obligations, an “Impairment” of such Series);
provided that the existence of a maximum claim with respect to any Real Property (as defined in the Credit Agreement) with a fair market value in excess of $20,000,000 subject to a mortgage that applies to all First-Lien Obligations shall not
be deemed to be an Impairment of any Series of First-Lien Obligations. In the event of any Impairment with respect to any Series of First-Lien Obligations, the results of such Impairment shall be borne solely by the holders of such Series of
First-Lien Obligations, and the rights of the holders of such Series of First-Lien Obligations (including, without limitation, the right to receive distributions in respect of such Series of First-Lien Obligations pursuant to Section 2.01) set
forth herein shall be modified to the extent necessary so that the effects of such Impairment are borne solely by the holders of the Series of such First-Lien Obligations subject to such Impairment. Additionally, in the event the First-Lien
Obligations of any Series are modified pursuant to applicable law (including, without limitation, pursuant to Section 1129 of the Bankruptcy Code), any reference to such First-Lien Obligations or the First-Lien Security Documents governing such
First-Lien Obligations shall refer to such obligations or such documents as so modified. 
 ARTICLE II 

Priorities and Agreements with Respect to Shared Collateral 

SECTION 2.01 Priority of Claims. 

(a) Anything contained herein or in any of the Secured Credit Documents to the contrary notwithstanding (but subject to Section 1.03), if
an Event of Default has occurred and is continuing, and the Controlling Collateral Agent or any First-Lien Secured Party is taking action to enforce rights in respect of any Shared Collateral, or any distribution is made in respect of any Shared
Collateral in any Bankruptcy Case of the Borrower or any other Grantor or any First-Lien Secured Party receives any payment pursuant to any intercreditor agreement (other than this Agreement) with respect to any Shared Collateral, the proceeds of
any sale, collection or other liquidation of any such Collateral by the Controlling Collateral Agent or any First-Lien Secured Party on account of such enforcement of rights or remedies or 

  
 -7- 

 
received by the Controlling Collateral Agent or any First-Lien Secured Party pursuant to any such intercreditor agreement with respect to such Shared Collateral and proceeds of any such
distribution (subject, in the case of any such distribution, to the sentence immediately following) to which the First-Lien Obligations are entitled under any intercreditor agreement (other than this Agreement) (all proceeds of any sale, collection
or other liquidation of any Collateral and all proceeds of any such distribution being collectively referred to as “Proceeds”), shall be applied (i) FIRST, to the payment of all amounts owing to each Collateral Agent (in its
capacity as such) pursuant to the terms of any Secured Credit Document, (ii) SECOND, subject to Section 1.03, to the payment in full of the First-Lien Obligations of each Series on a ratable basis, with such Proceeds to be applied to the
First-Lien Obligations of a given Series in accordance with the terms of the applicable Secured Credit Documents and (iii) THIRD, after payment of all First-Lien Obligations, to the Borrower and the other Grantors or their successors or
assigns, as their interests may appear, or to whomsoever may be lawfully entitled to receive the same, or as a court of competent jurisdiction may direct. Notwithstanding the foregoing, with respect to any Shared Collateral for which a third party
(other than a First-Lien Secured Party) has a lien or security interest that is junior in priority to the security interest of any Series of First-Lien Obligations but senior (as determined by appropriate legal proceedings in the case of any
dispute) to the security interest of any other Series of First-Lien Obligations (such third party, an “Intervening Creditor”), the value of any Shared Collateral or Proceeds allocated to such Intervening Creditor shall be deducted
on a ratable basis solely from the Shared Collateral or Proceeds to be distributed in respect of the Series of First-Lien Obligations with respect to which such Impairment exists. 

(b) Notwithstanding the date, time, method, manner or order of grant, attachment or perfection of any Liens securing any Series of First-Lien
Obligations granted on the Shared Collateral and notwithstanding any provision of the Uniform Commercial Code of any jurisdiction, or any other applicable law or the Secured Credit Documents or any defect or deficiencies in the Liens securing the
First-Lien Obligations of any Series or any other circumstance whatsoever (but, in each case, subject to Section 1.03), each First-Lien Secured Party hereby agrees that the Liens securing each Series of First-Lien Obligations on any Shared
Collateral shall be of equal priority. 
 (c) Notwithstanding anything in this Agreement or any other First-Lien Security Documents to the
contrary, Collateral consisting of cash and cash equivalents pledged to secure Credit Agreement Obligations consisting of reimbursement obligations in respect of Letters of Credit or otherwise held by the Credit Agreement Collateral Agent pursuant
to Section 3.10, 2.26 or Section 8 of the Credit Agreement (or any equivalent successor provision) shall be applied as specified in the Credit Agreement and will not constitute Shared Collateral. 

SECTION 2.02 Actions with Respect to Shared Collateral; Prohibition on Contesting Liens. 

(a) Only the Controlling Collateral Agent shall act or refrain from acting with respect to any Shared Collateral (including with respect to
any intercreditor agreement with respect to any Shared Collateral). At any time when the Credit Agreement Collateral Agent is the Controlling Collateral Agent, no Additional First-Lien Secured Party shall or shall instruct any Collateral Agent to,
and neither the Notes Collateral Agent nor any other Collateral Agent that is not the Controlling Collateral Agent shall, commence any judicial or nonjudicial foreclosure proceedings with respect to, seek to have a trustee, receiver, liquidator or
similar official appointed for or over, attempt any action to take possession of, exercise any right, remedy or power with respect to, or otherwise take any action to enforce its security interest in or realize upon, or take any other action
available to it in respect of, any Shared Collateral (including with respect to any intercreditor agreement with respect to any Shared Collateral), whether under any Additional First-Lien Security Document, applicable law or otherwise, it being
agreed that only the Credit Agreement Collateral Agent, acting in accordance with the Credit Agreement Collateral Documents, shall be entitled to take any such actions or exercise any such remedies with respect to Shared Collateral at such time.

  
 -8- 

 (b) With respect to any Shared Collateral at any time when the Notes Collateral Agent is the
Controlling Collateral Agent, (i) the Controlling Collateral Agent shall act only on the instructions of the Applicable Authorized Representative, (ii) the Controlling Collateral Agent shall not follow any instructions with respect to such
Shared Collateral (including with respect to any intercreditor agreement with respect to any Shared Collateral) from any Non-Controlling Authorized Representative (or any other First-Lien Secured Party other than the Applicable Authorized
Representative) and (iii) no Non-Controlling Authorized Representative or other First-Lien Secured Party (other than the Applicable Authorized Representative) shall or shall instruct the Controlling Collateral Agent to, commence any judicial or
non-judicial foreclosure proceedings with respect to, seek to have a trustee, receiver, liquidator or similar official appointed for or over, attempt any action to take possession of, exercise any right, remedy or power with respect to, or otherwise
take any action to enforce its security interest in or realize upon, or take any other action available to it in respect of, any Shared Collateral (including with respect to any intercreditor agreement with respect to any Shared Collateral), whether
under any First-Lien Security Document, applicable law or otherwise, it being agreed that only the Controlling Collateral Agent, acting on the instructions of the Applicable Authorized Representative and in accordance with the applicable Additional
First-Lien Security Documents, shall be entitled to take any such actions or exercise any such remedies with respect to Shared Collateral. 

(c) Notwithstanding the equal priority of the Liens securing each Series of First-Lien Obligations, the Controlling Collateral Agent may deal
with the Shared Collateral as if such Controlling Collateral Agent had a senior Lien on such Collateral. No Non-Controlling Authorized Representative or Non-Controlling Secured Party will contest, protest or object to any foreclosure proceeding or
action brought by the Controlling Collateral Agent, the Applicable Authorized Representative or the Controlling Secured Party or any other exercise by the Controlling Collateral Agent, the Applicable Authorized Representative or the Controlling
Secured Party of any rights and remedies relating to the Shared Collateral, or to cause the Controlling Collateral Agent to do so. The foregoing shall not be construed to limit the rights and priorities of any First-Lien Secured Party, the
Controlling Collateral Agent or any Authorized Representative with respect to any Collateral not constituting Shared Collateral. 
 (d) Each
of the First-Lien Secured Parties agrees that it will not (and hereby waives any right to) question or contest or support any other Person in contesting, in any proceeding (including any Insolvency or Liquidation Proceeding), the perfection,
priority, validity, attachment or enforceability of a Lien held by or on behalf of any of the First-Lien Secured Parties in all or any part of the Collateral, or the provisions of this Agreement; provided that nothing in this Agreement shall
be construed to prevent or impair the rights of any Collateral Agent or any Authorized Representative to enforce this Agreement. 
 SECTION
2.03 No Interference; Payment Over. 
 (a) Each First-Lien Secured Party agrees that (i) it will not challenge or question in any
proceeding the validity or enforceability of any First-Lien Obligations of any Series or any First-Lien Security Document or the validity, attachment, perfection or priority of any Lien under any First-Lien Security Document or the validity or
enforceability of the priorities, rights or duties established by or other provisions of this Agreement; (ii) it will not take or cause to be taken any action the purpose or intent of which is, or could be, to interfere, hinder or delay, in any
manner, whether by judicial proceedings or otherwise, any sale, transfer or other disposition of the Shared Collateral by the Controlling Collateral Agent, (iii) except as provided in Section 2.02, it shall have no right to (A) direct the
Controlling Collateral Agent or any other First-Lien Secured Party to exercise, and shall not exercise, any right, remedy or power with respect to any Shared Collateral (including pursuant to any intercreditor agreement) or (B) consent to the

  
 -9- 

 
exercise by the Controlling Collateral Agent or any other First-Lien Secured Party of any right, remedy or power with respect to any Shared Collateral, (iv) it will not institute any suit or
assert in any suit, bankruptcy, insolvency or other proceeding any claim against the Controlling Collateral Agent or any other First-Lien Secured Party seeking damages from or other relief by way of specific performance, instructions or otherwise
with respect to any Shared Collateral, and none of the Controlling Collateral Agent, any Applicable Authorized Representative or any other First-Lien Secured Party shall be liable for any action taken or omitted to be taken by the Controlling
Collateral Agent, such Applicable Authorized Representative or other First-Lien Secured Party with respect to any Shared Collateral in accordance with the provisions of this Agreement, (v) it will not seek, and hereby waives any right, to have
any Shared Collateral or any part thereof marshaled upon any foreclosure or other disposition of such Collateral and (vi) it will not attempt, directly or indirectly, whether by judicial proceedings or otherwise, to challenge the enforceability
of any provision of this Agreement; provided that nothing in this Agreement shall be construed to prevent or impair the rights of any of the Controlling Collateral Agent or any other First-Lien Secured Party to enforce this Agreement. 

(b) Each First-Lien Secured Party hereby agrees that if it shall obtain possession of any Shared Collateral or shall realize any proceeds or
payment in respect of any such Shared Collateral, pursuant to any First-Lien Security Document or by the exercise of any rights available to it under applicable law or in any Insolvency or Liquidation Proceeding or through any other exercise of
remedies (including pursuant to any intercreditor agreement), at any time prior to the Discharge of each of the First-Lien Obligations, then it shall hold such Shared Collateral, proceeds or payment in trust for the other First-Lien Secured Parties
and promptly transfer such Shared Collateral, proceeds or payment, as the case may be, to the Controlling Collateral Agent, to be distributed in accordance with the provisions of Section 2.01 hereof. 

SECTION 2.04 Automatic Release of Liens; Amendments to First-Lien Security Documents. 

(a) If, at any time the Controlling Collateral Agent forecloses upon or otherwise exercises remedies against any Shared Collateral resulting in
a sale or disposition thereof, then (whether or not any Insolvency or Liquidation Proceeding is pending at the time) the Liens in favor of each other Collateral Agent for the benefit of each Series of First-Lien Secured Parties upon such Shared
Collateral will automatically be released and discharged as and when, but only to the extent, such Liens of the Controlling Collateral Agent on such Shared Collateral are released and discharged; provided that any proceeds of any Shared
Collateral realized therefrom shall be applied pursuant to Section 2.01. 
 (b) Each Collateral Agent and Authorized Representative
agrees to execute and deliver all such authorizations and other instruments as shall reasonably be requested by the Controlling Collateral Agent to evidence and confirm any release of Shared Collateral provided for in this Section. 

SECTION 2.05 Certain Agreements with Respect to Bankruptcy or Insolvency Proceedings. 

(a) This Agreement shall continue in full force and effect notwithstanding the commencement of any proceeding under the Bankruptcy Code or any
other Federal, state or foreign bankruptcy, insolvency, receivership or similar law by or against the Borrower or any of its Subsidiaries. The parties hereto acknowledge that the provisions of this Agreement are intended to be enforceable as
contemplated by Section 510(a) of the Bankruptcy Code. 
 (b) If the Borrower and/or any other Grantor shall become subject to a case
(a “Bankruptcy Case”) under the Bankruptcy Code and shall, as debtor(s)-in-possession, move for approval of financing (“DIP Financing”)
to be provided by one or more lenders (the “DIP Lenders”) under Section 364 of the Bankruptcy Code or any equivalent provision of any other Bankruptcy Law or the use of cash collateral

  
 -10- 

 
under Section 363 of the Bankruptcy Code or any equivalent provision of any other Bankruptcy Law, each First-Lien Secured Party (other than any Controlling Secured Party or the Authorized
Representative of any Controlling Secured Party) agrees that it will raise no objection to any such financing or to the Liens on the Shared Collateral securing the same (“DIP Financing Liens”) or to any use of cash collateral that
constitutes Shared Collateral, unless the Controlling Collateral Agent (in the case of the Notes Collateral Agent, acting on the instructions of the Applicable Authorized Representative) shall then oppose or object to such DIP Financing or such DIP
Financing Liens or use of cash collateral (and (i) to the extent that such DIP Financing Liens are senior to the Liens on any such Shared Collateral for the benefit of the Controlling Secured Parties, each Non-Controlling Secured Party will
subordinate its Liens with respect to such Shared Collateral on the same terms as the Liens of the Controlling Secured Parties (other than any Liens of any First-Lien Secured Parties constituting DIP Financing Liens) are subordinated thereto, and
(ii) to the extent that such DIP Financing Liens rank pari passu with the Liens on any such Shared Collateral granted to secure the First-Lien Obligations of the Controlling Secured Parties, each Non-Controlling Secured Party will
confirm the priorities with respect to such Shared Collateral as set forth herein), in each case so long as (A) the First-Lien Secured Parties of each Series retain the benefit of their Liens on all such Shared Collateral pledged to the DIP
Lenders, including proceeds thereof arising after the commencement of such proceeding, with the same priority vis-à-vis all the other First-Lien Secured Parties (other than any Liens of the First-Lien Secured Parties constituting DIP
Financing Liens) as existed prior to the commencement of the Bankruptcy Case, (B) the First-Lien Secured Parties of each Series are granted Liens on any additional collateral pledged to any First-Lien Secured Parties as adequate protection or
otherwise in connection with such DIP Financing or use of cash collateral, with the same priority vis-à-vis the First-Lien Secured Parties as set forth in this Agreement, (C) if any amount of such DIP Financing or cash collateral is
applied to repay any of the First-Lien Obligations, such amount is applied pursuant to Section 2.01, and (D) if any First-Lien Secured Parties are granted adequate protection, including in the form of periodic payments, in connection with
such DIP Financing or use of cash collateral, the proceeds of such adequate protection are applied pursuant to Section 2.01; provided that this Agreement shall not limit the right of the First-Lien Secured Parties of each Series to
object to the grant of a Lien to secure the DIP Financing over any Collateral subject to Liens in favor of the First-Lien Secured Parties of such Series or its Authorized Representative that shall not constitute Shared Collateral; and
provided, further, that the First-Lien Secured Parties receiving adequate protection shall not object to any other First-Lien Secured Party receiving adequate protection comparable to any adequate protection granted to such First-Lien
Secured Parties in connection with a DIP Financing or use of cash collateral. 
 SECTION 2.06 Reinstatement. In the event that any of
the First-Lien Obligations shall be paid in full and such payment or any part thereof shall subsequently, for whatever reason (including an order or judgment for disgorgement of a preference under the Bankruptcy Code, or any similar law, or the
settlement of any claim in respect thereof), be required to be returned or repaid, the terms and conditions of this Article II shall be fully applicable thereto until all such First-Lien Obligations shall again have been paid in full in cash. 

SECTION 2.07 Insurance. As between the First-Lien Secured Parties, the Controlling Collateral Agent shall have the right to adjust or
settle any insurance policy or claim covering or constituting Shared Collateral in the event of any loss thereunder and to approve any award granted in any condemnation or similar proceeding affecting the Shared Collateral. 

SECTION 2.08 Refinancings, etc. The First-Lien Obligations of any Series may, subject to the limitations set forth in the then extant
Secured Credit Documents, be increased, extended, renewed, replaced, restated, supplemented, restructured, repaid, refunded, Refinanced (in whole or in part) or otherwise amended or modified from time to time, in each case, without notice to, or the
consent (except to the extent a consent is otherwise required to permit the Refinancing transaction under any Secured Credit Document) of any First-Lien Secured Party of any other Series, all without affecting the priorities

  
 -11- 

 
provided for herein or the other provisions hereof; provided that the Authorized Representative of the holders of any such Refinancing indebtedness shall have executed a Joinder Agreement
on behalf of the holders of such Refinancing indebtedness. 
 SECTION 2.09 Possessory Collateral Agent as Gratuitous Bailee for
Perfection. 
 (a) The Possessory Collateral shall be delivered to the Credit Agreement Collateral Agent and the Credit Agreement
Collateral Agent agrees to hold any Shared Collateral constituting Possessory Collateral that is part of the Collateral in its possession or control (or in the possession or control of its agents or bailees) as gratuitous bailee for the benefit of
each other First-Lien Secured Party and any assignee solely for the purpose of perfecting the security interest granted in such Possessory Collateral, if any, pursuant to the applicable First-Lien Security Documents, in each case, subject to the
terms and conditions of this Section 2.09; provided that at any time the Credit Agreement Collateral Agent is not the Controlling Collateral Agent, the Credit Agreement Collateral Agent shall, at the request of the Notes Collateral
Agent, promptly deliver all Possessory Collateral to the Notes Collateral Agent together with any necessary endorsements (or otherwise allow the Notes Collateral Agent to obtain control of such Possessory Collateral). The Borrower shall take such
further action as is required to effectuate the transfer contemplated hereby and shall indemnify each Collateral Agent for loss or damage suffered by such Collateral Agent as a result of such transfer except for loss or damage suffered by such
Collateral Agent as a result of its own willful misconduct, gross negligence or bad faith. 
 (b) The Controlling Collateral Agent agrees to
hold any Shared Collateral constituting Possessory Collateral, from time to time in its possession, as gratuitous bailee for the benefit of each other First-Lien Secured Party and any assignee, solely for the purpose of perfecting the security
interest granted in such Possessory Collateral, if any, pursuant to the applicable First-Lien Security Documents, in each case, subject to the terms and conditions of this Section 2.09. 

(c) The duties or responsibilities of each Collateral Agent under this Section 2.09 shall be limited solely to holding any Shared
Collateral constituting Possessory Collateral as gratuitous bailee for the benefit of each other First-Lien Secured Party for purposes of perfecting the Lien held by such First-Lien Secured Parties thereon. 

SECTION 2.10 Amendments to Security Documents. 

(a) Without the prior written consent of the Credit Agreement Collateral Agent, each Additional First-Lien Secured Party agrees that no
Additional First-Lien Security Document may be amended, supplemented or otherwise modified or entered into to the extent such amendment, supplement or modification, or the terms of any new Additional First-Lien Security Document would be prohibited
by, or would require any Grantor to act or refrain from acting in a manner that would violate, any of the terms of this Agreement. 
 (b)
Without the prior written consent of the Notes Collateral Agent, the Credit Agreement Collateral Agent agrees that no Credit Agreement Security Document may be amended, supplemented or otherwise modified or entered into to the extent such amendment,
supplement or modification, or the terms of any new Credit Agreement Security Document would be prohibited by, or would require any Grantor to act or refrain from acting in a manner that would violate, any of the terms of this Agreement. 

(c) In making determinations required by this Section 2.10, each Collateral Agent may conclusively rely on a certificate of an Authorized
Officer of the Borrower. 

  
 -12- 

 ARTICLE III 

Existence and Amounts of Liens and Obligations 

SECTION 3.01 Determinations with Respect to Amounts of Liens and Obligations. Whenever a Collateral Agent or any Authorized
Representative shall be required, in connection with the exercise of its rights or the performance of its obligations hereunder, to determine the existence or amount of any First-Lien Obligations of any Series, or the Shared Collateral subject to
any Lien securing the First-Lien Obligations of any Series, it may request that such information be furnished to it in writing by each other Authorized Representative or Collateral Agent and shall be entitled to make such determination or not make
any determination on the basis of the information so furnished; provided, however, that if an Authorized Representative or a Collateral Agent shall fail or refuse reasonably promptly to provide the requested information, the requesting
Collateral Agent or Authorized Representative shall be entitled to make any such determination by such method as it may, in the exercise of its good faith judgment, determine, including by reliance upon a certificate of the Borrower. Each Collateral
Agent and each Authorized Representative may rely conclusively, and shall be fully protected in so relying, on any determination made by it in accordance with the provisions of the preceding sentence (or as otherwise directed by a court of competent
jurisdiction) and shall have no liability to any Grantor, any First-Lien Secured Party or any other person as a result of such determination. 

ARTICLE IV 
 The Controlling
Collateral Agent 
 ARTICLE 4.01 Authority. 

(a) Notwithstanding any other provision of this Agreement, nothing herein shall be construed to impose any fiduciary or other duty on any
Controlling Collateral Agent to any Non-Controlling Secured Party or give any Non-Controlling Secured Party the right to direct any Controlling Collateral Agent, except that each Controlling Collateral Agent shall be obligated to distribute proceeds
of any Shared Collateral in accordance with Section 2.01 hereof. 
 (b) In furtherance of the foregoing, each Non-Controlling Secured
Party acknowledges and agrees that the Controlling Collateral Agent shall be entitled, for the benefit of the First-Lien Secured Parties, to sell, transfer or otherwise dispose of or deal with any Shared Collateral as provided herein and in the
First-Lien Security Documents, as applicable, pursuant to which the Controlling Collateral Agent is the collateral agent for such Shared Collateral, without regard to any rights to which the Non-Controlling Secured Parties would otherwise be
entitled as a result of the First-Lien Obligations held by such Non-Controlling Secured Parties. Without limiting the foregoing, each Non-Controlling Secured Party agrees that none of the Controlling Collateral Agent, the Applicable Authorized
Representative or any other First-Lien Secured Party shall have any duty or obligation first to marshal or realize upon any type of Shared Collateral (or any other Collateral securing any of the First-Lien Obligations), or to sell, dispose of or
otherwise liquidate all or any portion of such Shared Collateral (or any other Collateral securing any First-Lien Obligations), in any manner that would maximize the return to the Non-Controlling Secured Parties, notwithstanding that the order and
timing of any such realization, sale, disposition or liquidation may affect the amount of proceeds actually received by the Non-Controlling Secured Parties from such realization, sale, disposition or liquidation. Except with respect to any actions
expressly prohibited or required to be taken by this Agreement, each of the First-Lien Secured Parties waives any claim it may now or hereafter have against any Collateral Agent or the Authorized Representative of any other Series of First-Lien
Obligations or any other First-Lien Secured Party of any other Series arising out of (i) any actions which any Collateral Agent, Authorized Representative or the First-Lien Secured Parties take or

  
 -13- 

 
omit to take (including, actions with respect to the creation, perfection or continuation of Liens on any Collateral, actions with respect to the foreclosure upon, sale, release or depreciation
of, or failure to realize upon, any of the Collateral and actions with respect to the collection of any claim for all or any part of the First-Lien Obligations from any account debtor, guarantor or any other party) in accordance with the First-Lien
Security Documents or any other agreement related thereto or to the collection of the First-Lien Obligations or the valuation, use, protection or release of any security for the First-Lien Obligations, (ii) any election by any Applicable
Authorized Representative or any holders of First-Lien Obligations, in any proceeding instituted under the Bankruptcy Code, of the application of Section 1111(b) of the Bankruptcy Code or (iii) subject to Section 2.05, any borrowing
by, or grant of a security interest or administrative expense priority under Section 364 of the Bankruptcy Code or any equivalent provision of any other Bankruptcy Law, by the Borrower or any of its Subsidiaries, as debtor-in-possession.
Notwithstanding any other provision of this Agreement, the Controlling Collateral Agent shall not accept any Shared Collateral in full or partial satisfaction of any First-Lien Obligations pursuant to Section 9-620 of the Uniform Commercial
Code of any jurisdiction, without the consent of each Authorized Representative representing holders of First-Lien Obligations for whom such Collateral constitutes Shared Collateral. 

ARTICLE V 
 Miscellaneous

 SECTION 5.01 Notices. All notices and other communications provided for herein shall be in writing and shall be delivered by
hand or overnight courier service, mailed by certified or registered mail or sent by telecopy, as follows: 
 (a) if to the
Credit Agreement Collateral Agent, to it at [                            ], Attention of
[            ] (Fax No. [                    ]); 

(b) if to the Initial Additional Authorized Representative, to it at [        ],
Attention of [            ] (Fax No. [                    ]); 

(c) if to any other Additional Authorized Representative, to it at the address set forth in the applicable Joinder Agreement.

 Unless otherwise specifically provided herein, any notice or other communication herein required or permitted to be given shall be in
writing and, may be personally served, telecopied, electronically mailed or sent by courier service or U.S. mail and shall be deemed to have been given when delivered in person or by courier service, upon receipt of a telecopy or electronic mail or
upon receipt via U.S. mail (registered or certified, with postage prepaid and properly addressed). For the purposes hereof, the addresses of the parties hereto shall be as set forth above or, as to each party, at such other address as may be
designated by such party in a written notice to all of the other parties. 
 SECTION 5.02 Waivers; Amendment; Joinder Agreements.

 (a) No failure or delay on the part of any party hereto in exercising any right or power hereunder shall operate as a waiver thereof, nor
shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights
and remedies of the parties hereto are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Agreement or consent to any departure by any party therefrom shall in any event be
effective unless the same shall be permitted by Section 5.02(b), and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice or demand on any party hereto in any case shall
entitle such party to any other or further notice or demand in similar or other circumstances. 

  
 -14- 

 (b) Neither this Agreement nor any provision hereof may be terminated, waived, amended or
modified (other than pursuant to any Joinder Agreement) except pursuant to an agreement or agreements in writing entered into by each Authorized Representative and each Collateral Agent (and with respect to any such termination, waiver, amendment or
modification which by the terms of this Agreement requires the Borrower’s consent or which increases the obligations or reduces the rights of or otherwise materially adversely affects the Borrower or any other Grantor, with the consent of the
Borrower). 
 (c) Notwithstanding the foregoing, without the consent of any First-Lien Secured Party (and with respect to any termination,
waiver, amendment or modification which by the terms of this Agreement requires the Borrower’s consent or which increases the obligations or reduces the rights of or otherwise materially adversely affects the Borrower or any other Grantor, with
the consent of the Borrower), any Authorized Representative may become a party hereto by execution and delivery of a Joinder Agreement in accordance with Section 5.13 and upon such execution and delivery, such Authorized Representative and the
Additional First-Lien Secured Parties and Additional First-Lien Obligations of the Series for which such Authorized Representative is acting shall be subject to the terms hereof. 

(d) Notwithstanding the foregoing, in connection with any Refinancing of First-Lien Obligations of any Series, or the incurrence of Additional
First-Lien Obligations of any Series, the Collateral Agents and the Authorized Representatives then party hereto shall enter (and are hereby authorized to enter without the consent of any other First-Lien Secured Party or any Loan Party), at the
request of any Collateral Agent, any Authorized Representative or the Borrower, into such amendments or modifications of this Agreement as are reasonably necessary to reflect such Refinancing or such incurrence and are reasonably satisfactory to
each such Collateral Agent and each such Authorized Representative, provided that any Collateral Agent or Authorized Representative may condition its execution and delivery of any such amendment or modification on a receipt of a certificate
from an Authorized Officer of the Borrower to the effect that such Refinancing or incurrence is permitted by the then existing Secured Credit Documents. 

SECTION 5.03 Parties in Interest. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their
respective successors and assigns, as well as the other First-Lien Secured Parties, all of whom are intended to be bound by, and to be third party beneficiaries of, this Agreement. 

SECTION 5.04 Survival of Agreement. All covenants, agreements, representations and warranties made by any party in this Agreement shall
be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of this Agreement. 

SECTION 5.05 Counterparts. This Agreement may be executed by one or more of the parties to this Agreement on any number of separate
counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Agreement by facsimile or other electronic transmission shall be effective as
delivery of a manually executed counterpart hereof. 
 SECTION 5.06 Severability. Any provision of this Agreement that is prohibited
or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. The parties shall endeavor in good faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic
effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 

  
 -15- 

 SECTION 5.07 GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES
UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 
 SECTION
5.08 Submission to Jurisdiction Waivers; Consent to Service of Process. Each Collateral Agent and each Authorized Representative, on behalf of itself and the First-Lien Secured Parties of the Series for whom it is acting, irrevocably and
unconditionally: 
 (a) submits for itself and its property in any legal action or proceeding relating to this Agreement and
the First-Lien Security Documents, or for recognition and enforcement of any judgment in respect thereof, to the exclusive jurisdiction of the courts the State of New York located in the Borough of Manhattan, the courts of the United States for the
Southern District of New York, and appellate courts from any thereof; 
 (b) consents and agrees that any such action or
proceeding shall be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees
not to plead or claim the same; 
 (c) agrees that service of process in any such action or proceeding may be effected by
mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such Person (or its Authorized Representative) at the address set forth in Section 5.01; 

(d) agrees that nothing herein shall affect the right of any other party hereto (or any First-Lien Secured Party) to effect
service of process in any other manner permitted by law; and 
 (e) waives, to the maximum extent not prohibited by law, any
right it may have to claim or recover in any legal action or proceeding referred to in this Section 5.08 any special, exemplary, punitive or consequential damages. 

SECTION 5.09 WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR
PROCEEDING RELATING TO THIS AGREEMENT OR FOR ANY COUNTERCLAIM THEREIN. 
 SECTION 5.10 Headings. Article, Section and Annex headings
used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement. 

SECTION 5.11 Conflicts. In the event of any conflict or inconsistency between the provisions of this Agreement and the provisions of
any of the First-Lien Security Documents or any of the other Secured Credit Documents, the provisions of this Agreement shall control. 

SECTION 5.12 Provisions Solely to Define Relative Rights. The provisions of this Agreement are and are intended solely for the purpose
of defining the relative rights of the First-Lien Secured Parties in relation to one another. None of the Borrower, any other Grantor or any other creditor thereof shall have any rights or obligations hereunder, except as expressly provided in this
Agreement (provided that 

  
 -16- 

 
nothing in this Agreement (other than Section 2.04, 2.05, 2.08, 2.09 or Article V) is intended to or will amend, waive or otherwise modify the provisions of the Credit Agreement or any
Additional First-Lien Documents), and none of the Borrower or any other Grantor may rely on the terms hereof (other than Sections 2.04, 2.05, 2.08, 2.09 and Article V). Nothing in this Agreement is intended to or shall impair the obligations of any
Grantor, which are absolute and unconditional, to pay the First-Lien Obligations as and when the same shall become due and payable in accordance with their terms. 

SECTION 5.13 Additional Senior Debt. To the extent, but only to the extent permitted by the provisions of the then extant Secured
Credit Documents, the Borrower may incur additional indebtedness after the date hereof that is secured on an equal and ratable basis by the Liens securing the First-Lien Obligations (such indebtedness referred to as “Additional Senior Class
Debt”). Any such Additional Senior Class Debt may be secured by a Lien and may be Guaranteed by the Grantors on a senior basis, in each case under and pursuant to the Additional First-Lien Documents, if and subject to the condition that the
Authorized Representative of any such Additional Senior Class Debt (each, an “Additional Senior Class Debt Representative”), acting on behalf of the holders of such Additional Senior Class Debt (such Authorized Representative and
holders in respect of any Additional Senior Class Debt being referred to as the “Additional Senior Class Debt Parties”), becomes a party to this Agreement as an Authorized Representative by satisfying the conditions set forth in
clauses (i) through (iv) of the immediately succeeding paragraph. 
 In order for an Additional Senior Class Debt Representative
to become a party to this Agreement as an Authorized Representative, 
 (i) such Additional Senior Class Debt Representative,
each Collateral Agent, each Authorized Representative and each Grantor shall have executed and delivered a Joinder Agreement (with such changes as may be reasonably approved by the Collateral Agents and Additional Senior Class Debt Representative)
pursuant to which such Additional Senior Class Debt Representative becomes an Authorized Representative hereunder, and the Additional Senior Class Debt in respect of which such Additional Senior Class Debt Representative is the Authorized
Representative constitutes Additional First-Lien Obligations and the related Additional Senior Class Debt Parties become subject hereto and bound hereby as Additional First-Lien Secured Parties; 

(ii) the Borrower shall have (x) delivered to each Collateral Agent true and complete copies of each of the Additional
First-Lien Documents relating to such Additional Senior Class Debt, certified as being true and correct by an authorized officer of the Borrower and (y) identified in a certificate of an authorized officer the obligations to be designated as
Additional First-Lien Obligations and the initial aggregate principal amount or face amount thereof and certified that such obligations are permitted to be incurred and secured on a pari passu basis with the then extant First-Lien Obligations
and by the terms of the then extant Secured Credit Documents; 
 (iii) all filings, recordations and/or amendments or
supplements to the First-Lien Security Documents necessary or desirable in the reasonable judgment of the Controlling Collateral Agent to confirm and perfect the Liens securing the relevant obligations relating to such Additional Senior Class Debt
shall have been made, executed and/or delivered (or, with respect to any such filings or recordations, acceptable provisions to perform such filings or recordations shall have been taken in the reasonable judgment of the Controlling Collateral
Agent), and all fees and taxes in connection therewith shall have been paid (or acceptable provisions to make such payments have been taken in the reasonable judgment of the Controlling Collateral Agent); and 

(iv) the Additional First-Lien Documents, as applicable, relating to such Additional Senior Class Debt shall provide, in a
manner reasonably satisfactory to each Collateral Agent, 

  
 -17- 

 
that each Additional Senior Class Debt Party with respect to such Additional Senior Class Debt will be subject to and bound by the provisions of this Agreement in its capacity as a holder of such
Additional Senior Class Debt. 
 Each Authorized Representative acknowledges and agrees that upon execution and delivery of a Joinder
Agreement substantially in the form of Annex II by an Additional Senior Class Debt Representative and each Grantor in accordance with this Section 5.13, the Notes Collateral Agent will continue to act in its capacity as Notes Collateral Agent
in respect of the then existing Authorized Representatives (other than the Administrative Agent) and such additional Authorized Representative. 

SECTION 5.14 Agent Capacities. Except as expressly provided herein or in the Credit Agreement Security Documents, JPMorgan Chase Bank,
N.A. is acting in the capacities of Administrative Agent and Credit Agreement Collateral Agent solely for the Credit Agreement Secured Parties. Except as expressly provided herein or in the Additional First-Lien Security Documents,
[                    ] is acting in the capacity of Notes Collateral Agent solely for the Additional First-Lien Secured Parties. Except as expressly
set forth herein, none of the Administrative Agent, the Credit Agreement Collateral Agent or the Notes Collateral Agent shall have any duties or obligations in respect of any of the Collateral, all of such duties and obligations, if any, being
subject to and governed by the applicable Secured Credit Documents. 
 SECTION 5.15 Integration. This Agreement together with the
other Secured Credit Documents and the First-Lien Security Documents represents the agreement of each of the Grantors and the First-Lien Secured Parties with respect to the subject matter hereof and there are no promises, undertakings,
representations or warranties by any Grantor, the Credit Agreement Collateral Agent, or any other First-Lien Secured Party relative to the subject matter hereof not expressly set forth or referred to herein or in the other Secured Credit Documents.

 SECTION 5.16 Additional Grantors. The Borrower agrees that, if any Subsidiary shall become a Grantor after the date hereof, it
will cause such Subsidiary to within 15 Business Days following the end of the Fiscal Quarter in which such Person becomes a Subsidiary become party hereto by executing and delivering an instrument in the form of Annex III. Upon such execution and
delivery, such Subsidiary will become a Grantor hereunder with the same force and effect as if originally named as a Grantor herein. The execution and delivery of such instrument shall not require the consent of any other party hereunder, and will
be acknowledged by the Administrative Agent, the Initial Additional Authorized Representative and each additional Authorized Representative. The rights and obligations of each Grantor hereunder shall remain in full force and effect notwithstanding
the addition of any new Grantor as a party to this Agreement. 
 SECTION 5.17 Administrative Agent and Representative. It is understood and
agreed that (a) the Administrative Agent is entering into this Agreement in its capacity as administrative agent and collateral agent under the Credit Agreement and the provisions of Section 9 of the Credit Agreement applicable to the
Agents (as defined therein) thereunder shall also apply to the Administrative Agent hereunder and (b) [                    ] is entering into
this Agreement in its capacity as [Trustee] under [indenture] and the provisions of Article [                    ] of such indenture applicable
to the Trustee thereunder shall also apply to the Trustee hereunder. 

  
 -18- 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	JPMORGAN CHASE BANK, N.A.,
	as Credit Agreement Collateral Agent
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	 JPMORGAN CHASE BANK, N.A.,

as Authorized Representative for the Credit Agreement Secured Parties

		
	By:	 	  

	Name:	 	
	Title:	 	
	
	
[                    ],

as Notes Collateral Agent and as Initial Additional Authorized Representative

		
	By:	 	  

	Name:	 	
	Title:	 	

  
 S-1 

 
			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	[GRANTORS]
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 S-2 

 ANNEX I 

Grantors 
 Schedule 1 

  
 ANNEX I-1 

 ANNEX II 

[FORM OF] JOINDER NO.
[                    ] dated as of [            ], 201[  ] to the FIRST-LIEN
INTERCREDITOR AGREEMENT dated as of [            ], 201[  ] (the “First-Lien Intercreditor Agreement”), among DAVITA HEALTHCARE PARTNERS INC., a Delaware
corporation (the “Borrower”), and certain subsidiaries and affiliates of the Borrower (each, a “Grantor”), JPMORGAN CHASE BANK, N.A., as Credit Agreement Collateral Agent for the Credit Agreement Secured Parties
under the First-Lien Security Documents (in such capacity, the “Credit Agreement Collateral Agent”), JPMORGAN CHASE BANK, N.A., as Authorized Representative for the Credit Agreement Secured Parties,
[                    ] as Initial Additional Authorized Representative, and the additional Authorized Representatives from time to time a party
thereto.1 
 A. Capitalized terms used herein but not otherwise defined herein shall
have the meanings assigned to such terms in the First-Lien Intercreditor Agreement. 
 B. As a condition to the ability of the Borrower to
incur Additional First-Lien Obligations and to secure such Additional Senior Class Debt with the liens and security interests created by the Additional First-Lien Security Documents relating thereto, the Additional Senior Class Debt Representative
in respect of such Additional Senior Class Debt is required to become an Authorized Representative, and such Additional Senior Class Debt and the Additional Senior Class Debt Parties in respect thereof are required to become subject to and bound by,
the First-Lien Intercreditor Agreement. Section 5.13 of the First-Lien Intercreditor Agreement provides that such Additional Senior Class Debt Representative may become an Authorized Representative, and such Additional Senior Class Debt and
such Additional Senior Class Debt Parties may become subject to and bound by the First-Lien Intercreditor Agreement as Additional First-Lien Obligations and Additional First-Lien Secured Parties, respectively, upon the execution and delivery by the
Senior Debt Class Representative of an instrument in the form of this Joinder Agreement and the satisfaction of the other conditions set forth in Section 5.13 of the First-Lien Intercreditor Agreement. The undersigned Additional Senior Class
Debt Representative (the “New Representative”) is executing this Joinder Agreement in accordance with the requirements of the First-Lien Intercreditor Agreement and the First-Lien Security Documents. 

Accordingly, each Collateral Agent, each Authorized Representative and the New Representative agree as follows: 

SECTION 1. In accordance with Section 5.13 of the First-Lien Intercreditor Agreement, the New Representative by its signature below
becomes an Authorized Representative under, and the related Additional Senior Class Debt and Additional Senior Class Debt Parties become subject to and bound by, the First-Lien Intercreditor Agreement as Additional First-Lien Obligations and
Additional First-Lien Secured Parties, with the same force and effect as if the New Representative had originally been named therein as an Authorized Representative and the New Representative, on its behalf and on behalf of such Additional Senior
Class Debt Parties, hereby agrees to all the terms and provisions of the First-Lien Intercreditor Agreement applicable to it as Authorized Representative and to the Additional Senior Class Debt Parties that it represents as Additional First-Lien
Secured Parties. Each reference to an “Authorized Representative” in the First-Lien Intercreditor Agreement shall be deemed to include the New Representative. The First-Lien Intercreditor Agreement is hereby incorporated herein by
reference. 
  
  

	1 	In the event of the Refinancing of the Credit Agreement Obligations, revise to reflect joinder by a new Credit Agreement Collateral Agent 

  
 ANNEX II-1 

 SECTION 2. The New Representative represents and warrants to each Collateral Agent, each
Authorized Representative and the other First-Lien Secured Parties, individually, that (i) it has full power and authority to enter into this Joinder, in its capacity as [trustee/administrative agent and] collateral agent, (ii) this
Joinder has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency
or similar laws affecting the enforcement of creditors’ rights generally or by equitable principles relating to enforceability and (iii) the Additional First-Lien Documents relating to such Additional Senior Class Debt provide that, upon
the New Representative’s entry into this Agreement, the Additional Senior Class Debt Parties in respect of such Additional Senior Class Debt will be subject to and bound by the provisions of the First-Lien Intercreditor Agreement as Additional
First-Lien Secured Parties. 
 SECTION 3. This Joinder may be executed in counterparts, each of which shall constitute an original, but all
of which when taken together shall constitute a single contract. This Joinder shall become effective when each Collateral Agent shall have received a counterpart of this Joinder that bears the signatures of the New Representative. Delivery of an
executed signature page to this Joinder by facsimile transmission shall be effective as delivery of a manually signed counterpart of this Joinder. 

SECTION 4. Except as expressly supplemented hereby, the First-Lien Intercreditor Agreement shall remain in full force and effect. 

SECTION 5. THIS JOINDER AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN
ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 
 SECTION 6. In case any one or more of the provisions contained in this Joinder
should be held invalid, illegal or unenforceable in any respect, no party hereto shall be required to comply with such provision for so long as such provision is held to be invalid, illegal or unenforceable, but the validity, legality and
enforceability of the remaining provisions contained herein and in the First-Lien Intercreditor Agreement shall not in any way be affected or impaired. The parties hereto shall endeavor in good-faith
negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 

SECTION 7. All communications and notices hereunder shall be in writing and given as provided in Section 5.01 of the First-Lien
Intercreditor Agreement. All communications and notices hereunder to the New Representative shall be given to it at its address set forth below its signature hereto. 

SECTION 8. The Borrower agrees to reimburse each Collateral Agent and each Authorized Representative for its reasonable out-of-pocket expenses
in connection with this Joinder, including the reasonable fees, other charges and disbursements of counsel, in each case as required by the applicable Secured Credit Documents. 

  
 ANNEX II-2 

 IN WITNESS WHEREOF, the New Representative has duly executed this Joinder to the First-Lien
Intercreditor Agreement as of the day and year first above written. 
  

			
	[NAME OF NEW REPRESENTATIVE], as
	[        ] and as collateral agent for the holders of
[                    ],
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	Address for notices:
	
	  

	  

	attention of:
                                         
                        
	Telecopy:
                                         
                            

  
 ANNEX II-3 

			
	Acknowledged by:
	
	 JPMORGAN CHASE BANK, N.A.,
 as the
Credit Agreement Collateral Agent and Authorized Representative,

		
	By:	 	  

	Name:	 	
	Title:	 	
	
	 [                    ],

as the Initial Additional Authorized Representative [and the Notes Collateral Agent],

		
	By:	 	  

	Name:	 	
	Title:	 	
	
	[OTHER AUTHORIZED REPRESENTATIVES]
	
	 DAVITA HEALTHCARE PARTNERS INC.,
 as
Borrower

		
	By:	 	  

	Name:	 	
	Title:	 	
	
	THE OTHER GRANTORS
	LISTED ON SCHEDULE I HERETO,
		
	By:	 	  

	Name:	 	
	Title:	 	

  
 ANNEX II-4 

 Schedule I to the 

Supplement to the 
 First-Lien
Intercreditor Agreement 
 Grantors 

[                    ] 

  
 Schedule I-1 

 SUPPLEMENT NO. [    ] dated as of
[            ], 201[    ], to the FIRST LIEN INTERCREDITOR AGREEMENT dated as of [            ],
201[    ] (the “First Lien Intercreditor Agreement”), among DAVITA HEALTHCARE PARTNERS INC., a Delaware corporation (the “Borrower”), certain subsidiaries and affiliates of the Borrower (each a
“Grantor”), JPMorgan Chase Bank, N.A., as Administrative Agent under the Credit Agreement, [            ], as Initial Additional Authorized Representative, and the
additional Authorized Representatives from time to time party thereto. 
 A. Capitalized terms used herein and not otherwise defined herein
shall have the meanings assigned to such terms in the First Lien Intercreditor Agreement. 
 B. The Grantors have entered into the First
Lien Intercreditor Agreement. Pursuant to the Credit Agreement and certain Additional First-Lien Documents, certain newly acquired or organized Subsidiaries of the Borrower are required to enter into the First Lien Intercreditor Agreement.
Section 5.16 of the First Lien Intercreditor Agreement provides that such Subsidiaries may become party to the First Lien Intercreditor Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned
Subsidiary (the “New Grantor”) is executing this Supplement in accordance with the requirements of the Credit Agreement and the Additional First-Lien Documents. 

Accordingly, each Authorized Representative and the New Subsidiary Grantor agree as follows: 

SECTION 1. In accordance with Section 5.16 of the First Lien Intercreditor Agreement, the New Grantor by its signature below becomes a
Grantor under the First Lien Intercreditor Agreement with the same force and effect as if originally named therein as a Grantor, and the New Grantor hereby agrees to all the terms and provisions of the First Lien Intercreditor Agreement applicable
to it as a Grantor thereunder. Each reference to a “Grantor” in the First Lien Intercreditor Agreement shall be deemed to include the New Grantor. The First Lien Intercreditor Agreement is hereby incorporated herein by reference. 

SECTION 2. The New Grantor represents and warrants to each Authorized Representative and the other Secured Parties that this Supplement has
been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as such enforceability may be limited by Bankruptcy Law and by general principles
of equity. 
 SECTION 3. This Supplement may be executed in counterparts, each of which shall constitute an original, but all of which when
taken together shall constitute a single contract. This Supplement shall become effective when each Authorized Representative shall have received a counterpart of this Supplement that bears the signature of the New Grantor. Delivery of an executed
signature page to this Supplement by facsimile transmission or other electronic method shall be as effective as delivery of a manually signed counterpart of this Supplement. 

SECTION 4. Except as expressly supplemented hereby, the First Lien Intercreditor Agreement shall remain in full force and effect. 

  
 Q-1 

 SECTION 5. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF
THE STATE OF NEW YORK. 
 SECTION 6. In case any one or more of the provisions contained in this Supplement should be held invalid,
illegal or unenforceable in any respect, no party hereto shall be required to comply with such provision for so long as such provision is held to be invalid, illegal or unenforceable, but the validity, legality and enforceability of the remaining
provisions contained herein and in the First Lien Intercreditor Agreement shall not in any way be affected or impaired. The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with
valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 

SECTION 7. All communications and notices hereunder shall be in writing and given as provided in Section 5.01 of the First Lien
Intercreditor Agreement. All communications and notices hereunder to the New Grantor shall be given to it in care of the Borrower as specified in the First Lien Intercreditor Agreement. 

SECTION 8. The Borrower agrees to reimburse each Authorized Representative for its reasonable out-of-pocket expenses in connection with this
Supplement, including the reasonable fees, other charges and disbursements of counsel for each Authorized Representative as required by the applicable Secured Credit Documents. 

  
 Q-2 

 IN WITNESS WHEREOF, the New Grantor, and each Authorized Representative have duly executed this
Supplement to the First Lien Intercreditor Agreement as of the day and year first above written. 
  

			
	[NAME OF NEW SUBSIDIARY GRANTOR]
		
	By:	 	  

	Name:	 	
	Title:	 	

 Acknowledged by: 

JPMORGAN CHASE BANK, N.A., 
 as the Credit Agreement Collateral
Agent and Authorized Representative, 
  

			
	By:	 	  

	Name:	 	
	Title:	 	

[                    ], 

as the Initial Additional Authorized Representative [and the Notes Collateral Agent and], 

 

			
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	[OTHER AUTHORIZED REPRESENTATIVES]

  
 Q-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]